data_2gow_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gow _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.4 t . . . . . 0 N--CA 1.428 -1.559 0 N-CA-C 108.319 -0.993 . . . . 65.140000000000001 108.319 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -72.52 156.13 54.34 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.077 1.851 . . . . 73.5 111.012 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.57 7.2 1.14 Allowed 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.671 0.989 . . . . 44.130000000000003 113.671 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -109.24 -6.06 15.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.644 -0.502 . . . . 74.209999999999994 109.644 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.4 mmm -130.19 154.51 47.47 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.237 0.541 . . . . 71.239999999999995 110.543 -172.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.408 ' CD1' ' HG ' ' A' ' 73' ' ' LEU . 2.7 pp -115.92 131.12 69.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.946 -0.57 . . . . 75.319999999999993 110.072 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -84.57 114.5 22.02 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.039 -1.467 . . . . 71.239999999999995 107.039 -177.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.444 ' HG ' HD23 ' A' ' 14' ' ' LEU . 41.7 tp -121.32 133.17 55.11 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.946 0.721 . . . . 64.519999999999996 112.946 -172.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -108.57 121.39 44.9 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 115.14 -0.937 . . . . 73.430000000000007 108.737 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.51 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.2 mm? -99.37 120.27 39.31 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.885 -1.052 . . . . 72.439999999999998 108.612 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.404 HG21 HG21 ' A' ' 21' ' ' THR . 32.1 mt -107.33 122.88 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 108.451 -0.944 . . . . 75.109999999999999 108.451 177.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.59 160.48 18.17 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 116.384 -0.371 . . . . 63.409999999999997 110.346 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.7 t -58.66 -26.15 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.643 0.777 . . . . 74.430000000000007 111.569 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -76.43 -6.09 50.2 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.768 -0.651 . . . . 64.329999999999998 111.214 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.08 6.74 66.51 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.502 -0.856 . . . . 65.340000000000003 112.032 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -87.61 131.41 34.43 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.045 -0.724 . . . . 75.439999999999998 109.045 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.404 HG21 HG21 ' A' ' 15' ' ' ILE . 68.5 p -111.44 129.77 55.92 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 120.364 -0.534 . . . . 71.030000000000001 110.276 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.64 139.77 53.57 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.482 -1.303 . . . . 72.450000000000003 107.482 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -133.58 130.61 38.64 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.927 -1.109 . . . . 71.209999999999994 109.285 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.656 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.6 m-85 -145.17 160.35 41.58 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 123.526 0.73 . . . . 63.539999999999999 109.299 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.1 tp -84.09 125.7 32.37 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.689 -1.226 . . . . 64.120000000000005 107.689 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.656 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 82.4 m-85 -127.81 168.47 15.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.05 0.453 . . . . 75.230000000000004 111.022 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.469 ' HB2' ' OD2' ' A' ' 30' ' ' ASP . 20.4 m -92.87 140.53 23.59 Favored Pre-proline 0 N--CA 1.424 -1.774 0 N-CA-C 108.366 -0.976 . . . . 70.510000000000005 108.366 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -60.01 -18.79 52.42 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.632 2.221 . . . . 61.340000000000003 113.267 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -81.35 -11.76 59.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.208 -0.451 . . . . 60.219999999999999 111.197 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.469 ' OD2' ' HB2' ' A' ' 27' ' ' SER . 22.0 m-20 -78.99 153.76 30.06 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.836 -0.54 . . . . 74.230000000000004 111.751 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.471 ' O ' HG13 ' A' ' 35' ' ' ILE . 25.8 p -95.35 131.31 41.6 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.111 0.481 . . . . 74.219999999999999 111.521 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.462 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -51.93 -41.83 62.33 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 124.262 1.025 . . . . 62.200000000000003 113.706 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.7 p -74.86 -30.95 61.49 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.471 0.545 . . . . 74.109999999999999 112.471 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -69.08 -42.48 76.13 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 107.402 -1.333 . . . . 74.319999999999993 107.402 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.507 HG21 ' CZ ' ' A' ' 26' ' ' PHE . 67.0 mt -60.97 -43.61 96.36 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.216 0 CA-C-N 114.175 -1.375 . . . . 53.409999999999997 110.745 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.72 -42.6 57.36 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.086 0.555 . . . . 74.439999999999998 111.874 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.599 ' HE2' ' O ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -72.14 -39.77 68.55 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.078 -1.452 . . . . 71.019999999999996 107.078 -178.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -61.87 -45.74 92.46 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.612 -0.722 . . . . 74.120000000000005 110.97 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.51 HG21 ' CB ' ' A' ' 14' ' ' LEU . 26.8 m -71.61 -31.99 44.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 112.693 0.627 . . . . 73.150000000000006 112.693 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 . . . . . 0 N--CA 1.482 1.132 0 O-C-N 123.127 0.267 . . . . 71.140000000000001 111.471 173.13 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 CA--C 1.502 -0.902 0 N-CA-C 108.715 -0.846 . . . . 72.0 108.715 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.459 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 83.0 mtp180 -138.26 162.3 34.67 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.174 0.511 . . . . 74.209999999999994 109.892 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 4.5 pp -123.12 135.54 54.41 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 115.603 -0.726 . . . . 71.099999999999994 110.727 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 85.7 mt -110.45 123.32 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 N-CA-C 108.48 -0.933 . . . . 70.510000000000005 108.48 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -100.91 50.27 0.87 Allowed 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 106.649 -1.612 . . . . 74.340000000000003 106.649 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 60.69 93.5 0.04 OUTLIER 'General case' 0 N--CA 1.394 -3.243 0 C-N-CA 127.6 2.36 . . . . 72.209999999999994 112.168 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.99 -29.42 10.01 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.236 -0.893 . . . . 72.230000000000004 112.848 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -130.51 137.76 49.9 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.972 0.731 . . . . 74.310000000000002 112.972 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 47.8 m-85 -88.6 113.67 24.42 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 106.293 -1.743 . . . . 74.230000000000004 106.293 175.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.539 HD12 ' CD2' ' A' ' 76' ' ' LEU 0.258 29.1 mt -79.16 -43.54 23.74 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 117.936 -1.506 . . . . 73.120000000000005 112.471 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.661 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.6 t-80 -173.82 -175.62 1.1 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.552 -1.277 . . . . 71.329999999999998 107.552 176.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -85.03 -14.16 70.07 Favored Glycine 0 C--N 1.302 -1.347 0 N-CA-C 115.743 1.057 . . . . 43.020000000000003 115.743 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -167.64 28.08 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 118.192 0.996 . . . . 64.5 109.846 -172.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.412 HG22 ' HB1' ' A' ' 75' ' ' ALA . 11.9 p -74.67 147.63 8.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.265 -0.643 . . . . 73.549999999999997 109.265 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.556 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 45.7 p -78.77 158.4 28.25 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 112.419 0.526 . . . . 72.239999999999995 112.419 -173.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.479 ' O ' HD11 ' A' ' 78' ' ' LEU . 3.6 mm? -60.02 -41.38 92.04 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.413 0.685 . . . . 73.140000000000001 111.862 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.57 -37.99 94.24 Favored Glycine 0 C--N 1.317 -0.521 0 N-CA-C 111.36 -0.696 . . . . 54.130000000000003 111.36 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.412 ' HB1' HG22 ' A' ' 71' ' ' VAL . . . -74.88 -16.04 60.69 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 122.798 0.439 . . . . 53.32 111.547 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 72' ' ' THR . 62.7 mt -83.77 -4.7 58.85 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.252 -0.647 . . . . 63.009999999999998 109.252 177.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.6 mptt 71.28 79.55 0.16 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.69 1.196 . . . . 74.299999999999997 111.297 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.479 HD11 ' O ' ' A' ' 73' ' ' LEU . 10.8 mp -123.47 117.11 27.94 Favored Pre-proline 0 CA--C 1.494 -1.192 0 CA-C-N 115.526 -0.761 . . . . 75.099999999999994 111.474 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.502 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 11.0 Cg_exo -64.11 122.85 10.98 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 121.728 1.618 . . . . 75.329999999999998 109.197 171.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.407 ' HA ' HG21 ' A' ' 10' ' ' ILE . 1.1 p90 -69.77 144.44 52.69 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.338 0.589 . . . . 74.140000000000001 112.171 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.38 9.05 60.71 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.087 -0.96 . . . . 65.420000000000002 113.157 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -132.01 163.87 27.45 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 117.863 0.831 . . . . 75.340000000000003 110.622 176.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 25.7 m -91.66 129.37 37.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.407 0.622 . . . . 54.049999999999997 111.361 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.6 m -122.23 133.37 54.71 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.834 -0.621 . . . . 74.409999999999997 110.292 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.2 p -104.57 139.34 25.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 109.887 -0.412 . . . . 71.329999999999998 109.887 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 85.7 mtp -138.25 153.49 49.08 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-O 121.009 0.433 . . . . 54.329999999999998 111.079 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.439 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 59.1 m-70 -111.26 126.84 55.31 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.609 -1.256 . . . . 61.32 107.609 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.456 ' N ' HD22 ' A' ' 88' ' ' LEU . 2.4 mm? -113.47 142.2 46.2 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 122.156 -0.34 . . . . 44.43 110.201 -176.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.84 134.01 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 121.223 0.535 . . . . 74.049999999999997 111.009 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 107.983 -1.118 . . . . 73.310000000000002 107.983 176.515 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.3 t . . . . . 0 N--CA 1.43 -1.438 0 N-CA-C 108.631 -0.877 . . . . 53.130000000000003 108.631 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -63.52 166.42 15.44 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.22 1.947 . . . . 71.409999999999997 112.197 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.46 11.74 20.74 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.607 -0.724 . . . . 71.319999999999993 109.491 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -121.72 -3.67 9.24 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.174 -0.921 . . . . 73.530000000000001 108.582 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.7 mmm -126.93 152.32 47.29 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.925 -0.768 . . . . 74.439999999999998 108.925 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -111.88 139.37 36.65 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 N-CA-C 109.275 -0.639 . . . . 72.129999999999995 109.275 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -88.17 116.28 26.26 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.923 -1.14 . . . . 55.149999999999999 107.923 -176.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.42 ' HG ' ' CD2' ' A' ' 14' ' ' LEU . 45.7 tp -127.36 132.99 50.1 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 121.156 0.503 . . . . 74.049999999999997 112.185 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -109.6 120.65 43.14 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 108.561 -0.903 . . . . 74.209999999999994 108.561 174.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.533 ' CB ' HG22 ' A' ' 39' ' ' VAL . 1.8 mm? -100.23 120.71 40.32 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 114.591 -1.186 . . . . 75.409999999999997 108.677 -178.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.2 mt -104.36 123.01 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 108.811 -0.811 . . . . 74.310000000000002 108.811 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.39 165.0 20.66 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.632 -0.713 . . . . 74.329999999999998 110.745 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.6 t -65.18 -21.07 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-O 121.887 0.851 . . . . 43.420000000000002 109.399 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.6 m -76.03 -4.45 41.35 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.45 1.1 . . . . 72.439999999999998 111.418 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.26 6.93 88.97 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.805 -0.918 . . . . 51.229999999999997 110.805 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -87.89 131.14 34.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.283 -1.006 . . . . 64.239999999999995 108.283 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.5 p -111.31 129.32 56.03 Favored 'General case' 0 N--CA 1.417 -2.096 0 C-N-CA 120.269 -0.572 . . . . 73.409999999999997 109.562 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 39' ' ' VAL . 95.8 mttt -131.66 139.31 49.05 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.282 -1.007 . . . . 73.109999999999999 108.282 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -130.43 131.1 45.06 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.774 -0.77 . . . . 62.100000000000001 109.617 -175.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.659 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.2 m-85 -144.9 159.7 42.48 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 122.795 0.438 . . . . 62.340000000000003 109.83 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.45 126.47 32.26 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.624 -1.25 . . . . 63.409999999999997 107.624 174.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.659 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 90.1 m-85 -127.36 163.47 23.92 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.572 -0.529 . . . . 74.239999999999995 109.572 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.7 p -85.33 147.35 46.96 Favored Pre-proline 0 N--CA 1.41 -2.439 0 N-CA-C 107.741 -1.207 . . . . 73.329999999999998 107.741 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.489 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 55.6 Cg_endo -62.31 -11.36 22.16 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.803 2.335 . . . . 72.510000000000005 111.712 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -86.6 -15.87 38.48 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.29 -0.868 . . . . 71.219999999999999 111.242 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -71.76 153.74 41.78 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.15 0.5 . . . . 75.549999999999997 111.245 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.438 ' O ' HG13 ' A' ' 35' ' ' ILE . 19.4 m -96.52 129.46 43.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.006 -1.109 . . . . 71.299999999999997 108.006 177.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -51.03 -38.27 50.37 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.637 0.977 . . . . 74.019999999999996 113.637 -176.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 p -77.62 -29.05 51.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.132 0.492 . . . . 53.219999999999999 111.93 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.99 -41.58 82.08 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.907 -1.516 . . . . 63.32 106.907 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.489 HG23 ' CZ ' ' A' ' 26' ' ' PHE . 70.5 mt -64.13 -42.63 96.17 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.472 0 CA-C-N 113.715 -1.584 . . . . 74.530000000000001 110.43 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.01 -40.15 43.71 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 123.173 0.589 . . . . 74.409999999999997 111.842 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.83 -31.17 64.6 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.441 0.638 . . . . 74.549999999999997 110.323 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -74.13 -47.9 32.98 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.207 -0.906 . . . . 70.200000000000003 110.009 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.533 HG22 ' CB ' ' A' ' 14' ' ' LEU . 27.4 m -71.37 -32.1 45.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.923 -0.485 . . . . 72.239999999999995 111.9 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 63.7 t80 . . . . . 0 C--O 1.246 0.888 0 N-CA-C 108.508 -0.923 . . . . 73.219999999999999 108.508 177.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 N--CA 1.445 -0.722 0 N-CA-C 109.506 -0.553 . . . . 72.200000000000003 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -140.29 142.73 35.67 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.828 -0.804 . . . . 72.239999999999995 108.828 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 4.5 pp -126.05 138.9 53.75 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.052 0.453 . . . . 72.420000000000002 111.451 -176.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.422 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 90.1 mt -108.96 119.91 59.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 108.456 -0.942 . . . . 55.32 108.456 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -101.3 75.59 1.64 Allowed 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.353 -1.351 . . . . 75.219999999999999 107.353 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 36.78 85.68 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.77 0 C-N-CA 127.587 2.355 . . . . 53.039999999999999 113.23 -176.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.87 -57.29 0.62 Allowed Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 115.447 -0.797 . . . . 75.109999999999999 113.156 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -130.07 159.66 36.09 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 112.627 0.603 . . . . 72.299999999999997 112.627 -176.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 33.1 m-85 -89.35 112.82 24.01 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.926 -1.138 . . . . 74.420000000000002 107.926 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.44 HD13 HD23 ' A' ' 76' ' ' LEU . 83.5 mt -80.2 -47.19 15.06 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 113.547 0.943 . . . . 65.140000000000001 113.547 -175.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.636 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.4 t-80 -165.33 174.74 9.8 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 106.614 -1.624 . . . . 74.329999999999998 106.614 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.11 -1.88 88.37 Favored Glycine 0 C--N 1.307 -1.067 0 C-N-CA 120.261 -0.971 . . . . 37.640000000000001 114.396 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -175.72 28.16 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 117.822 0.811 . . . . 73.349999999999994 112.221 -173.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.426 ' H ' HD23 ' A' ' 60' ' ' LEU . 13.0 p -70.24 142.68 15.51 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 C-N-CA 120.46 -0.496 . . . . 73.239999999999995 109.808 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.448 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 31.8 p -78.54 157.67 28.75 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.852 -0.613 . . . . 74.319999999999993 111.836 -175.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.481 HD22 ' H ' ' A' ' 73' ' ' LEU . 1.8 mm? -66.25 -32.87 74.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.406 -0.361 . . . . 65.409999999999997 110.784 -177.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.04 -36.38 92.82 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 111.178 -0.769 . . . . 75.219999999999999 111.178 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.97 -15.27 61.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.12 0.568 . . . . 73.540000000000006 110.893 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 72' ' ' THR . 73.4 mt -82.79 14.87 2.94 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.675 0.39 . . . . 72.140000000000001 111.226 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.6 24.1 10.21 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.759 0.824 . . . . 75.209999999999994 110.619 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 96.2 mt -91.8 125.14 58.32 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 112.511 0.56 . . . . 73.0 112.511 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 3.5 Cg_endo -86.35 170.3 8.08 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.846 2.364 . . . . 73.109999999999999 110.484 172.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.489 ' CE2' ' HG3' ' A' ' 28' ' ' PRO . 75.2 m-85 -78.7 151.35 32.21 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.781 -0.451 . . . . 75.409999999999997 109.781 -178.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.93 0.96 90.59 Favored Glycine 0 C--N 1.308 -1.022 0 C-N-CA 120.668 -0.777 . . . . 73.230000000000004 114.232 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -102.37 136.45 42.18 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 117.509 0.655 . . . . 65.310000000000002 110.021 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.505 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 54.6 m -87.19 116.78 25.49 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.006 -0.739 . . . . 71.349999999999994 109.006 176.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.3 m -115.81 142.43 46.77 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.55 -0.75 . . . . 65.219999999999999 110.471 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -111.45 135.59 50.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 120.793 0.33 . . . . 73.319999999999993 110.354 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 87.0 mtp -138.35 153.24 48.97 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 120.862 0.363 . . . . 63.409999999999997 110.276 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.437 ' C ' HD22 ' A' ' 88' ' ' LEU . 21.5 m-70 -111.59 132.7 54.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.989 -1.115 . . . . 74.299999999999997 107.989 178.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.475 ' N ' HD22 ' A' ' 88' ' ' LEU . 2.5 mm? -119.47 144.53 46.93 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 120.614 -0.434 . . . . 65.349999999999994 111.113 -176.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.7 m -120.52 134.94 62.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.8 -0.636 . . . . 74.040000000000006 109.43 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.496 0 CA-C-N 115.878 -0.601 . . . . 73.140000000000001 109.788 -176.967 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.8 t . . . . . 0 N--CA 1.432 -1.341 0 N-CA-C 108.676 -0.861 . . . . 72.230000000000004 108.676 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -72.01 143.24 40.14 Favored 'Trans proline' 0 C--O 1.251 1.159 0 C-N-CA 121.889 1.726 . . . . 73.010000000000005 110.421 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.81 72.14 4.33 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 121.996 0.903 . . . . 70.209999999999994 109.821 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -169.11 -28.18 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 113.612 -1.631 . . . . 75.310000000000002 107.727 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 92.9 mmm -117.52 145.73 44.03 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.819 -1.082 . . . . 71.219999999999999 109.128 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.414 ' CD1' ' HG ' ' A' ' 73' ' ' LEU . 2.8 pp -99.31 136.06 32.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 109.208 -0.664 . . . . 73.439999999999998 109.208 175.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.451 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 5.4 t30 -91.93 107.69 19.39 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.7 -1.222 . . . . 63.310000000000002 107.7 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.424 ' HG ' HD22 ' A' ' 14' ' ' LEU . 43.5 tp -112.77 132.77 55.09 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 116.055 -0.52 . . . . 62.229999999999997 111.723 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -106.82 121.51 44.55 Favored 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 108.291 -1.003 . . . . 73.439999999999998 108.291 173.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.539 ' CB ' HG22 ' A' ' 39' ' ' VAL . 1.7 mm? -98.74 128.61 45.04 Favored 'General case' 0 C--N 1.268 -2.947 0 CA-C-N 114.258 -1.337 . . . . 65.430000000000007 109.353 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.411 HG23 HG21 ' A' ' 21' ' ' THR . 14.8 mm -107.47 119.33 56.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 107.744 -1.206 . . . . 73.25 107.744 175.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.7 tp -84.09 153.05 23.99 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 110.058 -0.349 . . . . 72.5 110.058 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.468 ' CG1' ' HA ' ' A' ' 89' ' ' VAL . 30.7 m -60.0 -13.36 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.829 0.851 . . . . 63.109999999999999 113.059 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.3 t -89.53 -2.78 58.46 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.275 -0.639 . . . . 64.319999999999993 109.275 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.21 7.93 79.19 Favored Glycine 0 C--N 1.337 0.583 0 CA-C-N 115.922 -0.581 . . . . 37.850000000000001 112.597 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -87.78 131.05 34.65 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.345 -0.983 . . . . 73.239999999999995 108.345 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.411 HG21 HG23 ' A' ' 15' ' ' ILE . 63.1 p -107.46 143.65 35.52 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.538 -0.912 . . . . 72.120000000000005 108.538 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.444 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 48.5 tptt -145.08 147.23 32.33 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.595 -0.842 . . . . 75.540000000000006 109.155 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -137.06 131.09 32.27 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 119.713 -0.795 . . . . 65.530000000000001 110.201 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.716 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 84.6 m-85 -145.14 160.97 40.6 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 123.888 0.875 . . . . 73.209999999999994 110.387 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.7 126.02 30.4 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.634 -1.247 . . . . 72.340000000000003 107.634 171.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.716 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 83.6 m-85 -130.68 164.45 25.0 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.37 -0.974 . . . . 74.319999999999993 108.37 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.5 p -90.1 150.3 43.13 Favored Pre-proline 0 N--CA 1.42 -1.947 0 N-CA-C 107.747 -1.205 . . . . 61.439999999999998 107.747 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.11 -14.75 30.19 Favored 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 122.044 1.829 . . . . 71.530000000000001 112.077 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -87.15 -9.68 54.64 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.892 -0.595 . . . . 62.219999999999999 110.545 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -76.02 154.01 36.06 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.81 -0.556 . . . . 71.530000000000001 111.193 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.535 ' O ' HG13 ' A' ' 35' ' ' ILE . 41.0 m -96.52 121.59 38.5 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 109.649 -0.5 . . . . 71.430000000000007 109.649 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.473 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -49.2 -52.5 26.38 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.115 1.524 . . . . 71.239999999999995 115.115 -173.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.4 m -79.46 -20.01 48.43 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 121.823 -0.548 . . . . 70.430000000000007 111.465 -175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.87 -41.46 78.34 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.14 -1.8 . . . . 75.219999999999999 106.14 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 31' ' ' SER . 73.3 mt -62.79 -34.68 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 114.034 -1.439 . . . . 75.230000000000004 110.749 175.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.94 -32.9 48.26 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 122.442 0.297 . . . . 55.509999999999998 111.577 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.564 ' HE2' ' O ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -72.91 -38.13 66.99 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 107.154 -1.425 . . . . 73.430000000000007 107.154 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 43.0 t-80 -62.95 -54.02 44.99 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.897 0.879 . . . . 75.129999999999995 110.747 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.539 HG22 ' CB ' ' A' ' 14' ' ' LEU . 26.8 m -68.22 -29.98 46.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.023 -0.989 . . . . 75.239999999999995 112.411 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 64.3 t80 . . . . . 0 N--CA 1.469 0.481 0 C-N-CA 124.278 1.031 . . . . 74.109999999999999 111.09 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.55 HD11 ' O ' ' A' ' 58' ' ' LEU 0.257 3.5 pp . . . . . 0 N--CA 1.429 -1.504 0 CA-C-O 121.973 0.892 . . . . 71.329999999999998 111.995 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 97.4 mtt180 -142.61 163.15 33.61 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.53 -1.213 . . . . 72.040000000000006 109.899 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 4.1 pp -129.16 142.39 50.89 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.178 0.807 . . . . 73.349999999999994 113.178 -173.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.7 mt -117.56 124.41 73.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 114.907 -1.042 . . . . 52.030000000000001 108.359 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.436 ' CD2' HD12 ' A' ' 67' ' ' LEU . 1.8 t80 -101.32 60.87 0.92 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 122.038 0.923 . . . . 74.319999999999993 109.629 -176.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 63.91 17.39 10.52 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 113.902 -1.499 . . . . 73.219999999999999 112.488 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.39 -65.96 0.01 OUTLIER Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 120.734 -0.746 . . . . 72.140000000000001 112.031 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -130.49 176.03 8.49 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.822 0.344 . . . . 72.200000000000003 110.583 -177.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.593 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 85.8 m-85 -86.84 120.96 28.68 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.465 -1.309 . . . . 74.209999999999994 107.465 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.514 ' CD1' HD21 ' A' ' 76' ' ' LEU . 76.5 mt -80.1 -47.07 15.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.747 0.784 . . . . 71.400000000000006 109.915 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -163.11 -173.46 3.43 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 125.602 1.561 . . . . 74.430000000000007 107.771 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -84.34 -37.3 11.11 Favored Glycine 0 N--CA 1.416 -2.688 0 C-N-CA 120.499 -0.858 . . . . 53.32 113.72 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -160.22 39.12 0.18 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.312 1.053 . . . . 72.209999999999994 108.961 -172.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.442 HG13 HD21 ' A' ' 60' ' ' LEU . 7.6 p -66.2 147.42 12.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-N 114.593 -1.185 . . . . 74.140000000000001 110.023 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.55 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 42.4 p -78.55 156.91 28.96 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 116.21 -0.45 . . . . 70.430000000000007 111.408 -175.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.421 ' H ' HD23 ' A' ' 73' ' ' LEU . 2.5 mm? -66.34 -30.76 71.23 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.517 0.562 . . . . 63.009999999999998 112.517 -176.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.48 -30.37 76.41 Favored Glycine 0 C--O 1.229 -0.167 0 N-CA-C 111.192 -0.763 . . . . 63.299999999999997 111.192 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.31 -15.51 60.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.371 0.605 . . . . 73.120000000000005 109.961 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 72' ' ' THR . 61.2 mt -92.84 11.95 25.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.425 -0.807 . . . . 72.519999999999996 111.834 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.531 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.6 mptt 67.74 19.27 9.7 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.539 0.736 . . . . 71.019999999999996 110.975 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 79.4 mt -83.66 122.14 76.51 Favored Pre-proline 0 N--CA 1.441 -0.918 0 CA-C-N 116.03 -0.532 . . . . 63.350000000000001 110.895 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.438 ' HG2' ' HG3' ' A' ' 82' ' ' LYS . 6.6 Cg_endo -83.71 140.21 9.15 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 122.227 1.951 . . . . 74.200000000000003 111.708 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -70.44 141.97 52.04 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 112.596 0.591 . . . . 75.400000000000006 112.596 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.85 -1.17 70.73 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.759 -1.109 . . . . 74.329999999999998 111.599 -174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.438 ' HG3' ' HG2' ' A' ' 79' ' ' PRO . 31.7 mmmt -108.36 158.04 17.85 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.82 0.343 . . . . 73.0 110.41 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 86.5 m -103.69 125.22 50.03 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.666 -0.697 . . . . 73.219999999999999 110.077 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.0 m -133.64 142.76 48.22 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.127 -0.488 . . . . 74.319999999999993 110.402 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.4 132.62 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 121.066 0.46 . . . . 54.130000000000003 110.688 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 90.4 mtp -136.17 153.43 51.26 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.153 0.502 . . . . 74.310000000000002 111.395 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -103.05 132.88 48.99 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.648 -0.705 . . . . 75.299999999999997 109.413 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.427 ' N ' HD22 ' A' ' 88' ' ' LEU . 2.4 mm? -120.04 142.38 48.89 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.125 -0.694 . . . . 74.439999999999998 109.125 -176.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.468 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 35.2 m -116.78 133.76 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 C-N-CA 119.932 -0.707 . . . . 73.430000000000007 110.994 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.547 0 N-CA-C 105.909 -1.885 . . . . 53.049999999999997 105.909 175.524 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.475 ' CG2' ' HB2' ' A' ' 11' ' ' ASN . 10.8 t . . . . . 0 N--CA 1.426 -1.664 0 N-CA-C 109.077 -0.712 . . . . 43.520000000000003 109.077 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -69.81 152.02 68.95 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.025 1.817 . . . . 75.519999999999996 110.646 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.47 72.23 4.98 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-O 122.462 1.125 . . . . 74.340000000000003 109.162 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -170.65 -28.41 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 112.784 -2.007 . . . . 71.340000000000003 107.566 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.6 mmm -113.87 160.67 18.5 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.05 -0.977 . . . . 64.150000000000006 108.734 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -121.79 139.58 48.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.189 -0.671 . . . . 65.129999999999995 109.189 173.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -94.02 110.78 22.45 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.785 -1.191 . . . . 64.420000000000002 107.785 -177.166 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.2 tp -115.9 132.91 56.51 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.826 -0.625 . . . . 75.25 112.069 -174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -111.36 121.27 44.79 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 114.994 -1.003 . . . . 61.329999999999998 109.018 173.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.58 ' CB ' HG22 ' A' ' 39' ' ' VAL . 1.9 mm? -98.6 121.4 40.5 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.825 -1.08 . . . . 75.0 108.316 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.1 mt -102.95 127.15 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 C-N-CA 119.586 -0.846 . . . . 74.099999999999994 109.642 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -83.8 155.51 22.97 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.44 -0.8 . . . . 72.349999999999994 110.24 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.3 m -64.12 -19.11 24.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 122.893 0.477 . . . . 70.420000000000002 111.898 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.2 m -80.95 1.93 28.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.21 0.529 . . . . 74.349999999999994 110.424 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.08 12.75 82.11 Favored Glycine 0 CA--C 1.501 -0.803 0 N-CA-C 111.804 -0.518 . . . . 73.420000000000002 111.804 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -88.63 135.77 33.33 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.035 -1.469 . . . . 74.299999999999997 107.035 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.6 p -112.67 129.28 56.45 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 119.801 -0.76 . . . . 73.519999999999996 109.88 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -122.93 137.53 54.92 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.939 -1.134 . . . . 74.430000000000007 107.939 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -138.13 131.65 30.79 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.755 -0.778 . . . . 70.120000000000005 110.08 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.645 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 89.3 m-85 -145.5 160.14 42.05 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 123.933 0.893 . . . . 73.219999999999999 109.011 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.1 mt -79.57 125.5 29.68 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 107.065 -1.457 . . . . 65.409999999999997 107.065 170.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.645 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 87.8 m-85 -123.8 163.16 21.76 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.927 -1.138 . . . . 63.310000000000002 107.927 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 84.7 p -87.62 148.47 44.07 Favored Pre-proline 0 C--N 1.288 -2.095 0 N-CA-C 108.226 -1.027 . . . . 73.209999999999994 108.226 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.98 -14.87 35.42 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.252 1.968 . . . . 44.299999999999997 111.355 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -82.9 -17.8 42.46 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.066 -0.97 . . . . 73.140000000000001 110.281 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.418 ' O ' HD23 ' A' ' 73' ' ' LEU . 18.1 m-20 -67.95 154.61 41.23 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.009 0.433 . . . . 63.109999999999999 110.666 176.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.548 ' O ' HG13 ' A' ' 35' ' ' ILE . 51.1 m -105.13 129.53 53.51 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 116.039 -0.528 . . . . 74.209999999999994 110.536 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.494 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -49.86 -50.22 46.4 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.007 1.484 . . . . 75.120000000000005 115.007 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m -76.14 -27.15 56.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.284 0.493 . . . . 73.129999999999995 110.676 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.89 -45.55 91.98 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.239 -1.393 . . . . 60.409999999999997 107.239 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.549 ' O ' HG21 ' A' ' 39' ' ' VAL . 66.1 mt -65.18 -42.49 94.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 114.348 -1.296 . . . . 74.219999999999999 110.657 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.422 ' O ' ' HD1' ' A' ' 40' ' ' TYR . . . -50.07 -50.08 49.24 Favored 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 122.856 0.462 . . . . 75.349999999999994 111.154 175.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -64.4 -38.44 91.03 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 108.142 -1.058 . . . . 73.040000000000006 108.142 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.488 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 35.3 t-80 -61.21 -54.26 46.45 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 114.844 -1.071 . . . . 72.340000000000003 110.706 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.58 HG22 ' CB ' ' A' ' 14' ' ' LEU . 27.1 m -69.97 -32.17 50.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 115.756 -0.656 . . . . 72.519999999999996 112.264 -178.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.422 ' HD1' ' O ' ' A' ' 36' ' ' ALA . 11.7 m-85 . . . . . 0 C--O 1.235 0.33 0 N-CA-C 112.764 0.653 . . . . 74.150000000000006 112.764 174.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 CA--C 1.5 -0.962 0 N-CA-C 109.195 -0.668 . . . . 37.759999999999998 109.195 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -140.77 155.06 46.5 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.081 -0.711 . . . . 75.340000000000003 109.081 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.622 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 4.3 pp -135.39 144.47 46.59 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.395 -0.821 . . . . 75.439999999999998 110.189 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 87' ' ' HIS . 98.7 mt -117.34 122.45 69.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 108.708 -0.849 . . . . 63.439999999999998 108.708 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -100.97 87.94 3.41 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.906 -1.516 . . . . 74.430000000000007 106.906 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 69.55 -64.94 0.32 Allowed 'General case' 0 N--CA 1.408 -2.527 0 C-N-CA 127.409 2.283 . . . . 63.039999999999999 112.401 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.47 -43.88 0.62 Allowed Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.205 -0.997 . . . . 74.400000000000006 113.712 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.85 162.26 18.4 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 115.049 1.5 . . . . 65.030000000000001 115.049 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.622 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 38.4 m-85 -84.19 117.5 23.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.018 -0.992 . . . . 74.219999999999999 108.335 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.507 HD11 ' CD2' ' A' ' 76' ' ' LEU . 66.4 mt -80.18 -47.2 15.07 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 114.6 1.333 . . . . 71.340000000000003 114.6 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.406 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 9.7 t60 -165.83 167.31 16.99 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.138 -1.43 . . . . 71.0 107.138 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.99 -19.08 63.11 Favored Glycine 0 C--O 1.209 -1.435 0 N-CA-C 114.187 0.435 . . . . 74.420000000000002 114.187 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.4 ' OD1' ' HB3' ' A' ' 31' ' ' SER . 65.3 t30 177.88 80.36 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 108.864 -0.791 . . . . 72.219999999999999 108.864 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.456 ' H ' HD23 ' A' ' 60' ' ' LEU . 9.1 p -102.55 151.34 6.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.028 -0.73 . . . . 70.340000000000003 109.028 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 55.1 p -78.51 157.64 28.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.598 0.237 . . . . 74.310000000000002 111.172 -178.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.456 ' H ' HD23 ' A' ' 73' ' ' LEU . 1.9 mm? -67.74 -32.43 73.03 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 120.715 0.293 . . . . 74.420000000000002 110.766 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.62 -41.22 99.84 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.672 -0.971 . . . . 44.340000000000003 110.672 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.413 ' HB1' HG23 ' A' ' 71' ' ' VAL . . . -68.99 -15.84 63.58 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.099 0.56 . . . . 43.219999999999999 111.269 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.507 ' CD2' HD11 ' A' ' 67' ' ' LEU . 87.1 mt -82.52 -1.6 50.98 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.852 0.461 . . . . 74.230000000000004 110.105 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.5 mptt 69.77 57.56 0.31 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.331 1.052 . . . . 64.25 110.551 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' A' ' 76' ' ' LEU . 10.3 mp -109.52 124.2 34.47 Favored Pre-proline 0 C--N 1.304 -1.382 0 CA-C-N 115.382 -0.826 . . . . 75.439999999999998 110.41 175.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -76.17 154.48 37.13 Favored 'Trans proline' 0 N--CA 1.432 -2.09 0 C-N-CA 121.608 1.539 . . . . 54.219999999999999 108.883 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -72.74 154.41 40.69 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.048 -0.723 . . . . 74.040000000000006 109.048 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.454 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 75.91 10.65 85.04 Favored Glycine 0 C--N 1.304 -1.228 0 C-N-CA 120.802 -0.713 . . . . 62.200000000000003 113.04 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -110.62 153.57 25.0 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.638 -0.504 . . . . 62.240000000000002 109.638 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.501 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 56.9 m -104.98 129.74 53.34 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.347 -0.612 . . . . 72.010000000000005 109.347 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.8 m -138.72 142.26 38.9 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.119 0.485 . . . . 64.319999999999993 110.928 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.9 p -109.56 142.39 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 115.672 -0.695 . . . . 74.129999999999995 110.374 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 91.1 mtp -135.78 153.88 51.4 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 120.987 0.422 . . . . 62.350000000000001 110.403 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.463 ' C ' HD21 ' A' ' 88' ' ' LEU . 82.4 m-70 -106.02 131.25 53.54 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.925 -1.139 . . . . 74.219999999999999 107.925 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.463 HD21 ' C ' ' A' ' 87' ' ' HIS . 2.5 mm? -122.85 143.91 49.55 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.578 -0.449 . . . . 73.120000000000005 110.781 -176.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.74 137.0 52.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 121.051 0.453 . . . . 73.219999999999999 110.682 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.41 0 CA-C-N 115.6 -0.727 . . . . 55.329999999999998 109.046 178.877 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.445 ' CG2' ' HB2' ' A' ' 11' ' ' ASN . 3.7 t . . . . . 0 N--CA 1.436 -1.147 0 N-CA-C 110.664 -0.124 . . . . 61.299999999999997 110.664 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -74.9 165.28 31.72 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.674 2.249 . . . . 72.140000000000001 110.585 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.83 68.57 10.52 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 122.013 0.911 . . . . 75.150000000000006 110.179 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -167.44 -30.03 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 113.66 -1.609 . . . . 75.239999999999995 107.929 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 90.5 mmm -105.41 158.57 16.56 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.472 -1.24 . . . . 72.150000000000006 109.312 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -119.32 140.12 44.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 109.313 -0.625 . . . . 74.530000000000001 109.313 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.535 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -90.93 112.7 24.68 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.897 -1.149 . . . . 73.239999999999995 107.897 -176.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.42 ' HG ' HD21 ' A' ' 14' ' ' LEU . 35.4 tp -117.29 132.96 56.5 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.44 0.638 . . . . 75.420000000000002 112.578 -174.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 -106.95 121.44 44.44 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 115.12 -0.945 . . . . 63.140000000000001 108.853 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.535 ' CB ' HG23 ' A' ' 39' ' ' VAL . 2.2 mm? -99.48 120.87 40.33 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.209 -0.905 . . . . 72.329999999999998 108.884 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 86' ' ' MET . 23.4 mm -99.49 116.71 43.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 107.118 -1.438 . . . . 74.420000000000002 107.118 177.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.46 167.45 21.82 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 123.292 0.37 . . . . 73.329999999999998 111.693 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -67.61 -28.64 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.746 0.784 . . . . 63.409999999999997 110.242 -176.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -76.79 4.43 9.7 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.144 -0.935 . . . . 73.040000000000006 111.454 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.65 10.32 86.29 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 111.672 -0.571 . . . . 72.400000000000006 111.672 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -91.53 131.8 36.71 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.717 -0.846 . . . . 72.409999999999997 108.717 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.432 HG21 HD12 ' A' ' 15' ' ' ILE . 59.8 p -104.91 135.03 47.02 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 116.572 -0.285 . . . . 74.530000000000001 110.286 -175.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -142.46 139.61 31.63 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.266 -1.013 . . . . 74.150000000000006 108.266 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -134.44 132.57 39.49 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.016 -0.674 . . . . 63.210000000000001 111.55 -171.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.593 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 90.7 m-85 -144.99 160.81 40.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.161 0.584 . . . . 73.420000000000002 110.881 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.4 mt -79.36 126.6 31.02 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.306 -0.998 . . . . 53.240000000000002 108.306 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.593 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 78.4 m-85 -127.35 161.57 28.34 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.104 0.478 . . . . 74.329999999999998 110.411 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.507 ' HB2' ' OD2' ' A' ' 30' ' ' ASP . 31.4 m -84.71 137.05 38.62 Favored Pre-proline 0 N--CA 1.411 -2.386 0 N-CA-C 107.951 -1.129 . . . . 73.319999999999993 107.951 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.429 ' O ' ' HB ' ' A' ' 72' ' ' THR . 30.4 Cg_endo -60.18 -14.55 29.53 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.083 2.522 . . . . 70.430000000000007 113.878 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -85.89 -8.17 58.22 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.017 0.377 . . . . 74.129999999999995 112.017 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.507 ' OD2' ' HB2' ' A' ' 27' ' ' SER . 11.8 m-20 -79.28 153.71 29.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.736 0.303 . . . . 65.430000000000007 111.078 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.444 ' O ' HG13 ' A' ' 35' ' ' ILE . 67.2 m -95.03 124.35 39.02 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.509 -0.314 . . . . 55.310000000000002 110.492 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.491 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -49.32 -41.34 38.24 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.563 1.145 . . . . 74.120000000000005 113.782 -177.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 p -71.48 -32.78 68.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.023 0.439 . . . . 75.349999999999994 111.872 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.68 -42.25 82.42 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.098 -1.075 . . . . 75.030000000000001 108.098 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.463 ' O ' HG22 ' A' ' 39' ' ' VAL . 68.7 mt -60.9 -43.18 95.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.011 -1.449 . . . . 71.299999999999997 110.906 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.0 -41.89 60.05 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.504 0.721 . . . . 60.539999999999999 112.106 176.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.514 ' HE2' ' O ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -72.59 -33.78 66.96 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 107.153 -1.425 . . . . 71.439999999999998 107.153 -177.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -70.09 -50.97 35.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.362 1.065 . . . . 74.530000000000001 111.789 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.535 HG23 ' CB ' ' A' ' 14' ' ' LEU . 30.6 m -68.05 -31.47 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 113.35 0.87 . . . . 44.130000000000003 113.35 -177.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.6 t80 . . . . . 0 N--CA 1.468 0.47 0 O-C-N 124.061 0.85 . . . . 70.329999999999998 112.288 -177.73 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.413 ' C ' ' HD3' ' A' ' 59' ' ' ARG . 96.9 mt . . . . . 0 N--CA 1.44 -0.927 0 N-CA-C 110.359 -0.237 . . . . 53.329999999999998 110.359 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -137.97 148.84 45.6 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 109.75 -0.463 . . . . 70.230000000000004 109.75 172.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.689 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 4.5 pp -120.45 131.6 54.84 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 115.462 -0.79 . . . . 54.32 110.341 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.454 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 88.0 mt -103.14 124.3 57.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.507 0 N-CA-C 107.522 -1.288 . . . . 63.119999999999997 107.522 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -99.65 84.79 3.0 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 106.252 -1.759 . . . . 75.530000000000001 106.252 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 66.58 -65.64 0.2 Allowed 'General case' 0 N--CA 1.405 -2.7 0 C-N-CA 127.58 2.352 . . . . 75.120000000000005 111.724 -175.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.25 -14.48 2.97 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 120.859 -0.686 . . . . 60.310000000000002 114.747 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.92 148.0 45.96 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 118.612 1.206 . . . . 73.409999999999997 110.826 -178.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -84.36 111.59 19.57 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.559 -1.274 . . . . 73.519999999999996 107.559 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.498 HD11 HD22 ' A' ' 76' ' ' LEU . 59.5 mt -81.18 -46.99 14.03 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 114.404 1.261 . . . . 70.049999999999997 114.404 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.689 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.0 t-80 -171.65 176.17 3.79 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.925 -1.509 . . . . 71.409999999999997 106.925 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -85.71 -1.07 87.56 Favored Glycine 0 C--N 1.3 -1.44 0 N-CA-C 115.867 1.107 . . . . 74.219999999999999 115.867 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -169.39 19.32 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 118.429 1.115 . . . . 71.319999999999993 111.935 -170.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.4 HG13 HD23 ' A' ' 60' ' ' LEU . 11.3 p -74.92 146.74 9.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 120.653 -0.419 . . . . 72.5 110.223 -175.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.464 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 38.6 p -78.88 157.85 28.22 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.743 -0.662 . . . . 75.219999999999999 111.292 -175.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.495 ' H ' HD23 ' A' ' 73' ' ' LEU . 1.2 mm? -66.4 -34.97 79.16 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.473 -0.33 . . . . 62.310000000000002 110.752 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.33 -35.06 90.38 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.556 -0.83 . . . . 70.310000000000002 111.281 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.42 -16.45 60.35 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 122.796 0.438 . . . . 74.349999999999994 111.404 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.498 HD22 HD11 ' A' ' 67' ' ' LEU . 45.4 mt -82.87 1.93 36.87 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.129 -0.693 . . . . 70.109999999999999 109.129 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.94 74.32 0.14 Allowed 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.08 1.352 . . . . 54.350000000000001 111.356 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.421 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.5 mp -127.33 112.13 21.31 Favored Pre-proline 0 CA--C 1.497 -1.067 0 CA-C-N 115.302 -0.863 . . . . 75.329999999999998 111.49 176.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.28 154.46 72.1 Favored 'Trans proline' 0 N--CA 1.445 -1.337 0 C-N-CA 122.08 1.853 . . . . 63.109999999999999 108.011 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -69.48 144.25 53.28 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.181 -0.674 . . . . 72.340000000000003 109.181 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.42 9.98 68.72 Favored Glycine 0 C--N 1.305 -1.155 0 C-N-CA 119.892 -1.147 . . . . 37.75 113.347 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -101.55 138.2 38.86 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 117.374 0.587 . . . . 74.129999999999995 110.342 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 58.8 m -92.13 117.51 29.92 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.872 -1.159 . . . . 75.129999999999995 107.872 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.0 m -130.68 135.91 48.29 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.083 -0.508 . . . . 64.150000000000006 111.229 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.14 138.46 26.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 116.065 -0.516 . . . . 74.450000000000003 111.453 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.495 ' O ' HG12 ' A' ' 15' ' ' ILE . 86.1 mtp -134.46 152.07 51.56 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.96 -0.385 . . . . 71.239999999999995 109.96 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.454 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 23.1 m-70 -108.13 132.02 54.04 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.098 -1.075 . . . . 53.329999999999998 108.098 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.428 ' N ' HD22 ' A' ' 88' ' ' LEU . 2.5 mm? -116.9 141.88 47.65 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 120.366 -0.534 . . . . 64.140000000000001 111.016 -176.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.62 132.65 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 CA-C-N 115.863 -0.608 . . . . 75.540000000000006 109.773 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.267 0 CA-C-N 115.824 -0.625 . . . . 61.329999999999998 109.513 179.648 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.432 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 15.1 t . . . . . 0 N--CA 1.423 -1.798 0 N-CA-C 107.91 -1.144 . . . . 73.310000000000002 107.91 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -69.71 151.22 69.3 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 122.298 1.999 . . . . 64.230000000000004 111.888 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.65 69.9 6.04 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 122.061 0.934 . . . . 72.420000000000002 109.949 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -173.47 -21.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.386 -1.733 . . . . 60.32 107.672 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.2 mmm -118.26 160.11 22.18 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.892 -1.049 . . . . 73.109999999999999 108.968 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -125.11 137.91 56.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.843 -0.799 . . . . 73.540000000000006 108.843 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.518 HD21 HG22 ' A' ' 83' ' ' THR . 4.9 t30 -92.06 107.73 19.42 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.713 -1.217 . . . . 72.299999999999997 107.713 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.458 ' HG ' HD23 ' A' ' 14' ' ' LEU . 45.5 tp -111.11 133.1 53.74 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.656 -0.702 . . . . 71.010000000000005 112.559 -171.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.405 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 35.9 ttp180 -109.5 121.03 44.29 Favored 'General case' 0 N--CA 1.414 -2.244 0 CA-C-N 115.195 -0.911 . . . . 75.109999999999999 109.008 174.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.564 ' CB ' HG22 ' A' ' 39' ' ' VAL . 2.0 mm? -101.45 126.71 48.27 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-N 114.462 -1.245 . . . . 63.340000000000003 108.504 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.0 mt -104.32 127.31 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 C-N-CA 119.379 -0.928 . . . . 73.209999999999994 109.477 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.14 156.87 20.85 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.365 -0.606 . . . . 74.519999999999996 109.365 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.52 -13.01 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.474 0.546 . . . . 75.109999999999999 112.474 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.8 t -76.1 -12.15 60.06 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.717 0.77 . . . . 74.420000000000002 109.06 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.13 -3.28 64.24 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.677 -0.569 . . . . 65.230000000000004 111.677 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.1 134.74 33.69 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.731 0.3 . . . . 74.049999999999997 110.332 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 67.5 p -98.61 150.11 22.08 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 121.193 0.521 . . . . 71.519999999999996 110.753 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.4 138.44 47.69 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.027 -1.471 . . . . 71.230000000000004 107.027 174.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HG3' ' HB2' ' A' ' 13' ' ' ARG . 27.0 tt0 -137.68 129.65 28.83 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.072 -1.084 . . . . 70.540000000000006 108.072 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.676 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 97.3 m-85 -145.91 159.41 43.27 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.905 -0.776 . . . . 73.310000000000002 108.905 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.0 tp -83.19 124.92 31.0 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 106.862 -1.533 . . . . 70.450000000000003 106.862 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.676 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 94.2 m-85 -129.52 163.6 25.59 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.76 -0.83 . . . . 73.120000000000005 108.76 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.8 p -87.79 145.1 36.1 Favored Pre-proline 0 N--CA 1.41 -2.443 0 N-CA-C 107.339 -1.356 . . . . 74.439999999999998 107.339 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 26.6 Cg_endo -61.62 -11.63 21.17 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 122.329 2.02 . . . . 62.310000000000002 112.37 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.88 -7.27 49.77 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 109.364 -0.606 . . . . 65.140000000000001 109.364 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -71.9 154.09 41.45 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 122.087 -0.383 . . . . 75.099999999999994 110.09 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.527 ' O ' HG13 ' A' ' 35' ' ' ILE . 8.3 p -94.77 121.4 36.32 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-O 121.04 0.448 . . . . 73.540000000000006 111.445 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -46.0 -51.68 13.11 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.178 1.548 . . . . 72.209999999999994 115.178 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.429 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 18.7 m -78.16 -20.69 51.48 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.633 -0.827 . . . . 74.450000000000003 112.502 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -69.25 -42.44 75.61 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 106.45 -1.685 . . . . 64.409999999999997 106.45 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.538 ' O ' HG21 ' A' ' 39' ' ' VAL . 61.3 mt -62.29 -40.21 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.473 -1.239 . . . . 72.430000000000007 110.055 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.31 -43.96 53.9 Favored 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 123.051 0.54 . . . . 73.409999999999997 111.332 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.505 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 1.7 tmtp? -72.83 -37.91 67.29 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.898 -0.778 . . . . 74.239999999999995 108.898 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -56.87 -50.75 71.53 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.419 -0.81 . . . . 73.329999999999998 109.971 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.564 HG22 ' CB ' ' A' ' 14' ' ' LEU . 29.5 m -73.29 -32.38 37.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.629 -0.714 . . . . 73.540000000000006 111.129 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.0 t80 . . . . . 0 CA--C 1.519 -0.224 0 C-N-CA 123.555 0.742 . . . . 75.310000000000002 110.755 176.263 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 2.1 pt? . . . . . 0 CA--C 1.488 -1.431 0 N-CA-C 107.109 -1.441 . . . . 64.109999999999999 107.109 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 38.5 ptt180 -131.45 159.78 37.07 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-O 121.847 0.832 . . . . 65.299999999999997 112.828 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 4.4 pp -115.4 146.72 41.33 Favored 'General case' 0 N--CA 1.407 -2.585 0 CA-C-N 114.657 -1.156 . . . . 62.240000000000002 112.349 -171.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 94.9 mt -116.67 122.79 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.637 0 CA-C-N 114.351 -1.295 . . . . 72.540000000000006 107.773 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -100.16 89.42 4.01 Favored 'General case' 0 C--N 1.263 -3.18 0 N-CA-C 105.667 -1.975 . . . . 62.420000000000002 105.667 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 69.94 -70.05 0.16 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.325 -1.761 . . . . 75.400000000000006 112.717 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.47 2.44 3.46 Favored Glycine 0 C--N 1.313 -0.73 0 C-N-CA 119.94 -1.124 . . . . 74.439999999999998 113.043 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -130.72 140.94 50.37 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.121 0.415 . . . . 65.200000000000003 112.121 -176.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -83.59 113.82 21.09 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.464 -1.309 . . . . 75.299999999999997 107.464 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.5 HD13 HD22 ' A' ' 76' ' ' LEU . 60.8 mt -79.79 -46.21 17.38 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 119.48 -0.888 . . . . 65.030000000000001 112.733 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.544 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.6 t60 -169.9 169.71 8.1 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 104.091 -2.559 . . . . 60.009999999999998 104.091 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -63.67 -47.13 89.56 Favored Glycine 0 C--O 1.201 -1.966 0 C-N-CA 120.185 -1.007 . . . . 64.239999999999995 113.589 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.455 ' OD1' ' HB2' ' A' ' 31' ' ' SER . 10.2 t30 -152.58 72.0 0.96 Allowed 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 122.348 1.07 . . . . 61.049999999999997 109.517 -172.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.472 HG13 HD22 ' A' ' 60' ' ' LEU . 7.2 p -101.62 151.29 5.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 113.617 -1.629 . . . . 73.340000000000003 108.079 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.441 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 42.0 p -78.12 158.73 29.0 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.677 0.275 . . . . 71.439999999999998 111.406 -175.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.51 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 1.2 mm? -68.27 -32.72 73.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.365 -0.38 . . . . 72.530000000000001 111.146 -176.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.19 -36.95 93.88 Favored Glycine 0 C--O 1.24 0.507 0 N-CA-C 110.743 -0.943 . . . . 72.430000000000007 110.743 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HB3' HG21 ' A' ' 71' ' ' VAL . . . -71.48 -15.43 62.32 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.011 0.524 . . . . 74.209999999999994 110.835 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.5 HD22 HD13 ' A' ' 67' ' ' LEU . 86.5 mt -82.58 6.31 18.05 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.402 0.681 . . . . 71.349999999999994 110.237 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 77.03 10.94 2.47 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.824 1.249 . . . . 54.32 111.828 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.476 HD12 ' HB2' ' A' ' 76' ' ' LEU . 9.6 mp -72.37 119.26 73.89 Favored Pre-proline 0 C--O 1.24 0.565 0 N-CA-C 112.95 0.722 . . . . 75.349999999999994 112.95 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.85 159.41 34.63 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.022 2.481 . . . . 65.430000000000007 109.75 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -77.25 156.73 31.24 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.388 -0.597 . . . . 74.25 109.388 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 79.55 10.19 86.11 Favored Glycine 0 C--N 1.308 -0.973 0 C-N-CA 120.896 -0.669 . . . . 74.510000000000005 113.546 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -115.62 155.81 26.98 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 120.798 0.332 . . . . 44.509999999999998 111.414 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.518 HG22 HD21 ' A' ' 11' ' ' ASN . 84.1 m -105.2 125.89 51.48 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.761 -0.654 . . . . 74.209999999999994 109.266 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.3 m -136.34 142.2 43.82 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.905 0.383 . . . . 75.329999999999998 111.85 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.47 142.2 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.031 -0.531 . . . . 55.020000000000003 110.744 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 93.0 mtp -137.0 153.26 50.71 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.276 0.56 . . . . 74.129999999999995 110.949 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.432 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 35.0 m-70 -111.56 130.8 55.62 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.773 -1.566 . . . . 61.520000000000003 106.773 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.465 ' N ' HD21 ' A' ' 88' ' ' LEU . 2.2 mm? -119.12 143.49 47.15 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.635 -0.426 . . . . 70.409999999999997 111.249 -174.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.88 134.24 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.503 -0.554 . . . . 61.43 109.503 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.635 0 N-CA-C 109.717 -0.475 . . . . 54.200000000000003 109.717 177.409 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.407 -2.602 0 N-CA-C 110.605 -0.146 . . . . 75.430000000000007 110.605 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.07 144.07 51.24 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.918 1.745 . . . . 72.040000000000006 109.109 172.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.35 71.3 3.83 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.772 0.796 . . . . 74.129999999999995 111.23 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -175.48 -27.43 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.95 -1.477 . . . . 64.420000000000002 108.14 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.9 mmm -110.45 157.46 19.55 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.605 -1.18 . . . . 74.129999999999995 108.866 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.13 134.79 52.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 110.079 -0.341 . . . . 73.010000000000005 110.079 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 3.6 t30 -92.75 107.55 19.31 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 107.964 -1.124 . . . . 64.209999999999994 107.964 -176.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.444 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.1 tp -111.84 132.57 54.61 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.676 0.75 . . . . 74.319999999999993 112.389 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -107.19 119.98 40.86 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 108.333 -0.988 . . . . 72.530000000000001 108.333 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.503 ' CB ' HG22 ' A' ' 39' ' ' VAL . 2.5 mm? -99.09 125.73 44.68 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 124.704 1.201 . . . . 74.010000000000005 110.023 -177.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.0 mt -100.2 117.61 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 108.441 -0.948 . . . . 75.519999999999996 108.441 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.8 mt -75.1 162.21 28.73 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.108 -0.496 . . . . 64.430000000000007 111.733 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.32 -15.8 20.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.484 -0.78 . . . . 72.409999999999997 110.219 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.0 m -76.81 -14.71 59.88 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.438 -0.801 . . . . 72.120000000000005 109.295 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.7 1.83 67.82 Favored Glycine 0 CA--C 1.501 -0.837 0 CA-C-N 115.882 -0.599 . . . . 53.039999999999999 112.076 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.491 ' HB3' ' HZ3' ' A' ' 20' ' ' LYS . 2.0 mmmp? -89.12 133.06 34.53 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.103 -1.073 . . . . 75.109999999999999 108.103 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 76.9 p -98.78 129.8 45.21 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.877 -0.786 . . . . 65.430000000000007 108.877 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -127.93 149.38 50.35 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.702 -0.851 . . . . 71.439999999999998 108.702 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -136.34 131.25 34.05 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.447 -0.901 . . . . 51.219999999999999 109.791 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.57 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.5 m-85 -144.73 159.21 43.22 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 123.735 0.814 . . . . 74.420000000000002 108.85 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.5 tp -89.36 128.5 35.91 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.626 -0.879 . . . . 54.25 108.626 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 97.0 m-85 -132.2 173.95 10.72 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.977 -0.379 . . . . 71.299999999999997 109.977 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.2 p -98.76 150.46 36.72 Favored Pre-proline 0 N--CA 1.421 -1.896 0 N-CA-C 108.331 -0.988 . . . . 73.140000000000001 108.331 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.33 -11.38 22.29 Favored 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 122.257 1.971 . . . . 75.019999999999996 111.989 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -79.82 -22.15 43.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.301 1.041 . . . . 73.049999999999997 111.258 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -67.55 153.46 43.65 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.319 0.489 . . . . 73.409999999999997 112.319 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.472 ' O ' HG13 ' A' ' 35' ' ' ILE . 51.7 p -100.38 118.91 37.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.54 -0.541 . . . . 74.109999999999999 109.54 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.493 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . . . -46.09 -51.19 14.29 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 115.205 1.557 . . . . 70.129999999999995 115.205 -173.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.7 m -71.85 -26.15 62.25 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 122.011 -0.43 . . . . 70.340000000000003 111.649 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.37 -41.19 76.84 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 107.75 -1.204 . . . . 73.400000000000006 107.75 173.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.557 ' O ' HG21 ' A' ' 39' ' ' VAL . 66.2 mt -60.66 -40.11 83.68 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 CA-C-N 114.031 -1.44 . . . . 72.420000000000002 110.186 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.417 ' HB1' ' HG ' ' A' ' 88' ' ' LEU . . . -50.12 -40.64 46.67 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 123.4 0.68 . . . . 71.430000000000007 111.026 176.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -73.22 -43.64 60.91 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.793 -0.639 . . . . 73.430000000000007 109.746 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -61.45 -39.91 92.55 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.728 0.811 . . . . 72.340000000000003 111.636 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.557 HG21 ' O ' ' A' ' 35' ' ' ILE . 29.4 m -77.08 -31.86 18.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.192 -0.458 . . . . 72.519999999999996 111.69 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 50.9 t80 . . . . . 0 CA--C 1.535 0.396 0 O-C-N 124.102 0.876 . . . . 74.010000000000005 110.273 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.594 ' O ' ' HD2' ' A' ' 59' ' ' ARG . 2.9 mm? . . . . . 0 CA--C 1.504 -0.814 0 CA-C-O 120.759 0.314 . . . . 71.430000000000007 110.922 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.594 ' HD2' ' O ' ' A' ' 58' ' ' LEU . 3.3 mpt_? -130.07 162.85 27.84 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 123.78 0.832 . . . . 72.209999999999994 109.138 174.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 4.2 pp -148.19 144.49 27.77 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.671 -0.492 . . . . 72.420000000000002 109.671 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 88.5 mt -117.67 119.17 60.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.774 -0.825 . . . . 75.140000000000001 108.774 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.491 ' HH ' HD23 ' A' ' 78' ' ' LEU . 36.1 t80 -101.97 86.01 2.8 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.351 -0.611 . . . . 74.5 109.351 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 44.98 70.55 0.33 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.707 -1.588 . . . . 74.25 112.228 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.06 -72.5 0.45 Allowed Glycine 0 N--CA 1.431 -1.666 0 C-N-CA 119.907 -1.139 . . . . 75.109999999999999 113.261 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -117.13 164.77 14.26 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 117.518 0.659 . . . . 72.450000000000003 112.772 -173.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.566 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 67.9 m-85 -86.11 113.85 22.49 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.46 -1.311 . . . . 72.430000000000007 107.46 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.501 HD13 ' CD2' ' A' ' 76' ' ' LEU . 70.0 mt -80.13 -47.32 14.94 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.398 1.259 . . . . 71.109999999999999 114.398 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.476 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 8.4 t60 -174.64 151.82 1.54 Allowed 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 107.218 -1.401 . . . . 74.010000000000005 107.218 -174.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.83 1.3 39.63 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.073 1.189 . . . . 65.030000000000001 116.073 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -168.7 27.55 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.144 0.972 . . . . 72.5 110.053 -169.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 68' ' ' HIS . 12.6 p -84.17 142.92 12.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 119.592 -0.843 . . . . 65.209999999999994 110.219 -177.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.405 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 49.2 p -81.44 160.22 24.06 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.94 -0.573 . . . . 63.329999999999998 111.304 -177.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.466 HD22 ' H ' ' A' ' 73' ' ' LEU . 1.9 mm? -65.42 -33.09 75.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.208 -0.451 . . . . 73.519999999999996 111.811 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.64 -30.87 75.14 Favored Glycine 0 C--O 1.238 0.352 0 C-N-CA 120.099 -1.048 . . . . 74.129999999999995 111.085 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.408 ' HB2' HG21 ' A' ' 71' ' ' VAL . . . -74.5 -15.35 60.88 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.456 0.702 . . . . 71.319999999999993 110.646 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.501 ' CD2' HD13 ' A' ' 67' ' ' LEU . 74.3 mt -81.95 11.49 5.01 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.413 -0.588 . . . . 72.129999999999995 109.413 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER 67.99 17.79 9.54 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.771 1.228 . . . . 73.030000000000001 110.856 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.491 HD23 ' HH ' ' A' ' 62' ' ' TYR . 91.5 mt -82.86 120.08 75.59 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 115.775 -0.648 . . . . 60.130000000000003 110.753 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -82.21 138.83 10.23 Favored 'Trans proline' 0 N--CA 1.435 -1.964 0 C-N-CA 122.145 1.896 . . . . 55.450000000000003 110.531 175.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -67.41 149.91 49.64 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.358 0.599 . . . . 71.310000000000002 112.504 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.69 5.79 64.44 Favored Glycine 0 N--CA 1.432 -1.573 0 CA-C-N 115.203 -0.908 . . . . 72.010000000000005 111.763 -174.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -124.0 164.89 18.42 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 109.843 -0.429 . . . . 63.219999999999999 109.843 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.419 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 64.2 m -106.69 134.65 49.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.7 0.286 . . . . 72.230000000000004 110.283 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.5 m -141.02 142.36 34.24 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 122.212 -0.305 . . . . 74.319999999999993 111.706 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.7 p -108.92 142.76 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 122.774 0.43 . . . . 74.019999999999996 110.118 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 92.8 mtp -136.22 152.94 51.29 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 120.994 0.426 . . . . 74.150000000000006 110.515 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 30.6 m-70 -104.46 130.16 52.39 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.269 -1.382 . . . . 75.239999999999995 107.269 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.423 ' N ' HD21 ' A' ' 88' ' ' LEU . 2.5 mm? -117.79 144.4 45.38 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.524 -0.471 . . . . 64.519999999999996 110.762 -176.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.1 m -133.28 134.65 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 109.344 -0.613 . . . . 73.310000000000002 109.344 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.27 0 CA-C-O 121.066 0.46 . . . . 73.150000000000006 110.759 177.746 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.427 HG12 HD13 ' A' ' 25' ' ' LEU . 26.0 t . . . . . 0 N--CA 1.432 -1.339 0 N-CA-C 109.201 -0.666 . . . . 53.210000000000001 109.201 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.89 161.26 33.34 Favored 'Trans proline' 0 C--O 1.247 0.955 0 C-N-CA 122.574 2.183 . . . . 71.420000000000002 111.207 177.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.94 74.13 6.69 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 121.869 0.843 . . . . 72.120000000000005 109.101 175.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -171.2 -28.64 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.524 -1.671 . . . . 74.540000000000006 108.594 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 89.1 mmm -111.97 151.86 28.76 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.776 -1.102 . . . . 74.030000000000001 108.867 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.456 HD11 ' O ' ' A' ' 10' ' ' ILE . 2.7 pp -111.34 136.32 47.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-O 120.817 0.341 . . . . 65.219999999999999 110.687 176.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.01 111.58 18.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.775 -1.194 . . . . 73.200000000000003 107.775 -177.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.432 ' HG ' HD21 ' A' ' 14' ' ' LEU . 40.0 tp -118.01 132.93 56.33 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.482 0.658 . . . . 73.030000000000001 112.627 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.453 ' HD2' ' OE1' ' A' ' 23' ' ' GLU . 19.0 ttt85 -113.48 122.34 47.02 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 114.994 -1.003 . . . . 61.109999999999999 108.878 175.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.503 ' CB ' HG23 ' A' ' 39' ' ' VAL . 1.9 mm? -100.09 125.11 46.14 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 124.502 1.121 . . . . 73.099999999999994 108.609 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.594 HG12 ' O ' ' A' ' 86' ' ' MET . 18.8 mm -99.28 123.71 52.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.629 -1.248 . . . . 73.329999999999998 107.629 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.23 156.87 24.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.399 -0.593 . . . . 74.530000000000001 109.399 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.413 ' CG1' ' HA ' ' A' ' 89' ' ' VAL . 35.3 m -66.21 -14.24 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.153 0.427 . . . . 53.109999999999999 112.153 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.2 t -76.27 -16.85 59.71 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.859 -0.61 . . . . 72.019999999999996 109.686 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.57 -6.19 57.33 Favored Glycine 0 N--CA 1.433 -1.559 0 C-N-CA 120.576 -0.821 . . . . 52.299999999999997 112.178 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -86.88 140.05 30.03 Favored 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 119.182 -1.007 . . . . 51.5 110.401 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.475 HG21 HD12 ' A' ' 15' ' ' ILE . 62.0 p -99.11 137.15 38.04 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 115.07 -0.968 . . . . 75.120000000000005 109.651 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -126.86 138.28 53.3 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.29 -1.744 . . . . 72.319999999999993 106.29 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.453 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 26.3 tt0 -137.71 131.15 30.94 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.09 -1.044 . . . . 64.239999999999995 110.818 -176.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.567 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 86.1 m-85 -145.03 159.79 42.39 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 123.382 0.673 . . . . 74.319999999999993 109.267 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.427 HD13 HG12 ' A' ' 5' ' ' VAL . 41.2 tp -84.67 125.15 32.25 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.386 -0.968 . . . . 63.229999999999997 108.386 176.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 96.3 m-85 -128.9 174.44 9.5 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.225 -0.657 . . . . 74.310000000000002 109.225 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.0 p -97.59 154.14 38.05 Favored Pre-proline 0 N--CA 1.431 -1.408 0 C-N-CA 119.193 -1.003 . . . . 64.549999999999997 108.818 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 45.0 Cg_endo -64.18 -12.9 34.84 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.576 2.184 . . . . 74.099999999999994 112.105 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -93.33 -7.33 45.13 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.161 -0.472 . . . . 65.530000000000001 111.642 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -79.2 153.28 30.12 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 120.485 -0.486 . . . . 72.409999999999997 111.186 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.492 ' O ' HG13 ' A' ' 35' ' ' ILE . 45.5 m -93.17 122.41 35.53 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.664 0.269 . . . . 73.400000000000006 110.775 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.469 ' HB1' ' CD2' ' A' ' 60' ' ' LEU . . . -49.34 -46.81 47.35 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.919 1.288 . . . . 42.32 113.409 -176.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 p -67.5 -33.71 75.65 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 113.05 0.759 . . . . 65.530000000000001 113.05 -177.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.54 -44.89 66.57 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.606 -1.257 . . . . 63.200000000000003 107.606 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 31' ' ' SER . 69.4 mt -55.29 -40.79 58.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 114.539 -1.209 . . . . 75.540000000000006 111.148 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.7 -37.65 42.55 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 123.549 0.74 . . . . 75.439999999999998 111.647 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -73.81 -34.58 64.66 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 120.755 0.312 . . . . 73.040000000000006 111.208 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -71.93 -44.25 63.94 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.405 -0.361 . . . . 70.439999999999998 111.829 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.503 HG23 ' CB ' ' A' ' 14' ' ' LEU . 27.4 m -65.24 -31.07 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 120.814 0.34 . . . . 75.549999999999997 110.886 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.7 t80 . . . . . 0 C--O 1.242 0.701 0 CA-C-N 115.431 -0.804 . . . . 73.019999999999996 111.542 175.807 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 CA--C 1.502 -0.87 0 CA-C-O 120.875 0.369 . . . . 75.329999999999998 110.02 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.443 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 27.9 ptt180 -147.1 143.79 28.57 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.981 0.419 . . . . 72.239999999999995 111.003 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 4.4 pp -113.89 144.02 43.73 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.739 -0.664 . . . . 73.239999999999995 111.478 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.522 ' HB ' ' O ' ' A' ' 87' ' ' HIS . 90.9 mt -109.65 124.68 66.56 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 108.358 -0.979 . . . . 75.030000000000001 108.358 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.42 ' CD2' HD11 ' A' ' 67' ' ' LEU . 19.4 t80 -100.49 92.17 5.02 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 106.825 -1.546 . . . . 74.349999999999994 106.825 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 65.43 -67.09 0.14 Allowed 'General case' 0 N--CA 1.399 -2.981 0 C-N-CA 127.341 2.256 . . . . 50.100000000000001 112.173 -175.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.57 -44.93 0.87 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.633 -0.794 . . . . 38.210000000000001 114.135 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.15 159.04 23.23 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 115.435 1.643 . . . . 74.420000000000002 115.435 -174.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.547 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 63.9 m-85 -80.13 113.33 18.23 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.274 -0.875 . . . . 64.319999999999993 108.875 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.485 HD13 HD23 ' A' ' 76' ' ' LEU . 85.4 mt -81.33 -48.77 11.53 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.579 0.955 . . . . 71.329999999999998 113.579 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.711 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 14.7 t-80 -169.25 167.07 10.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.799 -1.556 . . . . 75.230000000000004 106.799 -173.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -85.25 -0.57 88.56 Favored Glycine 0 C--N 1.299 -1.489 0 N-CA-C 115.227 0.851 . . . . 55.210000000000001 115.227 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -168.04 28.69 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 118.187 0.993 . . . . 70.049999999999997 109.801 -169.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.9 p -85.12 138.02 19.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 C-N-CA 119.696 -0.801 . . . . 75.409999999999997 109.528 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.1 p -79.81 159.6 26.44 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.333 0.494 . . . . 75.420000000000002 112.333 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 3.3 mm? -59.42 -41.4 89.44 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 123.521 0.728 . . . . 72.329999999999998 111.844 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.99 -29.94 69.03 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.404 -0.427 . . . . 63.009999999999998 112.564 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.72 -15.17 59.32 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 122.923 0.489 . . . . 60.299999999999997 110.891 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.485 HD23 HD13 ' A' ' 67' ' ' LEU . 42.9 mt -83.46 5.4 23.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.387 -0.37 . . . . 70.030000000000001 110.404 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.405 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 8.8 mptt 62.67 76.92 0.35 Allowed 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.455 1.102 . . . . 62.100000000000001 109.434 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.414 HD22 ' HH ' ' A' ' 62' ' ' TYR . 84.4 mt -131.26 120.81 18.25 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 116.224 -0.444 . . . . 70.349999999999994 111.371 -174.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.11 157.85 38.02 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 121.943 1.762 . . . . 75.030000000000001 109.669 170.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -78.71 150.62 32.47 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.767 -0.457 . . . . 71.310000000000002 109.767 -175.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.09 -11.45 72.09 Favored Glycine 0 C--N 1.308 -1.003 0 N-CA-C 114.756 0.662 . . . . 52.119999999999997 114.756 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.43 154.54 19.73 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.97 -1.092 . . . . 61.049999999999997 110.756 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.0 m -85.13 117.82 24.32 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.306 0.574 . . . . 72.120000000000005 111.017 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.7 m -105.41 125.52 51.08 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.386 -0.968 . . . . 72.120000000000005 108.386 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.3 p -108.74 122.3 63.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.643 0.735 . . . . 54.43 110.752 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.594 ' O ' HG12 ' A' ' 15' ' ' ILE . 87.0 mtp -122.97 150.63 42.73 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-N 116.192 -0.458 . . . . 71.439999999999998 109.899 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.522 ' O ' ' HB ' ' A' ' 61' ' ' ILE . 39.9 m-70 -106.31 128.9 54.33 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.67 -1.233 . . . . 74.230000000000004 107.67 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.402 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.8 mm? -118.48 139.46 51.39 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 120.163 -0.615 . . . . 72.219999999999999 110.641 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.413 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 33.0 m -123.06 131.18 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.127 0 N-CA-C 108.582 -0.896 . . . . 70.420000000000002 108.582 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.553 0 CA-C-N 116.174 -0.466 . . . . 51.140000000000001 110.359 176.253 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.5 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 25.8 t . . . . . 0 N--CA 1.431 -1.387 0 N-CA-C 107.863 -1.162 . . . . 74.129999999999995 107.863 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -68.92 145.65 62.77 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 122.249 1.966 . . . . 62.340000000000003 112.11 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.3 78.01 7.01 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 122.396 1.093 . . . . 75.329999999999998 109.82 176.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -160.4 -41.88 0.05 OUTLIER 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 113.034 -1.894 . . . . 62.0 106.958 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.453 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 8.5 ptm -124.44 159.98 29.25 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.287 -1.324 . . . . 64.209999999999994 111.047 -175.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.89 140.6 28.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.338 0.589 . . . . 74.530000000000001 112.582 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -87.59 107.85 18.79 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.393 -0.966 . . . . 53.25 108.393 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.451 ' HG ' HD21 ' A' ' 14' ' ' LEU . 43.2 tp -117.24 132.85 56.54 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.291 0.567 . . . . 73.25 112.411 -173.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 35.7 ttp-105 -107.44 120.9 43.46 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 108.733 -0.84 . . . . 72.530000000000001 108.733 173.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.595 ' CB ' HG22 ' A' ' 39' ' ' VAL . 2.5 mm? -97.34 121.96 39.82 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.219 -1.355 . . . . 74.540000000000006 109.337 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.6 mt -99.77 119.36 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 N-CA-C 108.272 -1.01 . . . . 72.340000000000003 108.272 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.04 166.79 23.11 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.478 -0.783 . . . . 74.319999999999993 111.436 -175.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.7 m -70.74 -14.35 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.504 0.669 . . . . 73.25 110.665 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 m -83.69 -6.24 59.39 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 114.923 -1.035 . . . . 74.129999999999995 110.11 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.81 -4.67 84.96 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.852 -0.69 . . . . 52.439999999999998 112.64 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -87.54 131.9 34.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.898 0.38 . . . . 73.239999999999995 110.252 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.8 p -98.94 129.94 45.28 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.998 -0.546 . . . . 75.140000000000001 110.068 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -131.44 139.11 49.32 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.043 -0.725 . . . . 73.420000000000002 109.043 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 29.4 tt0 -125.23 133.84 52.56 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.324 -0.55 . . . . 75.549999999999997 110.587 -174.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.64 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 95.3 m-85 -144.66 160.0 41.9 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.105 0.562 . . . . 75.409999999999997 109.489 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.44 ' HG ' ' HE2' ' A' ' 9' ' ' MET . 23.7 tp -87.52 126.17 34.76 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.174 -1.047 . . . . 72.030000000000001 108.174 177.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.64 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 96.8 m-85 -132.77 173.94 10.84 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.749 -0.834 . . . . 74.439999999999998 108.749 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 99.7 p -97.09 151.34 37.65 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 108.515 -0.92 . . . . 71.049999999999997 108.515 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 37.3 Cg_endo -63.11 -11.87 27.13 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.594 2.196 . . . . 73.049999999999997 112.409 177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -86.2 -17.24 35.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.542 -0.754 . . . . 75.400000000000006 109.999 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -69.93 154.76 41.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.486 0.66 . . . . 73.409999999999997 112.429 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.532 ' O ' HG13 ' A' ' 35' ' ' ILE . 3.3 p -91.69 118.21 30.45 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 115.357 -0.838 . . . . 72.040000000000006 110.848 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.4 -51.29 59.86 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.83 1.252 . . . . 52.140000000000001 113.623 -174.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.1 m -72.11 -22.6 61.31 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 120.861 0.362 . . . . 72.109999999999999 111.6 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -70.66 -48.88 52.64 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.502 -0.925 . . . . 64.239999999999995 108.502 172.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 31' ' ' SER . 72.5 mt -54.81 -43.91 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 114.278 -1.328 . . . . 73.030000000000001 110.102 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.27 -34.37 23.09 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.165 0.986 . . . . 74.230000000000004 111.763 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -74.03 -49.7 23.08 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 109.539 -0.541 . . . . 53.530000000000001 109.539 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -59.95 -40.76 90.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.41 -0.814 . . . . 64.0 111.568 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.595 HG22 ' CB ' ' A' ' 14' ' ' LEU . 36.0 m -73.95 -31.3 30.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.418 -0.355 . . . . 71.430000000000007 111.654 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.4 t80 . . . . . 0 C--O 1.232 0.157 0 O-C-N 123.446 0.466 . . . . 74.200000000000003 110.855 179.386 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 C--O 1.241 0.636 0 CA-C-O 120.915 0.388 . . . . 73.319999999999993 111.86 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -144.82 164.16 31.88 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 124.149 0.98 . . . . 70.510000000000005 108.41 175.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.575 HD21 ' H ' ' A' ' 71' ' ' VAL . 3.7 pp -147.17 148.4 31.49 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 109.444 -0.576 . . . . 75.109999999999999 109.444 172.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 87' ' ' HIS . 90.3 mt -118.27 129.63 74.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 108.644 -0.873 . . . . 74.230000000000004 108.644 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -100.03 81.51 2.43 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 106.292 -1.744 . . . . 74.409999999999997 106.292 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.324 17.6 tm0? 59.34 -38.56 0.07 Allowed 'General case' 0 N--CA 1.414 -2.228 0 C-N-CA 129.042 2.937 . . . . 62.549999999999997 116.38 -176.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.35 -52.25 0.18 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.801 -0.714 . . . . 73.329999999999998 112.651 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.64 162.24 14.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.49 1.293 . . . . 74.099999999999994 114.49 -178.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 43.9 m-85 -88.28 113.54 23.99 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.866 -1.161 . . . . 74.219999999999999 107.866 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.21 -48.93 12.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 119.179 -1.008 . . . . 51.509999999999998 112.31 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.517 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 60.1 m80 -159.81 177.88 10.36 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.698 -0.853 . . . . 73.209999999999994 108.698 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.63 -4.17 85.62 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.978 -0.629 . . . . 71.219999999999999 112.584 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.4 t30 175.74 79.61 0.0 OUTLIER 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.527 1.131 . . . . 54.25 110.273 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.575 ' H ' HD21 ' A' ' 60' ' ' LEU . 9.2 p -104.33 146.15 12.09 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.765 0 N-CA-C 106.783 -1.562 . . . . 70.510000000000005 106.783 172.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.3 p -78.52 158.19 28.64 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.397 -0.521 . . . . 64.299999999999997 111.532 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 2.0 mm? -66.26 -34.71 78.62 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.148 0.499 . . . . 60.32 111.003 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.14 -31.38 79.08 Favored Glycine 0 CA--C 1.516 0.155 0 C-N-CA 120.6 -0.81 . . . . 72.329999999999998 111.234 176.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.403 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -72.4 -15.0 61.84 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 122.959 0.503 . . . . 64.340000000000003 110.872 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.503 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 64.5 mt -82.19 3.38 27.5 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.88 -0.415 . . . . 75.430000000000007 109.88 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.23 26.12 2.78 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.451 1.1 . . . . 72.340000000000003 111.135 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.503 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 65.1 mt -76.53 127.68 83.9 Favored Pre-proline 0 C--O 1.244 0.791 0 CA-C-N 116.555 -0.293 . . . . 75.540000000000006 111.138 -178.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.71 147.0 30.82 Favored 'Trans proline' 0 N--CA 1.435 -1.919 0 C-N-CA 121.439 1.426 . . . . 73.129999999999995 108.46 170.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.497 ' CE1' ' HG3' ' A' ' 28' ' ' PRO . 12.4 m-30 -69.51 145.67 52.48 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.191 -0.67 . . . . 73.420000000000002 109.191 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.5 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 89.41 1.77 77.73 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 120.165 -1.016 . . . . 64.310000000000002 113.55 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -101.49 145.22 29.28 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 117.041 0.42 . . . . 74.109999999999999 109.955 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.4 m -87.19 117.48 25.96 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.917 -0.772 . . . . 65.120000000000005 108.917 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.9 m -114.21 134.97 54.55 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.609 -0.723 . . . . 75.319999999999993 110.935 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.8 131.25 62.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 120.991 0.424 . . . . 62.299999999999997 110.349 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 89.7 mtp -135.51 153.2 51.8 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-O 120.81 0.338 . . . . 70.540000000000006 110.479 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.483 ' O ' ' HB ' ' A' ' 61' ' ' ILE . 27.8 m-70 -106.58 135.42 48.13 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.474 -1.306 . . . . 75.400000000000006 107.474 176.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.442 HD23 ' C ' ' A' ' 87' ' ' HIS . 2.4 mm? -123.53 137.05 54.85 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 120.249 -0.58 . . . . 71.549999999999997 110.188 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.4 m -126.46 133.47 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-O 121.58 0.705 . . . . 74.329999999999998 111.199 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.772 0 N-CA-C 108.469 -0.937 . . . . 74.120000000000005 108.469 176.694 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.407 HG13 HD21 ' A' ' 25' ' ' LEU . 24.9 t . . . . . 0 N--CA 1.442 -0.859 0 N-CA-C 109.652 -0.499 . . . . 74.430000000000007 109.652 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.3 142.45 79.54 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.426 2.084 . . . . 74.230000000000004 112.395 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.97 70.82 6.61 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 122.121 0.962 . . . . 73.129999999999995 109.884 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -168.0 -37.04 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 104.909 -2.256 . . . . 74.109999999999999 104.909 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 86.0 mmm -102.58 156.74 17.41 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.622 -1.627 . . . . 75.239999999999995 108.985 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -117.92 140.22 42.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 107.509 -1.293 . . . . 74.349999999999994 107.509 172.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 67.1 t30 -91.81 125.24 36.45 Favored 'General case' 0 CA--C 1.485 -1.537 0 C-N-CA 118.765 -1.174 . . . . 64.430000000000007 107.876 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.462 ' HG ' HD21 ' A' ' 14' ' ' LEU . 44.7 tp -126.21 133.65 51.46 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-O 121.149 0.5 . . . . 70.310000000000002 112.112 -174.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 17.8 ttp180 -106.1 120.63 42.3 Favored 'General case' 0 N--CA 1.405 -2.71 0 N-CA-C 108.659 -0.867 . . . . 72.549999999999997 108.659 173.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.514 ' CB ' HG22 ' A' ' 39' ' ' VAL . 2.1 mm? -99.56 122.31 42.44 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 113.966 -1.47 . . . . 63.229999999999997 109.275 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.471 HG23 HG22 ' A' ' 21' ' ' THR . 15.0 mm -105.07 123.31 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.513 -1.291 . . . . 64.0 107.513 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 2.5 mm? -93.92 158.3 15.71 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.245 -0.582 . . . . 72.109999999999999 110.969 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.489 ' CG1' ' HA ' ' A' ' 89' ' ' VAL . 32.2 m -52.85 -30.29 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 115.009 1.485 . . . . 73.129999999999995 115.009 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.4 m -86.61 4.88 38.41 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.992 0.425 . . . . 63.009999999999998 111.351 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.47 24.92 49.17 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.208 -0.757 . . . . 61.240000000000002 111.208 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 73.4 mmtt -86.97 130.82 34.3 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 104.688 -2.338 . . . . 65.150000000000006 104.688 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.471 HG22 HG23 ' A' ' 15' ' ' ILE . 38.7 p -126.3 128.68 47.51 Favored 'General case' 0 C--N 1.278 -2.53 0 C-N-CA 119.644 -0.822 . . . . 72.239999999999995 111.648 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -142.39 147.21 35.84 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.32 -0.4 . . . . 75.530000000000001 111.025 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 21.0 tt0 -125.9 130.2 50.85 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 107.68 -1.23 . . . . 63.509999999999998 107.68 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.68 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 96.4 m-85 -145.11 158.97 43.67 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.703 0.287 . . . . 63.200000000000003 110.452 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.407 HD21 HG13 ' A' ' 5' ' ' VAL . 96.5 mt -79.76 125.66 29.96 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.99 -1.115 . . . . 71.299999999999997 107.99 175.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.68 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 90.1 m-85 -129.86 163.15 26.94 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.59 -0.522 . . . . 73.319999999999993 109.59 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.0 m -88.99 141.13 29.29 Favored Pre-proline 0 N--CA 1.395 -3.185 0 N-CA-C 107.613 -1.255 . . . . 74.530000000000001 107.613 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.456 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 34.7 Cg_endo -62.4 -11.98 25.4 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.203 1.935 . . . . 73.510000000000005 112.186 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -78.89 -20.27 49.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.433 1.093 . . . . 72.25 110.046 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.447 ' O ' HD21 ' A' ' 73' ' ' LEU . 63.5 m-20 -75.44 154.16 37.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.184 -0.462 . . . . 64.329999999999998 111.347 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.538 ' HB2' ' OD1' ' A' ' 70' ' ' ASN . 13.4 p -101.1 132.07 46.73 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.276 0.473 . . . . 65.140000000000001 112.276 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.47 -59.34 3.56 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.662 1.727 . . . . 62.240000000000002 115.662 -174.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.7 m -72.78 -19.7 61.31 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.504 0.668 . . . . 55.549999999999997 111.258 -174.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 14.3 t70 -70.15 -47.93 59.55 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.493 -1.299 . . . . 62.310000000000002 107.493 172.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 31' ' ' SER . 73.3 mt -59.03 -35.28 56.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.671 -1.149 . . . . 73.140000000000001 110.84 176.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.41 -33.56 21.22 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.029 0.532 . . . . 72.549999999999997 110.665 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 5.5 mptp? -68.87 -51.72 37.31 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.71 0.291 . . . . 73.329999999999998 110.312 174.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -57.52 -43.0 83.94 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.992 -0.549 . . . . 71.010000000000005 111.889 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.514 HG22 ' CB ' ' A' ' 14' ' ' LEU . 35.8 m -76.9 -31.53 19.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 112.381 0.512 . . . . 74.409999999999997 112.381 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 65.1 t80 . . . . . 0 C--N 1.323 -0.559 0 C-N-CA 120.404 -0.519 . . . . 74.209999999999994 109.761 176.647 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.9 mt . . . . . 0 CA--C 1.483 -1.605 0 N-CA-C 107.27 -1.381 . . . . 62.140000000000001 107.27 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 10.3 ptt180 -146.46 162.72 37.67 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.442 -0.799 . . . . 64.319999999999993 111.567 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 4.5 pp -127.11 150.32 49.54 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 115.6 -0.727 . . . . 75.030000000000001 112.044 -171.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.4 mt -118.79 120.02 62.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.17 -0.923 . . . . 74.230000000000004 108.58 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.424 ' CD2' HD12 ' A' ' 67' ' ' LEU . 17.0 t80 -101.53 65.52 1.04 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.057 -1.09 . . . . 72.439999999999998 108.057 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 53.83 83.93 0.07 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.828 -1.533 . . . . 74.319999999999993 113.496 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.55 -58.51 0.5 Allowed Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.535 -0.841 . . . . 64.209999999999994 112.803 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -130.87 162.88 28.65 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 120.095 -0.642 . . . . 75.329999999999998 112.693 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.521 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 78.8 m-85 -83.73 122.27 28.42 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.073 -1.454 . . . . 73.25 107.073 175.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.455 HD11 ' CD2' ' A' ' 76' ' ' LEU . 54.6 mt -79.71 -46.37 17.22 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 118.804 -1.158 . . . . 72.219999999999999 111.289 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.481 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.0 t-160 -165.86 178.88 6.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.361 -2.089 . . . . 74.439999999999998 105.361 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -71.54 -42.23 55.89 Favored Glycine 0 C--O 1.208 -1.472 0 C-N-CA 120.346 -0.931 . . . . 74.549999999999997 112.675 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.538 ' OD1' ' HB2' ' A' ' 31' ' ' SER . 60.7 t30 -159.93 75.93 0.62 Allowed 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 108.613 -0.884 . . . . 75.129999999999995 108.613 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.503 HG11 HD21 ' A' ' 60' ' ' LEU . 11.2 p -102.06 152.08 5.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.228 -1.351 . . . . 70.400000000000006 109.066 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.1 p -77.61 160.68 28.38 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.488 0.551 . . . . 74.430000000000007 112.488 -173.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.479 ' H ' HD21 ' A' ' 73' ' ' LEU . 1.3 mm? -68.98 -34.55 75.49 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 116.134 -0.484 . . . . 72.319999999999993 111.189 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.05 -29.67 75.09 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.496 -0.859 . . . . 41.32 111.193 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.443 ' HB3' HG23 ' A' ' 71' ' ' VAL . . . -73.79 -15.24 61.19 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 122.972 0.509 . . . . 74.329999999999998 111.199 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.459 HD11 ' SD ' ' A' ' 86' ' ' MET . 58.6 mt -83.83 2.39 38.48 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.867 0.467 . . . . 72.450000000000003 110.224 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER 65.22 78.06 0.29 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.984 0.914 . . . . 62.130000000000003 109.276 -176.544 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.0 mt -133.46 133.33 22.58 Favored Pre-proline 0 C--O 1.243 0.749 0 CA-C-N 116.093 -0.503 . . . . 74.109999999999999 111.239 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -81.33 155.97 19.23 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.293 1.996 . . . . 65.120000000000005 109.229 171.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -76.71 153.65 34.9 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.74 -0.837 . . . . 73.450000000000003 108.74 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 83.97 2.37 89.56 Favored Glycine 0 C--N 1.3 -1.467 0 C-N-CA 120.25 -0.976 . . . . 73.530000000000001 113.09 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.21 151.68 23.78 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 110.2 -0.296 . . . . 54.439999999999998 110.2 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.437 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 90.1 m -102.18 127.17 49.23 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.146 0.498 . . . . 64.439999999999998 110.158 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 84.8 m -128.72 141.98 51.15 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.938 -0.573 . . . . 64.209999999999994 110.604 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.9 137.5 41.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.779 0.323 . . . . 72.120000000000005 110.877 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.459 ' SD ' HD11 ' A' ' 76' ' ' LEU . 93.6 mtp -135.51 152.73 51.61 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 122.882 0.473 . . . . 75.549999999999997 110.176 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -109.61 131.06 55.41 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.662 -0.866 . . . . 73.120000000000005 108.662 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 88' ' ' LEU . 2.5 mm? -117.87 137.63 52.66 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 110.06 -0.348 . . . . 74.109999999999999 110.06 -175.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.489 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 32.6 m -121.71 133.87 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-O 121.142 0.496 . . . . 74.310000000000002 110.706 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.035 0 CA-C-N 115.645 -0.707 . . . . 64.109999999999999 109.991 176.963 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.488 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 39.0 t . . . . . 0 N--CA 1.418 -2.066 0 N-CA-C 109.306 -0.627 . . . . 61.039999999999999 109.306 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 8' ' ' ASP . 73.3 Cg_endo -79.39 172.52 14.44 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.5 2.134 . . . . 64.129999999999995 111.972 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.42 30.22 0.29 Allowed 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.992 0.917 . . . . 71.400000000000006 110.639 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 6' ' ' PRO . 24.6 t70 -133.42 -14.68 2.54 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.714 -0.676 . . . . 65.310000000000002 110.14 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.3 mmm -121.68 155.4 35.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.036 -0.529 . . . . 73.25 110.092 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 pp -120.28 140.27 44.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-O 120.883 0.373 . . . . 70.019999999999996 110.949 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -90.84 111.04 22.28 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 109.06 -0.719 . . . . 71.129999999999995 109.06 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.431 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.1 tp -119.54 133.11 55.82 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.758 -0.656 . . . . 73.140000000000001 112.31 -174.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -108.63 121.25 44.62 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 114.986 -1.007 . . . . 72.25 108.388 173.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.535 ' CB ' HG23 ' A' ' 39' ' ' VAL . 2.1 mm? -99.44 123.72 43.96 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.061 -0.972 . . . . 72.340000000000003 109.273 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.6 mt -104.46 129.22 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 N-CA-C 108.736 -0.838 . . . . 74.420000000000002 108.736 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.68 166.17 17.29 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.789 -0.642 . . . . 74.510000000000005 110.169 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.13 -19.43 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-O 121.745 0.784 . . . . 74.430000000000007 109.983 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.442 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 22.8 p -76.06 -10.6 59.55 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.561 -0.745 . . . . 75.239999999999995 111.35 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.44 2.52 76.45 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 110.715 -0.954 . . . . 73.129999999999995 110.715 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.442 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 12.6 mptt -86.65 133.61 33.68 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.791 -0.448 . . . . 75.099999999999994 109.791 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.9 p -113.73 137.26 51.87 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 116.117 -0.492 . . . . 62.130000000000003 111.531 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -134.88 147.5 49.87 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.064 -0.717 . . . . 71.299999999999997 109.064 174.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -135.46 131.58 36.34 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.397 -0.594 . . . . 75.439999999999998 109.397 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.706 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 94.4 m-85 -144.04 160.02 41.6 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.951 -0.759 . . . . 65.209999999999994 108.951 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.403 HD12 HG12 ' A' ' 5' ' ' VAL . 41.3 tp -82.28 125.04 30.5 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.292 -1.373 . . . . 74.239999999999995 107.292 175.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.706 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 83.8 m-85 -128.97 166.59 18.88 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.446 -0.575 . . . . 74.310000000000002 109.446 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.7 p -92.83 146.94 33.09 Favored Pre-proline 0 N--CA 1.417 -2.092 0 C-N-CA 119.308 -0.957 . . . . 75.420000000000002 108.62 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.466 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 35.3 Cg_endo -61.86 -11.4 20.93 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.72 2.28 . . . . 71.340000000000003 112.1 177.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -79.97 -23.06 41.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.216 -0.902 . . . . 71.129999999999995 110.973 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.433 ' O ' HD21 ' A' ' 73' ' ' LEU . 22.6 m-20 -67.44 154.78 40.59 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 112.88 0.696 . . . . 75.439999999999998 112.88 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.52 ' O ' HG13 ' A' ' 35' ' ' ILE . 43.7 m -97.08 124.6 41.14 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.65 -0.705 . . . . 53.310000000000002 109.829 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.509 ' HB3' HD21 ' A' ' 60' ' ' LEU . . . -50.5 -50.0 54.04 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.539 0.735 . . . . 64.010000000000005 112.937 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 p -65.65 -30.63 71.36 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 112.355 0.502 . . . . 73.5 112.355 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.66 -46.24 66.56 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.8 -0.815 . . . . 72.010000000000005 108.8 174.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 31' ' ' SER . 67.3 mt -60.22 -39.15 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 114.811 -1.086 . . . . 72.439999999999998 111.138 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.88 -38.61 36.37 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.418 0.687 . . . . 71.430000000000007 111.299 176.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -72.49 -40.92 66.52 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.242 -0.435 . . . . 64.150000000000006 111.079 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -65.89 -42.54 90.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.629 -0.714 . . . . 61.130000000000003 111.161 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.535 HG23 ' CB ' ' A' ' 14' ' ' LEU . 27.4 m -76.84 -30.72 18.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 112.157 0.428 . . . . 72.519999999999996 112.157 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.2 t80 . . . . . 0 C--O 1.243 0.719 0 O-C-N 123.565 0.54 . . . . 75.549999999999997 111.795 -179.452 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.7 tp . . . . . 0 N--CA 1.447 -0.605 0 N-CA-C 108.494 -0.928 . . . . 65.329999999999998 108.494 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -137.22 160.53 38.75 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.088 -0.505 . . . . 72.030000000000001 109.721 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 4.5 pp -127.62 140.76 51.89 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.581 -0.736 . . . . 73.140000000000001 109.495 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.469 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 92.5 mt -111.89 126.33 69.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.783 -0.821 . . . . 61.149999999999999 108.783 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -100.58 84.32 2.74 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.715 -1.217 . . . . 73.219999999999999 107.715 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 68.16 -50.24 0.54 Allowed 'General case' 0 N--CA 1.405 -2.676 0 C-N-CA 127.505 2.322 . . . . 53.530000000000001 112.69 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.9 -45.76 0.18 Allowed Glycine 0 N--CA 1.436 -1.338 0 C-N-CA 120.601 -0.809 . . . . 61.200000000000003 113.987 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -110.58 160.9 16.24 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.55 0.574 . . . . 64.409999999999997 112.55 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 68.4 m-85 -87.1 113.79 23.14 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.018 -1.104 . . . . 64.420000000000002 108.018 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.557 HD13 ' CD2' ' A' ' 76' ' ' LEU . 43.2 mt -80.63 -45.21 17.64 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 114.113 1.153 . . . . 64.450000000000003 114.113 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.655 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 8.1 t60 -167.48 169.93 11.73 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.735 -1.58 . . . . 75.010000000000005 106.735 -175.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.85 -1.31 88.98 Favored Glycine 0 C--N 1.309 -0.954 0 C-N-CA 120.73 -0.748 . . . . 72.129999999999995 113.148 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 178.49 64.9 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.826 -0.805 . . . . 72.409999999999997 108.826 -173.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.532 ' H ' HD22 ' A' ' 60' ' ' LEU . 11.2 p -104.18 151.17 6.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.852 -1.166 . . . . 72.0 107.852 174.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.424 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 58.9 p -84.04 158.28 21.52 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 121.42 -0.112 . . . . 62.119999999999997 110.962 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.504 ' H ' HD21 ' A' ' 73' ' ' LEU . 1.5 mm? -65.29 -32.75 74.57 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.977 0.418 . . . . 65.439999999999998 110.79 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.48 -32.31 83.77 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.098 -0.801 . . . . 61.310000000000002 111.098 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.435 ' HB1' HG23 ' A' ' 71' ' ' VAL . . . -79.19 -15.14 58.51 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 122.803 0.441 . . . . 70.219999999999999 111.088 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.557 ' CD2' HD13 ' A' ' 67' ' ' LEU . 66.8 mt -82.38 1.16 38.57 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.945 -0.761 . . . . 71.420000000000002 108.945 176.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.1 mptt 78.84 14.89 1.16 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.056 1.342 . . . . 63.439999999999998 113.18 178.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.476 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.6 mp -60.67 120.26 51.33 Favored Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 113.485 0.92 . . . . 75.150000000000006 113.485 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -73.05 150.41 48.31 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.485 2.123 . . . . 74.329999999999998 108.565 170.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -78.06 142.24 38.3 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.454 -0.943 . . . . 75.239999999999995 108.454 -175.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 92.63 -3.25 74.57 Favored Glycine 0 C--N 1.298 -1.533 0 C-N-CA 119.955 -1.117 . . . . 60.329999999999998 114.151 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -104.42 153.89 20.54 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 117.367 0.583 . . . . 63.450000000000003 111.621 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.7 m -92.61 118.6 31.19 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.33 -0.619 . . . . 74.299999999999997 109.33 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 84.1 m -119.98 136.93 54.36 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 116.39 -0.368 . . . . 74.530000000000001 110.516 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.4 p -110.52 135.45 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-O 121.045 0.45 . . . . 72.219999999999999 110.964 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 87.6 mtp -134.48 153.72 51.78 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 120.896 0.379 . . . . 71.549999999999997 111.64 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 63.3 m-70 -107.73 135.13 49.67 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.682 -1.229 . . . . 72.040000000000006 107.682 176.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 88' ' ' LEU . 2.4 mm? -121.73 133.76 54.94 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 120.161 -0.616 . . . . 73.310000000000002 110.156 -177.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.51 134.57 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 121.662 0.744 . . . . 70.400000000000006 111.827 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.826 0 N-CA-C 107.407 -1.331 . . . . 55.549999999999997 107.407 175.321 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.479 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 47.5 t . . . . . 0 N--CA 1.435 -1.207 0 N-CA-C 109.019 -0.734 . . . . 65.219999999999999 109.019 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -70.87 149.68 60.23 Favored 'Trans proline' 0 C--O 1.25 1.097 0 C-N-CA 122.332 2.022 . . . . 72.420000000000002 112.089 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.42 75.33 7.26 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.905 0.86 . . . . 62.119999999999997 108.73 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -171.99 -25.55 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.642 -1.617 . . . . 71.040000000000006 107.646 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.6 mmm -114.42 144.84 42.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.947 -1.024 . . . . 72.129999999999995 109.626 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -105.76 135.66 43.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 116.191 -0.459 . . . . 74.329999999999998 110.014 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -89.7 110.71 21.58 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.744 -0.836 . . . . 73.019999999999996 108.744 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.452 ' HG ' HD23 ' A' ' 14' ' ' LEU . 43.6 tp -119.51 132.85 55.85 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.629 -0.714 . . . . 64.439999999999998 111.769 -174.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.404 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 35.8 ttp-105 -109.26 120.76 43.49 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 108.651 -0.87 . . . . 63.240000000000002 108.651 173.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.471 HD22 HG12 ' A' ' 39' ' ' VAL . 2.1 mm? -96.44 120.91 37.61 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.787 -1.097 . . . . 74.340000000000003 109.966 -177.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.477 HG22 ' OG1' ' A' ' 21' ' ' THR . 19.0 mt -108.91 117.51 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 N-CA-C 107.045 -1.465 . . . . 75.420000000000002 107.045 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.58 156.96 20.51 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 116.073 -0.512 . . . . 62.240000000000002 111.576 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -58.04 -25.77 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 124.019 0.928 . . . . 72.230000000000004 111.91 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.2 m -76.81 -1.33 27.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.94 0.4 . . . . 74.239999999999995 111.017 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.03 15.85 71.35 Favored Glycine 0 CA--C 1.496 -1.123 0 N-CA-C 111.65 -0.58 . . . . 54.140000000000001 111.65 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -92.42 143.3 26.51 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.892 -1.522 . . . . 75.329999999999998 106.892 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.477 ' OG1' HG22 ' A' ' 15' ' ' ILE . 78.4 m -131.31 141.38 49.93 Favored 'General case' 0 C--N 1.277 -2.555 0 C-N-CA 120.136 -0.626 . . . . 71.319999999999993 109.758 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -150.63 139.82 21.2 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.608 -0.886 . . . . 72.409999999999997 108.608 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.404 ' HG3' ' HB2' ' A' ' 13' ' ' ARG . 27.8 tt0 -123.69 133.09 53.95 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.787 -0.365 . . . . 74.409999999999997 110.533 -177.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.699 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 90.2 m-85 -145.17 161.21 40.06 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 123.4 0.68 . . . . 61.520000000000003 109.728 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.72 125.84 30.18 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.68 -1.23 . . . . 73.219999999999999 107.68 170.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.699 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 85.7 m-85 -125.16 167.35 14.95 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.886 -0.783 . . . . 74.299999999999997 108.886 177.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 99.0 p -94.65 147.54 33.36 Favored Pre-proline 0 N--CA 1.414 -2.249 0 C-N-CA 118.895 -1.122 . . . . 73.129999999999995 108.225 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.82 -11.56 21.52 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.686 2.257 . . . . 64.340000000000003 112.312 177.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -84.44 -18.39 36.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.553 -0.748 . . . . 62.100000000000001 110.983 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.417 ' O ' HD23 ' A' ' 73' ' ' LEU . 35.1 m-20 -74.07 153.86 39.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.874 0.368 . . . . 74.25 110.374 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.409 ' O ' HG13 ' A' ' 35' ' ' ILE . 36.2 m -98.97 131.6 44.91 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.937 -0.764 . . . . 60.450000000000003 108.937 176.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.516 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . . . -51.29 -36.57 43.0 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.396 0.887 . . . . 70.299999999999997 113.396 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.451 ' OG ' ' HA ' ' A' ' 70' ' ' ASN . 7.2 p -69.24 -36.66 77.41 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.851 0.685 . . . . 63.409999999999997 112.851 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.66 -43.29 89.82 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.145 -1.057 . . . . 75.340000000000003 108.145 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.52 HG22 ' CZ ' ' A' ' 26' ' ' PHE . 57.0 mt -59.5 -41.31 84.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 114.847 -1.07 . . . . 75.340000000000003 111.964 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.94 -42.38 48.37 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 123.043 0.537 . . . . 70.319999999999993 111.472 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -73.52 -38.62 65.24 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 120.69 0.281 . . . . 65.129999999999995 111.323 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -59.77 -45.2 93.0 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.581 -0.736 . . . . 73.209999999999994 110.535 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.471 HG12 HD22 ' A' ' 14' ' ' LEU . 34.9 m -75.29 -31.83 24.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-O 121.047 0.451 . . . . 74.25 112.139 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.8 t80 . . . . . 0 N--CA 1.48 1.055 0 CA-C-N 115.783 -0.644 . . . . 73.310000000000002 110.76 176.614 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.44 -0.974 0 N-CA-C 107.251 -1.388 . . . . 74.409999999999997 107.251 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -137.93 142.55 40.58 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.594 -0.842 . . . . 64.0 109.249 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 4.6 pp -114.19 134.97 54.55 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.969 -0.56 . . . . 74.439999999999998 110.707 -178.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 72.3 mt -109.39 119.92 59.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 115.295 -0.866 . . . . 74.049999999999997 108.763 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -101.91 102.78 13.38 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 102.917 -2.994 . . . . 71.430000000000007 102.917 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -18.78 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 127.999 2.52 . . . . 71.040000000000006 113.881 -163.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.52 -67.81 0.4 Allowed Glycine 0 N--CA 1.42 -2.394 0 CA-C-N 113.165 -1.834 . . . . 61.200000000000003 110.27 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -130.61 173.65 10.68 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 120.788 0.327 . . . . 72.299999999999997 111.539 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -94.66 114.18 26.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.956 -1.868 . . . . 75.019999999999996 105.956 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.539 HD12 HD21 ' A' ' 76' ' ' LEU . 90.6 mt -79.19 -48.12 14.78 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 119.224 -0.99 . . . . 74.140000000000001 113.537 -175.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.654 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -167.69 174.52 7.62 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.043 -0.355 . . . . 73.150000000000006 110.043 179.682 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.47 -1.52 85.76 Favored Glycine 0 C--N 1.306 -1.131 0 N-CA-C 115.279 0.872 . . . . 55.340000000000003 115.279 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.451 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 2.7 t-20 -173.22 25.04 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.727 1.264 . . . . 73.239999999999995 110.529 -171.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.451 HG11 HD23 ' A' ' 60' ' ' LEU . 13.3 p -80.42 145.47 9.04 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 O-C-N 122.082 -0.386 . . . . 63.119999999999997 110.121 -176.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.526 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 64.0 p -79.02 157.52 28.06 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 122.992 0.517 . . . . 62.520000000000003 111.993 -175.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.506 ' H ' HD23 ' A' ' 73' ' ' LEU . 1.7 mm? -65.38 -32.68 74.45 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 120.943 0.402 . . . . 73.099999999999994 110.526 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.76 -34.94 88.82 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.817 -0.706 . . . . 74.239999999999995 111.353 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.417 ' HB1' HG23 ' A' ' 71' ' ' VAL . . . -78.64 -15.58 58.35 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.898 0.479 . . . . 74.340000000000003 110.863 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.539 HD21 HD12 ' A' ' 67' ' ' LEU . 65.8 mt -86.33 -3.69 59.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 74.040000000000006 110.083 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.6 mptt 70.27 72.05 0.22 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.561 1.145 . . . . 73.099999999999994 111.421 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.403 HD23 ' HB3' ' A' ' 73' ' ' LEU . 10.4 mp -115.37 118.55 39.53 Favored Pre-proline 0 CA--C 1.491 -1.314 0 CA-C-N 116.0 -0.546 . . . . 75.299999999999997 110.822 175.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.07 139.96 44.01 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.99 1.794 . . . . 73.129999999999995 109.085 172.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -69.7 140.82 53.59 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.0 -0.741 . . . . 74.450000000000003 109.0 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 92.05 -9.14 77.12 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.254 -0.974 . . . . 64.319999999999993 113.359 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -101.65 153.28 19.91 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.456 -0.498 . . . . 61.310000000000002 112.275 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.3 m -91.12 118.31 30.32 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.19 -0.914 . . . . 62.020000000000003 110.275 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.3 m -122.4 138.88 54.39 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.951 -0.568 . . . . 75.239999999999995 109.708 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.53 140.44 28.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 110.281 -0.266 . . . . 75.420000000000002 110.281 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 86.6 mtp -138.96 153.76 48.23 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 111.819 0.303 . . . . 73.519999999999996 111.819 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.486 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 83.5 m-70 -106.37 137.39 44.42 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.801 -0.814 . . . . 55.140000000000001 108.801 175.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 88' ' ' LEU . 2.1 mm? -125.28 131.64 53.05 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 122.215 -0.303 . . . . 65.439999999999998 110.894 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.13 135.25 64.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.047 0.451 . . . . 74.230000000000004 110.03 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.259 0 O-C-N 122.279 -0.263 . . . . 52.310000000000002 111.238 -177.857 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.432 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 16.7 t . . . . . 0 N--CA 1.437 -1.08 0 N-CA-C 110.133 -0.321 . . . . 71.140000000000001 110.133 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -68.87 147.42 68.52 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.09 1.86 . . . . 73.430000000000007 110.83 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.05 65.86 7.37 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.979 0.895 . . . . 64.329999999999998 112.055 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -163.26 -31.49 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.688 -1.597 . . . . 73.310000000000002 106.688 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.9 mmm -102.79 148.81 25.15 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.244 -1.343 . . . . 74.329999999999998 109.007 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.406 HD11 ' O ' ' A' ' 10' ' ' ILE . 2.9 pp -107.69 132.1 56.18 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 108.816 -0.809 . . . . 74.150000000000006 108.816 173.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.503 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -88.76 113.78 24.68 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.955 -1.498 . . . . 73.239999999999995 106.955 -177.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.453 ' HG ' HD22 ' A' ' 14' ' ' LEU . 42.6 tp -118.96 133.11 56.04 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 121.164 0.506 . . . . 73.439999999999998 112.087 -173.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.49 ' HD2' ' OE1' ' A' ' 23' ' ' GLU . 20.6 ttt85 -107.02 121.32 44.22 Favored 'General case' 0 N--CA 1.407 -2.578 0 CA-C-N 115.365 -0.834 . . . . 65.109999999999999 108.815 174.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.625 ' CB ' HG22 ' A' ' 39' ' ' VAL . 2.0 mm? -101.3 120.72 40.68 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.568 -1.196 . . . . 73.040000000000006 108.893 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.427 HG22 HG22 ' A' ' 21' ' ' THR . 26.8 mt -104.69 124.71 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 N-CA-C 108.953 -0.758 . . . . 60.450000000000003 108.953 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.3 mt -79.46 168.81 18.95 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.918 -0.583 . . . . 52.32 110.91 -177.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 89' ' ' VAL . 60.0 t -63.84 -31.16 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 122.676 0.39 . . . . 73.239999999999995 111.587 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.1 m -79.0 6.1 10.13 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 122.033 -0.417 . . . . 74.219999999999999 112.069 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.27 13.67 82.54 Favored Glycine 0 CA--C 1.507 -0.412 0 C-N-CA 120.474 -0.869 . . . . 60.109999999999999 111.681 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.476 ' HB3' ' HZ3' ' A' ' 20' ' ' LYS . 2.7 mmmp? -88.03 137.48 32.29 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.845 -1.169 . . . . 74.010000000000005 107.845 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.427 HG22 HG22 ' A' ' 15' ' ' ILE . 73.2 p -117.97 138.02 52.46 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.731 -0.788 . . . . 65.239999999999995 112.841 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.54 ' HD2' ' O ' ' A' ' 39' ' ' VAL . 58.7 mttp -133.26 147.35 51.93 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.511 -0.922 . . . . 74.530000000000001 108.511 169.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.49 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 29.5 tt0 -135.78 131.29 35.29 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.671 -0.863 . . . . 61.32 108.671 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.606 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.6 m-85 -144.75 160.15 41.71 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 122.664 0.386 . . . . 71.120000000000005 109.989 -177.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -82.46 125.73 31.42 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.325 -0.991 . . . . 70.040000000000006 108.325 173.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.606 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 89.8 m-85 -128.92 173.84 10.04 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.537 -0.912 . . . . 74.540000000000006 108.537 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.0 p -100.22 153.14 37.92 Favored Pre-proline 0 N--CA 1.408 -2.556 0 N-CA-C 107.494 -1.298 . . . . 75.430000000000007 107.494 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 40.0 Cg_endo -61.76 -11.45 20.81 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 122.801 2.334 . . . . 74.120000000000005 112.161 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -96.81 -4.24 40.77 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.636 -0.711 . . . . 74.409999999999997 112.243 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -74.7 153.31 38.92 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 119.861 -0.735 . . . . 64.540000000000006 110.833 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.515 ' O ' HG13 ' A' ' 35' ' ' ILE . 53.7 m -92.54 119.89 32.46 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 120.567 0.222 . . . . 74.209999999999994 110.619 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -45.44 -41.7 9.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.337 1.455 . . . . 72.049999999999997 113.568 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.481 ' OG ' ' HB3' ' A' ' 70' ' ' ASN . 24.2 p -69.53 -41.28 76.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.014 0.435 . . . . 75.420000000000002 111.658 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -63.55 -41.77 98.42 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.514 -1.291 . . . . 75.299999999999997 107.514 177.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.543 ' O ' HG21 ' A' ' 39' ' ' VAL . 60.7 mt -61.78 -49.21 85.18 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.565 0 CA-C-N 114.619 -1.173 . . . . 75.030000000000001 110.408 178.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.02 -44.93 51.58 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.905 0.882 . . . . 73.219999999999999 112.043 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.447 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 1.8 tmtp? -73.21 -41.21 64.03 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.515 -0.921 . . . . 73.219999999999999 108.515 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -56.54 -45.26 81.26 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.646 1.179 . . . . 75.420000000000002 110.671 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.625 HG22 ' CB ' ' A' ' 14' ' ' LEU . 33.8 m -77.62 -29.64 16.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.371 -0.831 . . . . 74.430000000000007 111.826 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.4 t80 . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.356 -0.979 . . . . 74.340000000000003 108.356 176.86 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 CA--C 1.493 -1.219 0 N-CA-C 109.964 -0.384 . . . . 71.340000000000003 109.964 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -144.8 147.84 33.34 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.743 -0.662 . . . . 73.430000000000007 110.764 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 1.2 pt? -101.56 133.24 46.53 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 113.248 0.832 . . . . 64.219999999999999 113.248 -174.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.451 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 82.4 mt -102.49 119.03 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 107.302 -1.37 . . . . 62.130000000000003 107.302 175.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.409 ' HH ' HD23 ' A' ' 78' ' ' LEU . 39.4 t80 -101.64 73.6 1.45 Allowed 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.711 0.767 . . . . 71.109999999999999 109.16 -176.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 70.53 -48.5 0.65 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 113.406 -1.725 . . . . 74.219999999999999 112.942 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.42 -65.42 0.74 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 121.03 -0.605 . . . . 54.100000000000001 113.198 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.549 ' NH1' ' HA ' ' A' ' 67' ' ' LEU . 3.1 ppt_? -131.06 176.64 8.08 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.702 0.63 . . . . 73.120000000000005 112.702 -174.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 71.8 m-85 -79.16 118.0 20.71 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.483 -0.932 . . . . 75.109999999999999 108.483 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.549 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 92.8 mt -79.26 -48.82 13.49 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.425 -0.91 . . . . 73.430000000000007 110.763 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -162.92 -171.77 2.81 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 124.293 1.037 . . . . 54.299999999999997 108.983 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.04 -43.22 7.22 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 110.99 -0.844 . . . . 62.100000000000001 110.99 175.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.481 ' HB3' ' OG ' ' A' ' 33' ' ' SER . 4.4 p-10 -148.71 77.86 1.39 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 122.447 1.118 . . . . 72.0 112.033 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.469 ' CG1' HD11 ' A' ' 60' ' ' LEU . 9.4 p -102.11 142.7 15.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 106.166 -1.791 . . . . 72.510000000000005 106.166 173.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.456 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 57.2 p -78.25 157.75 29.16 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.169 0.433 . . . . 65.319999999999993 112.169 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 1.9 mm? -64.82 -30.94 71.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.031 -0.531 . . . . 74.310000000000002 110.952 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.51 -36.62 92.75 Favored Glycine 0 C--N 1.33 0.207 0 N-CA-C 110.833 -0.907 . . . . 73.329999999999998 110.833 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.99 -15.35 62.57 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.262 0.625 . . . . 73.219999999999999 110.686 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 72' ' ' THR . 62.9 mt -84.11 13.73 4.86 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.056 -0.52 . . . . 73.420000000000002 111.116 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.5 mptt 67.37 24.68 8.87 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.663 0.785 . . . . 71.219999999999999 110.528 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.418 HD22 ' HE3' ' A' ' 82' ' ' LYS . 80.2 mt -93.97 122.33 62.19 Favored Pre-proline 0 C--N 1.311 -1.09 0 CA-C-N 115.798 -0.637 . . . . 53.509999999999998 111.04 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.93 171.45 16.47 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.242 1.961 . . . . 62.43 109.699 172.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.416 ' CE1' ' HG3' ' A' ' 28' ' ' PRO . 5.1 m-85 -84.97 170.74 12.73 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.829 -0.804 . . . . 75.540000000000006 108.829 -176.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 74.83 10.17 83.43 Favored Glycine 0 C--N 1.306 -1.101 0 N-CA-C 115.218 0.847 . . . . 71.230000000000004 115.218 173.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HE3' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -131.28 162.7 29.44 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 118.237 1.019 . . . . 65.310000000000002 111.914 178.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.503 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 33.3 m -96.81 126.71 42.16 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 116.145 -0.479 . . . . 74.099999999999994 110.804 -178.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.1 m -115.51 141.48 48.0 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.708 -0.678 . . . . 74.219999999999999 109.691 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.0 p -111.31 130.39 64.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 120.916 0.388 . . . . 45.439999999999998 110.016 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 90.9 mtp -138.38 153.11 48.93 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.051 0.453 . . . . 73.510000000000005 112.071 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.467 ' C ' HD21 ' A' ' 88' ' ' LEU . 60.5 m-70 -108.97 131.32 55.17 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.658 -0.868 . . . . 75.040000000000006 108.658 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.467 HD21 ' C ' ' A' ' 87' ' ' HIS . 3.2 mm? -121.95 144.65 48.75 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 120.784 0.326 . . . . 73.109999999999999 110.893 -177.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.424 ' HA ' ' CG2' ' A' ' 17' ' ' VAL . 27.8 m -119.78 136.69 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 CA-C-N 115.777 -0.647 . . . . 75.120000000000005 110.423 176.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.659 0 N-CA-C 107.293 -1.373 . . . . 72.230000000000004 107.293 174.142 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.485 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 21.2 t . . . . . 0 N--CA 1.438 -1.059 0 N-CA-C 108.853 -0.795 . . . . 54.32 108.853 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -72.34 153.23 55.94 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.165 1.91 . . . . 54.43 111.664 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.86 71.3 5.31 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 122.379 1.085 . . . . 62.119999999999997 109.623 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -167.12 -27.81 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 112.883 -1.962 . . . . 70.420000000000002 106.954 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.1 mmm -112.8 153.08 28.38 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.861 -1.063 . . . . 63.229999999999997 108.778 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -113.9 136.74 49.41 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 N-CA-C 109.757 -0.46 . . . . 63.140000000000001 109.757 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -86.3 107.63 18.05 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.359 -1.349 . . . . 65.340000000000003 107.359 -176.662 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.429 ' HG ' HD23 ' A' ' 14' ' ' LEU . 40.7 tp -119.75 133.6 55.55 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 112.742 0.645 . . . . 74.129999999999995 112.742 -173.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.8 ttp-105 -108.58 121.21 44.53 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.492 -0.776 . . . . 73.019999999999996 109.027 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.593 ' CB ' HG22 ' A' ' 39' ' ' VAL . 2.0 mm? -99.3 121.13 40.65 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 114.701 -1.136 . . . . 73.329999999999998 108.365 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.1 mt -101.37 123.93 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 C-N-CA 119.126 -1.03 . . . . 64.140000000000001 109.459 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.6 mt -81.79 165.07 21.23 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.896 -0.593 . . . . 72.150000000000006 110.383 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.9 m -69.27 -14.6 18.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.503 0.668 . . . . 62.119999999999997 110.81 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.3 m -78.83 1.51 23.13 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 124.43 1.092 . . . . 71.329999999999998 110.482 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.61 20.28 77.1 Favored Glycine 0 CA--C 1.499 -0.96 0 N-CA-C 110.705 -0.958 . . . . 38.060000000000002 110.705 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -108.47 134.67 50.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.076 -1.083 . . . . 75.319999999999993 108.076 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 75.9 p -108.33 137.71 45.83 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 120.247 -0.581 . . . . 62.43 111.07 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -124.93 139.23 54.01 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.969 -1.123 . . . . 73.450000000000003 107.969 169.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -130.81 130.39 43.6 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.354 -0.98 . . . . 73.209999999999994 108.354 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.646 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.0 m-85 -145.18 159.87 42.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.373 -0.603 . . . . 74.349999999999994 109.373 -178.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.6 mt -80.42 125.72 30.28 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 107.637 -1.246 . . . . 71.239999999999995 107.637 173.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.646 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 84.4 m-85 -128.27 166.02 19.39 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.1 -1.074 . . . . 73.109999999999999 108.1 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.4 p -92.47 149.44 38.24 Favored Pre-proline 0 N--CA 1.414 -2.266 0 C-N-CA 118.903 -1.119 . . . . 74.25 108.218 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.454 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 40.2 Cg_endo -62.16 -11.2 20.94 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 122.773 2.316 . . . . 73.329999999999998 112.214 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -93.03 -10.05 37.55 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.727 -0.67 . . . . 75.239999999999995 111.579 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -73.94 153.65 39.69 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.824 0.345 . . . . 72.120000000000005 111.02 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.497 ' O ' HG13 ' A' ' 35' ' ' ILE . 20.4 m -87.24 118.45 26.67 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.348 -0.982 . . . . 74.519999999999996 108.348 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.509 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . . . -54.33 -39.52 67.13 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.663 0.785 . . . . 71.430000000000007 112.689 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 p -73.4 -32.63 64.55 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.223 0.535 . . . . 63.229999999999997 111.526 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -66.9 -43.77 82.54 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.964 -1.125 . . . . 74.230000000000004 107.964 175.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.595 ' O ' HG21 ' A' ' 39' ' ' VAL . 69.4 mt -60.82 -41.59 89.19 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.946 0 CA-C-N 114.364 -1.289 . . . . 65.540000000000006 110.291 177.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 40' ' ' TYR . . . -50.13 -40.08 45.08 Favored 'General case' 0 C--O 1.212 -0.875 0 C-N-CA 122.855 0.462 . . . . 74.120000000000005 111.255 176.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -73.29 -38.46 65.89 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.255 0.55 . . . . 61.039999999999999 110.403 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.448 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 6.0 t60 -59.08 -50.35 74.38 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.895 1.278 . . . . 73.549999999999997 110.292 177.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.595 HG21 ' O ' ' A' ' 35' ' ' ILE . 27.2 m -76.09 -30.35 20.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 123.413 0.685 . . . . 75.219999999999999 112.223 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 47.6 t80 . . . . . 0 N--CA 1.487 1.413 0 C-N-CA 123.669 0.787 . . . . 73.409999999999997 110.78 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.601 ' O ' ' HD2' ' A' ' 59' ' ' ARG . 96.2 mt . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 110.435 -0.209 . . . . 71.239999999999995 110.435 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.601 ' HD2' ' O ' ' A' ' 58' ' ' LEU . 4.4 mpt_? -129.88 150.32 51.23 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 123.291 0.636 . . . . 71.439999999999998 110.118 176.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 4.0 pp -135.34 140.34 44.99 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.805 0.336 . . . . 63.25 111.123 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 95.6 mt -112.66 122.42 66.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 109.03 -0.73 . . . . 71.310000000000002 109.03 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -100.96 87.57 3.32 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 107.048 -1.464 . . . . 75.010000000000005 107.048 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 69.45 -61.5 0.44 Allowed 'General case' 0 N--CA 1.404 -2.74 0 C-N-CA 127.168 2.187 . . . . 71.230000000000004 112.885 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.27 -28.42 1.22 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.177 -1.011 . . . . 73.340000000000003 114.591 -177.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.19 161.31 31.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.483 1.142 . . . . 74.140000000000001 111.992 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.6 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 79.7 m-85 -81.53 117.11 21.66 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.408 -0.96 . . . . 74.230000000000004 108.408 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.503 HD12 HD22 ' A' ' 76' ' ' LEU . 47.6 mt -80.16 -47.68 14.34 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.836 1.05 . . . . 74.299999999999997 113.836 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.444 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 9.2 t60 178.53 134.16 0.08 Allowed 'General case' 0 C--O 1.21 -0.995 0 N-CA-C 107.534 -1.284 . . . . 75.109999999999999 107.534 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.19 1.41 0.09 OUTLIER Glycine 0 CA--C 1.547 2.044 0 N-CA-C 118.335 2.094 . . . . 73.109999999999999 118.335 -174.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -162.77 21.04 0.09 Allowed 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 119.115 1.457 . . . . 74.329999999999998 109.313 -172.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 68' ' ' HIS . 11.0 p -81.38 144.89 9.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 119.939 -0.705 . . . . 64.340000000000003 110.161 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.414 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 40.5 p -82.71 162.44 21.79 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.903 -0.589 . . . . 63.5 111.545 -177.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 73' ' ' LEU . 1.7 mm? -66.99 -35.82 80.8 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.187 -0.46 . . . . 74.25 111.693 -175.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.53 -33.33 86.16 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.374 -0.917 . . . . 73.450000000000003 111.164 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.89 -15.92 60.69 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 123.03 0.532 . . . . 72.439999999999998 111.485 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.503 HD22 HD12 ' A' ' 67' ' ' LEU . 42.5 mt -84.87 -3.48 58.7 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.904 -0.776 . . . . 74.310000000000002 108.904 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.31 77.77 0.12 Allowed 'General case' 0 C--O 1.244 0.8 0 C-N-CA 125.701 1.601 . . . . 73.219999999999999 111.278 -175.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 73' ' ' LEU . 10.6 mp -126.31 111.05 23.63 Favored Pre-proline 0 CA--C 1.497 -1.093 0 CA-C-N 115.274 -0.876 . . . . 75.439999999999998 111.048 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.85 142.37 62.65 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 121.915 1.744 . . . . 70.310000000000002 108.631 172.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -65.51 146.46 54.82 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.872 0.368 . . . . 73.25 110.619 -174.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.485 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 82.57 4.22 90.2 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.866 -0.606 . . . . 73.430000000000007 113.778 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -106.28 154.32 20.92 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 117.51 0.655 . . . . 54.530000000000001 112.409 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.493 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 52.6 m -91.62 121.1 32.98 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 115.534 -0.757 . . . . 75.120000000000005 110.315 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.5 m -130.82 135.63 47.92 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.832 -0.622 . . . . 75.109999999999999 110.501 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.8 p -108.14 142.2 21.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.98 -0.555 . . . . 73.140000000000001 110.851 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 91.2 mtp -135.55 153.29 51.75 Favored 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 123.021 0.528 . . . . 73.25 109.948 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.46 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 64.4 m-70 -105.2 125.49 51.03 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.067 -1.457 . . . . 74.120000000000005 107.067 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.79 142.75 46.51 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 120.04 -0.664 . . . . 73.519999999999996 110.938 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.62 132.58 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 N-CA-C 108.013 -1.106 . . . . 74.099999999999994 108.013 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.559 0 N-CA-C 109.563 -0.532 . . . . 75.120000000000005 109.563 179.685 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.4 t . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 107.759 -1.2 . . . . 61.229999999999997 107.759 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 8' ' ' ASP . 25.3 Cg_endo -61.18 19.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.534 3.489 . . . . 73.030000000000001 118.374 -170.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 63.41 -32.41 0.11 Allowed 'General case' 0 C--O 1.194 -1.855 0 C-N-CA 125.187 1.395 . . . . 73.340000000000003 114.607 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 6' ' ' PRO . 29.9 t70 -86.89 -10.03 54.31 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.94 0.876 . . . . 72.450000000000003 110.089 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.1 mmm -124.52 153.47 42.02 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.382 -0.827 . . . . 73.439999999999998 109.22 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.403 HG22 ' HA ' ' A' ' 80' ' ' PHE . 2.8 pp -100.04 139.13 22.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 107.979 -1.119 . . . . 55.030000000000001 107.979 173.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.485 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -98.9 121.96 41.52 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.18 -1.044 . . . . 73.439999999999998 108.18 -175.636 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.441 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.1 tp -126.68 133.66 50.89 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 112.458 0.54 . . . . 62.340000000000003 112.458 -175.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -108.18 121.47 44.92 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.697 -0.683 . . . . 74.340000000000003 109.558 171.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.552 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.3 mm? -95.92 127.22 41.75 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 124.854 1.262 . . . . 64.230000000000004 108.685 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 86' ' ' MET . 17.8 mm -99.72 120.25 48.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.568 -0.901 . . . . 72.450000000000003 108.568 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.2 mp -78.45 153.52 31.38 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.059 -0.719 . . . . 71.019999999999996 109.059 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.4 m -69.72 -13.64 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.579 0.704 . . . . 75.329999999999998 111.128 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.7 m -76.42 -9.78 58.9 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.392 -0.822 . . . . 75.420000000000002 109.792 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.56 7.19 61.94 Favored Glycine 0 CA--C 1.498 -0.997 0 CA-C-N 116.105 -0.498 . . . . 74.329999999999998 112.744 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -87.61 131.58 34.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.49 -0.929 . . . . 75.319999999999993 108.49 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.466 HG21 HD12 ' A' ' 15' ' ' ILE . 29.1 p -104.83 129.09 53.2 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.157 -1.423 . . . . 51.25 107.157 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -131.42 138.71 49.2 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.534 -0.913 . . . . 73.310000000000002 108.534 -175.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.426 ' CD ' HD22 ' A' ' 11' ' ' ASN . 1.0 OUTLIER -132.38 131.33 41.74 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.185 0.439 . . . . 72.25 112.185 -170.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.613 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 94.2 m-85 -144.61 160.24 41.48 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 115.276 -0.875 . . . . 74.109999999999999 110.513 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.7 mt -80.75 126.04 30.81 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.85 -1.167 . . . . 64.219999999999999 107.85 173.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.613 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 80.0 m-85 -128.35 165.09 21.25 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.876 -0.416 . . . . 72.010000000000005 109.876 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.5 m -92.51 142.92 26.45 Favored Pre-proline 0 N--CA 1.414 -2.259 0 N-CA-C 107.431 -1.322 . . . . 73.129999999999995 107.431 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.0 -11.34 21.11 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.751 2.301 . . . . 55.329999999999998 113.087 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -83.0 -17.49 43.2 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.055 0.942 . . . . 64.329999999999998 110.879 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.79 154.34 42.11 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.806 0.669 . . . . 55.450000000000003 112.806 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.521 ' O ' HG13 ' A' ' 35' ' ' ILE . 18.3 m -96.16 122.82 39.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.339 -0.846 . . . . 73.310000000000002 109.638 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.489 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -50.16 -51.8 40.62 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.834 1.049 . . . . 63.549999999999997 113.834 -176.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -69.58 -28.1 65.68 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.267 0.556 . . . . 62.329999999999998 110.831 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.44 -46.58 72.69 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.264 -1.013 . . . . 73.510000000000005 108.264 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 31' ' ' SER . 69.5 mt -59.89 -43.49 92.23 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.342 0 CA-C-N 114.543 -1.208 . . . . 74.140000000000001 110.29 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.409 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -50.41 -48.63 56.05 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.89 0.876 . . . . 74.230000000000004 111.799 178.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -72.41 -32.16 66.11 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.68 -0.859 . . . . 73.510000000000005 108.68 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -69.74 -51.23 35.98 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.625 0.77 . . . . 75.030000000000001 110.7 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.552 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.2 m -62.42 -32.07 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 123.103 0.561 . . . . 63.109999999999999 112.355 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.5 t80 . . . . . 0 C--O 1.239 0.518 0 O-C-N 123.662 0.601 . . . . 75.530000000000001 110.045 178.506 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.3 tp . . . . . 0 N--CA 1.445 -0.71 0 N-CA-C 108.867 -0.79 . . . . 75.120000000000005 108.867 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -141.57 163.3 33.31 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.142 0.496 . . . . 53.439999999999998 111.171 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 4.5 pp -141.08 150.69 43.23 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.554 -0.748 . . . . 61.219999999999999 110.265 -176.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.0 mt -122.82 126.78 74.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 108.891 -0.781 . . . . 51.149999999999999 108.891 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.423 ' HH ' HD23 ' A' ' 78' ' ' LEU . 13.7 t80 -100.16 72.22 1.64 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.483 -1.303 . . . . 75.420000000000002 107.483 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 65.06 -56.58 0.29 Allowed 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 128.109 2.564 . . . . 61.43 112.672 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.39 -62.17 1.35 Allowed Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 121.59 -0.338 . . . . 62.420000000000002 113.225 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.424 ' HD3' ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -131.03 175.96 8.64 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 117.369 0.585 . . . . 71.530000000000001 111.873 -175.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 56.0 m-85 -80.21 118.86 22.27 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.976 -1.12 . . . . 74.209999999999994 107.976 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.0 mt -79.72 -47.2 15.71 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.482 -0.887 . . . . 75.129999999999995 111.926 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.532 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 12.3 t60 -169.08 168.19 10.15 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 105.278 -2.119 . . . . 72.209999999999994 105.278 -174.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.88 -1.77 87.69 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 120.276 -0.964 . . . . 37.899999999999999 113.318 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 31' ' ' SER . 48.8 t-20 -177.84 73.62 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.449 0.642 . . . . 74.319999999999993 109.775 -174.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.51 ' H ' HD23 ' A' ' 60' ' ' LEU . 14.5 p -104.51 151.76 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 N-CA-C 108.726 -0.842 . . . . 72.230000000000004 108.726 175.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.45 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 64.2 p -87.18 162.6 17.4 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 118.124 0.42 . . . . 74.430000000000007 110.682 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.497 ' H ' HD21 ' A' ' 73' ' ' LEU . 1.5 mm? -68.59 -34.8 76.41 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.783 0.325 . . . . 70.329999999999998 111.055 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.9 -34.22 89.26 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.717 -0.754 . . . . 65.299999999999997 111.26 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.402 ' HB3' HG21 ' A' ' 71' ' ' VAL . . . -72.8 -15.52 61.63 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.014 0.525 . . . . 60.509999999999998 111.571 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 72' ' ' THR . 70.9 mt -82.31 -1.66 50.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 75.420000000000002 109.93 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.416 ' N ' ' HD2' ' A' ' 77' ' ' LYS . 9.8 mptt 65.19 72.17 0.43 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 108.936 -0.764 . . . . 72.040000000000006 108.936 -175.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.423 HD23 ' HH ' ' A' ' 62' ' ' TYR . 94.5 mt -131.32 123.34 19.55 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-N 115.567 -0.742 . . . . 74.109999999999999 110.508 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -80.07 143.65 16.22 Favored 'Trans proline' 0 N--CA 1.429 -2.269 0 C-N-CA 122.041 1.827 . . . . 72.230000000000004 110.326 173.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.403 ' HA ' HG22 ' A' ' 10' ' ' ILE . 1.6 p90 -75.36 148.38 39.29 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 115.033 -0.985 . . . . 74.409999999999997 110.227 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.59 2.73 67.24 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.174 -1.012 . . . . 62.329999999999998 110.912 -174.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -120.93 157.97 28.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 122.1 0.16 . . . . 61.240000000000002 110.645 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 26.2 m -105.69 127.32 53.0 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.147 0.498 . . . . 74.340000000000003 110.574 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.2 m -125.67 142.93 51.26 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.807 -0.633 . . . . 75.319999999999993 110.196 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.66 138.19 42.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 120.826 0.346 . . . . 74.129999999999995 110.203 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.54 ' O ' HG12 ' A' ' 15' ' ' ILE . 90.1 mtp -135.1 152.2 51.43 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.948 -0.39 . . . . 72.439999999999998 109.948 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.454 ' C ' HD23 ' A' ' 88' ' ' LEU . 50.4 m-70 -104.07 134.14 47.83 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 109.045 -0.724 . . . . 71.209999999999994 109.045 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.454 HD23 ' C ' ' A' ' 87' ' ' HIS . 2.4 mm? -123.02 144.09 49.5 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 120.482 -0.487 . . . . 74.540000000000006 109.798 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.63 134.05 62.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 116.011 -0.54 . . . . 71.25 109.948 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.568 0 CA-C-N 115.815 -0.63 . . . . 73.319999999999993 109.361 179.314 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.456 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 38.3 t . . . . . 0 N--CA 1.431 -1.388 0 N-CA-C 109.051 -0.722 . . . . 73.219999999999999 109.051 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.22 166.67 8.77 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.682 2.254 . . . . 75.120000000000005 112.52 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.61 7.78 39.86 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.697 -0.683 . . . . 75.319999999999993 110.358 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -123.09 -0.22 8.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.033 -0.53 . . . . 75.349999999999994 110.184 175.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.1 mmm -130.74 155.77 46.09 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.964 -0.754 . . . . 64.150000000000006 108.964 -178.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.406 HD11 ' O ' ' A' ' 10' ' ' ILE . 2.9 pp -122.73 134.11 66.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.002 -0.74 . . . . 71.420000000000002 109.002 174.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.485 HD21 HG22 ' A' ' 83' ' ' THR . 6.4 t30 -90.83 109.87 21.08 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.536 -0.913 . . . . 74.319999999999993 108.536 -175.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.429 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.0 tp -113.4 135.56 53.73 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 112.563 0.579 . . . . 75.510000000000005 112.563 -172.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 33.5 ttp180 -106.22 120.26 41.37 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 108.684 -0.858 . . . . 60.039999999999999 108.684 172.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.448 ' CB ' HG23 ' A' ' 39' ' ' VAL . 2.7 mm? -93.19 127.36 38.73 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.123 -1.399 . . . . 64.230000000000004 109.392 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.481 HG12 HG21 ' A' ' 21' ' ' THR . 22.6 mt -101.33 119.95 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 C-N-CA 118.937 -1.105 . . . . 65.519999999999996 109.369 176.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.5 tp -78.38 159.63 28.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.499 -0.773 . . . . 75.310000000000002 110.689 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.7 m -61.83 -13.76 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.913 0.885 . . . . 73.239999999999995 113.156 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.3 t -82.28 -10.03 59.26 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.566 -0.531 . . . . 63.210000000000001 109.566 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.23 11.44 62.89 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.069 -0.813 . . . . 73.120000000000005 111.069 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.67 148.99 26.78 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.093 -0.706 . . . . 63.32 109.093 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.481 HG21 HG12 ' A' ' 15' ' ' ILE . 69.5 p -112.33 152.55 28.42 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.084 0.468 . . . . 73.219999999999999 112.244 -174.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -146.22 139.7 26.02 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.445 -0.798 . . . . 72.040000000000006 110.575 169.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 27.4 tt0 -122.18 132.31 54.39 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.809 -0.632 . . . . 74.219999999999999 109.939 -173.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.697 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 89.7 m-85 -144.26 158.83 43.52 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.859 -0.793 . . . . 74.150000000000006 108.859 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.8 tp -85.62 125.39 33.1 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.043 -1.095 . . . . 74.310000000000002 108.043 176.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.697 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 89.9 m-85 -130.31 172.87 11.37 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.474 -0.565 . . . . 72.099999999999994 109.474 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.7 p -95.52 150.52 37.61 Favored Pre-proline 0 N--CA 1.409 -2.514 0 N-CA-C 107.099 -1.445 . . . . 53.5 107.099 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.661 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 57.9 Cg_endo -64.61 -11.51 29.17 Favored 'Trans proline' 0 C--N 1.321 -0.868 0 C-N-CA 122.297 1.998 . . . . 72.450000000000003 111.423 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -91.58 -6.0 53.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.387 -0.824 . . . . 64.049999999999997 111.83 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -75.77 151.48 37.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 120.628 -0.429 . . . . 74.409999999999997 110.504 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.597 ' O ' HG13 ' A' ' 35' ' ' ILE . 54.0 m -87.07 119.98 27.87 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 110.001 -0.37 . . . . 73.329999999999998 110.001 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.475 ' CB ' HD12 ' A' ' 60' ' ' LEU . . . -45.01 -56.18 4.87 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.723 1.379 . . . . 74.510000000000005 114.723 -176.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.2 m -75.65 -21.71 57.42 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.215 -0.594 . . . . 75.5 111.957 -176.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.09 -40.2 78.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.032 -1.47 . . . . 74.5 107.032 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 31' ' ' SER . 70.0 mt -63.74 -42.42 95.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 CA-C-N 114.401 -1.272 . . . . 75.099999999999994 109.986 176.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.61 -36.76 56.94 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.058 0.543 . . . . 73.420000000000002 111.771 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -72.62 -37.06 68.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.065 0.46 . . . . 75.120000000000005 110.068 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -70.08 -48.26 58.45 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.619 -0.719 . . . . 74.239999999999995 111.802 -178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.448 HG23 ' CB ' ' A' ' 14' ' ' LEU . 27.6 m -63.26 -31.07 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.021 0.439 . . . . 73.519999999999996 111.431 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.2 t80 . . . . . 0 CA--C 1.543 0.71 0 CA-C-N 115.182 -0.917 . . . . 73.329999999999998 111.761 175.864 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.422 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 97.0 mt . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 108.199 -1.037 . . . . 64.319999999999993 108.199 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 68' ' ' HIS . 18.2 tpt180 -146.85 141.62 26.8 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.096 -0.705 . . . . 73.430000000000007 109.096 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.475 HD12 ' CB ' ' A' ' 32' ' ' ALA . 1.2 pt? -112.81 140.93 47.18 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 121.064 -0.254 . . . . 71.209999999999994 111.201 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 61.9 mt -111.64 117.38 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.926 -0.768 . . . . 75.239999999999995 108.926 176.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.533 ' CB ' HD22 ' A' ' 67' ' ' LEU . 33.4 t80 -105.35 76.08 1.2 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.842 -0.743 . . . . 73.239999999999995 109.002 174.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 63' ' ' GLN 0.331 15.0 mm100 36.2 83.69 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 116.222 1.934 . . . . 62.310000000000002 116.222 178.515 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.89 -63.3 0.62 Allowed Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 114.879 -1.055 . . . . 70.420000000000002 110.908 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -130.81 156.4 45.06 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.047 -0.661 . . . . 75.109999999999999 112.077 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -87.48 114.08 23.77 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 104.648 -2.353 . . . . 71.129999999999995 104.648 175.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.533 HD22 ' CB ' ' A' ' 62' ' ' TYR . 1.4 mm? -72.3 -50.31 27.96 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 119.603 -0.839 . . . . 72.530000000000001 112.198 -168.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.488 ' HB2' HG22 ' A' ' 71' ' ' VAL . 19.6 m80 179.73 -161.31 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 126.65 1.98 . . . . 74.209999999999994 106.262 -176.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 58' ' ' LEU . . . -84.51 -46.3 5.83 Favored Glycine 0 C--O 1.208 -1.476 0 N-CA-C 115.46 0.944 . . . . 73.099999999999994 115.46 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -134.64 34.58 3.19 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.392 1.096 . . . . 71.510000000000005 113.231 -172.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 68' ' ' HIS . 74.0 t -62.03 137.65 23.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.533 -0.543 . . . . 75.549999999999997 109.533 176.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.585 ' HB ' ' O ' ' A' ' 28' ' ' PRO . 29.0 p -78.52 156.81 29.07 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.848 -0.615 . . . . 72.340000000000003 110.805 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.487 ' H ' HD21 ' A' ' 73' ' ' LEU . 2.2 mm? -64.86 -35.44 81.12 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.594 -0.73 . . . . 72.209999999999994 110.133 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.57 -36.54 93.36 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.907 -0.588 . . . . 65.299999999999997 111.864 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.41 -16.62 63.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.986 0.422 . . . . 71.219999999999999 110.939 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.44 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 75.4 mt -83.79 12.43 6.02 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.765 0.826 . . . . 75.340000000000003 111.046 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.74 19.65 9.63 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.204 1.002 . . . . 73.120000000000005 110.491 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.44 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 94.0 mt -80.7 116.98 65.81 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.191 -0.459 . . . . 72.129999999999995 111.224 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.58 161.27 31.21 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 C-N-CA 122.071 1.847 . . . . 61.439999999999998 110.829 175.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.661 ' CE2' ' HG3' ' A' ' 28' ' ' PRO . 71.7 m-85 -79.36 163.53 24.78 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.685 -0.857 . . . . 73.099999999999994 108.685 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.456 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 83.52 0.14 89.85 Favored Glycine 0 C--N 1.301 -1.371 0 C-N-CA 120.624 -0.798 . . . . 74.209999999999994 114.784 175.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.95 157.68 35.47 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 118.971 -1.092 . . . . 74.25 112.688 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.485 HG22 HD21 ' A' ' 11' ' ' ASN . 24.6 m -90.02 120.92 31.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.564 -0.744 . . . . 71.439999999999998 110.247 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.0 m -113.42 135.17 54.17 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.605 -0.271 . . . . 52.43 110.977 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.15 126.88 70.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 N-CA-C 109.676 -0.49 . . . . 74.209999999999994 109.676 175.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.438 ' O ' HG13 ' A' ' 15' ' ' ILE . 85.4 mtp -136.39 153.46 51.1 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-O 121.198 0.523 . . . . 75.439999999999998 112.098 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.482 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 40.9 m-70 -102.24 137.15 40.87 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.458 -0.792 . . . . 75.420000000000002 109.936 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.426 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.6 mm? -120.53 141.42 50.27 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.958 -0.756 . . . . 73.439999999999998 108.958 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.454 ' CG2' ' HB3' ' A' ' 59' ' ' ARG . 30.2 m -125.36 136.08 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-O 121.731 0.777 . . . . 72.340000000000003 111.05 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.413 0 N-CA-C 106.343 -1.725 . . . . 75.230000000000004 106.343 177.235 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.556 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 17.0 t . . . . . 0 N--CA 1.443 -0.808 0 N-CA-C 109.713 -0.477 . . . . 74.530000000000001 109.713 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.65 170.92 16.4 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.387 2.058 . . . . 62.030000000000001 111.616 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 80' ' ' PHE . . . -79.14 14.56 1.41 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.341 0.591 . . . . 64.129999999999995 111.484 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -108.32 -11.37 15.22 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.486 -0.561 . . . . 73.150000000000006 109.486 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.4 mmm -130.9 158.03 41.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.024 -0.535 . . . . 74.420000000000002 110.328 -174.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.43 ' CD1' ' HG ' ' A' ' 73' ' ' LEU . 2.8 pp -119.01 140.88 41.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.586 -0.524 . . . . 74.239999999999995 109.586 174.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.452 HD21 HG23 ' A' ' 83' ' ' THR . 7.3 t30 -94.83 115.73 27.85 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.424 -0.954 . . . . 73.510000000000005 108.424 -176.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.433 ' HG ' HD22 ' A' ' 14' ' ' LEU . 42.3 tp -117.77 133.88 55.49 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.646 0.736 . . . . 71.439999999999998 112.57 -173.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.483 ' HD2' ' OE1' ' A' ' 23' ' ' GLU . 21.8 ttt85 -106.61 120.52 42.18 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 108.14 -1.059 . . . . 63.210000000000001 108.14 176.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 14' ' ' LEU . 2.0 mm? -100.67 127.48 47.06 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.875 -1.057 . . . . 64.239999999999995 109.635 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 86' ' ' MET . 21.3 mm -99.28 116.53 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 106.917 -1.512 . . . . 63.43 106.917 175.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.77 158.38 33.6 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.348 -0.387 . . . . 71.540000000000006 110.619 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 90' ' ' ALA . 90.2 t -66.01 -23.32 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 121.602 0.715 . . . . 75.209999999999994 110.2 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.2 m -75.56 -3.87 36.71 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.12 -0.945 . . . . 72.439999999999998 110.127 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.15 8.8 84.97 Favored Glycine 0 CA--C 1.495 -1.189 0 N-CA-C 111.579 -0.609 . . . . 53.210000000000001 111.579 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -87.19 131.44 34.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.558 -1.275 . . . . 74.409999999999997 107.558 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.5 p -107.76 129.28 55.06 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 109.905 -0.406 . . . . 55.530000000000001 109.905 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -148.47 149.92 32.53 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.183 -0.607 . . . . 72.200000000000003 110.344 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.483 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 29.7 tt0 -130.45 132.74 45.85 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.893 -0.14 . . . . 74.530000000000001 110.97 -170.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.501 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 35.0 m-85 -143.23 160.57 40.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.624 0.726 . . . . 73.209999999999994 112.107 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.472 ' CD1' HG11 ' A' ' 5' ' ' VAL . 37.3 tp -85.66 126.07 33.65 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.15 -0.932 . . . . 63.009999999999998 109.325 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.501 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 97.5 m-85 -133.42 171.12 14.5 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.672 -0.492 . . . . 73.409999999999997 109.672 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.3 p -94.99 150.65 38.05 Favored Pre-proline 0 N--CA 1.419 -2.001 0 C-N-CA 119.054 -1.058 . . . . 75.400000000000006 108.206 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -62.85 -11.39 24.03 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.43 2.087 . . . . 74.219999999999999 111.784 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -79.68 -21.35 44.81 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.199 1.0 . . . . 73.299999999999997 109.777 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -75.77 152.27 37.4 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 116.321 -0.4 . . . . 70.230000000000004 110.429 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.519 ' O ' HG13 ' A' ' 35' ' ' ILE . 77.1 p -106.16 138.29 42.6 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 109.972 -0.381 . . . . 62.539999999999999 109.972 178.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.542 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -50.95 -49.62 59.53 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.864 1.061 . . . . 61.119999999999997 113.864 -175.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.0 m -64.52 -31.63 72.93 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 120.949 0.404 . . . . 52.219999999999999 110.891 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 20.6 t70 -70.12 -45.47 66.82 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.869 -0.789 . . . . 72.310000000000002 108.869 175.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 31' ' ' SER . 60.9 mt -60.78 -33.64 56.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.155 -0.93 . . . . 72.310000000000002 112.281 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.71 -40.43 40.49 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 110.491 -0.188 . . . . 72.420000000000002 110.491 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 1.6 mptm? -64.11 -44.68 91.52 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.343 0.592 . . . . 72.049999999999997 109.838 177.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -62.57 -43.42 98.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.053 -1.43 . . . . 61.210000000000001 110.118 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.462 HG12 HD21 ' A' ' 14' ' ' LEU . 36.0 m -74.9 -32.17 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 113.76 1.022 . . . . 64.129999999999995 113.76 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 113.266 0.839 . . . . 75.150000000000006 113.266 176.326 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 CA--C 1.488 -1.407 0 N-CA-C 107.639 -1.245 . . . . 75.519999999999996 107.639 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.419 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 17.3 ptt180 -147.2 159.93 43.05 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.226 0.536 . . . . 72.129999999999995 112.262 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 4.4 pp -127.83 144.62 51.09 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.407 -0.815 . . . . 63.329999999999998 111.445 -172.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.449 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 85.6 mt -112.87 118.79 58.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.82 -0.807 . . . . 72.209999999999994 108.82 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -105.1 74.75 1.13 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.558 -0.534 . . . . 73.510000000000005 109.558 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 43.26 80.03 0.04 OUTLIER 'General case' 0 C--O 1.244 0.786 0 O-C-N 124.725 1.266 . . . . 63.509999999999998 113.367 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.74 -72.05 0.48 Allowed Glycine 0 N--CA 1.419 -2.439 0 CA-C-N 114.879 -1.055 . . . . 41.240000000000002 111.624 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -130.83 174.41 10.0 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.23 0.538 . . . . 70.219999999999999 112.375 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.582 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 71.0 m-85 -87.78 117.34 26.55 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 105.905 -1.887 . . . . 71.430000000000007 105.905 172.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.81 -47.96 14.33 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.728 -0.789 . . . . 74.439999999999998 112.258 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.513 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 10.4 t60 -172.67 158.04 3.97 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.736 -1.579 . . . . 72.430000000000007 106.736 -177.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -69.45 -0.65 24.63 Favored Glycine 0 CA--C 1.542 1.736 0 N-CA-C 117.091 1.596 . . . . 51.32 117.091 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -175.71 31.65 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.239 1.52 . . . . 62.340000000000003 109.362 -171.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.43 HG11 HD23 ' A' ' 60' ' ' LEU . 10.6 p -78.85 138.77 19.5 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 119.527 -0.869 . . . . 75.540000000000006 109.171 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.403 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 47.3 p -79.56 157.48 27.36 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.015 0.436 . . . . 63.350000000000001 112.032 -175.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.43 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 3.1 mm? -61.36 -34.22 74.93 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.612 -0.722 . . . . 72.129999999999995 111.487 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.32 -30.03 76.7 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.0 -0.619 . . . . 63.32 111.907 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.68 -15.74 58.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.397 0.617 . . . . 74.510000000000005 110.276 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.443 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 53.3 mt -83.19 12.89 4.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.825 -0.625 . . . . 74.140000000000001 111.158 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.0 mptt 69.46 12.56 8.27 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.209 1.004 . . . . 73.420000000000002 111.106 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.443 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 89.7 mt -76.03 121.81 85.72 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 112.374 0.509 . . . . 74.120000000000005 112.374 -175.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -75.57 159.04 39.67 Favored 'Trans proline' 0 N--CA 1.442 -1.515 0 C-N-CA 122.091 1.861 . . . . 51.43 109.754 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.415 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 12.0 m-85 -80.67 151.51 28.92 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.059 -0.719 . . . . 63.539999999999999 109.059 -174.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.556 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 84.95 4.01 87.4 Favored Glycine 0 C--N 1.306 -1.112 0 C-N-CA 120.493 -0.861 . . . . 64.319999999999993 113.53 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -110.35 149.27 30.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 117.013 0.406 . . . . 72.109999999999999 111.085 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.452 HG23 HD21 ' A' ' 11' ' ' ASN . 94.6 m -91.2 123.49 34.68 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.596 -0.729 . . . . 73.430000000000007 110.38 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.3 m -118.56 131.38 56.21 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.264 -0.88 . . . . 73.010000000000005 110.316 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.452 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 7.5 p -103.25 124.46 57.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.989 0.423 . . . . 75.340000000000003 110.281 177.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.449 ' O ' HG12 ' A' ' 15' ' ' ILE . 91.0 mtp -129.37 152.21 49.17 Favored 'General case' 0 CA--C 1.486 -1.5 0 CA-C-O 121.368 0.604 . . . . 75.319999999999993 110.603 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.449 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 38.5 m-70 -106.32 126.17 51.91 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.433 -0.803 . . . . 71.319999999999993 108.913 -178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -115.05 144.03 44.27 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-O 121.071 0.462 . . . . 62.43 111.992 -176.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.96 132.17 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 115.462 -0.79 . . . . 65.209999999999994 108.987 176.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.415 ' H ' HG22 ' A' ' 17' ' ' VAL . . . . . . . . 0 C--N 1.301 -1.505 0 CA-C-N 115.59 -0.732 . . . . 65.420000000000002 109.686 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.422 HG12 ' CD1' ' A' ' 25' ' ' LEU . 11.7 t . . . . . 0 N--CA 1.431 -1.376 0 N-CA-C 109.445 -0.576 . . . . 71.040000000000006 109.445 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -71.9 149.01 52.75 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 122.11 1.873 . . . . 72.129999999999995 109.876 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.35 73.32 5.98 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.059 0.933 . . . . 64.540000000000006 110.137 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -169.51 -37.91 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.458 -1.682 . . . . 61.530000000000001 106.458 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.0 mmm -96.99 143.64 27.65 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.523 -1.671 . . . . 75.299999999999997 108.675 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -98.66 140.81 17.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-O 121.033 0.444 . . . . 53.420000000000002 111.273 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.592 ' OD1' HG21 ' A' ' 83' ' ' THR . 18.7 t-20 -87.64 125.85 34.61 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.282 -0.636 . . . . 51.020000000000003 109.282 177.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.474 ' HG ' ' CD2' ' A' ' 14' ' ' LEU . 30.6 tp -131.8 132.21 43.56 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-O 121.326 0.584 . . . . 75.200000000000003 111.468 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.491 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . 23.1 ttt85 -106.93 120.99 43.53 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-N 114.917 -1.038 . . . . 75.230000000000004 109.115 175.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.545 ' CB ' HG22 ' A' ' 39' ' ' VAL . 1.8 mm? -103.74 126.49 50.91 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.04 -0.982 . . . . 74.439999999999998 108.823 -178.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 86' ' ' MET . 34.2 mt -99.47 119.36 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 107.944 -1.132 . . . . 73.0 107.944 175.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.9 mt -72.15 154.12 41.25 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.485 -0.779 . . . . 72.109999999999999 110.245 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.5 t -63.71 -15.99 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 122.086 0.946 . . . . 71.420000000000002 109.577 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.3 t -80.2 -10.19 59.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.187 -0.915 . . . . 65.230000000000004 110.447 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.51 70.4 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.574 -0.822 . . . . 63.399999999999999 112.392 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -87.32 135.53 33.29 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.666 -0.414 . . . . 63.030000000000001 110.901 176.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.6 p -100.95 129.88 46.86 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.721 -0.672 . . . . 64.219999999999999 110.316 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -140.6 138.68 34.61 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.2 -0.6 . . . . 75.140000000000001 111.183 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 28.7 tt0 -121.93 140.8 52.0 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 115.502 -0.772 . . . . 71.010000000000005 109.133 -173.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.689 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 72.1 m-85 -143.72 160.32 40.92 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 123.523 0.729 . . . . 75.209999999999994 109.985 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.422 ' CD1' HG12 ' A' ' 5' ' ' VAL . 32.9 tp -82.25 125.75 31.31 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 107.338 -1.356 . . . . 74.219999999999999 107.338 175.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.689 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 86.3 m-85 -132.07 172.77 11.96 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.862 -0.421 . . . . 72.400000000000006 109.862 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.1 p -100.02 148.93 35.51 Favored Pre-proline 0 C--N 1.286 -2.188 0 N-CA-C 107.589 -1.264 . . . . 60.340000000000003 107.589 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.69 -11.94 22.82 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 121.73 1.62 . . . . 72.129999999999995 112.079 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -80.05 -23.29 41.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.331 0.652 . . . . 70.129999999999995 111.156 177.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' O ' HD21 ' A' ' 73' ' ' LEU . 36.2 m-20 -66.89 154.38 41.12 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 120.769 0.319 . . . . 63.100000000000001 111.655 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.566 ' O ' HG13 ' A' ' 35' ' ' ILE . 44.2 m -98.52 124.03 43.02 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 122.295 -0.253 . . . . 62.229999999999997 110.579 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.446 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -46.63 -59.4 3.04 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 114.503 1.297 . . . . 71.400000000000006 114.503 -176.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 m -67.06 -27.83 67.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.223 0.535 . . . . 75.129999999999995 111.455 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.49 -47.26 67.5 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.733 -1.21 . . . . 70.140000000000001 107.733 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 31' ' ' SER . 77.1 mt -56.16 -36.34 45.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.132 -0.94 . . . . 74.409999999999997 111.621 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.75 -36.85 38.74 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.098 0.559 . . . . 72.319999999999993 112.357 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.6 -42.96 63.95 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 107.096 -1.446 . . . . 63.109999999999999 107.096 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.484 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 43.2 t-80 -55.87 -54.05 49.37 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.016 -1.447 . . . . 73.319999999999993 111.124 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.545 HG22 ' CB ' ' A' ' 14' ' ' LEU . 28.9 m -70.68 -31.64 46.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.035 -0.984 . . . . 64.209999999999994 112.362 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 86.6 t80 . . . . . 0 C--O 1.244 0.782 0 N-CA-C 112.447 0.536 . . . . 74.409999999999997 112.447 -179.162 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 CA--C 1.503 -0.858 0 N-CA-C 108.076 -1.083 . . . . 70.209999999999994 108.076 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -143.53 142.82 31.28 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.366 -0.605 . . . . 75.430000000000007 109.366 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 4.6 pp -130.31 132.72 46.0 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 120.99 0.424 . . . . 64.0 110.758 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 86.8 mt -108.32 120.6 59.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 121.47 0.652 . . . . 63.140000000000001 109.545 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -101.83 85.39 2.7 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 108.683 -0.858 . . . . 75.400000000000006 108.683 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 59.86 18.42 7.4 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.141 -1.391 . . . . 73.439999999999998 114.19 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.58 -52.85 0.37 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.367 -0.92 . . . . 73.439999999999998 112.985 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.4 156.32 23.67 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.065 -0.654 . . . . 63.310000000000002 111.361 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 85.8 m-85 -78.6 122.53 26.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.617 -1.253 . . . . 73.340000000000003 107.617 176.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.512 HD12 ' CD2' ' A' ' 76' ' ' LEU . 45.9 mt -79.71 -46.54 16.91 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 118.978 -1.089 . . . . 61.140000000000001 112.711 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.53 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.3 t-80 -165.48 172.6 11.93 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.005 -1.85 . . . . 73.430000000000007 106.005 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.56 -25.58 75.47 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.289 -0.958 . . . . 74.530000000000001 114.064 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -175.25 72.21 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.998 0.904 . . . . 74.230000000000004 109.054 -175.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.482 HG12 HD21 ' A' ' 76' ' ' LEU . 7.2 p -102.88 151.25 6.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 114.194 -1.366 . . . . 70.310000000000002 108.821 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.513 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 40.4 p -78.46 157.35 28.97 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 120.718 0.294 . . . . 72.109999999999999 111.212 -175.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.514 ' HA ' HD13 ' A' ' 76' ' ' LEU . 1.2 mm? -63.85 -27.5 69.21 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.765 0.426 . . . . 74.310000000000002 111.478 -177.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.66 -37.69 93.79 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.513 -1.035 . . . . 63.039999999999999 110.513 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.462 ' HB3' HG21 ' A' ' 71' ' ' VAL . . . -79.56 -16.87 55.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.341 0.591 . . . . 71.239999999999995 109.91 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.514 HD13 ' HA ' ' A' ' 73' ' ' LEU . 92.7 mt -86.51 2.96 46.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.693 -0.685 . . . . 65.420000000000002 110.716 176.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 11.1 mptt 69.56 21.2 6.81 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.9 0.88 . . . . 71.030000000000001 112.911 178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 10.4 mp -67.54 126.26 92.33 Favored Pre-proline 0 CA--C 1.511 -0.543 0 C-N-CA 119.726 -0.789 . . . . 65.209999999999994 111.426 176.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 5.6 Cg_endo -86.6 137.22 4.8 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 122.427 2.085 . . . . 71.109999999999999 112.029 178.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -73.92 128.15 34.74 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.643 -0.708 . . . . 74.120000000000005 111.12 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.82 -6.01 76.67 Favored Glycine 0 C--N 1.3 -1.435 0 CA-C-N 115.096 -0.957 . . . . 51.109999999999999 111.925 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.52 ' O ' ' HB3' ' A' ' 11' ' ' ASN . 92.6 mttt -116.67 149.29 40.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 117.389 0.594 . . . . 74.319999999999993 111.655 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.592 HG21 ' OD1' ' A' ' 11' ' ' ASN . 30.7 m -84.81 136.35 33.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.12 -0.491 . . . . 74.299999999999997 110.86 -177.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.9 m -139.55 132.11 28.76 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.886 -0.412 . . . . 71.129999999999995 109.886 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.491 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 10.8 p -99.79 138.87 22.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.21 0.528 . . . . 65.310000000000002 111.441 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.408 ' SD ' HD12 ' A' ' 76' ' ' LEU . 81.4 mtp -137.97 152.38 48.86 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 116.074 -0.512 . . . . 73.530000000000001 110.315 177.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.477 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 25.2 m-70 -111.14 128.25 55.83 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.844 -1.539 . . . . 73.420000000000002 106.844 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.36 140.15 49.38 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.178 -0.609 . . . . 70.129999999999995 110.383 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.1 m -129.99 142.12 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 109.291 -0.633 . . . . 75.239999999999995 109.291 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.278 -2.507 0 N-CA-C 105.854 -1.906 . . . . 72.540000000000006 105.854 176.002 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.484 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 3.6 t . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 110.036 -0.357 . . . . 74.219999999999999 110.036 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 8' ' ' ASP . 88.2 Cg_endo -84.95 166.99 11.22 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.957 1.771 . . . . 60.030000000000001 111.077 177.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.39 30.63 0.41 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.828 0.823 . . . . 62.020000000000003 109.837 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 6' ' ' PRO . 19.6 t70 -120.43 -28.75 4.93 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.842 -1.072 . . . . 72.150000000000006 109.369 175.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.8 mtp -121.83 155.51 35.2 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 115.955 -0.566 . . . . 62.109999999999999 110.44 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.24 137.5 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 CA-C-N 115.591 -0.731 . . . . 71.120000000000005 109.507 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.42 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 2.4 t-20 -91.05 107.59 19.3 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 108.134 -1.062 . . . . 62.229999999999997 108.134 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.445 ' HG ' HD23 ' A' ' 14' ' ' LEU . 39.8 tp -112.56 132.97 54.85 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 115.283 -0.871 . . . . 71.040000000000006 111.545 -174.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -107.6 120.87 43.4 Favored 'General case' 0 N--CA 1.402 -2.863 0 N-CA-C 108.069 -1.085 . . . . 71.540000000000006 108.069 173.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.532 ' CB ' HG22 ' A' ' 39' ' ' VAL . 2.0 mm? -98.32 120.3 38.5 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.757 -1.11 . . . . 72.450000000000003 109.075 -178.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.434 HG12 HG21 ' A' ' 21' ' ' THR . 30.7 mt -103.64 118.4 50.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.565 -0.902 . . . . 73.400000000000006 108.565 177.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.87 163.51 26.68 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 123.691 0.619 . . . . 60.109999999999999 110.835 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.6 m -57.7 -27.11 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.09 0.774 . . . . 73.450000000000003 113.09 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.5 t -77.39 -16.08 59.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.653 0.263 . . . . 75.430000000000007 111.165 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.416 ' C ' ' HE3' ' A' ' 20' ' ' LYS . . . 100.81 5.68 53.33 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.994 -1.098 . . . . 62.219999999999999 111.843 -176.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.608 ' N ' ' HE3' ' A' ' 20' ' ' LYS . 0.5 OUTLIER -86.5 131.44 34.18 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.126 -1.065 . . . . 72.420000000000002 108.126 177.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.434 HG21 HG12 ' A' ' 15' ' ' ILE . 72.5 p -107.2 133.05 52.36 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 120.457 -0.497 . . . . 71.340000000000003 111.6 -175.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -122.37 139.57 53.68 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.591 -0.892 . . . . 62.399999999999999 108.591 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -131.42 129.55 41.4 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.649 -0.82 . . . . 73.230000000000004 109.087 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.616 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.0 m-85 -146.54 160.7 41.8 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.035 0.534 . . . . 75.109999999999999 110.581 -178.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.431 ' CD2' HG13 ' A' ' 5' ' ' VAL . 75.4 mt -79.64 126.54 31.05 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.441 -0.578 . . . . 63.450000000000003 109.441 172.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.616 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 94.5 m-85 -131.58 167.75 18.87 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.213 -1.032 . . . . 72.420000000000002 108.213 175.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.3 p -94.35 151.7 39.61 Favored Pre-proline 0 N--CA 1.411 -2.387 0 C-N-CA 119.129 -1.028 . . . . 53.130000000000003 108.246 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.5 ' O ' ' HB ' ' A' ' 72' ' ' THR . 31.3 Cg_endo -60.17 -11.73 16.96 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.628 2.219 . . . . 63.329999999999998 112.418 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -96.17 -4.86 41.84 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.055 0.391 . . . . 72.120000000000005 112.055 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -76.02 154.06 36.0 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 120.474 -0.49 . . . . 63.420000000000002 110.363 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.589 ' O ' HG13 ' A' ' 35' ' ' ILE . 47.9 t -89.93 118.96 29.89 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.167 -0.679 . . . . 74.109999999999999 109.167 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.491 ' HB3' HD23 ' A' ' 60' ' ' LEU . . . -50.94 -41.9 59.36 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.173 0.989 . . . . 75.010000000000005 113.157 -176.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.2 t -77.34 -32.34 55.11 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.221 0.534 . . . . 65.439999999999998 110.24 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.0 -37.53 84.35 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.825 -1.176 . . . . 75.319999999999993 107.825 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 31' ' ' SER . 71.7 mt -64.45 -39.77 86.74 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 CA-C-N 114.587 -1.188 . . . . 64.310000000000002 110.611 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.88 -38.9 62.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.982 0.42 . . . . 73.200000000000003 111.463 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 -40.81 66.7 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 107.262 -1.384 . . . . 73.329999999999998 107.262 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 49.6 t-80 -57.96 -54.09 50.87 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.16 0.984 . . . . 71.540000000000006 110.916 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 35' ' ' ILE . 29.6 m -66.38 -30.92 51.37 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 N-CA-C 113.255 0.835 . . . . 75.209999999999994 113.255 -178.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 76.4 t80 . . . . . 0 C--O 1.243 0.745 0 O-C-N 123.609 0.568 . . . . 63.140000000000001 110.708 177.14 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 CA--C 1.512 -0.507 0 N-CA-C 110.015 -0.365 . . . . 70.0 110.015 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 39.2 mmt180 -137.14 148.43 46.63 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.641 -0.503 . . . . 73.150000000000006 109.641 177.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.73 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 4.4 pp -130.92 139.71 50.11 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 110.115 -0.328 . . . . 74.310000000000002 110.115 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 87' ' ' HIS . 79.0 mt -112.75 119.65 60.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.288 0.566 . . . . 62.420000000000002 109.535 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -102.0 73.88 1.42 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.662 -1.236 . . . . 71.209999999999994 107.662 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 58.61 86.05 0.09 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 113.344 -1.753 . . . . 75.129999999999995 112.085 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.11 -56.59 0.6 Allowed Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.677 -0.692 . . . . 36.840000000000003 114.02 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -117.52 153.98 32.25 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.667 0.988 . . . . 75.230000000000004 113.667 -172.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.589 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 93.3 m-85 -82.91 117.15 22.55 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 108.443 -0.947 . . . . 75.510000000000005 108.443 176.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.523 HD11 HD21 ' A' ' 76' ' ' LEU . 81.8 mt -80.73 -47.98 13.2 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.288 -0.965 . . . . 71.109999999999999 112.749 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.73 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.5 t-80 -170.01 167.33 9.0 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 105.909 -1.885 . . . . 74.219999999999999 105.909 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.52 -1.28 87.83 Favored Glycine 0 C--N 1.3 -1.425 0 N-CA-C 115.785 1.074 . . . . 74.329999999999998 115.785 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -164.9 22.75 0.06 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.255 1.026 . . . . 72.239999999999995 110.442 -170.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.424 HG13 HD21 ' A' ' 60' ' ' LEU . 9.0 p -79.53 136.88 22.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 119.419 -0.912 . . . . 74.430000000000007 109.031 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.604 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 42.7 p -78.7 158.49 28.31 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.424 -0.353 . . . . 55.350000000000001 111.658 -173.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.493 ' H ' HD23 ' A' ' 73' ' ' LEU . 1.9 mm? -64.07 -27.08 68.86 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.106 -0.497 . . . . 64.400000000000006 110.897 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.26 -38.43 95.1 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.352 -1.099 . . . . 71.329999999999998 110.352 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.29 -16.81 57.39 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.194 0.521 . . . . 53.030000000000001 110.096 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 72' ' ' THR . 86.9 mt -86.24 4.41 38.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.918 -0.583 . . . . 72.409999999999997 111.33 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER 68.88 25.3 6.17 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.947 0.899 . . . . 75.319999999999993 113.254 177.641 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.403 HD22 ' HB3' ' A' ' 73' ' ' LEU . 10.2 mp -72.76 123.53 89.66 Favored Pre-proline 0 C--O 1.236 0.384 0 C-N-CA 120.083 -0.647 . . . . 64.040000000000006 111.322 175.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -80.2 146.96 18.15 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.444 2.096 . . . . 65.329999999999998 111.088 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -73.73 141.94 46.34 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.191 -1.04 . . . . 72.340000000000003 108.191 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.484 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 82.01 -3.92 78.07 Favored Glycine 0 C--N 1.3 -1.435 0 C-N-CA 120.735 -0.745 . . . . 53.119999999999997 113.521 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -116.13 145.64 42.9 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 117.163 0.481 . . . . 73.150000000000006 111.463 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.42 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 23.5 m -85.19 125.1 32.57 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.967 -0.56 . . . . 73.519999999999996 110.99 -177.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.1 m -125.09 135.9 53.13 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.977 -0.556 . . . . 73.420000000000002 109.508 176.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.43 137.8 31.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.352 -0.385 . . . . 73.129999999999995 110.889 -178.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 82.8 mtp -138.69 153.45 48.54 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 120.902 0.382 . . . . 52.229999999999997 111.325 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.45 ' O ' ' HB ' ' A' ' 61' ' ' ILE . 25.6 m-70 -103.93 129.27 51.46 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 107.229 -1.397 . . . . 71.319999999999993 107.229 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.431 HD23 ' C ' ' A' ' 87' ' ' HIS . 2.8 mm? -123.9 140.19 53.23 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 119.66 -0.816 . . . . 75.140000000000001 110.681 -176.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.417 ' CG2' ' HB2' ' A' ' 59' ' ' ARG . 25.2 m -118.7 133.68 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.829 0 CA-C-O 121.711 0.767 . . . . 74.439999999999998 109.445 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.268 -2.942 0 N-CA-C 105.108 -2.182 . . . . 65.439999999999998 105.108 174.647 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.484 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 17.7 t . . . . . 0 N--CA 1.431 -1.387 0 N-CA-C 110.087 -0.338 . . . . 72.409999999999997 110.087 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.44 ' C ' ' H ' ' A' ' 8' ' ' ASP . 3.4 Cg_exo -75.07 162.69 36.54 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.204 1.936 . . . . 74.230000000000004 111.05 175.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.88 36.85 0.63 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.864 0.84 . . . . 53.219999999999999 109.597 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 6' ' ' PRO . 27.1 t70 -133.72 -19.13 2.1 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.632 -1.167 . . . . 70.219999999999999 109.446 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.2 mmm -124.29 150.68 45.12 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.641 -0.708 . . . . 71.409999999999997 110.07 -174.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -101.61 139.09 23.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.998 -0.742 . . . . 74.120000000000005 108.998 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.418 HD21 HG23 ' A' ' 83' ' ' THR . 6.0 t30 -96.69 114.39 26.03 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.234 -1.024 . . . . 74.540000000000006 108.234 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.429 ' HG ' HD22 ' A' ' 14' ' ' LEU . 44.4 tp -120.16 133.46 55.49 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 112.586 0.587 . . . . 74.349999999999994 112.586 -172.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 49.1 ttt180 -108.47 120.71 43.21 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 108.443 -0.947 . . . . 75.310000000000002 108.443 174.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.56 ' CB ' HG23 ' A' ' 39' ' ' VAL . 2.3 mm? -98.53 122.29 41.54 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-N 114.531 -1.213 . . . . 64.230000000000004 109.605 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.491 HG21 HG21 ' A' ' 21' ' ' THR . 22.1 mt -112.22 125.46 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.635 -0.876 . . . . 74.310000000000002 108.635 177.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -94.47 161.57 14.17 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 116.323 -0.399 . . . . 73.040000000000006 110.884 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.405 ' CG1' HG11 ' A' ' 89' ' ' VAL . 28.6 m -60.5 -14.67 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.4 0.68 . . . . 65.439999999999998 112.757 179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.1 m -79.79 -7.16 58.5 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 116.199 -0.455 . . . . 61.409999999999997 110.351 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.55 0.54 81.92 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 116.265 -0.425 . . . . 60.299999999999997 112.598 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -87.67 133.93 33.74 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.237 -0.653 . . . . 75.439999999999998 109.237 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.491 HG21 HG21 ' A' ' 15' ' ' ILE . 40.2 p -116.73 131.87 56.84 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 109.585 -0.524 . . . . 75.439999999999998 109.585 -177.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' A' ' 39' ' ' VAL . 63.8 mttp -129.32 139.97 51.56 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 110.022 -0.362 . . . . 64.409999999999997 110.022 174.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 27.2 tt0 -125.09 130.0 51.37 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.257 -0.646 . . . . 72.409999999999997 109.257 -177.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.584 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 95.8 m-85 -146.14 160.52 41.82 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 122.946 0.498 . . . . 74.420000000000002 111.081 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.2 mt -82.57 126.28 32.11 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.503 -0.555 . . . . 71.129999999999995 109.503 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.584 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 95.5 m-85 -132.58 166.1 22.89 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.115 -1.068 . . . . 62.229999999999997 108.115 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.4 p -89.71 150.46 44.11 Favored Pre-proline 0 N--CA 1.418 -2.054 0 N-CA-C 108.194 -1.039 . . . . 65.129999999999995 108.194 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.32 -11.68 17.26 Favored 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 122.59 2.194 . . . . 63.210000000000001 112.287 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -91.72 -9.81 42.41 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.582 0.753 . . . . 72.319999999999993 111.221 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -71.15 154.09 41.99 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.147 0.499 . . . . 72.239999999999995 111.409 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.517 ' O ' HG13 ' A' ' 35' ' ' ILE . 49.9 m -95.11 121.23 36.53 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.76 -0.655 . . . . 72.150000000000006 110.425 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -49.22 -42.66 41.15 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.207 1.003 . . . . 60.210000000000001 113.088 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 5.8 p -73.06 -34.13 66.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.895 0.379 . . . . 63.130000000000003 112.008 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.4 -47.12 80.41 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.03 -1.1 . . . . 75.310000000000002 108.03 175.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.545 ' O ' HG22 ' A' ' 39' ' ' VAL . 68.6 mt -59.67 -46.24 93.52 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.379 0 CA-C-N 114.342 -1.299 . . . . 72.319999999999993 110.683 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.45 -46.6 56.72 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.438 0.695 . . . . 72.140000000000001 111.742 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.527 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 7.6 tmtt? -73.28 -33.63 65.32 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.736 -0.839 . . . . 54.439999999999998 108.736 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -66.2 -51.97 52.56 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.196 0.998 . . . . 60.350000000000001 110.734 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.56 HG23 ' CB ' ' A' ' 14' ' ' LEU . 27.7 m -65.29 -30.22 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.744 0.817 . . . . 74.140000000000001 111.509 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.527 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 64.9 t80 . . . . . 0 C--O 1.234 0.257 0 CA-C-N 115.303 -0.862 . . . . 65.230000000000004 111.861 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 83.2 mt . . . . . 0 CA--C 1.509 -0.621 0 N-CA-C 109.693 -0.484 . . . . 74.340000000000003 109.693 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -137.28 144.67 42.81 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.024 -1.102 . . . . 71.349999999999994 108.024 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -109.38 147.0 33.5 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 113.959 1.096 . . . . 72.409999999999997 113.959 178.314 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -117.53 119.51 61.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.214 -1.032 . . . . 65.420000000000002 108.214 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.524 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 11.8 t80 -100.33 90.95 4.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.74 -1.207 . . . . 73.329999999999998 107.74 176.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 71.96 -70.3 0.16 Allowed 'General case' 0 N--CA 1.401 -2.913 0 C-N-CA 127.05 2.14 . . . . 73.019999999999996 112.392 -176.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.9 -47.75 1.07 Allowed Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 119.877 -1.154 . . . . 62.25 115.196 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -124.19 170.34 10.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 118.049 0.924 . . . . 72.409999999999997 112.991 -172.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 73.7 m-85 -83.7 118.33 23.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.742 -0.836 . . . . 74.129999999999995 108.742 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.524 ' CD1' ' HB3' ' A' ' 62' ' ' TYR . 7.0 mp -80.77 -45.96 16.17 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 113.553 0.945 . . . . 72.349999999999994 113.553 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -168.84 172.27 7.89 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 106.774 -1.565 . . . . 51.420000000000002 106.774 -173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.44 -1.51 87.85 Favored Glycine 0 C--N 1.306 -1.126 0 N-CA-C 111.783 -0.527 . . . . 75.329999999999998 111.783 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -175.92 80.93 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.497 -1.297 . . . . 75.420000000000002 107.497 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 p -104.93 151.7 7.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.546 -1.279 . . . . 72.040000000000006 107.546 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.2 p -91.17 158.11 16.81 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 118.232 0.469 . . . . 73.530000000000001 110.203 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.466 ' H ' HD21 ' A' ' 73' ' ' LEU . 1.9 mm? -69.32 -30.63 68.73 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.04 0.447 . . . . 62.240000000000002 110.642 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.1 -35.02 91.51 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.187 -0.765 . . . . 72.409999999999997 111.187 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.03 -15.7 63.05 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.2 0.6 . . . . 36.609999999999999 111.282 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 65.2 mt -85.11 -1.6 57.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 73.420000000000002 110.158 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 8.8 mptt 63.41 72.34 0.48 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.359 1.064 . . . . 55.149999999999999 109.375 -177.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.435 HD11 ' HB3' ' A' ' 73' ' ' LEU . 87.7 mt -125.17 117.74 25.43 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 115.479 -0.782 . . . . 71.329999999999998 111.423 -175.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.67 152.12 64.36 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.403 2.068 . . . . 74.230000000000004 110.147 172.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -75.92 148.39 38.26 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.734 -0.839 . . . . 73.230000000000004 108.734 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.484 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 91.99 -10.79 73.71 Favored Glycine 0 C--N 1.296 -1.671 0 C-N-CA 119.744 -1.217 . . . . 63.240000000000002 113.043 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -101.23 138.98 37.53 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.148 0.499 . . . . 75.299999999999997 111.884 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.418 HG23 HD21 ' A' ' 11' ' ' ASN . 35.1 m -79.88 118.46 21.66 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.201 -0.909 . . . . 73.239999999999995 109.94 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.7 m -116.78 129.42 56.09 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.921 -0.581 . . . . 64.019999999999996 109.55 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -104.89 140.36 23.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.905 -0.405 . . . . 70.299999999999997 109.905 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 92.4 mtp -138.23 153.58 49.11 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 120.869 0.366 . . . . 75.319999999999993 111.042 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.4 ' C ' HD22 ' A' ' 88' ' ' LEU . 88.3 m-70 -106.59 129.6 54.49 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.077 -1.083 . . . . 75.120000000000005 108.077 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.463 ' N ' HD22 ' A' ' 88' ' ' LEU . 2.0 mm? -122.6 139.34 54.04 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 122.126 -0.359 . . . . 55.109999999999999 110.447 -175.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.405 HG11 ' CG1' ' A' ' 17' ' ' VAL . 29.1 m -116.87 132.48 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 C-N-CA 119.892 -0.723 . . . . 64.530000000000001 109.721 176.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.711 0 N-CA-C 107.789 -1.189 . . . . 70.109999999999999 107.789 176.03 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.429 -1.51 0 N-CA-C 107.788 -1.19 . . . . 75.340000000000003 107.788 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.7 t -127.86 125.44 39.71 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.331 -0.989 . . . . 70.010000000000005 108.331 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 68.27 108.83 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.346 1.029 . . . . 72.129999999999995 110.428 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.4 t -92.03 115.34 64.46 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 108.319 -0.993 . . . . 65.140000000000001 108.319 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -72.52 156.13 54.34 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.077 1.851 . . . . 73.5 111.012 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.57 7.2 1.14 Allowed 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.671 0.989 . . . . 44.130000000000003 113.671 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -109.24 -6.06 15.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.644 -0.502 . . . . 74.209999999999994 109.644 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.4 mmm -130.19 154.51 47.47 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.237 0.541 . . . . 71.239999999999995 110.543 -172.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.408 ' CD1' ' HG ' ' A' ' 73' ' ' LEU . 2.7 pp -115.92 131.12 69.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.946 -0.57 . . . . 75.319999999999993 110.072 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -84.57 114.5 22.02 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.039 -1.467 . . . . 71.239999999999995 107.039 -177.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.444 ' HG ' HD23 ' A' ' 14' ' ' LEU . 41.7 tp -121.32 133.17 55.11 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.946 0.721 . . . . 64.519999999999996 112.946 -172.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -108.57 121.39 44.9 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 115.14 -0.937 . . . . 73.430000000000007 108.737 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.51 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.2 mm? -99.37 120.27 39.31 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.885 -1.052 . . . . 72.439999999999998 108.612 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.404 HG21 HG21 ' A' ' 21' ' ' THR . 32.1 mt -107.33 122.88 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 108.451 -0.944 . . . . 75.109999999999999 108.451 177.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.59 160.48 18.17 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 116.384 -0.371 . . . . 63.409999999999997 110.346 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.7 t -58.66 -26.15 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.643 0.777 . . . . 74.430000000000007 111.569 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -76.43 -6.09 50.2 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.768 -0.651 . . . . 64.329999999999998 111.214 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.08 6.74 66.51 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.502 -0.856 . . . . 65.340000000000003 112.032 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -87.61 131.41 34.43 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.045 -0.724 . . . . 75.439999999999998 109.045 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.404 HG21 HG21 ' A' ' 15' ' ' ILE . 68.5 p -111.44 129.77 55.92 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 120.364 -0.534 . . . . 71.030000000000001 110.276 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.64 139.77 53.57 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.482 -1.303 . . . . 72.450000000000003 107.482 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -133.58 130.61 38.64 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.927 -1.109 . . . . 71.209999999999994 109.285 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.656 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.6 m-85 -145.17 160.35 41.58 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 123.526 0.73 . . . . 63.539999999999999 109.299 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.1 tp -84.09 125.7 32.37 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.689 -1.226 . . . . 64.120000000000005 107.689 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.656 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 82.4 m-85 -127.81 168.47 15.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.05 0.453 . . . . 75.230000000000004 111.022 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.469 ' HB2' ' OD2' ' A' ' 30' ' ' ASP . 20.4 m -92.87 140.53 23.59 Favored Pre-proline 0 N--CA 1.424 -1.774 0 N-CA-C 108.366 -0.976 . . . . 70.510000000000005 108.366 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -60.01 -18.79 52.42 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.632 2.221 . . . . 61.340000000000003 113.267 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -81.35 -11.76 59.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.208 -0.451 . . . . 60.219999999999999 111.197 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.469 ' OD2' ' HB2' ' A' ' 27' ' ' SER . 22.0 m-20 -78.99 153.76 30.06 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.836 -0.54 . . . . 74.230000000000004 111.751 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.471 ' O ' HG13 ' A' ' 35' ' ' ILE . 25.8 p -95.35 131.31 41.6 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.111 0.481 . . . . 74.219999999999999 111.521 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.462 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -51.93 -41.83 62.33 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 124.262 1.025 . . . . 62.200000000000003 113.706 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.7 p -74.86 -30.95 61.49 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.471 0.545 . . . . 74.109999999999999 112.471 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -69.08 -42.48 76.13 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 107.402 -1.333 . . . . 74.319999999999993 107.402 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.507 HG21 ' CZ ' ' A' ' 26' ' ' PHE . 67.0 mt -60.97 -43.61 96.36 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.216 0 CA-C-N 114.175 -1.375 . . . . 53.409999999999997 110.745 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.72 -42.6 57.36 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.086 0.555 . . . . 74.439999999999998 111.874 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.599 ' HE2' ' O ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -72.14 -39.77 68.55 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.078 -1.452 . . . . 71.019999999999996 107.078 -178.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -61.87 -45.74 92.46 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.612 -0.722 . . . . 74.120000000000005 110.97 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.51 HG21 ' CB ' ' A' ' 14' ' ' LEU . 26.8 m -71.61 -31.99 44.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 112.693 0.627 . . . . 73.150000000000006 112.693 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -51.38 -48.87 62.41 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 123.127 0.267 . . . . 71.140000000000001 111.471 173.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -167.26 -86.88 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.598 0.962 . . . . 72.049999999999997 113.598 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -109.19 164.74 12.18 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.041 -0.355 . . . . 71.420000000000002 110.041 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 55.6 p-90 -64.98 134.58 96.11 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 113.153 0.797 . . . . 74.109999999999999 113.153 -174.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.02 137.57 76.64 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 123.481 2.787 . . . . 75.25 111.978 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 64.6 mtt -95.45 -60.07 1.74 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.402 -0.363 . . . . 74.0 111.383 -176.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -154.44 75.59 1.0 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.877 0.846 . . . . 55.210000000000001 112.751 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' A' ' 49' ' ' GLU . 70.4 t-105 57.39 86.94 0.07 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.083 -1.417 . . . . 74.310000000000002 112.152 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.433 ' HG3' ' HD3' ' A' ' 97' ' ' PRO . 13.7 mp0 -73.82 87.53 1.75 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.915 -1.039 . . . . 73.209999999999994 110.352 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.443 ' HA ' HD11 ' A' ' 57' ' ' ILE . 16.8 pt-20 -106.61 -171.55 1.91 Allowed 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.87 -1.059 . . . . 70.299999999999997 110.252 -177.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 3.1 tm-20 -78.09 141.68 38.63 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 106.215 -1.772 . . . . 73.099999999999994 106.215 173.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -53.75 -44.88 70.34 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.352 1.612 . . . . 63.310000000000002 115.352 -169.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.7 m -85.93 14.91 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.879 0 CA-C-O 121.789 0.804 . . . . 55.020000000000003 111.06 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 t 81.07 114.23 0.06 Allowed 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 127.163 2.185 . . . . 65.030000000000001 114.07 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 46.5 m -151.92 99.46 2.92 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 114.064 -1.425 . . . . 62.130000000000003 107.609 175.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.26 -27.59 9.47 Favored 'Trans proline' 0 C--N 1.329 -0.497 0 C-N-CA 122.056 1.837 . . . . 74.420000000000002 112.787 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -73.66 -4.7 35.9 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.136 0.493 . . . . 71.420000000000002 112.321 -174.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 90' ' ' ALA . 2.3 pp -77.89 -15.54 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 O-C-N 121.964 -0.46 . . . . 73.040000000000006 111.987 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.9 mt -104.61 105.06 15.01 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.715 -0.846 . . . . 72.0 108.715 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.459 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 83.0 mtp180 -138.26 162.3 34.67 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.174 0.511 . . . . 74.209999999999994 109.892 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 4.5 pp -123.12 135.54 54.41 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 115.603 -0.726 . . . . 71.099999999999994 110.727 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 85.7 mt -110.45 123.32 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 N-CA-C 108.48 -0.933 . . . . 70.510000000000005 108.48 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -100.91 50.27 0.87 Allowed 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 106.649 -1.612 . . . . 74.340000000000003 106.649 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 60.69 93.5 0.04 OUTLIER 'General case' 0 N--CA 1.394 -3.243 0 C-N-CA 127.6 2.36 . . . . 72.209999999999994 112.168 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.99 -29.42 10.01 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.236 -0.893 . . . . 72.230000000000004 112.848 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -130.51 137.76 49.9 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.972 0.731 . . . . 74.310000000000002 112.972 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 47.8 m-85 -88.6 113.67 24.42 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 106.293 -1.743 . . . . 74.230000000000004 106.293 175.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.539 HD12 ' CD2' ' A' ' 76' ' ' LEU 0.258 29.1 mt -79.16 -43.54 23.74 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 117.936 -1.506 . . . . 73.120000000000005 112.471 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.661 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.6 t-80 -173.82 -175.62 1.1 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.552 -1.277 . . . . 71.329999999999998 107.552 176.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -85.03 -14.16 70.07 Favored Glycine 0 C--N 1.302 -1.347 0 N-CA-C 115.743 1.057 . . . . 43.020000000000003 115.743 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -167.64 28.08 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 118.192 0.996 . . . . 64.5 109.846 -172.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.412 HG22 ' HB1' ' A' ' 75' ' ' ALA . 11.9 p -74.67 147.63 8.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.265 -0.643 . . . . 73.549999999999997 109.265 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.556 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 45.7 p -78.77 158.4 28.25 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 112.419 0.526 . . . . 72.239999999999995 112.419 -173.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.479 ' O ' HD11 ' A' ' 78' ' ' LEU . 3.6 mm? -60.02 -41.38 92.04 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.413 0.685 . . . . 73.140000000000001 111.862 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.57 -37.99 94.24 Favored Glycine 0 C--N 1.317 -0.521 0 N-CA-C 111.36 -0.696 . . . . 54.130000000000003 111.36 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.412 ' HB1' HG22 ' A' ' 71' ' ' VAL . . . -74.88 -16.04 60.69 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 122.798 0.439 . . . . 53.32 111.547 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 72' ' ' THR . 62.7 mt -83.77 -4.7 58.85 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.252 -0.647 . . . . 63.009999999999998 109.252 177.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.6 mptt 71.28 79.55 0.16 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.69 1.196 . . . . 74.299999999999997 111.297 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.479 HD11 ' O ' ' A' ' 73' ' ' LEU . 10.8 mp -123.47 117.11 27.94 Favored Pre-proline 0 CA--C 1.494 -1.192 0 CA-C-N 115.526 -0.761 . . . . 75.099999999999994 111.474 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.502 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 11.0 Cg_exo -64.11 122.85 10.98 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 121.728 1.618 . . . . 75.329999999999998 109.197 171.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.407 ' HA ' HG21 ' A' ' 10' ' ' ILE . 1.1 p90 -69.77 144.44 52.69 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.338 0.589 . . . . 74.140000000000001 112.171 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.38 9.05 60.71 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.087 -0.96 . . . . 65.420000000000002 113.157 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -132.01 163.87 27.45 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 117.863 0.831 . . . . 75.340000000000003 110.622 176.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 25.7 m -91.66 129.37 37.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.407 0.622 . . . . 54.049999999999997 111.361 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.6 m -122.23 133.37 54.71 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.834 -0.621 . . . . 74.409999999999997 110.292 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.2 p -104.57 139.34 25.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 109.887 -0.412 . . . . 71.329999999999998 109.887 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 85.7 mtp -138.25 153.49 49.08 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-O 121.009 0.433 . . . . 54.329999999999998 111.079 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.439 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 59.1 m-70 -111.26 126.84 55.31 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.609 -1.256 . . . . 61.32 107.609 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.456 ' N ' HD22 ' A' ' 88' ' ' LEU . 2.4 mm? -113.47 142.2 46.2 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 122.156 -0.34 . . . . 44.43 110.201 -176.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.84 134.01 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 121.223 0.535 . . . . 74.049999999999997 111.009 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 57' ' ' ILE . . . -134.42 136.42 43.27 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 107.983 -1.118 . . . . 73.310000000000002 107.983 176.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.44 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 99.3 mtt180 -133.48 126.92 32.17 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 110.074 -0.343 . . . . 60.009999999999998 110.074 -174.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 58.23 23.1 9.94 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.398 0.679 . . . . 74.200000000000003 111.159 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 t -79.95 137.4 36.85 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.455 -0.793 . . . . 75.230000000000004 110.04 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.2 mp -98.08 135.91 21.22 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 109.03 -0.73 . . . . 75.329999999999998 109.03 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -66.98 106.53 1.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.584 1.522 . . . . 73.120000000000005 108.85 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 66.74 109.43 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.192 0.997 . . . . 73.340000000000003 110.166 -174.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.433 ' HD3' ' HG3' ' A' ' 48' ' ' GLU . 4.1 Cg_endo -49.45 -66.22 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.36 2.707 . . . . 73.420000000000002 113.777 -174.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.471 ' HB3' HE22 ' A' ' 100' ' ' GLN . 7.9 t30 -147.08 15.71 1.18 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.181 0.991 . . . . 74.209999999999994 108.631 174.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.6 t 71.93 17.72 5.18 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.456 -1.247 . . . . 71.030000000000001 113.377 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.471 HE22 ' HB3' ' A' ' 98' ' ' ASN . 1.8 mp0 -63.1 -50.94 68.53 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 119.62 -0.832 . . . . 60.030000000000001 111.388 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.24 34.64 57.75 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 107.939 -2.064 . . . . 63.530000000000001 107.939 -172.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -71.11 115.99 10.89 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.406 -0.897 . . . . 63.109999999999999 110.437 -176.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -138.98 176.77 8.4 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.648 -1.16 . . . . 65.109999999999999 108.967 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -99.96 169.96 8.84 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 105.792 -1.929 . . . . 62.030000000000001 105.792 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.504 ' NE ' ' HA ' ' A' ' 105' ' ' ARG . 3.8 mmp_? -61.79 -50.46 72.26 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 118.11 0.413 . . . . 75.120000000000005 111.355 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 54.3 29.98 11.73 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.225 1.01 . . . . 63.109999999999999 110.81 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -148.62 122.82 9.55 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 115.477 -0.783 . . . . 72.299999999999997 110.355 -174.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.0 p -67.84 130.4 42.87 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 116.09 -0.505 . . . . 73.450000000000003 109.91 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.86 -27.14 6.92 Favored Glycine 0 C--N 1.308 -1.0 0 N-CA-C 108.317 -1.913 . . . . 44.020000000000003 108.317 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -93.96 -175.17 3.63 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 114.06 -1.07 . . . . 70.040000000000006 108.466 176.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.6 m 67.0 100.1 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.043 0.937 . . . . 51.409999999999997 111.962 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -96.88 102.72 14.56 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.194 0.521 . . . . 74.310000000000002 110.066 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 65.4 m -92.68 159.96 15.21 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.071 -0.714 . . . . 70.340000000000003 109.071 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 67.9 m -73.33 138.56 45.47 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.071 0.462 . . . . 74.200000000000003 110.194 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.1 m -119.27 153.61 21.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 116.093 -0.503 . . . . 75.5 109.784 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.1 tp -165.73 80.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.829 0.823 . . . . 72.209999999999994 110.328 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 C--N 1.316 -0.861 0 N-CA-C 105.764 -1.939 . . . . 74.340000000000003 105.764 179.856 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.5 p . . . . . 0 N--CA 1.428 -1.546 0 CA-C-O 122.229 1.014 . . . . 75.040000000000006 111.378 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.0 m -149.18 16.05 0.93 Allowed 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.145 -1.428 . . . . 63.240000000000002 107.145 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -150.32 -174.08 4.64 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 104.383 -2.451 . . . . 73.109999999999999 104.383 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.3 t -92.26 115.64 65.08 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 108.631 -0.877 . . . . 53.130000000000003 108.631 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -63.52 166.42 15.44 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.22 1.947 . . . . 71.409999999999997 112.197 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.46 11.74 20.74 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.607 -0.724 . . . . 71.319999999999993 109.491 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -121.72 -3.67 9.24 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.174 -0.921 . . . . 73.530000000000001 108.582 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.7 mmm -126.93 152.32 47.29 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.925 -0.768 . . . . 74.439999999999998 108.925 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -111.88 139.37 36.65 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 N-CA-C 109.275 -0.639 . . . . 72.129999999999995 109.275 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -88.17 116.28 26.26 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.923 -1.14 . . . . 55.149999999999999 107.923 -176.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.42 ' HG ' ' CD2' ' A' ' 14' ' ' LEU . 45.7 tp -127.36 132.99 50.1 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 121.156 0.503 . . . . 74.049999999999997 112.185 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -109.6 120.65 43.14 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 108.561 -0.903 . . . . 74.209999999999994 108.561 174.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.533 ' CB ' HG22 ' A' ' 39' ' ' VAL . 1.8 mm? -100.23 120.71 40.32 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 114.591 -1.186 . . . . 75.409999999999997 108.677 -178.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.2 mt -104.36 123.01 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 108.811 -0.811 . . . . 74.310000000000002 108.811 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.39 165.0 20.66 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.632 -0.713 . . . . 74.329999999999998 110.745 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.6 t -65.18 -21.07 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-O 121.887 0.851 . . . . 43.420000000000002 109.399 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.6 m -76.03 -4.45 41.35 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.45 1.1 . . . . 72.439999999999998 111.418 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.26 6.93 88.97 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.805 -0.918 . . . . 51.229999999999997 110.805 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -87.89 131.14 34.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.283 -1.006 . . . . 64.239999999999995 108.283 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.5 p -111.31 129.32 56.03 Favored 'General case' 0 N--CA 1.417 -2.096 0 C-N-CA 120.269 -0.572 . . . . 73.409999999999997 109.562 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 39' ' ' VAL . 95.8 mttt -131.66 139.31 49.05 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.282 -1.007 . . . . 73.109999999999999 108.282 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -130.43 131.1 45.06 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.774 -0.77 . . . . 62.100000000000001 109.617 -175.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.659 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.2 m-85 -144.9 159.7 42.48 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 122.795 0.438 . . . . 62.340000000000003 109.83 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.45 126.47 32.26 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.624 -1.25 . . . . 63.409999999999997 107.624 174.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.659 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 90.1 m-85 -127.36 163.47 23.92 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.572 -0.529 . . . . 74.239999999999995 109.572 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.7 p -85.33 147.35 46.96 Favored Pre-proline 0 N--CA 1.41 -2.439 0 N-CA-C 107.741 -1.207 . . . . 73.329999999999998 107.741 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.489 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 55.6 Cg_endo -62.31 -11.36 22.16 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.803 2.335 . . . . 72.510000000000005 111.712 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -86.6 -15.87 38.48 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.29 -0.868 . . . . 71.219999999999999 111.242 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -71.76 153.74 41.78 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.15 0.5 . . . . 75.549999999999997 111.245 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.438 ' O ' HG13 ' A' ' 35' ' ' ILE . 19.4 m -96.52 129.46 43.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.006 -1.109 . . . . 71.299999999999997 108.006 177.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -51.03 -38.27 50.37 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.637 0.977 . . . . 74.019999999999996 113.637 -176.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 p -77.62 -29.05 51.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.132 0.492 . . . . 53.219999999999999 111.93 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.99 -41.58 82.08 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.907 -1.516 . . . . 63.32 106.907 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.489 HG23 ' CZ ' ' A' ' 26' ' ' PHE . 70.5 mt -64.13 -42.63 96.17 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.472 0 CA-C-N 113.715 -1.584 . . . . 74.530000000000001 110.43 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.01 -40.15 43.71 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 123.173 0.589 . . . . 74.409999999999997 111.842 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.83 -31.17 64.6 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.441 0.638 . . . . 74.549999999999997 110.323 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -74.13 -47.9 32.98 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.207 -0.906 . . . . 70.200000000000003 110.009 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.533 HG22 ' CB ' ' A' ' 14' ' ' LEU . 27.4 m -71.37 -32.1 45.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.923 -0.485 . . . . 72.239999999999995 111.9 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -49.67 -49.78 46.1 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 108.508 -0.923 . . . . 73.219999999999999 108.508 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -177.41 106.18 0.06 Allowed 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 124.166 0.916 . . . . 72.239999999999995 110.378 172.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.251 43.0 m-80 65.09 -116.22 0.36 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.229 1.566 . . . . 64.510000000000005 115.229 177.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -115.52 145.4 34.38 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 108.591 -0.892 . . . . 73.200000000000003 108.591 175.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -44.98 110.98 0.26 Allowed 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 121.944 1.763 . . . . 74.019999999999996 109.827 168.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.9 ttt -51.53 140.01 19.04 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 112.926 0.713 . . . . 72.230000000000004 112.926 -173.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -54.39 -56.91 13.83 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.749 -1.114 . . . . 74.430000000000007 111.194 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 10.4 m0 -79.98 99.34 7.58 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.444 -0.947 . . . . 71.230000000000004 108.444 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -120.09 104.37 10.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.267 -0.424 . . . . 73.25 110.555 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -161.19 103.24 1.26 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.926 -1.138 . . . . 74.219999999999999 107.926 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.533 ' OE1' ' HG3' ' A' ' 51' ' ' GLN . 0.2 OUTLIER -135.55 104.0 5.66 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 104.487 -2.412 . . . . 74.120000000000005 104.487 176.17 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.533 ' HG3' ' OE1' ' A' ' 50' ' ' GLU . 49.0 mt-30 59.67 38.83 21.75 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.714 0.634 . . . . 64.319999999999993 109.858 -174.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.6 t 78.11 -39.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.82 1.248 . . . . 72.420000000000002 111.261 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.6 m 66.16 97.86 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.2 1.0 . . . . 62.109999999999999 111.723 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.1 p -79.83 158.19 73.21 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 122.054 -0.404 . . . . 64.239999999999995 110.351 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -71.83 -15.72 29.73 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 121.993 1.795 . . . . 73.329999999999998 109.615 173.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -68.22 -13.34 62.17 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.98 -1.464 . . . . 52.030000000000001 111.411 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.0 pp -77.92 -19.82 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 120.791 0.329 . . . . 74.239999999999995 110.42 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.4 mp -78.63 106.59 10.71 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.506 -0.553 . . . . 72.200000000000003 109.506 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -140.29 142.73 35.67 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.828 -0.804 . . . . 72.239999999999995 108.828 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 4.5 pp -126.05 138.9 53.75 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.052 0.453 . . . . 72.420000000000002 111.451 -176.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.422 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 90.1 mt -108.96 119.91 59.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 108.456 -0.942 . . . . 55.32 108.456 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -101.3 75.59 1.64 Allowed 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.353 -1.351 . . . . 75.219999999999999 107.353 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 36.78 85.68 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.77 0 C-N-CA 127.587 2.355 . . . . 53.039999999999999 113.23 -176.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.87 -57.29 0.62 Allowed Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 115.447 -0.797 . . . . 75.109999999999999 113.156 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -130.07 159.66 36.09 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 112.627 0.603 . . . . 72.299999999999997 112.627 -176.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 33.1 m-85 -89.35 112.82 24.01 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.926 -1.138 . . . . 74.420000000000002 107.926 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.44 HD13 HD23 ' A' ' 76' ' ' LEU . 83.5 mt -80.2 -47.19 15.06 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 113.547 0.943 . . . . 65.140000000000001 113.547 -175.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.636 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.4 t-80 -165.33 174.74 9.8 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 106.614 -1.624 . . . . 74.329999999999998 106.614 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.11 -1.88 88.37 Favored Glycine 0 C--N 1.307 -1.067 0 C-N-CA 120.261 -0.971 . . . . 37.640000000000001 114.396 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -175.72 28.16 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 117.822 0.811 . . . . 73.349999999999994 112.221 -173.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.426 ' H ' HD23 ' A' ' 60' ' ' LEU . 13.0 p -70.24 142.68 15.51 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 C-N-CA 120.46 -0.496 . . . . 73.239999999999995 109.808 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.448 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 31.8 p -78.54 157.67 28.75 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.852 -0.613 . . . . 74.319999999999993 111.836 -175.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.481 HD22 ' H ' ' A' ' 73' ' ' LEU . 1.8 mm? -66.25 -32.87 74.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.406 -0.361 . . . . 65.409999999999997 110.784 -177.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.04 -36.38 92.82 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 111.178 -0.769 . . . . 75.219999999999999 111.178 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.97 -15.27 61.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.12 0.568 . . . . 73.540000000000006 110.893 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 72' ' ' THR . 73.4 mt -82.79 14.87 2.94 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.675 0.39 . . . . 72.140000000000001 111.226 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.6 24.1 10.21 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.759 0.824 . . . . 75.209999999999994 110.619 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 96.2 mt -91.8 125.14 58.32 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 112.511 0.56 . . . . 73.0 112.511 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 3.5 Cg_endo -86.35 170.3 8.08 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.846 2.364 . . . . 73.109999999999999 110.484 172.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.489 ' CE2' ' HG3' ' A' ' 28' ' ' PRO . 75.2 m-85 -78.7 151.35 32.21 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.781 -0.451 . . . . 75.409999999999997 109.781 -178.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.93 0.96 90.59 Favored Glycine 0 C--N 1.308 -1.022 0 C-N-CA 120.668 -0.777 . . . . 73.230000000000004 114.232 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -102.37 136.45 42.18 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 117.509 0.655 . . . . 65.310000000000002 110.021 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.505 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 54.6 m -87.19 116.78 25.49 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.006 -0.739 . . . . 71.349999999999994 109.006 176.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.3 m -115.81 142.43 46.77 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.55 -0.75 . . . . 65.219999999999999 110.471 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -111.45 135.59 50.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 120.793 0.33 . . . . 73.319999999999993 110.354 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 87.0 mtp -138.35 153.24 48.97 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 120.862 0.363 . . . . 63.409999999999997 110.276 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.437 ' C ' HD22 ' A' ' 88' ' ' LEU . 21.5 m-70 -111.59 132.7 54.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.989 -1.115 . . . . 74.299999999999997 107.989 178.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.475 ' N ' HD22 ' A' ' 88' ' ' LEU . 2.5 mm? -119.47 144.53 46.93 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 120.614 -0.434 . . . . 65.349999999999994 111.113 -176.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.7 m -120.52 134.94 62.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.8 -0.636 . . . . 74.040000000000006 109.43 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.436 ' HB1' ' OG1' ' A' ' 93' ' ' THR . . . -133.01 144.9 50.4 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.878 -0.601 . . . . 73.140000000000001 109.788 -176.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -140.78 147.94 39.88 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 108.024 -1.102 . . . . 61.149999999999999 108.024 -177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 53.7 28.53 8.2 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 122.18 0.99 . . . . 62.149999999999999 110.391 -177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.436 ' OG1' ' HB1' ' A' ' 90' ' ' ALA . 44.1 m -89.77 139.8 30.22 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 114.578 -1.192 . . . . 73.540000000000006 109.615 -176.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.3 mp -68.55 131.11 91.64 Favored Pre-proline 0 C--N 1.304 -1.375 0 CA-C-N 115.512 -0.767 . . . . 63.32 110.517 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.24 -38.1 95.6 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.181 2.588 . . . . 75.019999999999996 113.683 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -159.35 142.32 10.4 Favored Pre-proline 0 C--N 1.322 -0.602 0 C-N-CA 120.994 -0.283 . . . . 73.239999999999995 111.107 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.2 -63.62 0.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.003 1.802 . . . . 74.299999999999997 109.982 170.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -168.05 76.9 0.14 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 112.763 0.653 . . . . 73.239999999999995 112.763 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.7 m 45.87 28.04 0.55 Allowed 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.644 2.09 . . . . 71.329999999999998 116.644 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -81.06 -51.14 8.81 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.598 -0.841 . . . . 61.240000000000002 110.603 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.36 -18.96 6.11 Favored Glycine 0 C--N 1.32 -0.36 0 CA-C-N 115.665 -0.698 . . . . 74.439999999999998 112.666 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -136.14 156.81 48.15 Favored 'General case' 0 CA--C 1.485 -1.548 0 O-C-N 122.526 -0.396 . . . . 71.310000000000002 111.178 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -109.05 -40.79 4.89 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 124.134 0.896 . . . . 73.010000000000005 108.79 175.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -163.43 146.66 10.3 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.993 -1.114 . . . . 71.239999999999995 107.993 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -71.91 -50.8 26.02 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.151 0.5 . . . . 74.420000000000002 110.26 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -167.27 156.19 10.06 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 104.348 -2.464 . . . . 74.209999999999994 104.348 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.535 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 1.2 tpmt? -53.71 -43.62 69.17 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 123.512 0.725 . . . . 73.230000000000004 110.892 -178.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.8 t -158.61 -23.53 0.08 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.644 -0.422 . . . . 64.129999999999995 111.826 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -83.39 75.48 2.37 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 121.001 -0.619 . . . . 63.43 112.843 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -54.18 133.0 44.33 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 122.741 0.416 . . . . 75.230000000000004 110.307 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.2 t -61.73 -43.43 98.86 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.329 0.585 . . . . 72.510000000000005 109.938 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -111.63 113.29 25.58 Favored 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 106.676 -1.601 . . . . 74.200000000000003 106.676 176.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 45.1 t -149.64 154.18 38.21 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.537 -0.912 . . . . 61.140000000000001 108.537 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 63.9 m -77.07 95.77 4.29 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.654 -0.869 . . . . 65.010000000000005 108.654 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.4 m -115.95 160.43 15.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.81 -0.632 . . . . 71.299999999999997 110.704 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 116' ' ' ILE . 2.1 mp -86.52 95.9 5.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 121.862 0.839 . . . . 71.319999999999993 108.835 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.6 tp . . . . . 0 C--N 1.291 -1.935 0 N-CA-C 107.312 -1.366 . . . . 75.540000000000006 107.312 -177.399 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 112.81 0.67 . . . . 65.349999999999994 112.81 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.6 t -98.42 136.58 38.36 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 106.625 -1.62 . . . . 73.0 106.625 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.5 m120 69.43 115.53 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.844 0.83 . . . . 72.209999999999994 111.729 -173.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.8 t -87.93 131.75 42.17 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 108.676 -0.861 . . . . 72.230000000000004 108.676 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -72.01 143.24 40.14 Favored 'Trans proline' 0 C--O 1.251 1.159 0 C-N-CA 121.889 1.726 . . . . 73.010000000000005 110.421 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.81 72.14 4.33 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 121.996 0.903 . . . . 70.209999999999994 109.821 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -169.11 -28.18 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 113.612 -1.631 . . . . 75.310000000000002 107.727 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 92.9 mmm -117.52 145.73 44.03 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.819 -1.082 . . . . 71.219999999999999 109.128 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.414 ' CD1' ' HG ' ' A' ' 73' ' ' LEU . 2.8 pp -99.31 136.06 32.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 109.208 -0.664 . . . . 73.439999999999998 109.208 175.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.451 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 5.4 t30 -91.93 107.69 19.39 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.7 -1.222 . . . . 63.310000000000002 107.7 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.424 ' HG ' HD22 ' A' ' 14' ' ' LEU . 43.5 tp -112.77 132.77 55.09 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 116.055 -0.52 . . . . 62.229999999999997 111.723 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -106.82 121.51 44.55 Favored 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 108.291 -1.003 . . . . 73.439999999999998 108.291 173.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.539 ' CB ' HG22 ' A' ' 39' ' ' VAL . 1.7 mm? -98.74 128.61 45.04 Favored 'General case' 0 C--N 1.268 -2.947 0 CA-C-N 114.258 -1.337 . . . . 65.430000000000007 109.353 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.411 HG23 HG21 ' A' ' 21' ' ' THR . 14.8 mm -107.47 119.33 56.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 107.744 -1.206 . . . . 73.25 107.744 175.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.7 tp -84.09 153.05 23.99 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 110.058 -0.349 . . . . 72.5 110.058 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.468 ' CG1' ' HA ' ' A' ' 89' ' ' VAL . 30.7 m -60.0 -13.36 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.829 0.851 . . . . 63.109999999999999 113.059 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.3 t -89.53 -2.78 58.46 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.275 -0.639 . . . . 64.319999999999993 109.275 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.21 7.93 79.19 Favored Glycine 0 C--N 1.337 0.583 0 CA-C-N 115.922 -0.581 . . . . 37.850000000000001 112.597 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -87.78 131.05 34.65 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.345 -0.983 . . . . 73.239999999999995 108.345 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.411 HG21 HG23 ' A' ' 15' ' ' ILE . 63.1 p -107.46 143.65 35.52 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.538 -0.912 . . . . 72.120000000000005 108.538 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.444 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 48.5 tptt -145.08 147.23 32.33 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.595 -0.842 . . . . 75.540000000000006 109.155 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -137.06 131.09 32.27 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 119.713 -0.795 . . . . 65.530000000000001 110.201 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.716 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 84.6 m-85 -145.14 160.97 40.6 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 123.888 0.875 . . . . 73.209999999999994 110.387 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.7 126.02 30.4 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.634 -1.247 . . . . 72.340000000000003 107.634 171.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.716 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 83.6 m-85 -130.68 164.45 25.0 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.37 -0.974 . . . . 74.319999999999993 108.37 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.5 p -90.1 150.3 43.13 Favored Pre-proline 0 N--CA 1.42 -1.947 0 N-CA-C 107.747 -1.205 . . . . 61.439999999999998 107.747 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.11 -14.75 30.19 Favored 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 122.044 1.829 . . . . 71.530000000000001 112.077 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -87.15 -9.68 54.64 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.892 -0.595 . . . . 62.219999999999999 110.545 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -76.02 154.01 36.06 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.81 -0.556 . . . . 71.530000000000001 111.193 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.535 ' O ' HG13 ' A' ' 35' ' ' ILE . 41.0 m -96.52 121.59 38.5 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 109.649 -0.5 . . . . 71.430000000000007 109.649 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.473 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -49.2 -52.5 26.38 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.115 1.524 . . . . 71.239999999999995 115.115 -173.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.4 m -79.46 -20.01 48.43 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 121.823 -0.548 . . . . 70.430000000000007 111.465 -175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.87 -41.46 78.34 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.14 -1.8 . . . . 75.219999999999999 106.14 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 31' ' ' SER . 73.3 mt -62.79 -34.68 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 114.034 -1.439 . . . . 75.230000000000004 110.749 175.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.94 -32.9 48.26 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 122.442 0.297 . . . . 55.509999999999998 111.577 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.564 ' HE2' ' O ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -72.91 -38.13 66.99 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 107.154 -1.425 . . . . 73.430000000000007 107.154 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 43' ' ' TRP . 43.0 t-80 -62.95 -54.02 44.99 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.897 0.879 . . . . 75.129999999999995 110.747 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.539 HG22 ' CB ' ' A' ' 14' ' ' LEU . 26.8 m -68.22 -29.98 46.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.023 -0.989 . . . . 75.239999999999995 112.411 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 64.3 t80 -46.63 -48.86 19.8 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.278 1.031 . . . . 74.109999999999999 111.09 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -177.15 -74.59 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.299 0.374 . . . . 71.019999999999996 110.305 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -103.16 150.16 23.93 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.215 -1.402 . . . . 64.129999999999995 107.215 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 38' ' ' HIS . 30.2 p-90 -79.44 147.21 67.67 Favored Pre-proline 0 C--N 1.301 -1.533 0 C-N-CA 120.362 -0.535 . . . . 74.329999999999998 110.511 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.56 96.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.899 2.399 . . . . 64.140000000000001 113.851 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.534 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 0.3 OUTLIER -138.51 74.81 1.49 Allowed 'General case' 0 N--CA 1.428 -1.565 0 CA-C-O 122.023 0.916 . . . . 74.340000000000003 109.17 177.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -169.66 -165.5 0.51 Allowed 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 104.14 -2.541 . . . . 64.549999999999997 104.14 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.3 t90 -108.99 -84.98 0.54 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 119.678 1.126 . . . . 72.209999999999994 110.94 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -155.21 134.67 12.54 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.424 -1.324 . . . . 72.420000000000002 107.424 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -154.09 -60.07 0.13 Allowed 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.485 -0.561 . . . . 54.340000000000003 109.485 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 92' ' ' GLU . 8.1 tp10 -96.01 115.25 27.14 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 106.93 -1.507 . . . . 70.319999999999993 106.93 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 86.0 mm-40 66.87 94.14 0.07 Allowed 'General case' 0 C--O 1.24 0.563 0 O-C-N 124.355 1.034 . . . . 74.430000000000007 109.703 -174.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.6 m -108.25 135.55 46.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 115.092 -0.958 . . . . 73.329999999999998 112.129 -172.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.0 m 58.57 27.62 15.95 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.921 0.888 . . . . 70.439999999999998 112.454 174.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.6 t -126.83 104.78 23.23 Favored Pre-proline 0 N--CA 1.425 -1.675 0 C-N-CA 120.639 -0.424 . . . . 70.549999999999997 110.878 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.28 -15.74 22.51 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.274 1.983 . . . . 74.340000000000003 110.671 176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -61.01 -20.23 62.25 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 123.879 0.871 . . . . 62.310000000000002 112.129 -177.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 90' ' ' ALA . 33.8 pt -77.28 -28.14 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 120.522 -0.471 . . . . 62.109999999999999 111.133 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.55 HD11 ' O ' ' A' ' 58' ' ' LEU 0.257 3.5 pp -106.29 109.03 20.84 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.973 0.892 . . . . 71.329999999999998 111.995 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 97.4 mtt180 -142.61 163.15 33.61 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.53 -1.213 . . . . 72.040000000000006 109.899 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 4.1 pp -129.16 142.39 50.89 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.178 0.807 . . . . 73.349999999999994 113.178 -173.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.7 mt -117.56 124.41 73.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 114.907 -1.042 . . . . 52.030000000000001 108.359 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.436 ' CD2' HD12 ' A' ' 67' ' ' LEU . 1.8 t80 -101.32 60.87 0.92 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 122.038 0.923 . . . . 74.319999999999993 109.629 -176.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 63.91 17.39 10.52 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 113.902 -1.499 . . . . 73.219999999999999 112.488 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.39 -65.96 0.01 OUTLIER Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 120.734 -0.746 . . . . 72.140000000000001 112.031 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -130.49 176.03 8.49 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.822 0.344 . . . . 72.200000000000003 110.583 -177.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.593 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 85.8 m-85 -86.84 120.96 28.68 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.465 -1.309 . . . . 74.209999999999994 107.465 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.514 ' CD1' HD21 ' A' ' 76' ' ' LEU . 76.5 mt -80.1 -47.07 15.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.747 0.784 . . . . 71.400000000000006 109.915 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -163.11 -173.46 3.43 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 125.602 1.561 . . . . 74.430000000000007 107.771 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -84.34 -37.3 11.11 Favored Glycine 0 N--CA 1.416 -2.688 0 C-N-CA 120.499 -0.858 . . . . 53.32 113.72 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -160.22 39.12 0.18 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.312 1.053 . . . . 72.209999999999994 108.961 -172.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.442 HG13 HD21 ' A' ' 60' ' ' LEU . 7.6 p -66.2 147.42 12.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-N 114.593 -1.185 . . . . 74.140000000000001 110.023 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.55 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 42.4 p -78.55 156.91 28.96 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 116.21 -0.45 . . . . 70.430000000000007 111.408 -175.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.421 ' H ' HD23 ' A' ' 73' ' ' LEU . 2.5 mm? -66.34 -30.76 71.23 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.517 0.562 . . . . 63.009999999999998 112.517 -176.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.48 -30.37 76.41 Favored Glycine 0 C--O 1.229 -0.167 0 N-CA-C 111.192 -0.763 . . . . 63.299999999999997 111.192 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.31 -15.51 60.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.371 0.605 . . . . 73.120000000000005 109.961 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 72' ' ' THR . 61.2 mt -92.84 11.95 25.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.425 -0.807 . . . . 72.519999999999996 111.834 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.531 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.6 mptt 67.74 19.27 9.7 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.539 0.736 . . . . 71.019999999999996 110.975 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 79.4 mt -83.66 122.14 76.51 Favored Pre-proline 0 N--CA 1.441 -0.918 0 CA-C-N 116.03 -0.532 . . . . 63.350000000000001 110.895 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.438 ' HG2' ' HG3' ' A' ' 82' ' ' LYS . 6.6 Cg_endo -83.71 140.21 9.15 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 122.227 1.951 . . . . 74.200000000000003 111.708 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -70.44 141.97 52.04 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 112.596 0.591 . . . . 75.400000000000006 112.596 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.85 -1.17 70.73 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.759 -1.109 . . . . 74.329999999999998 111.599 -174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.438 ' HG3' ' HG2' ' A' ' 79' ' ' PRO . 31.7 mmmt -108.36 158.04 17.85 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.82 0.343 . . . . 73.0 110.41 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 86.5 m -103.69 125.22 50.03 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.666 -0.697 . . . . 73.219999999999999 110.077 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.0 m -133.64 142.76 48.22 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.127 -0.488 . . . . 74.319999999999993 110.402 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.4 132.62 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 121.066 0.46 . . . . 54.130000000000003 110.688 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 90.4 mtp -136.17 153.43 51.26 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.153 0.502 . . . . 74.310000000000002 111.395 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -103.05 132.88 48.99 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.648 -0.705 . . . . 75.299999999999997 109.413 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.427 ' N ' HD22 ' A' ' 88' ' ' LEU . 2.4 mm? -120.04 142.38 48.89 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.125 -0.694 . . . . 74.439999999999998 109.125 -176.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.468 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 35.2 m -116.78 133.76 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 C-N-CA 119.932 -0.707 . . . . 73.430000000000007 110.994 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 57' ' ' ILE . . . -133.77 146.5 50.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 105.909 -1.885 . . . . 53.049999999999997 105.909 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 51' ' ' GLN . 40.3 ttm180 -124.77 112.21 16.43 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 120.037 -0.665 . . . . 71.099999999999994 110.641 -172.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 39.2 mt-10 55.69 37.62 29.09 Favored 'General case' 0 C--O 1.203 -1.384 0 O-C-N 124.412 1.07 . . . . 74.510000000000005 110.97 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 36.9 m -88.65 113.22 23.99 Favored 'General case' 0 N--CA 1.409 -2.523 0 CA-C-N 114.567 -1.197 . . . . 72.040000000000006 108.751 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.08 161.83 21.6 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 123.32 0.648 . . . . 75.120000000000005 112.344 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.04 155.36 19.01 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.79 2.327 . . . . 73.319999999999993 111.206 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.426 ' CD ' ' HZ2' ' A' ' 37' ' ' LYS . 9.5 mp0 -64.79 145.32 98.88 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 115.826 -0.624 . . . . 73.319999999999993 111.631 -178.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -75.06 -30.34 7.17 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 C-N-CA 121.531 1.488 . . . . 73.540000000000006 109.16 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 70.84 17.11 6.48 Favored 'General case' 0 C--N 1.378 1.846 0 C-N-CA 124.686 1.194 . . . . 72.25 108.215 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.3 p -88.66 -5.67 57.98 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.191 -1.368 . . . . 71.140000000000001 111.212 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -83.56 -30.34 27.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 119.318 -0.953 . . . . 74.329999999999998 109.827 176.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.67 24.35 75.39 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.519 -0.764 . . . . 61.520000000000003 111.569 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -89.7 111.75 22.82 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 120.465 -0.494 . . . . 64.040000000000006 109.934 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -125.37 106.98 10.23 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.378 -0.971 . . . . 74.109999999999999 108.378 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -82.34 121.32 26.54 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.038 -0.528 . . . . 64.040000000000006 110.7 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -71.5 -24.65 62.02 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.322 -0.854 . . . . 75.349999999999994 112.129 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 70.53 101.18 0.06 Allowed 'General case' 0 C--O 1.25 1.082 0 C-N-CA 123.812 0.845 . . . . 73.230000000000004 113.258 175.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? 72.22 -59.11 0.57 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.404 1.482 . . . . 73.409999999999997 109.787 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.1 p -70.95 136.6 48.58 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.655 -1.239 . . . . 71.230000000000004 107.655 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -69.84 -32.16 70.19 Favored Glycine 0 CA--C 1.5 -0.855 0 C-N-CA 120.323 -0.942 . . . . 65.120000000000005 111.201 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -144.73 146.9 32.41 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 108.671 -0.863 . . . . 63.109999999999999 108.671 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.2 m -86.77 74.79 9.74 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.276 -1.009 . . . . 71.209999999999994 108.276 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -157.66 116.69 3.24 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.145 -1.389 . . . . 64.150000000000006 108.336 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.6 t -76.78 121.8 23.85 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.481 -0.563 . . . . 73.230000000000004 109.481 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.7 p -69.34 122.27 18.57 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.9 -0.778 . . . . 73.129999999999995 108.9 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.7 m -95.47 127.61 47.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.65 0.738 . . . . 74.420000000000002 112.515 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.69 108.57 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 108.295 -1.002 . . . . 74.310000000000002 108.295 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 tm? . . . . . 0 C--N 1.287 -2.132 0 N-CA-C 105.702 -1.962 . . . . 55.140000000000001 105.702 -179.943 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.42 -1.94 0 N-CA-C 107.465 -1.309 . . . . 73.109999999999999 107.465 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.0 t -136.12 119.02 16.26 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.167 -0.613 . . . . 71.219999999999999 110.683 -174.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -77.47 128.22 33.84 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 107.648 -1.241 . . . . 74.530000000000001 107.648 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.475 ' CG2' ' HB2' ' A' ' 11' ' ' ASN . 10.8 t -80.76 119.73 77.0 Favored Pre-proline 0 C--N 1.283 -2.287 0 N-CA-C 109.077 -0.712 . . . . 43.520000000000003 109.077 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -69.81 152.02 68.95 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.025 1.817 . . . . 75.519999999999996 110.646 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.47 72.23 4.98 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-O 122.462 1.125 . . . . 74.340000000000003 109.162 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -170.65 -28.41 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 112.784 -2.007 . . . . 71.340000000000003 107.566 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.6 mmm -113.87 160.67 18.5 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.05 -0.977 . . . . 64.150000000000006 108.734 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -121.79 139.58 48.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.189 -0.671 . . . . 65.129999999999995 109.189 173.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -94.02 110.78 22.45 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.785 -1.191 . . . . 64.420000000000002 107.785 -177.166 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.2 tp -115.9 132.91 56.51 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.826 -0.625 . . . . 75.25 112.069 -174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -111.36 121.27 44.79 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 114.994 -1.003 . . . . 61.329999999999998 109.018 173.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.58 ' CB ' HG22 ' A' ' 39' ' ' VAL . 1.9 mm? -98.6 121.4 40.5 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.825 -1.08 . . . . 75.0 108.316 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.1 mt -102.95 127.15 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 C-N-CA 119.586 -0.846 . . . . 74.099999999999994 109.642 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -83.8 155.51 22.97 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.44 -0.8 . . . . 72.349999999999994 110.24 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.3 m -64.12 -19.11 24.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 122.893 0.477 . . . . 70.420000000000002 111.898 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.2 m -80.95 1.93 28.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.21 0.529 . . . . 74.349999999999994 110.424 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.08 12.75 82.11 Favored Glycine 0 CA--C 1.501 -0.803 0 N-CA-C 111.804 -0.518 . . . . 73.420000000000002 111.804 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -88.63 135.77 33.33 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.035 -1.469 . . . . 74.299999999999997 107.035 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.6 p -112.67 129.28 56.45 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 119.801 -0.76 . . . . 73.519999999999996 109.88 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -122.93 137.53 54.92 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.939 -1.134 . . . . 74.430000000000007 107.939 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -138.13 131.65 30.79 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.755 -0.778 . . . . 70.120000000000005 110.08 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.645 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 89.3 m-85 -145.5 160.14 42.05 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 123.933 0.893 . . . . 73.219999999999999 109.011 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.1 mt -79.57 125.5 29.68 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 107.065 -1.457 . . . . 65.409999999999997 107.065 170.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.645 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 87.8 m-85 -123.8 163.16 21.76 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.927 -1.138 . . . . 63.310000000000002 107.927 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 84.7 p -87.62 148.47 44.07 Favored Pre-proline 0 C--N 1.288 -2.095 0 N-CA-C 108.226 -1.027 . . . . 73.209999999999994 108.226 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.98 -14.87 35.42 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.252 1.968 . . . . 44.299999999999997 111.355 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -82.9 -17.8 42.46 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.066 -0.97 . . . . 73.140000000000001 110.281 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' O ' HD23 ' A' ' 73' ' ' LEU . 18.1 m-20 -67.95 154.61 41.23 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.009 0.433 . . . . 63.109999999999999 110.666 176.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.548 ' O ' HG13 ' A' ' 35' ' ' ILE . 51.1 m -105.13 129.53 53.51 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 116.039 -0.528 . . . . 74.209999999999994 110.536 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.494 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -49.86 -50.22 46.4 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.007 1.484 . . . . 75.120000000000005 115.007 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m -76.14 -27.15 56.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.284 0.493 . . . . 73.129999999999995 110.676 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.89 -45.55 91.98 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.239 -1.393 . . . . 60.409999999999997 107.239 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.549 ' O ' HG21 ' A' ' 39' ' ' VAL . 66.1 mt -65.18 -42.49 94.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 114.348 -1.296 . . . . 74.219999999999999 110.657 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.422 ' O ' ' HD1' ' A' ' 40' ' ' TYR . . . -50.07 -50.08 49.24 Favored 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 122.856 0.462 . . . . 75.349999999999994 111.154 175.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -64.4 -38.44 91.03 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 108.142 -1.058 . . . . 73.040000000000006 108.142 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.488 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 35.3 t-80 -61.21 -54.26 46.45 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 114.844 -1.071 . . . . 72.340000000000003 110.706 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.58 HG22 ' CB ' ' A' ' 14' ' ' LEU . 27.1 m -69.97 -32.17 50.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 115.756 -0.656 . . . . 72.519999999999996 112.264 -178.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.422 ' HD1' ' O ' ' A' ' 36' ' ' ALA . 11.7 m-85 -64.44 -49.26 72.17 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.764 0.653 . . . . 74.150000000000006 112.764 174.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -135.25 -74.06 0.46 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.784 -0.767 . . . . 64.430000000000007 113.065 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -149.62 172.71 14.6 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 105.59 -2.004 . . . . 73.340000000000003 105.59 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 21.5 p-90 -67.67 128.83 93.55 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 118.972 0.805 . . . . 74.340000000000003 111.855 -175.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.23 137.13 39.45 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.961 2.441 . . . . 53.229999999999997 112.133 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 62.5 mtm -126.41 -75.25 0.58 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.922 -1.14 . . . . 74.329999999999998 107.922 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t70 177.13 89.09 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.184 -1.784 . . . . 73.030000000000001 106.184 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 20.6 t90 -128.03 -172.77 2.77 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.49 -0.93 . . . . 75.450000000000003 108.49 -174.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -86.2 -16.83 36.51 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 112.174 0.435 . . . . 70.239999999999995 112.174 -177.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 56.65 -91.5 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.422 0.689 . . . . 71.420000000000002 111.458 -173.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 10.4 tp10 -86.64 -54.55 4.33 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.555 -0.906 . . . . 73.239999999999995 108.555 175.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -169.5 -52.93 0.02 OUTLIER 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 115.837 -0.619 . . . . 72.230000000000004 112.488 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.02 13.18 5.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 113.177 0.806 . . . . 62.520000000000003 113.177 -175.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.451 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 42.6 m 65.9 110.71 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.671 0.788 . . . . 64.140000000000001 110.435 -176.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.2 m -108.97 99.57 35.84 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 116.434 -0.348 . . . . 72.209999999999994 111.428 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 53' ' ' SER . 9.3 Cg_endo -90.9 -20.24 0.86 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.946 1.764 . . . . 74.109999999999999 112.656 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -68.48 -22.81 64.54 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.494 0.664 . . . . 75.519999999999996 110.775 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.444 ' CG2' ' HB2' ' A' ' 91' ' ' ARG . 2.1 pp -78.24 -17.13 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 115.229 -0.896 . . . . 74.219999999999999 113.184 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.1 mp -68.79 101.33 1.31 Allowed 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.195 -0.668 . . . . 37.759999999999998 109.195 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -140.77 155.06 46.5 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.081 -0.711 . . . . 75.340000000000003 109.081 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.622 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 4.3 pp -135.39 144.47 46.59 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.395 -0.821 . . . . 75.439999999999998 110.189 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 87' ' ' HIS . 98.7 mt -117.34 122.45 69.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 108.708 -0.849 . . . . 63.439999999999998 108.708 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -100.97 87.94 3.41 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.906 -1.516 . . . . 74.430000000000007 106.906 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 69.55 -64.94 0.32 Allowed 'General case' 0 N--CA 1.408 -2.527 0 C-N-CA 127.409 2.283 . . . . 63.039999999999999 112.401 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.47 -43.88 0.62 Allowed Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.205 -0.997 . . . . 74.400000000000006 113.712 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.85 162.26 18.4 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 115.049 1.5 . . . . 65.030000000000001 115.049 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.622 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 38.4 m-85 -84.19 117.5 23.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.018 -0.992 . . . . 74.219999999999999 108.335 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.507 HD11 ' CD2' ' A' ' 76' ' ' LEU . 66.4 mt -80.18 -47.2 15.07 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 114.6 1.333 . . . . 71.340000000000003 114.6 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.406 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 9.7 t60 -165.83 167.31 16.99 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.138 -1.43 . . . . 71.0 107.138 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.99 -19.08 63.11 Favored Glycine 0 C--O 1.209 -1.435 0 N-CA-C 114.187 0.435 . . . . 74.420000000000002 114.187 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.4 ' OD1' ' HB3' ' A' ' 31' ' ' SER . 65.3 t30 177.88 80.36 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 108.864 -0.791 . . . . 72.219999999999999 108.864 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.456 ' H ' HD23 ' A' ' 60' ' ' LEU . 9.1 p -102.55 151.34 6.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.028 -0.73 . . . . 70.340000000000003 109.028 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 55.1 p -78.51 157.64 28.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.598 0.237 . . . . 74.310000000000002 111.172 -178.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.456 ' H ' HD23 ' A' ' 73' ' ' LEU . 1.9 mm? -67.74 -32.43 73.03 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 120.715 0.293 . . . . 74.420000000000002 110.766 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.62 -41.22 99.84 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.672 -0.971 . . . . 44.340000000000003 110.672 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.413 ' HB1' HG23 ' A' ' 71' ' ' VAL . . . -68.99 -15.84 63.58 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.099 0.56 . . . . 43.219999999999999 111.269 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.507 ' CD2' HD11 ' A' ' 67' ' ' LEU . 87.1 mt -82.52 -1.6 50.98 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.852 0.461 . . . . 74.230000000000004 110.105 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.5 mptt 69.77 57.56 0.31 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.331 1.052 . . . . 64.25 110.551 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' A' ' 76' ' ' LEU . 10.3 mp -109.52 124.2 34.47 Favored Pre-proline 0 C--N 1.304 -1.382 0 CA-C-N 115.382 -0.826 . . . . 75.439999999999998 110.41 175.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -76.17 154.48 37.13 Favored 'Trans proline' 0 N--CA 1.432 -2.09 0 C-N-CA 121.608 1.539 . . . . 54.219999999999999 108.883 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -72.74 154.41 40.69 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.048 -0.723 . . . . 74.040000000000006 109.048 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.454 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 75.91 10.65 85.04 Favored Glycine 0 C--N 1.304 -1.228 0 C-N-CA 120.802 -0.713 . . . . 62.200000000000003 113.04 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -110.62 153.57 25.0 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.638 -0.504 . . . . 62.240000000000002 109.638 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.501 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 56.9 m -104.98 129.74 53.34 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.347 -0.612 . . . . 72.010000000000005 109.347 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.8 m -138.72 142.26 38.9 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.119 0.485 . . . . 64.319999999999993 110.928 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.9 p -109.56 142.39 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 115.672 -0.695 . . . . 74.129999999999995 110.374 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 91.1 mtp -135.78 153.88 51.4 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 120.987 0.422 . . . . 62.350000000000001 110.403 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.463 ' C ' HD21 ' A' ' 88' ' ' LEU . 82.4 m-70 -106.02 131.25 53.54 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.925 -1.139 . . . . 74.219999999999999 107.925 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.463 HD21 ' C ' ' A' ' 87' ' ' HIS . 2.5 mm? -122.85 143.91 49.55 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.578 -0.449 . . . . 73.120000000000005 110.781 -176.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.74 137.0 52.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 121.051 0.453 . . . . 73.219999999999999 110.682 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.45 137.52 45.76 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.6 -0.727 . . . . 55.329999999999998 109.046 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.444 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 99.6 mtt180 -134.72 112.83 11.08 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.084 -0.507 . . . . 72.319999999999993 109.713 -177.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 42.3 mt-10 59.37 28.48 17.84 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.362 1.077 . . . . 75.219999999999999 109.696 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.9 m -80.39 -33.48 37.1 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.207 -1.361 . . . . 72.439999999999998 109.246 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 96' ' ' GLU . 4.9 mp -109.16 141.24 23.03 Favored Pre-proline 0 N--CA 1.426 -1.628 0 N-CA-C 107.534 -1.284 . . . . 75.109999999999999 107.534 175.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.02 16.1 1.82 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.379 2.053 . . . . 73.319999999999993 110.625 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 94' ' ' LEU . 41.4 mt-10 -143.01 161.99 45.72 Favored Pre-proline 0 N--CA 1.437 -1.114 0 C-N-CA 125.371 1.469 . . . . 71.200000000000003 107.171 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -61.25 -63.71 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.925 1.75 . . . . 61.310000000000002 110.134 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 178.54 79.97 0.01 OUTLIER 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.735 0.814 . . . . 73.5 110.211 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.9 m 64.21 -36.06 0.17 Allowed 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 117.063 2.245 . . . . 74.219999999999999 117.063 173.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -79.05 -51.04 10.11 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 121.707 -0.621 . . . . 71.519999999999996 111.929 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.55 7.04 85.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.914 -0.66 . . . . 73.430000000000007 112.863 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -137.16 135.74 37.62 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 122.491 -0.417 . . . . 75.430000000000007 110.361 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -107.32 83.88 1.88 Allowed 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.427 -1.323 . . . . 72.310000000000002 107.427 175.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -145.66 -178.72 6.24 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.157 0.504 . . . . 75.439999999999998 112.105 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.443 ' HG3' ' HB2' ' A' ' 110' ' ' GLU . 4.8 mpt_? -72.09 -44.96 62.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.082 -0.963 . . . . 62.130000000000003 112.242 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 71.9 -62.82 0.45 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.74 0.816 . . . . 73.530000000000001 109.045 -171.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -132.63 -179.88 5.73 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.808 -1.553 . . . . 72.349999999999994 106.808 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.7 p -71.54 111.88 7.2 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.494 0.664 . . . . 61.420000000000002 110.877 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.91 -56.17 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 110.591 -1.004 . . . . 65.319999999999993 110.591 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.443 ' HB2' ' HG3' ' A' ' 105' ' ' ARG . 58.4 mm-40 -63.25 -56.95 12.27 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.064 -0.254 . . . . 72.549999999999997 111.054 176.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.7 p -179.99 178.11 0.62 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.069 -1.086 . . . . 74.329999999999998 108.069 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -166.91 134.66 2.57 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 122.567 0.347 . . . . 75.109999999999999 110.556 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 20.4 p -149.72 177.94 9.33 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.572 -1.27 . . . . 64.230000000000004 107.572 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 24.8 p -67.28 106.73 2.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.215 0.531 . . . . 73.519999999999996 110.11 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.8 m -113.57 147.35 17.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 121.11 0.481 . . . . 75.430000000000007 111.485 -176.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.34 101.24 12.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.44 -0.948 . . . . 74.340000000000003 108.44 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 tm? . . . . . 0 C--N 1.295 -1.79 0 N-CA-C 107.041 -1.466 . . . . 64.5 107.041 -177.783 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.4 m . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 109.195 -0.668 . . . . 74.010000000000005 109.195 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.0 m -90.75 97.22 11.05 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.736 -0.666 . . . . 71.420000000000002 110.335 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -73.19 119.42 17.4 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 109.063 -0.717 . . . . 72.430000000000007 109.063 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.445 ' CG2' ' HB2' ' A' ' 11' ' ' ASN . 3.7 t -95.88 119.69 64.38 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 115.509 -0.769 . . . . 61.299999999999997 110.664 -173.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -74.9 165.28 31.72 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.674 2.249 . . . . 72.140000000000001 110.585 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.83 68.57 10.52 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 122.013 0.911 . . . . 75.150000000000006 110.179 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -167.44 -30.03 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 113.66 -1.609 . . . . 75.239999999999995 107.929 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 90.5 mmm -105.41 158.57 16.56 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.472 -1.24 . . . . 72.150000000000006 109.312 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -119.32 140.12 44.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 109.313 -0.625 . . . . 74.530000000000001 109.313 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.535 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -90.93 112.7 24.68 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.897 -1.149 . . . . 73.239999999999995 107.897 -176.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.42 ' HG ' HD21 ' A' ' 14' ' ' LEU . 35.4 tp -117.29 132.96 56.5 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.44 0.638 . . . . 75.420000000000002 112.578 -174.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 -106.95 121.44 44.44 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 115.12 -0.945 . . . . 63.140000000000001 108.853 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.535 ' CB ' HG23 ' A' ' 39' ' ' VAL . 2.2 mm? -99.48 120.87 40.33 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.209 -0.905 . . . . 72.329999999999998 108.884 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 86' ' ' MET . 23.4 mm -99.49 116.71 43.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 107.118 -1.438 . . . . 74.420000000000002 107.118 177.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.46 167.45 21.82 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 123.292 0.37 . . . . 73.329999999999998 111.693 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -67.61 -28.64 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.746 0.784 . . . . 63.409999999999997 110.242 -176.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -76.79 4.43 9.7 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.144 -0.935 . . . . 73.040000000000006 111.454 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.65 10.32 86.29 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 111.672 -0.571 . . . . 72.400000000000006 111.672 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -91.53 131.8 36.71 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.717 -0.846 . . . . 72.409999999999997 108.717 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.432 HG21 HD12 ' A' ' 15' ' ' ILE . 59.8 p -104.91 135.03 47.02 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 116.572 -0.285 . . . . 74.530000000000001 110.286 -175.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -142.46 139.61 31.63 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.266 -1.013 . . . . 74.150000000000006 108.266 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -134.44 132.57 39.49 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.016 -0.674 . . . . 63.210000000000001 111.55 -171.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.593 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 90.7 m-85 -144.99 160.81 40.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.161 0.584 . . . . 73.420000000000002 110.881 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.4 mt -79.36 126.6 31.02 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.306 -0.998 . . . . 53.240000000000002 108.306 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.593 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 78.4 m-85 -127.35 161.57 28.34 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.104 0.478 . . . . 74.329999999999998 110.411 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.507 ' HB2' ' OD2' ' A' ' 30' ' ' ASP . 31.4 m -84.71 137.05 38.62 Favored Pre-proline 0 N--CA 1.411 -2.386 0 N-CA-C 107.951 -1.129 . . . . 73.319999999999993 107.951 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.429 ' O ' ' HB ' ' A' ' 72' ' ' THR . 30.4 Cg_endo -60.18 -14.55 29.53 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.083 2.522 . . . . 70.430000000000007 113.878 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -85.89 -8.17 58.22 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.017 0.377 . . . . 74.129999999999995 112.017 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.507 ' OD2' ' HB2' ' A' ' 27' ' ' SER . 11.8 m-20 -79.28 153.71 29.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.736 0.303 . . . . 65.430000000000007 111.078 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.444 ' O ' HG13 ' A' ' 35' ' ' ILE . 67.2 m -95.03 124.35 39.02 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.509 -0.314 . . . . 55.310000000000002 110.492 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.491 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -49.32 -41.34 38.24 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.563 1.145 . . . . 74.120000000000005 113.782 -177.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 p -71.48 -32.78 68.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.023 0.439 . . . . 75.349999999999994 111.872 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.68 -42.25 82.42 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.098 -1.075 . . . . 75.030000000000001 108.098 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.463 ' O ' HG22 ' A' ' 39' ' ' VAL . 68.7 mt -60.9 -43.18 95.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.011 -1.449 . . . . 71.299999999999997 110.906 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.0 -41.89 60.05 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.504 0.721 . . . . 60.539999999999999 112.106 176.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.514 ' HE2' ' O ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -72.59 -33.78 66.96 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 107.153 -1.425 . . . . 71.439999999999998 107.153 -177.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -70.09 -50.97 35.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.362 1.065 . . . . 74.530000000000001 111.789 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.535 HG23 ' CB ' ' A' ' 14' ' ' LEU . 30.6 m -68.05 -31.47 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 113.35 0.87 . . . . 44.130000000000003 113.35 -177.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -46.79 -49.28 20.12 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 124.061 0.85 . . . . 70.329999999999998 112.288 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.8 t70 170.72 -69.82 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.622 -0.881 . . . . 70.219999999999999 108.622 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -89.01 127.24 35.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.895 -1.502 . . . . 71.310000000000002 107.918 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -81.01 147.01 60.36 Favored Pre-proline 0 C--N 1.3 -1.548 0 C-N-CA 120.798 -0.361 . . . . 75.420000000000002 111.643 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.47 0.51 0.25 Allowed 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 124.228 3.285 . . . . 71.340000000000003 116.465 -173.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 52.8 ttm -76.49 -23.73 53.76 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 122.015 -0.428 . . . . 75.200000000000003 110.381 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.02 -27.64 64.83 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.869 0.692 . . . . 61.210000000000001 112.869 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.466 ' CZ3' ' HB3' ' A' ' 96' ' ' GLU . 8.5 t-105 72.16 106.59 0.07 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.978 0.911 . . . . 75.439999999999998 111.879 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.31 115.74 28.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.12 0.486 . . . . 65.409999999999997 111.936 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -88.22 98.37 11.53 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 108.853 -0.795 . . . . 73.209999999999994 108.853 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -96.35 153.14 17.99 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.059 -0.719 . . . . 73.549999999999997 109.059 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -63.06 -57.03 12.02 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.281 -0.637 . . . . 71.510000000000005 109.281 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.0 p -104.24 93.46 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 122.037 0.922 . . . . 72.310000000000002 109.657 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.2 m -88.81 148.47 23.89 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.609 -0.723 . . . . 64.439999999999998 109.21 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.429 ' O ' HG13 ' A' ' 57' ' ' ILE . 46.4 m -147.94 130.36 7.73 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 109.711 -0.477 . . . . 72.129999999999995 109.711 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -82.75 -28.88 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 121.79 1.66 . . . . 72.200000000000003 111.98 176.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -76.75 -0.21 22.89 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.624 0.972 . . . . 74.5 113.624 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.539 ' HA ' ' NH1' ' A' ' 59' ' ' ARG . 2.5 pp -77.56 -9.32 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 112.381 0.511 . . . . 64.219999999999999 112.381 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.413 ' C ' ' HD3' ' A' ' 59' ' ' ARG . 96.9 mt -81.96 108.21 15.28 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.02 -0.537 . . . . 53.329999999999998 110.359 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.539 ' NH1' ' HA ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -137.97 148.84 45.6 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 109.75 -0.463 . . . . 70.230000000000004 109.75 172.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.689 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 4.5 pp -120.45 131.6 54.84 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 115.462 -0.79 . . . . 54.32 110.341 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.454 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 88.0 mt -103.14 124.3 57.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.507 0 N-CA-C 107.522 -1.288 . . . . 63.119999999999997 107.522 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -99.65 84.79 3.0 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 106.252 -1.759 . . . . 75.530000000000001 106.252 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 66.58 -65.64 0.2 Allowed 'General case' 0 N--CA 1.405 -2.7 0 C-N-CA 127.58 2.352 . . . . 75.120000000000005 111.724 -175.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.25 -14.48 2.97 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 120.859 -0.686 . . . . 60.310000000000002 114.747 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.92 148.0 45.96 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 118.612 1.206 . . . . 73.409999999999997 110.826 -178.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -84.36 111.59 19.57 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.559 -1.274 . . . . 73.519999999999996 107.559 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.498 HD11 HD22 ' A' ' 76' ' ' LEU . 59.5 mt -81.18 -46.99 14.03 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 114.404 1.261 . . . . 70.049999999999997 114.404 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.689 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.0 t-80 -171.65 176.17 3.79 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.925 -1.509 . . . . 71.409999999999997 106.925 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -85.71 -1.07 87.56 Favored Glycine 0 C--N 1.3 -1.44 0 N-CA-C 115.867 1.107 . . . . 74.219999999999999 115.867 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -169.39 19.32 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 118.429 1.115 . . . . 71.319999999999993 111.935 -170.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.4 HG13 HD23 ' A' ' 60' ' ' LEU . 11.3 p -74.92 146.74 9.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 120.653 -0.419 . . . . 72.5 110.223 -175.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.464 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 38.6 p -78.88 157.85 28.22 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.743 -0.662 . . . . 75.219999999999999 111.292 -175.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.495 ' H ' HD23 ' A' ' 73' ' ' LEU . 1.2 mm? -66.4 -34.97 79.16 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.473 -0.33 . . . . 62.310000000000002 110.752 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.33 -35.06 90.38 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.556 -0.83 . . . . 70.310000000000002 111.281 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.42 -16.45 60.35 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 122.796 0.438 . . . . 74.349999999999994 111.404 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.498 HD22 HD11 ' A' ' 67' ' ' LEU . 45.4 mt -82.87 1.93 36.87 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.129 -0.693 . . . . 70.109999999999999 109.129 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.94 74.32 0.14 Allowed 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.08 1.352 . . . . 54.350000000000001 111.356 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.421 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.5 mp -127.33 112.13 21.31 Favored Pre-proline 0 CA--C 1.497 -1.067 0 CA-C-N 115.302 -0.863 . . . . 75.329999999999998 111.49 176.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.28 154.46 72.1 Favored 'Trans proline' 0 N--CA 1.445 -1.337 0 C-N-CA 122.08 1.853 . . . . 63.109999999999999 108.011 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -69.48 144.25 53.28 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.181 -0.674 . . . . 72.340000000000003 109.181 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.42 9.98 68.72 Favored Glycine 0 C--N 1.305 -1.155 0 C-N-CA 119.892 -1.147 . . . . 37.75 113.347 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -101.55 138.2 38.86 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 117.374 0.587 . . . . 74.129999999999995 110.342 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 58.8 m -92.13 117.51 29.92 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.872 -1.159 . . . . 75.129999999999995 107.872 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.0 m -130.68 135.91 48.29 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.083 -0.508 . . . . 64.150000000000006 111.229 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.14 138.46 26.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 116.065 -0.516 . . . . 74.450000000000003 111.453 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.495 ' O ' HG12 ' A' ' 15' ' ' ILE . 86.1 mtp -134.46 152.07 51.56 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.96 -0.385 . . . . 71.239999999999995 109.96 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.454 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 23.1 m-70 -108.13 132.02 54.04 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.098 -1.075 . . . . 53.329999999999998 108.098 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.428 ' N ' HD22 ' A' ' 88' ' ' LEU . 2.5 mm? -116.9 141.88 47.65 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 120.366 -0.534 . . . . 64.140000000000001 111.016 -176.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.62 132.65 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 CA-C-N 115.863 -0.608 . . . . 75.540000000000006 109.773 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.3 130.34 34.92 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.824 -0.625 . . . . 61.329999999999998 109.513 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.456 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 99.8 mtt180 -123.7 130.75 53.12 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.959 -0.756 . . . . 75.140000000000001 108.959 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 70.41 -19.15 0.22 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 113.394 0.887 . . . . 60.399999999999999 113.394 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 91' ' ' ARG . 77.7 m 78.77 141.7 0.07 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.563 1.145 . . . . 72.129999999999995 110.995 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.0 tp -81.49 126.98 74.86 Favored Pre-proline 0 N--CA 1.435 -1.207 0 CA-C-N 116.069 -0.514 . . . . 75.450000000000003 109.772 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -68.07 -58.44 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.801 2.334 . . . . 72.129999999999995 111.416 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.466 ' HB3' ' CZ3' ' A' ' 47' ' ' TRP . 0.1 OUTLIER -117.02 129.98 24.94 Favored Pre-proline 0 N--CA 1.434 -1.25 0 CA-C-N 115.869 -0.605 . . . . 75.340000000000003 111.628 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -48.27 -47.71 18.98 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 123.854 3.036 . . . . 64.340000000000003 113.762 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -166.13 -66.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.025 0.38 . . . . 71.439999999999998 112.025 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 63.6 p -173.05 24.17 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.851 0.358 . . . . 54.210000000000001 110.752 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -60.25 -52.41 65.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.339 -0.392 . . . . 74.319999999999993 111.753 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 56.18 27.47 52.31 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.328 -0.463 . . . . 52.229999999999997 112.291 -176.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -132.07 143.41 50.02 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 122.95 0.5 . . . . 72.430000000000007 110.331 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -115.85 -172.23 2.12 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.238 -1.764 . . . . 74.400000000000006 106.238 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -68.79 105.34 2.29 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.125 -0.63 . . . . 73.310000000000002 109.482 174.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.648 ' NH1' ' HA ' ' A' ' 110' ' ' GLU . 3.2 tmm_? -69.31 -39.84 78.0 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.139 -0.937 . . . . 70.420000000000002 108.831 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 66.28 -78.18 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.816 1.246 . . . . 71.319999999999993 112.617 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -140.94 -44.99 0.39 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.297 -0.41 . . . . 61.119999999999997 110.195 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.3 p -53.0 128.34 26.97 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.732 0.813 . . . . 72.299999999999997 112.767 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.28 -47.14 3.28 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.986 -0.446 . . . . 73.510000000000005 111.986 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.648 ' HA ' ' NH1' ' A' ' 105' ' ' ARG . 15.3 tp10 61.27 86.45 0.1 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.262 1.025 . . . . 72.0 112.383 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.2 m -109.43 92.69 4.15 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 115.072 -0.967 . . . . 75.219999999999999 109.73 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -178.04 -58.37 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 105.499 -2.037 . . . . 74.140000000000001 105.499 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 51.6 t -163.35 100.4 0.94 Allowed 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 114.384 -1.28 . . . . 53.109999999999999 107.691 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 63.6 m -51.76 -60.98 2.55 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.303 0.641 . . . . 74.450000000000003 110.66 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.81 160.96 30.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 106.526 -1.657 . . . . 74.200000000000003 106.526 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.8 pt -75.61 88.45 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 122.359 1.076 . . . . 71.430000000000007 111.759 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.6 tm? . . . . . 0 N--CA 1.424 -1.761 0 N-CA-C 106.139 -1.8 . . . . 74.120000000000005 106.139 179.793 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.245 0.865 0 N-CA-C 107.296 -1.372 . . . . 70.219999999999999 107.296 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.4 p -80.63 108.63 14.43 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.365 -0.606 . . . . 73.420000000000002 109.365 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 65.16 -162.11 0.27 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.271 -1.381 . . . . 72.0 107.271 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.432 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 15.1 t -107.05 114.67 61.17 Favored Pre-proline 0 N--CA 1.423 -1.798 0 N-CA-C 107.91 -1.144 . . . . 73.310000000000002 107.91 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -69.71 151.22 69.3 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 122.298 1.999 . . . . 64.230000000000004 111.888 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.65 69.9 6.04 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 122.061 0.934 . . . . 72.420000000000002 109.949 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -173.47 -21.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.386 -1.733 . . . . 60.32 107.672 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.2 mmm -118.26 160.11 22.18 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.892 -1.049 . . . . 73.109999999999999 108.968 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -125.11 137.91 56.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.843 -0.799 . . . . 73.540000000000006 108.843 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.518 HD21 HG22 ' A' ' 83' ' ' THR . 4.9 t30 -92.06 107.73 19.42 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.713 -1.217 . . . . 72.299999999999997 107.713 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.458 ' HG ' HD23 ' A' ' 14' ' ' LEU . 45.5 tp -111.11 133.1 53.74 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.656 -0.702 . . . . 71.010000000000005 112.559 -171.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.405 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 35.9 ttp180 -109.5 121.03 44.29 Favored 'General case' 0 N--CA 1.414 -2.244 0 CA-C-N 115.195 -0.911 . . . . 75.109999999999999 109.008 174.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.564 ' CB ' HG22 ' A' ' 39' ' ' VAL . 2.0 mm? -101.45 126.71 48.27 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-N 114.462 -1.245 . . . . 63.340000000000003 108.504 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.0 mt -104.32 127.31 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 C-N-CA 119.379 -0.928 . . . . 73.209999999999994 109.477 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.14 156.87 20.85 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.365 -0.606 . . . . 74.519999999999996 109.365 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.52 -13.01 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.474 0.546 . . . . 75.109999999999999 112.474 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.8 t -76.1 -12.15 60.06 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.717 0.77 . . . . 74.420000000000002 109.06 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.13 -3.28 64.24 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.677 -0.569 . . . . 65.230000000000004 111.677 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.1 134.74 33.69 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.731 0.3 . . . . 74.049999999999997 110.332 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 67.5 p -98.61 150.11 22.08 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 121.193 0.521 . . . . 71.519999999999996 110.753 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.4 138.44 47.69 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.027 -1.471 . . . . 71.230000000000004 107.027 174.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HG3' ' HB2' ' A' ' 13' ' ' ARG . 27.0 tt0 -137.68 129.65 28.83 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.072 -1.084 . . . . 70.540000000000006 108.072 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.676 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 97.3 m-85 -145.91 159.41 43.27 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.905 -0.776 . . . . 73.310000000000002 108.905 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.0 tp -83.19 124.92 31.0 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 106.862 -1.533 . . . . 70.450000000000003 106.862 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.676 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 94.2 m-85 -129.52 163.6 25.59 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.76 -0.83 . . . . 73.120000000000005 108.76 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.8 p -87.79 145.1 36.1 Favored Pre-proline 0 N--CA 1.41 -2.443 0 N-CA-C 107.339 -1.356 . . . . 74.439999999999998 107.339 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 26.6 Cg_endo -61.62 -11.63 21.17 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 122.329 2.02 . . . . 62.310000000000002 112.37 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.88 -7.27 49.77 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 109.364 -0.606 . . . . 65.140000000000001 109.364 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -71.9 154.09 41.45 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 122.087 -0.383 . . . . 75.099999999999994 110.09 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.527 ' O ' HG13 ' A' ' 35' ' ' ILE . 8.3 p -94.77 121.4 36.32 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-O 121.04 0.448 . . . . 73.540000000000006 111.445 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -46.0 -51.68 13.11 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.178 1.548 . . . . 72.209999999999994 115.178 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.429 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 18.7 m -78.16 -20.69 51.48 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.633 -0.827 . . . . 74.450000000000003 112.502 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -69.25 -42.44 75.61 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 106.45 -1.685 . . . . 64.409999999999997 106.45 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.538 ' O ' HG21 ' A' ' 39' ' ' VAL . 61.3 mt -62.29 -40.21 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.473 -1.239 . . . . 72.430000000000007 110.055 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.31 -43.96 53.9 Favored 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 123.051 0.54 . . . . 73.409999999999997 111.332 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.505 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 1.7 tmtp? -72.83 -37.91 67.29 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.898 -0.778 . . . . 74.239999999999995 108.898 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 32.8 t-80 -56.87 -50.75 71.53 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.419 -0.81 . . . . 73.329999999999998 109.971 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.564 HG22 ' CB ' ' A' ' 14' ' ' LEU . 29.5 m -73.29 -32.38 37.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.629 -0.714 . . . . 73.540000000000006 111.129 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -56.16 -48.18 76.8 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.555 0.742 . . . . 75.310000000000002 110.755 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -141.99 -65.53 0.41 Allowed 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.046 -0.662 . . . . 73.430000000000007 110.482 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 38' ' ' HIS . 56.7 t30 -161.26 174.13 14.03 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.697 -1.594 . . . . 73.209999999999994 106.697 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.3 p-90 -59.26 127.42 84.16 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 118.249 0.477 . . . . 74.420000000000002 111.268 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -65.97 127.43 17.69 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.92 1.747 . . . . 65.109999999999999 109.736 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 51.1 ttm -79.52 -17.2 54.58 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.916 -0.584 . . . . 73.25 110.778 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -147.04 -168.27 3.0 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.152 -1.795 . . . . 74.409999999999997 106.152 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -87.23 135.15 33.41 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 118.81 0.732 . . . . 75.140000000000001 111.197 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.503 ' O ' HD13 ' A' ' 57' ' ' ILE . 24.3 mm-40 -83.26 107.99 16.18 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.55 -0.75 . . . . 44.130000000000003 110.359 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.24 170.42 16.29 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 123.752 0.657 . . . . 52.149999999999999 110.672 176.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -103.62 41.78 1.24 Allowed 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.1 -0.704 . . . . 73.510000000000005 109.1 -172.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 59.91 44.01 14.16 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.487 1.137 . . . . 71.540000000000006 109.652 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.431 ' C ' ' H ' ' A' ' 54' ' ' SER . 27.4 m -118.08 -21.88 4.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 113.941 -1.481 . . . . 61.409999999999997 110.56 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.6 m 67.79 -12.88 0.27 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.885 1.274 . . . . 75.530000000000001 112.876 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.431 ' H ' ' C ' ' A' ' 52' ' ' VAL . 41.7 m -80.24 114.36 46.42 Favored Pre-proline 0 N--CA 1.436 -1.175 0 C-N-CA 123.186 0.595 . . . . 73.439999999999998 110.528 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.441 ' O ' HD23 ' A' ' 58' ' ' LEU . 40.2 Cg_endo -65.99 -14.96 46.88 Favored 'Trans proline' 0 C--O 1.209 -0.964 0 C-N-CA 123.428 2.752 . . . . 51.030000000000001 114.68 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.02 -5.83 1.15 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 115.147 1.536 . . . . 73.129999999999995 115.147 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 90' ' ' ALA . 2.5 pp -82.94 -29.38 8.23 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.123 0 C-N-CA 120.195 -0.602 . . . . 75.329999999999998 110.152 174.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 55' ' ' PRO . 2.1 pt? -111.33 95.34 5.46 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 107.109 -1.441 . . . . 64.109999999999999 107.109 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 38.5 ptt180 -131.45 159.78 37.07 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-O 121.847 0.832 . . . . 65.299999999999997 112.828 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 4.4 pp -115.4 146.72 41.33 Favored 'General case' 0 N--CA 1.407 -2.585 0 CA-C-N 114.657 -1.156 . . . . 62.240000000000002 112.349 -171.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 94.9 mt -116.67 122.79 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.637 0 CA-C-N 114.351 -1.295 . . . . 72.540000000000006 107.773 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -100.16 89.42 4.01 Favored 'General case' 0 C--N 1.263 -3.18 0 N-CA-C 105.667 -1.975 . . . . 62.420000000000002 105.667 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 69.94 -70.05 0.16 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.325 -1.761 . . . . 75.400000000000006 112.717 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.47 2.44 3.46 Favored Glycine 0 C--N 1.313 -0.73 0 C-N-CA 119.94 -1.124 . . . . 74.439999999999998 113.043 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -130.72 140.94 50.37 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.121 0.415 . . . . 65.200000000000003 112.121 -176.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -83.59 113.82 21.09 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.464 -1.309 . . . . 75.299999999999997 107.464 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.5 HD13 HD22 ' A' ' 76' ' ' LEU . 60.8 mt -79.79 -46.21 17.38 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 119.48 -0.888 . . . . 65.030000000000001 112.733 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.544 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.6 t60 -169.9 169.71 8.1 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 104.091 -2.559 . . . . 60.009999999999998 104.091 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -63.67 -47.13 89.56 Favored Glycine 0 C--O 1.201 -1.966 0 C-N-CA 120.185 -1.007 . . . . 64.239999999999995 113.589 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.455 ' OD1' ' HB2' ' A' ' 31' ' ' SER . 10.2 t30 -152.58 72.0 0.96 Allowed 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 122.348 1.07 . . . . 61.049999999999997 109.517 -172.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.472 HG13 HD22 ' A' ' 60' ' ' LEU . 7.2 p -101.62 151.29 5.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 113.617 -1.629 . . . . 73.340000000000003 108.079 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.441 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 42.0 p -78.12 158.73 29.0 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.677 0.275 . . . . 71.439999999999998 111.406 -175.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.51 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 1.2 mm? -68.27 -32.72 73.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.365 -0.38 . . . . 72.530000000000001 111.146 -176.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.19 -36.95 93.88 Favored Glycine 0 C--O 1.24 0.507 0 N-CA-C 110.743 -0.943 . . . . 72.430000000000007 110.743 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HB3' HG21 ' A' ' 71' ' ' VAL . . . -71.48 -15.43 62.32 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.011 0.524 . . . . 74.209999999999994 110.835 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.5 HD22 HD13 ' A' ' 67' ' ' LEU . 86.5 mt -82.58 6.31 18.05 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.402 0.681 . . . . 71.349999999999994 110.237 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 77.03 10.94 2.47 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.824 1.249 . . . . 54.32 111.828 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.476 HD12 ' HB2' ' A' ' 76' ' ' LEU . 9.6 mp -72.37 119.26 73.89 Favored Pre-proline 0 C--O 1.24 0.565 0 N-CA-C 112.95 0.722 . . . . 75.349999999999994 112.95 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.85 159.41 34.63 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.022 2.481 . . . . 65.430000000000007 109.75 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -77.25 156.73 31.24 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.388 -0.597 . . . . 74.25 109.388 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 79.55 10.19 86.11 Favored Glycine 0 C--N 1.308 -0.973 0 C-N-CA 120.896 -0.669 . . . . 74.510000000000005 113.546 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -115.62 155.81 26.98 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 120.798 0.332 . . . . 44.509999999999998 111.414 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.518 HG22 HD21 ' A' ' 11' ' ' ASN . 84.1 m -105.2 125.89 51.48 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.761 -0.654 . . . . 74.209999999999994 109.266 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.3 m -136.34 142.2 43.82 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.905 0.383 . . . . 75.329999999999998 111.85 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.47 142.2 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.031 -0.531 . . . . 55.020000000000003 110.744 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 93.0 mtp -137.0 153.26 50.71 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.276 0.56 . . . . 74.129999999999995 110.949 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.432 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 35.0 m-70 -111.56 130.8 55.62 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.773 -1.566 . . . . 61.520000000000003 106.773 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.465 ' N ' HD21 ' A' ' 88' ' ' LEU . 2.2 mm? -119.12 143.49 47.15 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.635 -0.426 . . . . 70.409999999999997 111.249 -174.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.88 134.24 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.503 -0.554 . . . . 61.43 109.503 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 57' ' ' ILE . . . -134.01 138.03 45.12 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.717 -0.475 . . . . 54.200000000000003 109.717 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -119.48 134.98 54.96 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 107.289 -1.374 . . . . 74.329999999999998 107.289 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 62.56 28.66 16.79 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 123.938 0.774 . . . . 73.530000000000001 109.025 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.8 t -71.12 153.05 42.84 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 109.438 -0.578 . . . . 64.329999999999998 109.438 -176.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 mp -98.82 141.37 22.78 Favored Pre-proline 0 C--N 1.282 -2.341 0 CA-C-O 120.918 0.389 . . . . 75.209999999999994 111.15 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.83 -152.11 0.04 OUTLIER 'Trans proline' 0 C--O 1.258 1.498 0 C-N-CA 122.563 2.175 . . . . 71.329999999999998 109.255 173.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.14 135.97 76.26 Favored Pre-proline 0 C--N 1.314 -0.975 0 C-N-CA 119.422 -0.911 . . . . 70.310000000000002 110.587 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.22 -1.69 11.83 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.146 1.897 . . . . 65.530000000000001 111.216 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 71.51 -7.03 1.27 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.563 1.145 . . . . 70.219999999999999 112.216 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.3 m -85.03 -0.49 54.62 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 122.852 0.461 . . . . 71.420000000000002 110.844 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -84.36 -51.26 7.1 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.909 0.707 . . . . 72.430000000000007 112.909 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 57.43 20.19 36.51 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 121.152 -0.547 . . . . 75.230000000000004 112.307 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.557 ' NE2' ' HB2' ' A' ' 106' ' ' GLU . 37.9 tt0 -111.69 127.17 55.69 Favored 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 123.054 0.542 . . . . 75.310000000000002 111.582 -177.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -75.47 -57.06 4.12 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.089 -1.448 . . . . 72.230000000000004 107.089 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -177.38 -49.02 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.443 -1.253 . . . . 60.350000000000001 110.589 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 -59.63 -50.28 74.48 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.392 0.516 . . . . 73.129999999999995 112.392 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.557 ' HB2' ' NE2' ' A' ' 102' ' ' GLN . 0.3 OUTLIER 66.65 -74.74 0.06 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.715 1.206 . . . . 65.310000000000002 111.671 176.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -146.68 135.66 22.45 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.957 -0.757 . . . . 65.239999999999995 108.957 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.9 m 74.16 -12.79 0.84 Allowed 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 123.932 0.893 . . . . 64.299999999999997 112.0 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.54 -12.92 71.48 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 111.045 -0.822 . . . . 75.230000000000004 111.045 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -56.01 132.91 51.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.581 0.752 . . . . 74.010000000000005 111.394 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.1 m -117.4 109.0 16.24 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.763 -0.653 . . . . 71.430000000000007 109.844 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -76.92 108.24 9.82 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.433 -1.321 . . . . 65.209999999999994 107.433 177.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.18 -21.55 66.78 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.782 -0.644 . . . . 74.409999999999997 112.05 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 68.0 m 62.77 92.56 0.06 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.744 0.817 . . . . 65.030000000000001 110.323 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.3 m -71.61 82.38 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 114.275 1.213 . . . . 73.200000000000003 114.275 -175.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.5 pt -120.49 107.86 21.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 114.738 -1.119 . . . . 64.439999999999998 108.403 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 C--N 1.294 -1.815 0 CA-C-O 118.411 -0.804 . . . . 71.120000000000005 109.861 -177.109 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.435 -1.187 0 N-CA-C 110.16 -0.311 . . . . 74.310000000000002 110.16 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.437 ' N ' HG13 ' A' ' 115' ' ' VAL . 33.7 m -96.32 94.99 7.77 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.215 0.531 . . . . 63.140000000000001 111.033 177.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -127.86 130.1 48.03 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 105.282 -2.118 . . . . 73.530000000000001 105.282 172.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.0 t -121.68 124.44 27.13 Favored Pre-proline 0 N--CA 1.407 -2.602 0 C-N-CA 119.047 -1.061 . . . . 75.430000000000007 110.605 -171.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.07 144.07 51.24 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.918 1.745 . . . . 72.040000000000006 109.109 172.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.35 71.3 3.83 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.772 0.796 . . . . 74.129999999999995 111.23 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -175.48 -27.43 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.95 -1.477 . . . . 64.420000000000002 108.14 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.9 mmm -110.45 157.46 19.55 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.605 -1.18 . . . . 74.129999999999995 108.866 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.13 134.79 52.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 110.079 -0.341 . . . . 73.010000000000005 110.079 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 3.6 t30 -92.75 107.55 19.31 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 107.964 -1.124 . . . . 64.209999999999994 107.964 -176.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.444 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.1 tp -111.84 132.57 54.61 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.676 0.75 . . . . 74.319999999999993 112.389 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -107.19 119.98 40.86 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 108.333 -0.988 . . . . 72.530000000000001 108.333 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.503 ' CB ' HG22 ' A' ' 39' ' ' VAL . 2.5 mm? -99.09 125.73 44.68 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 124.704 1.201 . . . . 74.010000000000005 110.023 -177.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.0 mt -100.2 117.61 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 108.441 -0.948 . . . . 75.519999999999996 108.441 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.8 mt -75.1 162.21 28.73 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.108 -0.496 . . . . 64.430000000000007 111.733 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.32 -15.8 20.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.484 -0.78 . . . . 72.409999999999997 110.219 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.0 m -76.81 -14.71 59.88 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.438 -0.801 . . . . 72.120000000000005 109.295 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.7 1.83 67.82 Favored Glycine 0 CA--C 1.501 -0.837 0 CA-C-N 115.882 -0.599 . . . . 53.039999999999999 112.076 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.491 ' HB3' ' HZ3' ' A' ' 20' ' ' LYS . 2.0 mmmp? -89.12 133.06 34.53 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.103 -1.073 . . . . 75.109999999999999 108.103 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 76.9 p -98.78 129.8 45.21 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.877 -0.786 . . . . 65.430000000000007 108.877 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -127.93 149.38 50.35 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.702 -0.851 . . . . 71.439999999999998 108.702 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -136.34 131.25 34.05 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.447 -0.901 . . . . 51.219999999999999 109.791 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.57 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.5 m-85 -144.73 159.21 43.22 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 123.735 0.814 . . . . 74.420000000000002 108.85 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.5 tp -89.36 128.5 35.91 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.626 -0.879 . . . . 54.25 108.626 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 97.0 m-85 -132.2 173.95 10.72 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.977 -0.379 . . . . 71.299999999999997 109.977 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.2 p -98.76 150.46 36.72 Favored Pre-proline 0 N--CA 1.421 -1.896 0 N-CA-C 108.331 -0.988 . . . . 73.140000000000001 108.331 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.33 -11.38 22.29 Favored 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 122.257 1.971 . . . . 75.019999999999996 111.989 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -79.82 -22.15 43.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.301 1.041 . . . . 73.049999999999997 111.258 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -67.55 153.46 43.65 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.319 0.489 . . . . 73.409999999999997 112.319 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.472 ' O ' HG13 ' A' ' 35' ' ' ILE . 51.7 p -100.38 118.91 37.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.54 -0.541 . . . . 74.109999999999999 109.54 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.493 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . . . -46.09 -51.19 14.29 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 115.205 1.557 . . . . 70.129999999999995 115.205 -173.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.7 m -71.85 -26.15 62.25 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 122.011 -0.43 . . . . 70.340000000000003 111.649 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.37 -41.19 76.84 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 107.75 -1.204 . . . . 73.400000000000006 107.75 173.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.557 ' O ' HG21 ' A' ' 39' ' ' VAL . 66.2 mt -60.66 -40.11 83.68 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 CA-C-N 114.031 -1.44 . . . . 72.420000000000002 110.186 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.417 ' HB1' ' HG ' ' A' ' 88' ' ' LEU . . . -50.12 -40.64 46.67 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 123.4 0.68 . . . . 71.430000000000007 111.026 176.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.454 ' HB2' ' HG3' ' A' ' 44' ' ' PRO . 35.0 mmtp -73.22 -43.64 60.91 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.793 -0.639 . . . . 73.430000000000007 109.746 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.491 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 13.2 t60 -61.45 -39.91 92.55 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.728 0.811 . . . . 72.340000000000003 111.636 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.557 HG21 ' O ' ' A' ' 35' ' ' ILE . 29.4 m -77.08 -31.86 18.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.192 -0.458 . . . . 72.519999999999996 111.69 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 50.9 t80 -59.67 -49.58 77.17 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 124.102 0.876 . . . . 74.010000000000005 110.273 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -179.65 90.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.615 0.572 . . . . 71.409999999999997 111.576 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.491 ' O ' ' HA ' ' A' ' 38' ' ' HIS . 23.1 t-20 72.24 170.49 0.32 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.388 1.075 . . . . 74.030000000000001 111.119 176.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -73.87 123.9 89.71 Favored Pre-proline 0 C--N 1.312 -1.043 0 O-C-N 122.023 -0.423 . . . . 75.129999999999995 111.278 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.454 ' HG3' ' HB2' ' A' ' 37' ' ' LYS . 34.3 Cg_endo -62.0 -50.01 5.7 Favored 'Trans proline' 0 C--O 1.248 0.999 0 C-N-CA 122.804 2.336 . . . . 50.200000000000003 112.536 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.51 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 2.4 mmt 69.92 -64.82 0.34 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.266 1.027 . . . . 74.310000000000002 112.848 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -172.19 -37.78 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.262 0.553 . . . . 71.420000000000002 110.367 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 25.6 m-90 -82.98 91.09 7.09 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.348 0.594 . . . . 74.5 111.152 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -119.27 -171.33 2.09 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.114 -1.069 . . . . 72.349999999999994 108.114 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -73.95 135.46 43.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.983 -1.118 . . . . 72.439999999999998 107.983 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 71.26 5.8 5.57 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 124.292 0.995 . . . . 74.349999999999994 110.042 -172.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 62.95 -85.61 0.02 OUTLIER 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.146 1.378 . . . . 62.340000000000003 110.884 -176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -128.2 86.11 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.784 0.802 . . . . 74.549999999999997 110.397 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.3 m -61.2 -58.15 9.5 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.019 -0.991 . . . . 71.109999999999999 110.332 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.492 ' O ' HG12 ' A' ' 57' ' ' ILE . 77.2 p 178.96 158.24 0.66 Allowed Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 107.144 -1.428 . . . . 65.540000000000006 107.144 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.31 -16.53 24.78 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 121.809 1.673 . . . . 73.400000000000006 110.725 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -75.02 -3.04 30.09 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.591 -0.731 . . . . 64.109999999999999 111.822 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 91' ' ' ARG . 34.3 pt -81.76 -11.56 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 120.141 -0.624 . . . . 71.030000000000001 109.769 176.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.594 ' O ' ' HD2' ' A' ' 59' ' ' ARG . 2.9 mm? -95.11 108.88 21.0 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 115.852 -0.613 . . . . 71.430000000000007 110.922 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.594 ' HD2' ' O ' ' A' ' 58' ' ' LEU . 3.3 mpt_? -130.07 162.85 27.84 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 123.78 0.832 . . . . 72.209999999999994 109.138 174.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 4.2 pp -148.19 144.49 27.77 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.671 -0.492 . . . . 72.420000000000002 109.671 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 88.5 mt -117.67 119.17 60.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.774 -0.825 . . . . 75.140000000000001 108.774 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.491 ' HH ' HD23 ' A' ' 78' ' ' LEU . 36.1 t80 -101.97 86.01 2.8 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.351 -0.611 . . . . 74.5 109.351 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 44.98 70.55 0.33 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.707 -1.588 . . . . 74.25 112.228 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.06 -72.5 0.45 Allowed Glycine 0 N--CA 1.431 -1.666 0 C-N-CA 119.907 -1.139 . . . . 75.109999999999999 113.261 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -117.13 164.77 14.26 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 117.518 0.659 . . . . 72.450000000000003 112.772 -173.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.566 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 67.9 m-85 -86.11 113.85 22.49 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.46 -1.311 . . . . 72.430000000000007 107.46 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.501 HD13 ' CD2' ' A' ' 76' ' ' LEU . 70.0 mt -80.13 -47.32 14.94 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.398 1.259 . . . . 71.109999999999999 114.398 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.476 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 8.4 t60 -174.64 151.82 1.54 Allowed 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 107.218 -1.401 . . . . 74.010000000000005 107.218 -174.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.83 1.3 39.63 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.073 1.189 . . . . 65.030000000000001 116.073 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -168.7 27.55 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.144 0.972 . . . . 72.5 110.053 -169.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 68' ' ' HIS . 12.6 p -84.17 142.92 12.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 119.592 -0.843 . . . . 65.209999999999994 110.219 -177.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.405 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 49.2 p -81.44 160.22 24.06 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.94 -0.573 . . . . 63.329999999999998 111.304 -177.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.466 HD22 ' H ' ' A' ' 73' ' ' LEU . 1.9 mm? -65.42 -33.09 75.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.208 -0.451 . . . . 73.519999999999996 111.811 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.64 -30.87 75.14 Favored Glycine 0 C--O 1.238 0.352 0 C-N-CA 120.099 -1.048 . . . . 74.129999999999995 111.085 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.408 ' HB2' HG21 ' A' ' 71' ' ' VAL . . . -74.5 -15.35 60.88 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.456 0.702 . . . . 71.319999999999993 110.646 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.501 ' CD2' HD13 ' A' ' 67' ' ' LEU . 74.3 mt -81.95 11.49 5.01 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.413 -0.588 . . . . 72.129999999999995 109.413 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER 67.99 17.79 9.54 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.771 1.228 . . . . 73.030000000000001 110.856 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.491 HD23 ' HH ' ' A' ' 62' ' ' TYR . 91.5 mt -82.86 120.08 75.59 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 115.775 -0.648 . . . . 60.130000000000003 110.753 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -82.21 138.83 10.23 Favored 'Trans proline' 0 N--CA 1.435 -1.964 0 C-N-CA 122.145 1.896 . . . . 55.450000000000003 110.531 175.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -67.41 149.91 49.64 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.358 0.599 . . . . 71.310000000000002 112.504 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.69 5.79 64.44 Favored Glycine 0 N--CA 1.432 -1.573 0 CA-C-N 115.203 -0.908 . . . . 72.010000000000005 111.763 -174.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -124.0 164.89 18.42 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 109.843 -0.429 . . . . 63.219999999999999 109.843 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.419 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 64.2 m -106.69 134.65 49.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.7 0.286 . . . . 72.230000000000004 110.283 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.5 m -141.02 142.36 34.24 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 122.212 -0.305 . . . . 74.319999999999993 111.706 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.7 p -108.92 142.76 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 122.774 0.43 . . . . 74.019999999999996 110.118 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 92.8 mtp -136.22 152.94 51.29 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 120.994 0.426 . . . . 74.150000000000006 110.515 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 30.6 m-70 -104.46 130.16 52.39 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.269 -1.382 . . . . 75.239999999999995 107.269 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.423 ' N ' HD21 ' A' ' 88' ' ' LEU . 2.5 mm? -117.79 144.4 45.38 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.524 -0.471 . . . . 64.519999999999996 110.762 -176.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.1 m -133.28 134.65 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 109.344 -0.613 . . . . 73.310000000000002 109.344 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.33 139.4 45.63 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.066 0.46 . . . . 73.150000000000006 110.759 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.511 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -101.63 141.84 33.88 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 103.122 -2.918 . . . . 75.030000000000001 103.122 175.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 57.25 48.65 14.7 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.966 -1.124 . . . . 72.340000000000003 107.966 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 t -56.5 164.84 1.27 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.235 1.017 . . . . 73.519999999999996 113.143 -175.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.409 ' HB2' ' HD2' ' A' ' 37' ' ' LYS . 32.1 tp -65.28 148.88 97.67 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-N 113.975 -1.466 . . . . 60.43 109.239 -178.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.94 156.7 14.83 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.313 2.008 . . . . 64.239999999999995 110.952 172.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -135.32 152.42 76.67 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 116.465 -0.334 . . . . 65.519999999999996 110.562 -174.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.28 -64.84 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.009 1.806 . . . . 72.519999999999996 109.409 172.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -174.86 91.7 0.06 Allowed 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 115.166 -0.925 . . . . 64.230000000000004 110.107 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.7 p 58.45 -37.13 0.05 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 117.464 2.394 . . . . 70.230000000000004 117.464 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -79.87 -51.65 8.86 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.756 0.65 . . . . 74.230000000000004 112.756 -173.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.98 45.52 95.97 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 107.847 -2.101 . . . . 75.019999999999996 107.847 -171.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -70.78 122.31 19.63 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 114.704 1.372 . . . . 75.129999999999995 114.704 -171.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -163.37 148.6 11.28 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 127.602 2.361 . . . . 70.519999999999996 105.327 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.486 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 13.9 m120 -120.8 -168.91 1.73 Allowed 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 104.966 -2.235 . . . . 74.129999999999995 104.966 174.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -71.82 -36.12 70.14 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 117.548 -1.661 . . . . 72.319999999999993 107.326 171.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.611 ' O ' ' HB3' ' A' ' 110' ' ' GLU . 46.5 mt-10 57.98 -167.21 0.14 Allowed 'General case' 0 C--N 1.354 0.803 0 CA-C-N 114.322 -1.308 . . . . 65.049999999999997 111.754 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.613 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 7.0 tmtm? -86.35 -8.51 57.63 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.17 -1.048 . . . . 62.229999999999997 108.17 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.8 m -91.61 94.66 9.52 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 115.736 -0.665 . . . . 74.209999999999994 110.182 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.95 40.12 5.62 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.881 -0.888 . . . . 55.039999999999999 110.881 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.611 ' HB3' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -99.67 -176.36 3.25 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.188 0.994 . . . . 72.420000000000002 113.62 -177.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.1 m -148.17 97.21 2.74 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.032 -1.84 . . . . 65.409999999999997 106.032 174.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -75.07 89.5 2.46 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.465 0.65 . . . . 74.299999999999997 110.702 -174.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 70.0 m -148.99 160.43 43.31 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.494 -0.775 . . . . 74.299999999999997 109.64 -177.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 60.2 m -87.06 110.41 20.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.346 -1.353 . . . . 51.43 107.346 176.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.437 HG13 ' N ' ' A' ' 3' ' ' SER . 23.2 m -85.24 154.07 3.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.046 0.45 . . . . 74.299999999999997 111.981 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.4 tp -120.83 123.65 70.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.955 -0.566 . . . . 72.409999999999997 109.507 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.5 tm? . . . . . 0 C--N 1.306 -1.294 0 N-CA-C 107.516 -1.29 . . . . 75.140000000000001 107.516 -179.298 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.1 m . . . . . 0 N--CA 1.427 -1.583 0 N-CA-C 108.642 -0.873 . . . . 72.349999999999994 108.642 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.6 m 70.56 -165.46 0.16 Allowed 'General case' 0 C--O 1.248 0.984 0 C-N-CA 123.661 0.784 . . . . 74.409999999999997 110.303 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -57.1 152.1 14.03 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.287 0.565 . . . . 73.010000000000005 111.269 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.427 HG12 HD13 ' A' ' 25' ' ' LEU . 26.0 t -92.22 114.46 62.3 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 109.201 -0.666 . . . . 53.210000000000001 109.201 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.89 161.26 33.34 Favored 'Trans proline' 0 C--O 1.247 0.955 0 C-N-CA 122.574 2.183 . . . . 71.420000000000002 111.207 177.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.94 74.13 6.69 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 121.869 0.843 . . . . 72.120000000000005 109.101 175.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -171.2 -28.64 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.524 -1.671 . . . . 74.540000000000006 108.594 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 89.1 mmm -111.97 151.86 28.76 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.776 -1.102 . . . . 74.030000000000001 108.867 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.456 HD11 ' O ' ' A' ' 10' ' ' ILE . 2.7 pp -111.34 136.32 47.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-O 120.817 0.341 . . . . 65.219999999999999 110.687 176.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.01 111.58 18.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.775 -1.194 . . . . 73.200000000000003 107.775 -177.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.432 ' HG ' HD21 ' A' ' 14' ' ' LEU . 40.0 tp -118.01 132.93 56.33 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.482 0.658 . . . . 73.030000000000001 112.627 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.453 ' HD2' ' OE1' ' A' ' 23' ' ' GLU . 19.0 ttt85 -113.48 122.34 47.02 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 114.994 -1.003 . . . . 61.109999999999999 108.878 175.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.503 ' CB ' HG23 ' A' ' 39' ' ' VAL . 1.9 mm? -100.09 125.11 46.14 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 124.502 1.121 . . . . 73.099999999999994 108.609 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.594 HG12 ' O ' ' A' ' 86' ' ' MET . 18.8 mm -99.28 123.71 52.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.629 -1.248 . . . . 73.329999999999998 107.629 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.23 156.87 24.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.399 -0.593 . . . . 74.530000000000001 109.399 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.413 ' CG1' ' HA ' ' A' ' 89' ' ' VAL . 35.3 m -66.21 -14.24 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.153 0.427 . . . . 53.109999999999999 112.153 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.2 t -76.27 -16.85 59.71 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.859 -0.61 . . . . 72.019999999999996 109.686 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.57 -6.19 57.33 Favored Glycine 0 N--CA 1.433 -1.559 0 C-N-CA 120.576 -0.821 . . . . 52.299999999999997 112.178 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -86.88 140.05 30.03 Favored 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 119.182 -1.007 . . . . 51.5 110.401 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.475 HG21 HD12 ' A' ' 15' ' ' ILE . 62.0 p -99.11 137.15 38.04 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 115.07 -0.968 . . . . 75.120000000000005 109.651 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -126.86 138.28 53.3 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.29 -1.744 . . . . 72.319999999999993 106.29 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.453 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 26.3 tt0 -137.71 131.15 30.94 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.09 -1.044 . . . . 64.239999999999995 110.818 -176.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.567 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 86.1 m-85 -145.03 159.79 42.39 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 123.382 0.673 . . . . 74.319999999999993 109.267 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.427 HD13 HG12 ' A' ' 5' ' ' VAL . 41.2 tp -84.67 125.15 32.25 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.386 -0.968 . . . . 63.229999999999997 108.386 176.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 96.3 m-85 -128.9 174.44 9.5 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.225 -0.657 . . . . 74.310000000000002 109.225 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.0 p -97.59 154.14 38.05 Favored Pre-proline 0 N--CA 1.431 -1.408 0 C-N-CA 119.193 -1.003 . . . . 64.549999999999997 108.818 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 45.0 Cg_endo -64.18 -12.9 34.84 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.576 2.184 . . . . 74.099999999999994 112.105 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -93.33 -7.33 45.13 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.161 -0.472 . . . . 65.530000000000001 111.642 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -79.2 153.28 30.12 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 120.485 -0.486 . . . . 72.409999999999997 111.186 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.492 ' O ' HG13 ' A' ' 35' ' ' ILE . 45.5 m -93.17 122.41 35.53 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.664 0.269 . . . . 73.400000000000006 110.775 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.469 ' HB1' ' CD2' ' A' ' 60' ' ' LEU . . . -49.34 -46.81 47.35 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.919 1.288 . . . . 42.32 113.409 -176.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 p -67.5 -33.71 75.65 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 113.05 0.759 . . . . 65.530000000000001 113.05 -177.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.54 -44.89 66.57 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.606 -1.257 . . . . 63.200000000000003 107.606 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 31' ' ' SER . 69.4 mt -55.29 -40.79 58.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 114.539 -1.209 . . . . 75.540000000000006 111.148 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.7 -37.65 42.55 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 123.549 0.74 . . . . 75.439999999999998 111.647 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.494 ' HB2' ' HG3' ' A' ' 44' ' ' PRO . 98.3 mttt -73.81 -34.58 64.66 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 120.755 0.312 . . . . 73.040000000000006 111.208 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.403 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 71.7 t60 -71.93 -44.25 63.94 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.405 -0.361 . . . . 70.439999999999998 111.829 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.503 HG23 ' CB ' ' A' ' 14' ' ' LEU . 27.4 m -65.24 -31.07 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 120.814 0.34 . . . . 75.549999999999997 110.886 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -70.76 -51.09 29.39 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.431 -0.804 . . . . 73.019999999999996 111.542 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -179.13 137.31 0.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 118.096 0.407 . . . . 73.129999999999995 111.996 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.605 ' ND2' ' H ' ' A' ' 43' ' ' TRP . 0.3 OUTLIER 60.04 -172.7 0.12 Allowed 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 124.741 1.216 . . . . 74.439999999999998 108.289 -179.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.605 ' H ' ' ND2' ' A' ' 42' ' ' ASN . 67.3 p-90 -114.09 130.29 24.04 Favored Pre-proline 0 N--CA 1.43 -1.457 0 N-CA-C 107.312 -1.366 . . . . 73.040000000000006 107.312 171.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.494 ' HG3' ' HB2' ' A' ' 37' ' ' LYS . 44.3 Cg_endo -92.46 152.43 2.97 Favored 'Trans proline' 0 N--CA 1.423 -2.623 0 C-N-CA 120.906 1.07 . . . . 73.219999999999999 112.567 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 25.2 ttt -91.82 -36.97 13.22 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.501 -1.666 . . . . 71.219999999999999 106.501 169.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.8 t70 42.97 67.77 0.59 Allowed 'General case' 0 CA--C 1.503 -0.852 0 O-C-N 125.829 1.956 . . . . 63.100000000000001 111.258 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 29.2 t90 -101.6 -40.77 6.86 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 113.574 -1.648 . . . . 74.430000000000007 108.856 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -112.72 -177.49 3.16 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.911 -0.774 . . . . 62.240000000000002 108.911 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.57 ' HG2' ' H ' ' A' ' 50' ' ' GLU . 41.2 tt0 -141.14 -173.88 3.85 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.417 -1.327 . . . . 61.450000000000003 107.417 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.57 ' H ' ' HG2' ' A' ' 49' ' ' GLU . 18.9 mm-40 -50.49 163.64 0.16 Allowed 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.364 1.066 . . . . 50.409999999999997 113.002 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -45.05 -59.6 2.51 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.027 1.331 . . . . 62.25 114.561 -172.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.4 p -100.16 -2.36 9.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-O 121.983 0.897 . . . . 73.230000000000004 109.239 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.0 m 66.82 162.11 0.17 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.289 -1.323 . . . . 75.400000000000006 113.161 176.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.2 m -165.84 85.41 0.98 Allowed Pre-proline 0 C--N 1.31 -1.117 0 C-N-CA 125.158 1.383 . . . . 75.439999999999998 108.013 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -59.1 -16.64 34.22 Favored 'Trans proline' 0 N--CA 1.487 1.146 0 C-N-CA 123.023 2.482 . . . . 73.299999999999997 113.398 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -61.51 -19.4 62.04 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.541 0.736 . . . . 73.530000000000001 110.327 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.7 pp -80.14 -16.29 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 116.206 -0.452 . . . . 74.230000000000004 110.785 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.3 mt -109.43 92.26 3.98 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 116.183 -0.462 . . . . 75.329999999999998 110.02 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.443 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 27.9 ptt180 -147.1 143.79 28.57 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.981 0.419 . . . . 72.239999999999995 111.003 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 4.4 pp -113.89 144.02 43.73 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.739 -0.664 . . . . 73.239999999999995 111.478 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.522 ' HB ' ' O ' ' A' ' 87' ' ' HIS . 90.9 mt -109.65 124.68 66.56 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 108.358 -0.979 . . . . 75.030000000000001 108.358 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.42 ' CD2' HD11 ' A' ' 67' ' ' LEU . 19.4 t80 -100.49 92.17 5.02 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 106.825 -1.546 . . . . 74.349999999999994 106.825 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 65.43 -67.09 0.14 Allowed 'General case' 0 N--CA 1.399 -2.981 0 C-N-CA 127.341 2.256 . . . . 50.100000000000001 112.173 -175.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.57 -44.93 0.87 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.633 -0.794 . . . . 38.210000000000001 114.135 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.15 159.04 23.23 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 115.435 1.643 . . . . 74.420000000000002 115.435 -174.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.547 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 63.9 m-85 -80.13 113.33 18.23 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.274 -0.875 . . . . 64.319999999999993 108.875 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.485 HD13 HD23 ' A' ' 76' ' ' LEU . 85.4 mt -81.33 -48.77 11.53 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.579 0.955 . . . . 71.329999999999998 113.579 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.711 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 14.7 t-80 -169.25 167.07 10.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.799 -1.556 . . . . 75.230000000000004 106.799 -173.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -85.25 -0.57 88.56 Favored Glycine 0 C--N 1.299 -1.489 0 N-CA-C 115.227 0.851 . . . . 55.210000000000001 115.227 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -168.04 28.69 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 118.187 0.993 . . . . 70.049999999999997 109.801 -169.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.9 p -85.12 138.02 19.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 C-N-CA 119.696 -0.801 . . . . 75.409999999999997 109.528 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.1 p -79.81 159.6 26.44 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.333 0.494 . . . . 75.420000000000002 112.333 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 3.3 mm? -59.42 -41.4 89.44 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 123.521 0.728 . . . . 72.329999999999998 111.844 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.99 -29.94 69.03 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.404 -0.427 . . . . 63.009999999999998 112.564 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.72 -15.17 59.32 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 122.923 0.489 . . . . 60.299999999999997 110.891 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.485 HD23 HD13 ' A' ' 67' ' ' LEU . 42.9 mt -83.46 5.4 23.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.387 -0.37 . . . . 70.030000000000001 110.404 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.405 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 8.8 mptt 62.67 76.92 0.35 Allowed 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.455 1.102 . . . . 62.100000000000001 109.434 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.414 HD22 ' HH ' ' A' ' 62' ' ' TYR . 84.4 mt -131.26 120.81 18.25 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 116.224 -0.444 . . . . 70.349999999999994 111.371 -174.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.11 157.85 38.02 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 121.943 1.762 . . . . 75.030000000000001 109.669 170.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -78.71 150.62 32.47 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.767 -0.457 . . . . 71.310000000000002 109.767 -175.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.09 -11.45 72.09 Favored Glycine 0 C--N 1.308 -1.003 0 N-CA-C 114.756 0.662 . . . . 52.119999999999997 114.756 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.43 154.54 19.73 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.97 -1.092 . . . . 61.049999999999997 110.756 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.0 m -85.13 117.82 24.32 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.306 0.574 . . . . 72.120000000000005 111.017 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.7 m -105.41 125.52 51.08 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.386 -0.968 . . . . 72.120000000000005 108.386 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.3 p -108.74 122.3 63.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.643 0.735 . . . . 54.43 110.752 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.594 ' O ' HG12 ' A' ' 15' ' ' ILE . 87.0 mtp -122.97 150.63 42.73 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-N 116.192 -0.458 . . . . 71.439999999999998 109.899 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.522 ' O ' ' HB ' ' A' ' 61' ' ' ILE . 39.9 m-70 -106.31 128.9 54.33 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.67 -1.233 . . . . 74.230000000000004 107.67 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.402 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.8 mm? -118.48 139.46 51.39 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 120.163 -0.615 . . . . 72.219999999999999 110.641 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.413 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 33.0 m -123.06 131.18 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.127 0 N-CA-C 108.582 -0.896 . . . . 70.420000000000002 108.582 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.01 143.59 42.82 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.174 -0.466 . . . . 51.140000000000001 110.359 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -133.39 148.72 51.83 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.303 -1.74 . . . . 75.310000000000002 106.303 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 56.2 29.3 14.54 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.491 0.662 . . . . 70.010000000000005 110.546 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.7 t -72.02 146.22 47.79 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.082 -0.963 . . . . 73.430000000000007 111.837 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 mp -97.14 125.44 45.84 Favored Pre-proline 0 C--N 1.291 -1.945 0 CA-C-N 114.887 -1.052 . . . . 73.439999999999998 108.298 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -89.07 8.65 3.81 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.65 2.233 . . . . 74.310000000000002 111.584 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 98' ' ' ASN . 9.6 pt-20 -165.55 137.96 3.39 Favored Pre-proline 0 N--CA 1.439 -1.0 0 CA-C-N 116.116 -0.493 . . . . 75.209999999999994 111.706 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -60.06 -50.41 7.55 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.86 2.373 . . . . 74.019999999999996 108.898 171.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 96' ' ' GLU . 9.5 t30 -151.97 174.04 14.12 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 100.468 -3.901 . . . . 73.329999999999998 100.468 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.3 m -74.21 71.6 1.7 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 120.779 1.627 . . . . 73.349999999999994 112.507 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -87.76 -43.06 12.16 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-N 115.894 -0.594 . . . . 74.329999999999998 109.612 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.7 12.1 63.79 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.162 -0.926 . . . . 65.109999999999999 113.189 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -80.88 109.06 15.09 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 118.37 -1.332 . . . . 73.310000000000002 110.637 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -116.51 1.0 12.87 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 108.267 -1.012 . . . . 65.099999999999994 108.267 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -58.92 140.46 55.42 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 113.174 -1.83 . . . . 75.530000000000001 110.203 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.434 ' HD2' ' OG ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -60.47 -35.32 75.6 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.507 1.123 . . . . 74.420000000000002 110.578 -177.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 107' ' ' LYS . 1.9 tm-20 65.59 178.88 0.2 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 124.696 1.198 . . . . 65.150000000000006 109.02 174.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.421 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 87.2 tttt 72.49 127.41 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.746 0.818 . . . . 71.310000000000002 111.962 -177.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.0 p -54.55 116.24 2.56 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.375 -0.83 . . . . 62.030000000000001 111.521 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 136.71 -35.15 2.14 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 120.75 -0.738 . . . . 74.219999999999999 111.583 -177.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 62.08 28.88 17.44 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.501 0.721 . . . . 75.129999999999995 110.511 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.434 ' OG ' ' HD2' ' A' ' 105' ' ' ARG . 67.7 m 75.03 124.6 0.04 OUTLIER 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.057 0.943 . . . . 75.420000000000002 110.904 -173.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -66.72 102.44 0.93 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.396 -0.82 . . . . 64.099999999999994 110.24 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.6 m -82.96 103.53 12.49 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.725 -0.843 . . . . 55.530000000000001 108.725 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 68.7 m -72.57 111.24 7.56 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 116.015 -0.539 . . . . 72.140000000000001 110.214 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.7 t -79.39 -36.02 17.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.509 -0.769 . . . . 61.439999999999998 109.001 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.8 176.1 8.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.3 -0.863 . . . . 54.399999999999999 108.924 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--N 1.303 -1.416 0 N-CA-C 106.991 -1.485 . . . . 74.129999999999995 106.991 178.547 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.4 p . . . . . 0 N--CA 1.428 -1.546 0 N-CA-C 109.759 -0.46 . . . . 73.239999999999995 109.759 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.8 t -132.4 91.21 2.9 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.581 -0.896 . . . . 74.420000000000002 108.581 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.439 ' N ' HD21 ' A' ' 4' ' ' ASN . 0.7 OUTLIER 67.38 -174.1 0.19 Allowed 'General case' 0 C--O 1.25 1.099 0 C-N-CA 123.928 0.891 . . . . 74.209999999999994 110.436 -177.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.5 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 25.8 t -124.87 115.63 26.4 Favored Pre-proline 0 N--CA 1.431 -1.387 0 N-CA-C 107.863 -1.162 . . . . 74.129999999999995 107.863 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -68.92 145.65 62.77 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 122.249 1.966 . . . . 62.340000000000003 112.11 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.3 78.01 7.01 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 122.396 1.093 . . . . 75.329999999999998 109.82 176.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -160.4 -41.88 0.05 OUTLIER 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 113.034 -1.894 . . . . 62.0 106.958 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.453 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 8.5 ptm -124.44 159.98 29.25 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.287 -1.324 . . . . 64.209999999999994 111.047 -175.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.89 140.6 28.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.338 0.589 . . . . 74.530000000000001 112.582 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -87.59 107.85 18.79 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.393 -0.966 . . . . 53.25 108.393 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.451 ' HG ' HD21 ' A' ' 14' ' ' LEU . 43.2 tp -117.24 132.85 56.54 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.291 0.567 . . . . 73.25 112.411 -173.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 35.7 ttp-105 -107.44 120.9 43.46 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 108.733 -0.84 . . . . 72.530000000000001 108.733 173.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.595 ' CB ' HG22 ' A' ' 39' ' ' VAL . 2.5 mm? -97.34 121.96 39.82 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.219 -1.355 . . . . 74.540000000000006 109.337 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.6 mt -99.77 119.36 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 N-CA-C 108.272 -1.01 . . . . 72.340000000000003 108.272 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.04 166.79 23.11 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.478 -0.783 . . . . 74.319999999999993 111.436 -175.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.7 m -70.74 -14.35 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.504 0.669 . . . . 73.25 110.665 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 m -83.69 -6.24 59.39 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 114.923 -1.035 . . . . 74.129999999999995 110.11 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.81 -4.67 84.96 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.852 -0.69 . . . . 52.439999999999998 112.64 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -87.54 131.9 34.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.898 0.38 . . . . 73.239999999999995 110.252 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.8 p -98.94 129.94 45.28 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.998 -0.546 . . . . 75.140000000000001 110.068 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -131.44 139.11 49.32 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.043 -0.725 . . . . 73.420000000000002 109.043 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 29.4 tt0 -125.23 133.84 52.56 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.324 -0.55 . . . . 75.549999999999997 110.587 -174.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.64 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 95.3 m-85 -144.66 160.0 41.9 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.105 0.562 . . . . 75.409999999999997 109.489 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.44 ' HG ' ' HE2' ' A' ' 9' ' ' MET . 23.7 tp -87.52 126.17 34.76 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.174 -1.047 . . . . 72.030000000000001 108.174 177.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.64 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 96.8 m-85 -132.77 173.94 10.84 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.749 -0.834 . . . . 74.439999999999998 108.749 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 99.7 p -97.09 151.34 37.65 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 108.515 -0.92 . . . . 71.049999999999997 108.515 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 37.3 Cg_endo -63.11 -11.87 27.13 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.594 2.196 . . . . 73.049999999999997 112.409 177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -86.2 -17.24 35.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.542 -0.754 . . . . 75.400000000000006 109.999 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -69.93 154.76 41.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.486 0.66 . . . . 73.409999999999997 112.429 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.532 ' O ' HG13 ' A' ' 35' ' ' ILE . 3.3 p -91.69 118.21 30.45 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 115.357 -0.838 . . . . 72.040000000000006 110.848 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.4 -51.29 59.86 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.83 1.252 . . . . 52.140000000000001 113.623 -174.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.1 m -72.11 -22.6 61.31 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 120.861 0.362 . . . . 72.109999999999999 111.6 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -70.66 -48.88 52.64 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.502 -0.925 . . . . 64.239999999999995 108.502 172.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 31' ' ' SER . 72.5 mt -54.81 -43.91 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 114.278 -1.328 . . . . 73.030000000000001 110.102 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.27 -34.37 23.09 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.165 0.986 . . . . 74.230000000000004 111.763 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.531 ' HB2' ' HG3' ' A' ' 44' ' ' PRO . 33.4 mmtp -74.03 -49.7 23.08 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 109.539 -0.541 . . . . 53.530000000000001 109.539 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -59.95 -40.76 90.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.41 -0.814 . . . . 64.0 111.568 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.595 HG22 ' CB ' ' A' ' 14' ' ' LEU . 36.0 m -73.95 -31.3 30.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.418 -0.355 . . . . 71.430000000000007 111.654 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -56.47 -49.71 73.83 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 123.446 0.466 . . . . 74.200000000000003 110.855 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.5 t70 171.86 -57.68 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 O-C-N 123.733 0.646 . . . . 72.430000000000007 110.773 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -81.81 166.04 20.35 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.468 -0.938 . . . . 64.120000000000005 108.468 -175.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -111.24 122.27 38.19 Favored Pre-proline 0 C--N 1.29 -2.011 0 CA-C-O 120.669 0.271 . . . . 75.099999999999994 110.392 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.531 ' HG3' ' HB2' ' A' ' 37' ' ' LYS . 75.4 Cg_exo -49.61 99.77 0.04 OUTLIER 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 123.375 2.716 . . . . 74.239999999999995 114.993 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 96.5 mmm -148.81 -43.83 0.15 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.741 0.816 . . . . 73.120000000000005 110.55 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 95' ' ' PRO . 9.9 m-20 -133.73 175.97 8.97 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.652 -0.869 . . . . 73.0 108.652 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.8 p90 -156.35 169.48 24.49 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.608 -0.437 . . . . 70.340000000000003 109.999 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -141.72 109.16 5.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 105.493 -2.04 . . . . 74.409999999999997 105.493 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.68 124.68 32.48 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.917 1.08 . . . . 71.030000000000001 113.917 -169.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.2 154.0 38.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.616 -0.72 . . . . 62.32 109.221 172.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 60.88 24.52 14.51 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.92 1.081 . . . . 63.340000000000003 113.92 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 52' ' ' VAL . 25.9 t 67.98 38.66 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 122.049 0.928 . . . . 74.5 109.207 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.1 m -60.76 104.8 0.38 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.398 1.094 . . . . 43.43 112.749 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 57' ' ' ILE . 20.0 m -106.65 -176.35 0.41 Allowed Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 114.008 -1.451 . . . . 52.229999999999997 107.813 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -52.06 -16.37 4.42 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 122.916 2.411 . . . . 61.43 112.596 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -56.07 -23.59 34.65 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.434 1.493 . . . . 72.439999999999998 111.586 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.447 HG23 ' HB3' ' A' ' 91' ' ' ARG . 2.3 pp -77.69 -11.16 13.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 112.442 0.534 . . . . 74.299999999999997 112.442 -178.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.1 mt -91.77 116.55 28.99 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 120.915 0.388 . . . . 73.319999999999993 111.86 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -144.82 164.16 31.88 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 124.149 0.98 . . . . 70.510000000000005 108.41 175.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.575 HD21 ' H ' ' A' ' 71' ' ' VAL . 3.7 pp -147.17 148.4 31.49 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 109.444 -0.576 . . . . 75.109999999999999 109.444 172.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 87' ' ' HIS . 90.3 mt -118.27 129.63 74.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 108.644 -0.873 . . . . 74.230000000000004 108.644 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -100.03 81.51 2.43 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 106.292 -1.744 . . . . 74.409999999999997 106.292 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.324 17.6 tm0? 59.34 -38.56 0.07 Allowed 'General case' 0 N--CA 1.414 -2.228 0 C-N-CA 129.042 2.937 . . . . 62.549999999999997 116.38 -176.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.35 -52.25 0.18 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.801 -0.714 . . . . 73.329999999999998 112.651 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.64 162.24 14.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.49 1.293 . . . . 74.099999999999994 114.49 -178.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 43.9 m-85 -88.28 113.54 23.99 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.866 -1.161 . . . . 74.219999999999999 107.866 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.21 -48.93 12.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 119.179 -1.008 . . . . 51.509999999999998 112.31 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.517 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 60.1 m80 -159.81 177.88 10.36 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.698 -0.853 . . . . 73.209999999999994 108.698 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 103' ' ' ARG . . . -85.63 -4.17 85.62 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.978 -0.629 . . . . 71.219999999999999 112.584 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.48 HD21 ' HA ' ' A' ' 102' ' ' GLN . 56.4 t30 175.74 79.61 0.0 OUTLIER 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.527 1.131 . . . . 54.25 110.273 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.575 ' H ' HD21 ' A' ' 60' ' ' LEU . 9.2 p -104.33 146.15 12.09 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.765 0 N-CA-C 106.783 -1.562 . . . . 70.510000000000005 106.783 172.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.3 p -78.52 158.19 28.64 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.397 -0.521 . . . . 64.299999999999997 111.532 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 2.0 mm? -66.26 -34.71 78.62 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.148 0.499 . . . . 60.32 111.003 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.14 -31.38 79.08 Favored Glycine 0 CA--C 1.516 0.155 0 C-N-CA 120.6 -0.81 . . . . 72.329999999999998 111.234 176.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.403 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -72.4 -15.0 61.84 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 122.959 0.503 . . . . 64.340000000000003 110.872 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.503 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 64.5 mt -82.19 3.38 27.5 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.88 -0.415 . . . . 75.430000000000007 109.88 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.23 26.12 2.78 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.451 1.1 . . . . 72.340000000000003 111.135 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.503 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 65.1 mt -76.53 127.68 83.9 Favored Pre-proline 0 C--O 1.244 0.791 0 CA-C-N 116.555 -0.293 . . . . 75.540000000000006 111.138 -178.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.71 147.0 30.82 Favored 'Trans proline' 0 N--CA 1.435 -1.919 0 C-N-CA 121.439 1.426 . . . . 73.129999999999995 108.46 170.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.497 ' CE1' ' HG3' ' A' ' 28' ' ' PRO . 12.4 m-30 -69.51 145.67 52.48 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.191 -0.67 . . . . 73.420000000000002 109.191 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.5 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 89.41 1.77 77.73 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 120.165 -1.016 . . . . 64.310000000000002 113.55 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -101.49 145.22 29.28 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 117.041 0.42 . . . . 74.109999999999999 109.955 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.4 m -87.19 117.48 25.96 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.917 -0.772 . . . . 65.120000000000005 108.917 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.9 m -114.21 134.97 54.55 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.609 -0.723 . . . . 75.319999999999993 110.935 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.8 131.25 62.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 120.991 0.424 . . . . 62.299999999999997 110.349 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 89.7 mtp -135.51 153.2 51.8 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-O 120.81 0.338 . . . . 70.540000000000006 110.479 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.483 ' O ' ' HB ' ' A' ' 61' ' ' ILE . 27.8 m-70 -106.58 135.42 48.13 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.474 -1.306 . . . . 75.400000000000006 107.474 176.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.442 HD23 ' C ' ' A' ' 87' ' ' HIS . 2.4 mm? -123.53 137.05 54.85 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 120.249 -0.58 . . . . 71.549999999999997 110.188 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.4 m -126.46 133.47 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-O 121.58 0.705 . . . . 74.329999999999998 111.199 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.12 133.28 39.05 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.469 -0.937 . . . . 74.120000000000005 108.469 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.447 ' HB3' HG23 ' A' ' 57' ' ' ILE . 56.6 ttt180 -88.0 134.85 33.64 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.277 -1.379 . . . . 72.439999999999998 107.277 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 71.59 -43.09 0.55 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.957 1.303 . . . . 64.219999999999999 112.123 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.425 ' H ' ' C ' ' A' ' 91' ' ' ARG . 45.4 m 73.74 83.44 0.12 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 124.933 1.293 . . . . 74.150000000000006 112.604 177.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.45 143.34 47.73 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 114.28 -1.327 . . . . 72.239999999999995 107.796 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.506 ' HB2' ' O ' ' A' ' 46' ' ' ASP . 46.2 Cg_exo -56.35 -54.58 3.72 Favored 'Trans proline' 0 C--O 1.213 -0.763 0 C-N-CA 122.482 2.122 . . . . 74.540000000000006 111.273 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.89 148.51 75.74 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 107.869 -1.16 . . . . 71.349999999999994 107.869 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.578 ' CG ' ' HA2' ' A' ' 101' ' ' GLY . 14.1 Cg_endo -54.35 -67.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.746 2.297 . . . . 62.130000000000003 110.621 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.7 t30 176.06 80.25 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 126.127 1.771 . . . . 74.310000000000002 106.353 173.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.1 m 65.11 -63.53 0.19 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.406 1.483 . . . . 75.329999999999998 114.86 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -89.94 -50.48 6.0 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.464 0.65 . . . . 74.219999999999999 109.708 -171.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.578 ' HA2' ' CG ' ' A' ' 97' ' ' PRO . . . 131.73 -33.33 2.76 Favored Glycine 0 CA--C 1.488 -1.641 0 N-CA-C 110.184 -1.166 . . . . 75.310000000000002 110.184 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.481 ' OE1' ' HD3' ' A' ' 105' ' ' ARG . 57.3 tt0 -90.0 148.4 23.1 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.817 -0.692 . . . . 74.120000000000005 109.775 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.454 ' HB2' ' HA3' ' A' ' 69' ' ' GLY . 14.6 tpt180 -48.77 -58.73 4.34 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.567 1.147 . . . . 64.549999999999997 109.426 173.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -177.09 158.89 1.58 Allowed 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.055 -1.832 . . . . 64.219999999999999 106.055 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.481 ' HD3' ' OE1' ' A' ' 102' ' ' GLN . 40.7 mmt180 -65.41 -31.5 72.64 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.103 -0.702 . . . . 75.450000000000003 109.103 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 76.71 151.57 0.12 Allowed 'General case' 0 C--N 1.353 0.737 0 C-N-CA 125.706 1.602 . . . . 71.349999999999994 110.251 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.54 -48.65 76.83 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.26 0.553 . . . . 62.420000000000002 109.808 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.5 p -90.83 89.55 7.53 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 107.26 -1.385 . . . . 74.239999999999995 107.26 170.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 154.59 -32.35 0.69 Allowed Glycine 0 N--CA 1.432 -1.576 0 C-N-CA 119.61 -1.281 . . . . 55.100000000000001 112.9 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -63.1 98.18 0.13 Allowed 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.209 0.528 . . . . 73.510000000000005 110.835 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.9 t 63.25 88.79 0.09 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 114.578 -1.192 . . . . 74.230000000000004 108.097 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -53.0 107.7 0.25 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 115.542 -0.754 . . . . 74.439999999999998 111.311 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 11.9 p -67.7 133.83 50.01 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.677 -1.147 . . . . 72.329999999999998 111.875 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 23.5 p -85.09 87.34 7.36 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-O 121.725 0.774 . . . . 73.129999999999995 109.31 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.48 127.97 73.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.161 -0.927 . . . . 65.219999999999999 110.518 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 13.5 tt -158.7 108.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-O 121.588 0.708 . . . . 71.5 110.962 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 tm? . . . . . 0 C--N 1.308 -1.197 0 N-CA-C 106.401 -1.703 . . . . 70.040000000000006 106.401 178.697 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.426 -1.658 0 N-CA-C 107.671 -1.233 . . . . 75.310000000000002 107.671 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.3 m -151.65 174.56 13.33 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 116.505 -0.316 . . . . 65.439999999999998 110.236 -176.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -78.88 156.2 28.74 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.984 -1.117 . . . . 74.329999999999998 107.984 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.407 HG13 HD21 ' A' ' 25' ' ' LEU . 24.9 t -80.76 121.79 81.45 Favored Pre-proline 0 C--N 1.308 -1.204 0 C-N-CA 120.325 -0.55 . . . . 74.430000000000007 109.652 -176.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.455 ' HA ' ' CD1' ' A' ' 117' ' ' LEU . 3.4 Cg_exo -64.3 142.45 79.54 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.426 2.084 . . . . 74.230000000000004 112.395 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.97 70.82 6.61 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 122.121 0.962 . . . . 73.129999999999995 109.884 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -168.0 -37.04 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 104.909 -2.256 . . . . 74.109999999999999 104.909 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 86.0 mmm -102.58 156.74 17.41 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.622 -1.627 . . . . 75.239999999999995 108.985 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -117.92 140.22 42.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 107.509 -1.293 . . . . 74.349999999999994 107.509 172.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 67.1 t30 -91.81 125.24 36.45 Favored 'General case' 0 CA--C 1.485 -1.537 0 C-N-CA 118.765 -1.174 . . . . 64.430000000000007 107.876 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.462 ' HG ' HD21 ' A' ' 14' ' ' LEU . 44.7 tp -126.21 133.65 51.46 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-O 121.149 0.5 . . . . 70.310000000000002 112.112 -174.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 17.8 ttp180 -106.1 120.63 42.3 Favored 'General case' 0 N--CA 1.405 -2.71 0 N-CA-C 108.659 -0.867 . . . . 72.549999999999997 108.659 173.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.514 ' CB ' HG22 ' A' ' 39' ' ' VAL . 2.1 mm? -99.56 122.31 42.44 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 113.966 -1.47 . . . . 63.229999999999997 109.275 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.471 HG23 HG22 ' A' ' 21' ' ' THR . 15.0 mm -105.07 123.31 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.513 -1.291 . . . . 64.0 107.513 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 2.5 mm? -93.92 158.3 15.71 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.245 -0.582 . . . . 72.109999999999999 110.969 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.489 ' CG1' ' HA ' ' A' ' 89' ' ' VAL . 32.2 m -52.85 -30.29 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 115.009 1.485 . . . . 73.129999999999995 115.009 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.4 m -86.61 4.88 38.41 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.992 0.425 . . . . 63.009999999999998 111.351 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.47 24.92 49.17 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.208 -0.757 . . . . 61.240000000000002 111.208 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 73.4 mmtt -86.97 130.82 34.3 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 104.688 -2.338 . . . . 65.150000000000006 104.688 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.471 HG22 HG23 ' A' ' 15' ' ' ILE . 38.7 p -126.3 128.68 47.51 Favored 'General case' 0 C--N 1.278 -2.53 0 C-N-CA 119.644 -0.822 . . . . 72.239999999999995 111.648 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -142.39 147.21 35.84 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.32 -0.4 . . . . 75.530000000000001 111.025 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 21.0 tt0 -125.9 130.2 50.85 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 107.68 -1.23 . . . . 63.509999999999998 107.68 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.68 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 96.4 m-85 -145.11 158.97 43.67 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.703 0.287 . . . . 63.200000000000003 110.452 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.407 HD21 HG13 ' A' ' 5' ' ' VAL . 96.5 mt -79.76 125.66 29.96 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.99 -1.115 . . . . 71.299999999999997 107.99 175.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.68 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 90.1 m-85 -129.86 163.15 26.94 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.59 -0.522 . . . . 73.319999999999993 109.59 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.0 m -88.99 141.13 29.29 Favored Pre-proline 0 N--CA 1.395 -3.185 0 N-CA-C 107.613 -1.255 . . . . 74.530000000000001 107.613 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.456 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 34.7 Cg_endo -62.4 -11.98 25.4 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.203 1.935 . . . . 73.510000000000005 112.186 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -78.89 -20.27 49.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.433 1.093 . . . . 72.25 110.046 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.447 ' O ' HD21 ' A' ' 73' ' ' LEU . 63.5 m-20 -75.44 154.16 37.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.184 -0.462 . . . . 64.329999999999998 111.347 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.538 ' HB2' ' OD1' ' A' ' 70' ' ' ASN . 13.4 p -101.1 132.07 46.73 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.276 0.473 . . . . 65.140000000000001 112.276 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.47 -59.34 3.56 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.662 1.727 . . . . 62.240000000000002 115.662 -174.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.7 m -72.78 -19.7 61.31 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.504 0.668 . . . . 55.549999999999997 111.258 -174.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.528 ' OD2' ' HG3' ' A' ' 97' ' ' PRO . 14.3 t70 -70.15 -47.93 59.55 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.493 -1.299 . . . . 62.310000000000002 107.493 172.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 31' ' ' SER . 73.3 mt -59.03 -35.28 56.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.671 -1.149 . . . . 73.140000000000001 110.84 176.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.41 -33.56 21.22 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.029 0.532 . . . . 72.549999999999997 110.665 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 5.5 mptp? -68.87 -51.72 37.31 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.71 0.291 . . . . 73.329999999999998 110.312 174.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.486 ' ND1' ' HE3' ' A' ' 43' ' ' TRP . 51.8 t60 -57.52 -43.0 83.94 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.992 -0.549 . . . . 71.010000000000005 111.889 -177.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.514 HG22 ' CB ' ' A' ' 14' ' ' LEU . 35.8 m -76.9 -31.53 19.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 112.381 0.512 . . . . 74.409999999999997 112.381 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -68.38 -47.15 68.12 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.404 -0.519 . . . . 74.209999999999994 109.761 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.458 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . 6.5 m-20 -137.42 -89.95 0.25 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.55 0.944 . . . . 74.019999999999996 113.55 176.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 38' ' ' HIS . 40.3 t-20 -129.22 170.72 13.24 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.949 -1.5 . . . . 63.240000000000002 106.949 -176.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.486 ' HE3' ' ND1' ' A' ' 38' ' ' HIS . 58.5 t-105 -61.07 134.49 92.97 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.499 -0.556 . . . . 73.230000000000004 109.499 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.44 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 64.0 Cg_exo -42.41 101.54 0.04 OUTLIER 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 124.105 3.203 . . . . 73.140000000000001 113.024 176.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.423 ' HG3' ' O ' ' A' ' 43' ' ' TRP . 69.2 mtm -137.55 -60.64 0.65 Allowed 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 115.353 -0.84 . . . . 73.420000000000002 110.375 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -107.0 -73.77 0.68 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.233 -0.587 . . . . 74.319999999999993 110.184 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.458 ' CH2' ' HB2' ' A' ' 41' ' ' ASP . 89.3 m95 60.08 -179.77 0.09 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 115.408 1.632 . . . . 75.540000000000006 115.408 177.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -155.98 164.03 38.97 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.813 -0.63 . . . . 73.540000000000006 109.492 -172.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.445 ' HA ' HG21 ' A' ' 93' ' ' THR . 12.7 pt-20 -131.22 140.91 49.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.05 -1.092 . . . . 72.200000000000003 108.05 173.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.447 ' HB2' ' CD ' ' A' ' 92' ' ' GLU . 0.6 OUTLIER -60.52 -72.91 0.1 Allowed 'General case' 0 C--O 1.24 0.569 0 N-CA-C 111.775 0.287 . . . . 65.019999999999996 111.775 -179.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.13 -91.06 0.5 Allowed 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 119.915 -0.714 . . . . 74.019999999999996 109.1 174.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.0 m -151.66 125.48 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 123.974 0.91 . . . . 70.109999999999999 108.943 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.2 m -130.15 169.58 15.17 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 120.662 -0.415 . . . . 74.120000000000005 110.451 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.631 ' O ' HG13 ' A' ' 57' ' ' ILE . 45.7 p -91.48 123.31 64.21 Favored Pre-proline 0 N--CA 1.429 -1.496 0 N-CA-C 109.14 -0.689 . . . . 75.329999999999998 109.14 177.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.78 -17.02 9.42 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 123.117 2.545 . . . . 74.439999999999998 112.998 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -63.4 -13.28 38.08 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.774 0.83 . . . . 75.010000000000005 111.204 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.631 HG13 ' O ' ' A' ' 54' ' ' SER . 2.0 pp -78.18 -16.03 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 122.204 -0.31 . . . . 73.530000000000001 111.773 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.9 mt -78.84 96.1 5.56 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 107.27 -1.381 . . . . 62.140000000000001 107.27 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 10.3 ptt180 -146.46 162.72 37.67 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.442 -0.799 . . . . 64.319999999999993 111.567 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 4.5 pp -127.11 150.32 49.54 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 115.6 -0.727 . . . . 75.030000000000001 112.044 -171.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.4 mt -118.79 120.02 62.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.17 -0.923 . . . . 74.230000000000004 108.58 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.424 ' CD2' HD12 ' A' ' 67' ' ' LEU . 17.0 t80 -101.53 65.52 1.04 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.057 -1.09 . . . . 72.439999999999998 108.057 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 53.83 83.93 0.07 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.828 -1.533 . . . . 74.319999999999993 113.496 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.55 -58.51 0.5 Allowed Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.535 -0.841 . . . . 64.209999999999994 112.803 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -130.87 162.88 28.65 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 120.095 -0.642 . . . . 75.329999999999998 112.693 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.521 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 78.8 m-85 -83.73 122.27 28.42 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.073 -1.454 . . . . 73.25 107.073 175.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.455 HD11 ' CD2' ' A' ' 76' ' ' LEU . 54.6 mt -79.71 -46.37 17.22 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 118.804 -1.158 . . . . 72.219999999999999 111.289 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.481 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.0 t-160 -165.86 178.88 6.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.361 -2.089 . . . . 74.439999999999998 105.361 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -71.54 -42.23 55.89 Favored Glycine 0 C--O 1.208 -1.472 0 C-N-CA 120.346 -0.931 . . . . 74.549999999999997 112.675 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.538 ' OD1' ' HB2' ' A' ' 31' ' ' SER . 60.7 t30 -159.93 75.93 0.62 Allowed 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 108.613 -0.884 . . . . 75.129999999999995 108.613 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.503 HG11 HD21 ' A' ' 60' ' ' LEU . 11.2 p -102.06 152.08 5.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.228 -1.351 . . . . 70.400000000000006 109.066 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.1 p -77.61 160.68 28.38 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.488 0.551 . . . . 74.430000000000007 112.488 -173.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.479 ' H ' HD21 ' A' ' 73' ' ' LEU . 1.3 mm? -68.98 -34.55 75.49 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 116.134 -0.484 . . . . 72.319999999999993 111.189 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.05 -29.67 75.09 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.496 -0.859 . . . . 41.32 111.193 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.443 ' HB3' HG23 ' A' ' 71' ' ' VAL . . . -73.79 -15.24 61.19 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 122.972 0.509 . . . . 74.329999999999998 111.199 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.459 HD11 ' SD ' ' A' ' 86' ' ' MET . 58.6 mt -83.83 2.39 38.48 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.867 0.467 . . . . 72.450000000000003 110.224 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER 65.22 78.06 0.29 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.984 0.914 . . . . 62.130000000000003 109.276 -176.544 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.0 mt -133.46 133.33 22.58 Favored Pre-proline 0 C--O 1.243 0.749 0 CA-C-N 116.093 -0.503 . . . . 74.109999999999999 111.239 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -81.33 155.97 19.23 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.293 1.996 . . . . 65.120000000000005 109.229 171.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -76.71 153.65 34.9 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.74 -0.837 . . . . 73.450000000000003 108.74 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 83.97 2.37 89.56 Favored Glycine 0 C--N 1.3 -1.467 0 C-N-CA 120.25 -0.976 . . . . 73.530000000000001 113.09 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.21 151.68 23.78 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 110.2 -0.296 . . . . 54.439999999999998 110.2 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.437 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 90.1 m -102.18 127.17 49.23 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.146 0.498 . . . . 64.439999999999998 110.158 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 84.8 m -128.72 141.98 51.15 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.938 -0.573 . . . . 64.209999999999994 110.604 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.9 137.5 41.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.779 0.323 . . . . 72.120000000000005 110.877 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.459 ' SD ' HD11 ' A' ' 76' ' ' LEU . 93.6 mtp -135.51 152.73 51.61 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 122.882 0.473 . . . . 75.549999999999997 110.176 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -109.61 131.06 55.41 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.662 -0.866 . . . . 73.120000000000005 108.662 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 88' ' ' LEU . 2.5 mm? -117.87 137.63 52.66 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 110.06 -0.348 . . . . 74.109999999999999 110.06 -175.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.489 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 32.6 m -121.71 133.87 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-O 121.142 0.496 . . . . 74.310000000000002 110.706 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.38 120.93 19.34 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.645 -0.707 . . . . 64.109999999999999 109.991 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.467 ' H ' HD12 ' A' ' 57' ' ' ILE . 2.5 tmt_? -88.17 112.67 23.0 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 108.076 -1.083 . . . . 72.010000000000005 108.076 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.476 ' O ' ' HB ' ' A' ' 93' ' ' THR . 31.2 tt0 64.95 -88.21 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 124.766 1.291 . . . . 75.319999999999993 107.939 -176.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 92' ' ' GLU . 12.7 t 154.91 143.71 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.911 1.284 . . . . 73.030000000000001 110.55 175.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.74 160.32 27.69 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 104.825 -2.287 . . . . 72.120000000000005 104.825 165.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.64 -84.55 0.01 OUTLIER 'Trans proline' 0 C--O 1.26 1.622 0 C-N-CA 121.745 1.63 . . . . 73.439999999999998 113.899 -176.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.507 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 1.3 pp20? -172.35 167.98 3.09 Favored Pre-proline 0 CA--C 1.56 1.356 0 CA-C-O 119.32 -0.371 . . . . 73.239999999999995 110.619 -176.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.528 ' HG3' ' OD2' ' A' ' 34' ' ' ASP . 7.3 Cg_endo -46.44 -66.32 0.15 Allowed 'Trans proline' 0 CA--C 1.555 1.528 0 C-N-CA 124.577 3.518 . . . . 65.530000000000001 117.595 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -165.38 18.76 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.364 0.602 . . . . 73.340000000000003 111.316 -167.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.9 t 62.13 75.0 0.42 Allowed 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 124.038 0.935 . . . . 72.420000000000002 108.978 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.402 ' HB2' ' HE1' ' A' ' 43' ' ' TRP . 45.7 mt-30 -68.89 -51.09 43.82 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 114.707 -1.133 . . . . 73.109999999999999 111.708 -175.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.87 11.13 60.1 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.845 -0.693 . . . . 64.030000000000001 112.597 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -78.29 111.69 14.52 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.421 0.629 . . . . 72.099999999999994 111.945 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -150.44 22.93 0.82 Allowed 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.394 -0.821 . . . . 71.420000000000002 110.287 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.42 ' HB3' ' HG3' ' A' ' 106' ' ' GLU . 37.6 t30 -110.43 175.07 5.57 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.885 -1.524 . . . . 54.109999999999999 106.885 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -67.4 -48.96 65.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 118.269 0.486 . . . . 74.349999999999994 109.775 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.42 ' HG3' ' HB3' ' A' ' 104' ' ' ASN . 45.9 mt-10 55.97 26.1 9.5 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.113 1.153 . . . . 71.019999999999996 114.113 169.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -136.49 155.75 49.55 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.502 -0.317 . . . . 73.200000000000003 110.5 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.6 p -66.79 133.27 49.79 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.76 -0.654 . . . . 72.310000000000002 112.384 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.75 ' HA3' ' SG ' ' A' ' 113' ' ' CYS . . . 91.13 -50.09 3.05 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.589 -0.605 . . . . 74.329999999999998 111.589 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 75.13 91.72 0.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.416 1.487 . . . . 71.230000000000004 113.845 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.4 m 69.97 -33.04 0.25 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 115.391 1.626 . . . . 72.230000000000004 115.391 172.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -82.53 -11.38 58.49 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.008 0.744 . . . . 75.030000000000001 113.008 -176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.75 ' SG ' ' HA3' ' A' ' 109' ' ' GLY . 60.4 m -74.23 95.24 2.59 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.489 -0.56 . . . . 71.519999999999996 109.489 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 80.3 m -152.23 107.51 3.28 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.533 -0.303 . . . . 53.439999999999998 111.054 -177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.2 m -82.74 130.58 35.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 109.363 -0.606 . . . . 74.109999999999999 109.363 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 60.8 mt 62.04 84.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.776 0.83 . . . . 64.319999999999993 111.01 -177.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.455 ' CD1' ' HA ' ' A' ' 6' ' ' PRO . 5.1 tt . . . . . 0 C--O 1.252 1.231 0 N-CA-C 106.877 -1.527 . . . . 75.109999999999999 106.877 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 p . . . . . 0 N--CA 1.427 -1.613 0 N-CA-C 110.169 -0.308 . . . . 54.5 110.169 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.7 m -151.3 136.62 17.65 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.456 -0.572 . . . . 71.510000000000005 109.456 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -76.02 138.7 41.06 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 108.637 -0.875 . . . . 65.430000000000007 108.637 176.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.488 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 39.0 t -100.41 116.61 64.19 Favored Pre-proline 0 N--CA 1.418 -2.066 0 N-CA-C 109.306 -0.627 . . . . 61.039999999999999 109.306 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 8' ' ' ASP . 73.3 Cg_endo -79.39 172.52 14.44 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.5 2.134 . . . . 64.129999999999995 111.972 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.42 30.22 0.29 Allowed 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.992 0.917 . . . . 71.400000000000006 110.639 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 6' ' ' PRO . 24.6 t70 -133.42 -14.68 2.54 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.714 -0.676 . . . . 65.310000000000002 110.14 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.3 mmm -121.68 155.4 35.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.036 -0.529 . . . . 73.25 110.092 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 pp -120.28 140.27 44.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-O 120.883 0.373 . . . . 70.019999999999996 110.949 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -90.84 111.04 22.28 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 109.06 -0.719 . . . . 71.129999999999995 109.06 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.431 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.1 tp -119.54 133.11 55.82 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.758 -0.656 . . . . 73.140000000000001 112.31 -174.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -108.63 121.25 44.62 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 114.986 -1.007 . . . . 72.25 108.388 173.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.535 ' CB ' HG23 ' A' ' 39' ' ' VAL . 2.1 mm? -99.44 123.72 43.96 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.061 -0.972 . . . . 72.340000000000003 109.273 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.6 mt -104.46 129.22 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 N-CA-C 108.736 -0.838 . . . . 74.420000000000002 108.736 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.68 166.17 17.29 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.789 -0.642 . . . . 74.510000000000005 110.169 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.13 -19.43 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-O 121.745 0.784 . . . . 74.430000000000007 109.983 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.442 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 22.8 p -76.06 -10.6 59.55 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.561 -0.745 . . . . 75.239999999999995 111.35 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.44 2.52 76.45 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 110.715 -0.954 . . . . 73.129999999999995 110.715 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.442 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 12.6 mptt -86.65 133.61 33.68 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.791 -0.448 . . . . 75.099999999999994 109.791 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.9 p -113.73 137.26 51.87 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 116.117 -0.492 . . . . 62.130000000000003 111.531 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -134.88 147.5 49.87 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.064 -0.717 . . . . 71.299999999999997 109.064 174.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -135.46 131.58 36.34 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.397 -0.594 . . . . 75.439999999999998 109.397 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.706 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 94.4 m-85 -144.04 160.02 41.6 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.951 -0.759 . . . . 65.209999999999994 108.951 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.403 HD12 HG12 ' A' ' 5' ' ' VAL . 41.3 tp -82.28 125.04 30.5 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.292 -1.373 . . . . 74.239999999999995 107.292 175.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.706 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 83.8 m-85 -128.97 166.59 18.88 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.446 -0.575 . . . . 74.310000000000002 109.446 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.7 p -92.83 146.94 33.09 Favored Pre-proline 0 N--CA 1.417 -2.092 0 C-N-CA 119.308 -0.957 . . . . 75.420000000000002 108.62 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.466 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 35.3 Cg_endo -61.86 -11.4 20.93 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.72 2.28 . . . . 71.340000000000003 112.1 177.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -79.97 -23.06 41.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.216 -0.902 . . . . 71.129999999999995 110.973 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.433 ' O ' HD21 ' A' ' 73' ' ' LEU . 22.6 m-20 -67.44 154.78 40.59 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 112.88 0.696 . . . . 75.439999999999998 112.88 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.52 ' O ' HG13 ' A' ' 35' ' ' ILE . 43.7 m -97.08 124.6 41.14 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.65 -0.705 . . . . 53.310000000000002 109.829 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.509 ' HB3' HD21 ' A' ' 60' ' ' LEU . . . -50.5 -50.0 54.04 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.539 0.735 . . . . 64.010000000000005 112.937 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 p -65.65 -30.63 71.36 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 112.355 0.502 . . . . 73.5 112.355 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.66 -46.24 66.56 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.8 -0.815 . . . . 72.010000000000005 108.8 174.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 31' ' ' SER . 67.3 mt -60.22 -39.15 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 114.811 -1.086 . . . . 72.439999999999998 111.138 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.88 -38.61 36.37 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.418 0.687 . . . . 71.430000000000007 111.299 176.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -72.49 -40.92 66.52 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.242 -0.435 . . . . 64.150000000000006 111.079 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -65.89 -42.54 90.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.629 -0.714 . . . . 61.130000000000003 111.161 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.535 HG23 ' CB ' ' A' ' 14' ' ' LEU . 27.4 m -76.84 -30.72 18.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 112.157 0.428 . . . . 72.519999999999996 112.157 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -47.29 -48.85 24.73 Favored 'General case' 0 C--O 1.243 0.719 0 O-C-N 123.565 0.54 . . . . 75.549999999999997 111.795 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.3 t70 178.98 -60.47 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.561 -0.533 . . . . 72.209999999999994 109.561 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -98.03 -161.17 0.85 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.504 -0.771 . . . . 72.340000000000003 109.655 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.6 p-90 -111.69 137.73 21.32 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 109.492 -0.558 . . . . 74.409999999999997 109.492 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -55.49 111.24 0.7 Allowed 'Trans proline' 0 C--O 1.254 1.296 0 C-N-CA 122.576 2.184 . . . . 54.450000000000003 112.026 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.655 ' SD ' ' HA3' ' A' ' 109' ' ' GLY . 55.1 mtt -87.21 153.21 21.67 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.491 -0.777 . . . . 73.310000000000002 110.488 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -65.54 -42.03 92.38 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.652 -0.704 . . . . 44.450000000000003 112.047 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -93.89 -4.14 50.47 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.209 0.818 . . . . 74.430000000000007 113.209 -174.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 45' ' ' MET . 8.5 pt-20 -67.93 -43.06 80.03 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.783 -0.767 . . . . 73.099999999999994 111.933 -175.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.426 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 43.0 mt-10 64.15 -78.5 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.265 1.026 . . . . 74.109999999999999 112.025 -175.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 43.95 63.22 1.67 Allowed 'General case' 0 C--N 1.355 0.809 0 CA-C-O 122.554 1.169 . . . . 71.430000000000007 108.693 -173.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.634 ' NE2' ' HA ' ' A' ' 55' ' ' PRO . 63.2 tt0 -174.65 -46.64 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 104.929 -2.249 . . . . 71.25 104.929 -171.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.0 t 46.78 78.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 113.251 -1.795 . . . . 75.420000000000002 113.58 172.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.3 t 64.91 1.88 1.58 Allowed 'General case' 0 CA--C 1.559 1.325 0 CA-C-N 115.027 -0.988 . . . . 64.129999999999995 112.838 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.8 m -119.11 82.65 22.57 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 109.154 -0.684 . . . . 45.109999999999999 109.154 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.634 ' HA ' ' NE2' ' A' ' 51' ' ' GLN . 57.2 Cg_endo -71.54 -16.92 30.45 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.443 2.096 . . . . 72.209999999999994 113.908 -173.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -62.34 -16.0 51.69 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.276 0.631 . . . . 72.140000000000001 112.677 -176.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.1 pp -77.93 -21.73 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 120.809 0.338 . . . . 72.019999999999996 111.731 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.7 tp -90.78 99.52 12.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.494 -0.928 . . . . 65.329999999999998 108.494 -177.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -137.22 160.53 38.75 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.088 -0.505 . . . . 72.030000000000001 109.721 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 4.5 pp -127.62 140.76 51.89 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.581 -0.736 . . . . 73.140000000000001 109.495 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.469 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 92.5 mt -111.89 126.33 69.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.783 -0.821 . . . . 61.149999999999999 108.783 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -100.58 84.32 2.74 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.715 -1.217 . . . . 73.219999999999999 107.715 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 68.16 -50.24 0.54 Allowed 'General case' 0 N--CA 1.405 -2.676 0 C-N-CA 127.505 2.322 . . . . 53.530000000000001 112.69 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.9 -45.76 0.18 Allowed Glycine 0 N--CA 1.436 -1.338 0 C-N-CA 120.601 -0.809 . . . . 61.200000000000003 113.987 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -110.58 160.9 16.24 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.55 0.574 . . . . 64.409999999999997 112.55 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 68.4 m-85 -87.1 113.79 23.14 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.018 -1.104 . . . . 64.420000000000002 108.018 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.557 HD13 ' CD2' ' A' ' 76' ' ' LEU . 43.2 mt -80.63 -45.21 17.64 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 114.113 1.153 . . . . 64.450000000000003 114.113 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.655 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 8.1 t60 -167.48 169.93 11.73 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.735 -1.58 . . . . 75.010000000000005 106.735 -175.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.85 -1.31 88.98 Favored Glycine 0 C--N 1.309 -0.954 0 C-N-CA 120.73 -0.748 . . . . 72.129999999999995 113.148 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 178.49 64.9 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.826 -0.805 . . . . 72.409999999999997 108.826 -173.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.532 ' H ' HD22 ' A' ' 60' ' ' LEU . 11.2 p -104.18 151.17 6.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.852 -1.166 . . . . 72.0 107.852 174.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.424 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 58.9 p -84.04 158.28 21.52 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 121.42 -0.112 . . . . 62.119999999999997 110.962 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.504 ' H ' HD21 ' A' ' 73' ' ' LEU . 1.5 mm? -65.29 -32.75 74.57 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.977 0.418 . . . . 65.439999999999998 110.79 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.48 -32.31 83.77 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.098 -0.801 . . . . 61.310000000000002 111.098 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.435 ' HB1' HG23 ' A' ' 71' ' ' VAL . . . -79.19 -15.14 58.51 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 122.803 0.441 . . . . 70.219999999999999 111.088 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.557 ' CD2' HD13 ' A' ' 67' ' ' LEU . 66.8 mt -82.38 1.16 38.57 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.945 -0.761 . . . . 71.420000000000002 108.945 176.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.1 mptt 78.84 14.89 1.16 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.056 1.342 . . . . 63.439999999999998 113.18 178.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.476 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.6 mp -60.67 120.26 51.33 Favored Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 113.485 0.92 . . . . 75.150000000000006 113.485 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -73.05 150.41 48.31 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.485 2.123 . . . . 74.329999999999998 108.565 170.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -78.06 142.24 38.3 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.454 -0.943 . . . . 75.239999999999995 108.454 -175.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 92.63 -3.25 74.57 Favored Glycine 0 C--N 1.298 -1.533 0 C-N-CA 119.955 -1.117 . . . . 60.329999999999998 114.151 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -104.42 153.89 20.54 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 117.367 0.583 . . . . 63.450000000000003 111.621 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.7 m -92.61 118.6 31.19 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.33 -0.619 . . . . 74.299999999999997 109.33 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 84.1 m -119.98 136.93 54.36 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 116.39 -0.368 . . . . 74.530000000000001 110.516 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.4 p -110.52 135.45 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-O 121.045 0.45 . . . . 72.219999999999999 110.964 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 87.6 mtp -134.48 153.72 51.78 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 120.896 0.379 . . . . 71.549999999999997 111.64 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 63.3 m-70 -107.73 135.13 49.67 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.682 -1.229 . . . . 72.040000000000006 107.682 176.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 88' ' ' LEU . 2.4 mm? -121.73 133.76 54.94 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 120.161 -0.616 . . . . 73.310000000000002 110.156 -177.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.51 134.57 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 121.662 0.744 . . . . 70.400000000000006 111.827 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.03 145.85 49.82 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.407 -1.331 . . . . 55.549999999999997 107.407 175.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.5 ttm180 -109.98 153.15 24.96 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.017 -1.475 . . . . 74.25 107.017 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.517 ' O ' HG22 ' A' ' 93' ' ' THR . 6.9 tp10 -36.38 -53.13 0.84 Allowed 'General case' 0 N--CA 1.48 1.06 0 O-C-N 124.972 1.42 . . . . 73.319999999999993 110.019 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 92' ' ' GLU . 1.8 p -169.93 -85.94 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 125.718 1.607 . . . . 72.510000000000005 109.833 172.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.72 160.7 35.75 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 109.395 -0.594 . . . . 74.030000000000001 109.395 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -62.31 90.59 0.12 Allowed 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.47 2.113 . . . . 73.329999999999998 111.772 175.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 49.4 85.84 0.17 Allowed Pre-proline 0 C--N 1.319 -0.745 0 C-N-CA 126.333 1.853 . . . . 75.439999999999998 114.611 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.88 -60.96 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.787 1.658 . . . . 71.329999999999998 109.52 175.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -175.45 17.16 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 106.757 -1.572 . . . . 71.519999999999996 106.757 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.4 m 50.38 69.29 0.64 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.801 -1.09 . . . . 71.230000000000004 111.374 -172.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -88.08 -23.13 23.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.897 -1.047 . . . . 71.129999999999995 110.631 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.62 21.82 20.51 Favored Glycine 0 C--N 1.303 -1.297 0 N-CA-C 108.363 -1.895 . . . . 61.109999999999999 108.363 -170.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.485 ' O ' ' HG3' ' A' ' 92' ' ' GLU . 25.0 tt0 -82.03 110.39 17.23 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.446 -0.877 . . . . 74.439999999999998 110.75 -178.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -161.08 -164.43 1.17 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.962 -1.866 . . . . 71.340000000000003 105.962 175.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -69.93 157.11 38.05 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 119.247 0.931 . . . . 64.209999999999994 111.591 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -52.72 -24.68 9.16 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.811 1.644 . . . . 72.420000000000002 113.984 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 78.83 111.72 0.07 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.061 0.944 . . . . 72.420000000000002 111.192 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 72.17 -60.93 0.51 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.052 1.341 . . . . 74.319999999999993 112.207 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.2 p -88.54 107.12 18.73 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 107.664 -1.235 . . . . 72.239999999999995 107.664 175.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.655 ' HA3' ' SD ' ' A' ' 45' ' ' MET . . . -72.14 -28.03 69.08 Favored Glycine 0 C--N 1.306 -1.107 0 C-N-CA 120.374 -0.917 . . . . 55.020000000000003 112.526 -176.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.78 151.42 38.84 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 120.832 0.348 . . . . 73.420000000000002 111.068 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 49.1 m -104.38 -51.12 3.17 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.253 -1.388 . . . . 75.109999999999999 107.253 170.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 64.53 -80.9 0.03 OUTLIER 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.856 1.262 . . . . 74.439999999999998 111.841 175.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 84.0 m -162.49 -45.7 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.049 -1.834 . . . . 70.340000000000003 106.049 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 24.4 p -151.9 139.52 19.7 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.164 -1.38 . . . . 73.519999999999996 107.322 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.8 m -108.26 95.19 3.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.361 1.077 . . . . 74.239999999999995 111.03 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.3 tp -153.75 129.71 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 114.029 -1.441 . . . . 75.140000000000001 108.695 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.255 1.358 0 CA-C-O 118.149 -0.929 . . . . 73.430000000000007 112.915 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.1 m . . . . . 0 C--O 1.235 0.292 0 N-CA-C 115.051 1.501 . . . . 73.430000000000007 115.051 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.8 t -133.71 123.01 24.21 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 104.371 -2.455 . . . . 62.229999999999997 104.371 172.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 74.23 100.31 0.07 Allowed 'General case' 0 N--CA 1.476 0.873 0 O-C-N 124.249 0.968 . . . . 71.420000000000002 109.767 -169.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.479 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 47.5 t -90.26 129.1 46.8 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 109.019 -0.734 . . . . 65.219999999999999 109.019 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -70.87 149.68 60.23 Favored 'Trans proline' 0 C--O 1.25 1.097 0 C-N-CA 122.332 2.022 . . . . 72.420000000000002 112.089 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.42 75.33 7.26 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.905 0.86 . . . . 62.119999999999997 108.73 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -171.99 -25.55 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.642 -1.617 . . . . 71.040000000000006 107.646 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.6 mmm -114.42 144.84 42.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.947 -1.024 . . . . 72.129999999999995 109.626 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -105.76 135.66 43.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 116.191 -0.459 . . . . 74.329999999999998 110.014 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -89.7 110.71 21.58 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.744 -0.836 . . . . 73.019999999999996 108.744 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.452 ' HG ' HD23 ' A' ' 14' ' ' LEU . 43.6 tp -119.51 132.85 55.85 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.629 -0.714 . . . . 64.439999999999998 111.769 -174.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.404 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 35.8 ttp-105 -109.26 120.76 43.49 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 108.651 -0.87 . . . . 63.240000000000002 108.651 173.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.471 HD22 HG12 ' A' ' 39' ' ' VAL . 2.1 mm? -96.44 120.91 37.61 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.787 -1.097 . . . . 74.340000000000003 109.966 -177.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.477 HG22 ' OG1' ' A' ' 21' ' ' THR . 19.0 mt -108.91 117.51 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 N-CA-C 107.045 -1.465 . . . . 75.420000000000002 107.045 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.58 156.96 20.51 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 116.073 -0.512 . . . . 62.240000000000002 111.576 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -58.04 -25.77 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 124.019 0.928 . . . . 72.230000000000004 111.91 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.2 m -76.81 -1.33 27.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.94 0.4 . . . . 74.239999999999995 111.017 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.03 15.85 71.35 Favored Glycine 0 CA--C 1.496 -1.123 0 N-CA-C 111.65 -0.58 . . . . 54.140000000000001 111.65 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -92.42 143.3 26.51 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.892 -1.522 . . . . 75.329999999999998 106.892 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.477 ' OG1' HG22 ' A' ' 15' ' ' ILE . 78.4 m -131.31 141.38 49.93 Favored 'General case' 0 C--N 1.277 -2.555 0 C-N-CA 120.136 -0.626 . . . . 71.319999999999993 109.758 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -150.63 139.82 21.2 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.608 -0.886 . . . . 72.409999999999997 108.608 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.404 ' HG3' ' HB2' ' A' ' 13' ' ' ARG . 27.8 tt0 -123.69 133.09 53.95 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.787 -0.365 . . . . 74.409999999999997 110.533 -177.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.699 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 90.2 m-85 -145.17 161.21 40.06 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 123.4 0.68 . . . . 61.520000000000003 109.728 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.72 125.84 30.18 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.68 -1.23 . . . . 73.219999999999999 107.68 170.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.699 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 85.7 m-85 -125.16 167.35 14.95 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.886 -0.783 . . . . 74.299999999999997 108.886 177.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 99.0 p -94.65 147.54 33.36 Favored Pre-proline 0 N--CA 1.414 -2.249 0 C-N-CA 118.895 -1.122 . . . . 73.129999999999995 108.225 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.82 -11.56 21.52 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.686 2.257 . . . . 64.340000000000003 112.312 177.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -84.44 -18.39 36.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.553 -0.748 . . . . 62.100000000000001 110.983 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.417 ' O ' HD23 ' A' ' 73' ' ' LEU . 35.1 m-20 -74.07 153.86 39.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.874 0.368 . . . . 74.25 110.374 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.409 ' O ' HG13 ' A' ' 35' ' ' ILE . 36.2 m -98.97 131.6 44.91 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.937 -0.764 . . . . 60.450000000000003 108.937 176.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.516 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . . . -51.29 -36.57 43.0 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.396 0.887 . . . . 70.299999999999997 113.396 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.451 ' OG ' ' HA ' ' A' ' 70' ' ' ASN . 7.2 p -69.24 -36.66 77.41 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.851 0.685 . . . . 63.409999999999997 112.851 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.66 -43.29 89.82 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.145 -1.057 . . . . 75.340000000000003 108.145 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.52 HG22 ' CZ ' ' A' ' 26' ' ' PHE . 57.0 mt -59.5 -41.31 84.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 114.847 -1.07 . . . . 75.340000000000003 111.964 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.94 -42.38 48.37 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 123.043 0.537 . . . . 70.319999999999993 111.472 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 95' ' ' PRO . 28.6 mmmt -73.52 -38.62 65.24 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 120.69 0.281 . . . . 65.129999999999995 111.323 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -59.77 -45.2 93.0 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.581 -0.736 . . . . 73.209999999999994 110.535 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.471 HG12 HD22 ' A' ' 14' ' ' LEU . 34.9 m -75.29 -31.83 24.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-O 121.047 0.451 . . . . 74.25 112.139 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -68.87 -22.37 64.21 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.783 -0.644 . . . . 73.310000000000002 110.76 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . 0.315 29.6 t70 91.62 84.56 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 125.806 1.642 . . . . 74.219999999999999 113.835 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.1 t30 171.69 132.9 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 127.208 2.203 . . . . 63.43 105.652 175.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -85.65 120.49 72.97 Favored Pre-proline 0 C--N 1.284 -2.245 0 C-N-CA 119.938 -0.705 . . . . 74.209999999999994 109.649 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.453 ' HG3' ' HB2' ' A' ' 37' ' ' LYS . 53.8 Cg_exo -59.28 94.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.679 2.253 . . . . 73.310000000000002 112.264 172.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 50.3 ttm -155.11 117.54 4.24 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.75 -1.574 . . . . 73.310000000000002 106.75 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t70 78.2 134.59 0.06 Allowed 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.607 1.163 . . . . 71.109999999999999 110.131 -173.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' NE1' ' HA ' ' A' ' 98' ' ' ASN . 25.2 m-90 -55.85 -50.41 70.67 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 113.649 0.981 . . . . 70.150000000000006 113.649 -173.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.517 ' OE2' ' HG3' ' A' ' 95' ' ' PRO . 47.8 mt-10 67.24 -55.77 0.45 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.882 0.873 . . . . 73.439999999999998 110.468 -170.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' A' ' 52' ' ' VAL . 45.7 mt-10 73.1 -19.12 0.33 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.987 1.715 . . . . 73.329999999999998 114.764 174.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 70.07 -55.96 0.59 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.902 0.881 . . . . 73.310000000000002 111.601 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -173.66 -37.72 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.276 0.63 . . . . 75.340000000000003 109.412 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 49' ' ' GLU . 29.4 m -91.86 172.26 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.82 -0.627 . . . . 64.25 110.19 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -138.83 94.36 2.82 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 109.322 -0.621 . . . . 70.230000000000004 109.322 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.3 m -160.8 117.67 1.43 Allowed Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 123.977 0.911 . . . . 62.020000000000003 108.838 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.53 -16.55 30.56 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.433 2.088 . . . . 70.510000000000005 111.271 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -74.39 0.27 15.04 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.685 -1.143 . . . . 62.409999999999997 112.724 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' A' ' 91' ' ' ARG . 2.5 pp -76.77 -21.28 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.086 0.47 . . . . 73.209999999999994 110.912 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.456 ' N ' HD13 ' A' ' 57' ' ' ILE . 96.4 mt -89.3 125.35 35.07 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 107.251 -1.388 . . . . 74.409999999999997 107.251 176.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -137.93 142.55 40.58 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.594 -0.842 . . . . 64.0 109.249 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 4.6 pp -114.19 134.97 54.55 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.969 -0.56 . . . . 74.439999999999998 110.707 -178.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 72.3 mt -109.39 119.92 59.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 115.295 -0.866 . . . . 74.049999999999997 108.763 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -101.91 102.78 13.38 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 102.917 -2.994 . . . . 71.430000000000007 102.917 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -18.78 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 127.999 2.52 . . . . 71.040000000000006 113.881 -163.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.52 -67.81 0.4 Allowed Glycine 0 N--CA 1.42 -2.394 0 CA-C-N 113.165 -1.834 . . . . 61.200000000000003 110.27 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -130.61 173.65 10.68 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 120.788 0.327 . . . . 72.299999999999997 111.539 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -94.66 114.18 26.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.956 -1.868 . . . . 75.019999999999996 105.956 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.539 HD12 HD21 ' A' ' 76' ' ' LEU . 90.6 mt -79.19 -48.12 14.78 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 119.224 -0.99 . . . . 74.140000000000001 113.537 -175.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.654 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -167.69 174.52 7.62 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.043 -0.355 . . . . 73.150000000000006 110.043 179.682 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.47 -1.52 85.76 Favored Glycine 0 C--N 1.306 -1.131 0 N-CA-C 115.279 0.872 . . . . 55.340000000000003 115.279 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.451 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 2.7 t-20 -173.22 25.04 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.727 1.264 . . . . 73.239999999999995 110.529 -171.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.451 HG11 HD23 ' A' ' 60' ' ' LEU . 13.3 p -80.42 145.47 9.04 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 O-C-N 122.082 -0.386 . . . . 63.119999999999997 110.121 -176.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.526 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 64.0 p -79.02 157.52 28.06 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 122.992 0.517 . . . . 62.520000000000003 111.993 -175.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.506 ' H ' HD23 ' A' ' 73' ' ' LEU . 1.7 mm? -65.38 -32.68 74.45 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 120.943 0.402 . . . . 73.099999999999994 110.526 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.76 -34.94 88.82 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.817 -0.706 . . . . 74.239999999999995 111.353 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.417 ' HB1' HG23 ' A' ' 71' ' ' VAL . . . -78.64 -15.58 58.35 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.898 0.479 . . . . 74.340000000000003 110.863 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.539 HD21 HD12 ' A' ' 67' ' ' LEU . 65.8 mt -86.33 -3.69 59.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 74.040000000000006 110.083 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.6 mptt 70.27 72.05 0.22 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.561 1.145 . . . . 73.099999999999994 111.421 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.403 HD23 ' HB3' ' A' ' 73' ' ' LEU . 10.4 mp -115.37 118.55 39.53 Favored Pre-proline 0 CA--C 1.491 -1.314 0 CA-C-N 116.0 -0.546 . . . . 75.299999999999997 110.822 175.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.07 139.96 44.01 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.99 1.794 . . . . 73.129999999999995 109.085 172.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -69.7 140.82 53.59 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.0 -0.741 . . . . 74.450000000000003 109.0 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 92.05 -9.14 77.12 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.254 -0.974 . . . . 64.319999999999993 113.359 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -101.65 153.28 19.91 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.456 -0.498 . . . . 61.310000000000002 112.275 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.3 m -91.12 118.31 30.32 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.19 -0.914 . . . . 62.020000000000003 110.275 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.3 m -122.4 138.88 54.39 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.951 -0.568 . . . . 75.239999999999995 109.708 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.53 140.44 28.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 110.281 -0.266 . . . . 75.420000000000002 110.281 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 86.6 mtp -138.96 153.76 48.23 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 111.819 0.303 . . . . 73.519999999999996 111.819 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.486 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 83.5 m-70 -106.37 137.39 44.42 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.801 -0.814 . . . . 55.140000000000001 108.801 175.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 88' ' ' LEU . 2.1 mm? -125.28 131.64 53.05 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 122.215 -0.303 . . . . 65.439999999999998 110.894 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.13 135.25 64.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.047 0.451 . . . . 74.230000000000004 110.03 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.29 127.65 32.21 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 122.279 -0.263 . . . . 52.310000000000002 111.238 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.523 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 58.3 ttt180 -84.42 117.07 23.4 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.605 -0.517 . . . . 64.450000000000003 109.605 175.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 70.94 -4.08 1.84 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.053 0.941 . . . . 75.340000000000003 112.902 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.431 ' H ' ' C ' ' A' ' 91' ' ' ARG . 18.2 m 55.42 79.64 0.15 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.496 1.518 . . . . 74.409999999999997 114.062 172.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.438 ' HB2' HD11 ' A' ' 57' ' ' ILE . 6.5 mp -94.17 142.0 24.34 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.739 -0.838 . . . . 71.439999999999998 108.739 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.517 ' HG3' ' OE2' ' A' ' 48' ' ' GLU . 36.7 Cg_endo -67.53 -65.15 0.04 OUTLIER 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 122.824 2.35 . . . . 70.450000000000003 114.277 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -111.41 122.32 37.87 Favored Pre-proline 0 N--CA 1.416 -2.156 0 CA-C-N 116.308 -0.405 . . . . 50.030000000000001 109.912 -174.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -59.15 -53.89 3.18 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.683 2.255 . . . . 64.140000000000001 112.851 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.518 ' HA ' ' NE1' ' A' ' 47' ' ' TRP . 9.8 t30 -169.8 24.35 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.192 0.52 . . . . 72.209999999999994 111.58 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.8 m 62.66 14.81 7.5 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.35 0.66 . . . . 61.229999999999997 111.544 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -87.41 -51.84 5.71 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 115.327 1.602 . . . . 72.219999999999999 115.327 -172.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.93 31.99 80.43 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.153 -1.179 . . . . 73.239999999999995 110.153 -173.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -125.96 164.47 20.72 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.114 -1.069 . . . . 74.209999999999994 108.114 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -84.06 92.34 7.85 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.72 -0.792 . . . . 73.409999999999997 111.384 -175.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 60.7 t30 69.58 -177.88 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.692 0.797 . . . . 65.140000000000001 111.555 174.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -52.68 -42.14 64.49 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.588 1.155 . . . . 65.230000000000004 110.464 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.25 148.09 34.43 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 105.08 -2.193 . . . . 71.439999999999998 105.08 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -60.92 -44.61 96.97 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 123.458 0.703 . . . . 75.439999999999998 112.799 -176.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.4 p -133.17 -30.29 1.35 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.585 0.587 . . . . 72.299999999999997 112.585 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.9 59.83 3.55 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 121.19 -0.529 . . . . 74.140000000000001 113.233 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.0 110.37 4.42 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.876 -0.787 . . . . 73.109999999999999 108.876 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.2 t -83.54 123.42 29.73 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.747 -1.115 . . . . 72.340000000000003 113.474 -168.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -105.81 93.94 4.92 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 105.165 -2.161 . . . . 41.229999999999997 105.165 167.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 25.9 p -86.07 170.09 12.55 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 112.81 0.671 . . . . 73.099999999999994 112.81 -171.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 41.3 t -74.02 104.46 4.87 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.183 -0.917 . . . . 75.439999999999998 108.945 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.79 107.58 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.893 0 CA-C-O 122.184 0.992 . . . . 72.420000000000002 110.585 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.9 tp -131.25 138.64 52.8 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 107.463 -1.31 . . . . 73.439999999999998 107.463 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.8 tt . . . . . 0 C--N 1.298 -1.635 0 N-CA-C 107.353 -1.351 . . . . 75.129999999999995 107.353 -179.173 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 p . . . . . 0 N--CA 1.431 -1.375 0 N-CA-C 111.721 0.267 . . . . 71.540000000000006 111.721 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.1 m -78.72 102.71 8.22 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.325 -1.361 . . . . 51.549999999999997 107.325 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 71.98 175.38 0.29 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 107.29 -1.374 . . . . 72.209999999999994 107.29 -171.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.432 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 16.7 t -100.52 131.81 23.27 Favored Pre-proline 0 C--N 1.284 -2.246 0 O-C-N 121.524 -0.735 . . . . 71.140000000000001 110.133 -174.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -68.87 147.42 68.52 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.09 1.86 . . . . 73.430000000000007 110.83 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.05 65.86 7.37 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.979 0.895 . . . . 64.329999999999998 112.055 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -163.26 -31.49 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.688 -1.597 . . . . 73.310000000000002 106.688 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.9 mmm -102.79 148.81 25.15 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.244 -1.343 . . . . 74.329999999999998 109.007 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.406 HD11 ' O ' ' A' ' 10' ' ' ILE . 2.9 pp -107.69 132.1 56.18 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 108.816 -0.809 . . . . 74.150000000000006 108.816 173.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.503 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -88.76 113.78 24.68 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.955 -1.498 . . . . 73.239999999999995 106.955 -177.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.453 ' HG ' HD22 ' A' ' 14' ' ' LEU . 42.6 tp -118.96 133.11 56.04 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 121.164 0.506 . . . . 73.439999999999998 112.087 -173.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.49 ' HD2' ' OE1' ' A' ' 23' ' ' GLU . 20.6 ttt85 -107.02 121.32 44.22 Favored 'General case' 0 N--CA 1.407 -2.578 0 CA-C-N 115.365 -0.834 . . . . 65.109999999999999 108.815 174.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.625 ' CB ' HG22 ' A' ' 39' ' ' VAL . 2.0 mm? -101.3 120.72 40.68 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.568 -1.196 . . . . 73.040000000000006 108.893 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.427 HG22 HG22 ' A' ' 21' ' ' THR . 26.8 mt -104.69 124.71 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 N-CA-C 108.953 -0.758 . . . . 60.450000000000003 108.953 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.3 mt -79.46 168.81 18.95 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.918 -0.583 . . . . 52.32 110.91 -177.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 89' ' ' VAL . 60.0 t -63.84 -31.16 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 122.676 0.39 . . . . 73.239999999999995 111.587 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.1 m -79.0 6.1 10.13 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 122.033 -0.417 . . . . 74.219999999999999 112.069 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.27 13.67 82.54 Favored Glycine 0 CA--C 1.507 -0.412 0 C-N-CA 120.474 -0.869 . . . . 60.109999999999999 111.681 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.476 ' HB3' ' HZ3' ' A' ' 20' ' ' LYS . 2.7 mmmp? -88.03 137.48 32.29 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.845 -1.169 . . . . 74.010000000000005 107.845 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.427 HG22 HG22 ' A' ' 15' ' ' ILE . 73.2 p -117.97 138.02 52.46 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.731 -0.788 . . . . 65.239999999999995 112.841 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.54 ' HD2' ' O ' ' A' ' 39' ' ' VAL . 58.7 mttp -133.26 147.35 51.93 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.511 -0.922 . . . . 74.530000000000001 108.511 169.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.49 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 29.5 tt0 -135.78 131.29 35.29 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.671 -0.863 . . . . 61.32 108.671 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.606 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.6 m-85 -144.75 160.15 41.71 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 122.664 0.386 . . . . 71.120000000000005 109.989 -177.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -82.46 125.73 31.42 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.325 -0.991 . . . . 70.040000000000006 108.325 173.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.606 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 89.8 m-85 -128.92 173.84 10.04 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.537 -0.912 . . . . 74.540000000000006 108.537 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.0 p -100.22 153.14 37.92 Favored Pre-proline 0 N--CA 1.408 -2.556 0 N-CA-C 107.494 -1.298 . . . . 75.430000000000007 107.494 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 40.0 Cg_endo -61.76 -11.45 20.81 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 122.801 2.334 . . . . 74.120000000000005 112.161 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -96.81 -4.24 40.77 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.636 -0.711 . . . . 74.409999999999997 112.243 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -74.7 153.31 38.92 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 119.861 -0.735 . . . . 64.540000000000006 110.833 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.515 ' O ' HG13 ' A' ' 35' ' ' ILE . 53.7 m -92.54 119.89 32.46 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 120.567 0.222 . . . . 74.209999999999994 110.619 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -45.44 -41.7 9.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.337 1.455 . . . . 72.049999999999997 113.568 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.481 ' OG ' ' HB3' ' A' ' 70' ' ' ASN . 24.2 p -69.53 -41.28 76.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.014 0.435 . . . . 75.420000000000002 111.658 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -63.55 -41.77 98.42 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.514 -1.291 . . . . 75.299999999999997 107.514 177.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.543 ' O ' HG21 ' A' ' 39' ' ' VAL . 60.7 mt -61.78 -49.21 85.18 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.565 0 CA-C-N 114.619 -1.173 . . . . 75.030000000000001 110.408 178.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.02 -44.93 51.58 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.905 0.882 . . . . 73.219999999999999 112.043 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.447 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 1.8 tmtp? -73.21 -41.21 64.03 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.515 -0.921 . . . . 73.219999999999999 108.515 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -56.54 -45.26 81.26 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.646 1.179 . . . . 75.420000000000002 110.671 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.625 HG22 ' CB ' ' A' ' 14' ' ' LEU . 33.8 m -77.62 -29.64 16.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.371 -0.831 . . . . 74.430000000000007 111.826 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -47.13 -48.26 23.26 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.356 -0.979 . . . . 74.340000000000003 108.356 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . 0.254 11.1 m-20 179.28 -52.35 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 125.865 1.666 . . . . 65.530000000000001 113.0 170.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -116.32 -177.86 3.27 Favored 'General case' 0 C--O 1.209 -1.043 0 N-CA-C 109.518 -0.549 . . . . 61.509999999999998 109.518 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -90.37 138.78 26.86 Favored Pre-proline 0 C--N 1.309 -1.181 0 O-C-N 121.901 -0.499 . . . . 74.25 110.994 -175.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -72.42 99.28 1.01 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.761 1.641 . . . . 65.420000000000002 110.275 172.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 51.1 ttm -149.94 89.26 1.59 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.928 -0.578 . . . . 74.400000000000006 110.287 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -159.37 152.89 22.64 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.007 -1.479 . . . . 73.349999999999994 107.007 177.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -63.85 -34.5 78.07 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 123.179 0.299 . . . . 71.209999999999994 111.733 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 11.2 pt-20 -132.29 -40.94 1.0 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.288 -0.565 . . . . 74.299999999999997 112.326 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 65.18 -71.59 0.08 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.267 1.427 . . . . 61.340000000000003 109.657 -173.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -129.23 109.98 11.59 Favored 'General case' 0 C--O 1.253 1.27 0 C-N-CA 122.998 0.519 . . . . 72.239999999999995 111.614 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.429 ' HG2' HG21 ' A' ' 52' ' ' VAL . 35.7 tt0 73.74 -68.23 0.23 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.323 1.449 . . . . 72.319999999999993 113.729 175.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 48' ' ' GLU . 97.3 t -137.43 -53.69 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.653 -0.869 . . . . 62.310000000000002 108.653 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.3 m -171.66 -43.14 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 104.794 -2.299 . . . . 72.010000000000005 104.794 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.632 ' O ' HG12 ' A' ' 57' ' ' ILE . 18.1 m 55.1 71.21 1.34 Allowed Pre-proline 0 N--CA 1.441 -0.879 0 CA-C-N 113.157 -1.838 . . . . 75.030000000000001 112.46 174.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -62.76 -20.48 71.22 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.234 1.956 . . . . 72.420000000000002 112.887 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -16.35 49.3 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.994 0.738 . . . . 44.439999999999998 112.994 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 54' ' ' SER . 27.5 pt -84.55 -29.15 6.89 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 C-N-CA 120.723 -0.391 . . . . 72.129999999999995 111.123 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.489 ' HG ' HG13 ' A' ' 57' ' ' ILE . 88.9 mt -107.15 107.51 18.51 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 116.24 -0.436 . . . . 71.340000000000003 109.964 -177.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -144.8 147.84 33.34 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.743 -0.662 . . . . 73.430000000000007 110.764 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 1.2 pt? -101.56 133.24 46.53 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 113.248 0.832 . . . . 64.219999999999999 113.248 -174.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.451 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 82.4 mt -102.49 119.03 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 107.302 -1.37 . . . . 62.130000000000003 107.302 175.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.409 ' HH ' HD23 ' A' ' 78' ' ' LEU . 39.4 t80 -101.64 73.6 1.45 Allowed 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.711 0.767 . . . . 71.109999999999999 109.16 -176.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 70.53 -48.5 0.65 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 113.406 -1.725 . . . . 74.219999999999999 112.942 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.42 -65.42 0.74 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 121.03 -0.605 . . . . 54.100000000000001 113.198 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.549 ' NH1' ' HA ' ' A' ' 67' ' ' LEU . 3.1 ppt_? -131.06 176.64 8.08 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.702 0.63 . . . . 73.120000000000005 112.702 -174.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 71.8 m-85 -79.16 118.0 20.71 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.483 -0.932 . . . . 75.109999999999999 108.483 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.549 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 92.8 mt -79.26 -48.82 13.49 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.425 -0.91 . . . . 73.430000000000007 110.763 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -162.92 -171.77 2.81 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 124.293 1.037 . . . . 54.299999999999997 108.983 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.04 -43.22 7.22 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 110.99 -0.844 . . . . 62.100000000000001 110.99 175.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.481 ' HB3' ' OG ' ' A' ' 33' ' ' SER . 4.4 p-10 -148.71 77.86 1.39 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 122.447 1.118 . . . . 72.0 112.033 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.469 ' CG1' HD11 ' A' ' 60' ' ' LEU . 9.4 p -102.11 142.7 15.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 106.166 -1.791 . . . . 72.510000000000005 106.166 173.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.456 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 57.2 p -78.25 157.75 29.16 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.169 0.433 . . . . 65.319999999999993 112.169 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 1.9 mm? -64.82 -30.94 71.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.031 -0.531 . . . . 74.310000000000002 110.952 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.51 -36.62 92.75 Favored Glycine 0 C--N 1.33 0.207 0 N-CA-C 110.833 -0.907 . . . . 73.329999999999998 110.833 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.99 -15.35 62.57 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.262 0.625 . . . . 73.219999999999999 110.686 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 72' ' ' THR . 62.9 mt -84.11 13.73 4.86 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.056 -0.52 . . . . 73.420000000000002 111.116 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.5 mptt 67.37 24.68 8.87 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.663 0.785 . . . . 71.219999999999999 110.528 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.418 HD22 ' HE3' ' A' ' 82' ' ' LYS . 80.2 mt -93.97 122.33 62.19 Favored Pre-proline 0 C--N 1.311 -1.09 0 CA-C-N 115.798 -0.637 . . . . 53.509999999999998 111.04 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.93 171.45 16.47 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.242 1.961 . . . . 62.43 109.699 172.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.416 ' CE1' ' HG3' ' A' ' 28' ' ' PRO . 5.1 m-85 -84.97 170.74 12.73 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.829 -0.804 . . . . 75.540000000000006 108.829 -176.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 74.83 10.17 83.43 Favored Glycine 0 C--N 1.306 -1.101 0 N-CA-C 115.218 0.847 . . . . 71.230000000000004 115.218 173.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HE3' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -131.28 162.7 29.44 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 118.237 1.019 . . . . 65.310000000000002 111.914 178.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.503 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 33.3 m -96.81 126.71 42.16 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 116.145 -0.479 . . . . 74.099999999999994 110.804 -178.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.1 m -115.51 141.48 48.0 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.708 -0.678 . . . . 74.219999999999999 109.691 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.0 p -111.31 130.39 64.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 120.916 0.388 . . . . 45.439999999999998 110.016 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 90.9 mtp -138.38 153.11 48.93 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.051 0.453 . . . . 73.510000000000005 112.071 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.467 ' C ' HD21 ' A' ' 88' ' ' LEU . 60.5 m-70 -108.97 131.32 55.17 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.658 -0.868 . . . . 75.040000000000006 108.658 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.467 HD21 ' C ' ' A' ' 87' ' ' HIS . 3.2 mm? -121.95 144.65 48.75 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 120.784 0.326 . . . . 73.109999999999999 110.893 -177.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.424 ' HA ' ' CG2' ' A' ' 17' ' ' VAL . 27.8 m -119.78 136.69 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 CA-C-N 115.777 -0.647 . . . . 75.120000000000005 110.423 176.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.502 ' HB3' ' OG1' ' A' ' 93' ' ' THR . . . -133.1 145.07 50.39 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.293 -1.373 . . . . 72.230000000000004 107.293 174.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -139.62 128.27 23.15 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.128 -1.434 . . . . 63.100000000000001 107.128 -173.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 71.25 -10.09 0.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.74 0.816 . . . . 73.420000000000002 111.939 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 90' ' ' ALA . 43.8 m -56.32 128.35 35.42 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.859 1.264 . . . . 64.209999999999994 111.727 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -86.72 150.33 50.44 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 115.499 -0.773 . . . . 70.150000000000006 109.13 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.51 -42.38 55.44 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.414 2.076 . . . . 75.239999999999995 111.345 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -130.33 139.64 36.23 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 107.8 -1.185 . . . . 74.430000000000007 107.8 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -39.81 -64.67 0.21 Allowed 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 124.777 3.652 . . . . 54.439999999999998 115.378 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -167.54 79.39 0.18 Allowed 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 121.122 -0.231 . . . . 72.319999999999993 111.331 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.5 m 46.29 33.8 1.97 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 113.293 0.849 . . . . 71.420000000000002 113.293 175.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.43 ' HB2' ' HG2' ' A' ' 102' ' ' GLN . 11.6 pt20 -68.85 -44.79 72.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.354 0.501 . . . . 74.230000000000004 112.354 -174.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.8 25.51 59.08 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.487 -0.387 . . . . 45.509999999999998 112.882 -176.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.43 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 12.3 mm-40 -85.08 119.63 25.69 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.695 -0.297 . . . . 74.0 111.394 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 103' ' ' ARG . 1.2 tmm_? 72.14 -35.81 0.34 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.847 1.659 . . . . 74.239999999999995 111.745 175.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.417 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 55.9 t30 76.47 -174.86 0.11 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.415 1.086 . . . . 74.099999999999994 109.858 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.417 ' H ' ' CG ' ' A' ' 104' ' ' ASN . 78.7 mtp180 -58.36 -28.92 65.57 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 123.762 0.825 . . . . 73.219999999999999 110.74 176.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 108' ' ' THR . 12.0 tp10 -177.35 157.41 1.32 Allowed 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 104.702 -2.333 . . . . 71.049999999999997 104.702 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -74.0 -20.79 60.22 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.055 -0.658 . . . . 63.219999999999999 110.67 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.422 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 7.4 t -153.79 95.65 1.9 Allowed 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 115.036 -0.984 . . . . 74.510000000000005 108.396 170.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.47 33.7 0.02 OUTLIER Glycine 0 C--N 1.305 -1.173 0 CA-C-N 115.403 -0.817 . . . . 61.439999999999998 111.69 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.78 -167.8 1.46 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.445 -0.946 . . . . 65.329999999999998 108.445 176.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.1 m -71.45 82.8 0.8 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.588 0.709 . . . . 73.200000000000003 111.715 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.9 p30 179.87 -27.18 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 126.195 1.798 . . . . 44.329999999999998 108.387 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 83.6 m -88.56 87.88 7.42 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 108.907 -0.775 . . . . 64.400000000000006 108.907 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 18.2 p -107.06 116.16 31.45 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.125 -0.943 . . . . 64.140000000000001 110.006 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 p -92.63 89.62 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 CA-C-O 122.166 0.984 . . . . 74.239999999999995 109.766 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.2 tt -118.96 132.03 70.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.097 -0.956 . . . . 72.409999999999997 109.173 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.6 tp . . . . . 0 C--N 1.291 -1.952 0 CA-C-O 118.653 -0.689 . . . . 45.399999999999999 109.211 -177.939 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.425 -1.721 0 N-CA-C 107.445 -1.317 . . . . 61.43 107.445 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.0 t -149.41 -165.65 2.34 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.563 -1.273 . . . . 71.219999999999999 107.563 -176.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -71.56 117.22 12.84 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.705 -0.479 . . . . 74.430000000000007 109.705 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.485 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 21.2 t -80.88 119.72 76.89 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 108.853 -0.795 . . . . 54.32 108.853 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -72.34 153.23 55.94 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.165 1.91 . . . . 54.43 111.664 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.86 71.3 5.31 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 122.379 1.085 . . . . 62.119999999999997 109.623 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -167.12 -27.81 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 112.883 -1.962 . . . . 70.420000000000002 106.954 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.1 mmm -112.8 153.08 28.38 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.861 -1.063 . . . . 63.229999999999997 108.778 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -113.9 136.74 49.41 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 N-CA-C 109.757 -0.46 . . . . 63.140000000000001 109.757 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -86.3 107.63 18.05 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.359 -1.349 . . . . 65.340000000000003 107.359 -176.662 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.429 ' HG ' HD23 ' A' ' 14' ' ' LEU . 40.7 tp -119.75 133.6 55.55 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 112.742 0.645 . . . . 74.129999999999995 112.742 -173.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.8 ttp-105 -108.58 121.21 44.53 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.492 -0.776 . . . . 73.019999999999996 109.027 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.593 ' CB ' HG22 ' A' ' 39' ' ' VAL . 2.0 mm? -99.3 121.13 40.65 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 114.701 -1.136 . . . . 73.329999999999998 108.365 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.1 mt -101.37 123.93 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 C-N-CA 119.126 -1.03 . . . . 64.140000000000001 109.459 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.6 mt -81.79 165.07 21.23 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.896 -0.593 . . . . 72.150000000000006 110.383 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.9 m -69.27 -14.6 18.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.503 0.668 . . . . 62.119999999999997 110.81 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.3 m -78.83 1.51 23.13 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 124.43 1.092 . . . . 71.329999999999998 110.482 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.61 20.28 77.1 Favored Glycine 0 CA--C 1.499 -0.96 0 N-CA-C 110.705 -0.958 . . . . 38.060000000000002 110.705 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -108.47 134.67 50.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.076 -1.083 . . . . 75.319999999999993 108.076 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 75.9 p -108.33 137.71 45.83 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 120.247 -0.581 . . . . 62.43 111.07 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -124.93 139.23 54.01 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.969 -1.123 . . . . 73.450000000000003 107.969 169.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -130.81 130.39 43.6 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.354 -0.98 . . . . 73.209999999999994 108.354 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.646 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.0 m-85 -145.18 159.87 42.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.373 -0.603 . . . . 74.349999999999994 109.373 -178.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.6 mt -80.42 125.72 30.28 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 107.637 -1.246 . . . . 71.239999999999995 107.637 173.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.646 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 84.4 m-85 -128.27 166.02 19.39 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.1 -1.074 . . . . 73.109999999999999 108.1 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.4 p -92.47 149.44 38.24 Favored Pre-proline 0 N--CA 1.414 -2.266 0 C-N-CA 118.903 -1.119 . . . . 74.25 108.218 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.454 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 40.2 Cg_endo -62.16 -11.2 20.94 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 122.773 2.316 . . . . 73.329999999999998 112.214 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -93.03 -10.05 37.55 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.727 -0.67 . . . . 75.239999999999995 111.579 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -73.94 153.65 39.69 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.824 0.345 . . . . 72.120000000000005 111.02 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.497 ' O ' HG13 ' A' ' 35' ' ' ILE . 20.4 m -87.24 118.45 26.67 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.348 -0.982 . . . . 74.519999999999996 108.348 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.509 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . . . -54.33 -39.52 67.13 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.663 0.785 . . . . 71.430000000000007 112.689 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 p -73.4 -32.63 64.55 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.223 0.535 . . . . 63.229999999999997 111.526 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -66.9 -43.77 82.54 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.964 -1.125 . . . . 74.230000000000004 107.964 175.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.595 ' O ' HG21 ' A' ' 39' ' ' VAL . 69.4 mt -60.82 -41.59 89.19 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.946 0 CA-C-N 114.364 -1.289 . . . . 65.540000000000006 110.291 177.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 40' ' ' TYR . . . -50.13 -40.08 45.08 Favored 'General case' 0 C--O 1.212 -0.875 0 C-N-CA 122.855 0.462 . . . . 74.120000000000005 111.255 176.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -73.29 -38.46 65.89 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.255 0.55 . . . . 61.039999999999999 110.403 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.448 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 6.0 t60 -59.08 -50.35 74.38 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.895 1.278 . . . . 73.549999999999997 110.292 177.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.595 HG21 ' O ' ' A' ' 35' ' ' ILE . 27.2 m -76.09 -30.35 20.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 123.413 0.685 . . . . 75.219999999999999 112.223 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 47.6 t80 -47.39 -48.51 25.94 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.669 0.787 . . . . 73.409999999999997 110.78 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -151.83 -62.34 0.17 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.945 0.402 . . . . 71.400000000000006 110.222 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -150.59 167.26 27.8 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 106.544 -1.651 . . . . 75.329999999999998 106.544 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.5 t90 -59.61 125.16 79.02 Favored Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 122.61 0.364 . . . . 75.310000000000002 110.832 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.54 99.03 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.228 1.952 . . . . 62.100000000000001 112.953 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 28.0 ttt -82.37 -42.34 18.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.748 -1.204 . . . . 72.219999999999999 107.748 176.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -100.28 150.23 22.78 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 105.031 -2.211 . . . . 75.519999999999996 105.031 172.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -86.37 -90.49 0.11 Allowed 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.986 -1.086 . . . . 74.450000000000003 112.952 -174.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 53' ' ' SER . 5.5 mp0 -133.97 134.87 43.04 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.999 -1.482 . . . . 71.310000000000002 106.999 175.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 95' ' ' PRO . 30.8 tt0 -143.9 27.86 1.45 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.883 0.849 . . . . 73.049999999999997 108.754 177.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.93 -48.22 81.39 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 105.955 -1.869 . . . . 74.109999999999999 105.955 176.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -138.84 -59.66 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.258 -0.883 . . . . 71.010000000000005 109.673 173.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.9 t -147.43 139.36 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.257 -1.016 . . . . 62.039999999999999 108.257 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 48' ' ' GLU . 36.9 m -57.06 121.38 9.87 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 109.744 -0.465 . . . . 75.299999999999997 109.744 176.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.429 ' O ' HG13 ' A' ' 57' ' ' ILE . 38.2 m -135.89 109.56 10.0 Favored Pre-proline 0 N--CA 1.432 -1.37 0 CA-C-N 116.035 -0.53 . . . . 62.109999999999999 110.687 -173.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.79 -15.32 46.92 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.537 2.158 . . . . 72.120000000000005 111.528 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -62.98 -13.96 41.65 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 124.26 1.024 . . . . 73.400000000000006 112.174 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 54' ' ' SER . 2.1 pp -84.45 -16.17 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-O 121.16 0.505 . . . . 64.430000000000007 110.383 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.601 ' O ' ' HD2' ' A' ' 59' ' ' ARG . 96.2 mt -83.52 93.58 7.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.489 -0.778 . . . . 71.239999999999995 110.435 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.601 ' HD2' ' O ' ' A' ' 58' ' ' LEU . 4.4 mpt_? -129.88 150.32 51.23 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 123.291 0.636 . . . . 71.439999999999998 110.118 176.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 4.0 pp -135.34 140.34 44.99 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.805 0.336 . . . . 63.25 111.123 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 95.6 mt -112.66 122.42 66.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 109.03 -0.73 . . . . 71.310000000000002 109.03 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -100.96 87.57 3.32 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 107.048 -1.464 . . . . 75.010000000000005 107.048 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 69.45 -61.5 0.44 Allowed 'General case' 0 N--CA 1.404 -2.74 0 C-N-CA 127.168 2.187 . . . . 71.230000000000004 112.885 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.27 -28.42 1.22 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.177 -1.011 . . . . 73.340000000000003 114.591 -177.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.19 161.31 31.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.483 1.142 . . . . 74.140000000000001 111.992 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.6 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 79.7 m-85 -81.53 117.11 21.66 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.408 -0.96 . . . . 74.230000000000004 108.408 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.503 HD12 HD22 ' A' ' 76' ' ' LEU . 47.6 mt -80.16 -47.68 14.34 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.836 1.05 . . . . 74.299999999999997 113.836 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.444 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 9.2 t60 178.53 134.16 0.08 Allowed 'General case' 0 C--O 1.21 -0.995 0 N-CA-C 107.534 -1.284 . . . . 75.109999999999999 107.534 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.19 1.41 0.09 OUTLIER Glycine 0 CA--C 1.547 2.044 0 N-CA-C 118.335 2.094 . . . . 73.109999999999999 118.335 -174.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -162.77 21.04 0.09 Allowed 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 119.115 1.457 . . . . 74.329999999999998 109.313 -172.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 68' ' ' HIS . 11.0 p -81.38 144.89 9.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 119.939 -0.705 . . . . 64.340000000000003 110.161 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.414 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 40.5 p -82.71 162.44 21.79 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.903 -0.589 . . . . 63.5 111.545 -177.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 73' ' ' LEU . 1.7 mm? -66.99 -35.82 80.8 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.187 -0.46 . . . . 74.25 111.693 -175.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.53 -33.33 86.16 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.374 -0.917 . . . . 73.450000000000003 111.164 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.89 -15.92 60.69 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 123.03 0.532 . . . . 72.439999999999998 111.485 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.503 HD22 HD12 ' A' ' 67' ' ' LEU . 42.5 mt -84.87 -3.48 58.7 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.904 -0.776 . . . . 74.310000000000002 108.904 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.31 77.77 0.12 Allowed 'General case' 0 C--O 1.244 0.8 0 C-N-CA 125.701 1.601 . . . . 73.219999999999999 111.278 -175.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 73' ' ' LEU . 10.6 mp -126.31 111.05 23.63 Favored Pre-proline 0 CA--C 1.497 -1.093 0 CA-C-N 115.274 -0.876 . . . . 75.439999999999998 111.048 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.85 142.37 62.65 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 121.915 1.744 . . . . 70.310000000000002 108.631 172.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -65.51 146.46 54.82 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.872 0.368 . . . . 73.25 110.619 -174.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.485 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 82.57 4.22 90.2 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.866 -0.606 . . . . 73.430000000000007 113.778 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -106.28 154.32 20.92 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 117.51 0.655 . . . . 54.530000000000001 112.409 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.493 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 52.6 m -91.62 121.1 32.98 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 115.534 -0.757 . . . . 75.120000000000005 110.315 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.5 m -130.82 135.63 47.92 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.832 -0.622 . . . . 75.109999999999999 110.501 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.8 p -108.14 142.2 21.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.98 -0.555 . . . . 73.140000000000001 110.851 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 91.2 mtp -135.55 153.29 51.75 Favored 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 123.021 0.528 . . . . 73.25 109.948 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.46 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 64.4 m-70 -105.2 125.49 51.03 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.067 -1.457 . . . . 74.120000000000005 107.067 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.79 142.75 46.51 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 120.04 -0.664 . . . . 73.519999999999996 110.938 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.62 132.58 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 N-CA-C 108.013 -1.106 . . . . 74.099999999999994 108.013 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.39 140.26 46.18 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.563 -0.532 . . . . 75.120000000000005 109.563 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -138.08 149.2 45.77 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.875 -1.157 . . . . 74.319999999999993 107.875 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 51.27 31.49 7.03 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 123.875 0.734 . . . . 71.219999999999999 111.203 175.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.8 m -78.0 16.95 0.65 Allowed 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 124.339 1.055 . . . . 71.409999999999997 111.389 -173.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.2 mp -105.72 134.78 19.55 Favored Pre-proline 0 N--CA 1.42 -1.954 0 CA-C-N 115.937 -0.574 . . . . 54.549999999999997 110.254 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.511 ' O ' ' HB3' ' A' ' 49' ' ' GLU . 11.8 Cg_exo -73.27 3.35 4.73 Favored 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 123.425 2.75 . . . . 62.520000000000003 112.174 177.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HG2' ' HD2' ' A' ' 97' ' ' PRO . 0.0 OUTLIER -159.33 137.4 7.47 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 104.982 -2.229 . . . . 64.420000000000002 104.982 176.924 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.41 ' HD2' ' HG2' ' A' ' 96' ' ' GLU . 14.2 Cg_exo -24.27 -56.72 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.906 1 C-N-CA 126.081 4.52 . . . . 73.519999999999996 116.041 -176.183 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -155.82 14.56 0.35 Allowed 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.22 -0.592 . . . . 71.230000000000004 109.567 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.4 m 65.98 35.68 6.29 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.707 -1.22 . . . . 72.150000000000006 107.707 -174.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -68.32 -29.79 68.62 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 113.836 -1.529 . . . . 73.5 111.202 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.02 -29.73 9.42 Favored Glycine 0 N--CA 1.424 -2.163 0 N-CA-C 110.724 -0.951 . . . . 64.129999999999995 110.724 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -85.81 109.82 18.94 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.785 -0.766 . . . . 75.099999999999994 109.129 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -176.13 103.31 0.07 Allowed 'General case' 0 C--N 1.308 -1.218 0 O-C-N 124.102 0.876 . . . . 74.25 110.288 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -96.72 135.02 39.24 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.804 -1.184 . . . . 75.400000000000006 107.804 172.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -58.14 -49.97 75.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.484 -1.302 . . . . 73.329999999999998 107.484 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.458 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 45.0 mt-10 -156.85 167.33 30.78 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 105.451 -2.055 . . . . 73.120000000000005 105.451 173.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -68.07 100.3 0.98 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.316 0.579 . . . . 73.230000000000004 109.715 176.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.8 m 63.59 34.43 12.47 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 122.266 1.031 . . . . 73.109999999999999 108.22 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.458 ' HA3' ' HB2' ' A' ' 106' ' ' GLU . . . -124.03 22.71 6.7 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 119.071 -1.538 . . . . 73.099999999999994 115.779 -174.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.74 87.17 7.15 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 118.225 -1.39 . . . . 74.299999999999997 109.789 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 73.9 m 69.48 92.74 0.08 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 113.678 -1.601 . . . . 73.209999999999994 110.953 -172.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -78.65 -33.59 47.06 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.09 -0.959 . . . . 42.200000000000003 109.264 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.4 m 63.45 84.07 0.15 Allowed 'General case' 0 C--O 1.243 0.715 0 N-CA-C 107.799 -1.186 . . . . 74.409999999999997 107.799 -172.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 60.1 m -78.01 114.11 16.57 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 114.22 -1.354 . . . . 70.299999999999997 111.887 -172.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -90.81 83.73 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-O 122.458 1.123 . . . . 71.519999999999996 110.032 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.6 tp -101.53 109.97 27.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.569 -1.196 . . . . 73.140000000000001 109.246 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.2 tp . . . . . 0 C--N 1.298 -1.637 0 N-CA-C 109.004 -0.739 . . . . 75.049999999999997 109.004 -177.094 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.7 p . . . . . 0 N--CA 1.44 -0.937 0 N-CA-C 108.767 -0.827 . . . . 73.329999999999998 108.767 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.0 t -101.08 0.7 38.4 Favored 'General case' 0 N--CA 1.421 -1.883 0 C-N-CA 120.952 -0.299 . . . . 45.310000000000002 111.725 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -155.54 -70.06 0.12 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 119.877 -0.729 . . . . 73.439999999999998 112.204 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.4 t -97.06 115.39 65.72 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 107.759 -1.2 . . . . 61.229999999999997 107.759 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 8' ' ' ASP . 25.3 Cg_endo -61.18 19.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.534 3.489 . . . . 73.030000000000001 118.374 -170.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 63.41 -32.41 0.11 Allowed 'General case' 0 C--O 1.194 -1.855 0 C-N-CA 125.187 1.395 . . . . 73.340000000000003 114.607 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 6' ' ' PRO . 29.9 t70 -86.89 -10.03 54.31 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.94 0.876 . . . . 72.450000000000003 110.089 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.1 mmm -124.52 153.47 42.02 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.382 -0.827 . . . . 73.439999999999998 109.22 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.403 HG22 ' HA ' ' A' ' 80' ' ' PHE . 2.8 pp -100.04 139.13 22.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 107.979 -1.119 . . . . 55.030000000000001 107.979 173.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.485 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -98.9 121.96 41.52 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.18 -1.044 . . . . 73.439999999999998 108.18 -175.636 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.441 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.1 tp -126.68 133.66 50.89 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 112.458 0.54 . . . . 62.340000000000003 112.458 -175.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -108.18 121.47 44.92 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.697 -0.683 . . . . 74.340000000000003 109.558 171.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.552 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.3 mm? -95.92 127.22 41.75 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 124.854 1.262 . . . . 64.230000000000004 108.685 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 86' ' ' MET . 17.8 mm -99.72 120.25 48.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.568 -0.901 . . . . 72.450000000000003 108.568 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.2 mp -78.45 153.52 31.38 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.059 -0.719 . . . . 71.019999999999996 109.059 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.4 m -69.72 -13.64 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.579 0.704 . . . . 75.329999999999998 111.128 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.7 m -76.42 -9.78 58.9 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.392 -0.822 . . . . 75.420000000000002 109.792 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.56 7.19 61.94 Favored Glycine 0 CA--C 1.498 -0.997 0 CA-C-N 116.105 -0.498 . . . . 74.329999999999998 112.744 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -87.61 131.58 34.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.49 -0.929 . . . . 75.319999999999993 108.49 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.466 HG21 HD12 ' A' ' 15' ' ' ILE . 29.1 p -104.83 129.09 53.2 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.157 -1.423 . . . . 51.25 107.157 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -131.42 138.71 49.2 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.534 -0.913 . . . . 73.310000000000002 108.534 -175.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.426 ' CD ' HD22 ' A' ' 11' ' ' ASN . 1.0 OUTLIER -132.38 131.33 41.74 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.185 0.439 . . . . 72.25 112.185 -170.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.613 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 94.2 m-85 -144.61 160.24 41.48 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 115.276 -0.875 . . . . 74.109999999999999 110.513 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.7 mt -80.75 126.04 30.81 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.85 -1.167 . . . . 64.219999999999999 107.85 173.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.613 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 80.0 m-85 -128.35 165.09 21.25 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.876 -0.416 . . . . 72.010000000000005 109.876 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.5 m -92.51 142.92 26.45 Favored Pre-proline 0 N--CA 1.414 -2.259 0 N-CA-C 107.431 -1.322 . . . . 73.129999999999995 107.431 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.0 -11.34 21.11 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.751 2.301 . . . . 55.329999999999998 113.087 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -83.0 -17.49 43.2 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.055 0.942 . . . . 64.329999999999998 110.879 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.79 154.34 42.11 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.806 0.669 . . . . 55.450000000000003 112.806 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.521 ' O ' HG13 ' A' ' 35' ' ' ILE . 18.3 m -96.16 122.82 39.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.339 -0.846 . . . . 73.310000000000002 109.638 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.489 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -50.16 -51.8 40.62 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.834 1.049 . . . . 63.549999999999997 113.834 -176.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -69.58 -28.1 65.68 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.267 0.556 . . . . 62.329999999999998 110.831 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.44 -46.58 72.69 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.264 -1.013 . . . . 73.510000000000005 108.264 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 31' ' ' SER . 69.5 mt -59.89 -43.49 92.23 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.342 0 CA-C-N 114.543 -1.208 . . . . 74.140000000000001 110.29 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.409 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -50.41 -48.63 56.05 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.89 0.876 . . . . 74.230000000000004 111.799 178.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.426 ' HZ3' ' HB3' ' A' ' 49' ' ' GLU . 5.3 tmtp? -72.41 -32.16 66.11 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.68 -0.859 . . . . 73.510000000000005 108.68 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -69.74 -51.23 35.98 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.625 0.77 . . . . 75.030000000000001 110.7 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.552 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.2 m -62.42 -32.07 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 123.103 0.561 . . . . 63.109999999999999 112.355 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -56.31 -49.91 72.94 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.662 0.601 . . . . 75.530000000000001 110.045 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.0 t70 169.44 -76.22 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.298 1.039 . . . . 71.219999999999999 110.803 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -79.89 114.61 18.94 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.684 -0.689 . . . . 75.409999999999997 110.268 -176.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -59.98 141.22 90.02 Favored Pre-proline 0 C--O 1.241 0.62 0 O-C-N 123.48 0.488 . . . . 74.409999999999997 111.808 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HA ' ' OE1' ' A' ' 49' ' ' GLU . 23.9 Cg_endo -65.2 137.62 52.67 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.707 2.272 . . . . 60.119999999999997 113.131 -177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 50.9 ttp 87.11 9.77 0.17 Allowed 'General case' 0 C--O 1.245 0.817 0 C-N-CA 126.431 1.893 . . . . 70.430000000000007 111.691 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -73.46 -87.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.917 -0.771 . . . . 75.420000000000002 108.917 173.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.5 t90 173.23 170.83 0.14 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 106.457 -1.683 . . . . 73.340000000000003 106.457 175.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 95' ' ' PRO . 9.6 mm-40 59.13 24.19 12.52 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.372 0.606 . . . . 72.239999999999995 111.419 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.539 ' OE1' ' HA ' ' A' ' 44' ' ' PRO . 40.2 mt-10 -73.22 -23.59 60.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.521 -0.918 . . . . 74.200000000000003 108.521 177.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . 0.305 0.0 OUTLIER -175.9 -55.97 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 129.097 2.959 . . . . 73.430000000000007 105.881 169.206 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.505 ' HB2' ' OG ' ' A' ' 99' ' ' SER . 0.4 OUTLIER -149.99 -54.5 0.16 Allowed 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 102.868 -3.012 . . . . 72.099999999999994 102.868 167.119 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 58.2 t -119.61 -76.55 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 114.089 -1.414 . . . . 74.540000000000006 107.331 173.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.7 m 171.11 174.57 0.07 Allowed 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 127.598 2.359 . . . . 74.430000000000007 107.714 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.583 ' O ' HG13 ' A' ' 57' ' ' ILE . 17.2 m -121.9 136.31 26.08 Favored Pre-proline 0 C--N 1.294 -1.806 0 N-CA-C 107.656 -1.239 . . . . 60.100000000000001 107.656 176.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -75.72 -37.7 1.59 Allowed 'Trans proline' 0 CA--C 1.541 0.873 0 N-CA-C 115.524 1.317 . . . . 71.109999999999999 115.524 -177.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -79.44 -0.75 34.28 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.866 0.691 . . . . 72.319999999999993 112.866 -174.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.583 HG13 ' O ' ' A' ' 54' ' ' SER . 1.8 pp -93.69 -16.68 7.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-O 121.157 0.503 . . . . 63.310000000000002 110.114 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.3 tp -81.25 91.61 6.22 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.867 -0.79 . . . . 75.120000000000005 108.867 -176.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -141.57 163.3 33.31 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.142 0.496 . . . . 53.439999999999998 111.171 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 4.5 pp -141.08 150.69 43.23 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.554 -0.748 . . . . 61.219999999999999 110.265 -176.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.0 mt -122.82 126.78 74.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 108.891 -0.781 . . . . 51.149999999999999 108.891 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.423 ' HH ' HD23 ' A' ' 78' ' ' LEU . 13.7 t80 -100.16 72.22 1.64 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.483 -1.303 . . . . 75.420000000000002 107.483 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 65.06 -56.58 0.29 Allowed 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 128.109 2.564 . . . . 61.43 112.672 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.39 -62.17 1.35 Allowed Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 121.59 -0.338 . . . . 62.420000000000002 113.225 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.424 ' HD3' ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -131.03 175.96 8.64 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 117.369 0.585 . . . . 71.530000000000001 111.873 -175.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 56.0 m-85 -80.21 118.86 22.27 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.976 -1.12 . . . . 74.209999999999994 107.976 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.0 mt -79.72 -47.2 15.71 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.482 -0.887 . . . . 75.129999999999995 111.926 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.532 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 12.3 t60 -169.08 168.19 10.15 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 105.278 -2.119 . . . . 72.209999999999994 105.278 -174.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.88 -1.77 87.69 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 120.276 -0.964 . . . . 37.899999999999999 113.318 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 31' ' ' SER . 48.8 t-20 -177.84 73.62 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.449 0.642 . . . . 74.319999999999993 109.775 -174.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.51 ' H ' HD23 ' A' ' 60' ' ' LEU . 14.5 p -104.51 151.76 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 N-CA-C 108.726 -0.842 . . . . 72.230000000000004 108.726 175.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.45 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 64.2 p -87.18 162.6 17.4 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 118.124 0.42 . . . . 74.430000000000007 110.682 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.497 ' H ' HD21 ' A' ' 73' ' ' LEU . 1.5 mm? -68.59 -34.8 76.41 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.783 0.325 . . . . 70.329999999999998 111.055 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.9 -34.22 89.26 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.717 -0.754 . . . . 65.299999999999997 111.26 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.402 ' HB3' HG21 ' A' ' 71' ' ' VAL . . . -72.8 -15.52 61.63 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.014 0.525 . . . . 60.509999999999998 111.571 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 72' ' ' THR . 70.9 mt -82.31 -1.66 50.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 75.420000000000002 109.93 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.416 ' N ' ' HD2' ' A' ' 77' ' ' LYS . 9.8 mptt 65.19 72.17 0.43 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 108.936 -0.764 . . . . 72.040000000000006 108.936 -175.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.423 HD23 ' HH ' ' A' ' 62' ' ' TYR . 94.5 mt -131.32 123.34 19.55 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-N 115.567 -0.742 . . . . 74.109999999999999 110.508 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -80.07 143.65 16.22 Favored 'Trans proline' 0 N--CA 1.429 -2.269 0 C-N-CA 122.041 1.827 . . . . 72.230000000000004 110.326 173.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.403 ' HA ' HG22 ' A' ' 10' ' ' ILE . 1.6 p90 -75.36 148.38 39.29 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 115.033 -0.985 . . . . 74.409999999999997 110.227 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.59 2.73 67.24 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.174 -1.012 . . . . 62.329999999999998 110.912 -174.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -120.93 157.97 28.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 122.1 0.16 . . . . 61.240000000000002 110.645 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 26.2 m -105.69 127.32 53.0 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.147 0.498 . . . . 74.340000000000003 110.574 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.2 m -125.67 142.93 51.26 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.807 -0.633 . . . . 75.319999999999993 110.196 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.66 138.19 42.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 120.826 0.346 . . . . 74.129999999999995 110.203 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.54 ' O ' HG12 ' A' ' 15' ' ' ILE . 90.1 mtp -135.1 152.2 51.43 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.948 -0.39 . . . . 72.439999999999998 109.948 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.454 ' C ' HD23 ' A' ' 88' ' ' LEU . 50.4 m-70 -104.07 134.14 47.83 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 109.045 -0.724 . . . . 71.209999999999994 109.045 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.454 HD23 ' C ' ' A' ' 87' ' ' HIS . 2.4 mm? -123.02 144.09 49.5 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 120.482 -0.487 . . . . 74.540000000000006 109.798 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.63 134.05 62.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 116.011 -0.54 . . . . 71.25 109.948 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.14 145.96 49.78 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.815 -0.63 . . . . 73.319999999999993 109.361 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -145.6 146.83 31.52 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 106.626 -1.62 . . . . 75.140000000000001 106.626 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 56.81 35.35 26.14 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 124.214 0.946 . . . . 60.25 109.383 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.2 t -95.41 2.36 54.52 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 114.85 -1.068 . . . . 64.120000000000005 111.059 -176.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.1 mp -102.22 144.04 27.8 Favored Pre-proline 0 CA--C 1.513 -0.452 0 CA-C-N 116.236 -0.438 . . . . 74.230000000000004 110.465 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.413 ' HB3' ' O ' ' A' ' 48' ' ' GLU . 33.9 Cg_endo -66.81 135.86 39.76 Favored 'Trans proline' 0 C--O 1.246 0.88 0 C-N-CA 122.81 2.34 . . . . 65.129999999999995 113.363 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -111.68 152.07 43.83 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.165 -1.05 . . . . 63.130000000000003 108.165 170.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -41.97 -60.24 0.73 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.768 2.979 . . . . 65.420000000000002 112.687 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -142.91 13.95 1.89 Allowed 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.512 -1.292 . . . . 72.329999999999998 107.512 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.505 ' OG ' ' HB2' ' A' ' 51' ' ' GLN . 69.6 m 63.11 80.64 0.23 Allowed 'General case' 0 C--O 1.247 0.948 0 CA-C-N 114.326 -1.306 . . . . 72.239999999999995 113.207 -174.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -85.91 -40.28 16.07 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.706 -1.134 . . . . 73.230000000000004 110.255 174.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.23 0.52 10.58 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.592 -0.276 . . . . 73.540000000000006 113.443 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -131.93 111.86 11.92 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.714 -0.847 . . . . 63.009999999999998 108.714 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -80.89 -39.11 26.88 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.481 -0.781 . . . . 74.25 111.367 -176.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -89.73 172.84 8.63 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.913 -0.585 . . . . 70.400000000000006 110.518 -174.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.585 ' HB3' ' OE2' ' A' ' 110' ' ' GLU . 60.5 ttt180 -54.68 -51.84 64.23 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 109.52 -0.548 . . . . 75.219999999999999 109.52 176.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -139.52 -79.49 0.31 Allowed 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.514 -0.766 . . . . 73.019999999999996 111.742 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -177.12 177.67 1.21 Allowed 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 106.779 -1.563 . . . . 72.430000000000007 106.779 -169.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.2 p -56.08 115.73 2.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.032 0.444 . . . . 65.140000000000001 111.614 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 129.71 -41.18 1.58 Allowed Glycine 0 C--N 1.302 -1.348 0 N-CA-C 108.703 -1.759 . . . . 74.140000000000001 108.703 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.585 ' OE2' ' HB3' ' A' ' 105' ' ' ARG . 3.4 tp10 57.38 93.29 0.03 OUTLIER 'General case' 0 C--O 1.242 0.685 0 C-N-CA 126.366 1.866 . . . . 62.219999999999999 112.325 176.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.7 m -163.47 -158.48 0.47 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.337 -0.986 . . . . 71.219999999999999 108.337 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -121.3 87.13 2.7 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.915 -1.143 . . . . 74.340000000000003 107.915 172.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 60.0 m -90.61 89.2 7.43 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 115.126 -0.943 . . . . 74.120000000000005 110.985 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 50.5 t -127.64 98.2 5.12 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.404 -1.702 . . . . 74.109999999999999 106.404 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 29.9 m -76.35 99.17 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.973 0.892 . . . . 75.099999999999994 113.18 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.6 tt -106.38 89.05 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.057 -0.974 . . . . 75.349999999999994 108.612 175.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--N 1.297 -1.709 0 CA-C-N 115.087 -0.961 . . . . 64.120000000000005 109.945 -175.573 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.2 t . . . . . 0 N--CA 1.432 -1.34 0 N-CA-C 108.63 -0.878 . . . . 73.239999999999995 108.63 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.9 p -98.44 -5.68 31.99 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.724 0.773 . . . . 74.239999999999995 111.1 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.4 HD21 ' HA ' ' A' ' 117' ' ' LEU . 48.1 t30 -131.35 153.96 49.09 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.839 -1.171 . . . . 55.450000000000003 107.839 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.456 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 38.3 t -80.87 123.19 82.44 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 109.051 -0.722 . . . . 73.219999999999999 109.051 -178.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.22 166.67 8.77 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.682 2.254 . . . . 75.120000000000005 112.52 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.61 7.78 39.86 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.697 -0.683 . . . . 75.319999999999993 110.358 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -123.09 -0.22 8.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.033 -0.53 . . . . 75.349999999999994 110.184 175.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.1 mmm -130.74 155.77 46.09 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.964 -0.754 . . . . 64.150000000000006 108.964 -178.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.406 HD11 ' O ' ' A' ' 10' ' ' ILE . 2.9 pp -122.73 134.11 66.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.002 -0.74 . . . . 71.420000000000002 109.002 174.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.485 HD21 HG22 ' A' ' 83' ' ' THR . 6.4 t30 -90.83 109.87 21.08 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.536 -0.913 . . . . 74.319999999999993 108.536 -175.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.429 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.0 tp -113.4 135.56 53.73 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 112.563 0.579 . . . . 75.510000000000005 112.563 -172.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 33.5 ttp180 -106.22 120.26 41.37 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 108.684 -0.858 . . . . 60.039999999999999 108.684 172.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.448 ' CB ' HG23 ' A' ' 39' ' ' VAL . 2.7 mm? -93.19 127.36 38.73 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.123 -1.399 . . . . 64.230000000000004 109.392 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.481 HG12 HG21 ' A' ' 21' ' ' THR . 22.6 mt -101.33 119.95 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 C-N-CA 118.937 -1.105 . . . . 65.519999999999996 109.369 176.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.5 tp -78.38 159.63 28.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.499 -0.773 . . . . 75.310000000000002 110.689 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.7 m -61.83 -13.76 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.913 0.885 . . . . 73.239999999999995 113.156 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.3 t -82.28 -10.03 59.26 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.566 -0.531 . . . . 63.210000000000001 109.566 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.23 11.44 62.89 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.069 -0.813 . . . . 73.120000000000005 111.069 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.67 148.99 26.78 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.093 -0.706 . . . . 63.32 109.093 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.481 HG21 HG12 ' A' ' 15' ' ' ILE . 69.5 p -112.33 152.55 28.42 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.084 0.468 . . . . 73.219999999999999 112.244 -174.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.405 ' CG ' ' HD2' ' A' ' 103' ' ' ARG . 8.1 mmtp -146.22 139.7 26.02 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.445 -0.798 . . . . 72.040000000000006 110.575 169.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 27.4 tt0 -122.18 132.31 54.39 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.809 -0.632 . . . . 74.219999999999999 109.939 -173.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.697 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 89.7 m-85 -144.26 158.83 43.52 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.859 -0.793 . . . . 74.150000000000006 108.859 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 111' ' ' SER . 39.8 tp -85.62 125.39 33.1 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.043 -1.095 . . . . 74.310000000000002 108.043 176.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.697 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 89.9 m-85 -130.31 172.87 11.37 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.474 -0.565 . . . . 72.099999999999994 109.474 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.7 p -95.52 150.52 37.61 Favored Pre-proline 0 N--CA 1.409 -2.514 0 N-CA-C 107.099 -1.445 . . . . 53.5 107.099 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.661 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 57.9 Cg_endo -64.61 -11.51 29.17 Favored 'Trans proline' 0 C--N 1.321 -0.868 0 C-N-CA 122.297 1.998 . . . . 72.450000000000003 111.423 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -91.58 -6.0 53.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.387 -0.824 . . . . 64.049999999999997 111.83 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -75.77 151.48 37.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 120.628 -0.429 . . . . 74.409999999999997 110.504 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.597 ' O ' HG13 ' A' ' 35' ' ' ILE . 54.0 m -87.07 119.98 27.87 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 110.001 -0.37 . . . . 73.329999999999998 110.001 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.475 ' CB ' HD12 ' A' ' 60' ' ' LEU . . . -45.01 -56.18 4.87 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.723 1.379 . . . . 74.510000000000005 114.723 -176.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.2 m -75.65 -21.71 57.42 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.215 -0.594 . . . . 75.5 111.957 -176.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.09 -40.2 78.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.032 -1.47 . . . . 74.5 107.032 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 31' ' ' SER . 70.0 mt -63.74 -42.42 95.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 CA-C-N 114.401 -1.272 . . . . 75.099999999999994 109.986 176.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.61 -36.76 56.94 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.058 0.543 . . . . 73.420000000000002 111.771 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.454 ' HB2' ' HG3' ' A' ' 44' ' ' PRO . 73.3 mmtt -72.62 -37.06 68.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.065 0.46 . . . . 75.120000000000005 110.068 176.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.61 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 28.3 t60 -70.08 -48.26 58.45 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.619 -0.719 . . . . 74.239999999999995 111.802 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.448 HG23 ' CB ' ' A' ' 14' ' ' LEU . 27.6 m -63.26 -31.07 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.021 0.439 . . . . 73.519999999999996 111.431 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 70.2 t80 -61.34 -50.85 71.28 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.182 -0.917 . . . . 73.329999999999998 111.761 175.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 40' ' ' TYR . 12.8 t70 169.34 122.73 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.191 -0.67 . . . . 73.430000000000007 109.191 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.61 ' O ' ' HA ' ' A' ' 38' ' ' HIS . 53.7 t30 70.1 174.3 0.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 123.818 0.698 . . . . 74.450000000000003 110.085 177.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 32.4 p-90 -106.52 130.92 22.19 Favored Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 108.812 -0.81 . . . . 74.120000000000005 108.812 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.454 ' HG3' ' HB2' ' A' ' 37' ' ' LYS . 55.6 Cg_endo -69.24 94.45 0.49 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 121.85 1.7 . . . . 73.420000000000002 113.059 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.4 ttt -81.98 -31.14 31.27 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.274 -1.38 . . . . 73.400000000000006 107.274 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -155.77 -65.67 0.12 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.708 -1.96 . . . . 52.310000000000002 105.708 175.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.6 t90 59.95 5.78 0.81 Allowed 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 126.685 1.994 . . . . 74.299999999999997 114.308 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 68.36 119.02 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 124.204 1.002 . . . . 73.109999999999999 109.718 177.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -91.19 75.13 6.2 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.751 -0.593 . . . . 62.43 112.44 -175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.468 ' CG ' ' HA ' ' A' ' 93' ' ' THR 0.265 0.4 OUTLIER 41.59 69.18 0.37 Allowed 'General case' 0 C--O 1.255 1.367 0 N-CA-C 114.92 1.452 . . . . 75.150000000000006 114.92 179.3 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 61.19 20.8 11.31 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.408 1.483 . . . . 71.239999999999995 111.233 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.7 t 62.43 10.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.224 1.41 . . . . 73.430000000000007 110.123 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.0 t -98.96 -30.5 12.32 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 115.683 -0.69 . . . . 74.129999999999995 110.4 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.1 m -125.14 84.08 59.82 Favored Pre-proline 0 N--CA 1.439 -1.016 0 N-CA-C 112.705 0.632 . . . . 74.450000000000003 112.705 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -98.05 -18.69 0.18 Allowed 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 122.706 2.27 . . . . 74.439999999999998 112.521 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -83.44 -0.32 49.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.135 0.574 . . . . 62.43 111.259 -175.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.429 ' CG2' ' HB3' ' A' ' 91' ' ' ARG . 2.1 pp -77.46 -3.25 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 115.657 -0.702 . . . . 73.510000000000005 112.708 -176.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.422 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 97.0 mt -81.29 111.8 18.01 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.199 -1.037 . . . . 64.319999999999993 108.199 176.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 68' ' ' HIS . 18.2 tpt180 -146.85 141.62 26.8 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.096 -0.705 . . . . 73.430000000000007 109.096 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.475 HD12 ' CB ' ' A' ' 32' ' ' ALA . 1.2 pt? -112.81 140.93 47.18 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 121.064 -0.254 . . . . 71.209999999999994 111.201 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 61.9 mt -111.64 117.38 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.926 -0.768 . . . . 75.239999999999995 108.926 176.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.533 ' CB ' HD22 ' A' ' 67' ' ' LEU . 33.4 t80 -105.35 76.08 1.2 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.842 -0.743 . . . . 73.239999999999995 109.002 174.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 63' ' ' GLN 0.331 15.0 mm100 36.2 83.69 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 116.222 1.934 . . . . 62.310000000000002 116.222 178.515 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.89 -63.3 0.62 Allowed Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 114.879 -1.055 . . . . 70.420000000000002 110.908 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -130.81 156.4 45.06 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.047 -0.661 . . . . 75.109999999999999 112.077 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -87.48 114.08 23.77 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 104.648 -2.353 . . . . 71.129999999999995 104.648 175.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.533 HD22 ' CB ' ' A' ' 62' ' ' TYR . 1.4 mm? -72.3 -50.31 27.96 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 119.603 -0.839 . . . . 72.530000000000001 112.198 -168.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.488 ' HB2' HG22 ' A' ' 71' ' ' VAL . 19.6 m80 179.73 -161.31 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 126.65 1.98 . . . . 74.209999999999994 106.262 -176.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 58' ' ' LEU . . . -84.51 -46.3 5.83 Favored Glycine 0 C--O 1.208 -1.476 0 N-CA-C 115.46 0.944 . . . . 73.099999999999994 115.46 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -134.64 34.58 3.19 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.392 1.096 . . . . 71.510000000000005 113.231 -172.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 68' ' ' HIS . 74.0 t -62.03 137.65 23.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.533 -0.543 . . . . 75.549999999999997 109.533 176.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.585 ' HB ' ' O ' ' A' ' 28' ' ' PRO . 29.0 p -78.52 156.81 29.07 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.848 -0.615 . . . . 72.340000000000003 110.805 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.487 ' H ' HD21 ' A' ' 73' ' ' LEU . 2.2 mm? -64.86 -35.44 81.12 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.594 -0.73 . . . . 72.209999999999994 110.133 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.57 -36.54 93.36 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.907 -0.588 . . . . 65.299999999999997 111.864 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.41 -16.62 63.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.986 0.422 . . . . 71.219999999999999 110.939 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.44 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 75.4 mt -83.79 12.43 6.02 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.765 0.826 . . . . 75.340000000000003 111.046 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.74 19.65 9.63 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.204 1.002 . . . . 73.120000000000005 110.491 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.44 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 94.0 mt -80.7 116.98 65.81 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.191 -0.459 . . . . 72.129999999999995 111.224 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.58 161.27 31.21 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 C-N-CA 122.071 1.847 . . . . 61.439999999999998 110.829 175.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.661 ' CE2' ' HG3' ' A' ' 28' ' ' PRO . 71.7 m-85 -79.36 163.53 24.78 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.685 -0.857 . . . . 73.099999999999994 108.685 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.456 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 83.52 0.14 89.85 Favored Glycine 0 C--N 1.301 -1.371 0 C-N-CA 120.624 -0.798 . . . . 74.209999999999994 114.784 175.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.95 157.68 35.47 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 118.971 -1.092 . . . . 74.25 112.688 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.485 HG22 HD21 ' A' ' 11' ' ' ASN . 24.6 m -90.02 120.92 31.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.564 -0.744 . . . . 71.439999999999998 110.247 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.0 m -113.42 135.17 54.17 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.605 -0.271 . . . . 52.43 110.977 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.15 126.88 70.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 N-CA-C 109.676 -0.49 . . . . 74.209999999999994 109.676 175.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.438 ' O ' HG13 ' A' ' 15' ' ' ILE . 85.4 mtp -136.39 153.46 51.1 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-O 121.198 0.523 . . . . 75.439999999999998 112.098 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.482 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 40.9 m-70 -102.24 137.15 40.87 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.458 -0.792 . . . . 75.420000000000002 109.936 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.426 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.6 mm? -120.53 141.42 50.27 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.958 -0.756 . . . . 73.439999999999998 108.958 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.454 ' CG2' ' HB3' ' A' ' 59' ' ' ARG . 30.2 m -125.36 136.08 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-O 121.731 0.777 . . . . 72.340000000000003 111.05 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.93 146.97 51.0 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 106.343 -1.725 . . . . 75.230000000000004 106.343 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.429 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 79.2 ttt180 -134.59 132.65 39.31 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.183 -1.043 . . . . 74.209999999999994 108.183 -168.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 66.24 13.65 9.27 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.932 0.872 . . . . 71.109999999999999 109.904 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.468 ' HA ' ' CG ' ' A' ' 50' ' ' GLU . 4.9 t -88.24 177.94 6.74 Favored 'General case' 0 N--CA 1.401 -2.898 0 CA-C-N 115.023 -0.99 . . . . 64.239999999999995 108.822 -176.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mp -74.87 140.25 74.13 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 110.071 -0.344 . . . . 70.040000000000006 110.071 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -79.06 -178.93 5.01 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.172 1.914 . . . . 54.130000000000003 109.509 175.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.549 ' OE2' ' HA ' ' A' ' 99' ' ' SER . 0.3 OUTLIER -69.61 122.67 86.51 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 107.636 -1.246 . . . . 72.400000000000006 107.636 179.075 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -9.79 -67.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.379 2.154 1 C-N-CA 127.408 5.405 . . . . 73.439999999999998 117.075 -167.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -156.98 26.39 0.31 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.225 -1.768 . . . . 73.340000000000003 106.225 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.549 ' HA ' ' OE2' ' A' ' 96' ' ' GLU . 71.3 m 63.58 51.06 2.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.402 -1.272 . . . . 71.219999999999999 108.324 -170.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -87.79 -23.13 24.16 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 113.053 -1.885 . . . . 37.189999999999998 109.039 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.08 -24.16 5.55 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.351 -0.841 . . . . 73.420000000000002 112.228 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -81.44 111.92 18.23 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-O 121.088 0.47 . . . . 64.549999999999997 110.77 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.405 ' HD2' ' CG ' ' A' ' 22' ' ' LYS . 4.1 ptp180 -120.82 114.77 22.09 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 106.19 -1.781 . . . . 75.310000000000002 106.19 175.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . 0.296 53.2 m-80 -75.21 116.12 15.59 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 117.68 2.474 . . . . 73.430000000000007 117.68 -167.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.432 ' HE ' ' HB2' ' A' ' 110' ' ' GLU . 29.7 ttt180 -66.59 -30.48 70.77 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 112.653 -2.067 . . . . 72.019999999999996 109.783 171.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 70.14 104.44 0.06 Allowed 'General case' 0 C--O 1.212 -0.915 0 O-C-N 124.656 1.222 . . . . 74.129999999999995 110.431 -177.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.83 -18.04 64.1 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.562 -0.745 . . . . 62.200000000000003 112.805 -175.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.3 p -93.58 1.35 56.72 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.006 -0.678 . . . . 74.439999999999998 111.645 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.06 43.7 0.56 Allowed Glycine 0 C--O 1.24 0.517 0 N-CA-C 110.15 -1.18 . . . . 72.420000000000002 110.15 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.432 ' HB2' ' HE ' ' A' ' 105' ' ' ARG . 9.7 pt-20 -87.35 171.44 10.59 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.825 1.046 . . . . 63.210000000000001 113.825 -174.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 45.4 m -106.0 111.48 24.13 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.564 -1.198 . . . . 64.030000000000001 108.175 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.405 ' HB2' ' NH2' ' A' ' 105' ' ' ARG . 47.4 t30 -172.86 176.83 2.99 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.801 -0.814 . . . . 74.010000000000005 108.801 -174.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.0 m 66.91 -156.14 0.23 Allowed 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.658 0.783 . . . . 64.319999999999993 109.775 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 85.8 m 66.66 41.49 2.99 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.986 -0.746 . . . . 51.340000000000003 108.986 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.6 t -69.75 96.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.06 -0.973 . . . . 63.240000000000002 112.06 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.4 tp -144.64 103.45 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.225 -1.028 . . . . 65.129999999999995 108.225 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.507 ' H ' HD21 ' A' ' 117' ' ' LEU . 1.2 pt? . . . . . 0 N--CA 1.422 -1.835 0 CA-C-N 115.196 -0.911 . . . . 42.039999999999999 111.491 -174.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.443 -0.784 0 N-CA-C 109.839 -0.43 . . . . 74.439999999999998 109.839 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.9 t -125.17 5.71 7.84 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.654 -0.869 . . . . 75.329999999999998 108.654 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -151.39 155.05 37.84 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.213 -1.403 . . . . 72.409999999999997 107.213 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.556 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 17.0 t -99.95 115.26 65.7 Favored Pre-proline 0 C--N 1.313 -0.996 0 N-CA-C 109.713 -0.477 . . . . 74.530000000000001 109.713 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.65 170.92 16.4 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.387 2.058 . . . . 62.030000000000001 111.616 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 80' ' ' PHE . . . -79.14 14.56 1.41 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.341 0.591 . . . . 64.129999999999995 111.484 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -108.32 -11.37 15.22 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.486 -0.561 . . . . 73.150000000000006 109.486 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.4 mmm -130.9 158.03 41.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.024 -0.535 . . . . 74.420000000000002 110.328 -174.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.43 ' CD1' ' HG ' ' A' ' 73' ' ' LEU . 2.8 pp -119.01 140.88 41.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.586 -0.524 . . . . 74.239999999999995 109.586 174.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.452 HD21 HG23 ' A' ' 83' ' ' THR . 7.3 t30 -94.83 115.73 27.85 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.424 -0.954 . . . . 73.510000000000005 108.424 -176.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.433 ' HG ' HD22 ' A' ' 14' ' ' LEU . 42.3 tp -117.77 133.88 55.49 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.646 0.736 . . . . 71.439999999999998 112.57 -173.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.483 ' HD2' ' OE1' ' A' ' 23' ' ' GLU . 21.8 ttt85 -106.61 120.52 42.18 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 108.14 -1.059 . . . . 63.210000000000001 108.14 176.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 14' ' ' LEU . 2.0 mm? -100.67 127.48 47.06 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.875 -1.057 . . . . 64.239999999999995 109.635 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 86' ' ' MET . 21.3 mm -99.28 116.53 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 106.917 -1.512 . . . . 63.43 106.917 175.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.77 158.38 33.6 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.348 -0.387 . . . . 71.540000000000006 110.619 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 90' ' ' ALA . 90.2 t -66.01 -23.32 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 121.602 0.715 . . . . 75.209999999999994 110.2 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.2 m -75.56 -3.87 36.71 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.12 -0.945 . . . . 72.439999999999998 110.127 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.15 8.8 84.97 Favored Glycine 0 CA--C 1.495 -1.189 0 N-CA-C 111.579 -0.609 . . . . 53.210000000000001 111.579 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -87.19 131.44 34.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.558 -1.275 . . . . 74.409999999999997 107.558 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.5 p -107.76 129.28 55.06 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 109.905 -0.406 . . . . 55.530000000000001 109.905 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -148.47 149.92 32.53 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.183 -0.607 . . . . 72.200000000000003 110.344 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.483 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 29.7 tt0 -130.45 132.74 45.85 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.893 -0.14 . . . . 74.530000000000001 110.97 -170.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.501 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 35.0 m-85 -143.23 160.57 40.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.624 0.726 . . . . 73.209999999999994 112.107 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.472 ' CD1' HG11 ' A' ' 5' ' ' VAL . 37.3 tp -85.66 126.07 33.65 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.15 -0.932 . . . . 63.009999999999998 109.325 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.501 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 97.5 m-85 -133.42 171.12 14.5 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.672 -0.492 . . . . 73.409999999999997 109.672 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.3 p -94.99 150.65 38.05 Favored Pre-proline 0 N--CA 1.419 -2.001 0 C-N-CA 119.054 -1.058 . . . . 75.400000000000006 108.206 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -62.85 -11.39 24.03 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.43 2.087 . . . . 74.219999999999999 111.784 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -79.68 -21.35 44.81 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.199 1.0 . . . . 73.299999999999997 109.777 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -75.77 152.27 37.4 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 116.321 -0.4 . . . . 70.230000000000004 110.429 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.519 ' O ' HG13 ' A' ' 35' ' ' ILE . 77.1 p -106.16 138.29 42.6 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 109.972 -0.381 . . . . 62.539999999999999 109.972 178.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.542 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -50.95 -49.62 59.53 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.864 1.061 . . . . 61.119999999999997 113.864 -175.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.0 m -64.52 -31.63 72.93 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 120.949 0.404 . . . . 52.219999999999999 110.891 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.542 ' O ' ' HG3' ' A' ' 44' ' ' PRO . 20.6 t70 -70.12 -45.47 66.82 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.869 -0.789 . . . . 72.310000000000002 108.869 175.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 31' ' ' SER . 60.9 mt -60.78 -33.64 56.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.155 -0.93 . . . . 72.310000000000002 112.281 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.71 -40.43 40.49 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 110.491 -0.188 . . . . 72.420000000000002 110.491 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 1.6 mptm? -64.11 -44.68 91.52 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.343 0.592 . . . . 72.049999999999997 109.838 177.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -62.57 -43.42 98.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.053 -1.43 . . . . 61.210000000000001 110.118 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.462 HG12 HD21 ' A' ' 14' ' ' LEU . 36.0 m -74.9 -32.17 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 113.76 1.022 . . . . 64.129999999999995 113.76 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.425 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 39.0 m-85 -54.67 -49.61 70.22 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.266 0.839 . . . . 75.150000000000006 113.266 176.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 40' ' ' TYR . 5.4 p-10 165.59 -30.36 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.417 0.627 . . . . 54.530000000000001 109.332 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -91.36 169.79 10.51 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.736 -0.665 . . . . 75.209999999999994 110.91 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.484 ' C ' ' H ' ' A' ' 45' ' ' MET . 5.5 m-90 -111.17 122.8 36.81 Favored Pre-proline 0 N--CA 1.423 -1.785 0 N-CA-C 109.312 -0.625 . . . . 74.439999999999998 109.312 174.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.542 ' HG3' ' O ' ' A' ' 34' ' ' ASP . 19.7 Cg_endo -66.96 33.83 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 124.012 3.141 . . . . 75.430000000000007 113.841 177.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.484 ' H ' ' C ' ' A' ' 43' ' ' TRP . 54.7 ttm -127.5 75.34 1.59 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.998 -1.853 . . . . 65.099999999999994 105.998 173.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.425 ' CG ' ' H ' ' A' ' 47' ' ' TRP . 17.5 t70 -147.41 -155.0 0.59 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 105.078 -2.193 . . . . 75.010000000000005 105.078 -173.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.425 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 87.0 m95 -101.03 -29.21 12.29 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 108.607 -0.886 . . . . 74.319999999999993 108.607 176.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 54.76 82.63 0.09 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.036 0.934 . . . . 74.439999999999998 110.03 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -93.68 85.51 4.88 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 119.592 -0.843 . . . . 65.549999999999997 112.066 -174.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HB2' ' HD3' ' A' ' 95' ' ' PRO . 8.6 tp10 -139.76 135.15 32.78 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.922 -1.036 . . . . 72.109999999999999 108.358 176.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -83.22 95.87 8.27 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.876 -1.157 . . . . 73.540000000000006 107.876 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.94 104.68 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.933 0 CA-C-O 122.249 1.023 . . . . 54.350000000000001 112.038 -174.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.472 ' C ' ' HD3' ' A' ' 55' ' ' PRO . 33.7 t -97.43 3.42 50.9 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.01 -1.107 . . . . 72.439999999999998 108.01 177.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.541 ' O ' HG13 ' A' ' 57' ' ' ILE . 11.5 p -123.24 47.7 1.76 Allowed Pre-proline 0 CA--C 1.571 1.755 0 CA-C-N 114.193 -1.367 . . . . 72.150000000000006 111.579 -178.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.472 ' HD3' ' C ' ' A' ' 53' ' ' SER . 38.9 Cg_exo -60.18 -16.36 39.78 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 122.703 2.269 . . . . 70.230000000000004 113.487 -172.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -75.8 -1.07 23.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.953 -0.567 . . . . 71.109999999999999 111.842 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 54' ' ' SER . 2.2 pp -77.08 -18.82 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 120.9 0.381 . . . . 74.099999999999994 111.066 177.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 57' ' ' ILE . 96.9 mt -79.03 90.85 4.82 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 107.639 -1.245 . . . . 75.519999999999996 107.639 175.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.419 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 17.3 ptt180 -147.2 159.93 43.05 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.226 0.536 . . . . 72.129999999999995 112.262 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 4.4 pp -127.83 144.62 51.09 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.407 -0.815 . . . . 63.329999999999998 111.445 -172.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.449 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 85.6 mt -112.87 118.79 58.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.82 -0.807 . . . . 72.209999999999994 108.82 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -105.1 74.75 1.13 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.558 -0.534 . . . . 73.510000000000005 109.558 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 43.26 80.03 0.04 OUTLIER 'General case' 0 C--O 1.244 0.786 0 O-C-N 124.725 1.266 . . . . 63.509999999999998 113.367 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.74 -72.05 0.48 Allowed Glycine 0 N--CA 1.419 -2.439 0 CA-C-N 114.879 -1.055 . . . . 41.240000000000002 111.624 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -130.83 174.41 10.0 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.23 0.538 . . . . 70.219999999999999 112.375 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.582 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 71.0 m-85 -87.78 117.34 26.55 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 105.905 -1.887 . . . . 71.430000000000007 105.905 172.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.81 -47.96 14.33 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.728 -0.789 . . . . 74.439999999999998 112.258 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.513 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 10.4 t60 -172.67 158.04 3.97 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.736 -1.579 . . . . 72.430000000000007 106.736 -177.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -69.45 -0.65 24.63 Favored Glycine 0 CA--C 1.542 1.736 0 N-CA-C 117.091 1.596 . . . . 51.32 117.091 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -175.71 31.65 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.239 1.52 . . . . 62.340000000000003 109.362 -171.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.43 HG11 HD23 ' A' ' 60' ' ' LEU . 10.6 p -78.85 138.77 19.5 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 119.527 -0.869 . . . . 75.540000000000006 109.171 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.403 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 47.3 p -79.56 157.48 27.36 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.015 0.436 . . . . 63.350000000000001 112.032 -175.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.43 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 3.1 mm? -61.36 -34.22 74.93 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.612 -0.722 . . . . 72.129999999999995 111.487 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.32 -30.03 76.7 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.0 -0.619 . . . . 63.32 111.907 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.68 -15.74 58.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.397 0.617 . . . . 74.510000000000005 110.276 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.443 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 53.3 mt -83.19 12.89 4.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.825 -0.625 . . . . 74.140000000000001 111.158 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.0 mptt 69.46 12.56 8.27 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.209 1.004 . . . . 73.420000000000002 111.106 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.443 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 89.7 mt -76.03 121.81 85.72 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 112.374 0.509 . . . . 74.120000000000005 112.374 -175.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -75.57 159.04 39.67 Favored 'Trans proline' 0 N--CA 1.442 -1.515 0 C-N-CA 122.091 1.861 . . . . 51.43 109.754 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.415 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 12.0 m-85 -80.67 151.51 28.92 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.059 -0.719 . . . . 63.539999999999999 109.059 -174.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.556 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 84.95 4.01 87.4 Favored Glycine 0 C--N 1.306 -1.112 0 C-N-CA 120.493 -0.861 . . . . 64.319999999999993 113.53 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -110.35 149.27 30.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 117.013 0.406 . . . . 72.109999999999999 111.085 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.452 HG23 HD21 ' A' ' 11' ' ' ASN . 94.6 m -91.2 123.49 34.68 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.596 -0.729 . . . . 73.430000000000007 110.38 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.3 m -118.56 131.38 56.21 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.264 -0.88 . . . . 73.010000000000005 110.316 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.452 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 7.5 p -103.25 124.46 57.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.989 0.423 . . . . 75.340000000000003 110.281 177.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.449 ' O ' HG12 ' A' ' 15' ' ' ILE . 91.0 mtp -129.37 152.21 49.17 Favored 'General case' 0 CA--C 1.486 -1.5 0 CA-C-O 121.368 0.604 . . . . 75.319999999999993 110.603 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.449 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 38.5 m-70 -106.32 126.17 51.91 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.433 -0.803 . . . . 71.319999999999993 108.913 -178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -115.05 144.03 44.27 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-O 121.071 0.462 . . . . 62.43 111.992 -176.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.96 132.17 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 115.462 -0.79 . . . . 65.209999999999994 108.987 176.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.415 ' H ' HG22 ' A' ' 17' ' ' VAL . . . -136.83 145.47 44.48 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.59 -0.732 . . . . 65.420000000000002 109.686 177.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.464 ' H ' HD11 ' A' ' 57' ' ' ILE . 36.0 ttt-85 -135.0 151.68 51.05 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 105.544 -2.021 . . . . 75.209999999999994 105.544 178.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 70.26 -73.82 0.09 Allowed 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.516 0.51 . . . . 72.140000000000001 110.712 -175.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 94' ' ' LEU . 20.9 m 63.33 179.06 0.15 Allowed 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 124.687 1.195 . . . . 72.329999999999998 109.816 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.496 ' H ' HG22 ' A' ' 93' ' ' THR . 5.3 mp -68.33 127.02 93.3 Favored Pre-proline 0 C--N 1.293 -1.849 0 O-C-N 122.028 -0.42 . . . . 74.109999999999999 111.381 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 50' ' ' GLU . 33.1 Cg_exo -62.35 129.9 28.41 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 N-CA-C 106.348 -2.212 . . . . 61.039999999999999 106.348 168.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -73.37 131.23 83.11 Favored Pre-proline 0 C--N 1.292 -1.897 0 C-N-CA 120.382 -0.527 . . . . 73.230000000000004 111.35 -171.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -43.99 -48.31 9.42 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 124.227 3.285 . . . . 72.219999999999999 109.35 176.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -161.28 143.45 12.07 Favored 'General case' 0 N--CA 1.387 -3.608 1 N-CA-C 99.496 -4.261 . . . . 72.519999999999996 99.496 175.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.9 m -69.45 80.26 0.39 Allowed 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 119.176 0.898 . . . . 64.040000000000006 110.76 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -57.57 -50.08 74.28 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 115.629 -0.714 . . . . 72.329999999999998 110.865 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.32 -36.53 1.77 Allowed Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 121.235 -0.507 . . . . 71.510000000000005 112.706 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -110.17 111.45 22.79 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 122.182 0.991 . . . . 74.200000000000003 112.498 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 178.64 36.41 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 101.153 -3.647 . . . . 72.019999999999996 101.153 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -94.36 -33.07 13.32 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.438 -1.71 . . . . 64.209999999999994 111.366 -169.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 111' ' ' SER . 0.0 OUTLIER -60.84 -51.81 67.71 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.198 0.814 . . . . 70.150000000000006 113.198 -178.623 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.264 12.4 tt0 60.3 -47.91 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.399 1.629 . . . . 74.409999999999997 115.399 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.493 ' HZ1' ' HB2' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -91.63 157.04 17.19 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.89 -0.782 . . . . 51.240000000000002 108.89 177.157 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.1 t -82.97 147.4 28.23 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.151 -0.685 . . . . 62.439999999999998 109.151 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.65 30.18 22.0 Favored Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 111.223 -0.751 . . . . 45.149999999999999 111.223 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 68.43 159.56 0.17 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.218 1.007 . . . . 73.099999999999994 111.856 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' A' ' 105' ' ' ARG . 11.4 p -89.32 88.38 7.48 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-O 121.596 0.712 . . . . 74.239999999999995 110.246 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -135.64 106.54 6.63 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.08 -0.964 . . . . 73.400000000000006 109.143 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 65.5 m -115.47 169.21 9.33 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.198 -0.668 . . . . 45.119999999999997 109.198 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 46.1 t -135.74 145.17 46.35 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 110.12 -0.326 . . . . 74.239999999999995 110.12 -176.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.4 m -69.81 117.02 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-O 121.498 0.666 . . . . 70.129999999999995 111.284 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.9 tp -103.81 4.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 122.541 1.162 . . . . 73.549999999999997 108.486 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 N--CA 1.432 -1.355 0 CA-C-N 114.833 -1.076 . . . . 70.549999999999997 108.78 179.511 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.435 -1.22 0 CA-C-O 121.299 0.571 . . . . 74.409999999999997 111.573 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.4 m -147.37 112.61 5.53 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.643 -0.502 . . . . 74.430000000000007 109.643 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.1 t30 71.84 113.23 0.06 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.245 1.418 . . . . 71.239999999999995 111.554 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.422 HG12 ' CD1' ' A' ' 25' ' ' LEU . 11.7 t -103.78 115.41 63.5 Favored Pre-proline 0 N--CA 1.431 -1.376 0 N-CA-C 109.445 -0.576 . . . . 71.040000000000006 109.445 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -71.9 149.01 52.75 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 122.11 1.873 . . . . 72.129999999999995 109.876 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.35 73.32 5.98 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.059 0.933 . . . . 64.540000000000006 110.137 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -169.51 -37.91 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.458 -1.682 . . . . 61.530000000000001 106.458 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.0 mmm -96.99 143.64 27.65 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.523 -1.671 . . . . 75.299999999999997 108.675 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -98.66 140.81 17.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-O 121.033 0.444 . . . . 53.420000000000002 111.273 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.592 ' OD1' HG21 ' A' ' 83' ' ' THR . 18.7 t-20 -87.64 125.85 34.61 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.282 -0.636 . . . . 51.020000000000003 109.282 177.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.474 ' HG ' ' CD2' ' A' ' 14' ' ' LEU . 30.6 tp -131.8 132.21 43.56 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-O 121.326 0.584 . . . . 75.200000000000003 111.468 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.491 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . 23.1 ttt85 -106.93 120.99 43.53 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-N 114.917 -1.038 . . . . 75.230000000000004 109.115 175.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.545 ' CB ' HG22 ' A' ' 39' ' ' VAL . 1.8 mm? -103.74 126.49 50.91 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.04 -0.982 . . . . 74.439999999999998 108.823 -178.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 86' ' ' MET . 34.2 mt -99.47 119.36 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 107.944 -1.132 . . . . 73.0 107.944 175.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.9 mt -72.15 154.12 41.25 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.485 -0.779 . . . . 72.109999999999999 110.245 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.5 t -63.71 -15.99 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 122.086 0.946 . . . . 71.420000000000002 109.577 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.3 t -80.2 -10.19 59.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.187 -0.915 . . . . 65.230000000000004 110.447 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.51 70.4 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.574 -0.822 . . . . 63.399999999999999 112.392 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -87.32 135.53 33.29 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.666 -0.414 . . . . 63.030000000000001 110.901 176.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.6 p -100.95 129.88 46.86 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.721 -0.672 . . . . 64.219999999999999 110.316 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -140.6 138.68 34.61 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.2 -0.6 . . . . 75.140000000000001 111.183 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 28.7 tt0 -121.93 140.8 52.0 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 115.502 -0.772 . . . . 71.010000000000005 109.133 -173.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.689 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 72.1 m-85 -143.72 160.32 40.92 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 123.523 0.729 . . . . 75.209999999999994 109.985 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.422 ' CD1' HG12 ' A' ' 5' ' ' VAL . 32.9 tp -82.25 125.75 31.31 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 107.338 -1.356 . . . . 74.219999999999999 107.338 175.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.689 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 86.3 m-85 -132.07 172.77 11.96 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.862 -0.421 . . . . 72.400000000000006 109.862 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.1 p -100.02 148.93 35.51 Favored Pre-proline 0 C--N 1.286 -2.188 0 N-CA-C 107.589 -1.264 . . . . 60.340000000000003 107.589 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.69 -11.94 22.82 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 121.73 1.62 . . . . 72.129999999999995 112.079 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -80.05 -23.29 41.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.331 0.652 . . . . 70.129999999999995 111.156 177.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' O ' HD21 ' A' ' 73' ' ' LEU . 36.2 m-20 -66.89 154.38 41.12 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 120.769 0.319 . . . . 63.100000000000001 111.655 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.566 ' O ' HG13 ' A' ' 35' ' ' ILE . 44.2 m -98.52 124.03 43.02 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 122.295 -0.253 . . . . 62.229999999999997 110.579 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.446 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -46.63 -59.4 3.04 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 114.503 1.297 . . . . 71.400000000000006 114.503 -176.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 m -67.06 -27.83 67.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.223 0.535 . . . . 75.129999999999995 111.455 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.599 ' O ' ' HG3' ' A' ' 44' ' ' PRO . 23.8 t70 -68.49 -47.26 67.5 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.733 -1.21 . . . . 70.140000000000001 107.733 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 31' ' ' SER . 77.1 mt -56.16 -36.34 45.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.132 -0.94 . . . . 74.409999999999997 111.621 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.75 -36.85 38.74 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.098 0.559 . . . . 72.319999999999993 112.357 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.499 ' HZ1' ' CD ' ' A' ' 48' ' ' GLU . 0.6 OUTLIER -72.6 -42.96 63.95 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 107.096 -1.446 . . . . 63.109999999999999 107.096 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.531 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 43.2 t-80 -55.87 -54.05 49.37 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.016 -1.447 . . . . 73.319999999999993 111.124 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.545 HG22 ' CB ' ' A' ' 14' ' ' LEU . 28.9 m -70.68 -31.64 46.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.035 -0.984 . . . . 64.209999999999994 112.362 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -71.35 -48.58 49.35 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 112.447 0.536 . . . . 74.409999999999997 112.447 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -147.36 -56.08 0.24 Allowed 'General case' 0 C--O 1.241 0.653 0 N-CA-C 114.838 1.422 . . . . 64.409999999999997 114.838 -173.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 38' ' ' HIS . 66.6 t30 -151.5 -179.87 7.76 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.953 -1.128 . . . . 73.340000000000003 107.953 -171.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -71.29 130.12 88.2 Favored Pre-proline 0 C--N 1.309 -1.186 0 CA-C-N 118.294 0.497 . . . . 72.239999999999995 111.57 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.599 ' HG3' ' O ' ' A' ' 34' ' ' ASP . 35.2 Cg_endo -69.38 154.69 68.88 Favored 'Trans proline' 0 CA--C 1.506 -0.915 0 C-N-CA 123.136 2.558 . . . . 75.0 113.001 175.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.437 ' HE1' ' OE1' ' A' ' 102' ' ' GLN . 89.0 mmm -117.84 164.71 14.62 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.1 -1.444 . . . . 74.400000000000006 107.1 174.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -77.65 127.62 32.75 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.511 -0.922 . . . . 64.450000000000003 108.511 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 66.71 79.18 0.24 Allowed 'General case' 0 C--O 1.241 0.617 0 O-C-N 124.238 0.961 . . . . 73.040000000000006 109.449 -168.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.499 ' CD ' ' HZ1' ' A' ' 37' ' ' LYS . 8.1 tp10 -75.23 -34.83 61.48 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.579 -1.191 . . . . 65.340000000000003 108.322 -176.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 69.31 122.4 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 116.106 1.891 . . . . 64.540000000000006 116.106 174.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.36 -58.79 2.26 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 105.411 -2.07 . . . . 61.140000000000001 105.411 173.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -167.55 105.78 0.54 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.559 -0.746 . . . . 73.439999999999998 110.566 175.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.5 t 53.4 87.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.713 1.205 . . . . 71.140000000000001 112.672 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.8 m 63.48 91.38 0.07 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.476 1.111 . . . . 74.409999999999997 111.042 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.1 m -127.27 80.19 72.04 Favored Pre-proline 0 C--N 1.297 -1.683 0 C-N-CA 120.16 -0.616 . . . . 62.229999999999997 111.398 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -94.5 -21.31 0.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.729 1.619 . . . . 73.409999999999997 112.132 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -83.67 -2.45 56.2 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.63 -0.714 . . . . 63.0 111.102 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.3 pp -83.7 -15.18 11.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.825 -0.625 . . . . 75.230000000000004 111.231 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.9 mt -86.26 112.84 21.76 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.076 -1.083 . . . . 70.209999999999994 108.076 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -143.53 142.82 31.28 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.366 -0.605 . . . . 75.430000000000007 109.366 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 4.6 pp -130.31 132.72 46.0 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 120.99 0.424 . . . . 64.0 110.758 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 86.8 mt -108.32 120.6 59.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 121.47 0.652 . . . . 63.140000000000001 109.545 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -101.83 85.39 2.7 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 108.683 -0.858 . . . . 75.400000000000006 108.683 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 59.86 18.42 7.4 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.141 -1.391 . . . . 73.439999999999998 114.19 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.58 -52.85 0.37 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.367 -0.92 . . . . 73.439999999999998 112.985 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.4 156.32 23.67 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.065 -0.654 . . . . 63.310000000000002 111.361 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 85.8 m-85 -78.6 122.53 26.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.617 -1.253 . . . . 73.340000000000003 107.617 176.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.512 HD12 ' CD2' ' A' ' 76' ' ' LEU . 45.9 mt -79.71 -46.54 16.91 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 118.978 -1.089 . . . . 61.140000000000001 112.711 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.53 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.3 t-80 -165.48 172.6 11.93 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.005 -1.85 . . . . 73.430000000000007 106.005 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.56 -25.58 75.47 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.289 -0.958 . . . . 74.530000000000001 114.064 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -175.25 72.21 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.998 0.904 . . . . 74.230000000000004 109.054 -175.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.482 HG12 HD21 ' A' ' 76' ' ' LEU . 7.2 p -102.88 151.25 6.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 114.194 -1.366 . . . . 70.310000000000002 108.821 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.513 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 40.4 p -78.46 157.35 28.97 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 120.718 0.294 . . . . 72.109999999999999 111.212 -175.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.514 ' HA ' HD13 ' A' ' 76' ' ' LEU . 1.2 mm? -63.85 -27.5 69.21 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.765 0.426 . . . . 74.310000000000002 111.478 -177.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.66 -37.69 93.79 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.513 -1.035 . . . . 63.039999999999999 110.513 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.462 ' HB3' HG21 ' A' ' 71' ' ' VAL . . . -79.56 -16.87 55.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.341 0.591 . . . . 71.239999999999995 109.91 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.514 HD13 ' HA ' ' A' ' 73' ' ' LEU . 92.7 mt -86.51 2.96 46.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.693 -0.685 . . . . 65.420000000000002 110.716 176.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 11.1 mptt 69.56 21.2 6.81 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.9 0.88 . . . . 71.030000000000001 112.911 178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 10.4 mp -67.54 126.26 92.33 Favored Pre-proline 0 CA--C 1.511 -0.543 0 C-N-CA 119.726 -0.789 . . . . 65.209999999999994 111.426 176.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 5.6 Cg_endo -86.6 137.22 4.8 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 122.427 2.085 . . . . 71.109999999999999 112.029 178.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -73.92 128.15 34.74 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.643 -0.708 . . . . 74.120000000000005 111.12 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.82 -6.01 76.67 Favored Glycine 0 C--N 1.3 -1.435 0 CA-C-N 115.096 -0.957 . . . . 51.109999999999999 111.925 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.52 ' O ' ' HB3' ' A' ' 11' ' ' ASN . 92.6 mttt -116.67 149.29 40.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 117.389 0.594 . . . . 74.319999999999993 111.655 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.592 HG21 ' OD1' ' A' ' 11' ' ' ASN . 30.7 m -84.81 136.35 33.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.12 -0.491 . . . . 74.299999999999997 110.86 -177.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.9 m -139.55 132.11 28.76 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.886 -0.412 . . . . 71.129999999999995 109.886 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.491 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 10.8 p -99.79 138.87 22.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.21 0.528 . . . . 65.310000000000002 111.441 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.408 ' SD ' HD12 ' A' ' 76' ' ' LEU . 81.4 mtp -137.97 152.38 48.86 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 116.074 -0.512 . . . . 73.530000000000001 110.315 177.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.477 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 25.2 m-70 -111.14 128.25 55.83 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.844 -1.539 . . . . 73.420000000000002 106.844 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.36 140.15 49.38 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.178 -0.609 . . . . 70.129999999999995 110.383 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.1 m -129.99 142.12 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 109.291 -0.633 . . . . 75.239999999999995 109.291 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.492 ' HB1' ' HB ' ' A' ' 93' ' ' THR . . . -129.31 146.01 51.27 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 105.854 -1.906 . . . . 72.540000000000006 105.854 176.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.27 108.58 20.05 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 106.879 -1.526 . . . . 72.540000000000006 106.879 -171.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 52.08 23.27 2.18 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.131 0.972 . . . . 63.439999999999998 111.188 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.492 ' HB ' ' HB1' ' A' ' 90' ' ' ALA . 21.2 m -92.59 115.4 28.07 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 115.911 -0.586 . . . . 73.239999999999995 111.467 -172.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mp -84.51 152.38 60.45 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.627 -1.249 . . . . 72.209999999999994 107.627 174.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.9 83.97 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.188 1.925 . . . . 52.329999999999998 109.413 174.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 66.75 144.17 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 128.418 2.687 . . . . 74.140000000000001 109.785 -169.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -69.63 -4.29 13.64 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.026 1.817 . . . . 75.109999999999999 111.108 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 76.04 4.16 3.76 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 125.802 1.641 . . . . 74.430000000000007 110.96 -176.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.3 m -87.48 -9.31 54.91 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 114.944 -1.026 . . . . 65.219999999999999 109.539 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.415 ' HB3' ' HG3' ' A' ' 102' ' ' GLN . 46.0 mt-30 -87.75 -52.37 5.35 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 108.685 -0.857 . . . . 74.319999999999993 108.685 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.22 21.32 66.05 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.869 -1.059 . . . . 52.420000000000002 110.803 -178.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.437 ' OE1' ' HE1' ' A' ' 45' ' ' MET . 78.1 mt-30 -78.25 110.67 13.46 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 122.058 0.932 . . . . 54.399999999999999 111.565 -175.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -108.82 4.68 23.84 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.035 -1.438 . . . . 65.239999999999995 108.93 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -91.97 129.77 37.86 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.168 -1.378 . . . . 51.310000000000002 107.855 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.464 ' C ' ' H ' ' A' ' 107' ' ' LYS . 18.3 mmt180 -62.72 -32.5 73.62 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.369 0.418 . . . . 71.430000000000007 110.977 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 72.54 -39.7 0.45 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.801 1.241 . . . . 72.439999999999998 110.638 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.464 ' H ' ' C ' ' A' ' 105' ' ' ARG . 86.8 tttt -66.47 125.9 27.15 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 125.124 1.37 . . . . 74.109999999999999 107.302 173.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.9 t -71.83 -29.24 64.21 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.194 0.521 . . . . 74.310000000000002 110.632 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.459 ' O ' ' HE2' ' A' ' 107' ' ' LYS . . . -89.53 74.03 1.98 Allowed Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 109.665 -1.374 . . . . 45.119999999999997 109.665 176.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -55.1 128.74 35.16 Favored 'General case' 0 C--O 1.248 0.991 0 C-N-CA 123.066 0.546 . . . . 64.219999999999999 111.193 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.7 m -80.96 71.72 7.94 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.757 0.789 . . . . 60.119999999999997 112.313 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -164.98 19.11 0.05 OUTLIER 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.726 -1.124 . . . . 64.140000000000001 108.328 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 23.6 p -147.37 96.45 2.7 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.313 -0.858 . . . . 75.519999999999996 109.993 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 66.8 m -77.34 119.31 20.79 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.787 -0.82 . . . . 64.219999999999999 108.787 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.73 102.2 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 122.134 0.968 . . . . 74.010000000000005 111.668 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.5 tp -139.74 128.06 26.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 114.595 -1.184 . . . . 73.239999999999995 108.358 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 tm? . . . . . 0 C--N 1.293 -1.877 0 N-CA-C 106.788 -1.56 . . . . 71.230000000000004 106.788 -178.5 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.2 p . . . . . 0 N--CA 1.427 -1.612 0 CA-C-O 121.174 0.512 . . . . 74.530000000000001 110.42 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.6 p -151.59 179.57 8.26 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 116.005 -0.543 . . . . 71.219999999999999 110.486 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -90.06 -179.63 5.73 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.941 -1.503 . . . . 54.329999999999998 106.941 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.484 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 3.6 t -83.48 118.27 71.03 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 118.609 0.64 . . . . 74.219999999999999 110.036 -174.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 8' ' ' ASP . 88.2 Cg_endo -84.95 166.99 11.22 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.957 1.771 . . . . 60.030000000000001 111.077 177.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.39 30.63 0.41 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.828 0.823 . . . . 62.020000000000003 109.837 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 6' ' ' PRO . 19.6 t70 -120.43 -28.75 4.93 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.842 -1.072 . . . . 72.150000000000006 109.369 175.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.8 mtp -121.83 155.51 35.2 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 115.955 -0.566 . . . . 62.109999999999999 110.44 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.24 137.5 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 CA-C-N 115.591 -0.731 . . . . 71.120000000000005 109.507 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.42 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 2.4 t-20 -91.05 107.59 19.3 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 108.134 -1.062 . . . . 62.229999999999997 108.134 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.445 ' HG ' HD23 ' A' ' 14' ' ' LEU . 39.8 tp -112.56 132.97 54.85 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 115.283 -0.871 . . . . 71.040000000000006 111.545 -174.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -107.6 120.87 43.4 Favored 'General case' 0 N--CA 1.402 -2.863 0 N-CA-C 108.069 -1.085 . . . . 71.540000000000006 108.069 173.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.532 ' CB ' HG22 ' A' ' 39' ' ' VAL . 2.0 mm? -98.32 120.3 38.5 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.757 -1.11 . . . . 72.450000000000003 109.075 -178.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.434 HG12 HG21 ' A' ' 21' ' ' THR . 30.7 mt -103.64 118.4 50.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.565 -0.902 . . . . 73.400000000000006 108.565 177.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.87 163.51 26.68 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 123.691 0.619 . . . . 60.109999999999999 110.835 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.6 m -57.7 -27.11 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.09 0.774 . . . . 73.450000000000003 113.09 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.5 t -77.39 -16.08 59.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.653 0.263 . . . . 75.430000000000007 111.165 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.416 ' C ' ' HE3' ' A' ' 20' ' ' LYS . . . 100.81 5.68 53.33 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.994 -1.098 . . . . 62.219999999999999 111.843 -176.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.608 ' N ' ' HE3' ' A' ' 20' ' ' LYS . 0.5 OUTLIER -86.5 131.44 34.18 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.126 -1.065 . . . . 72.420000000000002 108.126 177.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.434 HG21 HG12 ' A' ' 15' ' ' ILE . 72.5 p -107.2 133.05 52.36 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 120.457 -0.497 . . . . 71.340000000000003 111.6 -175.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -122.37 139.57 53.68 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.591 -0.892 . . . . 62.399999999999999 108.591 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -131.42 129.55 41.4 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.649 -0.82 . . . . 73.230000000000004 109.087 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.616 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.0 m-85 -146.54 160.7 41.8 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.035 0.534 . . . . 75.109999999999999 110.581 -178.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.431 ' CD2' HG13 ' A' ' 5' ' ' VAL . 75.4 mt -79.64 126.54 31.05 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.441 -0.578 . . . . 63.450000000000003 109.441 172.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.616 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 94.5 m-85 -131.58 167.75 18.87 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.213 -1.032 . . . . 72.420000000000002 108.213 175.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.3 p -94.35 151.7 39.61 Favored Pre-proline 0 N--CA 1.411 -2.387 0 C-N-CA 119.129 -1.028 . . . . 53.130000000000003 108.246 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.5 ' O ' ' HB ' ' A' ' 72' ' ' THR . 31.3 Cg_endo -60.17 -11.73 16.96 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.628 2.219 . . . . 63.329999999999998 112.418 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -96.17 -4.86 41.84 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.055 0.391 . . . . 72.120000000000005 112.055 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -76.02 154.06 36.0 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 120.474 -0.49 . . . . 63.420000000000002 110.363 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.589 ' O ' HG13 ' A' ' 35' ' ' ILE . 47.9 t -89.93 118.96 29.89 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.167 -0.679 . . . . 74.109999999999999 109.167 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.491 ' HB3' HD23 ' A' ' 60' ' ' LEU . . . -50.94 -41.9 59.36 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.173 0.989 . . . . 75.010000000000005 113.157 -176.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.2 t -77.34 -32.34 55.11 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.221 0.534 . . . . 65.439999999999998 110.24 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.0 -37.53 84.35 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.825 -1.176 . . . . 75.319999999999993 107.825 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 31' ' ' SER . 71.7 mt -64.45 -39.77 86.74 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 CA-C-N 114.587 -1.188 . . . . 64.310000000000002 110.611 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.88 -38.9 62.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.982 0.42 . . . . 73.200000000000003 111.463 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 -40.81 66.7 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 107.262 -1.384 . . . . 73.329999999999998 107.262 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 49.6 t-80 -57.96 -54.09 50.87 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.16 0.984 . . . . 71.540000000000006 110.916 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 35' ' ' ILE . 29.6 m -66.38 -30.92 51.37 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 N-CA-C 113.255 0.835 . . . . 75.209999999999994 113.255 -178.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -49.55 -44.06 46.36 Favored 'General case' 0 C--O 1.243 0.745 0 O-C-N 123.609 0.568 . . . . 63.140000000000001 110.708 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.0 t70 177.65 -78.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.703 0.801 . . . . 63.549999999999997 110.647 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -101.52 143.64 31.27 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.269 -0.641 . . . . 63.509999999999998 109.269 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 35.4 p90 -77.63 142.29 66.0 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.121 -0.49 . . . . 75.430000000000007 112.022 -174.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.11 -48.56 6.18 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.879 3.053 . . . . 71.519999999999996 115.507 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 94.1 mmm 69.26 -71.42 0.12 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.857 0.863 . . . . 72.329999999999998 111.872 -173.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -157.38 -164.11 1.51 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 105.579 -2.008 . . . . 70.329999999999998 105.579 -175.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 28.6 p-90 -82.14 83.16 7.43 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 119.971 1.26 . . . . 75.120000000000005 110.313 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.02 -54.59 0.16 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.334 -1.303 . . . . 54.420000000000002 108.75 -175.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.06 -72.58 0.27 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 108.876 -0.787 . . . . 63.539999999999999 108.876 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -140.65 89.75 2.29 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.965 -0.383 . . . . 55.329999999999998 109.965 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 165.85 142.06 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 126.203 1.801 . . . . 74.430000000000007 107.266 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.416 ' CG1' ' HA ' ' A' ' 95' ' ' PRO . 5.7 p -148.35 -59.1 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 111.696 0.258 . . . . 73.120000000000005 111.696 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.2 t -154.87 78.28 1.05 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 119.828 -0.749 . . . . 74.319999999999993 111.95 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.2 t -178.53 104.31 0.2 Allowed Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 115.855 -0.612 . . . . 73.310000000000002 110.532 174.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -81.62 -15.97 9.43 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.024 1.816 . . . . 75.319999999999993 110.803 175.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -65.49 -17.31 64.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.287 -0.87 . . . . 70.400000000000006 111.703 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' A' ' 91' ' ' ARG . 2.2 pp -80.46 -13.31 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 116.379 -0.373 . . . . 71.040000000000006 111.972 -178.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.6 mp -87.44 100.65 12.91 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 110.015 -0.365 . . . . 70.0 110.015 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 39.2 mmt180 -137.14 148.43 46.63 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.641 -0.503 . . . . 73.150000000000006 109.641 177.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.73 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 4.4 pp -130.92 139.71 50.11 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 110.115 -0.328 . . . . 74.310000000000002 110.115 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 87' ' ' HIS . 79.0 mt -112.75 119.65 60.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.288 0.566 . . . . 62.420000000000002 109.535 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -102.0 73.88 1.42 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.662 -1.236 . . . . 71.209999999999994 107.662 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 58.61 86.05 0.09 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 113.344 -1.753 . . . . 75.129999999999995 112.085 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.11 -56.59 0.6 Allowed Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.677 -0.692 . . . . 36.840000000000003 114.02 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -117.52 153.98 32.25 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.667 0.988 . . . . 75.230000000000004 113.667 -172.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.589 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 93.3 m-85 -82.91 117.15 22.55 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 108.443 -0.947 . . . . 75.510000000000005 108.443 176.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.523 HD11 HD21 ' A' ' 76' ' ' LEU . 81.8 mt -80.73 -47.98 13.2 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.288 -0.965 . . . . 71.109999999999999 112.749 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.73 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.5 t-80 -170.01 167.33 9.0 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 105.909 -1.885 . . . . 74.219999999999999 105.909 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.52 -1.28 87.83 Favored Glycine 0 C--N 1.3 -1.425 0 N-CA-C 115.785 1.074 . . . . 74.329999999999998 115.785 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -164.9 22.75 0.06 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.255 1.026 . . . . 72.239999999999995 110.442 -170.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.424 HG13 HD21 ' A' ' 60' ' ' LEU . 9.0 p -79.53 136.88 22.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 119.419 -0.912 . . . . 74.430000000000007 109.031 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.604 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 42.7 p -78.7 158.49 28.31 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.424 -0.353 . . . . 55.350000000000001 111.658 -173.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.493 ' H ' HD23 ' A' ' 73' ' ' LEU . 1.9 mm? -64.07 -27.08 68.86 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.106 -0.497 . . . . 64.400000000000006 110.897 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.26 -38.43 95.1 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.352 -1.099 . . . . 71.329999999999998 110.352 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.29 -16.81 57.39 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.194 0.521 . . . . 53.030000000000001 110.096 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 72' ' ' THR . 86.9 mt -86.24 4.41 38.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.918 -0.583 . . . . 72.409999999999997 111.33 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER 68.88 25.3 6.17 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.947 0.899 . . . . 75.319999999999993 113.254 177.641 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.403 HD22 ' HB3' ' A' ' 73' ' ' LEU . 10.2 mp -72.76 123.53 89.66 Favored Pre-proline 0 C--O 1.236 0.384 0 C-N-CA 120.083 -0.647 . . . . 64.040000000000006 111.322 175.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -80.2 146.96 18.15 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.444 2.096 . . . . 65.329999999999998 111.088 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -73.73 141.94 46.34 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.191 -1.04 . . . . 72.340000000000003 108.191 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.484 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 82.01 -3.92 78.07 Favored Glycine 0 C--N 1.3 -1.435 0 C-N-CA 120.735 -0.745 . . . . 53.119999999999997 113.521 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -116.13 145.64 42.9 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 117.163 0.481 . . . . 73.150000000000006 111.463 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.42 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 23.5 m -85.19 125.1 32.57 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.967 -0.56 . . . . 73.519999999999996 110.99 -177.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.1 m -125.09 135.9 53.13 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.977 -0.556 . . . . 73.420000000000002 109.508 176.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.43 137.8 31.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.352 -0.385 . . . . 73.129999999999995 110.889 -178.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 82.8 mtp -138.69 153.45 48.54 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 120.902 0.382 . . . . 52.229999999999997 111.325 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.45 ' O ' ' HB ' ' A' ' 61' ' ' ILE . 25.6 m-70 -103.93 129.27 51.46 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 107.229 -1.397 . . . . 71.319999999999993 107.229 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.431 HD23 ' C ' ' A' ' 87' ' ' HIS . 2.8 mm? -123.9 140.19 53.23 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 119.66 -0.816 . . . . 75.140000000000001 110.681 -176.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.417 ' CG2' ' HB2' ' A' ' 59' ' ' ARG . 25.2 m -118.7 133.68 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.829 0 CA-C-O 121.711 0.767 . . . . 74.439999999999998 109.445 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.5 135.2 44.31 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 105.108 -2.182 . . . . 65.439999999999998 105.108 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.526 ' C ' ' H ' ' A' ' 93' ' ' THR . 82.0 mtt180 -106.22 151.67 24.49 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 106.635 -1.617 . . . . 64.439999999999998 106.635 -176.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -63.26 17.37 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 115.032 1.493 . . . . 55.240000000000002 115.032 -174.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.526 ' H ' ' C ' ' A' ' 91' ' ' ARG . 27.1 m 69.44 153.37 0.11 Allowed 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.181 1.792 . . . . 70.120000000000005 112.612 175.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.4 tp -108.04 132.66 20.9 Favored Pre-proline 0 N--CA 1.424 -1.752 0 N-CA-C 105.137 -2.172 . . . . 62.140000000000001 105.137 174.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.416 ' HA ' ' CG1' ' A' ' 52' ' ' VAL . 51.6 Cg_endo -74.4 -15.28 22.42 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.279 1.986 . . . . 70.340000000000003 114.145 -174.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -163.41 152.8 12.56 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 108.649 -0.871 . . . . 73.129999999999995 108.649 -175.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.07 -59.09 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.082 1.855 . . . . 72.209999999999994 110.781 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.4 t30 179.48 76.04 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.066 0.546 . . . . 75.310000000000002 110.825 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.9 m 42.9 35.92 0.8 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.139 1.376 . . . . 54.119999999999997 114.034 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -85.1 -16.78 39.42 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.561 0.696 . . . . 72.099999999999994 109.205 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.44 12.04 76.54 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 109.905 -1.278 . . . . 74.450000000000003 109.905 -177.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -114.57 144.25 43.69 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.013 -0.594 . . . . 70.209999999999994 109.737 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 104' ' ' ASN . 15.3 ptt-85 -147.17 -172.25 3.96 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.984 -1.487 . . . . 75.540000000000006 106.984 -177.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.551 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 79.5 m-20 -66.03 136.52 56.14 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.077 -1.453 . . . . 74.409999999999997 107.077 172.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.44 ' HD2' ' HB2' ' A' ' 110' ' ' GLU . 25.0 mmt180 -59.98 -36.15 76.53 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 122.017 0.913 . . . . 74.430000000000007 109.022 -176.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 173.89 -57.92 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 102.514 -3.143 . . . . 73.409999999999997 102.514 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -156.62 -46.47 0.07 Allowed 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 102.996 -2.964 . . . . 73.540000000000006 102.996 170.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.6 p -143.03 -168.43 2.79 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 112.949 -1.932 . . . . 73.230000000000004 106.613 172.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 131.99 -76.39 0.41 Allowed Glycine 0 CA--C 1.494 -1.281 0 C-N-CA 120.024 -1.084 . . . . 75.239999999999995 111.698 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.44 ' HB2' ' HD2' ' A' ' 105' ' ' ARG . 1.8 mp0 -84.47 -18.01 37.26 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 121.739 0.78 . . . . 74.319999999999993 109.521 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.4 t -161.51 155.26 21.84 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 106.496 -1.668 . . . . 71.030000000000001 106.496 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -143.17 125.0 15.07 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.725 -1.213 . . . . 71.230000000000004 107.725 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 t -82.14 101.85 10.69 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.517 0.675 . . . . 72.420000000000002 111.914 -175.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 12.5 p -72.89 124.57 25.68 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 108.106 -1.072 . . . . 64.510000000000005 108.106 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.6 m -64.9 121.79 14.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.269 0.556 . . . . 63.43 111.736 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 30.8 pt -80.82 156.02 4.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.714 -0.676 . . . . 71.239999999999995 110.727 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.9 tp . . . . . 0 C--N 1.292 -1.915 0 N-CA-C 108.546 -0.909 . . . . 64.5 108.546 -179.324 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.2 p . . . . . 0 C--O 1.251 1.14 0 N-CA-C 110.355 -0.239 . . . . 63.299999999999997 110.355 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.5 m 65.69 16.87 10.69 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.361 0.874 . . . . 54.310000000000002 113.361 173.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -147.09 107.65 4.11 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.151 -0.685 . . . . 74.230000000000004 109.151 176.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.484 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 17.7 t -107.74 123.03 39.11 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 110.087 -0.338 . . . . 72.409999999999997 110.087 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.44 ' C ' ' H ' ' A' ' 8' ' ' ASP . 3.4 Cg_exo -75.07 162.69 36.54 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.204 1.936 . . . . 74.230000000000004 111.05 175.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.88 36.85 0.63 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.864 0.84 . . . . 53.219999999999999 109.597 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 6' ' ' PRO . 27.1 t70 -133.72 -19.13 2.1 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.632 -1.167 . . . . 70.219999999999999 109.446 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.2 mmm -124.29 150.68 45.12 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.641 -0.708 . . . . 71.409999999999997 110.07 -174.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -101.61 139.09 23.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.998 -0.742 . . . . 74.120000000000005 108.998 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.418 HD21 HG23 ' A' ' 83' ' ' THR . 6.0 t30 -96.69 114.39 26.03 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.234 -1.024 . . . . 74.540000000000006 108.234 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.429 ' HG ' HD22 ' A' ' 14' ' ' LEU . 44.4 tp -120.16 133.46 55.49 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 112.586 0.587 . . . . 74.349999999999994 112.586 -172.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 49.1 ttt180 -108.47 120.71 43.21 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 108.443 -0.947 . . . . 75.310000000000002 108.443 174.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.56 ' CB ' HG23 ' A' ' 39' ' ' VAL . 2.3 mm? -98.53 122.29 41.54 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-N 114.531 -1.213 . . . . 64.230000000000004 109.605 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.491 HG21 HG21 ' A' ' 21' ' ' THR . 22.1 mt -112.22 125.46 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.635 -0.876 . . . . 74.310000000000002 108.635 177.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -94.47 161.57 14.17 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 116.323 -0.399 . . . . 73.040000000000006 110.884 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.405 ' CG1' HG11 ' A' ' 89' ' ' VAL . 28.6 m -60.5 -14.67 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.4 0.68 . . . . 65.439999999999998 112.757 179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.1 m -79.79 -7.16 58.5 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 116.199 -0.455 . . . . 61.409999999999997 110.351 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.55 0.54 81.92 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 116.265 -0.425 . . . . 60.299999999999997 112.598 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -87.67 133.93 33.74 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.237 -0.653 . . . . 75.439999999999998 109.237 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.491 HG21 HG21 ' A' ' 15' ' ' ILE . 40.2 p -116.73 131.87 56.84 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 109.585 -0.524 . . . . 75.439999999999998 109.585 -177.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' A' ' 39' ' ' VAL . 63.8 mttp -129.32 139.97 51.56 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 110.022 -0.362 . . . . 64.409999999999997 110.022 174.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 27.2 tt0 -125.09 130.0 51.37 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.257 -0.646 . . . . 72.409999999999997 109.257 -177.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.584 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 95.8 m-85 -146.14 160.52 41.82 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 122.946 0.498 . . . . 74.420000000000002 111.081 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.2 mt -82.57 126.28 32.11 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.503 -0.555 . . . . 71.129999999999995 109.503 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.584 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 95.5 m-85 -132.58 166.1 22.89 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.115 -1.068 . . . . 62.229999999999997 108.115 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.4 p -89.71 150.46 44.11 Favored Pre-proline 0 N--CA 1.418 -2.054 0 N-CA-C 108.194 -1.039 . . . . 65.129999999999995 108.194 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.32 -11.68 17.26 Favored 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 122.59 2.194 . . . . 63.210000000000001 112.287 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -91.72 -9.81 42.41 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.582 0.753 . . . . 72.319999999999993 111.221 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -71.15 154.09 41.99 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.147 0.499 . . . . 72.239999999999995 111.409 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.517 ' O ' HG13 ' A' ' 35' ' ' ILE . 49.9 m -95.11 121.23 36.53 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.76 -0.655 . . . . 72.150000000000006 110.425 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -49.22 -42.66 41.15 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.207 1.003 . . . . 60.210000000000001 113.088 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 5.8 p -73.06 -34.13 66.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.895 0.379 . . . . 63.130000000000003 112.008 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.4 -47.12 80.41 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.03 -1.1 . . . . 75.310000000000002 108.03 175.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.545 ' O ' HG22 ' A' ' 39' ' ' VAL . 68.6 mt -59.67 -46.24 93.52 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.379 0 CA-C-N 114.342 -1.299 . . . . 72.319999999999993 110.683 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.45 -46.6 56.72 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.438 0.695 . . . . 72.140000000000001 111.742 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.527 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 7.6 tmtt? -73.28 -33.63 65.32 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.736 -0.839 . . . . 54.439999999999998 108.736 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -66.2 -51.97 52.56 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.196 0.998 . . . . 60.350000000000001 110.734 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.56 HG23 ' CB ' ' A' ' 14' ' ' LEU . 27.7 m -65.29 -30.22 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.744 0.817 . . . . 74.140000000000001 111.509 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.527 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 64.9 t80 -47.61 -48.18 28.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.303 -0.862 . . . . 65.230000000000004 111.861 175.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -173.36 -49.16 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.71 0.767 . . . . 74.129999999999995 111.013 -178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -142.84 152.68 42.42 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.884 -1.053 . . . . 75.140000000000001 109.918 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -65.52 136.9 96.31 Favored Pre-proline 0 C--N 1.317 -0.835 0 O-C-N 123.42 0.45 . . . . 60.32 110.596 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.444 ' HA ' ' OD1' ' A' ' 46' ' ' ASP . 9.4 Cg_endo -56.08 101.87 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.646 2.231 . . . . 72.019999999999996 113.529 178.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 23.4 ptp -112.67 7.04 18.55 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 105.823 -1.918 . . . . 75.310000000000002 105.823 176.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.444 ' OD1' ' HA ' ' A' ' 44' ' ' PRO . 3.1 m-20 -74.87 168.76 19.27 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 112.159 -2.291 . . . . 61.210000000000001 110.567 -174.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -99.18 4.76 46.87 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.837 -0.62 . . . . 74.420000000000002 111.016 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 62.88 20.9 12.51 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 123.046 1.403 . . . . 74.310000000000002 108.751 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -124.45 126.35 45.78 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.064 -1.426 . . . . 75.530000000000001 109.776 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -144.88 112.76 6.34 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 105.865 -1.902 . . . . 73.129999999999995 105.865 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 76.25 -50.98 0.6 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.159 1.383 . . . . 73.420000000000002 108.754 -172.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.9 p -155.11 158.91 3.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 106.936 -1.505 . . . . 74.349999999999994 106.936 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.2 m -54.93 106.96 0.25 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.971 0.508 . . . . 73.540000000000006 109.897 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 m -136.6 98.08 11.16 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-O 120.871 0.367 . . . . 61.439999999999998 110.739 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.33 -16.46 10.81 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 C-N-CA 122.334 2.023 . . . . 74.209999999999994 112.739 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -70.45 -5.69 30.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.576 0.584 . . . . 41.340000000000003 112.576 -175.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 90' ' ' ALA . 2.4 pp -80.72 -14.14 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-O 120.681 0.277 . . . . 75.519999999999996 110.965 177.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.412 ' HG ' HD12 ' A' ' 57' ' ' ILE . 83.2 mt -111.2 103.08 11.47 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.693 -0.484 . . . . 74.340000000000003 109.693 176.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -137.28 144.67 42.81 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.024 -1.102 . . . . 71.349999999999994 108.024 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -109.38 147.0 33.5 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 113.959 1.096 . . . . 72.409999999999997 113.959 178.314 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -117.53 119.51 61.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.214 -1.032 . . . . 65.420000000000002 108.214 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.524 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 11.8 t80 -100.33 90.95 4.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.74 -1.207 . . . . 73.329999999999998 107.74 176.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 71.96 -70.3 0.16 Allowed 'General case' 0 N--CA 1.401 -2.913 0 C-N-CA 127.05 2.14 . . . . 73.019999999999996 112.392 -176.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.9 -47.75 1.07 Allowed Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 119.877 -1.154 . . . . 62.25 115.196 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -124.19 170.34 10.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 118.049 0.924 . . . . 72.409999999999997 112.991 -172.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 73.7 m-85 -83.7 118.33 23.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.742 -0.836 . . . . 74.129999999999995 108.742 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.524 ' CD1' ' HB3' ' A' ' 62' ' ' TYR . 7.0 mp -80.77 -45.96 16.17 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 113.553 0.945 . . . . 72.349999999999994 113.553 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -168.84 172.27 7.89 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 106.774 -1.565 . . . . 51.420000000000002 106.774 -173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.44 -1.51 87.85 Favored Glycine 0 C--N 1.306 -1.126 0 N-CA-C 111.783 -0.527 . . . . 75.329999999999998 111.783 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -175.92 80.93 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.497 -1.297 . . . . 75.420000000000002 107.497 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 p -104.93 151.7 7.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.546 -1.279 . . . . 72.040000000000006 107.546 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.2 p -91.17 158.11 16.81 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 118.232 0.469 . . . . 73.530000000000001 110.203 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.466 ' H ' HD21 ' A' ' 73' ' ' LEU . 1.9 mm? -69.32 -30.63 68.73 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.04 0.447 . . . . 62.240000000000002 110.642 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.1 -35.02 91.51 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.187 -0.765 . . . . 72.409999999999997 111.187 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.03 -15.7 63.05 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.2 0.6 . . . . 36.609999999999999 111.282 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 65.2 mt -85.11 -1.6 57.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 73.420000000000002 110.158 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 8.8 mptt 63.41 72.34 0.48 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.359 1.064 . . . . 55.149999999999999 109.375 -177.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.435 HD11 ' HB3' ' A' ' 73' ' ' LEU . 87.7 mt -125.17 117.74 25.43 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 115.479 -0.782 . . . . 71.329999999999998 111.423 -175.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.67 152.12 64.36 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.403 2.068 . . . . 74.230000000000004 110.147 172.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -75.92 148.39 38.26 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.734 -0.839 . . . . 73.230000000000004 108.734 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.484 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 91.99 -10.79 73.71 Favored Glycine 0 C--N 1.296 -1.671 0 C-N-CA 119.744 -1.217 . . . . 63.240000000000002 113.043 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -101.23 138.98 37.53 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.148 0.499 . . . . 75.299999999999997 111.884 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.418 HG23 HD21 ' A' ' 11' ' ' ASN . 35.1 m -79.88 118.46 21.66 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.201 -0.909 . . . . 73.239999999999995 109.94 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.7 m -116.78 129.42 56.09 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.921 -0.581 . . . . 64.019999999999996 109.55 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -104.89 140.36 23.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.905 -0.405 . . . . 70.299999999999997 109.905 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 92.4 mtp -138.23 153.58 49.11 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 120.869 0.366 . . . . 75.319999999999993 111.042 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.4 ' C ' HD22 ' A' ' 88' ' ' LEU . 88.3 m-70 -106.59 129.6 54.49 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.077 -1.083 . . . . 75.120000000000005 108.077 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.463 ' N ' HD22 ' A' ' 88' ' ' LEU . 2.0 mm? -122.6 139.34 54.04 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 122.126 -0.359 . . . . 55.109999999999999 110.447 -175.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.405 HG11 ' CG1' ' A' ' 17' ' ' VAL . 29.1 m -116.87 132.48 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 C-N-CA 119.892 -0.723 . . . . 64.530000000000001 109.721 176.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 57' ' ' ILE . . . -134.58 142.52 46.97 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.789 -1.189 . . . . 70.109999999999999 107.789 176.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.3 mtm105 -136.56 151.35 49.29 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.969 -0.382 . . . . 75.219999999999999 109.969 -174.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 46.43 62.09 2.46 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 125.076 1.485 . . . . 64.239999999999995 110.835 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.8 m -73.8 136.16 43.54 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-N 113.807 -1.542 . . . . 52.439999999999998 110.204 -175.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.57 154.47 93.15 Favored Pre-proline 0 C--N 1.308 -1.22 0 CA-C-N 115.849 -0.614 . . . . 70.519999999999996 110.585 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -51.6 135.02 47.99 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 123.206 2.604 . . . . 74.129999999999995 112.548 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.39 156.35 68.71 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 114.866 -1.061 . . . . 73.25 109.268 -175.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.75 -56.27 1.83 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.273 1.982 . . . . 72.239999999999995 110.997 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -163.75 14.94 0.06 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.555 -1.276 . . . . 71.439999999999998 107.555 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 26.3 t 54.32 79.64 0.13 Allowed 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.202 -1.363 . . . . 64.200000000000003 110.709 -172.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -87.39 -48.08 8.26 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.652 -0.703 . . . . 63.43 110.273 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.97 15.06 59.81 Favored Glycine 0 N--CA 1.465 0.623 0 CA-C-N 116.049 -0.523 . . . . 73.109999999999999 112.999 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -137.43 149.19 46.71 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.676 -1.231 . . . . 74.530000000000001 107.676 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -101.71 134.7 44.46 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.702 -1.592 . . . . 72.319999999999993 106.702 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -132.71 143.04 49.35 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.795 -0.762 . . . . 75.510000000000005 109.178 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -61.43 -50.98 70.62 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.166 -0.925 . . . . 75.450000000000003 110.075 -176.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 176.08 140.9 0.06 Allowed 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.435 0.694 . . . . 74.040000000000006 109.361 -174.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 60.3 pttt 54.31 8.41 0.19 Allowed 'General case' 0 N--CA 1.507 2.409 0 C-N-CA 126.979 2.112 . . . . 64.450000000000003 114.905 174.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.6 m 65.43 26.36 11.91 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-O 122.977 1.37 . . . . 62.329999999999998 109.519 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.14 69.98 0.33 Allowed Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 108.324 -1.91 . . . . 71.319999999999993 108.324 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.69 -177.19 0.73 Allowed 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 115.461 1.652 . . . . 65.430000000000007 115.461 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.3 m -67.02 99.45 0.65 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.679 -1.146 . . . . 74.040000000000006 110.866 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.96 135.62 0.37 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.384 1.074 . . . . 65.140000000000001 108.656 177.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 53.7 t -139.92 -60.36 0.54 Allowed 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.626 -0.509 . . . . 50.140000000000001 109.626 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 52.6 t -153.1 120.83 6.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.756 -0.831 . . . . 74.150000000000006 108.756 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.8 p -70.99 96.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 122.013 0.911 . . . . 75.049999999999997 110.75 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.5 tt -103.95 112.31 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-N 115.409 -0.814 . . . . 54.240000000000002 109.769 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.279 0.9 OUTLIER . . . . . 0 C--N 1.3 -1.563 0 CA-C-O 118.075 -0.964 . . . . 65.420000000000002 113.287 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.4 t . . . . . 0 N--CA 1.428 -1.559 0 N-CA-C 108.319 -0.993 . . . . 65.14 108.319 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -72.52 156.13 54.34 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.077 1.851 . . . . 71.54 111.012 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.57 7.2 1.14 Allowed 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.671 0.989 . . . . 44.13 113.671 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -109.24 -6.06 15.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.644 -0.502 . . . . 74.21 109.644 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.4 mmm -130.19 154.51 47.47 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.237 0.541 . . . . 71.24 110.543 -172.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.48 HG22 ' HA ' ' A' ' 80' ' ' PHE . 2.7 pp -115.92 131.12 69.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.946 -0.57 . . . . 62.51 110.072 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.554 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 48.2 t-20 -84.57 114.5 22.02 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.039 -1.467 . . . . 71.24 107.039 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.495 ' HG ' HD22 ' A' ' 14' ' ' LEU . 41.7 tp -121.32 133.17 55.11 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.946 0.721 . . . . 62.44 112.946 -172.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.447 ' HE ' ' HB ' ' A' ' 21' ' ' THR . 75.5 ttt180 -108.57 121.39 44.9 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 115.14 -0.937 . . . . 64.41 108.737 174.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.529 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.2 mm? -99.37 120.27 39.31 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.885 -1.052 . . . . 62.42 108.612 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.476 HG23 HG22 ' A' ' 21' ' ' THR . 32.1 mt -107.33 122.88 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 108.451 -0.944 . . . . 75.11 108.451 177.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.59 160.48 18.17 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 116.384 -0.371 . . . . 63.41 110.346 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.7 t -58.66 -26.15 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.643 0.777 . . . . 74.43 111.569 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -76.43 -6.09 50.2 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.768 -0.651 . . . . 64.33 111.214 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.08 6.74 66.51 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.502 -0.856 . . . . 65.34 112.032 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -87.61 131.41 34.43 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.045 -0.724 . . . . 75.44 109.045 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.476 HG22 HG23 ' A' ' 15' ' ' ILE . 68.5 p -111.44 129.77 55.92 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 120.364 -0.534 . . . . 71.03 110.276 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.64 139.77 53.57 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.482 -1.303 . . . . 72.45 107.482 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -133.58 130.61 38.64 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.927 -1.109 . . . . 71.21 109.285 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.673 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.6 m-85 -145.17 160.35 41.58 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 123.526 0.73 . . . . 63.54 109.299 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.1 tp -84.09 125.7 32.37 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.689 -1.226 . . . . 64.12 107.689 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.673 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 82.4 m-85 -127.81 168.47 15.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.05 0.453 . . . . 55.43 111.022 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.461 ' HB2' ' OD2' ' A' ' 30' ' ' ASP . 20.4 m -92.87 140.53 23.59 Favored Pre-proline 0 N--CA 1.424 -1.774 0 N-CA-C 108.366 -0.976 . . . . 70.51 108.366 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.464 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 27.3 Cg_endo -60.01 -18.79 52.42 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.632 2.221 . . . . 61.34 113.267 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -81.35 -11.76 59.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.208 -0.451 . . . . 60.22 111.197 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' A' ' 27' ' ' SER . 22.0 m-20 -78.99 153.76 30.06 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.836 -0.54 . . . . 74.23 111.751 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.471 ' O ' HG13 ' A' ' 35' ' ' ILE . 25.8 p -95.35 131.31 41.6 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.111 0.481 . . . . 74.22 111.521 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.713 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -51.93 -41.83 62.33 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 124.262 1.025 . . . . 62.2 113.706 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.7 p -74.86 -30.95 61.49 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.471 0.545 . . . . 72.13 112.471 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -69.08 -42.48 76.13 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 107.402 -1.333 . . . . 74.32 107.402 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.511 HG23 ' CZ ' ' A' ' 26' ' ' PHE . 67.0 mt -60.97 -43.61 96.36 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.216 0 CA-C-N 114.175 -1.375 . . . . 53.41 110.745 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.72 -42.6 57.36 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.086 0.555 . . . . 74.44 111.874 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.596 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -72.14 -39.77 68.55 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.078 -1.452 . . . . 71.02 107.078 -178.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -61.87 -45.74 92.46 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.612 -0.722 . . . . 74.12 110.97 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 14' ' ' LEU . 26.8 m -71.61 -31.99 44.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 112.693 0.627 . . . . 73.15 112.693 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 . . . . . 0 N--CA 1.482 1.132 0 O-C-N 123.127 0.267 . . . . 71.14 111.471 173.13 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 CA--C 1.502 -0.902 0 N-CA-C 108.715 -0.846 . . . . 72.0 108.715 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.5 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 83.0 mtp180 -138.26 162.3 34.67 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.174 0.511 . . . . 74.21 109.892 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.713 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.5 pp -123.12 135.54 54.41 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 115.603 -0.726 . . . . 71.1 110.727 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 85.7 mt -110.45 123.32 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 N-CA-C 108.48 -0.933 . . . . 70.51 108.48 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -100.91 50.27 0.87 Allowed 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 106.649 -1.612 . . . . 74.34 106.649 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 60.69 93.5 0.04 OUTLIER 'General case' 0 N--CA 1.394 -3.243 0 C-N-CA 127.6 2.36 . . . . 72.21 112.168 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.99 -29.42 10.01 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.236 -0.893 . . . . 72.23 112.848 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -130.51 137.76 49.9 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.972 0.731 . . . . 72.4 112.972 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -88.6 113.67 24.42 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 106.293 -1.743 . . . . 74.23 106.293 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.559 HD12 ' CD2' ' A' ' 76' ' ' LEU 0.258 29.1 mt -79.16 -43.54 23.74 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 117.936 -1.506 . . . . 73.12 112.471 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.669 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.6 t-80 -173.82 -175.62 1.1 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.552 -1.277 . . . . 71.33 107.552 176.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -85.03 -14.16 70.07 Favored Glycine 0 C--N 1.302 -1.347 0 N-CA-C 115.743 1.057 . . . . 43.02 115.743 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -167.64 28.08 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 118.192 0.996 . . . . 64.5 109.846 -172.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.561 HG12 HD21 ' A' ' 60' ' ' LEU . 11.9 p -74.67 147.63 8.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.265 -0.643 . . . . 73.55 109.265 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.573 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 45.7 p -78.77 158.4 28.25 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 112.419 0.526 . . . . 72.24 112.419 -173.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.52 HD13 HD12 ' A' ' 76' ' ' LEU . 3.6 mm? -60.02 -41.38 92.04 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.413 0.685 . . . . 73.14 111.862 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.57 -37.99 94.24 Favored Glycine 0 C--N 1.317 -0.521 0 N-CA-C 111.36 -0.696 . . . . 54.13 111.36 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.439 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -74.88 -16.04 60.69 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 122.798 0.439 . . . . 53.32 111.547 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 72' ' ' THR . 62.7 mt -83.77 -4.7 58.85 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.252 -0.647 . . . . 63.01 109.252 177.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.6 mptt 71.28 79.55 0.16 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.69 1.196 . . . . 74.3 111.297 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 73' ' ' LEU . 10.8 mp -123.47 117.11 27.94 Favored Pre-proline 0 CA--C 1.494 -1.192 0 CA-C-N 115.526 -0.761 . . . . 75.1 111.474 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.513 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 11.0 Cg_exo -64.11 122.85 10.98 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 121.728 1.618 . . . . 75.33 109.197 171.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.48 ' HA ' HG22 ' A' ' 10' ' ' ILE . 1.1 p90 -69.77 144.44 52.69 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.338 0.589 . . . . 74.14 112.171 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.38 9.05 60.71 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.087 -0.96 . . . . 65.42 113.157 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -132.01 163.87 27.45 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 117.863 0.831 . . . . 75.34 110.622 176.373 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.554 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 25.7 m -91.66 129.37 37.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.407 0.622 . . . . 53.13 111.361 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.6 m -122.23 133.37 54.71 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.834 -0.621 . . . . 74.41 110.292 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.2 p -104.57 139.34 25.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 109.887 -0.412 . . . . 71.33 109.887 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 85.7 mtp -138.25 153.49 49.08 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-O 121.009 0.433 . . . . 54.33 111.079 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.484 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 59.1 m-70 -111.26 126.84 55.31 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.609 -1.256 . . . . 53.15 107.609 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.4 mm? -113.47 142.2 46.2 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 122.156 -0.34 . . . . 44.43 110.201 -176.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.84 134.01 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 121.223 0.535 . . . . 74.05 111.009 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 107.983 -1.118 . . . . 73.31 107.983 176.515 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.4 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 29.3 t . . . . . 0 N--CA 1.43 -1.438 0 N-CA-C 108.631 -0.877 . . . . 53.13 108.631 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -63.52 166.42 15.44 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.22 1.947 . . . . 71.41 112.197 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.46 11.74 20.74 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.607 -0.724 . . . . 64.32 109.491 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -121.72 -3.67 9.24 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.174 -0.921 . . . . 73.53 108.582 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.7 mmm -126.93 152.32 47.29 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.925 -0.768 . . . . 74.44 108.925 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -111.88 139.37 36.65 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 N-CA-C 109.275 -0.639 . . . . 71.35 109.275 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.596 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 54.4 t-20 -88.17 116.28 26.26 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.923 -1.14 . . . . 55.15 107.923 -176.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.502 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.7 tp -127.36 132.99 50.1 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 121.156 0.503 . . . . 74.05 112.185 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.409 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 35.2 ttp180 -109.6 120.65 43.14 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 108.561 -0.903 . . . . 70.53 108.561 174.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.547 ' CB ' HG21 ' A' ' 39' ' ' VAL . 1.8 mm? -100.23 120.71 40.32 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 114.591 -1.186 . . . . 75.41 108.677 -178.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.463 HG23 HG22 ' A' ' 21' ' ' THR . 23.2 mt -104.36 123.01 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 108.811 -0.811 . . . . 73.5 108.811 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.39 165.0 20.66 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.632 -0.713 . . . . 74.33 110.745 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.6 t -65.18 -21.07 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-O 121.887 0.851 . . . . 43.42 109.399 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.6 m -76.03 -4.45 41.35 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.45 1.1 . . . . 53.11 111.418 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.26 6.93 88.97 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.805 -0.918 . . . . 51.23 110.805 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -87.89 131.14 34.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.283 -1.006 . . . . 64.24 108.283 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.463 HG22 HG23 ' A' ' 15' ' ' ILE . 80.5 p -111.31 129.32 56.03 Favored 'General case' 0 N--CA 1.417 -2.096 0 C-N-CA 120.269 -0.572 . . . . 72.4 109.562 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 39' ' ' VAL . 95.8 mttt -131.66 139.31 49.05 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.282 -1.007 . . . . 73.11 108.282 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.409 ' HG3' ' HB2' ' A' ' 13' ' ' ARG . 30.1 tt0 -130.43 131.1 45.06 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.774 -0.77 . . . . 62.1 109.617 -175.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.676 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.2 m-85 -144.9 159.7 42.48 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 122.795 0.438 . . . . 62.34 109.83 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.45 126.47 32.26 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.624 -1.25 . . . . 63.23 107.624 174.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.676 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 90.1 m-85 -127.36 163.47 23.92 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.572 -0.529 . . . . 74.24 109.572 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.7 p -85.33 147.35 46.96 Favored Pre-proline 0 N--CA 1.41 -2.439 0 N-CA-C 107.741 -1.207 . . . . 73.11 107.741 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.494 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 55.6 Cg_endo -62.31 -11.36 22.16 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.803 2.335 . . . . 72.51 111.712 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -86.6 -15.87 38.48 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.29 -0.868 . . . . 71.22 111.242 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -71.76 153.74 41.78 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.15 0.5 . . . . 61.43 111.245 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.438 ' O ' HG13 ' A' ' 35' ' ' ILE . 19.4 m -96.52 129.46 43.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.006 -1.109 . . . . 71.3 108.006 177.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.805 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -51.03 -38.27 50.37 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.637 0.977 . . . . 74.02 113.637 -176.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 p -77.62 -29.05 51.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.132 0.492 . . . . 53.22 111.93 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.99 -41.58 82.08 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.907 -1.516 . . . . 63.32 106.907 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.48 HG23 ' CZ ' ' A' ' 26' ' ' PHE . 70.5 mt -64.13 -42.63 96.17 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.472 0 CA-C-N 113.715 -1.584 . . . . 74.53 110.43 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.406 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.01 -40.15 43.71 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 123.173 0.589 . . . . 74.41 111.842 175.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.83 -31.17 64.6 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.441 0.638 . . . . 74.55 110.323 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -74.13 -47.9 32.98 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.207 -0.906 . . . . 65.55 110.009 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.547 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.4 m -71.37 -32.1 45.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.923 -0.485 . . . . 72.24 111.9 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 63.7 t80 . . . . . 0 C--O 1.246 0.888 0 N-CA-C 108.508 -0.923 . . . . 73.22 108.508 177.997 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 N--CA 1.445 -0.722 0 N-CA-C 109.506 -0.553 . . . . 63.42 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.413 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 98.7 mtt180 -140.29 142.73 35.67 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.828 -0.804 . . . . 72.24 108.828 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.805 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.5 pp -126.05 138.9 53.75 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.052 0.453 . . . . 72.42 111.451 -176.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.467 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 90.1 mt -108.96 119.91 59.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 108.456 -0.942 . . . . 55.32 108.456 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -101.3 75.59 1.64 Allowed 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.353 -1.351 . . . . 75.22 107.353 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.0 tm0? 36.78 85.68 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.77 0 C-N-CA 127.587 2.355 . . . . 53.04 113.23 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.87 -57.29 0.62 Allowed Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 115.447 -0.797 . . . . 75.11 113.156 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -130.07 159.66 36.09 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 112.627 0.603 . . . . 71.13 112.627 -176.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 33.1 m-85 -89.35 112.82 24.01 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.926 -1.138 . . . . 74.42 107.926 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.507 HD12 HD22 ' A' ' 76' ' ' LEU . 83.5 mt -80.2 -47.19 15.06 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 113.547 0.943 . . . . 65.14 113.547 -175.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.642 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.4 t-80 -165.33 174.74 9.8 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 106.614 -1.624 . . . . 74.33 106.614 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.11 -1.88 88.37 Favored Glycine 0 C--N 1.307 -1.067 0 C-N-CA 120.261 -0.971 . . . . 31.22 114.396 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -175.72 28.16 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 117.822 0.811 . . . . 73.35 112.221 -173.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.583 HG12 HD21 ' A' ' 60' ' ' LEU . 13.0 p -70.24 142.68 15.51 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 C-N-CA 120.46 -0.496 . . . . 73.24 109.808 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.457 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 31.8 p -78.54 157.67 28.75 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.852 -0.613 . . . . 44.03 111.836 -175.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.575 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.8 mm? -66.25 -32.87 74.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.406 -0.361 . . . . 61.42 110.784 -177.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.04 -36.38 92.82 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 111.178 -0.769 . . . . 75.22 111.178 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.406 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -73.97 -15.27 61.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.12 0.568 . . . . 73.54 110.893 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.507 HD22 HD12 ' A' ' 67' ' ' LEU . 73.4 mt -82.79 14.87 2.94 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.675 0.39 . . . . 72.14 111.226 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.6 24.1 10.21 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.759 0.824 . . . . 64.04 110.619 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.476 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 96.2 mt -91.8 125.14 58.32 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 112.511 0.56 . . . . 73.0 112.511 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 3.5 Cg_endo -86.35 170.3 8.08 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.846 2.364 . . . . 73.11 110.484 172.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.494 ' CE2' ' HG3' ' A' ' 28' ' ' PRO . 75.2 m-85 -78.7 151.35 32.21 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.781 -0.451 . . . . 75.41 109.781 -178.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.4 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 82.93 0.96 90.59 Favored Glycine 0 C--N 1.308 -1.022 0 C-N-CA 120.668 -0.777 . . . . 73.23 114.232 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -102.37 136.45 42.18 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 117.509 0.655 . . . . 65.31 110.021 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.596 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 54.6 m -87.19 116.78 25.49 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.006 -0.739 . . . . 71.35 109.006 176.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.3 m -115.81 142.43 46.77 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.55 -0.75 . . . . 53.41 110.471 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -111.45 135.59 50.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 120.793 0.33 . . . . 73.32 110.354 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 87.0 mtp -138.35 153.24 48.97 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 120.862 0.363 . . . . 63.41 110.276 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.467 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 21.5 m-70 -111.59 132.7 54.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.989 -1.115 . . . . 74.3 107.989 178.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.465 HD21 HD12 ' A' ' 14' ' ' LEU . 2.5 mm? -119.47 144.53 46.93 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 120.614 -0.434 . . . . 65.35 111.113 -176.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 59' ' ' ARG . 26.7 m -120.52 134.94 62.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.8 -0.636 . . . . 74.04 109.43 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.496 0 CA-C-N 115.878 -0.601 . . . . 73.14 109.788 -176.967 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.409 HG13 HD22 ' A' ' 25' ' ' LEU . 16.8 t . . . . . 0 N--CA 1.432 -1.341 0 N-CA-C 108.676 -0.861 . . . . 72.23 108.676 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -72.01 143.24 40.14 Favored 'Trans proline' 0 C--O 1.251 1.159 0 C-N-CA 121.889 1.726 . . . . 73.01 110.421 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.81 72.14 4.33 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 121.996 0.903 . . . . 70.21 109.821 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.422 ' H ' ' H ' ' A' ' 9' ' ' MET . 27.8 t70 -169.11 -28.18 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 113.612 -1.631 . . . . 75.31 107.727 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.422 ' H ' ' H ' ' A' ' 8' ' ' ASP . 92.9 mmm -117.52 145.73 44.03 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.819 -1.082 . . . . 71.22 109.128 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.471 HG22 ' HA ' ' A' ' 80' ' ' PHE . 2.8 pp -99.31 136.06 32.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 109.208 -0.664 . . . . 73.44 109.208 175.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.457 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 16.8 t-20 -91.93 107.69 19.39 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.7 -1.222 . . . . 63.31 107.7 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.504 ' HG ' HD22 ' A' ' 14' ' ' LEU . 43.5 tp -112.77 132.77 55.09 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 116.055 -0.52 . . . . 61.43 111.723 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -106.82 121.51 44.55 Favored 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 108.291 -1.003 . . . . 73.44 108.291 173.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.551 ' CB ' HG21 ' A' ' 39' ' ' VAL . 1.7 mm? -98.74 128.61 45.04 Favored 'General case' 0 C--N 1.268 -2.947 0 CA-C-N 114.258 -1.337 . . . . 62.31 109.353 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.487 HD12 HG22 ' A' ' 21' ' ' THR . 14.8 mm -107.47 119.33 56.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 107.744 -1.206 . . . . 73.25 107.744 175.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.7 tp -84.09 153.05 23.99 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 110.058 -0.349 . . . . 72.5 110.058 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.49 ' CG1' ' HA ' ' A' ' 89' ' ' VAL . 30.7 m -60.0 -13.36 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.829 0.851 . . . . 63.11 113.059 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.413 ' HB3' ' HD3' ' A' ' 20' ' ' LYS . 16.3 t -89.53 -2.78 58.46 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.275 -0.639 . . . . 64.32 109.275 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.21 7.93 79.19 Favored Glycine 0 C--N 1.337 0.583 0 CA-C-N 115.922 -0.581 . . . . 33.24 112.597 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HD3' ' HB3' ' A' ' 18' ' ' SER . 12.3 mptt -87.78 131.05 34.65 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.345 -0.983 . . . . 73.24 108.345 176.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.487 HG22 HD12 ' A' ' 15' ' ' ILE . 63.1 p -107.46 143.65 35.52 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.538 -0.912 . . . . 72.12 108.538 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 48.5 tptt -145.08 147.23 32.33 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.595 -0.842 . . . . 75.54 109.155 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -137.06 131.09 32.27 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 119.713 -0.795 . . . . 65.53 110.201 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.737 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 84.6 m-85 -145.14 160.97 40.6 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 123.888 0.875 . . . . 63.31 110.387 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.412 HD23 HD21 ' A' ' 11' ' ' ASN . 97.3 mt -79.7 126.02 30.4 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.634 -1.247 . . . . 53.33 107.634 171.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.737 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 83.6 m-85 -130.68 164.45 25.0 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.37 -0.974 . . . . 74.32 108.37 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.5 p -90.1 150.3 43.13 Favored Pre-proline 0 N--CA 1.42 -1.947 0 N-CA-C 107.747 -1.205 . . . . 61.44 107.747 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.428 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 28.7 Cg_endo -60.11 -14.75 30.19 Favored 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 122.044 1.829 . . . . 71.53 112.077 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -87.15 -9.68 54.64 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.892 -0.595 . . . . 62.22 110.545 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -76.02 154.01 36.06 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.81 -0.556 . . . . 71.53 111.193 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.532 ' O ' HG13 ' A' ' 35' ' ' ILE . 41.0 m -96.52 121.59 38.5 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 109.649 -0.5 . . . . 55.14 109.649 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.503 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -49.2 -52.5 26.38 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.115 1.524 . . . . 71.24 115.115 -173.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 14.4 m -79.46 -20.01 48.43 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 121.823 -0.548 . . . . 70.43 111.465 -175.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.87 -41.46 78.34 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.14 -1.8 . . . . 75.22 106.14 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 31' ' ' SER . 73.3 mt -62.79 -34.68 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 114.034 -1.439 . . . . 75.23 110.749 175.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 40' ' ' TYR . . . -52.94 -32.9 48.26 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 122.442 0.297 . . . . 55.51 111.577 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.551 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -72.91 -38.13 66.99 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 107.154 -1.425 . . . . 73.43 107.154 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 43.0 t-80 -62.95 -54.02 44.99 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.897 0.879 . . . . 72.31 110.747 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.551 HG21 ' CB ' ' A' ' 14' ' ' LEU . 26.8 m -68.22 -29.98 46.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.023 -0.989 . . . . 75.24 112.411 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 64.3 t80 . . . . . 0 N--CA 1.469 0.481 0 C-N-CA 124.278 1.031 . . . . 74.11 111.09 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.547 ' O ' HD12 ' A' ' 58' ' ' LEU 0.257 3.5 pp . . . . . 0 N--CA 1.429 -1.504 0 CA-C-O 121.973 0.892 . . . . 71.33 111.995 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.425 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 97.4 mtt180 -142.61 163.15 33.61 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.53 -1.213 . . . . 65.45 109.899 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 4.1 pp -129.16 142.39 50.89 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.178 0.807 . . . . 73.35 113.178 -173.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.7 mt -117.56 124.41 73.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 114.907 -1.042 . . . . 51.02 108.359 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.465 ' CD2' HD11 ' A' ' 67' ' ' LEU . 1.8 t80 -101.32 60.87 0.92 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 122.038 0.923 . . . . 74.32 109.629 -176.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 63.91 17.39 10.52 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 113.902 -1.499 . . . . 73.22 112.488 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.39 -65.96 0.01 OUTLIER Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 120.734 -0.746 . . . . 72.14 112.031 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -130.49 176.03 8.49 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.822 0.344 . . . . 72.2 110.583 -177.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 85.8 m-85 -86.84 120.96 28.68 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.465 -1.309 . . . . 74.21 107.465 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.575 ' CD1' HD22 ' A' ' 76' ' ' LEU . 76.5 mt -80.1 -47.07 15.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.747 0.784 . . . . 71.4 109.915 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -163.11 -173.46 3.43 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 125.602 1.561 . . . . 74.43 107.771 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -84.34 -37.3 11.11 Favored Glycine 0 N--CA 1.416 -2.688 0 C-N-CA 120.499 -0.858 . . . . 53.32 113.72 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.406 ' OD1' ' HB3' ' A' ' 31' ' ' SER . 64.3 t30 -160.22 39.12 0.18 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.312 1.053 . . . . 72.21 108.961 -172.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.586 HG12 HD21 ' A' ' 60' ' ' LEU . 7.6 p -66.2 147.42 12.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-N 114.593 -1.185 . . . . 74.14 110.023 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.557 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 42.4 p -78.55 156.91 28.96 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 116.21 -0.45 . . . . 70.43 111.408 -175.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.461 ' H ' HD22 ' A' ' 73' ' ' LEU . 2.5 mm? -66.34 -30.76 71.23 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.517 0.562 . . . . 63.01 112.517 -176.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.48 -30.37 76.41 Favored Glycine 0 C--O 1.229 -0.167 0 N-CA-C 111.192 -0.763 . . . . 63.3 111.192 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.31 -15.51 60.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.371 0.605 . . . . 73.12 109.961 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.575 HD22 ' CD1' ' A' ' 67' ' ' LEU . 61.2 mt -92.84 11.95 25.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.425 -0.807 . . . . 72.52 111.834 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.532 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.6 mptt 67.74 19.27 9.7 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.539 0.736 . . . . 61.55 110.975 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.433 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 79.4 mt -83.66 122.14 76.51 Favored Pre-proline 0 N--CA 1.441 -0.918 0 CA-C-N 116.03 -0.532 . . . . 63.35 110.895 -177.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.455 ' HG2' ' HG3' ' A' ' 82' ' ' LYS . 6.6 Cg_endo -83.71 140.21 9.15 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 122.227 1.951 . . . . 74.2 111.708 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.471 ' HA ' HG22 ' A' ' 10' ' ' ILE . 4.8 p90 -70.44 141.97 52.04 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 112.596 0.591 . . . . 75.4 112.596 177.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.85 -1.17 70.73 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.759 -1.109 . . . . 74.33 111.599 -174.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.455 ' HG3' ' HG2' ' A' ' 79' ' ' PRO . 31.7 mmmt -108.36 158.04 17.85 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.82 0.343 . . . . 73.0 110.41 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.457 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 86.5 m -103.69 125.22 50.03 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.666 -0.697 . . . . 73.22 110.077 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.0 m -133.64 142.76 48.22 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.127 -0.488 . . . . 74.32 110.402 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.4 132.62 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 121.066 0.46 . . . . 54.13 110.688 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 90.4 mtp -136.17 153.43 51.26 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.153 0.502 . . . . 74.31 111.395 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -103.05 132.88 48.99 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.648 -0.705 . . . . 75.3 109.413 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.407 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.4 mm? -120.04 142.38 48.89 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.125 -0.694 . . . . 74.44 109.125 -176.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.49 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 35.2 m -116.78 133.76 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 C-N-CA 119.932 -0.707 . . . . 73.43 110.994 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.547 0 N-CA-C 105.909 -1.885 . . . . 53.05 105.909 175.524 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.569 HG21 ' HB2' ' A' ' 11' ' ' ASN . 10.8 t . . . . . 0 N--CA 1.426 -1.664 0 N-CA-C 109.077 -0.712 . . . . 41.31 109.077 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -69.81 152.02 68.95 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.025 1.817 . . . . 75.52 110.646 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.47 72.23 4.98 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-O 122.462 1.125 . . . . 74.34 109.162 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -170.65 -28.41 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 112.784 -2.007 . . . . 71.34 107.566 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.6 mmm -113.87 160.67 18.5 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.05 -0.977 . . . . 55.3 108.734 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -121.79 139.58 48.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.189 -0.671 . . . . 62.44 109.189 173.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.569 ' HB2' HG21 ' A' ' 5' ' ' VAL . 43.5 t-20 -94.02 110.78 22.45 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.785 -1.191 . . . . 64.42 107.785 -177.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.478 ' HG ' HD22 ' A' ' 14' ' ' LEU . 46.2 tp -115.9 132.91 56.51 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.826 -0.625 . . . . 75.25 112.069 -174.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -111.36 121.27 44.79 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 114.994 -1.003 . . . . 54.44 109.018 173.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.592 ' CB ' HG21 ' A' ' 39' ' ' VAL . 1.9 mm? -98.6 121.4 40.5 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.825 -1.08 . . . . 75.0 108.316 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.1 mt -102.95 127.15 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 C-N-CA 119.586 -0.846 . . . . 74.1 109.642 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -83.8 155.51 22.97 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.44 -0.8 . . . . 72.35 110.24 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.3 m -64.12 -19.11 24.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 122.893 0.477 . . . . 70.42 111.898 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.437 ' HB2' ' HG2' ' A' ' 20' ' ' LYS . 20.2 m -80.95 1.93 28.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.21 0.529 . . . . 74.35 110.424 177.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.08 12.75 82.11 Favored Glycine 0 CA--C 1.501 -0.803 0 N-CA-C 111.804 -0.518 . . . . 73.42 111.804 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.437 ' HG2' ' HB2' ' A' ' 18' ' ' SER . 74.1 mmtt -88.63 135.77 33.33 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.035 -1.469 . . . . 74.3 107.035 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.6 p -112.67 129.28 56.45 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 119.801 -0.76 . . . . 73.52 109.88 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -122.93 137.53 54.92 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.939 -1.134 . . . . 74.43 107.939 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -138.13 131.65 30.79 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.755 -0.778 . . . . 70.12 110.08 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.653 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 89.3 m-85 -145.5 160.14 42.05 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 123.933 0.893 . . . . 73.22 109.011 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.1 mt -79.57 125.5 29.68 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 107.065 -1.457 . . . . 65.41 107.065 170.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.653 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 87.8 m-85 -123.8 163.16 21.76 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.927 -1.138 . . . . 63.31 107.927 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 84.7 p -87.62 148.47 44.07 Favored Pre-proline 0 C--N 1.288 -2.095 0 N-CA-C 108.226 -1.027 . . . . 73.21 108.226 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.98 -14.87 35.42 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.252 1.968 . . . . 44.3 111.355 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -82.9 -17.8 42.46 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.066 -0.97 . . . . 73.14 110.281 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.431 ' O ' HD22 ' A' ' 73' ' ' LEU . 18.1 m-20 -67.95 154.61 41.23 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.009 0.433 . . . . 63.11 110.666 176.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.552 ' O ' HG13 ' A' ' 35' ' ' ILE . 51.1 m -105.13 129.53 53.51 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 116.039 -0.528 . . . . 74.21 110.536 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.807 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -49.86 -50.22 46.4 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.007 1.484 . . . . 54.31 115.007 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m -76.14 -27.15 56.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.284 0.493 . . . . 73.13 110.676 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.89 -45.55 91.98 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.239 -1.393 . . . . 60.41 107.239 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 31' ' ' SER . 66.1 mt -65.18 -42.49 94.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 114.348 -1.296 . . . . 74.22 110.657 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.419 ' O ' ' HD1' ' A' ' 40' ' ' TYR . . . -50.07 -50.08 49.24 Favored 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 122.856 0.462 . . . . 75.35 111.154 175.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -64.4 -38.44 91.03 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 108.142 -1.058 . . . . 73.04 108.142 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.496 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 35.3 t-80 -61.21 -54.26 46.45 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 114.844 -1.071 . . . . 72.34 110.706 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.592 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.1 m -69.97 -32.17 50.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 115.756 -0.656 . . . . 72.52 112.264 -178.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.419 ' HD1' ' O ' ' A' ' 36' ' ' ALA . 11.7 m-85 . . . . . 0 C--O 1.235 0.33 0 N-CA-C 112.764 0.653 . . . . 74.15 112.764 174.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 CA--C 1.5 -0.962 0 N-CA-C 109.195 -0.668 . . . . 32.5 109.195 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.42 ' HD3' ' HA2' ' A' ' 69' ' ' GLY . 18.4 mmt180 -140.77 155.06 46.5 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.081 -0.711 . . . . 75.34 109.081 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.807 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.3 pp -135.39 144.47 46.59 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.395 -0.821 . . . . 75.44 110.189 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.459 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 98.7 mt -117.34 122.45 69.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 108.708 -0.849 . . . . 63.44 108.708 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -100.97 87.94 3.41 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.906 -1.516 . . . . 74.43 106.906 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 69.55 -64.94 0.32 Allowed 'General case' 0 N--CA 1.408 -2.527 0 C-N-CA 127.409 2.283 . . . . 63.04 112.401 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.47 -43.88 0.62 Allowed Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.205 -0.997 . . . . 74.4 113.712 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.85 162.26 18.4 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 115.049 1.5 . . . . 65.03 115.049 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.625 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 38.4 m-85 -84.19 117.5 23.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.018 -0.992 . . . . 72.31 108.335 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.504 HD12 ' CD2' ' A' ' 76' ' ' LEU . 66.4 mt -80.18 -47.2 15.07 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 114.6 1.333 . . . . 71.34 114.6 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.404 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 66.7 t-80 -165.83 167.31 16.99 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.138 -1.43 . . . . 71.0 107.138 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.42 ' HA2' ' HD3' ' A' ' 59' ' ' ARG . . . -63.99 -19.08 63.11 Favored Glycine 0 C--O 1.209 -1.435 0 N-CA-C 114.187 0.435 . . . . 74.42 114.187 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.424 ' OD1' ' HB3' ' A' ' 31' ' ' SER . 65.3 t30 177.88 80.36 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 108.864 -0.791 . . . . 72.22 108.864 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.715 HG12 HD21 ' A' ' 60' ' ' LEU . 9.1 p -102.55 151.34 6.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.028 -0.73 . . . . 70.34 109.028 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.492 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 55.1 p -78.51 157.64 28.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.598 0.237 . . . . 74.0 111.172 -178.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.518 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.9 mm? -67.74 -32.43 73.03 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 120.715 0.293 . . . . 72.4 110.766 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.62 -41.22 99.84 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.672 -0.971 . . . . 44.34 110.672 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -68.99 -15.84 63.58 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.099 0.56 . . . . 43.22 111.269 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.624 ' HB2' HD13 ' A' ' 78' ' ' LEU . 87.1 mt -82.52 -1.6 50.98 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.852 0.461 . . . . 74.23 110.105 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.5 mptt 69.77 57.56 0.31 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.331 1.052 . . . . 64.25 110.551 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.624 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.3 mp -109.52 124.2 34.47 Favored Pre-proline 0 C--N 1.304 -1.382 0 CA-C-N 115.382 -0.826 . . . . 75.44 110.41 175.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 4.6 Cg_exo -76.17 154.48 37.13 Favored 'Trans proline' 0 N--CA 1.432 -2.09 0 C-N-CA 121.608 1.539 . . . . 54.22 108.883 173.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -72.74 154.41 40.69 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.048 -0.723 . . . . 73.43 109.048 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 75.91 10.65 85.04 Favored Glycine 0 C--N 1.304 -1.228 0 C-N-CA 120.802 -0.713 . . . . 62.2 113.04 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -110.62 153.57 25.0 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.638 -0.504 . . . . 62.24 109.638 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.558 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 56.9 m -104.98 129.74 53.34 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.347 -0.612 . . . . 62.41 109.347 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.8 m -138.72 142.26 38.9 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.119 0.485 . . . . 64.32 110.928 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.9 p -109.56 142.39 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 115.672 -0.695 . . . . 51.23 110.374 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 91.1 mtp -135.78 153.88 51.4 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 120.987 0.422 . . . . 62.35 110.403 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.469 ' C ' HD22 ' A' ' 88' ' ' LEU . 82.4 m-70 -106.02 131.25 53.54 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.925 -1.139 . . . . 74.22 107.925 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.469 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.5 mm? -122.85 143.91 49.55 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.578 -0.449 . . . . 73.12 110.781 -176.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.74 137.0 52.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 121.051 0.453 . . . . 73.22 110.682 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.41 0 CA-C-N 115.6 -0.727 . . . . 55.33 109.046 178.877 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.5 HG21 ' HB2' ' A' ' 11' ' ' ASN . 3.7 t . . . . . 0 N--CA 1.436 -1.147 0 N-CA-C 110.664 -0.124 . . . . 32.01 110.664 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -74.9 165.28 31.72 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.674 2.249 . . . . 72.14 110.585 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.83 68.57 10.52 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 122.013 0.911 . . . . 75.15 110.179 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.41 ' H ' ' H ' ' A' ' 9' ' ' MET . 27.9 t70 -167.44 -30.03 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 113.66 -1.609 . . . . 75.24 107.929 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.41 ' H ' ' H ' ' A' ' 8' ' ' ASP . 90.5 mmm -105.41 158.57 16.56 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.472 -1.24 . . . . 72.15 109.312 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -119.32 140.12 44.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 109.313 -0.625 . . . . 74.53 109.313 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 53.4 t-20 -90.93 112.7 24.68 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.897 -1.149 . . . . 73.24 107.897 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.484 ' HG ' HD22 ' A' ' 14' ' ' LEU . 35.4 tp -117.29 132.96 56.5 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.44 0.638 . . . . 75.42 112.578 -174.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.414 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . 26.5 ttt85 -106.95 121.44 44.44 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 115.12 -0.945 . . . . 63.14 108.853 174.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.546 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.2 mm? -99.48 120.87 40.33 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.209 -0.905 . . . . 72.33 108.884 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.57 HD12 HG22 ' A' ' 21' ' ' THR . 23.4 mm -99.49 116.71 43.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 107.118 -1.438 . . . . 74.42 107.118 177.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.46 167.45 21.82 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 123.292 0.37 . . . . 73.33 111.693 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -67.61 -28.64 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.746 0.784 . . . . 63.41 110.242 -176.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -76.79 4.43 9.7 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.144 -0.935 . . . . 45.53 111.454 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.65 10.32 86.29 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 111.672 -0.571 . . . . 72.4 111.672 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -91.53 131.8 36.71 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.717 -0.846 . . . . 72.41 108.717 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.57 HG22 HD12 ' A' ' 15' ' ' ILE . 59.8 p -104.91 135.03 47.02 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 116.572 -0.285 . . . . 74.53 110.286 -175.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -142.46 139.61 31.63 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.266 -1.013 . . . . 74.15 108.266 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -134.44 132.57 39.49 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.016 -0.674 . . . . 63.21 111.55 -171.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.611 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 90.7 m-85 -144.99 160.81 40.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.161 0.584 . . . . 73.42 110.881 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.4 mt -79.36 126.6 31.02 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.306 -0.998 . . . . 45.33 108.306 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.611 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 78.4 m-85 -127.35 161.57 28.34 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.104 0.478 . . . . 73.21 110.411 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.502 ' HB2' ' OD2' ' A' ' 30' ' ' ASP . 31.4 m -84.71 137.05 38.62 Favored Pre-proline 0 N--CA 1.411 -2.386 0 N-CA-C 107.951 -1.129 . . . . 73.32 107.951 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.438 ' O ' ' HB ' ' A' ' 72' ' ' THR . 30.4 Cg_endo -60.18 -14.55 29.53 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.083 2.522 . . . . 70.43 113.878 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -85.89 -8.17 58.22 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.017 0.377 . . . . 74.13 112.017 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.502 ' OD2' ' HB2' ' A' ' 27' ' ' SER . 11.8 m-20 -79.28 153.71 29.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.736 0.303 . . . . 65.43 111.078 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.445 ' O ' HG13 ' A' ' 35' ' ' ILE . 67.2 m -95.03 124.35 39.02 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.509 -0.314 . . . . 55.31 110.492 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.718 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -49.32 -41.34 38.24 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.563 1.145 . . . . 74.12 113.782 -177.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 p -71.48 -32.78 68.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.023 0.439 . . . . 75.03 111.872 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.68 -42.25 82.42 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.098 -1.075 . . . . 75.03 108.098 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.46 ' O ' HG22 ' A' ' 39' ' ' VAL . 68.7 mt -60.9 -43.18 95.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.011 -1.449 . . . . 71.3 110.906 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.456 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -51.0 -41.89 60.05 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.504 0.721 . . . . 60.54 112.106 176.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.504 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -72.59 -33.78 66.96 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 107.153 -1.425 . . . . 71.44 107.153 -177.742 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -70.09 -50.97 35.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.362 1.065 . . . . 74.53 111.789 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.546 HG21 ' CB ' ' A' ' 14' ' ' LEU . 30.6 m -68.05 -31.47 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 113.35 0.87 . . . . 44.13 113.35 -177.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.6 t80 . . . . . 0 N--CA 1.468 0.47 0 O-C-N 124.061 0.85 . . . . 63.54 112.288 -177.73 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.413 ' C ' ' HD3' ' A' ' 59' ' ' ARG . 96.9 mt . . . . . 0 N--CA 1.44 -0.927 0 N-CA-C 110.359 -0.237 . . . . 23.31 110.359 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.461 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -137.97 148.84 45.6 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 109.75 -0.463 . . . . 62.25 109.75 172.76 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.718 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.5 pp -120.45 131.6 54.84 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 115.462 -0.79 . . . . 54.32 110.341 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 88.0 mt -103.14 124.3 57.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.507 0 N-CA-C 107.522 -1.288 . . . . 63.12 107.522 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -99.65 84.79 3.0 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 106.252 -1.759 . . . . 75.53 106.252 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 66.58 -65.64 0.2 Allowed 'General case' 0 N--CA 1.405 -2.7 0 C-N-CA 127.58 2.352 . . . . 75.12 111.724 -175.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.25 -14.48 2.97 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 120.859 -0.686 . . . . 60.31 114.747 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.492 ' H ' ' HD2' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -122.92 148.0 45.96 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 118.612 1.206 . . . . 73.41 110.826 -178.262 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -84.36 111.59 19.57 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.559 -1.274 . . . . 73.52 107.559 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.629 HD12 HD22 ' A' ' 76' ' ' LEU . 59.5 mt -81.18 -46.99 14.03 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 114.404 1.261 . . . . 70.05 114.404 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.694 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.0 t-80 -171.65 176.17 3.79 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.925 -1.509 . . . . 61.0 106.925 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -85.71 -1.07 87.56 Favored Glycine 0 C--N 1.3 -1.44 0 N-CA-C 115.867 1.107 . . . . 74.22 115.867 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -169.39 19.32 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 118.429 1.115 . . . . 71.32 111.935 -170.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.574 HG12 HD21 ' A' ' 60' ' ' LEU . 11.3 p -74.92 146.74 9.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 120.653 -0.419 . . . . 55.32 110.223 -175.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.482 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 38.6 p -78.88 157.85 28.22 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.743 -0.662 . . . . 75.22 111.292 -175.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.576 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.2 mm? -66.4 -34.97 79.16 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.473 -0.33 . . . . 62.31 110.752 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.33 -35.06 90.38 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.556 -0.83 . . . . 70.31 111.281 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -75.42 -16.45 60.35 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 122.796 0.438 . . . . 72.11 111.404 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.629 HD22 HD12 ' A' ' 67' ' ' LEU . 45.4 mt -82.87 1.93 36.87 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.129 -0.693 . . . . 70.11 109.129 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.94 74.32 0.14 Allowed 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.08 1.352 . . . . 54.35 111.356 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.468 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.5 mp -127.33 112.13 21.31 Favored Pre-proline 0 CA--C 1.497 -1.067 0 CA-C-N 115.302 -0.863 . . . . 71.24 111.49 176.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.28 154.46 72.1 Favored 'Trans proline' 0 N--CA 1.445 -1.337 0 C-N-CA 122.08 1.853 . . . . 52.34 108.011 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -69.48 144.25 53.28 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.181 -0.674 . . . . 72.34 109.181 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.42 9.98 68.72 Favored Glycine 0 C--N 1.305 -1.155 0 C-N-CA 119.892 -1.147 . . . . 35.05 113.347 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -101.55 138.2 38.86 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 117.374 0.587 . . . . 74.13 110.342 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.641 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 58.8 m -92.13 117.51 29.92 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.872 -1.159 . . . . 75.13 107.872 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.0 m -130.68 135.91 48.29 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.083 -0.508 . . . . 64.15 111.229 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.414 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 7.7 p -102.14 138.46 26.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 116.065 -0.516 . . . . 74.45 111.453 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.537 ' O ' HG12 ' A' ' 15' ' ' ILE . 86.1 mtp -134.46 152.07 51.56 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.96 -0.385 . . . . 71.24 109.96 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 23.1 m-70 -108.13 132.02 54.04 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.098 -1.075 . . . . 53.33 108.098 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.5 mm? -116.9 141.88 47.65 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 120.366 -0.534 . . . . 64.14 111.016 -176.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.62 132.65 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 CA-C-N 115.863 -0.608 . . . . 62.22 109.773 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.267 0 CA-C-N 115.824 -0.625 . . . . 51.4 109.513 179.648 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.428 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 15.1 t . . . . . 0 N--CA 1.423 -1.798 0 N-CA-C 107.91 -1.144 . . . . 65.35 107.91 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -69.71 151.22 69.3 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 122.298 1.999 . . . . 64.23 111.888 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.65 69.9 6.04 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 122.061 0.934 . . . . 43.23 109.949 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.409 ' H ' ' H ' ' A' ' 9' ' ' MET . 31.0 t70 -173.47 -21.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.386 -1.733 . . . . 60.32 107.672 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.409 ' H ' ' H ' ' A' ' 8' ' ' ASP . 94.2 mmm -118.26 160.11 22.18 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.892 -1.049 . . . . 73.11 108.968 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -125.11 137.91 56.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.843 -0.799 . . . . 73.54 108.843 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.4 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 9.1 t-20 -92.06 107.73 19.42 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.713 -1.217 . . . . 72.3 107.713 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.55 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.5 tp -111.11 133.1 53.74 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.656 -0.702 . . . . 71.01 112.559 -171.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.422 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 35.9 ttp180 -109.5 121.03 44.29 Favored 'General case' 0 N--CA 1.414 -2.244 0 CA-C-N 115.195 -0.911 . . . . 75.11 109.008 174.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.581 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.0 mm? -101.45 126.71 48.27 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-N 114.462 -1.245 . . . . 63.34 108.504 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 21' ' ' THR . 26.0 mt -104.32 127.31 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 C-N-CA 119.379 -0.928 . . . . 73.21 109.477 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.14 156.87 20.85 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.365 -0.606 . . . . 74.52 109.365 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.52 -13.01 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.474 0.546 . . . . 75.11 112.474 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.8 t -76.1 -12.15 60.06 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.717 0.77 . . . . 74.42 109.06 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.13 -3.28 64.24 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.677 -0.569 . . . . 65.23 111.677 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.1 134.74 33.69 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.731 0.3 . . . . 74.05 110.332 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 15' ' ' ILE . 67.5 p -98.61 150.11 22.08 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 121.193 0.521 . . . . 64.13 110.753 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.447 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -132.4 138.44 47.69 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.027 -1.471 . . . . 71.23 107.027 174.255 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HG3' ' HB2' ' A' ' 13' ' ' ARG . 27.0 tt0 -137.68 129.65 28.83 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.072 -1.084 . . . . 70.54 108.072 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.694 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 97.3 m-85 -145.91 159.41 43.27 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.905 -0.776 . . . . 73.31 108.905 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.0 tp -83.19 124.92 31.0 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 106.862 -1.533 . . . . 70.45 106.862 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.694 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 94.2 m-85 -129.52 163.6 25.59 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.76 -0.83 . . . . 71.2 108.76 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.8 p -87.79 145.1 36.1 Favored Pre-proline 0 N--CA 1.41 -2.443 0 N-CA-C 107.339 -1.356 . . . . 74.41 107.339 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.553 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 26.6 Cg_endo -61.62 -11.63 21.17 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 122.329 2.02 . . . . 62.31 112.37 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.88 -7.27 49.77 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 109.364 -0.606 . . . . 65.14 109.364 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -71.9 154.09 41.45 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 122.087 -0.383 . . . . 75.1 110.09 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.532 ' O ' HG13 ' A' ' 35' ' ' ILE . 8.3 p -94.77 121.4 36.32 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-O 121.04 0.448 . . . . 54.31 111.445 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.417 ' CB ' HD22 ' A' ' 60' ' ' LEU . . . -46.0 -51.68 13.11 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.178 1.548 . . . . 72.21 115.178 -174.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.532 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 18.7 m -78.16 -20.69 51.48 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.633 -0.827 . . . . 71.13 112.502 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -69.25 -42.44 75.61 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 106.45 -1.685 . . . . 61.31 106.45 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.534 ' O ' HG22 ' A' ' 39' ' ' VAL . 61.3 mt -62.29 -40.21 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.473 -1.239 . . . . 72.43 110.055 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.402 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.31 -43.96 53.9 Favored 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 123.051 0.54 . . . . 73.41 111.332 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.515 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 1.7 tmtp? -72.83 -37.91 67.29 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.898 -0.778 . . . . 74.24 108.898 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -56.87 -50.75 71.53 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.419 -0.81 . . . . 73.33 109.971 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.581 HG21 ' CB ' ' A' ' 14' ' ' LEU . 29.5 m -73.29 -32.38 37.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.629 -0.714 . . . . 64.4 111.129 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.0 t80 . . . . . 0 CA--C 1.519 -0.224 0 C-N-CA 123.555 0.742 . . . . 75.31 110.755 176.263 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 2.1 pt? . . . . . 0 CA--C 1.488 -1.431 0 N-CA-C 107.109 -1.441 . . . . 64.11 107.109 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 38.5 ptt180 -131.45 159.78 37.07 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-O 121.847 0.832 . . . . 65.3 112.828 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.647 HD21 HG12 ' A' ' 71' ' ' VAL . 4.4 pp -115.4 146.72 41.33 Favored 'General case' 0 N--CA 1.407 -2.585 0 CA-C-N 114.657 -1.156 . . . . 62.24 112.349 -171.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 94.9 mt -116.67 122.79 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.637 0 CA-C-N 114.351 -1.295 . . . . 72.54 107.773 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -100.16 89.42 4.01 Favored 'General case' 0 C--N 1.263 -3.18 0 N-CA-C 105.667 -1.975 . . . . 62.42 105.667 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 69.94 -70.05 0.16 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.325 -1.761 . . . . 73.25 112.717 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.47 2.44 3.46 Favored Glycine 0 C--N 1.313 -0.73 0 C-N-CA 119.94 -1.124 . . . . 74.44 113.043 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -130.72 140.94 50.37 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.121 0.415 . . . . 65.2 112.121 -176.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -83.59 113.82 21.09 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.464 -1.309 . . . . 75.3 107.464 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.611 HD12 HD22 ' A' ' 76' ' ' LEU . 60.8 mt -79.79 -46.21 17.38 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 119.48 -0.888 . . . . 65.03 112.733 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.552 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 50.2 t-80 -169.9 169.71 8.1 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 104.091 -2.559 . . . . 60.01 104.091 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -63.67 -47.13 89.56 Favored Glycine 0 C--O 1.201 -1.966 0 C-N-CA 120.185 -1.007 . . . . 64.24 113.589 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.453 ' OD1' ' HB2' ' A' ' 31' ' ' SER . 10.2 t30 -152.58 72.0 0.96 Allowed 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 122.348 1.07 . . . . 61.05 109.517 -172.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.647 HG12 HD21 ' A' ' 60' ' ' LEU . 7.2 p -101.62 151.29 5.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 113.617 -1.629 . . . . 73.34 108.079 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.458 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 42.0 p -78.12 158.73 29.0 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.677 0.275 . . . . 71.44 111.406 -175.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.59 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.2 mm? -68.27 -32.72 73.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.365 -0.38 . . . . 72.53 111.146 -176.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.19 -36.95 93.88 Favored Glycine 0 C--O 1.24 0.507 0 N-CA-C 110.743 -0.943 . . . . 72.43 110.743 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.464 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -71.48 -15.43 62.32 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.011 0.524 . . . . 74.21 110.835 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.611 HD22 HD12 ' A' ' 67' ' ' LEU . 86.5 mt -82.58 6.31 18.05 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.402 0.681 . . . . 71.35 110.237 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 77.03 10.94 2.47 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.824 1.249 . . . . 52.45 111.828 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.606 HD13 ' HB2' ' A' ' 76' ' ' LEU . 9.6 mp -72.37 119.26 73.89 Favored Pre-proline 0 C--O 1.24 0.565 0 N-CA-C 112.95 0.722 . . . . 74.43 112.95 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 4.3 Cg_exo -76.85 159.41 34.63 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.022 2.481 . . . . 65.43 109.75 173.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.41 ' CE1' ' HG3' ' A' ' 28' ' ' PRO . 7.6 m-85 -77.25 156.73 31.24 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.388 -0.597 . . . . 73.43 109.388 -176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.428 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 79.55 10.19 86.11 Favored Glycine 0 C--N 1.308 -0.973 0 C-N-CA 120.896 -0.669 . . . . 74.51 113.546 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -115.62 155.81 26.98 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 120.798 0.332 . . . . 44.51 111.414 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.4 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 84.1 m -105.2 125.89 51.48 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.761 -0.654 . . . . 74.21 109.266 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.3 m -136.34 142.2 43.82 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.905 0.383 . . . . 75.33 111.85 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.47 142.2 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.031 -0.531 . . . . 51.41 110.744 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 93.0 mtp -137.0 153.26 50.71 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.276 0.56 . . . . 74.13 110.949 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.481 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 35.0 m-70 -111.56 130.8 55.62 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.773 -1.566 . . . . 61.52 106.773 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.2 mm? -119.12 143.49 47.15 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.635 -0.426 . . . . 70.41 111.249 -174.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.88 134.24 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.503 -0.554 . . . . 54.41 109.503 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.635 0 N-CA-C 109.717 -0.475 . . . . 54.2 109.717 177.409 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 11' ' ' ASN . 2.0 t . . . . . 0 N--CA 1.407 -2.602 0 N-CA-C 110.605 -0.146 . . . . 75.43 110.605 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.07 144.07 51.24 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.918 1.745 . . . . 72.04 109.109 172.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.35 71.3 3.83 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.772 0.796 . . . . 74.13 111.23 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -175.48 -27.43 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.95 -1.477 . . . . 64.42 108.14 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.9 mmm -110.45 157.46 19.55 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.605 -1.18 . . . . 74.13 108.866 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.458 HG22 ' HA ' ' A' ' 80' ' ' PHE . 2.7 pp -111.13 134.79 52.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 110.079 -0.341 . . . . 73.01 110.079 174.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.456 ' HB2' HG22 ' A' ' 5' ' ' VAL . 10.1 t-20 -92.75 107.55 19.31 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 107.964 -1.124 . . . . 64.21 107.964 -176.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.575 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.1 tp -111.84 132.57 54.61 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.676 0.75 . . . . 74.32 112.389 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -107.19 119.98 40.86 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 108.333 -0.988 . . . . 72.53 108.333 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.575 HD22 ' HG ' ' A' ' 12' ' ' LEU . 2.5 mm? -99.09 125.73 44.68 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 124.704 1.201 . . . . 74.01 110.023 -177.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.439 HG23 HG22 ' A' ' 21' ' ' THR . 29.0 mt -100.2 117.61 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 108.441 -0.948 . . . . 75.52 108.441 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.497 HD21 HG23 ' A' ' 39' ' ' VAL . 68.8 mt -75.1 162.21 28.73 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.108 -0.496 . . . . 64.43 111.733 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.32 -15.8 20.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.484 -0.78 . . . . 71.35 110.219 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.0 m -76.81 -14.71 59.88 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.438 -0.801 . . . . 61.3 109.295 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.7 1.83 67.82 Favored Glycine 0 CA--C 1.501 -0.837 0 CA-C-N 115.882 -0.599 . . . . 53.04 112.076 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -89.12 133.06 34.53 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.103 -1.073 . . . . 75.11 108.103 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.439 HG22 HG23 ' A' ' 15' ' ' ILE . 76.9 p -98.78 129.8 45.21 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.877 -0.786 . . . . 63.15 108.877 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.454 ' HD2' HD11 ' A' ' 16' ' ' LEU . 26.6 mtpp -127.93 149.38 50.35 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.702 -0.851 . . . . 71.44 108.702 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -136.34 131.25 34.05 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.447 -0.901 . . . . 51.22 109.791 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.602 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.5 m-85 -144.73 159.21 43.22 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 123.735 0.814 . . . . 74.42 108.85 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.5 tp -89.36 128.5 35.91 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.626 -0.879 . . . . 54.25 108.626 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.602 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 97.0 m-85 -132.2 173.95 10.72 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.977 -0.379 . . . . 71.3 109.977 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.2 p -98.76 150.46 36.72 Favored Pre-proline 0 N--CA 1.421 -1.896 0 N-CA-C 108.331 -0.988 . . . . 73.14 108.331 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.431 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 36.2 Cg_endo -62.33 -11.38 22.29 Favored 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 122.257 1.971 . . . . 75.02 111.989 177.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -79.82 -22.15 43.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.301 1.041 . . . . 73.05 111.258 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -67.55 153.46 43.65 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.319 0.489 . . . . 72.44 112.319 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.476 ' O ' HG13 ' A' ' 35' ' ' ILE . 51.7 p -100.38 118.91 37.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.54 -0.541 . . . . 74.11 109.54 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.693 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -46.09 -51.19 14.29 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 115.205 1.557 . . . . 70.13 115.205 -173.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.7 m -71.85 -26.15 62.25 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 122.011 -0.43 . . . . 70.34 111.649 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.37 -41.19 76.84 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 107.75 -1.204 . . . . 73.4 107.75 173.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.554 ' O ' HG22 ' A' ' 39' ' ' VAL . 66.2 mt -60.66 -40.11 83.68 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 CA-C-N 114.031 -1.44 . . . . 72.42 110.186 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.489 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.12 -40.64 46.67 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 123.4 0.68 . . . . 71.43 111.026 176.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -73.22 -43.64 60.91 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.793 -0.639 . . . . 73.43 109.746 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -61.45 -39.91 92.55 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.728 0.811 . . . . 72.12 111.636 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 35' ' ' ILE . 29.4 m -77.08 -31.86 18.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.192 -0.458 . . . . 72.52 111.69 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 50.9 t80 . . . . . 0 CA--C 1.535 0.396 0 O-C-N 124.102 0.876 . . . . 74.01 110.273 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.599 ' O ' ' HD2' ' A' ' 59' ' ' ARG . 2.9 mm? . . . . . 0 CA--C 1.504 -0.814 0 CA-C-O 120.759 0.314 . . . . 71.43 110.922 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.599 ' HD2' ' O ' ' A' ' 58' ' ' LEU . 3.3 mpt_? -130.07 162.85 27.84 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 123.78 0.832 . . . . 72.21 109.138 174.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.693 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.2 pp -148.19 144.49 27.77 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.671 -0.492 . . . . 72.42 109.671 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.552 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 88.5 mt -117.67 119.17 60.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.774 -0.825 . . . . 75.14 108.774 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -101.97 86.01 2.8 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.351 -0.611 . . . . 74.5 109.351 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 44.98 70.55 0.33 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.707 -1.588 . . . . 74.25 112.228 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.06 -72.5 0.45 Allowed Glycine 0 N--CA 1.431 -1.666 0 C-N-CA 119.907 -1.139 . . . . 75.11 113.261 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -117.13 164.77 14.26 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 117.518 0.659 . . . . 72.45 112.772 -173.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 67.9 m-85 -86.11 113.85 22.49 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.46 -1.311 . . . . 72.31 107.46 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.575 HD12 HD22 ' A' ' 76' ' ' LEU . 70.0 mt -80.13 -47.32 14.94 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.398 1.259 . . . . 71.11 114.398 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.523 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 61.8 t-80 -174.64 151.82 1.54 Allowed 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 107.218 -1.401 . . . . 63.31 107.218 -174.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.83 1.3 39.63 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.073 1.189 . . . . 65.03 116.073 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -168.7 27.55 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.144 0.972 . . . . 72.5 110.053 -169.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.548 HG12 HD21 ' A' ' 60' ' ' LEU . 12.6 p -84.17 142.92 12.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 119.592 -0.843 . . . . 65.21 110.219 -177.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 49.2 p -81.44 160.22 24.06 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.94 -0.573 . . . . 63.33 111.304 -177.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.564 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.9 mm? -65.42 -33.09 75.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.208 -0.451 . . . . 72.25 111.811 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.64 -30.87 75.14 Favored Glycine 0 C--O 1.238 0.352 0 C-N-CA 120.099 -1.048 . . . . 74.13 111.085 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -74.5 -15.35 60.88 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.456 0.702 . . . . 52.41 110.646 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.575 HD22 HD12 ' A' ' 67' ' ' LEU . 74.3 mt -81.95 11.49 5.01 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.413 -0.588 . . . . 72.13 109.413 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.405 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER 67.99 17.79 9.54 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.771 1.228 . . . . 73.03 110.856 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.526 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 91.5 mt -82.86 120.08 75.59 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 115.775 -0.648 . . . . 60.13 110.753 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -82.21 138.83 10.23 Favored 'Trans proline' 0 N--CA 1.435 -1.964 0 C-N-CA 122.145 1.896 . . . . 55.45 110.531 175.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.458 ' HA ' HG22 ' A' ' 10' ' ' ILE . 5.6 p90 -67.41 149.91 49.64 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.358 0.599 . . . . 71.31 112.504 178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.69 5.79 64.44 Favored Glycine 0 N--CA 1.432 -1.573 0 CA-C-N 115.203 -0.908 . . . . 72.01 111.763 -174.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -124.0 164.89 18.42 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 109.843 -0.429 . . . . 63.22 109.843 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.444 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 64.2 m -106.69 134.65 49.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.7 0.286 . . . . 72.23 110.283 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.5 m -141.02 142.36 34.24 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 122.212 -0.305 . . . . 74.32 111.706 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.7 p -108.92 142.76 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 122.774 0.43 . . . . 74.02 110.118 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 92.8 mtp -136.22 152.94 51.29 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 120.994 0.426 . . . . 71.24 110.515 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.552 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 30.6 m-70 -104.46 130.16 52.39 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.269 -1.382 . . . . 72.01 107.269 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.489 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.5 mm? -117.79 144.4 45.38 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.524 -0.471 . . . . 64.52 110.762 -176.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.1 m -133.28 134.65 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 109.344 -0.613 . . . . 72.14 109.344 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.27 0 CA-C-O 121.066 0.46 . . . . 73.15 110.759 177.746 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.47 HG13 HD11 ' A' ' 25' ' ' LEU . 26.0 t . . . . . 0 N--CA 1.432 -1.339 0 N-CA-C 109.201 -0.666 . . . . 53.21 109.201 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.89 161.26 33.34 Favored 'Trans proline' 0 C--O 1.247 0.955 0 C-N-CA 122.574 2.183 . . . . 71.42 111.207 177.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.94 74.13 6.69 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 121.869 0.843 . . . . 72.12 109.101 175.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -171.2 -28.64 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.524 -1.671 . . . . 74.54 108.594 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 89.1 mmm -111.97 151.86 28.76 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.776 -1.102 . . . . 74.03 108.867 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.461 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.7 pp -111.34 136.32 47.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-O 120.817 0.341 . . . . 65.22 110.687 176.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.409 ' HB2' HG21 ' A' ' 5' ' ' VAL . 52.9 t-20 -83.01 111.58 18.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.775 -1.194 . . . . 73.2 107.775 -177.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.478 ' HG ' HD22 ' A' ' 14' ' ' LEU . 40.0 tp -118.01 132.93 56.33 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.482 0.658 . . . . 61.34 112.627 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.44 ' HD2' ' OE1' ' A' ' 23' ' ' GLU . 19.0 ttt85 -113.48 122.34 47.02 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 114.994 -1.003 . . . . 61.11 108.878 175.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.517 ' CB ' HG21 ' A' ' 39' ' ' VAL . 1.9 mm? -100.09 125.11 46.14 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 124.502 1.121 . . . . 73.1 108.609 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.637 HD12 HG22 ' A' ' 21' ' ' THR . 18.8 mm -99.28 123.71 52.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.629 -1.248 . . . . 73.33 107.629 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.23 156.87 24.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.399 -0.593 . . . . 74.53 109.399 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.435 ' CG1' ' HA ' ' A' ' 89' ' ' VAL . 35.3 m -66.21 -14.24 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.153 0.427 . . . . 53.11 112.153 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.2 t -76.27 -16.85 59.71 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.859 -0.61 . . . . 72.02 109.686 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.57 -6.19 57.33 Favored Glycine 0 N--CA 1.433 -1.559 0 C-N-CA 120.576 -0.821 . . . . 52.3 112.178 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -86.88 140.05 30.03 Favored 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 119.182 -1.007 . . . . 51.5 110.401 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.637 HG22 HD12 ' A' ' 15' ' ' ILE . 62.0 p -99.11 137.15 38.04 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 115.07 -0.968 . . . . 42.34 109.651 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -126.86 138.28 53.3 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.29 -1.744 . . . . 72.32 106.29 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 26.3 tt0 -137.71 131.15 30.94 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.09 -1.044 . . . . 64.24 110.818 -176.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.587 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 86.1 m-85 -145.03 159.79 42.39 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 123.382 0.673 . . . . 74.32 109.267 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.47 HD11 HG13 ' A' ' 5' ' ' VAL . 41.2 tp -84.67 125.15 32.25 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.386 -0.968 . . . . 63.23 108.386 176.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.587 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 96.3 m-85 -128.9 174.44 9.5 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.225 -0.657 . . . . 74.31 109.225 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.0 p -97.59 154.14 38.05 Favored Pre-proline 0 N--CA 1.431 -1.408 0 C-N-CA 119.193 -1.003 . . . . 64.55 108.818 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.589 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 45.0 Cg_endo -64.18 -12.9 34.84 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.576 2.184 . . . . 74.1 112.105 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -93.33 -7.33 45.13 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.161 -0.472 . . . . 65.53 111.642 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -79.2 153.28 30.12 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 120.485 -0.486 . . . . 72.41 111.186 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.489 ' O ' HG13 ' A' ' 35' ' ' ILE . 45.5 m -93.17 122.41 35.53 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.664 0.269 . . . . 73.4 110.775 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.717 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -49.34 -46.81 47.35 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.919 1.288 . . . . 42.32 113.409 -176.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 p -67.5 -33.71 75.65 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 113.05 0.759 . . . . 65.53 113.05 -177.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.54 -44.89 66.57 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.606 -1.257 . . . . 63.2 107.606 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 31' ' ' SER . 69.4 mt -55.29 -40.79 58.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 114.539 -1.209 . . . . 75.54 111.148 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.431 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.7 -37.65 42.55 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 123.549 0.74 . . . . 75.44 111.647 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -73.81 -34.58 64.66 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 120.755 0.312 . . . . 73.04 111.208 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -71.93 -44.25 63.94 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.405 -0.361 . . . . 70.44 111.829 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.517 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.4 m -65.24 -31.07 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 120.814 0.34 . . . . 72.34 110.886 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.7 t80 . . . . . 0 C--O 1.242 0.701 0 CA-C-N 115.431 -0.804 . . . . 73.02 111.542 175.807 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 CA--C 1.502 -0.87 0 CA-C-O 120.875 0.369 . . . . 75.33 110.02 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 27.9 ptt180 -147.1 143.79 28.57 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.981 0.419 . . . . 72.24 111.003 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.717 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.4 pp -113.89 144.02 43.73 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.739 -0.664 . . . . 64.3 111.478 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 90.9 mt -109.65 124.68 66.56 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 108.358 -0.979 . . . . 65.23 108.358 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.425 ' CD2' HD11 ' A' ' 67' ' ' LEU . 19.4 t80 -100.49 92.17 5.02 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 106.825 -1.546 . . . . 74.35 106.825 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 65.43 -67.09 0.14 Allowed 'General case' 0 N--CA 1.399 -2.981 0 C-N-CA 127.341 2.256 . . . . 50.1 112.173 -175.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.57 -44.93 0.87 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.633 -0.794 . . . . 23.25 114.135 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.15 159.04 23.23 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 115.435 1.643 . . . . 74.42 115.435 -174.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 63.9 m-85 -80.13 113.33 18.23 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.274 -0.875 . . . . 62.21 108.875 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.555 HD12 HD22 ' A' ' 76' ' ' LEU . 85.4 mt -81.33 -48.77 11.53 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.579 0.955 . . . . 71.33 113.579 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.715 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 14.7 t-80 -169.25 167.07 10.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.799 -1.556 . . . . 75.23 106.799 -173.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -85.25 -0.57 88.56 Favored Glycine 0 C--N 1.299 -1.489 0 N-CA-C 115.227 0.851 . . . . 55.21 115.227 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -168.04 28.69 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 118.187 0.993 . . . . 70.05 109.801 -169.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.483 HG12 HD21 ' A' ' 60' ' ' LEU . 10.9 p -85.12 138.02 19.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 C-N-CA 119.696 -0.801 . . . . 75.41 109.528 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.1 p -79.81 159.6 26.44 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.333 0.494 . . . . 75.42 112.333 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 3.3 mm? -59.42 -41.4 89.44 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 123.521 0.728 . . . . 72.33 111.844 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.99 -29.94 69.03 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.404 -0.427 . . . . 63.01 112.564 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.72 -15.17 59.32 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 122.923 0.489 . . . . 60.3 110.891 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.555 HD22 HD12 ' A' ' 67' ' ' LEU . 42.9 mt -83.46 5.4 23.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.387 -0.37 . . . . 70.03 110.404 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 8.8 mptt 62.67 76.92 0.35 Allowed 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.455 1.102 . . . . 61.11 109.434 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 73' ' ' LEU . 84.4 mt -131.26 120.81 18.25 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 116.224 -0.444 . . . . 70.35 111.371 -174.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.11 157.85 38.02 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 121.943 1.762 . . . . 75.03 109.669 170.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -78.71 150.62 32.47 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.767 -0.457 . . . . 71.31 109.767 -175.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.09 -11.45 72.09 Favored Glycine 0 C--N 1.308 -1.003 0 N-CA-C 114.756 0.662 . . . . 52.12 114.756 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.43 154.54 19.73 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.97 -1.092 . . . . 61.05 110.756 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.403 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 44.0 m -85.13 117.82 24.32 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.306 0.574 . . . . 72.12 111.017 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.7 m -105.41 125.52 51.08 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.386 -0.968 . . . . 53.55 108.386 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.3 p -108.74 122.3 63.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.643 0.735 . . . . 54.43 110.752 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.62 ' O ' HG12 ' A' ' 15' ' ' ILE . 87.0 mtp -122.97 150.63 42.73 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-N 116.192 -0.458 . . . . 71.44 109.899 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 39.9 m-70 -106.31 128.9 54.33 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.67 -1.233 . . . . 73.14 107.67 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.431 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.8 mm? -118.48 139.46 51.39 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 120.163 -0.615 . . . . 72.22 110.641 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.435 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 33.0 m -123.06 131.18 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.127 0 N-CA-C 108.582 -0.896 . . . . 70.42 108.582 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.553 0 CA-C-N 116.174 -0.466 . . . . 51.14 110.359 176.253 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.499 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 25.8 t . . . . . 0 N--CA 1.431 -1.387 0 N-CA-C 107.863 -1.162 . . . . 74.13 107.863 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -68.92 145.65 62.77 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 122.249 1.966 . . . . 62.22 112.11 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.3 78.01 7.01 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 122.396 1.093 . . . . 75.33 109.82 176.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -160.4 -41.88 0.05 OUTLIER 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 113.034 -1.894 . . . . 62.0 106.958 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.501 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 8.5 ptm -124.44 159.98 29.25 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.287 -1.324 . . . . 64.21 111.047 -175.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.89 140.6 28.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.338 0.589 . . . . 74.53 112.582 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -87.59 107.85 18.79 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.393 -0.966 . . . . 53.25 108.393 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.545 ' HG ' HD22 ' A' ' 14' ' ' LEU . 43.2 tp -117.24 132.85 56.54 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.291 0.567 . . . . 73.25 112.411 -173.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 35.7 ttp-105 -107.44 120.9 43.46 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 108.733 -0.84 . . . . 72.53 108.733 173.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.604 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.5 mm? -97.34 121.96 39.82 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.219 -1.355 . . . . 74.54 109.337 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.411 HG12 HG22 ' A' ' 21' ' ' THR . 31.6 mt -99.77 119.36 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 N-CA-C 108.272 -1.01 . . . . 72.34 108.272 176.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.04 166.79 23.11 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.478 -0.783 . . . . 74.32 111.436 -175.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.42 HG11 ' H ' ' A' ' 90' ' ' ALA . 28.7 m -70.74 -14.35 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.504 0.669 . . . . 73.25 110.665 177.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 m -83.69 -6.24 59.39 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 114.923 -1.035 . . . . 40.41 110.11 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.81 -4.67 84.96 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.852 -0.69 . . . . 52.44 112.64 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -87.54 131.9 34.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.898 0.38 . . . . 62.1 110.252 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.411 HG22 HG12 ' A' ' 15' ' ' ILE . 80.8 p -98.94 129.94 45.28 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.998 -0.546 . . . . 75.14 110.068 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -131.44 139.11 49.32 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.043 -0.725 . . . . 72.32 109.043 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 29.4 tt0 -125.23 133.84 52.56 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.324 -0.55 . . . . 75.55 110.587 -174.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.661 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 95.3 m-85 -144.66 160.0 41.9 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.105 0.562 . . . . 61.22 109.489 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.7 tp -87.52 126.17 34.76 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.174 -1.047 . . . . 72.03 108.174 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.661 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 96.8 m-85 -132.77 173.94 10.84 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.749 -0.834 . . . . 74.44 108.749 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 99.7 p -97.09 151.34 37.65 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 108.515 -0.92 . . . . 71.05 108.515 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.551 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 37.3 Cg_endo -63.11 -11.87 27.13 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.594 2.196 . . . . 53.0 112.409 177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -86.2 -17.24 35.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.542 -0.754 . . . . 54.2 109.999 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -69.93 154.76 41.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.486 0.66 . . . . 73.41 112.429 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.533 ' O ' HG13 ' A' ' 35' ' ' ILE . 3.3 p -91.69 118.21 30.45 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 115.357 -0.838 . . . . 64.33 110.848 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.4 -51.29 59.86 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.83 1.252 . . . . 34.11 113.623 -174.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.1 m -72.11 -22.6 61.31 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 120.861 0.362 . . . . 72.11 111.6 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -70.66 -48.88 52.64 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.502 -0.925 . . . . 64.24 108.502 172.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 31' ' ' SER . 72.5 mt -54.81 -43.91 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 114.278 -1.328 . . . . 73.03 110.102 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.471 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.27 -34.37 23.09 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.165 0.986 . . . . 74.23 111.763 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -74.03 -49.7 23.08 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 109.539 -0.541 . . . . 53.53 109.539 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -59.95 -40.76 90.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.41 -0.814 . . . . 63.13 111.568 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.604 HG21 ' CB ' ' A' ' 14' ' ' LEU . 36.0 m -73.95 -31.3 30.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.418 -0.355 . . . . 71.43 111.654 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.4 t80 . . . . . 0 C--O 1.232 0.157 0 O-C-N 123.446 0.466 . . . . 74.2 110.855 179.386 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 C--O 1.241 0.636 0 CA-C-O 120.915 0.388 . . . . 73.32 111.86 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 39.0 mmt180 -144.82 164.16 31.88 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 124.149 0.98 . . . . 70.51 108.41 175.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.673 HD21 ' H ' ' A' ' 71' ' ' VAL . 3.7 pp -147.17 148.4 31.49 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 109.444 -0.576 . . . . 75.11 109.444 172.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 90.3 mt -118.27 129.63 74.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 108.644 -0.873 . . . . 74.23 108.644 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -100.03 81.51 2.43 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 106.292 -1.744 . . . . 74.41 106.292 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.324 17.6 tm0? 59.34 -38.56 0.07 Allowed 'General case' 0 N--CA 1.414 -2.228 0 C-N-CA 129.042 2.937 . . . . 62.23 116.38 -176.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.35 -52.25 0.18 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.801 -0.714 . . . . 73.33 112.651 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.64 162.24 14.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.49 1.293 . . . . 74.1 114.49 -178.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 43.9 m-85 -88.28 113.54 23.99 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.866 -1.161 . . . . 74.22 107.866 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.21 -48.93 12.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 119.179 -1.008 . . . . 51.51 112.31 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.532 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 60.1 m80 -159.81 177.88 10.36 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.698 -0.853 . . . . 64.31 108.698 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -85.63 -4.17 85.62 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.978 -0.629 . . . . 71.22 112.584 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.4 t30 175.74 79.61 0.0 OUTLIER 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.527 1.131 . . . . 54.25 110.273 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.673 ' H ' HD21 ' A' ' 60' ' ' LEU . 9.2 p -104.33 146.15 12.09 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.765 0 N-CA-C 106.783 -1.562 . . . . 64.14 106.783 172.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.3 p -78.52 158.19 28.64 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.397 -0.521 . . . . 64.3 111.532 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 2.0 mm? -66.26 -34.71 78.62 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.148 0.499 . . . . 60.32 111.003 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.14 -31.38 79.08 Favored Glycine 0 CA--C 1.516 0.155 0 C-N-CA 120.6 -0.81 . . . . 72.33 111.234 176.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -72.4 -15.0 61.84 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 122.959 0.503 . . . . 64.34 110.872 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.553 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 64.5 mt -82.19 3.38 27.5 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.88 -0.415 . . . . 75.43 109.88 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.23 26.12 2.78 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.451 1.1 . . . . 72.34 111.135 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.553 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 65.1 mt -76.53 127.68 83.9 Favored Pre-proline 0 C--O 1.244 0.791 0 CA-C-N 116.555 -0.293 . . . . 75.54 111.138 -178.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.71 147.0 30.82 Favored 'Trans proline' 0 N--CA 1.435 -1.919 0 C-N-CA 121.439 1.426 . . . . 73.13 108.46 170.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.506 ' CE1' ' HG3' ' A' ' 28' ' ' PRO . 12.4 m-30 -69.51 145.67 52.48 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.191 -0.67 . . . . 73.42 109.191 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 89.41 1.77 77.73 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 120.165 -1.016 . . . . 64.31 113.55 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -101.49 145.22 29.28 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 117.041 0.42 . . . . 74.11 109.955 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.4 m -87.19 117.48 25.96 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.917 -0.772 . . . . 64.43 108.917 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.9 m -114.21 134.97 54.55 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.609 -0.723 . . . . 75.32 110.935 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.8 131.25 62.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 120.991 0.424 . . . . 55.15 110.349 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 89.7 mtp -135.51 153.2 51.8 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-O 120.81 0.338 . . . . 70.54 110.479 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.506 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 51.4 m80 -106.58 135.42 48.13 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.474 -1.306 . . . . 75.4 107.474 176.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.471 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.4 mm? -123.53 137.05 54.85 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 120.249 -0.58 . . . . 71.55 110.188 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.404 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 26.4 m -126.46 133.47 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-O 121.58 0.705 . . . . 74.33 111.199 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.42 ' H ' HG11 ' A' ' 17' ' ' VAL . . . . . . . . 0 C--N 1.295 -1.772 0 N-CA-C 108.469 -0.937 . . . . 73.03 108.469 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.458 HG13 HD22 ' A' ' 25' ' ' LEU . 24.9 t . . . . . 0 N--CA 1.442 -0.859 0 N-CA-C 109.652 -0.499 . . . . 74.43 109.652 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.3 142.45 79.54 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.426 2.084 . . . . 74.23 112.395 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.97 70.82 6.61 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 122.121 0.962 . . . . 73.13 109.884 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -168.0 -37.04 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 104.909 -2.256 . . . . 74.11 104.909 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 86.0 mmm -102.58 156.74 17.41 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.622 -1.627 . . . . 75.24 108.985 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.41 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.8 pp -117.92 140.22 42.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 107.509 -1.293 . . . . 74.35 107.509 172.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 67.1 t30 -91.81 125.24 36.45 Favored 'General case' 0 CA--C 1.485 -1.537 0 C-N-CA 118.765 -1.174 . . . . 64.43 107.876 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.575 ' HG ' HD22 ' A' ' 14' ' ' LEU . 44.7 tp -126.21 133.65 51.46 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-O 121.149 0.5 . . . . 70.31 112.112 -174.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 17.8 ttp180 -106.1 120.63 42.3 Favored 'General case' 0 N--CA 1.405 -2.71 0 N-CA-C 108.659 -0.867 . . . . 72.55 108.659 173.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.575 HD22 ' HG ' ' A' ' 12' ' ' LEU . 2.1 mm? -99.56 122.31 42.44 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 113.966 -1.47 . . . . 63.0 109.275 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.522 HG23 HG22 ' A' ' 21' ' ' THR . 15.0 mm -105.07 123.31 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.513 -1.291 . . . . 64.0 107.513 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 2.5 mm? -93.92 158.3 15.71 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.245 -0.582 . . . . 54.11 110.969 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.502 ' CG1' ' HA ' ' A' ' 89' ' ' VAL . 32.2 m -52.85 -30.29 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 115.009 1.485 . . . . 73.13 115.009 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.4 m -86.61 4.88 38.41 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.992 0.425 . . . . 63.01 111.351 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.47 24.92 49.17 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.208 -0.757 . . . . 61.24 111.208 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 73.4 mmtt -86.97 130.82 34.3 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 104.688 -2.338 . . . . 64.45 104.688 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.522 HG22 HG23 ' A' ' 15' ' ' ILE . 38.7 p -126.3 128.68 47.51 Favored 'General case' 0 C--N 1.278 -2.53 0 C-N-CA 119.644 -0.822 . . . . 72.24 111.648 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -142.39 147.21 35.84 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.32 -0.4 . . . . 75.53 111.025 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 21.0 tt0 -125.9 130.2 50.85 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 107.68 -1.23 . . . . 63.51 107.68 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.698 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 96.4 m-85 -145.11 158.97 43.67 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.703 0.287 . . . . 63.2 110.452 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.458 HD22 HG13 ' A' ' 5' ' ' VAL . 96.5 mt -79.76 125.66 29.96 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.99 -1.115 . . . . 71.3 107.99 175.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.698 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 90.1 m-85 -129.86 163.15 26.94 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.59 -0.522 . . . . 72.33 109.59 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.0 m -88.99 141.13 29.29 Favored Pre-proline 0 N--CA 1.395 -3.185 0 N-CA-C 107.613 -1.255 . . . . 60.33 107.613 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 34.7 Cg_endo -62.4 -11.98 25.4 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.203 1.935 . . . . 73.51 112.186 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -78.89 -20.27 49.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.433 1.093 . . . . 72.25 110.046 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.448 ' O ' HD22 ' A' ' 73' ' ' LEU . 63.5 m-20 -75.44 154.16 37.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.184 -0.462 . . . . 64.33 111.347 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.515 ' O ' HG13 ' A' ' 35' ' ' ILE . 13.4 p -101.1 132.07 46.73 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.276 0.473 . . . . 62.42 112.276 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.434 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -48.47 -59.34 3.56 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.662 1.727 . . . . 62.13 115.662 -174.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.7 m -72.78 -19.7 61.31 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.504 0.668 . . . . 55.55 111.258 -174.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 31' ' ' SER . 14.3 t70 -70.15 -47.93 59.55 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.493 -1.299 . . . . 62.31 107.493 172.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 31' ' ' SER . 73.3 mt -59.03 -35.28 56.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.671 -1.149 . . . . 73.14 110.84 176.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.418 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.41 -33.56 21.22 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.029 0.532 . . . . 72.55 110.665 175.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 5.5 mptp? -68.87 -51.72 37.31 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.71 0.291 . . . . 73.33 110.312 174.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -57.52 -43.0 83.94 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.992 -0.549 . . . . 71.01 111.889 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 14' ' ' LEU . 35.8 m -76.9 -31.53 19.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 112.381 0.512 . . . . 63.42 112.381 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 65.1 t80 . . . . . 0 C--N 1.323 -0.559 0 C-N-CA 120.404 -0.519 . . . . 61.03 109.761 176.647 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.9 mt . . . . . 0 CA--C 1.483 -1.605 0 N-CA-C 107.27 -1.381 . . . . 62.14 107.27 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 10.3 ptt180 -146.46 162.72 37.67 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.442 -0.799 . . . . 64.32 111.567 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.631 HD21 HG12 ' A' ' 71' ' ' VAL . 4.5 pp -127.11 150.32 49.54 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 115.6 -0.727 . . . . 75.03 112.044 -171.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.428 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 97.4 mt -118.79 120.02 62.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.17 -0.923 . . . . 74.23 108.58 176.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.432 ' CD2' HD11 ' A' ' 67' ' ' LEU . 17.0 t80 -101.53 65.52 1.04 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.057 -1.09 . . . . 72.44 108.057 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 53.83 83.93 0.07 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.828 -1.533 . . . . 74.32 113.496 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.55 -58.51 0.5 Allowed Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.535 -0.841 . . . . 64.21 112.803 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -130.87 162.88 28.65 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 120.095 -0.642 . . . . 75.33 112.693 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 78.8 m-85 -83.73 122.27 28.42 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.073 -1.454 . . . . 73.25 107.073 175.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.462 HD12 ' CD2' ' A' ' 76' ' ' LEU . 54.6 mt -79.71 -46.37 17.22 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 118.804 -1.158 . . . . 72.22 111.289 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.486 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.0 t-160 -165.86 178.88 6.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.361 -2.089 . . . . 72.41 105.361 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -71.54 -42.23 55.89 Favored Glycine 0 C--O 1.208 -1.472 0 C-N-CA 120.346 -0.931 . . . . 74.55 112.675 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.503 ' OD1' ' HB2' ' A' ' 31' ' ' SER . 60.7 t30 -159.93 75.93 0.62 Allowed 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 108.613 -0.884 . . . . 63.03 108.613 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.631 HG12 HD21 ' A' ' 60' ' ' LEU . 11.2 p -102.06 152.08 5.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.228 -1.351 . . . . 70.4 109.066 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.1 p -77.61 160.68 28.38 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.488 0.551 . . . . 74.43 112.488 -173.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.538 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.3 mm? -68.98 -34.55 75.49 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 116.134 -0.484 . . . . 72.32 111.189 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.05 -29.67 75.09 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.496 -0.859 . . . . 41.32 111.193 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.469 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -73.79 -15.24 61.19 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 122.972 0.509 . . . . 74.33 111.199 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.465 HD11 ' SD ' ' A' ' 86' ' ' MET . 58.6 mt -83.83 2.39 38.48 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.867 0.467 . . . . 55.33 110.224 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER 65.22 78.06 0.29 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.984 0.914 . . . . 62.13 109.276 -176.544 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 85.0 mt -133.46 133.33 22.58 Favored Pre-proline 0 C--O 1.243 0.749 0 CA-C-N 116.093 -0.503 . . . . 74.11 111.239 -175.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 2.0 Cg_endo -81.33 155.97 19.23 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.293 1.996 . . . . 65.12 109.229 171.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -76.71 153.65 34.9 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.74 -0.837 . . . . 73.45 108.74 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 83.97 2.37 89.56 Favored Glycine 0 C--N 1.3 -1.467 0 C-N-CA 120.25 -0.976 . . . . 73.53 113.09 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.21 151.68 23.78 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 110.2 -0.296 . . . . 54.44 110.2 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.47 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 90.1 m -102.18 127.17 49.23 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.146 0.498 . . . . 64.44 110.158 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 84.8 m -128.72 141.98 51.15 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.938 -0.573 . . . . 60.24 110.604 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.9 137.5 41.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.779 0.323 . . . . 72.12 110.877 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.465 ' SD ' HD11 ' A' ' 76' ' ' LEU . 93.6 mtp -135.51 152.73 51.61 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 122.882 0.473 . . . . 71.44 110.176 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.428 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 29.1 m-70 -109.61 131.06 55.41 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.662 -0.866 . . . . 73.12 108.662 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.418 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.5 mm? -117.87 137.63 52.66 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 110.06 -0.348 . . . . 74.11 110.06 -175.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.502 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 32.6 m -121.71 133.87 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-O 121.142 0.496 . . . . 74.31 110.706 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.035 0 CA-C-N 115.645 -0.707 . . . . 64.11 109.991 176.963 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.481 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 39.0 t . . . . . 0 N--CA 1.418 -2.066 0 N-CA-C 109.306 -0.627 . . . . 61.04 109.306 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.39 172.52 14.44 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.5 2.134 . . . . 64.13 111.972 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.42 30.22 0.29 Allowed 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.992 0.917 . . . . 71.4 110.639 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -133.42 -14.68 2.54 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.714 -0.676 . . . . 65.31 110.14 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.3 mmm -121.68 155.4 35.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.036 -0.529 . . . . 73.25 110.092 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 pp -120.28 140.27 44.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-O 120.883 0.373 . . . . 65.52 110.949 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -90.84 111.04 22.28 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 109.06 -0.719 . . . . 70.51 109.06 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.542 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.1 tp -119.54 133.11 55.82 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.758 -0.656 . . . . 73.14 112.31 -174.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -108.63 121.25 44.62 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 114.986 -1.007 . . . . 72.25 108.388 173.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.547 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.1 mm? -99.44 123.72 43.96 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.061 -0.972 . . . . 72.34 109.273 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.476 HG23 HG22 ' A' ' 21' ' ' THR . 29.6 mt -104.46 129.22 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 N-CA-C 108.736 -0.838 . . . . 74.42 108.736 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.68 166.17 17.29 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.789 -0.642 . . . . 74.51 110.169 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.13 -19.43 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-O 121.745 0.784 . . . . 74.43 109.983 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 p -76.06 -10.6 59.55 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.561 -0.745 . . . . 74.3 111.35 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.44 2.52 76.45 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 110.715 -0.954 . . . . 73.13 110.715 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.4 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 12.6 mptt -86.65 133.61 33.68 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.791 -0.448 . . . . 75.1 109.791 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.476 HG22 HG23 ' A' ' 15' ' ' ILE . 80.9 p -113.73 137.26 51.87 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 116.117 -0.492 . . . . 62.13 111.531 -173.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -134.88 147.5 49.87 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.064 -0.717 . . . . 71.3 109.064 174.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -135.46 131.58 36.34 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.397 -0.594 . . . . 75.44 109.397 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.717 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 94.4 m-85 -144.04 160.02 41.6 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.951 -0.759 . . . . 65.21 108.951 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.446 HD11 HG13 ' A' ' 5' ' ' VAL . 41.3 tp -82.28 125.04 30.5 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.292 -1.373 . . . . 74.24 107.292 175.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.717 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 83.8 m-85 -128.97 166.59 18.88 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.446 -0.575 . . . . 74.31 109.446 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.7 p -92.83 146.94 33.09 Favored Pre-proline 0 N--CA 1.417 -2.092 0 C-N-CA 119.308 -0.957 . . . . 75.42 108.62 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.512 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 35.3 Cg_endo -61.86 -11.4 20.93 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.72 2.28 . . . . 71.34 112.1 177.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -79.97 -23.06 41.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.216 -0.902 . . . . 71.13 110.973 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.423 ' O ' HD22 ' A' ' 73' ' ' LEU . 22.6 m-20 -67.44 154.78 40.59 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 112.88 0.696 . . . . 75.44 112.88 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.524 ' O ' HG13 ' A' ' 35' ' ' ILE . 43.7 m -97.08 124.6 41.14 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.65 -0.705 . . . . 44.22 109.829 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.84 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -50.5 -50.0 54.04 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.539 0.735 . . . . 61.43 112.937 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 p -65.65 -30.63 71.36 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 112.355 0.502 . . . . 73.5 112.355 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.66 -46.24 66.56 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.8 -0.815 . . . . 72.01 108.8 174.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 31' ' ' SER . 67.3 mt -60.22 -39.15 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 114.811 -1.086 . . . . 72.44 111.138 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.88 -38.61 36.37 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.418 0.687 . . . . 71.43 111.299 176.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -72.49 -40.92 66.52 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.242 -0.435 . . . . 64.15 111.079 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -65.89 -42.54 90.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.629 -0.714 . . . . 61.1 111.161 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.547 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.4 m -76.84 -30.72 18.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 112.157 0.428 . . . . 72.52 112.157 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.2 t80 . . . . . 0 C--O 1.243 0.719 0 O-C-N 123.565 0.54 . . . . 75.55 111.795 -179.452 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.7 tp . . . . . 0 N--CA 1.447 -0.605 0 N-CA-C 108.494 -0.928 . . . . 65.33 108.494 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -137.22 160.53 38.75 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.088 -0.505 . . . . 72.03 109.721 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.84 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.5 pp -127.62 140.76 51.89 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.581 -0.736 . . . . 73.14 109.495 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 92.5 mt -111.89 126.33 69.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.783 -0.821 . . . . 61.15 108.783 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -100.58 84.32 2.74 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.715 -1.217 . . . . 73.22 107.715 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 68.16 -50.24 0.54 Allowed 'General case' 0 N--CA 1.405 -2.676 0 C-N-CA 127.505 2.322 . . . . 53.53 112.69 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.9 -45.76 0.18 Allowed Glycine 0 N--CA 1.436 -1.338 0 C-N-CA 120.601 -0.809 . . . . 61.2 113.987 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -110.58 160.9 16.24 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.55 0.574 . . . . 64.41 112.55 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 68.4 m-85 -87.1 113.79 23.14 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.018 -1.104 . . . . 64.42 108.018 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.587 HD12 HD22 ' A' ' 76' ' ' LEU . 43.2 mt -80.63 -45.21 17.64 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 114.113 1.153 . . . . 64.45 114.113 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.664 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 8.1 t60 -167.48 169.93 11.73 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.735 -1.58 . . . . 75.01 106.735 -175.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.85 -1.31 88.98 Favored Glycine 0 C--N 1.309 -0.954 0 C-N-CA 120.73 -0.748 . . . . 72.13 113.148 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 178.49 64.9 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.826 -0.805 . . . . 62.44 108.826 -173.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.718 HG12 HD21 ' A' ' 60' ' ' LEU . 11.2 p -104.18 151.17 6.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.852 -1.166 . . . . 72.0 107.852 174.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.439 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 58.9 p -84.04 158.28 21.52 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 121.42 -0.112 . . . . 62.12 110.962 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.581 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.5 mm? -65.29 -32.75 74.57 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.977 0.418 . . . . 65.44 110.79 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.48 -32.31 83.77 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.098 -0.801 . . . . 61.31 111.098 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.479 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -79.19 -15.14 58.51 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 122.803 0.441 . . . . 70.22 111.088 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.587 HD22 HD12 ' A' ' 67' ' ' LEU . 66.8 mt -82.38 1.16 38.57 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.945 -0.761 . . . . 71.42 108.945 176.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.1 mptt 78.84 14.89 1.16 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.056 1.342 . . . . 63.44 113.18 178.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.6 mp -60.67 120.26 51.33 Favored Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 113.485 0.92 . . . . 74.42 113.485 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 16.2 Cg_exo -73.05 150.41 48.31 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.485 2.123 . . . . 74.33 108.565 170.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -78.06 142.24 38.3 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.454 -0.943 . . . . 75.24 108.454 -175.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.481 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 92.63 -3.25 74.57 Favored Glycine 0 C--N 1.298 -1.533 0 C-N-CA 119.955 -1.117 . . . . 60.33 114.151 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -104.42 153.89 20.54 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 117.367 0.583 . . . . 63.45 111.621 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.7 m -92.61 118.6 31.19 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.33 -0.619 . . . . 71.34 109.33 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 84.1 m -119.98 136.93 54.36 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 116.39 -0.368 . . . . 74.53 110.516 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.4 p -110.52 135.45 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-O 121.045 0.45 . . . . 72.22 110.964 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 87.6 mtp -134.48 153.72 51.78 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 120.896 0.379 . . . . 71.55 111.64 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.537 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 63.3 m-70 -107.73 135.13 49.67 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.682 -1.229 . . . . 72.04 107.682 176.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.432 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.4 mm? -121.73 133.76 54.94 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 120.161 -0.616 . . . . 73.31 110.156 -177.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.51 134.57 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 121.662 0.744 . . . . 60.11 111.827 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.826 0 N-CA-C 107.407 -1.331 . . . . 55.55 107.407 175.321 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.477 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 47.5 t . . . . . 0 N--CA 1.435 -1.207 0 N-CA-C 109.019 -0.734 . . . . 65.22 109.019 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -70.87 149.68 60.23 Favored 'Trans proline' 0 C--O 1.25 1.097 0 C-N-CA 122.332 2.022 . . . . 72.42 112.089 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.42 75.33 7.26 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.905 0.86 . . . . 62.12 108.73 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -171.99 -25.55 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.642 -1.617 . . . . 71.04 107.646 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.6 mmm -114.42 144.84 42.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.947 -1.024 . . . . 72.13 109.626 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -105.76 135.66 43.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.014 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.406 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 2.3 t-20 -89.7 110.71 21.58 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.744 -0.836 . . . . 73.02 108.744 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.518 ' HG ' HD22 ' A' ' 14' ' ' LEU . 43.6 tp -119.51 132.85 55.85 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.629 -0.714 . . . . 64.44 111.769 -174.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.8 ttp-105 -109.26 120.76 43.49 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 108.651 -0.87 . . . . 62.12 108.651 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.518 HD22 ' HG ' ' A' ' 12' ' ' LEU . 2.1 mm? -96.44 120.91 37.61 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.787 -1.097 . . . . 64.42 109.966 -177.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.483 HG23 ' OG1' ' A' ' 21' ' ' THR . 19.0 mt -108.91 117.51 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 N-CA-C 107.045 -1.465 . . . . 75.42 107.045 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.58 156.96 20.51 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 116.073 -0.512 . . . . 62.24 111.576 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -58.04 -25.77 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 124.019 0.928 . . . . 64.43 111.91 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.2 m -76.81 -1.33 27.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.94 0.4 . . . . 73.52 111.017 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.03 15.85 71.35 Favored Glycine 0 CA--C 1.496 -1.123 0 N-CA-C 111.65 -0.58 . . . . 54.14 111.65 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -92.42 143.3 26.51 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.892 -1.522 . . . . 75.33 106.892 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.483 ' OG1' HG23 ' A' ' 15' ' ' ILE . 78.4 m -131.31 141.38 49.93 Favored 'General case' 0 C--N 1.277 -2.555 0 C-N-CA 120.136 -0.626 . . . . 71.32 109.758 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -150.63 139.82 21.2 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.608 -0.886 . . . . 72.41 108.608 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -123.69 133.09 53.95 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.787 -0.365 . . . . 74.41 110.533 -177.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.708 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 90.2 m-85 -145.17 161.21 40.06 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 123.4 0.68 . . . . 61.52 109.728 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.72 125.84 30.18 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.68 -1.23 . . . . 73.22 107.68 170.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.708 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 85.7 m-85 -125.16 167.35 14.95 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.886 -0.783 . . . . 71.14 108.886 177.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 99.0 p -94.65 147.54 33.36 Favored Pre-proline 0 N--CA 1.414 -2.249 0 C-N-CA 118.895 -1.122 . . . . 62.41 108.225 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.414 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 37.5 Cg_endo -61.82 -11.56 21.52 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.686 2.257 . . . . 64.34 112.312 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -84.44 -18.39 36.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.553 -0.748 . . . . 53.45 110.983 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' O ' HD22 ' A' ' 73' ' ' LEU . 35.1 m-20 -74.07 153.86 39.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.874 0.368 . . . . 74.25 110.374 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.414 ' O ' HG13 ' A' ' 35' ' ' ILE . 36.2 m -98.97 131.6 44.91 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.937 -0.764 . . . . 51.2 108.937 176.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.823 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -51.29 -36.57 43.0 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.396 0.887 . . . . 70.3 113.396 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.514 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 7.2 p -69.24 -36.66 77.41 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.851 0.685 . . . . 63.41 112.851 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.66 -43.29 89.82 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.145 -1.057 . . . . 75.34 108.145 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.527 HG23 ' CZ ' ' A' ' 26' ' ' PHE . 57.0 mt -59.5 -41.31 84.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 114.847 -1.07 . . . . 75.34 111.964 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.94 -42.38 48.37 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 123.043 0.537 . . . . 70.32 111.472 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -73.52 -38.62 65.24 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 120.69 0.281 . . . . 65.13 111.323 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -59.77 -45.2 93.0 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.581 -0.736 . . . . 73.21 110.535 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.494 HG11 HD23 ' A' ' 14' ' ' LEU . 34.9 m -75.29 -31.83 24.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-O 121.047 0.451 . . . . 74.25 112.139 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.8 t80 . . . . . 0 N--CA 1.48 1.055 0 CA-C-N 115.783 -0.644 . . . . 73.31 110.76 176.614 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 96.4 mt . . . . . 0 N--CA 1.44 -0.974 0 N-CA-C 107.251 -1.388 . . . . 72.44 107.251 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -137.93 142.55 40.58 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.594 -0.842 . . . . 64.0 109.249 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.823 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.6 pp -114.19 134.97 54.55 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.969 -0.56 . . . . 74.44 110.707 -178.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 72.3 mt -109.39 119.92 59.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 115.295 -0.866 . . . . 74.05 108.763 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -101.91 102.78 13.38 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 102.917 -2.994 . . . . 64.4 102.917 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -18.78 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 127.999 2.52 . . . . 71.04 113.881 -163.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.52 -67.81 0.4 Allowed Glycine 0 N--CA 1.42 -2.394 0 CA-C-N 113.165 -1.834 . . . . 61.2 110.27 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -130.61 173.65 10.68 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 120.788 0.327 . . . . 72.3 111.539 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -94.66 114.18 26.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.956 -1.868 . . . . 75.02 105.956 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.667 HD12 HD22 ' A' ' 76' ' ' LEU . 90.6 mt -79.19 -48.12 14.78 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 119.224 -0.99 . . . . 74.14 113.537 -175.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.666 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -167.69 174.52 7.62 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.043 -0.355 . . . . 64.44 110.043 179.682 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.47 -1.52 85.76 Favored Glycine 0 C--N 1.306 -1.131 0 N-CA-C 115.279 0.872 . . . . 55.34 115.279 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.444 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 2.7 t-20 -173.22 25.04 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.727 1.264 . . . . 73.24 110.529 -171.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.659 HG12 HD21 ' A' ' 60' ' ' LEU . 13.3 p -80.42 145.47 9.04 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 O-C-N 122.082 -0.386 . . . . 63.12 110.121 -176.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.535 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 64.0 p -79.02 157.52 28.06 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 122.992 0.517 . . . . 62.52 111.993 -175.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.594 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.7 mm? -65.38 -32.68 74.45 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 120.943 0.402 . . . . 73.1 110.526 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.76 -34.94 88.82 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.817 -0.706 . . . . 74.24 111.353 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.444 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -78.64 -15.58 58.35 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.898 0.479 . . . . 74.34 110.863 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.667 HD22 HD12 ' A' ' 67' ' ' LEU . 65.8 mt -86.33 -3.69 59.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 74.04 110.083 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.6 mptt 70.27 72.05 0.22 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.561 1.145 . . . . 72.54 111.421 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.467 HD22 ' HB3' ' A' ' 73' ' ' LEU . 10.4 mp -115.37 118.55 39.53 Favored Pre-proline 0 CA--C 1.491 -1.314 0 CA-C-N 116.0 -0.546 . . . . 75.3 110.822 175.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.425 ' HG2' ' HD2' ' A' ' 82' ' ' LYS . 16.8 Cg_exo -69.07 139.96 44.01 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.99 1.794 . . . . 73.13 109.085 172.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -69.7 140.82 53.59 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.0 -0.741 . . . . 74.45 109.0 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.477 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 92.05 -9.14 77.12 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.254 -0.974 . . . . 64.32 113.359 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.425 ' HD2' ' HG2' ' A' ' 79' ' ' PRO . 94.6 mttt -101.65 153.28 19.91 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.456 -0.498 . . . . 54.35 112.275 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.406 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 30.3 m -91.12 118.31 30.32 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.19 -0.914 . . . . 62.02 110.275 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.3 m -122.4 138.88 54.39 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.951 -0.568 . . . . 75.24 109.708 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.53 140.44 28.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 110.281 -0.266 . . . . 75.42 110.281 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 86.6 mtp -138.96 153.76 48.23 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 111.819 0.303 . . . . 73.52 111.819 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.555 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 83.5 m-70 -106.37 137.39 44.42 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.801 -0.814 . . . . 55.14 108.801 175.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.458 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.1 mm? -125.28 131.64 53.05 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 122.215 -0.303 . . . . 65.44 110.894 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.13 135.25 64.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.047 0.451 . . . . 74.23 110.03 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.259 0 O-C-N 122.279 -0.263 . . . . 52.31 111.238 -177.857 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.565 HG22 HD21 ' A' ' 11' ' ' ASN . 16.7 t . . . . . 0 N--CA 1.437 -1.08 0 N-CA-C 110.133 -0.321 . . . . 71.14 110.133 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -68.87 147.42 68.52 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.09 1.86 . . . . 73.43 110.83 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.05 65.86 7.37 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.979 0.895 . . . . 64.33 112.055 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -163.26 -31.49 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.688 -1.597 . . . . 73.31 106.688 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.9 mmm -102.79 148.81 25.15 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.244 -1.343 . . . . 71.05 109.007 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.43 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.9 pp -107.69 132.1 56.18 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 108.816 -0.809 . . . . 74.15 108.816 173.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.565 HD21 HG22 ' A' ' 5' ' ' VAL . 45.8 t-20 -88.76 113.78 24.68 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.955 -1.498 . . . . 73.24 106.955 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.551 ' HG ' HD22 ' A' ' 14' ' ' LEU . 42.6 tp -118.96 133.11 56.04 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 121.164 0.506 . . . . 73.44 112.087 -173.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.484 ' HD2' ' OE1' ' A' ' 23' ' ' GLU . 20.6 ttt85 -107.02 121.32 44.22 Favored 'General case' 0 N--CA 1.407 -2.578 0 CA-C-N 115.365 -0.834 . . . . 65.11 108.815 174.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.639 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.0 mm? -101.3 120.72 40.68 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.568 -1.196 . . . . 54.23 108.893 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.541 HG23 HG22 ' A' ' 21' ' ' THR . 26.8 mt -104.69 124.71 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 N-CA-C 108.953 -0.758 . . . . 60.45 108.953 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.3 mt -79.46 168.81 18.95 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.918 -0.583 . . . . 52.32 110.91 -177.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.431 ' CG2' ' HA ' ' A' ' 89' ' ' VAL . 60.0 t -63.84 -31.16 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 122.676 0.39 . . . . 73.24 111.587 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.1 m -79.0 6.1 10.13 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 122.033 -0.417 . . . . 74.22 112.069 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.27 13.67 82.54 Favored Glycine 0 CA--C 1.507 -0.412 0 C-N-CA 120.474 -0.869 . . . . 60.11 111.681 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -88.03 137.48 32.29 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.845 -1.169 . . . . 74.01 107.845 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.541 HG22 HG23 ' A' ' 15' ' ' ILE . 73.2 p -117.97 138.02 52.46 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.731 -0.788 . . . . 65.24 112.841 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HD2' ' O ' ' A' ' 39' ' ' VAL . 58.7 mttp -133.26 147.35 51.93 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.511 -0.922 . . . . 74.53 108.511 169.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.484 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 29.5 tt0 -135.78 131.29 35.29 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.671 -0.863 . . . . 61.32 108.671 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.623 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.6 m-85 -144.75 160.15 41.71 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 122.664 0.386 . . . . 71.12 109.989 -177.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -82.46 125.73 31.42 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.325 -0.991 . . . . 70.04 108.325 173.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.623 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 89.8 m-85 -128.92 173.84 10.04 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.537 -0.912 . . . . 74.54 108.537 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.0 p -100.22 153.14 37.92 Favored Pre-proline 0 N--CA 1.408 -2.556 0 N-CA-C 107.494 -1.298 . . . . 75.43 107.494 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.547 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 40.0 Cg_endo -61.76 -11.45 20.81 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 122.801 2.334 . . . . 74.12 112.161 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -96.81 -4.24 40.77 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.636 -0.711 . . . . 74.41 112.243 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' HB2' HD11 ' A' ' 35' ' ' ILE . 27.4 m-20 -74.7 153.31 38.92 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 119.861 -0.735 . . . . 64.54 110.833 177.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.523 ' O ' HG13 ' A' ' 35' ' ' ILE . 53.7 m -92.54 119.89 32.46 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 120.567 0.222 . . . . 74.21 110.619 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.425 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -45.44 -41.7 9.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.337 1.455 . . . . 72.05 113.568 -178.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 24.2 p -69.53 -41.28 76.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.014 0.435 . . . . 75.42 111.658 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -63.55 -41.77 98.42 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.514 -1.291 . . . . 75.3 107.514 177.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.532 ' O ' HG22 ' A' ' 39' ' ' VAL . 60.7 mt -61.78 -49.21 85.18 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.565 0 CA-C-N 114.619 -1.173 . . . . 75.03 110.408 178.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.419 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.02 -44.93 51.58 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.905 0.882 . . . . 73.22 112.043 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.456 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 1.8 tmtp? -73.21 -41.21 64.03 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.515 -0.921 . . . . 73.22 108.515 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -56.54 -45.26 81.26 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.646 1.179 . . . . 75.42 110.671 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.639 HG21 ' CB ' ' A' ' 14' ' ' LEU . 33.8 m -77.62 -29.64 16.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.371 -0.831 . . . . 74.43 111.826 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.4 t80 . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.356 -0.979 . . . . 74.34 108.356 176.86 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 88.9 mt . . . . . 0 CA--C 1.493 -1.219 0 N-CA-C 109.964 -0.384 . . . . 71.34 109.964 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -144.8 147.84 33.34 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.743 -0.662 . . . . 73.43 110.764 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 1.2 pt? -101.56 133.24 46.53 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 113.248 0.832 . . . . 64.22 113.248 -174.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 82.4 mt -102.49 119.03 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 107.302 -1.37 . . . . 62.13 107.302 175.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -101.64 73.6 1.45 Allowed 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.711 0.767 . . . . 71.11 109.16 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 70.53 -48.5 0.65 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 113.406 -1.725 . . . . 74.22 112.942 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.42 -65.42 0.74 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 121.03 -0.605 . . . . 54.1 113.198 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.554 ' NH1' ' HA ' ' A' ' 67' ' ' LEU . 3.1 ppt_? -131.06 176.64 8.08 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.702 0.63 . . . . 73.12 112.702 -174.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 71.8 m-85 -79.16 118.0 20.71 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.483 -0.932 . . . . 64.33 108.483 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.554 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 92.8 mt -79.26 -48.82 13.49 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.425 -0.91 . . . . 64.14 110.763 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -162.92 -171.77 2.81 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 124.293 1.037 . . . . 54.3 108.983 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.04 -43.22 7.22 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 110.99 -0.844 . . . . 62.1 110.99 175.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.483 ' HB3' ' OG ' ' A' ' 33' ' ' SER . 4.4 p-10 -148.71 77.86 1.39 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 122.447 1.118 . . . . 71.3 112.033 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.477 ' CG1' HD11 ' A' ' 60' ' ' LEU . 9.4 p -102.11 142.7 15.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 106.166 -1.791 . . . . 72.51 106.166 173.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.466 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 57.2 p -78.25 157.75 29.16 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.169 0.433 . . . . 65.32 112.169 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.568 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.9 mm? -64.82 -30.94 71.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.031 -0.531 . . . . 62.23 110.952 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.51 -36.62 92.75 Favored Glycine 0 C--N 1.33 0.207 0 N-CA-C 110.833 -0.907 . . . . 73.33 110.833 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.99 -15.35 62.57 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.262 0.625 . . . . 73.22 110.686 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 72' ' ' THR . 62.9 mt -84.11 13.73 4.86 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.056 -0.52 . . . . 73.42 111.116 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.471 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.5 mptt 67.37 24.68 8.87 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.663 0.785 . . . . 71.22 110.528 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.481 HD22 ' HE3' ' A' ' 82' ' ' LYS . 80.2 mt -93.97 122.33 62.19 Favored Pre-proline 0 C--N 1.311 -1.09 0 CA-C-N 115.798 -0.637 . . . . 53.51 111.04 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.93 171.45 16.47 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.242 1.961 . . . . 62.43 109.699 172.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.426 ' CE1' ' HG3' ' A' ' 28' ' ' PRO . 5.1 m-85 -84.97 170.74 12.73 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.829 -0.804 . . . . 73.33 108.829 -176.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.45 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 74.83 10.17 83.43 Favored Glycine 0 C--N 1.306 -1.101 0 N-CA-C 115.218 0.847 . . . . 71.23 115.218 173.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HE3' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -131.28 162.7 29.44 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 118.237 1.019 . . . . 65.31 111.914 178.24 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.555 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 33.3 m -96.81 126.71 42.16 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 116.145 -0.479 . . . . 74.1 110.804 -178.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.1 m -115.51 141.48 48.0 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.708 -0.678 . . . . 74.22 109.691 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.0 p -111.31 130.39 64.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 120.916 0.388 . . . . 45.41 110.016 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.461 ' HE1' HD12 ' A' ' 60' ' ' LEU . 90.9 mtp -138.38 153.11 48.93 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.051 0.453 . . . . 73.51 112.071 -178.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.515 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 60.5 m-70 -108.97 131.32 55.17 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.658 -0.868 . . . . 72.31 108.658 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.466 HD22 ' C ' ' A' ' 87' ' ' HIS . 3.2 mm? -121.95 144.65 48.75 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 120.784 0.326 . . . . 62.04 110.893 -177.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.431 ' HA ' ' CG2' ' A' ' 17' ' ' VAL . 27.8 m -119.78 136.69 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 CA-C-N 115.777 -0.647 . . . . 75.12 110.423 176.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.659 0 N-CA-C 107.293 -1.373 . . . . 72.23 107.293 174.142 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 11' ' ' ASN . 21.2 t . . . . . 0 N--CA 1.438 -1.059 0 N-CA-C 108.853 -0.795 . . . . 54.32 108.853 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -72.34 153.23 55.94 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.165 1.91 . . . . 54.43 111.664 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.86 71.3 5.31 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 122.379 1.085 . . . . 62.12 109.623 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -167.12 -27.81 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 112.883 -1.962 . . . . 51.21 106.954 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.1 mmm -112.8 153.08 28.38 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.861 -1.063 . . . . 63.23 108.778 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.408 HD11 ' HG ' ' A' ' 73' ' ' LEU . 2.8 pp -113.9 136.74 49.41 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 N-CA-C 109.757 -0.46 . . . . 63.14 109.757 172.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 50.0 t-20 -86.3 107.63 18.05 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.359 -1.349 . . . . 65.34 107.359 -176.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.498 ' HG ' HD22 ' A' ' 14' ' ' LEU . 40.7 tp -119.75 133.6 55.55 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 112.742 0.645 . . . . 74.13 112.742 -173.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.8 ttp-105 -108.58 121.21 44.53 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.492 -0.776 . . . . 73.02 109.027 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.606 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.0 mm? -99.3 121.13 40.65 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 114.701 -1.136 . . . . 73.33 108.365 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.436 HG12 HG22 ' A' ' 21' ' ' THR . 24.1 mt -101.37 123.93 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 C-N-CA 119.126 -1.03 . . . . 64.14 109.459 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.6 mt -81.79 165.07 21.23 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.896 -0.593 . . . . 71.01 110.383 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.9 m -69.27 -14.6 18.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.503 0.668 . . . . 62.12 110.81 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.3 m -78.83 1.51 23.13 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 124.43 1.092 . . . . 44.2 110.482 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.61 20.28 77.1 Favored Glycine 0 CA--C 1.499 -0.96 0 N-CA-C 110.705 -0.958 . . . . 33.52 110.705 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -108.47 134.67 50.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.076 -1.083 . . . . 75.32 108.076 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.436 HG22 HG12 ' A' ' 15' ' ' ILE . 75.9 p -108.33 137.71 45.83 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 120.247 -0.581 . . . . 62.43 111.07 -177.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -124.93 139.23 54.01 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.969 -1.123 . . . . 73.45 107.969 169.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -130.81 130.39 43.6 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.354 -0.98 . . . . 53.32 108.354 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.656 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.0 m-85 -145.18 159.87 42.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.373 -0.603 . . . . 74.35 109.373 -178.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.408 HD22 HG13 ' A' ' 5' ' ' VAL . 74.6 mt -80.42 125.72 30.28 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 107.637 -1.246 . . . . 71.24 107.637 173.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.656 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 84.4 m-85 -128.27 166.02 19.39 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.1 -1.074 . . . . 73.11 108.1 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.4 p -92.47 149.44 38.24 Favored Pre-proline 0 N--CA 1.414 -2.266 0 C-N-CA 118.903 -1.119 . . . . 74.25 108.218 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.501 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 40.2 Cg_endo -62.16 -11.2 20.94 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 122.773 2.316 . . . . 61.44 112.214 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -93.03 -10.05 37.55 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.727 -0.67 . . . . 75.24 111.579 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -73.94 153.65 39.69 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.824 0.345 . . . . 72.12 111.02 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 35' ' ' ILE . 20.4 m -87.24 118.45 26.67 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.348 -0.982 . . . . 74.52 108.348 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.636 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -54.33 -39.52 67.13 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.663 0.785 . . . . 71.43 112.689 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 p -73.4 -32.63 64.55 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.223 0.535 . . . . 63.23 111.526 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -66.9 -43.77 82.54 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.964 -1.125 . . . . 73.13 107.964 175.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.587 ' O ' HG22 ' A' ' 39' ' ' VAL . 69.4 mt -60.82 -41.59 89.19 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.946 0 CA-C-N 114.364 -1.289 . . . . 65.54 110.291 177.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 40' ' ' TYR . . . -50.13 -40.08 45.08 Favored 'General case' 0 C--O 1.212 -0.875 0 C-N-CA 122.855 0.462 . . . . 74.12 111.255 176.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -73.29 -38.46 65.89 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.255 0.55 . . . . 61.04 110.403 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 6.0 t60 -59.08 -50.35 74.38 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.895 1.278 . . . . 73.55 110.292 177.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.606 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.2 m -76.09 -30.35 20.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 123.413 0.685 . . . . 53.03 112.223 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 47.6 t80 . . . . . 0 N--CA 1.487 1.413 0 C-N-CA 123.669 0.787 . . . . 73.41 110.78 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.609 ' O ' ' HD2' ' A' ' 59' ' ' ARG . 96.2 mt . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 110.435 -0.209 . . . . 70.13 110.435 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.609 ' HD2' ' O ' ' A' ' 58' ' ' LEU . 4.4 mpt_? -129.88 150.32 51.23 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 123.291 0.636 . . . . 71.44 110.118 176.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.636 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.0 pp -135.34 140.34 44.99 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.805 0.336 . . . . 54.24 111.123 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 95.6 mt -112.66 122.42 66.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 109.03 -0.73 . . . . 71.31 109.03 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -100.96 87.57 3.32 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 107.048 -1.464 . . . . 75.01 107.048 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 69.45 -61.5 0.44 Allowed 'General case' 0 N--CA 1.404 -2.74 0 C-N-CA 127.168 2.187 . . . . 71.23 112.885 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.27 -28.42 1.22 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.177 -1.011 . . . . 73.34 114.591 -177.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.19 161.31 31.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.483 1.142 . . . . 74.14 111.992 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.612 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 79.7 m-85 -81.53 117.11 21.66 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.408 -0.96 . . . . 74.23 108.408 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.623 HD12 HD22 ' A' ' 76' ' ' LEU . 47.6 mt -80.16 -47.68 14.34 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.836 1.05 . . . . 71.35 113.836 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.476 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 9.2 t60 178.53 134.16 0.08 Allowed 'General case' 0 C--O 1.21 -0.995 0 N-CA-C 107.534 -1.284 . . . . 63.13 107.534 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.19 1.41 0.09 OUTLIER Glycine 0 CA--C 1.547 2.044 0 N-CA-C 118.335 2.094 . . . . 73.11 118.335 -174.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -162.77 21.04 0.09 Allowed 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 119.115 1.457 . . . . 74.33 109.313 -172.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.483 HG12 HD21 ' A' ' 60' ' ' LEU . 11.0 p -81.38 144.89 9.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 119.939 -0.705 . . . . 64.34 110.161 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.433 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 40.5 p -82.71 162.44 21.79 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.903 -0.589 . . . . 63.5 111.545 -177.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.546 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.7 mm? -66.99 -35.82 80.8 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.187 -0.46 . . . . 74.25 111.693 -175.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.53 -33.33 86.16 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.374 -0.917 . . . . 73.45 111.164 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.438 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -74.89 -15.92 60.69 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 123.03 0.532 . . . . 72.44 111.485 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.623 HD22 HD12 ' A' ' 67' ' ' LEU . 42.5 mt -84.87 -3.48 58.7 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.904 -0.776 . . . . 74.31 108.904 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.31 77.77 0.12 Allowed 'General case' 0 C--O 1.244 0.8 0 C-N-CA 125.701 1.601 . . . . 73.22 111.278 -175.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.479 HD22 ' HB3' ' A' ' 73' ' ' LEU . 10.6 mp -126.31 111.05 23.63 Favored Pre-proline 0 CA--C 1.497 -1.093 0 CA-C-N 115.274 -0.876 . . . . 74.51 111.048 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.85 142.37 62.65 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 121.915 1.744 . . . . 70.31 108.631 172.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -65.51 146.46 54.82 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.872 0.368 . . . . 73.25 110.619 -174.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.48 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 82.57 4.22 90.2 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.866 -0.606 . . . . 73.43 113.778 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -106.28 154.32 20.92 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 117.51 0.655 . . . . 54.44 112.409 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.55 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 52.6 m -91.62 121.1 32.98 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 115.534 -0.757 . . . . 75.12 110.315 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.5 m -130.82 135.63 47.92 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.832 -0.622 . . . . 74.34 110.501 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.8 p -108.14 142.2 21.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.98 -0.555 . . . . 73.14 110.851 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 91.2 mtp -135.55 153.29 51.75 Favored 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 123.021 0.528 . . . . 73.25 109.948 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.516 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 64.4 m-70 -105.2 125.49 51.03 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.067 -1.457 . . . . 73.21 107.067 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.79 142.75 46.51 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 120.04 -0.664 . . . . 73.52 110.938 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.62 132.58 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 N-CA-C 108.013 -1.106 . . . . 74.1 108.013 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.559 0 N-CA-C 109.563 -0.532 . . . . 75.12 109.563 179.685 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.4 t . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 107.759 -1.2 . . . . 61.23 107.759 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.18 19.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.534 3.489 . . . . 73.03 118.374 -170.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 63.41 -32.41 0.11 Allowed 'General case' 0 C--O 1.194 -1.855 0 C-N-CA 125.187 1.395 . . . . 73.34 114.607 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -86.89 -10.03 54.31 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.94 0.876 . . . . 72.45 110.089 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.1 mmm -124.52 153.47 42.02 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.382 -0.827 . . . . 73.44 109.22 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.511 HG22 ' HA ' ' A' ' 80' ' ' PHE . 2.8 pp -100.04 139.13 22.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 107.979 -1.119 . . . . 55.03 107.979 173.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -98.9 121.96 41.52 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.18 -1.044 . . . . 73.44 108.18 -175.636 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.56 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.1 tp -126.68 133.66 50.89 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 112.458 0.54 . . . . 62.34 112.458 -175.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -108.18 121.47 44.92 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.697 -0.683 . . . . 74.34 109.558 171.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.568 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.3 mm? -95.92 127.22 41.75 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 124.854 1.262 . . . . 64.23 108.685 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.601 HD12 HG22 ' A' ' 21' ' ' THR . 17.8 mm -99.72 120.25 48.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.568 -0.901 . . . . 72.45 108.568 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.2 mp -78.45 153.52 31.38 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.059 -0.719 . . . . 61.0 109.059 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.4 m -69.72 -13.64 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.579 0.704 . . . . 73.03 111.128 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.7 m -76.42 -9.78 58.9 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.392 -0.822 . . . . 75.42 109.792 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.56 7.19 61.94 Favored Glycine 0 CA--C 1.498 -0.997 0 CA-C-N 116.105 -0.498 . . . . 74.33 112.744 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -87.61 131.58 34.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.49 -0.929 . . . . 75.32 108.49 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.601 HG22 HD12 ' A' ' 15' ' ' ILE . 29.1 p -104.83 129.09 53.2 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.157 -1.423 . . . . 51.25 107.157 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -131.42 138.71 49.2 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.534 -0.913 . . . . 73.31 108.534 -175.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.463 ' CD ' HD21 ' A' ' 11' ' ' ASN . 1.0 OUTLIER -132.38 131.33 41.74 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.185 0.439 . . . . 72.25 112.185 -170.762 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.632 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 94.2 m-85 -144.61 160.24 41.48 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 115.276 -0.875 . . . . 74.11 110.513 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.7 mt -80.75 126.04 30.81 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.85 -1.167 . . . . 64.22 107.85 173.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.632 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 80.0 m-85 -128.35 165.09 21.25 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.876 -0.416 . . . . 63.42 109.876 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.5 m -92.51 142.92 26.45 Favored Pre-proline 0 N--CA 1.414 -2.259 0 N-CA-C 107.431 -1.322 . . . . 60.23 107.431 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.0 -11.34 21.11 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.751 2.301 . . . . 55.33 113.087 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -83.0 -17.49 43.2 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.055 0.942 . . . . 64.33 110.879 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.79 154.34 42.11 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.806 0.669 . . . . 55.45 112.806 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.522 ' O ' HG13 ' A' ' 35' ' ' ILE . 18.3 m -96.16 122.82 39.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.339 -0.846 . . . . 73.31 109.638 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.75 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -50.16 -51.8 40.62 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.834 1.049 . . . . 63.55 113.834 -176.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -69.58 -28.1 65.68 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.267 0.556 . . . . 60.04 110.831 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.44 -46.58 72.69 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.264 -1.013 . . . . 73.51 108.264 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 31' ' ' SER . 69.5 mt -59.89 -43.49 92.23 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.342 0 CA-C-N 114.543 -1.208 . . . . 71.45 110.29 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.41 -48.63 56.05 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.89 0.876 . . . . 74.23 111.799 178.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -72.41 -32.16 66.11 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.68 -0.859 . . . . 73.51 108.68 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -69.74 -51.23 35.98 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.625 0.77 . . . . 75.03 110.7 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.568 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.2 m -62.42 -32.07 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 123.103 0.561 . . . . 54.13 112.355 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.5 t80 . . . . . 0 C--O 1.239 0.518 0 O-C-N 123.662 0.601 . . . . 75.53 110.045 178.506 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.3 tp . . . . . 0 N--CA 1.445 -0.71 0 N-CA-C 108.867 -0.79 . . . . 75.12 108.867 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -141.57 163.3 33.31 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.142 0.496 . . . . 53.44 111.171 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.75 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.5 pp -141.08 150.69 43.23 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.554 -0.748 . . . . 61.22 110.265 -176.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.0 mt -122.82 126.78 74.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 108.891 -0.781 . . . . 51.15 108.891 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -100.16 72.22 1.64 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.483 -1.303 . . . . 75.42 107.483 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 65.06 -56.58 0.29 Allowed 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 128.109 2.564 . . . . 61.43 112.672 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.39 -62.17 1.35 Allowed Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 121.59 -0.338 . . . . 62.42 113.225 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.522 ' HD3' ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -131.03 175.96 8.64 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 117.369 0.585 . . . . 71.53 111.873 -175.643 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 56.0 m-85 -80.21 118.86 22.27 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.976 -1.12 . . . . 73.41 107.976 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.0 mt -79.72 -47.2 15.71 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.482 -0.887 . . . . 74.12 111.926 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.527 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 12.3 t60 -169.08 168.19 10.15 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 105.278 -2.119 . . . . 72.21 105.278 -174.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.88 -1.77 87.69 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 120.276 -0.964 . . . . 32.13 113.318 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' A' ' 31' ' ' SER . 48.8 t-20 -177.84 73.62 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.449 0.642 . . . . 74.32 109.775 -174.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.656 HG12 HD21 ' A' ' 60' ' ' LEU . 14.5 p -104.51 151.76 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 N-CA-C 108.726 -0.842 . . . . 64.43 108.726 175.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.46 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 64.2 p -87.18 162.6 17.4 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 118.124 0.42 . . . . 74.43 110.682 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.558 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.5 mm? -68.59 -34.8 76.41 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.783 0.325 . . . . 70.33 111.055 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.9 -34.22 89.26 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.717 -0.754 . . . . 65.3 111.26 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -72.8 -15.52 61.63 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.014 0.525 . . . . 60.51 111.571 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 72' ' ' THR . 70.9 mt -82.31 -1.66 50.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 75.42 109.93 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 77' ' ' LYS . 9.8 mptt 65.19 72.17 0.43 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 108.936 -0.764 . . . . 71.01 108.936 -175.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.427 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 94.5 mt -131.32 123.34 19.55 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-N 115.567 -0.742 . . . . 74.11 110.508 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 4.5 Cg_exo -80.07 143.65 16.22 Favored 'Trans proline' 0 N--CA 1.429 -2.269 0 C-N-CA 122.041 1.827 . . . . 72.23 110.326 173.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.511 ' HA ' HG22 ' A' ' 10' ' ' ILE . 1.6 p90 -75.36 148.38 39.29 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 115.033 -0.985 . . . . 74.41 110.227 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.59 2.73 67.24 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.174 -1.012 . . . . 62.33 110.912 -174.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -120.93 157.97 28.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 122.1 0.16 . . . . 61.24 110.645 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.519 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 26.2 m -105.69 127.32 53.0 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.147 0.498 . . . . 74.34 110.574 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.2 m -125.67 142.93 51.26 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.807 -0.633 . . . . 75.32 110.196 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.66 138.19 42.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 120.826 0.346 . . . . 65.32 110.203 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.568 ' O ' HG12 ' A' ' 15' ' ' ILE . 90.1 mtp -135.1 152.2 51.43 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.948 -0.39 . . . . 72.44 109.948 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.456 ' C ' HD22 ' A' ' 88' ' ' LEU . 50.4 m-70 -104.07 134.14 47.83 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 109.045 -0.724 . . . . 71.15 109.045 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.533 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.4 mm? -123.02 144.09 49.5 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 120.482 -0.487 . . . . 74.54 109.798 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.63 134.05 62.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 116.011 -0.54 . . . . 71.25 109.948 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.568 0 CA-C-N 115.815 -0.63 . . . . 73.32 109.361 179.314 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.476 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 38.3 t . . . . . 0 N--CA 1.431 -1.388 0 N-CA-C 109.051 -0.722 . . . . 63.5 109.051 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.22 166.67 8.77 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.682 2.254 . . . . 75.12 112.52 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.61 7.78 39.86 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.697 -0.683 . . . . 75.32 110.358 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -123.09 -0.22 8.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.033 -0.53 . . . . 75.35 110.184 175.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.1 mmm -130.74 155.77 46.09 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.964 -0.754 . . . . 64.15 108.964 -178.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.43 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.9 pp -122.73 134.11 66.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.002 -0.74 . . . . 71.42 109.002 174.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -90.83 109.87 21.08 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.536 -0.913 . . . . 74.32 108.536 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.547 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.0 tp -113.4 135.56 53.73 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 112.563 0.579 . . . . 75.51 112.563 -172.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 33.5 ttp180 -106.22 120.26 41.37 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 108.684 -0.858 . . . . 60.04 108.684 172.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.547 HD22 ' HG ' ' A' ' 12' ' ' LEU . 2.7 mm? -93.19 127.36 38.73 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.123 -1.399 . . . . 63.45 109.392 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.587 HG12 HG22 ' A' ' 21' ' ' THR . 22.6 mt -101.33 119.95 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 C-N-CA 118.937 -1.105 . . . . 53.05 109.369 176.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.5 tp -78.38 159.63 28.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.499 -0.773 . . . . 75.31 110.689 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.7 m -61.83 -13.76 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.913 0.885 . . . . 73.24 113.156 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.3 t -82.28 -10.03 59.26 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.566 -0.531 . . . . 63.21 109.566 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.23 11.44 62.89 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.069 -0.813 . . . . 73.12 111.069 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.67 148.99 26.78 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.093 -0.706 . . . . 63.32 109.093 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.587 HG22 HG12 ' A' ' 15' ' ' ILE . 69.5 p -112.33 152.55 28.42 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.084 0.468 . . . . 71.22 112.244 -174.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -146.22 139.7 26.02 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.445 -0.798 . . . . 72.04 110.575 169.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 27.4 tt0 -122.18 132.31 54.39 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.809 -0.632 . . . . 74.22 109.939 -173.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.718 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 89.7 m-85 -144.26 158.83 43.52 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.859 -0.793 . . . . 74.15 108.859 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.8 tp -85.62 125.39 33.1 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.043 -1.095 . . . . 74.31 108.043 176.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 89.9 m-85 -130.31 172.87 11.37 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.474 -0.565 . . . . 53.23 109.474 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.7 p -95.52 150.52 37.61 Favored Pre-proline 0 N--CA 1.409 -2.514 0 N-CA-C 107.099 -1.445 . . . . 53.5 107.099 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.678 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 57.9 Cg_endo -64.61 -11.51 29.17 Favored 'Trans proline' 0 C--N 1.321 -0.868 0 C-N-CA 122.297 1.998 . . . . 72.45 111.423 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -91.58 -6.0 53.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.387 -0.824 . . . . 64.05 111.83 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.428 ' HB2' HD11 ' A' ' 35' ' ' ILE . 26.9 m-20 -75.77 151.48 37.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 120.628 -0.429 . . . . 74.41 110.504 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.598 ' O ' HG13 ' A' ' 35' ' ' ILE . 54.0 m -87.07 119.98 27.87 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 110.001 -0.37 . . . . 62.23 110.001 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.484 ' CB ' HD13 ' A' ' 60' ' ' LEU . . . -45.01 -56.18 4.87 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.723 1.379 . . . . 33.02 114.723 -176.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.403 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . 28.2 m -75.65 -21.71 57.42 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.215 -0.594 . . . . 54.3 111.957 -176.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.09 -40.2 78.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.032 -1.47 . . . . 74.5 107.032 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.598 HG13 ' O ' ' A' ' 31' ' ' SER . 70.0 mt -63.74 -42.42 95.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 CA-C-N 114.401 -1.272 . . . . 75.1 109.986 176.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.61 -36.76 56.94 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.058 0.543 . . . . 73.42 111.771 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -72.62 -37.06 68.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.065 0.46 . . . . 75.12 110.068 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -70.08 -48.26 58.45 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.619 -0.719 . . . . 74.24 111.802 -178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.456 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.6 m -63.26 -31.07 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.021 0.439 . . . . 73.52 111.431 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.2 t80 . . . . . 0 CA--C 1.543 0.71 0 CA-C-N 115.182 -0.917 . . . . 73.33 111.761 175.864 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.436 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 97.0 mt . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 108.199 -1.037 . . . . 33.52 108.199 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 68' ' ' HIS . 18.2 tpt180 -146.85 141.62 26.8 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.096 -0.705 . . . . 73.43 109.096 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.484 HD13 ' CB ' ' A' ' 32' ' ' ALA . 1.2 pt? -112.81 140.93 47.18 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 121.064 -0.254 . . . . 71.21 111.201 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 61.9 mt -111.64 117.38 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.926 -0.768 . . . . 75.24 108.926 176.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.547 ' CB ' HD21 ' A' ' 67' ' ' LEU . 33.4 t80 -105.35 76.08 1.2 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.842 -0.743 . . . . 73.24 109.002 174.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 63' ' ' GLN 0.331 15.0 mm100 36.2 83.69 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 116.222 1.934 . . . . 62.31 116.222 178.515 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.89 -63.3 0.62 Allowed Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 114.879 -1.055 . . . . 70.42 110.908 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -130.81 156.4 45.06 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.047 -0.661 . . . . 75.11 112.077 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.426 ' HB3' ' HE ' ' A' ' 59' ' ' ARG . 1.6 m-85 -87.48 114.08 23.77 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 104.648 -2.353 . . . . 63.21 104.648 175.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.547 HD21 ' CB ' ' A' ' 62' ' ' TYR . 1.4 mm? -72.3 -50.31 27.96 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 119.603 -0.839 . . . . 72.53 112.198 -168.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.641 ' HB2' HG23 ' A' ' 71' ' ' VAL . 19.6 m80 179.73 -161.31 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 126.65 1.98 . . . . 74.21 106.262 -176.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.454 ' H ' ' HB3' ' A' ' 68' ' ' HIS . . . -84.51 -46.3 5.83 Favored Glycine 0 C--O 1.208 -1.476 0 N-CA-C 115.46 0.944 . . . . 73.1 115.46 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -134.64 34.58 3.19 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.392 1.096 . . . . 71.51 113.231 -172.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.641 HG23 ' HB2' ' A' ' 68' ' ' HIS . 74.0 t -62.03 137.65 23.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.533 -0.543 . . . . 75.55 109.533 176.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.598 ' HB ' ' O ' ' A' ' 28' ' ' PRO . 29.0 p -78.52 156.81 29.07 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.848 -0.615 . . . . 72.34 110.805 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.567 ' H ' HD22 ' A' ' 73' ' ' LEU . 2.2 mm? -64.86 -35.44 81.12 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.594 -0.73 . . . . 72.21 110.133 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.57 -36.54 93.36 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.907 -0.588 . . . . 65.3 111.864 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.41 -16.62 63.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.986 0.422 . . . . 61.44 110.939 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 73' ' ' LEU . 75.4 mt -83.79 12.43 6.02 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.765 0.826 . . . . 53.11 111.046 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.74 19.65 9.63 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.204 1.002 . . . . 73.12 110.491 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.514 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 94.0 mt -80.7 116.98 65.81 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.191 -0.459 . . . . 72.13 111.224 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.404 ' HD2' ' HE2' ' A' ' 82' ' ' LYS . 74.4 Cg_endo -77.58 161.27 31.21 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 C-N-CA 122.071 1.847 . . . . 61.44 110.829 175.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.678 ' CE2' ' HG3' ' A' ' 28' ' ' PRO . 71.7 m-85 -79.36 163.53 24.78 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.685 -0.857 . . . . 64.11 108.685 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 83.52 0.14 89.85 Favored Glycine 0 C--N 1.301 -1.371 0 C-N-CA 120.624 -0.798 . . . . 74.21 114.784 175.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.404 ' HE2' ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -124.95 157.68 35.47 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 118.971 -1.092 . . . . 74.25 112.688 -179.285 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.6 m -90.02 120.92 31.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.564 -0.744 . . . . 71.44 110.247 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.0 m -113.42 135.17 54.17 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.605 -0.271 . . . . 52.43 110.977 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.15 126.88 70.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 N-CA-C 109.676 -0.49 . . . . 74.21 109.676 175.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.419 ' O ' HG13 ' A' ' 15' ' ' ILE . 85.4 mtp -136.39 153.46 51.1 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-O 121.198 0.523 . . . . 75.44 112.098 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 59.5 m80 -102.24 137.15 40.87 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.458 -0.792 . . . . 74.23 109.936 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.416 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.6 mm? -120.53 141.42 50.27 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.958 -0.756 . . . . 63.55 108.958 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 59' ' ' ARG . 30.2 m -125.36 136.08 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-O 121.731 0.777 . . . . 72.34 111.05 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.413 0 N-CA-C 106.343 -1.725 . . . . 75.23 106.343 177.235 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.537 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 17.0 t . . . . . 0 N--CA 1.443 -0.808 0 N-CA-C 109.713 -0.477 . . . . 74.53 109.713 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.65 170.92 16.4 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.387 2.058 . . . . 62.03 111.616 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HA ' ' HB2' ' A' ' 80' ' ' PHE . . . -79.14 14.56 1.41 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.341 0.591 . . . . 53.45 111.484 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -108.32 -11.37 15.22 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.486 -0.561 . . . . 73.15 109.486 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.4 mmm -130.9 158.03 41.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.024 -0.535 . . . . 74.42 110.328 -174.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.448 ' CD1' ' HG ' ' A' ' 73' ' ' LEU . 2.8 pp -119.01 140.88 41.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.586 -0.524 . . . . 74.24 109.586 174.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.436 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 13.1 t-20 -94.83 115.73 27.85 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.424 -0.954 . . . . 73.51 108.424 -176.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.537 ' HG ' HD22 ' A' ' 14' ' ' LEU . 42.3 tp -117.77 133.88 55.49 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.646 0.736 . . . . 54.23 112.57 -173.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.509 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . 21.8 ttt85 -106.61 120.52 42.18 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 108.14 -1.059 . . . . 63.21 108.14 176.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.537 HD22 ' HG ' ' A' ' 12' ' ' LEU . 2.0 mm? -100.67 127.48 47.06 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.875 -1.057 . . . . 64.24 109.635 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.491 HD12 HG22 ' A' ' 21' ' ' THR . 21.3 mm -99.28 116.53 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 106.917 -1.512 . . . . 62.2 106.917 175.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.77 158.38 33.6 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.348 -0.387 . . . . 71.54 110.619 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.494 HG21 ' H ' ' A' ' 90' ' ' ALA . 90.2 t -66.01 -23.32 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 121.602 0.715 . . . . 75.21 110.2 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.2 m -75.56 -3.87 36.71 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.12 -0.945 . . . . 61.14 110.127 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.15 8.8 84.97 Favored Glycine 0 CA--C 1.495 -1.189 0 N-CA-C 111.579 -0.609 . . . . 53.21 111.579 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -87.19 131.44 34.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.558 -1.275 . . . . 74.41 107.558 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.491 HG22 HD12 ' A' ' 15' ' ' ILE . 64.5 p -107.76 129.28 55.06 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 109.905 -0.406 . . . . 55.53 109.905 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -148.47 149.92 32.53 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.183 -0.607 . . . . 72.2 110.344 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.476 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 29.7 tt0 -130.45 132.74 45.85 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.893 -0.14 . . . . 74.53 110.97 -170.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.525 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 35.0 m-85 -143.23 160.57 40.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.624 0.726 . . . . 73.21 112.107 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.478 HD11 HG13 ' A' ' 5' ' ' VAL . 37.3 tp -85.66 126.07 33.65 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.15 -0.932 . . . . 63.01 109.325 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.525 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 97.5 m-85 -133.42 171.12 14.5 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.672 -0.492 . . . . 73.41 109.672 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.3 p -94.99 150.65 38.05 Favored Pre-proline 0 N--CA 1.419 -2.001 0 C-N-CA 119.054 -1.058 . . . . 63.24 108.206 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 42.2 Cg_endo -62.85 -11.39 24.03 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.43 2.087 . . . . 74.22 111.784 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -79.68 -21.35 44.81 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.199 1.0 . . . . 73.3 109.777 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -75.77 152.27 37.4 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 116.321 -0.4 . . . . 70.23 110.429 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.522 ' O ' HG13 ' A' ' 35' ' ' ILE . 77.1 p -106.16 138.29 42.6 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 109.972 -0.381 . . . . 62.54 109.972 178.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.723 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -50.95 -49.62 59.53 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.864 1.061 . . . . 61.12 113.864 -175.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.0 m -64.52 -31.63 72.93 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 120.949 0.404 . . . . 52.22 110.891 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -70.12 -45.47 66.82 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.869 -0.789 . . . . 72.31 108.869 175.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 31' ' ' SER . 60.9 mt -60.78 -33.64 56.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.155 -0.93 . . . . 72.31 112.281 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.71 -40.43 40.49 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 110.491 -0.188 . . . . 72.42 110.491 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -64.11 -44.68 91.52 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.343 0.592 . . . . 72.05 109.838 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -62.57 -43.42 98.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.053 -1.43 . . . . 61.14 110.118 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.502 HG11 HD23 ' A' ' 14' ' ' LEU . 36.0 m -74.9 -32.17 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 113.76 1.022 . . . . 64.13 113.76 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 113.266 0.839 . . . . 75.15 113.266 176.326 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 CA--C 1.488 -1.407 0 N-CA-C 107.639 -1.245 . . . . 75.52 107.639 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.473 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 17.3 ptt180 -147.2 159.93 43.05 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.226 0.536 . . . . 72.13 112.262 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.723 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.4 pp -127.83 144.62 51.09 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.407 -0.815 . . . . 63.33 111.445 -172.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 85.6 mt -112.87 118.79 58.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.82 -0.807 . . . . 72.21 108.82 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -105.1 74.75 1.13 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.558 -0.534 . . . . 63.21 109.558 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 43.26 80.03 0.04 OUTLIER 'General case' 0 C--O 1.244 0.786 0 O-C-N 124.725 1.266 . . . . 63.51 113.367 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.74 -72.05 0.48 Allowed Glycine 0 N--CA 1.419 -2.439 0 CA-C-N 114.879 -1.055 . . . . 41.24 111.624 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -130.83 174.41 10.0 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.23 0.538 . . . . 70.22 112.375 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 71.0 m-85 -87.78 117.34 26.55 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 105.905 -1.887 . . . . 71.43 105.905 172.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.424 ' CD1' HD22 ' A' ' 76' ' ' LEU . 81.1 mt -79.81 -47.96 14.33 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.728 -0.789 . . . . 63.12 112.258 -176.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.514 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 10.4 t60 -172.67 158.04 3.97 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.736 -1.579 . . . . 72.43 106.736 -177.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -69.45 -0.65 24.63 Favored Glycine 0 CA--C 1.542 1.736 0 N-CA-C 117.091 1.596 . . . . 51.32 117.091 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -175.71 31.65 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.239 1.52 . . . . 62.34 109.362 -171.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.577 HG12 HD21 ' A' ' 60' ' ' LEU . 10.6 p -78.85 138.77 19.5 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 119.527 -0.869 . . . . 75.54 109.171 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.413 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 47.3 p -79.56 157.48 27.36 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.015 0.436 . . . . 62.3 112.032 -175.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.448 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 3.1 mm? -61.36 -34.22 74.93 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.612 -0.722 . . . . 72.13 111.487 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.32 -30.03 76.7 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.0 -0.619 . . . . 63.32 111.907 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.68 -15.74 58.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.397 0.617 . . . . 61.1 110.276 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.511 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 53.3 mt -83.19 12.89 4.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.825 -0.625 . . . . 74.14 111.158 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.0 mptt 69.46 12.56 8.27 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.209 1.004 . . . . 73.42 111.106 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.511 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 89.7 mt -76.03 121.81 85.72 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 112.374 0.509 . . . . 74.12 112.374 -175.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.443 ' HG2' ' HG3' ' A' ' 82' ' ' LYS . 45.8 Cg_endo -75.57 159.04 39.67 Favored 'Trans proline' 0 N--CA 1.442 -1.515 0 C-N-CA 122.091 1.861 . . . . 51.43 109.754 174.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.477 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 12.0 m-85 -80.67 151.51 28.92 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.059 -0.719 . . . . 63.54 109.059 -174.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.537 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 84.95 4.01 87.4 Favored Glycine 0 C--N 1.306 -1.112 0 C-N-CA 120.493 -0.861 . . . . 64.32 113.53 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.443 ' HG3' ' HG2' ' A' ' 79' ' ' PRO . 75.2 mmtt -110.35 149.27 30.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 117.013 0.406 . . . . 72.11 111.085 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.436 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 94.6 m -91.2 123.49 34.68 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.596 -0.729 . . . . 73.43 110.38 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.3 m -118.56 131.38 56.21 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.264 -0.88 . . . . 73.01 110.316 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.509 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 7.5 p -103.25 124.46 57.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.989 0.423 . . . . 75.34 110.281 177.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.484 ' O ' HG12 ' A' ' 15' ' ' ILE . 91.0 mtp -129.37 152.21 49.17 Favored 'General case' 0 CA--C 1.486 -1.5 0 CA-C-O 121.368 0.604 . . . . 75.32 110.603 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.489 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 38.5 m-70 -106.32 126.17 51.91 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.433 -0.803 . . . . 71.32 108.913 -178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.484 HD11 ' HB1' ' A' ' 32' ' ' ALA . 4.1 mm? -115.05 144.03 44.27 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-O 121.071 0.462 . . . . 62.43 111.992 -176.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.96 132.17 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 115.462 -0.79 . . . . 65.21 108.987 176.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.494 ' H ' HG21 ' A' ' 17' ' ' VAL . . . . . . . . 0 C--N 1.301 -1.505 0 CA-C-N 115.59 -0.732 . . . . 65.42 109.686 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.437 HG13 ' CD1' ' A' ' 25' ' ' LEU . 11.7 t . . . . . 0 N--CA 1.431 -1.376 0 N-CA-C 109.445 -0.576 . . . . 71.04 109.445 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -71.9 149.01 52.75 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 122.11 1.873 . . . . 72.13 109.876 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.35 73.32 5.98 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.059 0.933 . . . . 52.12 110.137 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -169.51 -37.91 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.458 -1.682 . . . . 61.53 106.458 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.0 mmm -96.99 143.64 27.65 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.523 -1.671 . . . . 75.3 108.675 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -98.66 140.81 17.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-O 121.033 0.444 . . . . 53.42 111.273 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.57 ' OD1' HG23 ' A' ' 83' ' ' THR . 18.7 t-20 -87.64 125.85 34.61 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.282 -0.636 . . . . 51.02 109.282 177.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.573 ' HG ' HD22 ' A' ' 14' ' ' LEU . 30.6 tp -131.8 132.21 43.56 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-O 121.326 0.584 . . . . 75.2 111.468 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.534 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . 23.1 ttt85 -106.93 120.99 43.53 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-N 114.917 -1.038 . . . . 75.23 109.115 175.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.573 HD22 ' HG ' ' A' ' 12' ' ' LEU . 1.8 mm? -103.74 126.49 50.91 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.04 -0.982 . . . . 74.44 108.823 -178.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.2 mt -99.47 119.36 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 107.944 -1.132 . . . . 73.0 107.944 175.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.9 mt -72.15 154.12 41.25 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.485 -0.779 . . . . 72.11 110.245 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.5 t -63.71 -15.99 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 122.086 0.946 . . . . 71.42 109.577 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.3 t -80.2 -10.19 59.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.187 -0.915 . . . . 50.14 110.447 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.51 70.4 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.574 -0.822 . . . . 63.4 112.392 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -87.32 135.53 33.29 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.666 -0.414 . . . . 63.03 110.901 176.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.6 p -100.95 129.88 46.86 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.721 -0.672 . . . . 64.22 110.316 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -140.6 138.68 34.61 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.2 -0.6 . . . . 72.04 111.183 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 28.7 tt0 -121.93 140.8 52.0 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 115.502 -0.772 . . . . 71.01 109.133 -173.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.707 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 72.1 m-85 -143.72 160.32 40.92 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 123.523 0.729 . . . . 75.21 109.985 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.437 ' CD1' HG13 ' A' ' 5' ' ' VAL . 32.9 tp -82.25 125.75 31.31 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 107.338 -1.356 . . . . 55.03 107.338 175.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.707 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 86.3 m-85 -132.07 172.77 11.96 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.862 -0.421 . . . . 61.41 109.862 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.1 p -100.02 148.93 35.51 Favored Pre-proline 0 C--N 1.286 -2.188 0 N-CA-C 107.589 -1.264 . . . . 60.34 107.589 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.69 -11.94 22.82 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 121.73 1.62 . . . . 72.13 112.079 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -80.05 -23.29 41.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.331 0.652 . . . . 63.12 111.156 177.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.403 ' O ' HD22 ' A' ' 73' ' ' LEU . 36.2 m-20 -66.89 154.38 41.12 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 120.769 0.319 . . . . 63.1 111.655 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.567 ' O ' HG13 ' A' ' 35' ' ' ILE . 44.2 m -98.52 124.03 43.02 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 122.295 -0.253 . . . . 62.23 110.579 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.651 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -46.63 -59.4 3.04 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 114.503 1.297 . . . . 61.15 114.503 -176.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 m -67.06 -27.83 67.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.223 0.535 . . . . 75.13 111.455 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.49 -47.26 67.5 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.733 -1.21 . . . . 70.14 107.733 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 31' ' ' SER . 77.1 mt -56.16 -36.34 45.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.132 -0.94 . . . . 73.23 111.621 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.75 -36.85 38.74 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.098 0.559 . . . . 72.32 112.357 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.6 -42.96 63.95 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 107.096 -1.446 . . . . 63.11 107.096 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.493 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 43.2 t-80 -55.87 -54.05 49.37 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.016 -1.447 . . . . 72.41 111.124 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.562 HG21 ' CB ' ' A' ' 14' ' ' LEU . 28.9 m -70.68 -31.64 46.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.035 -0.984 . . . . 64.21 112.362 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 86.6 t80 . . . . . 0 C--O 1.244 0.782 0 N-CA-C 112.447 0.536 . . . . 74.41 112.447 -179.162 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 CA--C 1.503 -0.858 0 N-CA-C 108.076 -1.083 . . . . 70.21 108.076 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.451 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 97.4 mtt180 -143.53 142.82 31.28 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.366 -0.605 . . . . 75.43 109.366 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.6 pp -130.31 132.72 46.0 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 120.99 0.424 . . . . 64.0 110.758 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 86.8 mt -108.32 120.6 59.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 121.47 0.652 . . . . 63.14 109.545 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -101.83 85.39 2.7 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 108.683 -0.858 . . . . 64.15 108.683 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 59.86 18.42 7.4 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.141 -1.391 . . . . 73.44 114.19 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.58 -52.85 0.37 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.367 -0.92 . . . . 73.44 112.985 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.467 ' HD3' ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -113.4 156.32 23.67 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.065 -0.654 . . . . 63.31 111.361 -177.298 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 85.8 m-85 -78.6 122.53 26.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.617 -1.253 . . . . 73.24 107.617 176.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.573 HD12 HD22 ' A' ' 76' ' ' LEU . 45.9 mt -79.71 -46.54 16.91 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 118.978 -1.089 . . . . 61.14 112.711 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.525 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.3 t-80 -165.48 172.6 11.93 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.005 -1.85 . . . . 73.32 106.005 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.56 -25.58 75.47 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.289 -0.958 . . . . 74.53 114.064 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -175.25 72.21 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.998 0.904 . . . . 74.23 109.054 -175.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.575 HG12 HD21 ' A' ' 60' ' ' LEU . 7.2 p -102.88 151.25 6.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 114.194 -1.366 . . . . 70.31 108.821 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.534 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 40.4 p -78.46 157.35 28.97 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 120.718 0.294 . . . . 54.11 111.212 -175.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.596 ' HA ' HD12 ' A' ' 76' ' ' LEU . 1.2 mm? -63.85 -27.5 69.21 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.765 0.426 . . . . 74.31 111.478 -177.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.66 -37.69 93.79 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.513 -1.035 . . . . 63.04 110.513 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -79.56 -16.87 55.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.341 0.591 . . . . 54.41 109.91 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' ' 73' ' ' LEU . 92.7 mt -86.51 2.96 46.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.693 -0.685 . . . . 64.5 110.716 176.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 11.1 mptt 69.56 21.2 6.81 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.9 0.88 . . . . 71.03 112.911 178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.428 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.4 mp -67.54 126.26 92.33 Favored Pre-proline 0 CA--C 1.511 -0.543 0 C-N-CA 119.726 -0.789 . . . . 65.21 111.426 176.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -86.6 137.22 4.8 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 122.427 2.085 . . . . 71.11 112.029 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -73.92 128.15 34.74 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.643 -0.708 . . . . 74.12 111.12 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.82 -6.01 76.67 Favored Glycine 0 C--N 1.3 -1.435 0 CA-C-N 115.096 -0.957 . . . . 51.11 111.925 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 11' ' ' ASN . 92.6 mttt -116.67 149.29 40.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 117.389 0.594 . . . . 74.32 111.655 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.57 HG23 ' OD1' ' A' ' 11' ' ' ASN . 30.7 m -84.81 136.35 33.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.12 -0.491 . . . . 74.3 110.86 -177.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.9 m -139.55 132.11 28.76 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.886 -0.412 . . . . 71.13 109.886 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.534 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 10.8 p -99.79 138.87 22.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.21 0.528 . . . . 65.31 111.441 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.469 ' SD ' HD13 ' A' ' 76' ' ' LEU . 81.4 mtp -137.97 152.38 48.86 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 116.074 -0.512 . . . . 73.53 110.315 177.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.527 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 25.2 m-70 -111.14 128.25 55.83 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.844 -1.539 . . . . 73.42 106.844 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.36 140.15 49.38 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.178 -0.609 . . . . 70.13 110.383 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 59' ' ' ARG . 6.1 m -129.99 142.12 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 109.291 -0.633 . . . . 73.31 109.291 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.278 -2.507 0 N-CA-C 105.854 -1.906 . . . . 40.42 105.854 176.002 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.46 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 3.6 t . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 110.036 -0.357 . . . . 73.5 110.036 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.44 ' C ' ' H ' ' A' ' 8' ' ' ASP . 88.2 Cg_endo -84.95 166.99 11.22 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.957 1.771 . . . . 60.03 111.077 177.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.39 30.63 0.41 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.828 0.823 . . . . 62.02 109.837 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 6' ' ' PRO . 19.6 t70 -120.43 -28.75 4.93 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.842 -1.072 . . . . 72.15 109.369 175.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.8 mtp -121.83 155.51 35.2 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 115.955 -0.566 . . . . 62.11 110.44 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.24 137.5 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 CA-C-N 115.591 -0.731 . . . . 71.12 109.507 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.449 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 2.4 t-20 -91.05 107.59 19.3 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 108.134 -1.062 . . . . 62.23 108.134 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.529 ' HG ' HD22 ' A' ' 14' ' ' LEU . 39.8 tp -112.56 132.97 54.85 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 115.283 -0.871 . . . . 71.04 111.545 -174.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 74.6 ttt180 -107.6 120.87 43.4 Favored 'General case' 0 N--CA 1.402 -2.863 0 N-CA-C 108.069 -1.085 . . . . 71.54 108.069 173.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.546 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.0 mm? -98.32 120.3 38.5 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.757 -1.11 . . . . 72.45 109.075 -178.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.523 HG12 HG22 ' A' ' 21' ' ' THR . 30.7 mt -103.64 118.4 50.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.565 -0.902 . . . . 71.52 108.565 177.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.87 163.51 26.68 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 123.691 0.619 . . . . 60.11 110.835 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.6 m -57.7 -27.11 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.09 0.774 . . . . 73.45 113.09 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.5 t -77.39 -16.08 59.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.653 0.263 . . . . 75.43 111.165 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.428 ' C ' ' HE3' ' A' ' 20' ' ' LYS . . . 100.81 5.68 53.33 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.994 -1.098 . . . . 62.22 111.843 -176.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.611 ' HE3' ' N ' ' A' ' 20' ' ' LYS . 0.5 OUTLIER -86.5 131.44 34.18 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.126 -1.065 . . . . 72.42 108.126 177.344 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.523 HG22 HG12 ' A' ' 15' ' ' ILE . 72.5 p -107.2 133.05 52.36 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 120.457 -0.497 . . . . 71.32 111.6 -175.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -122.37 139.57 53.68 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.591 -0.892 . . . . 62.35 108.591 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 26.0 tt0 -131.42 129.55 41.4 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.649 -0.82 . . . . 71.21 109.087 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.638 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.0 m-85 -146.54 160.7 41.8 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.035 0.534 . . . . 65.41 110.581 -178.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.444 ' CD2' HG13 ' A' ' 5' ' ' VAL . 75.4 mt -79.64 126.54 31.05 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.441 -0.578 . . . . 60.43 109.441 172.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.638 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 94.5 m-85 -131.58 167.75 18.87 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.213 -1.032 . . . . 62.32 108.213 175.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.3 p -94.35 151.7 39.61 Favored Pre-proline 0 N--CA 1.411 -2.387 0 C-N-CA 119.129 -1.028 . . . . 53.13 108.246 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.505 ' O ' ' HB ' ' A' ' 72' ' ' THR . 31.3 Cg_endo -60.17 -11.73 16.96 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.628 2.219 . . . . 63.33 112.418 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -96.17 -4.86 41.84 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.055 0.391 . . . . 72.12 112.055 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -76.02 154.06 36.0 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 120.474 -0.49 . . . . 63.42 110.363 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.594 ' O ' HG13 ' A' ' 35' ' ' ILE . 47.9 t -89.93 118.96 29.89 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.167 -0.679 . . . . 74.11 109.167 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.739 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -50.94 -41.9 59.36 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.173 0.989 . . . . 75.01 113.157 -176.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.2 t -77.34 -32.34 55.11 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.221 0.534 . . . . 55.02 110.24 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.0 -37.53 84.35 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.825 -1.176 . . . . 75.32 107.825 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.594 HG13 ' O ' ' A' ' 31' ' ' SER . 71.7 mt -64.45 -39.77 86.74 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 CA-C-N 114.587 -1.188 . . . . 64.31 110.611 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.88 -38.9 62.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.982 0.42 . . . . 54.24 111.463 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 -40.81 66.7 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 107.262 -1.384 . . . . 73.33 107.262 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.424 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 49.6 t-80 -57.96 -54.09 50.87 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.16 0.984 . . . . 71.54 110.916 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.546 HG21 ' CB ' ' A' ' 14' ' ' LEU . 29.6 m -66.38 -30.92 51.37 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 N-CA-C 113.255 0.835 . . . . 75.21 113.255 -178.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 76.4 t80 . . . . . 0 C--O 1.243 0.745 0 O-C-N 123.609 0.568 . . . . 63.14 110.708 177.14 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 CA--C 1.512 -0.507 0 N-CA-C 110.015 -0.365 . . . . 64.54 110.015 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 39.2 mmt180 -137.14 148.43 46.63 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.641 -0.503 . . . . 73.15 109.641 177.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.739 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.4 pp -130.92 139.71 50.11 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 110.115 -0.328 . . . . 74.05 110.115 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 87' ' ' HIS . 79.0 mt -112.75 119.65 60.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.288 0.566 . . . . 54.51 109.535 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -102.0 73.88 1.42 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.662 -1.236 . . . . 61.05 107.662 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 58.61 86.05 0.09 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 113.344 -1.753 . . . . 75.13 112.085 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.11 -56.59 0.6 Allowed Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.677 -0.692 . . . . 23.11 114.02 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -117.52 153.98 32.25 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.667 0.988 . . . . 75.23 113.667 -172.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 93.3 m-85 -82.91 117.15 22.55 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 108.443 -0.947 . . . . 74.41 108.443 176.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.663 HD12 HD22 ' A' ' 76' ' ' LEU . 81.8 mt -80.73 -47.98 13.2 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.288 -0.965 . . . . 71.11 112.749 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.73 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.5 t-80 -170.01 167.33 9.0 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 105.909 -1.885 . . . . 65.03 105.909 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.52 -1.28 87.83 Favored Glycine 0 C--N 1.3 -1.425 0 N-CA-C 115.785 1.074 . . . . 74.33 115.785 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -164.9 22.75 0.06 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.255 1.026 . . . . 72.24 110.442 -170.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.561 HG13 HD21 ' A' ' 76' ' ' LEU . 9.0 p -79.53 136.88 22.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 119.419 -0.912 . . . . 74.43 109.031 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.63 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 42.7 p -78.7 158.49 28.31 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.424 -0.353 . . . . 41.44 111.658 -173.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.616 HD13 HD12 ' A' ' 76' ' ' LEU . 1.9 mm? -64.07 -27.08 68.86 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.106 -0.497 . . . . 64.4 110.897 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.26 -38.43 95.1 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.352 -1.099 . . . . 71.33 110.352 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.29 -16.81 57.39 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.194 0.521 . . . . 53.03 110.096 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.663 HD22 HD12 ' A' ' 67' ' ' LEU . 86.9 mt -86.24 4.41 38.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.918 -0.583 . . . . 72.41 111.33 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER 68.88 25.3 6.17 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.947 0.899 . . . . 75.32 113.254 177.641 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.446 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.2 mp -72.76 123.53 89.66 Favored Pre-proline 0 C--O 1.236 0.384 0 C-N-CA 120.083 -0.647 . . . . 64.04 111.322 175.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 1.3 Cg_endo -80.2 146.96 18.15 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.444 2.096 . . . . 65.33 111.088 176.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -73.73 141.94 46.34 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.191 -1.04 . . . . 70.25 108.191 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.46 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 82.01 -3.92 78.07 Favored Glycine 0 C--N 1.3 -1.435 0 C-N-CA 120.735 -0.745 . . . . 53.12 113.521 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -116.13 145.64 42.9 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 117.163 0.481 . . . . 73.15 111.463 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.449 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 23.5 m -85.19 125.1 32.57 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.967 -0.56 . . . . 73.42 110.99 -177.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.1 m -125.09 135.9 53.13 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.977 -0.556 . . . . 73.42 109.508 176.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.43 137.8 31.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.352 -0.385 . . . . 73.13 110.889 -178.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 82.8 mtp -138.69 153.45 48.54 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 120.902 0.382 . . . . 52.23 111.325 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.441 ' C ' HD22 ' A' ' 88' ' ' LEU . 25.6 m-70 -103.93 129.27 51.46 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 107.229 -1.397 . . . . 71.32 107.229 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.441 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.8 mm? -123.9 140.19 53.23 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 119.66 -0.816 . . . . 75.14 110.681 -176.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.43 ' CG2' ' HB2' ' A' ' 59' ' ' ARG . 25.2 m -118.7 133.68 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.829 0 CA-C-O 121.711 0.767 . . . . 74.44 109.445 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.268 -2.942 0 N-CA-C 105.108 -2.182 . . . . 65.44 105.108 174.647 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.489 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 17.7 t . . . . . 0 N--CA 1.431 -1.387 0 N-CA-C 110.087 -0.338 . . . . 72.41 110.087 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.07 162.69 36.54 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.204 1.936 . . . . 74.23 111.05 175.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.88 36.85 0.63 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.864 0.84 . . . . 53.22 109.597 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.72 -19.13 2.1 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.632 -1.167 . . . . 70.22 109.446 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.2 mmm -124.29 150.68 45.12 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.641 -0.708 . . . . 71.41 110.07 -174.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -101.61 139.09 23.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.998 -0.742 . . . . 52.4 108.998 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.432 HD22 HG23 ' A' ' 83' ' ' THR . 6.0 t30 -96.69 114.39 26.03 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.234 -1.024 . . . . 74.54 108.234 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.546 ' HG ' HD22 ' A' ' 14' ' ' LEU . 44.4 tp -120.16 133.46 55.49 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 112.586 0.587 . . . . 74.35 112.586 -172.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 49.1 ttt180 -108.47 120.71 43.21 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 108.443 -0.947 . . . . 75.31 108.443 174.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.573 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.3 mm? -98.53 122.29 41.54 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-N 114.531 -1.213 . . . . 55.32 109.605 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.642 HG23 HG22 ' A' ' 21' ' ' THR . 22.1 mt -112.22 125.46 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.635 -0.876 . . . . 74.31 108.635 177.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -94.47 161.57 14.17 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 116.323 -0.399 . . . . 64.35 110.884 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.417 ' CG1' HG12 ' A' ' 89' ' ' VAL . 28.6 m -60.5 -14.67 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.4 0.68 . . . . 60.55 112.757 179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.1 m -79.79 -7.16 58.5 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 116.199 -0.455 . . . . 54.24 110.351 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.55 0.54 81.92 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 116.265 -0.425 . . . . 60.3 112.598 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -87.67 133.93 33.74 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.237 -0.653 . . . . 75.44 109.237 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.642 HG22 HG23 ' A' ' 15' ' ' ILE . 40.2 p -116.73 131.87 56.84 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 109.585 -0.524 . . . . 75.44 109.585 -177.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HD2' ' O ' ' A' ' 39' ' ' VAL . 63.8 mttp -129.32 139.97 51.56 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 110.022 -0.362 . . . . 64.41 110.022 174.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 27.2 tt0 -125.09 130.0 51.37 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.257 -0.646 . . . . 72.41 109.257 -177.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.608 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 95.8 m-85 -146.14 160.52 41.82 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 122.946 0.498 . . . . 74.42 111.081 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.2 mt -82.57 126.28 32.11 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.503 -0.555 . . . . 71.13 109.503 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.608 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 95.5 m-85 -132.58 166.1 22.89 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.115 -1.068 . . . . 62.23 108.115 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.4 p -89.71 150.46 44.11 Favored Pre-proline 0 N--CA 1.418 -2.054 0 N-CA-C 108.194 -1.039 . . . . 65.13 108.194 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.451 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 34.2 Cg_endo -60.32 -11.68 17.26 Favored 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 122.59 2.194 . . . . 63.21 112.287 177.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -91.72 -9.81 42.41 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.582 0.753 . . . . 72.32 111.221 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -71.15 154.09 41.99 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.147 0.499 . . . . 72.24 111.409 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.519 ' O ' HG13 ' A' ' 35' ' ' ILE . 49.9 m -95.11 121.23 36.53 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.76 -0.655 . . . . 72.15 110.425 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.426 ' HB3' ' HG ' ' A' ' 60' ' ' LEU . . . -49.22 -42.66 41.15 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.207 1.003 . . . . 50.5 113.088 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 5.8 p -73.06 -34.13 66.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.895 0.379 . . . . 63.13 112.008 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.4 -47.12 80.41 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.03 -1.1 . . . . 75.31 108.03 175.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.54 ' O ' HG22 ' A' ' 39' ' ' VAL . 68.6 mt -59.67 -46.24 93.52 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.379 0 CA-C-N 114.342 -1.299 . . . . 72.32 110.683 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.402 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.45 -46.6 56.72 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.438 0.695 . . . . 72.14 111.742 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.541 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 7.6 tmtt? -73.28 -33.63 65.32 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.736 -0.839 . . . . 54.44 108.736 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -66.2 -51.97 52.56 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.196 0.998 . . . . 51.12 110.734 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.573 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.7 m -65.29 -30.22 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.744 0.817 . . . . 74.14 111.509 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.541 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 64.9 t80 . . . . . 0 C--O 1.234 0.257 0 CA-C-N 115.303 -0.862 . . . . 65.23 111.861 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 83.2 mt . . . . . 0 CA--C 1.509 -0.621 0 N-CA-C 109.693 -0.484 . . . . 74.34 109.693 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -137.28 144.67 42.81 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.024 -1.102 . . . . 71.35 108.024 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -109.38 147.0 33.5 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 113.959 1.096 . . . . 72.41 113.959 178.314 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -117.53 119.51 61.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.214 -1.032 . . . . 63.31 108.214 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.576 ' HB3' HD11 ' A' ' 67' ' ' LEU . 11.8 t80 -100.33 90.95 4.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.74 -1.207 . . . . 72.51 107.74 176.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 71.96 -70.3 0.16 Allowed 'General case' 0 N--CA 1.401 -2.913 0 C-N-CA 127.05 2.14 . . . . 73.02 112.392 -176.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.9 -47.75 1.07 Allowed Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 119.877 -1.154 . . . . 62.25 115.196 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -124.19 170.34 10.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 118.049 0.924 . . . . 72.41 112.991 -172.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.548 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 73.7 m-85 -83.7 118.33 23.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.742 -0.836 . . . . 73.21 108.742 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 62' ' ' TYR . 7.0 mp -80.77 -45.96 16.17 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 113.553 0.945 . . . . 64.41 113.553 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -168.84 172.27 7.89 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 106.774 -1.565 . . . . 51.42 106.774 -173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.44 -1.51 87.85 Favored Glycine 0 C--N 1.306 -1.126 0 N-CA-C 111.783 -0.527 . . . . 75.33 111.783 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -175.92 80.93 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.497 -1.297 . . . . 75.42 107.497 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 p -104.93 151.7 7.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.546 -1.279 . . . . 72.04 107.546 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.2 p -91.17 158.11 16.81 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 118.232 0.469 . . . . 73.04 110.203 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.528 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.9 mm? -69.32 -30.63 68.73 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.04 0.447 . . . . 44.23 110.642 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.1 -35.02 91.51 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.187 -0.765 . . . . 72.41 111.187 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.03 -15.7 63.05 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.2 0.6 . . . . 34.21 111.282 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.426 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 65.2 mt -85.11 -1.6 57.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 73.42 110.158 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 8.8 mptt 63.41 72.34 0.48 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.359 1.064 . . . . 55.15 109.375 -177.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 73' ' ' LEU . 87.7 mt -125.17 117.74 25.43 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 115.479 -0.782 . . . . 71.33 111.423 -175.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.67 152.12 64.36 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.403 2.068 . . . . 74.23 110.147 172.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -75.92 148.39 38.26 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.734 -0.839 . . . . 64.34 108.734 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.489 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 91.99 -10.79 73.71 Favored Glycine 0 C--N 1.296 -1.671 0 C-N-CA 119.744 -1.217 . . . . 63.24 113.043 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -101.23 138.98 37.53 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.148 0.499 . . . . 62.33 111.884 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.432 HG23 HD22 ' A' ' 11' ' ' ASN . 35.1 m -79.88 118.46 21.66 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.201 -0.909 . . . . 73.24 109.94 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.7 m -116.78 129.42 56.09 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.921 -0.581 . . . . 64.02 109.55 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -104.89 140.36 23.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.905 -0.405 . . . . 70.3 109.905 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 92.4 mtp -138.23 153.58 49.11 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 120.869 0.366 . . . . 75.32 111.042 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -106.59 129.6 54.49 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.077 -1.083 . . . . 75.12 108.077 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.0 mm? -122.6 139.34 54.04 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 122.126 -0.359 . . . . 55.11 110.447 -175.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.417 HG12 ' CG1' ' A' ' 17' ' ' VAL . 29.1 m -116.87 132.48 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 C-N-CA 119.892 -0.723 . . . . 64.53 109.721 176.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.711 0 N-CA-C 107.789 -1.189 . . . . 70.11 107.789 176.03 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.429 -1.51 0 N-CA-C 107.788 -1.19 . . . . 75.34 107.788 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.7 t -127.86 125.44 39.71 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.331 -0.989 . . . . 61.52 108.331 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 68.27 108.83 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.346 1.029 . . . . 72.13 110.428 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.4 t -92.03 115.34 64.46 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 108.319 -0.993 . . . . 65.14 108.319 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -72.52 156.13 54.34 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.077 1.851 . . . . 71.54 111.012 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.57 7.2 1.14 Allowed 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.671 0.989 . . . . 44.13 113.671 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -109.24 -6.06 15.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.644 -0.502 . . . . 74.21 109.644 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.4 mmm -130.19 154.51 47.47 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.237 0.541 . . . . 71.24 110.543 -172.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.48 HG22 ' HA ' ' A' ' 80' ' ' PHE . 2.7 pp -115.92 131.12 69.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.946 -0.57 . . . . 62.51 110.072 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.554 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 48.2 t-20 -84.57 114.5 22.02 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.039 -1.467 . . . . 71.24 107.039 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.495 ' HG ' HD22 ' A' ' 14' ' ' LEU . 41.7 tp -121.32 133.17 55.11 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.946 0.721 . . . . 62.44 112.946 -172.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.447 ' HE ' ' HB ' ' A' ' 21' ' ' THR . 75.5 ttt180 -108.57 121.39 44.9 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 115.14 -0.937 . . . . 64.41 108.737 174.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.529 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.2 mm? -99.37 120.27 39.31 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.885 -1.052 . . . . 62.42 108.612 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.476 HG23 HG22 ' A' ' 21' ' ' THR . 32.1 mt -107.33 122.88 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 108.451 -0.944 . . . . 75.11 108.451 177.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.59 160.48 18.17 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 116.384 -0.371 . . . . 63.41 110.346 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.7 t -58.66 -26.15 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.643 0.777 . . . . 74.43 111.569 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -76.43 -6.09 50.2 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.768 -0.651 . . . . 64.33 111.214 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.08 6.74 66.51 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.502 -0.856 . . . . 65.34 112.032 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -87.61 131.41 34.43 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.045 -0.724 . . . . 75.44 109.045 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.476 HG22 HG23 ' A' ' 15' ' ' ILE . 68.5 p -111.44 129.77 55.92 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 120.364 -0.534 . . . . 71.03 110.276 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.64 139.77 53.57 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.482 -1.303 . . . . 72.45 107.482 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -133.58 130.61 38.64 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.927 -1.109 . . . . 71.21 109.285 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.673 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.6 m-85 -145.17 160.35 41.58 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 123.526 0.73 . . . . 63.54 109.299 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.1 tp -84.09 125.7 32.37 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.689 -1.226 . . . . 64.12 107.689 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.673 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 82.4 m-85 -127.81 168.47 15.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.05 0.453 . . . . 55.43 111.022 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.461 ' HB2' ' OD2' ' A' ' 30' ' ' ASP . 20.4 m -92.87 140.53 23.59 Favored Pre-proline 0 N--CA 1.424 -1.774 0 N-CA-C 108.366 -0.976 . . . . 70.51 108.366 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.464 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 27.3 Cg_endo -60.01 -18.79 52.42 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.632 2.221 . . . . 61.34 113.267 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -81.35 -11.76 59.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.208 -0.451 . . . . 60.22 111.197 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' A' ' 27' ' ' SER . 22.0 m-20 -78.99 153.76 30.06 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.836 -0.54 . . . . 74.23 111.751 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.471 ' O ' HG13 ' A' ' 35' ' ' ILE . 25.8 p -95.35 131.31 41.6 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.111 0.481 . . . . 74.22 111.521 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.713 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -51.93 -41.83 62.33 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 124.262 1.025 . . . . 62.2 113.706 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.7 p -74.86 -30.95 61.49 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.471 0.545 . . . . 72.13 112.471 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -69.08 -42.48 76.13 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 107.402 -1.333 . . . . 74.32 107.402 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.511 HG23 ' CZ ' ' A' ' 26' ' ' PHE . 67.0 mt -60.97 -43.61 96.36 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.216 0 CA-C-N 114.175 -1.375 . . . . 53.41 110.745 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.72 -42.6 57.36 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.086 0.555 . . . . 74.44 111.874 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.596 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -72.14 -39.77 68.55 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.078 -1.452 . . . . 71.02 107.078 -178.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -61.87 -45.74 92.46 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.612 -0.722 . . . . 74.12 110.97 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 14' ' ' LEU . 26.8 m -71.61 -31.99 44.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 112.693 0.627 . . . . 73.15 112.693 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -51.38 -48.87 62.41 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 123.127 0.267 . . . . 71.14 111.471 173.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -167.26 -86.88 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.598 0.962 . . . . 72.05 113.598 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -109.19 164.74 12.18 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.041 -0.355 . . . . 71.42 110.041 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 55.6 p-90 -64.98 134.58 96.11 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 113.153 0.797 . . . . 71.24 113.153 -174.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.02 137.57 76.64 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 123.481 2.787 . . . . 75.25 111.978 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 64.6 mtt -95.45 -60.07 1.74 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.402 -0.363 . . . . 74.0 111.383 -176.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -154.44 75.59 1.0 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.877 0.846 . . . . 55.21 112.751 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.439 ' CD1' ' HB3' ' A' ' 49' ' ' GLU . 70.4 t-105 57.39 86.94 0.07 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.083 -1.417 . . . . 74.31 112.152 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.508 ' HG3' ' HD3' ' A' ' 97' ' ' PRO . 13.7 mp0 -73.82 87.53 1.75 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.915 -1.039 . . . . 73.21 110.352 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.499 ' HA ' HD11 ' A' ' 57' ' ' ILE . 16.8 pt-20 -106.61 -171.55 1.91 Allowed 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.87 -1.059 . . . . 70.3 110.252 -177.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 3.1 tm-20 -78.09 141.68 38.63 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 106.215 -1.772 . . . . 73.1 106.215 173.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -53.75 -44.88 70.34 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.352 1.612 . . . . 63.31 115.352 -169.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.7 m -85.93 14.91 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.879 0 CA-C-O 121.789 0.804 . . . . 45.41 111.06 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 t 81.07 114.23 0.06 Allowed 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 127.163 2.185 . . . . 43.52 114.07 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 46.5 m -151.92 99.46 2.92 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 114.064 -1.425 . . . . 42.54 107.609 175.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.26 -27.59 9.47 Favored 'Trans proline' 0 C--N 1.329 -0.497 0 C-N-CA 122.056 1.837 . . . . 74.42 112.787 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -73.66 -4.7 35.9 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.136 0.493 . . . . 71.42 112.321 -174.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.499 HD11 ' HA ' ' A' ' 49' ' ' GLU . 2.3 pp -77.89 -15.54 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 O-C-N 121.964 -0.46 . . . . 73.04 111.987 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.481 ' HG ' HD12 ' A' ' 57' ' ' ILE . 84.9 mt -104.61 105.06 15.01 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.715 -0.846 . . . . 72.0 108.715 175.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.5 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 83.0 mtp180 -138.26 162.3 34.67 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.174 0.511 . . . . 74.21 109.892 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.713 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.5 pp -123.12 135.54 54.41 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 115.603 -0.726 . . . . 71.1 110.727 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 85.7 mt -110.45 123.32 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 N-CA-C 108.48 -0.933 . . . . 70.51 108.48 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -100.91 50.27 0.87 Allowed 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 106.649 -1.612 . . . . 74.34 106.649 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 60.69 93.5 0.04 OUTLIER 'General case' 0 N--CA 1.394 -3.243 0 C-N-CA 127.6 2.36 . . . . 72.21 112.168 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.99 -29.42 10.01 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.236 -0.893 . . . . 72.23 112.848 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -130.51 137.76 49.9 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.972 0.731 . . . . 72.4 112.972 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -88.6 113.67 24.42 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 106.293 -1.743 . . . . 74.23 106.293 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.559 HD12 ' CD2' ' A' ' 76' ' ' LEU 0.258 29.1 mt -79.16 -43.54 23.74 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 117.936 -1.506 . . . . 73.12 112.471 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.669 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.6 t-80 -173.82 -175.62 1.1 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.552 -1.277 . . . . 71.33 107.552 176.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -85.03 -14.16 70.07 Favored Glycine 0 C--N 1.302 -1.347 0 N-CA-C 115.743 1.057 . . . . 43.02 115.743 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -167.64 28.08 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 118.192 0.996 . . . . 64.5 109.846 -172.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.561 HG12 HD21 ' A' ' 60' ' ' LEU . 11.9 p -74.67 147.63 8.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.265 -0.643 . . . . 73.55 109.265 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.573 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 45.7 p -78.77 158.4 28.25 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 112.419 0.526 . . . . 72.24 112.419 -173.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.52 HD13 HD12 ' A' ' 76' ' ' LEU . 3.6 mm? -60.02 -41.38 92.04 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.413 0.685 . . . . 73.14 111.862 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.57 -37.99 94.24 Favored Glycine 0 C--N 1.317 -0.521 0 N-CA-C 111.36 -0.696 . . . . 54.13 111.36 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.439 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -74.88 -16.04 60.69 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 122.798 0.439 . . . . 53.32 111.547 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 72' ' ' THR . 62.7 mt -83.77 -4.7 58.85 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.252 -0.647 . . . . 63.01 109.252 177.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.6 mptt 71.28 79.55 0.16 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.69 1.196 . . . . 74.3 111.297 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 73' ' ' LEU . 10.8 mp -123.47 117.11 27.94 Favored Pre-proline 0 CA--C 1.494 -1.192 0 CA-C-N 115.526 -0.761 . . . . 75.1 111.474 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.513 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 11.0 Cg_exo -64.11 122.85 10.98 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 121.728 1.618 . . . . 75.33 109.197 171.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.48 ' HA ' HG22 ' A' ' 10' ' ' ILE . 1.1 p90 -69.77 144.44 52.69 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.338 0.589 . . . . 74.14 112.171 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.38 9.05 60.71 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.087 -0.96 . . . . 65.42 113.157 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -132.01 163.87 27.45 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 117.863 0.831 . . . . 75.34 110.622 176.373 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.554 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 25.7 m -91.66 129.37 37.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.407 0.622 . . . . 53.13 111.361 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.6 m -122.23 133.37 54.71 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.834 -0.621 . . . . 74.41 110.292 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.2 p -104.57 139.34 25.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 109.887 -0.412 . . . . 71.33 109.887 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 85.7 mtp -138.25 153.49 49.08 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-O 121.009 0.433 . . . . 54.33 111.079 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.484 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 59.1 m-70 -111.26 126.84 55.31 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.609 -1.256 . . . . 53.15 107.609 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.4 mm? -113.47 142.2 46.2 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 122.156 -0.34 . . . . 44.43 110.201 -176.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.84 134.01 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 121.223 0.535 . . . . 74.05 111.009 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 57' ' ' ILE . . . -134.42 136.42 43.27 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 107.983 -1.118 . . . . 73.31 107.983 176.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.409 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 99.3 mtt180 -133.48 126.92 32.17 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 110.074 -0.343 . . . . 53.3 110.074 -174.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 58.23 23.1 9.94 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.398 0.679 . . . . 74.2 111.159 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 t -79.95 137.4 36.85 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.455 -0.793 . . . . 75.23 110.04 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.2 mp -98.08 135.91 21.22 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 109.03 -0.73 . . . . 72.21 109.03 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -66.98 106.53 1.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.584 1.522 . . . . 73.12 108.85 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 66.74 109.43 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.192 0.997 . . . . 73.34 110.166 -174.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.508 ' HD3' ' HG3' ' A' ' 48' ' ' GLU . 4.1 Cg_endo -49.45 -66.22 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.36 2.707 . . . . 71.44 113.777 -174.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.526 ' HB3' HE22 ' A' ' 100' ' ' GLN . 7.9 t30 -147.08 15.71 1.18 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.181 0.991 . . . . 74.21 108.631 174.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.6 t 71.93 17.72 5.18 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.456 -1.247 . . . . 60.32 113.377 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.526 HE22 ' HB3' ' A' ' 98' ' ' ASN . 1.8 mp0 -63.1 -50.94 68.53 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 119.62 -0.832 . . . . 60.03 111.388 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.24 34.64 57.75 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 107.939 -2.064 . . . . 63.53 107.939 -172.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -71.11 115.99 10.89 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.406 -0.897 . . . . 63.11 110.437 -176.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -138.98 176.77 8.4 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.648 -1.16 . . . . 65.11 108.967 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -99.96 169.96 8.84 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 105.792 -1.929 . . . . 62.03 105.792 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.506 ' NE ' ' HA ' ' A' ' 105' ' ' ARG . 3.8 mmp_? -61.79 -50.46 72.26 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 118.11 0.413 . . . . 75.12 111.355 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 54.3 29.98 11.73 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.225 1.01 . . . . 63.11 110.81 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -148.62 122.82 9.55 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 115.477 -0.783 . . . . 72.3 110.355 -174.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.0 p -67.84 130.4 42.87 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 116.09 -0.505 . . . . 73.45 109.91 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.86 -27.14 6.92 Favored Glycine 0 C--N 1.308 -1.0 0 N-CA-C 108.317 -1.913 . . . . 44.02 108.317 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -93.96 -175.17 3.63 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 114.06 -1.07 . . . . 70.04 108.466 176.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.6 m 67.0 100.1 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.043 0.937 . . . . 51.41 111.962 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -96.88 102.72 14.56 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.194 0.521 . . . . 74.31 110.066 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 65.4 m -92.68 159.96 15.21 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.071 -0.714 . . . . 70.34 109.071 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 67.9 m -73.33 138.56 45.47 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.071 0.462 . . . . 63.24 110.194 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.1 m -119.27 153.61 21.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 116.093 -0.503 . . . . 75.5 109.784 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.1 tp -165.73 80.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.829 0.823 . . . . 71.41 110.328 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 C--N 1.316 -0.861 0 N-CA-C 105.764 -1.939 . . . . 74.34 105.764 179.856 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.5 p . . . . . 0 N--CA 1.428 -1.546 0 CA-C-O 122.229 1.014 . . . . 75.04 111.378 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.0 m -149.18 16.05 0.93 Allowed 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.145 -1.428 . . . . 54.23 107.145 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -150.32 -174.08 4.64 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 104.383 -2.451 . . . . 73.11 104.383 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.4 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 29.3 t -92.26 115.64 65.08 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 108.631 -0.877 . . . . 53.13 108.631 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -63.52 166.42 15.44 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.22 1.947 . . . . 71.41 112.197 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.46 11.74 20.74 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.607 -0.724 . . . . 64.32 109.491 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -121.72 -3.67 9.24 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.174 -0.921 . . . . 73.53 108.582 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.7 mmm -126.93 152.32 47.29 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.925 -0.768 . . . . 74.44 108.925 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -111.88 139.37 36.65 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 N-CA-C 109.275 -0.639 . . . . 71.35 109.275 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.596 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 54.4 t-20 -88.17 116.28 26.26 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.923 -1.14 . . . . 55.15 107.923 -176.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.502 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.7 tp -127.36 132.99 50.1 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 121.156 0.503 . . . . 74.05 112.185 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.409 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 35.2 ttp180 -109.6 120.65 43.14 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 108.561 -0.903 . . . . 70.53 108.561 174.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.547 ' CB ' HG21 ' A' ' 39' ' ' VAL . 1.8 mm? -100.23 120.71 40.32 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 114.591 -1.186 . . . . 75.41 108.677 -178.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.463 HG23 HG22 ' A' ' 21' ' ' THR . 23.2 mt -104.36 123.01 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 108.811 -0.811 . . . . 73.5 108.811 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.39 165.0 20.66 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.632 -0.713 . . . . 74.33 110.745 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.6 t -65.18 -21.07 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-O 121.887 0.851 . . . . 43.42 109.399 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.6 m -76.03 -4.45 41.35 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.45 1.1 . . . . 53.11 111.418 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.26 6.93 88.97 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.805 -0.918 . . . . 51.23 110.805 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -87.89 131.14 34.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.283 -1.006 . . . . 64.24 108.283 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.463 HG22 HG23 ' A' ' 15' ' ' ILE . 80.5 p -111.31 129.32 56.03 Favored 'General case' 0 N--CA 1.417 -2.096 0 C-N-CA 120.269 -0.572 . . . . 72.4 109.562 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 39' ' ' VAL . 95.8 mttt -131.66 139.31 49.05 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.282 -1.007 . . . . 73.11 108.282 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.409 ' HG3' ' HB2' ' A' ' 13' ' ' ARG . 30.1 tt0 -130.43 131.1 45.06 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.774 -0.77 . . . . 62.1 109.617 -175.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.676 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.2 m-85 -144.9 159.7 42.48 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 122.795 0.438 . . . . 62.34 109.83 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.45 126.47 32.26 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.624 -1.25 . . . . 63.23 107.624 174.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.676 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 90.1 m-85 -127.36 163.47 23.92 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.572 -0.529 . . . . 74.24 109.572 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.7 p -85.33 147.35 46.96 Favored Pre-proline 0 N--CA 1.41 -2.439 0 N-CA-C 107.741 -1.207 . . . . 73.11 107.741 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.494 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 55.6 Cg_endo -62.31 -11.36 22.16 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.803 2.335 . . . . 72.51 111.712 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -86.6 -15.87 38.48 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.29 -0.868 . . . . 71.22 111.242 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -71.76 153.74 41.78 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.15 0.5 . . . . 61.43 111.245 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.438 ' O ' HG13 ' A' ' 35' ' ' ILE . 19.4 m -96.52 129.46 43.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.006 -1.109 . . . . 71.3 108.006 177.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.805 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -51.03 -38.27 50.37 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.637 0.977 . . . . 74.02 113.637 -176.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 p -77.62 -29.05 51.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.132 0.492 . . . . 53.22 111.93 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.99 -41.58 82.08 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.907 -1.516 . . . . 63.32 106.907 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.48 HG23 ' CZ ' ' A' ' 26' ' ' PHE . 70.5 mt -64.13 -42.63 96.17 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.472 0 CA-C-N 113.715 -1.584 . . . . 74.53 110.43 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.406 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.01 -40.15 43.71 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 123.173 0.589 . . . . 74.41 111.842 175.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.83 -31.17 64.6 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.441 0.638 . . . . 74.55 110.323 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -74.13 -47.9 32.98 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.207 -0.906 . . . . 65.55 110.009 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.547 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.4 m -71.37 -32.1 45.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.923 -0.485 . . . . 72.24 111.9 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -49.67 -49.78 46.1 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 108.508 -0.923 . . . . 73.22 108.508 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -177.41 106.18 0.06 Allowed 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 124.166 0.916 . . . . 72.24 110.378 172.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.251 43.0 m-80 65.09 -116.22 0.36 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.229 1.566 . . . . 63.54 115.229 177.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -115.52 145.4 34.38 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 108.591 -0.892 . . . . 73.2 108.591 175.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -44.98 110.98 0.26 Allowed 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 121.944 1.763 . . . . 74.02 109.827 168.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.9 ttt -51.53 140.01 19.04 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 112.926 0.713 . . . . 72.23 112.926 -173.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -54.39 -56.91 13.83 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.749 -1.114 . . . . 74.43 111.194 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 10.4 m0 -79.98 99.34 7.58 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.444 -0.947 . . . . 71.23 108.444 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -120.09 104.37 10.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.267 -0.424 . . . . 73.25 110.555 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -161.19 103.24 1.26 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.926 -1.138 . . . . 74.22 107.926 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.531 ' OE1' ' HG3' ' A' ' 51' ' ' GLN . 0.2 OUTLIER -135.55 104.0 5.66 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 104.487 -2.412 . . . . 74.12 104.487 176.17 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.531 ' HG3' ' OE1' ' A' ' 50' ' ' GLU . 49.0 mt-30 59.67 38.83 21.75 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.714 0.634 . . . . 64.32 109.858 -174.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.6 t 78.11 -39.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.82 1.248 . . . . 72.42 111.261 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.6 m 66.16 97.86 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.2 1.0 . . . . 62.11 111.723 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.1 p -79.83 158.19 73.21 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 122.054 -0.404 . . . . 44.32 110.351 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -71.83 -15.72 29.73 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 121.993 1.795 . . . . 64.34 109.615 173.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -68.22 -13.34 62.17 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.98 -1.464 . . . . 52.03 111.411 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.0 pp -77.92 -19.82 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 120.791 0.329 . . . . 74.24 110.42 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.4 mp -78.63 106.59 10.71 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.506 -0.553 . . . . 63.42 109.506 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.413 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 98.7 mtt180 -140.29 142.73 35.67 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.828 -0.804 . . . . 72.24 108.828 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.805 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.5 pp -126.05 138.9 53.75 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.052 0.453 . . . . 72.42 111.451 -176.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.467 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 90.1 mt -108.96 119.91 59.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 108.456 -0.942 . . . . 55.32 108.456 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -101.3 75.59 1.64 Allowed 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.353 -1.351 . . . . 75.22 107.353 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.0 tm0? 36.78 85.68 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.77 0 C-N-CA 127.587 2.355 . . . . 53.04 113.23 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.87 -57.29 0.62 Allowed Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 115.447 -0.797 . . . . 75.11 113.156 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -130.07 159.66 36.09 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 112.627 0.603 . . . . 71.13 112.627 -176.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 33.1 m-85 -89.35 112.82 24.01 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.926 -1.138 . . . . 74.42 107.926 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.507 HD12 HD22 ' A' ' 76' ' ' LEU . 83.5 mt -80.2 -47.19 15.06 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 113.547 0.943 . . . . 65.14 113.547 -175.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.642 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.4 t-80 -165.33 174.74 9.8 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 106.614 -1.624 . . . . 74.33 106.614 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.11 -1.88 88.37 Favored Glycine 0 C--N 1.307 -1.067 0 C-N-CA 120.261 -0.971 . . . . 31.22 114.396 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -175.72 28.16 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 117.822 0.811 . . . . 73.35 112.221 -173.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.583 HG12 HD21 ' A' ' 60' ' ' LEU . 13.0 p -70.24 142.68 15.51 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 C-N-CA 120.46 -0.496 . . . . 73.24 109.808 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.457 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 31.8 p -78.54 157.67 28.75 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.852 -0.613 . . . . 44.03 111.836 -175.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.575 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.8 mm? -66.25 -32.87 74.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.406 -0.361 . . . . 61.42 110.784 -177.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.04 -36.38 92.82 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 111.178 -0.769 . . . . 75.22 111.178 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.406 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -73.97 -15.27 61.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.12 0.568 . . . . 73.54 110.893 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.507 HD22 HD12 ' A' ' 67' ' ' LEU . 73.4 mt -82.79 14.87 2.94 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.675 0.39 . . . . 72.14 111.226 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.6 24.1 10.21 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.759 0.824 . . . . 64.04 110.619 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.476 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 96.2 mt -91.8 125.14 58.32 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 112.511 0.56 . . . . 73.0 112.511 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 3.5 Cg_endo -86.35 170.3 8.08 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.846 2.364 . . . . 73.11 110.484 172.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.494 ' CE2' ' HG3' ' A' ' 28' ' ' PRO . 75.2 m-85 -78.7 151.35 32.21 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.781 -0.451 . . . . 75.41 109.781 -178.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.4 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 82.93 0.96 90.59 Favored Glycine 0 C--N 1.308 -1.022 0 C-N-CA 120.668 -0.777 . . . . 73.23 114.232 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -102.37 136.45 42.18 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 117.509 0.655 . . . . 65.31 110.021 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.596 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 54.6 m -87.19 116.78 25.49 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.006 -0.739 . . . . 71.35 109.006 176.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.3 m -115.81 142.43 46.77 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.55 -0.75 . . . . 53.41 110.471 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -111.45 135.59 50.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 120.793 0.33 . . . . 73.32 110.354 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 87.0 mtp -138.35 153.24 48.97 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 120.862 0.363 . . . . 63.41 110.276 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.467 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 21.5 m-70 -111.59 132.7 54.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.989 -1.115 . . . . 74.3 107.989 178.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.465 HD21 HD12 ' A' ' 14' ' ' LEU . 2.5 mm? -119.47 144.53 46.93 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 120.614 -0.434 . . . . 65.35 111.113 -176.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 59' ' ' ARG . 26.7 m -120.52 134.94 62.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.8 -0.636 . . . . 74.04 109.43 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.454 ' HB1' ' OG1' ' A' ' 93' ' ' THR . . . -133.01 144.9 50.4 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.878 -0.601 . . . . 73.14 109.788 -176.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -140.78 147.94 39.88 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 108.024 -1.102 . . . . 61.15 108.024 -177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 53.7 28.53 8.2 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 122.18 0.99 . . . . 62.15 110.391 -177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.454 ' OG1' ' HB1' ' A' ' 90' ' ' ALA . 44.1 m -89.77 139.8 30.22 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 114.578 -1.192 . . . . 73.54 109.615 -176.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.3 mp -68.55 131.11 91.64 Favored Pre-proline 0 C--N 1.304 -1.375 0 CA-C-N 115.512 -0.767 . . . . 63.32 110.517 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.24 -38.1 95.6 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.181 2.588 . . . . 75.02 113.683 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -159.35 142.32 10.4 Favored Pre-proline 0 C--N 1.322 -0.602 0 C-N-CA 120.994 -0.283 . . . . 73.14 111.107 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.2 -63.62 0.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.003 1.802 . . . . 74.3 109.982 170.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -168.05 76.9 0.14 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 112.763 0.653 . . . . 73.24 112.763 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.7 m 45.87 28.04 0.55 Allowed 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.644 2.09 . . . . 71.33 116.644 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -81.06 -51.14 8.81 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.598 -0.841 . . . . 61.24 110.603 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.36 -18.96 6.11 Favored Glycine 0 C--N 1.32 -0.36 0 CA-C-N 115.665 -0.698 . . . . 74.44 112.666 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -136.14 156.81 48.15 Favored 'General case' 0 CA--C 1.485 -1.548 0 O-C-N 122.526 -0.396 . . . . 64.13 111.178 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -109.05 -40.79 4.89 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 124.134 0.896 . . . . 73.01 108.79 175.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -163.43 146.66 10.3 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.993 -1.114 . . . . 71.24 107.993 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.402 HH22 ' HB2' ' A' ' 112' ' ' ASN . 74.9 ttt180 -71.91 -50.8 26.02 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.151 0.5 . . . . 74.42 110.26 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -167.27 156.19 10.06 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 104.348 -2.464 . . . . 74.21 104.348 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.609 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 1.2 tpmt? -53.71 -43.62 69.17 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 123.512 0.725 . . . . 73.23 110.892 -178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.8 t -158.61 -23.53 0.08 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.644 -0.422 . . . . 64.13 111.826 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -83.39 75.48 2.37 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 121.001 -0.619 . . . . 63.43 112.843 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.442 ' HB2' ' HB2' ' A' ' 113' ' ' CYS . 19.4 mm-40 -54.18 133.0 44.33 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 122.741 0.416 . . . . 75.23 110.307 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.2 t -61.73 -43.43 98.86 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.329 0.585 . . . . 72.51 109.938 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.402 ' HB2' HH22 ' A' ' 105' ' ' ARG . 16.9 m120 -111.63 113.29 25.58 Favored 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 106.676 -1.601 . . . . 74.2 106.676 176.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 110' ' ' GLU . 45.1 t -149.64 154.18 38.21 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.537 -0.912 . . . . 61.14 108.537 -175.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 63.9 m -77.07 95.77 4.29 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.654 -0.869 . . . . 60.13 108.654 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.4 m -115.95 160.43 15.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.81 -0.632 . . . . 71.3 110.704 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.412 HD12 ' N ' ' A' ' 116' ' ' ILE . 2.1 mp -86.52 95.9 5.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 121.862 0.839 . . . . 71.32 108.835 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.6 tp . . . . . 0 C--N 1.291 -1.935 0 N-CA-C 107.312 -1.366 . . . . 75.54 107.312 -177.399 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 112.81 0.67 . . . . 65.35 112.81 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.6 t -98.42 136.58 38.36 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 106.625 -1.62 . . . . 73.0 106.625 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.5 m120 69.43 115.53 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.844 0.83 . . . . 72.21 111.729 -173.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.409 HG13 HD22 ' A' ' 25' ' ' LEU . 16.8 t -87.93 131.75 42.17 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 108.676 -0.861 . . . . 72.23 108.676 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -72.01 143.24 40.14 Favored 'Trans proline' 0 C--O 1.251 1.159 0 C-N-CA 121.889 1.726 . . . . 73.01 110.421 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.81 72.14 4.33 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 121.996 0.903 . . . . 70.21 109.821 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.422 ' H ' ' H ' ' A' ' 9' ' ' MET . 27.8 t70 -169.11 -28.18 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 113.612 -1.631 . . . . 75.31 107.727 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.422 ' H ' ' H ' ' A' ' 8' ' ' ASP . 92.9 mmm -117.52 145.73 44.03 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.819 -1.082 . . . . 71.22 109.128 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.471 HG22 ' HA ' ' A' ' 80' ' ' PHE . 2.8 pp -99.31 136.06 32.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 109.208 -0.664 . . . . 73.44 109.208 175.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.457 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 16.8 t-20 -91.93 107.69 19.39 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.7 -1.222 . . . . 63.31 107.7 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.504 ' HG ' HD22 ' A' ' 14' ' ' LEU . 43.5 tp -112.77 132.77 55.09 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 116.055 -0.52 . . . . 61.43 111.723 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -106.82 121.51 44.55 Favored 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 108.291 -1.003 . . . . 73.44 108.291 173.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.551 ' CB ' HG21 ' A' ' 39' ' ' VAL . 1.7 mm? -98.74 128.61 45.04 Favored 'General case' 0 C--N 1.268 -2.947 0 CA-C-N 114.258 -1.337 . . . . 62.31 109.353 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.487 HD12 HG22 ' A' ' 21' ' ' THR . 14.8 mm -107.47 119.33 56.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 107.744 -1.206 . . . . 73.25 107.744 175.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.7 tp -84.09 153.05 23.99 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 110.058 -0.349 . . . . 72.5 110.058 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.49 ' CG1' ' HA ' ' A' ' 89' ' ' VAL . 30.7 m -60.0 -13.36 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.829 0.851 . . . . 63.11 113.059 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.413 ' HB3' ' HD3' ' A' ' 20' ' ' LYS . 16.3 t -89.53 -2.78 58.46 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.275 -0.639 . . . . 64.32 109.275 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.21 7.93 79.19 Favored Glycine 0 C--N 1.337 0.583 0 CA-C-N 115.922 -0.581 . . . . 33.24 112.597 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HD3' ' HB3' ' A' ' 18' ' ' SER . 12.3 mptt -87.78 131.05 34.65 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.345 -0.983 . . . . 73.24 108.345 176.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.487 HG22 HD12 ' A' ' 15' ' ' ILE . 63.1 p -107.46 143.65 35.52 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.538 -0.912 . . . . 72.12 108.538 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 48.5 tptt -145.08 147.23 32.33 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.595 -0.842 . . . . 75.54 109.155 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -137.06 131.09 32.27 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 119.713 -0.795 . . . . 65.53 110.201 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.737 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 84.6 m-85 -145.14 160.97 40.6 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 123.888 0.875 . . . . 63.31 110.387 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.412 HD23 HD21 ' A' ' 11' ' ' ASN . 97.3 mt -79.7 126.02 30.4 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.634 -1.247 . . . . 53.33 107.634 171.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.737 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 83.6 m-85 -130.68 164.45 25.0 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.37 -0.974 . . . . 74.32 108.37 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.5 p -90.1 150.3 43.13 Favored Pre-proline 0 N--CA 1.42 -1.947 0 N-CA-C 107.747 -1.205 . . . . 61.44 107.747 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.428 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 28.7 Cg_endo -60.11 -14.75 30.19 Favored 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 122.044 1.829 . . . . 71.53 112.077 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -87.15 -9.68 54.64 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.892 -0.595 . . . . 62.22 110.545 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -76.02 154.01 36.06 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.81 -0.556 . . . . 71.53 111.193 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.532 ' O ' HG13 ' A' ' 35' ' ' ILE . 41.0 m -96.52 121.59 38.5 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 109.649 -0.5 . . . . 55.14 109.649 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.503 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -49.2 -52.5 26.38 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.115 1.524 . . . . 71.24 115.115 -173.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 14.4 m -79.46 -20.01 48.43 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 121.823 -0.548 . . . . 70.43 111.465 -175.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.87 -41.46 78.34 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.14 -1.8 . . . . 75.22 106.14 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 31' ' ' SER . 73.3 mt -62.79 -34.68 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 114.034 -1.439 . . . . 75.23 110.749 175.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 40' ' ' TYR . . . -52.94 -32.9 48.26 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 122.442 0.297 . . . . 55.51 111.577 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.551 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -72.91 -38.13 66.99 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 107.154 -1.425 . . . . 73.43 107.154 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 43' ' ' TRP . 43.0 t-80 -62.95 -54.02 44.99 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.897 0.879 . . . . 72.31 110.747 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.551 HG21 ' CB ' ' A' ' 14' ' ' LEU . 26.8 m -68.22 -29.98 46.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.023 -0.989 . . . . 75.24 112.411 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 64.3 t80 -46.63 -48.86 19.8 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.278 1.031 . . . . 74.11 111.09 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -177.15 -74.59 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.299 0.374 . . . . 71.02 110.305 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -103.16 150.16 23.93 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.215 -1.402 . . . . 64.13 107.215 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.614 ' HA ' ' HA ' ' A' ' 38' ' ' HIS . 30.2 p-90 -79.44 147.21 67.67 Favored Pre-proline 0 C--N 1.301 -1.533 0 C-N-CA 120.362 -0.535 . . . . 52.41 110.511 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.56 96.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.899 2.399 . . . . 64.14 113.851 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.492 ' HA ' ' CE ' ' A' ' 45' ' ' MET . 0.3 OUTLIER -138.51 74.81 1.49 Allowed 'General case' 0 N--CA 1.428 -1.565 0 CA-C-O 122.023 0.916 . . . . 74.34 109.17 177.254 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -169.66 -165.5 0.51 Allowed 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 104.14 -2.541 . . . . 64.55 104.14 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.3 t90 -108.99 -84.98 0.54 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 119.678 1.126 . . . . 72.21 110.94 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.417 ' HB3' HG12 ' A' ' 52' ' ' VAL . 21.8 mm-40 -155.21 134.67 12.54 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.424 -1.324 . . . . 72.42 107.424 -177.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -154.09 -60.07 0.13 Allowed 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.485 -0.561 . . . . 35.31 109.485 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.429 ' HG2' ' HB2' ' A' ' 94' ' ' LEU . 8.1 tp10 -96.01 115.25 27.14 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 106.93 -1.507 . . . . 70.32 106.93 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 86.0 mm-40 66.87 94.14 0.07 Allowed 'General case' 0 C--O 1.24 0.563 0 O-C-N 124.355 1.034 . . . . 74.43 109.703 -174.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.417 HG12 ' HB3' ' A' ' 48' ' ' GLU . 28.6 m -108.25 135.55 46.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 115.092 -0.958 . . . . 73.33 112.129 -172.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.0 m 58.57 27.62 15.95 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.921 0.888 . . . . 70.44 112.454 174.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.6 t -126.83 104.78 23.23 Favored Pre-proline 0 N--CA 1.425 -1.675 0 C-N-CA 120.639 -0.424 . . . . 70.55 110.878 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.28 -15.74 22.51 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.274 1.983 . . . . 74.34 110.671 176.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -61.01 -20.23 62.25 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 123.879 0.871 . . . . 62.31 112.129 -177.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 90' ' ' ALA . 33.8 pt -77.28 -28.14 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 120.522 -0.471 . . . . 62.11 111.133 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.547 ' O ' HD12 ' A' ' 58' ' ' LEU 0.257 3.5 pp -106.29 109.03 20.84 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.973 0.892 . . . . 71.33 111.995 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.425 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 97.4 mtt180 -142.61 163.15 33.61 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.53 -1.213 . . . . 65.45 109.899 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 4.1 pp -129.16 142.39 50.89 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.178 0.807 . . . . 73.35 113.178 -173.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.7 mt -117.56 124.41 73.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 114.907 -1.042 . . . . 51.02 108.359 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.465 ' CD2' HD11 ' A' ' 67' ' ' LEU . 1.8 t80 -101.32 60.87 0.92 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 122.038 0.923 . . . . 74.32 109.629 -176.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 63.91 17.39 10.52 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 113.902 -1.499 . . . . 73.22 112.488 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.39 -65.96 0.01 OUTLIER Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 120.734 -0.746 . . . . 72.14 112.031 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -130.49 176.03 8.49 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.822 0.344 . . . . 72.2 110.583 -177.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 85.8 m-85 -86.84 120.96 28.68 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.465 -1.309 . . . . 74.21 107.465 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.575 ' CD1' HD22 ' A' ' 76' ' ' LEU . 76.5 mt -80.1 -47.07 15.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.747 0.784 . . . . 71.4 109.915 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -163.11 -173.46 3.43 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 125.602 1.561 . . . . 74.43 107.771 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -84.34 -37.3 11.11 Favored Glycine 0 N--CA 1.416 -2.688 0 C-N-CA 120.499 -0.858 . . . . 53.32 113.72 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.406 ' OD1' ' HB3' ' A' ' 31' ' ' SER . 64.3 t30 -160.22 39.12 0.18 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.312 1.053 . . . . 72.21 108.961 -172.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.586 HG12 HD21 ' A' ' 60' ' ' LEU . 7.6 p -66.2 147.42 12.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-N 114.593 -1.185 . . . . 74.14 110.023 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.557 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 42.4 p -78.55 156.91 28.96 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 116.21 -0.45 . . . . 70.43 111.408 -175.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.461 ' H ' HD22 ' A' ' 73' ' ' LEU . 2.5 mm? -66.34 -30.76 71.23 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.517 0.562 . . . . 63.01 112.517 -176.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.48 -30.37 76.41 Favored Glycine 0 C--O 1.229 -0.167 0 N-CA-C 111.192 -0.763 . . . . 63.3 111.192 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.31 -15.51 60.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.371 0.605 . . . . 73.12 109.961 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.575 HD22 ' CD1' ' A' ' 67' ' ' LEU . 61.2 mt -92.84 11.95 25.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.425 -0.807 . . . . 72.52 111.834 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.532 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.6 mptt 67.74 19.27 9.7 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.539 0.736 . . . . 61.55 110.975 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.433 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 79.4 mt -83.66 122.14 76.51 Favored Pre-proline 0 N--CA 1.441 -0.918 0 CA-C-N 116.03 -0.532 . . . . 63.35 110.895 -177.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.455 ' HG2' ' HG3' ' A' ' 82' ' ' LYS . 6.6 Cg_endo -83.71 140.21 9.15 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 122.227 1.951 . . . . 74.2 111.708 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.471 ' HA ' HG22 ' A' ' 10' ' ' ILE . 4.8 p90 -70.44 141.97 52.04 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 112.596 0.591 . . . . 75.4 112.596 177.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.85 -1.17 70.73 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.759 -1.109 . . . . 74.33 111.599 -174.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.455 ' HG3' ' HG2' ' A' ' 79' ' ' PRO . 31.7 mmmt -108.36 158.04 17.85 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.82 0.343 . . . . 73.0 110.41 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.457 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 86.5 m -103.69 125.22 50.03 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.666 -0.697 . . . . 73.22 110.077 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.0 m -133.64 142.76 48.22 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.127 -0.488 . . . . 74.32 110.402 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.4 132.62 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 121.066 0.46 . . . . 54.13 110.688 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 90.4 mtp -136.17 153.43 51.26 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.153 0.502 . . . . 74.31 111.395 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -103.05 132.88 48.99 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.648 -0.705 . . . . 75.3 109.413 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.407 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.4 mm? -120.04 142.38 48.89 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.125 -0.694 . . . . 74.44 109.125 -176.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.49 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 35.2 m -116.78 133.76 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 C-N-CA 119.932 -0.707 . . . . 73.43 110.994 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 57' ' ' ILE . . . -133.77 146.5 50.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 105.909 -1.885 . . . . 53.05 105.909 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 51' ' ' GLN . 40.3 ttm180 -124.77 112.21 16.43 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 120.037 -0.665 . . . . 71.1 110.641 -172.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 39.2 mt-10 55.69 37.62 29.09 Favored 'General case' 0 C--O 1.203 -1.384 0 O-C-N 124.412 1.07 . . . . 74.51 110.97 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 36.9 m -88.65 113.22 23.99 Favored 'General case' 0 N--CA 1.409 -2.523 0 CA-C-N 114.567 -1.197 . . . . 34.22 108.751 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.429 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 10.9 mp -106.08 161.83 21.6 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 123.32 0.648 . . . . 60.42 112.344 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.04 155.36 19.01 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.79 2.327 . . . . 73.32 111.206 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -64.79 145.32 98.88 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 115.826 -0.624 . . . . 73.32 111.631 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -75.06 -30.34 7.17 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 C-N-CA 121.531 1.488 . . . . 73.54 109.16 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 70.84 17.11 6.48 Favored 'General case' 0 C--N 1.378 1.846 0 C-N-CA 124.686 1.194 . . . . 72.25 108.215 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.3 p -88.66 -5.67 57.98 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.191 -1.368 . . . . 65.41 111.212 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -83.56 -30.34 27.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 119.318 -0.953 . . . . 74.33 109.827 176.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.67 24.35 75.39 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.519 -0.764 . . . . 61.52 111.569 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -89.7 111.75 22.82 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 120.465 -0.494 . . . . 64.04 109.934 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -125.37 106.98 10.23 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.378 -0.971 . . . . 74.11 108.378 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -82.34 121.32 26.54 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.038 -0.528 . . . . 64.04 110.7 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.433 ' HD2' ' OG ' ' A' ' 111' ' ' SER . 41.6 mmt180 -71.5 -24.65 62.02 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.322 -0.854 . . . . 75.35 112.129 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 70.53 101.18 0.06 Allowed 'General case' 0 C--O 1.25 1.082 0 C-N-CA 123.812 0.845 . . . . 73.23 113.258 175.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? 72.22 -59.11 0.57 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.404 1.482 . . . . 73.41 109.787 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.1 p -70.95 136.6 48.58 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.655 -1.239 . . . . 71.23 107.655 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -69.84 -32.16 70.19 Favored Glycine 0 CA--C 1.5 -0.855 0 C-N-CA 120.323 -0.942 . . . . 65.12 111.201 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -144.73 146.9 32.41 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 108.671 -0.863 . . . . 63.11 108.671 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.433 ' OG ' ' HD2' ' A' ' 105' ' ' ARG . 50.2 m -86.77 74.79 9.74 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.276 -1.009 . . . . 71.21 108.276 176.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -157.66 116.69 3.24 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.145 -1.389 . . . . 64.15 108.336 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.6 t -76.78 121.8 23.85 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.481 -0.563 . . . . 62.15 109.481 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.7 p -69.34 122.27 18.57 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.9 -0.778 . . . . 73.13 108.9 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.7 m -95.47 127.61 47.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.65 0.738 . . . . 74.42 112.515 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.69 108.57 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 108.295 -1.002 . . . . 74.31 108.295 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 tm? . . . . . 0 C--N 1.287 -2.132 0 N-CA-C 105.702 -1.962 . . . . 55.14 105.702 -179.943 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.42 -1.94 0 N-CA-C 107.465 -1.309 . . . . 73.11 107.465 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.0 t -136.12 119.02 16.26 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.167 -0.613 . . . . 64.42 110.683 -174.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -77.47 128.22 33.84 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 107.648 -1.241 . . . . 63.12 107.648 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.569 HG21 ' HB2' ' A' ' 11' ' ' ASN . 10.8 t -80.76 119.73 77.0 Favored Pre-proline 0 C--N 1.283 -2.287 0 N-CA-C 109.077 -0.712 . . . . 41.31 109.077 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -69.81 152.02 68.95 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.025 1.817 . . . . 75.52 110.646 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.47 72.23 4.98 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-O 122.462 1.125 . . . . 74.34 109.162 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -170.65 -28.41 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 112.784 -2.007 . . . . 71.34 107.566 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.6 mmm -113.87 160.67 18.5 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.05 -0.977 . . . . 55.3 108.734 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -121.79 139.58 48.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.189 -0.671 . . . . 62.44 109.189 173.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.569 ' HB2' HG21 ' A' ' 5' ' ' VAL . 43.5 t-20 -94.02 110.78 22.45 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.785 -1.191 . . . . 64.42 107.785 -177.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.478 ' HG ' HD22 ' A' ' 14' ' ' LEU . 46.2 tp -115.9 132.91 56.51 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.826 -0.625 . . . . 75.25 112.069 -174.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -111.36 121.27 44.79 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 114.994 -1.003 . . . . 54.44 109.018 173.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.592 ' CB ' HG21 ' A' ' 39' ' ' VAL . 1.9 mm? -98.6 121.4 40.5 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.825 -1.08 . . . . 75.0 108.316 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.1 mt -102.95 127.15 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 C-N-CA 119.586 -0.846 . . . . 74.1 109.642 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -83.8 155.51 22.97 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.44 -0.8 . . . . 72.35 110.24 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.3 m -64.12 -19.11 24.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 122.893 0.477 . . . . 70.42 111.898 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.437 ' HB2' ' HG2' ' A' ' 20' ' ' LYS . 20.2 m -80.95 1.93 28.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.21 0.529 . . . . 74.35 110.424 177.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.08 12.75 82.11 Favored Glycine 0 CA--C 1.501 -0.803 0 N-CA-C 111.804 -0.518 . . . . 73.42 111.804 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.437 ' HG2' ' HB2' ' A' ' 18' ' ' SER . 74.1 mmtt -88.63 135.77 33.33 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.035 -1.469 . . . . 74.3 107.035 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.6 p -112.67 129.28 56.45 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 119.801 -0.76 . . . . 73.52 109.88 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -122.93 137.53 54.92 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.939 -1.134 . . . . 74.43 107.939 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -138.13 131.65 30.79 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.755 -0.778 . . . . 70.12 110.08 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.653 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 89.3 m-85 -145.5 160.14 42.05 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 123.933 0.893 . . . . 73.22 109.011 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.1 mt -79.57 125.5 29.68 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 107.065 -1.457 . . . . 65.41 107.065 170.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.653 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 87.8 m-85 -123.8 163.16 21.76 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.927 -1.138 . . . . 63.31 107.927 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 84.7 p -87.62 148.47 44.07 Favored Pre-proline 0 C--N 1.288 -2.095 0 N-CA-C 108.226 -1.027 . . . . 73.21 108.226 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.98 -14.87 35.42 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.252 1.968 . . . . 44.3 111.355 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -82.9 -17.8 42.46 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.066 -0.97 . . . . 73.14 110.281 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.431 ' O ' HD22 ' A' ' 73' ' ' LEU . 18.1 m-20 -67.95 154.61 41.23 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.009 0.433 . . . . 63.11 110.666 176.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.552 ' O ' HG13 ' A' ' 35' ' ' ILE . 51.1 m -105.13 129.53 53.51 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 116.039 -0.528 . . . . 74.21 110.536 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.807 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -49.86 -50.22 46.4 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.007 1.484 . . . . 54.31 115.007 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m -76.14 -27.15 56.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.284 0.493 . . . . 73.13 110.676 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.89 -45.55 91.98 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.239 -1.393 . . . . 60.41 107.239 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 31' ' ' SER . 66.1 mt -65.18 -42.49 94.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 114.348 -1.296 . . . . 74.22 110.657 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' O ' ' HD1' ' A' ' 40' ' ' TYR . . . -50.07 -50.08 49.24 Favored 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 122.856 0.462 . . . . 75.35 111.154 175.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -64.4 -38.44 91.03 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 108.142 -1.058 . . . . 73.04 108.142 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.496 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 35.3 t-80 -61.21 -54.26 46.45 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 114.844 -1.071 . . . . 72.34 110.706 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.592 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.1 m -69.97 -32.17 50.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 115.756 -0.656 . . . . 72.52 112.264 -178.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.423 ' HB3' HD11 ' A' ' 94' ' ' LEU . 11.7 m-85 -64.44 -49.26 72.17 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.764 0.653 . . . . 74.15 112.764 174.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -135.25 -74.06 0.46 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.784 -0.767 . . . . 64.43 113.065 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -149.62 172.71 14.6 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 105.59 -2.004 . . . . 73.34 105.59 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 21.5 p-90 -67.67 128.83 93.55 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 118.972 0.805 . . . . 70.35 111.855 -175.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.23 137.13 39.45 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.961 2.441 . . . . 53.23 112.133 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 62.5 mtm -126.41 -75.25 0.58 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.922 -1.14 . . . . 74.33 107.922 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t70 177.13 89.09 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.184 -1.784 . . . . 73.03 106.184 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 20.6 t90 -128.03 -172.77 2.77 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.49 -0.93 . . . . 75.45 108.49 -174.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -86.2 -16.83 36.51 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 112.174 0.435 . . . . 70.24 112.174 -177.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 56.65 -91.5 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.422 0.689 . . . . 65.34 111.458 -173.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 10.4 tp10 -86.64 -54.55 4.33 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.555 -0.906 . . . . 73.24 108.555 175.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -169.5 -52.93 0.02 OUTLIER 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 115.837 -0.619 . . . . 72.23 112.488 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.02 13.18 5.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 113.177 0.806 . . . . 62.52 113.177 -175.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.459 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 42.6 m 65.9 110.71 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.671 0.788 . . . . 64.14 110.435 -176.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.2 m -108.97 99.57 35.84 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 116.434 -0.348 . . . . 72.21 111.428 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 53' ' ' SER . 9.3 Cg_endo -90.9 -20.24 0.86 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.946 1.764 . . . . 74.11 112.656 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -68.48 -22.81 64.54 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.494 0.664 . . . . 73.11 110.775 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.458 ' CG2' ' HB2' ' A' ' 91' ' ' ARG . 2.1 pp -78.24 -17.13 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 115.229 -0.896 . . . . 74.22 113.184 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 55' ' ' PRO . 7.1 mp -68.79 101.33 1.31 Allowed 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.195 -0.668 . . . . 32.5 109.195 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.42 ' HD3' ' HA2' ' A' ' 69' ' ' GLY . 18.4 mmt180 -140.77 155.06 46.5 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.081 -0.711 . . . . 75.34 109.081 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.807 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.3 pp -135.39 144.47 46.59 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.395 -0.821 . . . . 75.44 110.189 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.459 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 98.7 mt -117.34 122.45 69.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 108.708 -0.849 . . . . 63.44 108.708 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -100.97 87.94 3.41 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.906 -1.516 . . . . 74.43 106.906 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 69.55 -64.94 0.32 Allowed 'General case' 0 N--CA 1.408 -2.527 0 C-N-CA 127.409 2.283 . . . . 63.04 112.401 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.47 -43.88 0.62 Allowed Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.205 -0.997 . . . . 74.4 113.712 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.85 162.26 18.4 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 115.049 1.5 . . . . 65.03 115.049 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.625 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 38.4 m-85 -84.19 117.5 23.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.018 -0.992 . . . . 72.31 108.335 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.504 HD12 ' CD2' ' A' ' 76' ' ' LEU . 66.4 mt -80.18 -47.2 15.07 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 114.6 1.333 . . . . 71.34 114.6 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.404 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 66.7 t-80 -165.83 167.31 16.99 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.138 -1.43 . . . . 71.0 107.138 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.42 ' HA2' ' HD3' ' A' ' 59' ' ' ARG . . . -63.99 -19.08 63.11 Favored Glycine 0 C--O 1.209 -1.435 0 N-CA-C 114.187 0.435 . . . . 74.42 114.187 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.424 ' OD1' ' HB3' ' A' ' 31' ' ' SER . 65.3 t30 177.88 80.36 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 108.864 -0.791 . . . . 72.22 108.864 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.715 HG12 HD21 ' A' ' 60' ' ' LEU . 9.1 p -102.55 151.34 6.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.028 -0.73 . . . . 70.34 109.028 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.492 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 55.1 p -78.51 157.64 28.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.598 0.237 . . . . 74.0 111.172 -178.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.518 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.9 mm? -67.74 -32.43 73.03 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 120.715 0.293 . . . . 72.4 110.766 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.62 -41.22 99.84 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.672 -0.971 . . . . 44.34 110.672 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -68.99 -15.84 63.58 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.099 0.56 . . . . 43.22 111.269 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.624 ' HB2' HD13 ' A' ' 78' ' ' LEU . 87.1 mt -82.52 -1.6 50.98 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.852 0.461 . . . . 74.23 110.105 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.5 mptt 69.77 57.56 0.31 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.331 1.052 . . . . 64.25 110.551 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.624 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.3 mp -109.52 124.2 34.47 Favored Pre-proline 0 C--N 1.304 -1.382 0 CA-C-N 115.382 -0.826 . . . . 75.44 110.41 175.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 4.6 Cg_exo -76.17 154.48 37.13 Favored 'Trans proline' 0 N--CA 1.432 -2.09 0 C-N-CA 121.608 1.539 . . . . 54.22 108.883 173.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -72.74 154.41 40.69 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.048 -0.723 . . . . 73.43 109.048 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 75.91 10.65 85.04 Favored Glycine 0 C--N 1.304 -1.228 0 C-N-CA 120.802 -0.713 . . . . 62.2 113.04 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -110.62 153.57 25.0 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.638 -0.504 . . . . 62.24 109.638 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.558 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 56.9 m -104.98 129.74 53.34 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.347 -0.612 . . . . 62.41 109.347 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.8 m -138.72 142.26 38.9 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.119 0.485 . . . . 64.32 110.928 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.9 p -109.56 142.39 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 115.672 -0.695 . . . . 51.23 110.374 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 91.1 mtp -135.78 153.88 51.4 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 120.987 0.422 . . . . 62.35 110.403 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.469 ' C ' HD22 ' A' ' 88' ' ' LEU . 82.4 m-70 -106.02 131.25 53.54 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.925 -1.139 . . . . 74.22 107.925 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.469 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.5 mm? -122.85 143.91 49.55 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.578 -0.449 . . . . 73.12 110.781 -176.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.74 137.0 52.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 121.051 0.453 . . . . 73.22 110.682 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.45 137.52 45.76 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.6 -0.727 . . . . 55.33 109.046 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.458 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 99.6 mtt180 -134.72 112.83 11.08 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.084 -0.507 . . . . 72.32 109.713 -177.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 42.3 mt-10 59.37 28.48 17.84 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.362 1.077 . . . . 75.22 109.696 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.9 m -80.39 -33.48 37.1 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.207 -1.361 . . . . 71.53 109.246 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.423 HD11 ' HB3' ' A' ' 40' ' ' TYR . 4.9 mp -109.16 141.24 23.03 Favored Pre-proline 0 N--CA 1.426 -1.628 0 N-CA-C 107.534 -1.284 . . . . 75.11 107.534 175.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.02 16.1 1.82 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.379 2.053 . . . . 73.32 110.625 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -143.01 161.99 45.72 Favored Pre-proline 0 N--CA 1.437 -1.114 0 C-N-CA 125.371 1.469 . . . . 71.2 107.171 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -61.25 -63.71 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.925 1.75 . . . . 61.31 110.134 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 178.54 79.97 0.01 OUTLIER 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.735 0.814 . . . . 73.5 110.211 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.9 m 64.21 -36.06 0.17 Allowed 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 117.063 2.245 . . . . 74.22 117.063 173.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -79.05 -51.04 10.11 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 121.707 -0.621 . . . . 71.52 111.929 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.55 7.04 85.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.914 -0.66 . . . . 73.43 112.863 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -137.16 135.74 37.62 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 122.491 -0.417 . . . . 75.43 110.361 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -107.32 83.88 1.88 Allowed 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.427 -1.323 . . . . 72.31 107.427 175.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -145.66 -178.72 6.24 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.157 0.504 . . . . 75.44 112.105 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.491 ' HG3' ' HB2' ' A' ' 110' ' ' GLU . 4.8 mpt_? -72.09 -44.96 62.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.082 -0.963 . . . . 53.33 112.242 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 71.9 -62.82 0.45 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.74 0.816 . . . . 73.53 109.045 -171.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 21.8 ptmt -132.63 -179.88 5.73 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.808 -1.553 . . . . 72.35 106.808 174.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.7 p -71.54 111.88 7.2 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.494 0.664 . . . . 61.42 110.877 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.91 -56.17 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 110.591 -1.004 . . . . 65.32 110.591 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 105' ' ' ARG . 58.4 mm-40 -63.25 -56.95 12.27 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.064 -0.254 . . . . 72.55 111.054 176.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.7 p -179.99 178.11 0.62 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.069 -1.086 . . . . 74.33 108.069 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -166.91 134.66 2.57 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 122.567 0.347 . . . . 75.11 110.556 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 20.4 p -149.72 177.94 9.33 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.572 -1.27 . . . . 64.23 107.572 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 24.8 p -67.28 106.73 2.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.215 0.531 . . . . 73.52 110.11 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.8 m -113.57 147.35 17.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 121.11 0.481 . . . . 75.43 111.485 -176.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.34 101.24 12.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.44 -0.948 . . . . 74.34 108.44 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 tm? . . . . . 0 C--N 1.295 -1.79 0 N-CA-C 107.041 -1.466 . . . . 64.5 107.041 -177.783 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.4 m . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 109.195 -0.668 . . . . 42.11 109.195 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.0 m -90.75 97.22 11.05 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.736 -0.666 . . . . 71.1 110.335 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -73.19 119.42 17.4 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 109.063 -0.717 . . . . 72.43 109.063 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.5 HG21 ' HB2' ' A' ' 11' ' ' ASN . 3.7 t -95.88 119.69 64.38 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 115.509 -0.769 . . . . 32.01 110.664 -173.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -74.9 165.28 31.72 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.674 2.249 . . . . 72.14 110.585 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.83 68.57 10.52 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 122.013 0.911 . . . . 75.15 110.179 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.41 ' H ' ' H ' ' A' ' 9' ' ' MET . 27.9 t70 -167.44 -30.03 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 113.66 -1.609 . . . . 75.24 107.929 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.41 ' H ' ' H ' ' A' ' 8' ' ' ASP . 90.5 mmm -105.41 158.57 16.56 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.472 -1.24 . . . . 72.15 109.312 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -119.32 140.12 44.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 109.313 -0.625 . . . . 74.53 109.313 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 53.4 t-20 -90.93 112.7 24.68 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.897 -1.149 . . . . 73.24 107.897 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.484 ' HG ' HD22 ' A' ' 14' ' ' LEU . 35.4 tp -117.29 132.96 56.5 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.44 0.638 . . . . 75.42 112.578 -174.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.414 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . 26.5 ttt85 -106.95 121.44 44.44 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 115.12 -0.945 . . . . 63.14 108.853 174.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.546 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.2 mm? -99.48 120.87 40.33 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.209 -0.905 . . . . 72.33 108.884 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.57 HD12 HG22 ' A' ' 21' ' ' THR . 23.4 mm -99.49 116.71 43.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 107.118 -1.438 . . . . 74.42 107.118 177.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.46 167.45 21.82 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 123.292 0.37 . . . . 73.33 111.693 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -67.61 -28.64 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.746 0.784 . . . . 63.41 110.242 -176.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -76.79 4.43 9.7 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.144 -0.935 . . . . 45.53 111.454 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.65 10.32 86.29 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 111.672 -0.571 . . . . 72.4 111.672 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -91.53 131.8 36.71 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.717 -0.846 . . . . 72.41 108.717 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.57 HG22 HD12 ' A' ' 15' ' ' ILE . 59.8 p -104.91 135.03 47.02 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 116.572 -0.285 . . . . 74.53 110.286 -175.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -142.46 139.61 31.63 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.266 -1.013 . . . . 74.15 108.266 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -134.44 132.57 39.49 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.016 -0.674 . . . . 63.21 111.55 -171.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.611 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 90.7 m-85 -144.99 160.81 40.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.161 0.584 . . . . 73.42 110.881 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.4 mt -79.36 126.6 31.02 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.306 -0.998 . . . . 45.33 108.306 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.611 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 78.4 m-85 -127.35 161.57 28.34 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.104 0.478 . . . . 73.21 110.411 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.502 ' HB2' ' OD2' ' A' ' 30' ' ' ASP . 31.4 m -84.71 137.05 38.62 Favored Pre-proline 0 N--CA 1.411 -2.386 0 N-CA-C 107.951 -1.129 . . . . 73.32 107.951 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.438 ' O ' ' HB ' ' A' ' 72' ' ' THR . 30.4 Cg_endo -60.18 -14.55 29.53 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.083 2.522 . . . . 70.43 113.878 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -85.89 -8.17 58.22 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.017 0.377 . . . . 74.13 112.017 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.502 ' OD2' ' HB2' ' A' ' 27' ' ' SER . 11.8 m-20 -79.28 153.71 29.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.736 0.303 . . . . 65.43 111.078 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.445 ' O ' HG13 ' A' ' 35' ' ' ILE . 67.2 m -95.03 124.35 39.02 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.509 -0.314 . . . . 55.31 110.492 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.718 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -49.32 -41.34 38.24 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.563 1.145 . . . . 74.12 113.782 -177.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 p -71.48 -32.78 68.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.023 0.439 . . . . 75.03 111.872 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.68 -42.25 82.42 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.098 -1.075 . . . . 75.03 108.098 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.46 ' O ' HG22 ' A' ' 39' ' ' VAL . 68.7 mt -60.9 -43.18 95.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.011 -1.449 . . . . 71.3 110.906 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.456 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -51.0 -41.89 60.05 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.504 0.721 . . . . 60.54 112.106 176.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.504 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -72.59 -33.78 66.96 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 107.153 -1.425 . . . . 71.44 107.153 -177.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -70.09 -50.97 35.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.362 1.065 . . . . 74.53 111.789 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.546 HG21 ' CB ' ' A' ' 14' ' ' LEU . 30.6 m -68.05 -31.47 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 113.35 0.87 . . . . 44.13 113.35 -177.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -46.79 -49.28 20.12 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 124.061 0.85 . . . . 63.54 112.288 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.8 t70 170.72 -69.82 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.622 -0.881 . . . . 70.22 108.622 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -89.01 127.24 35.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.895 -1.502 . . . . 71.31 107.918 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -81.01 147.01 60.36 Favored Pre-proline 0 C--N 1.3 -1.548 0 C-N-CA 120.798 -0.361 . . . . 75.12 111.643 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.47 0.51 0.25 Allowed 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 124.228 3.285 . . . . 71.34 116.465 -173.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 52.8 ttm -76.49 -23.73 53.76 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 122.015 -0.428 . . . . 75.2 110.381 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.02 -27.64 64.83 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.869 0.692 . . . . 61.21 112.869 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.464 ' CZ3' ' HB3' ' A' ' 96' ' ' GLU . 8.5 t-105 72.16 106.59 0.07 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.978 0.911 . . . . 75.44 111.879 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.31 115.74 28.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.12 0.486 . . . . 65.41 111.936 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -88.22 98.37 11.53 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 108.853 -0.795 . . . . 73.21 108.853 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -96.35 153.14 17.99 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.059 -0.719 . . . . 73.55 109.059 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -63.06 -57.03 12.02 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.281 -0.637 . . . . 71.51 109.281 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.0 p -104.24 93.46 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 122.037 0.922 . . . . 51.42 109.657 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.2 m -88.81 148.47 23.89 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.609 -0.723 . . . . 64.44 109.21 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 57' ' ' ILE . 46.4 m -147.94 130.36 7.73 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 109.711 -0.477 . . . . 52.34 109.711 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 54' ' ' SER . 5.5 Cg_exo -82.75 -28.88 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 121.79 1.66 . . . . 72.2 111.98 176.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -76.75 -0.21 22.89 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.624 0.972 . . . . 74.5 113.624 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.549 ' HA ' ' NH1' ' A' ' 59' ' ' ARG . 2.5 pp -77.56 -9.32 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 112.381 0.511 . . . . 64.22 112.381 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.413 ' C ' ' HD3' ' A' ' 59' ' ' ARG . 96.9 mt -81.96 108.21 15.28 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.02 -0.537 . . . . 23.31 110.359 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.549 ' NH1' ' HA ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -137.97 148.84 45.6 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 109.75 -0.463 . . . . 62.25 109.75 172.76 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.718 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.5 pp -120.45 131.6 54.84 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 115.462 -0.79 . . . . 54.32 110.341 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 88.0 mt -103.14 124.3 57.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.507 0 N-CA-C 107.522 -1.288 . . . . 63.12 107.522 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -99.65 84.79 3.0 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 106.252 -1.759 . . . . 75.53 106.252 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 66.58 -65.64 0.2 Allowed 'General case' 0 N--CA 1.405 -2.7 0 C-N-CA 127.58 2.352 . . . . 75.12 111.724 -175.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.25 -14.48 2.97 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 120.859 -0.686 . . . . 60.31 114.747 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.492 ' H ' ' HD2' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -122.92 148.0 45.96 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 118.612 1.206 . . . . 73.41 110.826 -178.262 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -84.36 111.59 19.57 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.559 -1.274 . . . . 73.52 107.559 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.629 HD12 HD22 ' A' ' 76' ' ' LEU . 59.5 mt -81.18 -46.99 14.03 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 114.404 1.261 . . . . 70.05 114.404 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.694 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.0 t-80 -171.65 176.17 3.79 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.925 -1.509 . . . . 61.0 106.925 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -85.71 -1.07 87.56 Favored Glycine 0 C--N 1.3 -1.44 0 N-CA-C 115.867 1.107 . . . . 74.22 115.867 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -169.39 19.32 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 118.429 1.115 . . . . 71.32 111.935 -170.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.574 HG12 HD21 ' A' ' 60' ' ' LEU . 11.3 p -74.92 146.74 9.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 120.653 -0.419 . . . . 55.32 110.223 -175.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.482 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 38.6 p -78.88 157.85 28.22 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.743 -0.662 . . . . 75.22 111.292 -175.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.576 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.2 mm? -66.4 -34.97 79.16 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.473 -0.33 . . . . 62.31 110.752 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.33 -35.06 90.38 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.556 -0.83 . . . . 70.31 111.281 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -75.42 -16.45 60.35 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 122.796 0.438 . . . . 72.11 111.404 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.629 HD22 HD12 ' A' ' 67' ' ' LEU . 45.4 mt -82.87 1.93 36.87 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.129 -0.693 . . . . 70.11 109.129 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.94 74.32 0.14 Allowed 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.08 1.352 . . . . 54.35 111.356 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.468 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.5 mp -127.33 112.13 21.31 Favored Pre-proline 0 CA--C 1.497 -1.067 0 CA-C-N 115.302 -0.863 . . . . 71.24 111.49 176.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.28 154.46 72.1 Favored 'Trans proline' 0 N--CA 1.445 -1.337 0 C-N-CA 122.08 1.853 . . . . 52.34 108.011 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -69.48 144.25 53.28 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.181 -0.674 . . . . 72.34 109.181 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.42 9.98 68.72 Favored Glycine 0 C--N 1.305 -1.155 0 C-N-CA 119.892 -1.147 . . . . 35.05 113.347 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -101.55 138.2 38.86 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 117.374 0.587 . . . . 74.13 110.342 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.641 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 58.8 m -92.13 117.51 29.92 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.872 -1.159 . . . . 75.13 107.872 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.0 m -130.68 135.91 48.29 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.083 -0.508 . . . . 64.15 111.229 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.414 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 7.7 p -102.14 138.46 26.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 116.065 -0.516 . . . . 74.45 111.453 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.537 ' O ' HG12 ' A' ' 15' ' ' ILE . 86.1 mtp -134.46 152.07 51.56 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.96 -0.385 . . . . 71.24 109.96 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 23.1 m-70 -108.13 132.02 54.04 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.098 -1.075 . . . . 53.33 108.098 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.5 mm? -116.9 141.88 47.65 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 120.366 -0.534 . . . . 64.14 111.016 -176.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.62 132.65 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 CA-C-N 115.863 -0.608 . . . . 62.22 109.773 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.3 130.34 34.92 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.824 -0.625 . . . . 51.4 109.513 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.473 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 99.8 mtt180 -123.7 130.75 53.12 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.959 -0.756 . . . . 75.14 108.959 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 70.41 -19.15 0.22 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 113.394 0.887 . . . . 60.4 113.394 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.402 ' H ' ' C ' ' A' ' 91' ' ' ARG . 77.7 m 78.77 141.7 0.07 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.563 1.145 . . . . 72.13 110.995 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 24.0 tp -81.49 126.98 74.86 Favored Pre-proline 0 N--CA 1.435 -1.207 0 CA-C-N 116.069 -0.514 . . . . 75.45 109.772 -177.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 94' ' ' LEU . 7.8 Cg_exo -68.07 -58.44 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.801 2.334 . . . . 72.13 111.416 176.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.464 ' HB3' ' CZ3' ' A' ' 47' ' ' TRP . 0.1 OUTLIER -117.02 129.98 24.94 Favored Pre-proline 0 N--CA 1.434 -1.25 0 CA-C-N 115.869 -0.605 . . . . 75.23 111.628 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -48.27 -47.71 18.98 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 123.854 3.036 . . . . 64.34 113.762 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -166.13 -66.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.025 0.38 . . . . 71.44 112.025 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 63.6 p -173.05 24.17 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.851 0.358 . . . . 54.21 110.752 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -60.25 -52.41 65.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.339 -0.392 . . . . 74.32 111.753 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 56.18 27.47 52.31 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.328 -0.463 . . . . 52.23 112.291 -176.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -132.07 143.41 50.02 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 122.95 0.5 . . . . 72.43 110.331 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -115.85 -172.23 2.12 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.238 -1.764 . . . . 74.4 106.238 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -68.79 105.34 2.29 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.125 -0.63 . . . . 73.31 109.482 174.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.665 ' NH1' ' HA ' ' A' ' 110' ' ' GLU . 3.2 tmm_? -69.31 -39.84 78.0 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.139 -0.937 . . . . 52.05 108.831 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 66.28 -78.18 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.816 1.246 . . . . 71.32 112.617 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -140.94 -44.99 0.39 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.297 -0.41 . . . . 61.12 110.195 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.3 p -53.0 128.34 26.97 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.732 0.813 . . . . 72.3 112.767 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.28 -47.14 3.28 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.986 -0.446 . . . . 73.51 111.986 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.665 ' HA ' ' NH1' ' A' ' 105' ' ' ARG . 15.3 tp10 61.27 86.45 0.1 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.262 1.025 . . . . 72.0 112.383 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.2 m -109.43 92.69 4.15 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 115.072 -0.967 . . . . 75.22 109.73 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -178.04 -58.37 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 105.499 -2.037 . . . . 74.04 105.499 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 51.6 t -163.35 100.4 0.94 Allowed 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 114.384 -1.28 . . . . 53.11 107.691 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 63.6 m -51.76 -60.98 2.55 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.303 0.641 . . . . 74.45 110.66 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.81 160.96 30.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 106.526 -1.657 . . . . 70.52 106.526 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.8 pt -75.61 88.45 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 122.359 1.076 . . . . 71.43 111.759 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.6 tm? . . . . . 0 N--CA 1.424 -1.761 0 N-CA-C 106.139 -1.8 . . . . 74.12 106.139 179.793 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.245 0.865 0 N-CA-C 107.296 -1.372 . . . . 65.21 107.296 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.4 p -80.63 108.63 14.43 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.365 -0.606 . . . . 73.42 109.365 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 65.16 -162.11 0.27 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.271 -1.381 . . . . 72.0 107.271 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.428 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 15.1 t -107.05 114.67 61.17 Favored Pre-proline 0 N--CA 1.423 -1.798 0 N-CA-C 107.91 -1.144 . . . . 65.35 107.91 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -69.71 151.22 69.3 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 122.298 1.999 . . . . 64.23 111.888 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.65 69.9 6.04 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 122.061 0.934 . . . . 43.23 109.949 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.409 ' H ' ' H ' ' A' ' 9' ' ' MET . 31.0 t70 -173.47 -21.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.386 -1.733 . . . . 60.32 107.672 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.409 ' H ' ' H ' ' A' ' 8' ' ' ASP . 94.2 mmm -118.26 160.11 22.18 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.892 -1.049 . . . . 73.11 108.968 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -125.11 137.91 56.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.843 -0.799 . . . . 73.54 108.843 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.4 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 9.1 t-20 -92.06 107.73 19.42 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.713 -1.217 . . . . 72.3 107.713 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.55 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.5 tp -111.11 133.1 53.74 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.656 -0.702 . . . . 71.01 112.559 -171.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.422 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 35.9 ttp180 -109.5 121.03 44.29 Favored 'General case' 0 N--CA 1.414 -2.244 0 CA-C-N 115.195 -0.911 . . . . 75.11 109.008 174.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.581 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.0 mm? -101.45 126.71 48.27 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-N 114.462 -1.245 . . . . 63.34 108.504 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 21' ' ' THR . 26.0 mt -104.32 127.31 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 C-N-CA 119.379 -0.928 . . . . 73.21 109.477 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.14 156.87 20.85 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.365 -0.606 . . . . 74.52 109.365 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.52 -13.01 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.474 0.546 . . . . 75.11 112.474 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.8 t -76.1 -12.15 60.06 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.717 0.77 . . . . 74.42 109.06 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.13 -3.28 64.24 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.677 -0.569 . . . . 65.23 111.677 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.1 134.74 33.69 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.731 0.3 . . . . 74.05 110.332 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 15' ' ' ILE . 67.5 p -98.61 150.11 22.08 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 121.193 0.521 . . . . 64.13 110.753 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.447 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -132.4 138.44 47.69 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.027 -1.471 . . . . 71.23 107.027 174.255 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HG3' ' HB2' ' A' ' 13' ' ' ARG . 27.0 tt0 -137.68 129.65 28.83 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.072 -1.084 . . . . 70.54 108.072 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.694 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 97.3 m-85 -145.91 159.41 43.27 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.905 -0.776 . . . . 73.31 108.905 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.0 tp -83.19 124.92 31.0 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 106.862 -1.533 . . . . 70.45 106.862 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.694 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 94.2 m-85 -129.52 163.6 25.59 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.76 -0.83 . . . . 71.2 108.76 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.8 p -87.79 145.1 36.1 Favored Pre-proline 0 N--CA 1.41 -2.443 0 N-CA-C 107.339 -1.356 . . . . 74.41 107.339 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.553 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 26.6 Cg_endo -61.62 -11.63 21.17 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 122.329 2.02 . . . . 62.31 112.37 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.88 -7.27 49.77 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 109.364 -0.606 . . . . 65.14 109.364 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -71.9 154.09 41.45 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 122.087 -0.383 . . . . 75.1 110.09 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.532 ' O ' HG13 ' A' ' 35' ' ' ILE . 8.3 p -94.77 121.4 36.32 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-O 121.04 0.448 . . . . 54.31 111.445 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.417 ' CB ' HD22 ' A' ' 60' ' ' LEU . . . -46.0 -51.68 13.11 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.178 1.548 . . . . 72.21 115.178 -174.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.532 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 18.7 m -78.16 -20.69 51.48 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.633 -0.827 . . . . 71.13 112.502 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -69.25 -42.44 75.61 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 106.45 -1.685 . . . . 61.31 106.45 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.534 ' O ' HG22 ' A' ' 39' ' ' VAL . 61.3 mt -62.29 -40.21 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.473 -1.239 . . . . 72.43 110.055 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.402 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.31 -43.96 53.9 Favored 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 123.051 0.54 . . . . 73.41 111.332 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.515 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 1.7 tmtp? -72.83 -37.91 67.29 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.898 -0.778 . . . . 74.24 108.898 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 32.8 t-80 -56.87 -50.75 71.53 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.419 -0.81 . . . . 73.33 109.971 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.581 HG21 ' CB ' ' A' ' 14' ' ' LEU . 29.5 m -73.29 -32.38 37.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.629 -0.714 . . . . 64.4 111.129 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -56.16 -48.18 76.8 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.555 0.742 . . . . 75.31 110.755 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -141.99 -65.53 0.41 Allowed 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.046 -0.662 . . . . 73.43 110.482 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 38' ' ' HIS . 56.7 t30 -161.26 174.13 14.03 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.697 -1.594 . . . . 73.21 106.697 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.3 p-90 -59.26 127.42 84.16 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 118.249 0.477 . . . . 73.34 111.268 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -65.97 127.43 17.69 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.92 1.747 . . . . 65.11 109.736 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 51.1 ttm -79.52 -17.2 54.58 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.916 -0.584 . . . . 73.25 110.778 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -147.04 -168.27 3.0 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.152 -1.795 . . . . 74.41 106.152 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -87.23 135.15 33.41 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 118.81 0.732 . . . . 75.14 111.197 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.509 ' O ' HD11 ' A' ' 57' ' ' ILE . 24.3 mm-40 -83.26 107.99 16.18 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.55 -0.75 . . . . 44.13 110.359 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.24 170.42 16.29 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 123.752 0.657 . . . . 52.15 110.672 176.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -103.62 41.78 1.24 Allowed 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.1 -0.704 . . . . 73.51 109.1 -172.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 59.91 44.01 14.16 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.487 1.137 . . . . 71.54 109.652 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.08 -21.88 4.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 113.941 -1.481 . . . . 61.41 110.56 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.6 m 67.79 -12.88 0.27 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.885 1.274 . . . . 75.53 112.876 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.7 m -80.24 114.36 46.42 Favored Pre-proline 0 N--CA 1.436 -1.175 0 C-N-CA 123.186 0.595 . . . . 73.44 110.528 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.447 ' O ' HD23 ' A' ' 58' ' ' LEU . 40.2 Cg_endo -65.99 -14.96 46.88 Favored 'Trans proline' 0 C--O 1.209 -0.964 0 C-N-CA 123.428 2.752 . . . . 42.44 114.68 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.02 -5.83 1.15 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 115.147 1.536 . . . . 73.13 115.147 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.509 HD11 ' O ' ' A' ' 48' ' ' GLU . 2.5 pp -82.94 -29.38 8.23 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.123 0 C-N-CA 120.195 -0.602 . . . . 64.51 110.152 174.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 2.1 pt? -111.33 95.34 5.46 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 107.109 -1.441 . . . . 64.11 107.109 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 38.5 ptt180 -131.45 159.78 37.07 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-O 121.847 0.832 . . . . 65.3 112.828 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.647 HD21 HG12 ' A' ' 71' ' ' VAL . 4.4 pp -115.4 146.72 41.33 Favored 'General case' 0 N--CA 1.407 -2.585 0 CA-C-N 114.657 -1.156 . . . . 62.24 112.349 -171.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 94.9 mt -116.67 122.79 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.637 0 CA-C-N 114.351 -1.295 . . . . 72.54 107.773 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -100.16 89.42 4.01 Favored 'General case' 0 C--N 1.263 -3.18 0 N-CA-C 105.667 -1.975 . . . . 62.42 105.667 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 69.94 -70.05 0.16 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.325 -1.761 . . . . 73.25 112.717 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.47 2.44 3.46 Favored Glycine 0 C--N 1.313 -0.73 0 C-N-CA 119.94 -1.124 . . . . 74.44 113.043 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -130.72 140.94 50.37 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.121 0.415 . . . . 65.2 112.121 -176.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -83.59 113.82 21.09 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.464 -1.309 . . . . 75.3 107.464 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.611 HD12 HD22 ' A' ' 76' ' ' LEU . 60.8 mt -79.79 -46.21 17.38 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 119.48 -0.888 . . . . 65.03 112.733 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.552 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 50.2 t-80 -169.9 169.71 8.1 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 104.091 -2.559 . . . . 60.01 104.091 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -63.67 -47.13 89.56 Favored Glycine 0 C--O 1.201 -1.966 0 C-N-CA 120.185 -1.007 . . . . 64.24 113.589 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.453 ' OD1' ' HB2' ' A' ' 31' ' ' SER . 10.2 t30 -152.58 72.0 0.96 Allowed 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 122.348 1.07 . . . . 61.05 109.517 -172.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.647 HG12 HD21 ' A' ' 60' ' ' LEU . 7.2 p -101.62 151.29 5.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 113.617 -1.629 . . . . 73.34 108.079 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.458 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 42.0 p -78.12 158.73 29.0 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.677 0.275 . . . . 71.44 111.406 -175.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.59 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.2 mm? -68.27 -32.72 73.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.365 -0.38 . . . . 72.53 111.146 -176.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.19 -36.95 93.88 Favored Glycine 0 C--O 1.24 0.507 0 N-CA-C 110.743 -0.943 . . . . 72.43 110.743 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.464 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -71.48 -15.43 62.32 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.011 0.524 . . . . 74.21 110.835 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.611 HD22 HD12 ' A' ' 67' ' ' LEU . 86.5 mt -82.58 6.31 18.05 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.402 0.681 . . . . 71.35 110.237 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 77.03 10.94 2.47 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.824 1.249 . . . . 52.45 111.828 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.606 HD13 ' HB2' ' A' ' 76' ' ' LEU . 9.6 mp -72.37 119.26 73.89 Favored Pre-proline 0 C--O 1.24 0.565 0 N-CA-C 112.95 0.722 . . . . 74.43 112.95 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 4.3 Cg_exo -76.85 159.41 34.63 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.022 2.481 . . . . 65.43 109.75 173.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.41 ' CE1' ' HG3' ' A' ' 28' ' ' PRO . 7.6 m-85 -77.25 156.73 31.24 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.388 -0.597 . . . . 73.43 109.388 -176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.428 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 79.55 10.19 86.11 Favored Glycine 0 C--N 1.308 -0.973 0 C-N-CA 120.896 -0.669 . . . . 74.51 113.546 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -115.62 155.81 26.98 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 120.798 0.332 . . . . 44.51 111.414 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.4 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 84.1 m -105.2 125.89 51.48 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.761 -0.654 . . . . 74.21 109.266 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.3 m -136.34 142.2 43.82 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.905 0.383 . . . . 75.33 111.85 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.47 142.2 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.031 -0.531 . . . . 51.41 110.744 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 93.0 mtp -137.0 153.26 50.71 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.276 0.56 . . . . 74.13 110.949 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.481 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 35.0 m-70 -111.56 130.8 55.62 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.773 -1.566 . . . . 61.52 106.773 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.2 mm? -119.12 143.49 47.15 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.635 -0.426 . . . . 70.41 111.249 -174.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.88 134.24 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.503 -0.554 . . . . 54.41 109.503 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 57' ' ' ILE . . . -134.01 138.03 45.12 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.717 -0.475 . . . . 54.2 109.717 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.402 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 72.1 mtp180 -119.48 134.98 54.96 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 107.289 -1.374 . . . . 74.33 107.289 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 62.56 28.66 16.79 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 123.938 0.774 . . . . 73.53 109.025 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.405 ' HB ' ' HB1' ' A' ' 90' ' ' ALA . 12.8 t -71.12 153.05 42.84 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 109.438 -0.578 . . . . 62.13 109.438 -176.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 mp -98.82 141.37 22.78 Favored Pre-proline 0 C--N 1.282 -2.341 0 CA-C-O 120.918 0.389 . . . . 75.21 111.15 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.83 -152.11 0.04 OUTLIER 'Trans proline' 0 C--O 1.258 1.498 0 C-N-CA 122.563 2.175 . . . . 71.33 109.255 173.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.14 135.97 76.26 Favored Pre-proline 0 C--N 1.314 -0.975 0 C-N-CA 119.422 -0.911 . . . . 70.31 110.587 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.22 -1.69 11.83 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.146 1.897 . . . . 65.53 111.216 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 71.51 -7.03 1.27 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.563 1.145 . . . . 70.22 112.216 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.3 m -85.03 -0.49 54.62 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 122.852 0.461 . . . . 71.42 110.844 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -84.36 -51.26 7.1 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.909 0.707 . . . . 72.43 112.909 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 57.43 20.19 36.51 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 121.152 -0.547 . . . . 75.23 112.307 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.566 ' NE2' ' HB2' ' A' ' 106' ' ' GLU . 37.9 tt0 -111.69 127.17 55.69 Favored 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 123.054 0.542 . . . . 75.31 111.582 -177.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -75.47 -57.06 4.12 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.089 -1.448 . . . . 72.23 107.089 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -177.38 -49.02 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.443 -1.253 . . . . 54.41 110.589 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 105' ' ' ARG . 49.4 mtt180 -59.63 -50.28 74.48 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.392 0.516 . . . . 73.13 112.392 -176.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.566 ' HB2' ' NE2' ' A' ' 102' ' ' GLN . 0.3 OUTLIER 66.65 -74.74 0.06 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.715 1.206 . . . . 65.31 111.671 176.649 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -146.68 135.66 22.45 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.957 -0.757 . . . . 65.24 108.957 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.9 m 74.16 -12.79 0.84 Allowed 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 123.932 0.893 . . . . 64.3 112.0 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.54 -12.92 71.48 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 111.045 -0.822 . . . . 75.23 111.045 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -56.01 132.91 51.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.581 0.752 . . . . 74.01 111.394 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.1 m -117.4 109.0 16.24 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.763 -0.653 . . . . 71.43 109.844 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -76.92 108.24 9.82 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.433 -1.321 . . . . 65.21 107.433 177.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.18 -21.55 66.78 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.782 -0.644 . . . . 74.41 112.05 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 68.0 m 62.77 92.56 0.06 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.744 0.817 . . . . 65.03 110.323 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.3 m -71.61 82.38 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 114.275 1.213 . . . . 73.2 114.275 -175.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.5 pt -120.49 107.86 21.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 114.738 -1.119 . . . . 62.54 108.403 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 C--N 1.294 -1.815 0 CA-C-O 118.411 -0.804 . . . . 71.12 109.861 -177.109 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.435 -1.187 0 N-CA-C 110.16 -0.311 . . . . 74.31 110.16 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.45 ' N ' HG11 ' A' ' 115' ' ' VAL . 33.7 m -96.32 94.99 7.77 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.215 0.531 . . . . 63.14 111.033 177.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.407 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 47.7 t30 -127.86 130.1 48.03 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 105.282 -2.118 . . . . 73.53 105.282 172.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 11' ' ' ASN . 2.0 t -121.68 124.44 27.13 Favored Pre-proline 0 N--CA 1.407 -2.602 0 C-N-CA 119.047 -1.061 . . . . 75.43 110.605 -171.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.07 144.07 51.24 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.918 1.745 . . . . 72.04 109.109 172.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.35 71.3 3.83 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.772 0.796 . . . . 74.13 111.23 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -175.48 -27.43 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.95 -1.477 . . . . 64.42 108.14 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.9 mmm -110.45 157.46 19.55 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.605 -1.18 . . . . 74.13 108.866 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.458 HG22 ' HA ' ' A' ' 80' ' ' PHE . 2.7 pp -111.13 134.79 52.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 110.079 -0.341 . . . . 73.01 110.079 174.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.47 HD22 HG23 ' A' ' 83' ' ' THR . 3.6 t30 -92.75 107.55 19.31 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 107.964 -1.124 . . . . 64.21 107.964 -176.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.575 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.1 tp -111.84 132.57 54.61 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.676 0.75 . . . . 74.32 112.389 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -107.19 119.98 40.86 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 108.333 -0.988 . . . . 72.53 108.333 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.575 HD22 ' HG ' ' A' ' 12' ' ' LEU . 2.5 mm? -99.09 125.73 44.68 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 124.704 1.201 . . . . 74.01 110.023 -177.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.439 HG23 HG22 ' A' ' 21' ' ' THR . 29.0 mt -100.2 117.61 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 108.441 -0.948 . . . . 75.52 108.441 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.497 HD21 HG23 ' A' ' 39' ' ' VAL . 68.8 mt -75.1 162.21 28.73 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.108 -0.496 . . . . 64.43 111.733 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.32 -15.8 20.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.484 -0.78 . . . . 71.35 110.219 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.0 m -76.81 -14.71 59.88 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.438 -0.801 . . . . 61.3 109.295 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.7 1.83 67.82 Favored Glycine 0 CA--C 1.501 -0.837 0 CA-C-N 115.882 -0.599 . . . . 53.04 112.076 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -89.12 133.06 34.53 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.103 -1.073 . . . . 75.11 108.103 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.439 HG22 HG23 ' A' ' 15' ' ' ILE . 76.9 p -98.78 129.8 45.21 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.877 -0.786 . . . . 63.15 108.877 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.454 ' HD2' HD11 ' A' ' 16' ' ' LEU . 26.6 mtpp -127.93 149.38 50.35 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.702 -0.851 . . . . 71.44 108.702 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -136.34 131.25 34.05 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.447 -0.901 . . . . 51.22 109.791 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.602 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.5 m-85 -144.73 159.21 43.22 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 123.735 0.814 . . . . 74.42 108.85 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.5 tp -89.36 128.5 35.91 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.626 -0.879 . . . . 54.25 108.626 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.602 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 97.0 m-85 -132.2 173.95 10.72 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.977 -0.379 . . . . 71.3 109.977 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.2 p -98.76 150.46 36.72 Favored Pre-proline 0 N--CA 1.421 -1.896 0 N-CA-C 108.331 -0.988 . . . . 73.14 108.331 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.431 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 36.2 Cg_endo -62.33 -11.38 22.29 Favored 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 122.257 1.971 . . . . 75.02 111.989 177.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -79.82 -22.15 43.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.301 1.041 . . . . 73.05 111.258 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -67.55 153.46 43.65 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.319 0.489 . . . . 72.44 112.319 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.476 ' O ' HG13 ' A' ' 35' ' ' ILE . 51.7 p -100.38 118.91 37.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.54 -0.541 . . . . 74.11 109.54 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.693 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -46.09 -51.19 14.29 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 115.205 1.557 . . . . 70.13 115.205 -173.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.7 m -71.85 -26.15 62.25 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 122.011 -0.43 . . . . 70.34 111.649 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.37 -41.19 76.84 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 107.75 -1.204 . . . . 73.4 107.75 173.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.554 ' O ' HG22 ' A' ' 39' ' ' VAL . 66.2 mt -60.66 -40.11 83.68 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 CA-C-N 114.031 -1.44 . . . . 72.42 110.186 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.489 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.12 -40.64 46.67 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 123.4 0.68 . . . . 71.43 111.026 176.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.557 ' HB2' ' HG3' ' A' ' 44' ' ' PRO . 35.0 mmtp -73.22 -43.64 60.91 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.793 -0.639 . . . . 73.43 109.746 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.513 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 13.2 t60 -61.45 -39.91 92.55 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.728 0.811 . . . . 72.12 111.636 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 35' ' ' ILE . 29.4 m -77.08 -31.86 18.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.192 -0.458 . . . . 72.52 111.69 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 50.9 t80 -59.67 -49.58 77.17 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 124.102 0.876 . . . . 74.01 110.273 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -179.65 90.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.615 0.572 . . . . 71.41 111.576 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 38' ' ' HIS . 23.1 t-20 72.24 170.49 0.32 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.388 1.075 . . . . 74.03 111.119 176.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -73.87 123.9 89.71 Favored Pre-proline 0 C--N 1.312 -1.043 0 O-C-N 122.023 -0.423 . . . . 75.13 111.278 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HG3' ' HB2' ' A' ' 37' ' ' LYS . 34.3 Cg_endo -62.0 -50.01 5.7 Favored 'Trans proline' 0 C--O 1.248 0.999 0 C-N-CA 122.804 2.336 . . . . 50.2 112.536 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.459 ' HA ' ' CE ' ' A' ' 45' ' ' MET . 2.4 mmt 69.92 -64.82 0.34 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.266 1.027 . . . . 74.31 112.848 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -172.19 -37.78 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.262 0.553 . . . . 71.42 110.367 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 25.6 m-90 -82.98 91.09 7.09 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.348 0.594 . . . . 74.5 111.152 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -119.27 -171.33 2.09 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.114 -1.069 . . . . 72.35 108.114 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -73.95 135.46 43.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.983 -1.118 . . . . 72.44 107.983 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 71.26 5.8 5.57 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 124.292 0.995 . . . . 74.35 110.042 -172.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 62.95 -85.61 0.02 OUTLIER 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.146 1.378 . . . . 62.34 110.884 -176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -128.2 86.11 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.784 0.802 . . . . 74.55 110.397 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.3 m -61.2 -58.15 9.5 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.019 -0.991 . . . . 71.11 110.332 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.502 ' O ' HG12 ' A' ' 57' ' ' ILE . 77.2 p 178.96 158.24 0.66 Allowed Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 107.144 -1.428 . . . . 65.54 107.144 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.31 -16.53 24.78 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 121.809 1.673 . . . . 73.4 110.725 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -75.02 -3.04 30.09 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.591 -0.731 . . . . 64.11 111.822 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 91' ' ' ARG . 34.3 pt -81.76 -11.56 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 120.141 -0.624 . . . . 71.03 109.769 176.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.599 ' O ' ' HD2' ' A' ' 59' ' ' ARG . 2.9 mm? -95.11 108.88 21.0 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 115.852 -0.613 . . . . 71.43 110.922 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.599 ' HD2' ' O ' ' A' ' 58' ' ' LEU . 3.3 mpt_? -130.07 162.85 27.84 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 123.78 0.832 . . . . 72.21 109.138 174.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.693 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.2 pp -148.19 144.49 27.77 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.671 -0.492 . . . . 72.42 109.671 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.552 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 88.5 mt -117.67 119.17 60.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.774 -0.825 . . . . 75.14 108.774 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -101.97 86.01 2.8 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.351 -0.611 . . . . 74.5 109.351 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 44.98 70.55 0.33 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.707 -1.588 . . . . 74.25 112.228 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.06 -72.5 0.45 Allowed Glycine 0 N--CA 1.431 -1.666 0 C-N-CA 119.907 -1.139 . . . . 75.11 113.261 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -117.13 164.77 14.26 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 117.518 0.659 . . . . 72.45 112.772 -173.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 67.9 m-85 -86.11 113.85 22.49 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.46 -1.311 . . . . 72.31 107.46 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.575 HD12 HD22 ' A' ' 76' ' ' LEU . 70.0 mt -80.13 -47.32 14.94 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.398 1.259 . . . . 71.11 114.398 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.523 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 61.8 t-80 -174.64 151.82 1.54 Allowed 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 107.218 -1.401 . . . . 63.31 107.218 -174.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.83 1.3 39.63 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.073 1.189 . . . . 65.03 116.073 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -168.7 27.55 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.144 0.972 . . . . 72.5 110.053 -169.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.548 HG12 HD21 ' A' ' 60' ' ' LEU . 12.6 p -84.17 142.92 12.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 119.592 -0.843 . . . . 65.21 110.219 -177.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 49.2 p -81.44 160.22 24.06 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.94 -0.573 . . . . 63.33 111.304 -177.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.564 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.9 mm? -65.42 -33.09 75.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.208 -0.451 . . . . 72.25 111.811 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.64 -30.87 75.14 Favored Glycine 0 C--O 1.238 0.352 0 C-N-CA 120.099 -1.048 . . . . 74.13 111.085 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -74.5 -15.35 60.88 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.456 0.702 . . . . 52.41 110.646 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.575 HD22 HD12 ' A' ' 67' ' ' LEU . 74.3 mt -81.95 11.49 5.01 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.413 -0.588 . . . . 72.13 109.413 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.405 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER 67.99 17.79 9.54 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.771 1.228 . . . . 73.03 110.856 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.526 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 91.5 mt -82.86 120.08 75.59 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 115.775 -0.648 . . . . 60.13 110.753 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -82.21 138.83 10.23 Favored 'Trans proline' 0 N--CA 1.435 -1.964 0 C-N-CA 122.145 1.896 . . . . 55.45 110.531 175.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.458 ' HA ' HG22 ' A' ' 10' ' ' ILE . 5.6 p90 -67.41 149.91 49.64 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.358 0.599 . . . . 71.31 112.504 178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.69 5.79 64.44 Favored Glycine 0 N--CA 1.432 -1.573 0 CA-C-N 115.203 -0.908 . . . . 72.01 111.763 -174.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -124.0 164.89 18.42 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 109.843 -0.429 . . . . 63.22 109.843 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.47 HG23 HD22 ' A' ' 11' ' ' ASN . 64.2 m -106.69 134.65 49.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.7 0.286 . . . . 72.23 110.283 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.5 m -141.02 142.36 34.24 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 122.212 -0.305 . . . . 74.32 111.706 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.7 p -108.92 142.76 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 122.774 0.43 . . . . 74.02 110.118 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 92.8 mtp -136.22 152.94 51.29 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 120.994 0.426 . . . . 71.24 110.515 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.552 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 30.6 m-70 -104.46 130.16 52.39 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.269 -1.382 . . . . 72.01 107.269 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.489 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.5 mm? -117.79 144.4 45.38 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.524 -0.471 . . . . 64.52 110.762 -176.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.1 m -133.28 134.65 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 109.344 -0.613 . . . . 72.14 109.344 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.33 139.4 45.63 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.066 0.46 . . . . 73.15 110.759 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.518 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -101.63 141.84 33.88 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 103.122 -2.918 . . . . 72.24 103.122 175.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 57.25 48.65 14.7 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.966 -1.124 . . . . 72.34 107.966 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 t -56.5 164.84 1.27 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.235 1.017 . . . . 73.52 113.143 -175.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 37' ' ' LYS . 32.1 tp -65.28 148.88 97.67 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-N 113.975 -1.466 . . . . 60.43 109.239 -178.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.461 ' HD2' HD12 ' A' ' 94' ' ' LEU . 71.4 Cg_exo -54.94 156.7 14.83 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.313 2.008 . . . . 64.24 110.952 172.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -135.32 152.42 76.67 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 116.465 -0.334 . . . . 65.52 110.562 -174.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.28 -64.84 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.009 1.806 . . . . 72.52 109.409 172.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -174.86 91.7 0.06 Allowed 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 115.166 -0.925 . . . . 64.23 110.107 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.7 p 58.45 -37.13 0.05 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 117.464 2.394 . . . . 70.23 117.464 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -79.87 -51.65 8.86 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.756 0.65 . . . . 74.23 112.756 -173.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.98 45.52 95.97 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 107.847 -2.101 . . . . 75.02 107.847 -171.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -70.78 122.31 19.63 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 114.704 1.372 . . . . 75.13 114.704 -171.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -163.37 148.6 11.28 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 127.602 2.361 . . . . 70.52 105.327 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.608 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 13.9 m120 -120.8 -168.91 1.73 Allowed 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 104.966 -2.235 . . . . 74.13 104.966 174.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -71.82 -36.12 70.14 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 117.548 -1.661 . . . . 72.32 107.326 171.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.62 ' O ' ' HB3' ' A' ' 110' ' ' GLU . 46.5 mt-10 57.98 -167.21 0.14 Allowed 'General case' 0 C--N 1.354 0.803 0 CA-C-N 114.322 -1.308 . . . . 65.05 111.754 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.624 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 7.0 tmtm? -86.35 -8.51 57.63 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.17 -1.048 . . . . 62.23 108.17 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.8 m -91.61 94.66 9.52 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 115.736 -0.665 . . . . 74.21 110.182 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.95 40.12 5.62 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.881 -0.888 . . . . 55.04 110.881 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.62 ' HB3' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -99.67 -176.36 3.25 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.188 0.994 . . . . 72.42 113.62 -177.564 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.407 ' CB ' ' HB3' ' A' ' 4' ' ' ASN . 40.1 m -148.17 97.21 2.74 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.032 -1.84 . . . . 65.41 106.032 174.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -75.07 89.5 2.46 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.465 0.65 . . . . 74.3 110.702 -174.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 70.0 m -148.99 160.43 43.31 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.494 -0.775 . . . . 74.3 109.64 -177.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 60.2 m -87.06 110.41 20.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.346 -1.353 . . . . 51.43 107.346 176.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.45 HG11 ' N ' ' A' ' 3' ' ' SER . 23.2 m -85.24 154.07 3.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.046 0.45 . . . . 74.3 111.981 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.4 tp -120.83 123.65 70.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.955 -0.566 . . . . 72.41 109.507 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.5 tm? . . . . . 0 C--N 1.306 -1.294 0 N-CA-C 107.516 -1.29 . . . . 75.14 107.516 -179.298 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.1 m . . . . . 0 N--CA 1.427 -1.583 0 N-CA-C 108.642 -0.873 . . . . 72.35 108.642 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.6 m 70.56 -165.46 0.16 Allowed 'General case' 0 C--O 1.248 0.984 0 C-N-CA 123.661 0.784 . . . . 74.41 110.303 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -57.1 152.1 14.03 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.287 0.565 . . . . 73.01 111.269 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.47 HG13 HD11 ' A' ' 25' ' ' LEU . 26.0 t -92.22 114.46 62.3 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 109.201 -0.666 . . . . 53.21 109.201 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.89 161.26 33.34 Favored 'Trans proline' 0 C--O 1.247 0.955 0 C-N-CA 122.574 2.183 . . . . 71.42 111.207 177.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.94 74.13 6.69 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 121.869 0.843 . . . . 72.12 109.101 175.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -171.2 -28.64 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.524 -1.671 . . . . 74.54 108.594 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 89.1 mmm -111.97 151.86 28.76 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.776 -1.102 . . . . 74.03 108.867 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.461 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.7 pp -111.34 136.32 47.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-O 120.817 0.341 . . . . 65.22 110.687 176.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.409 ' HB2' HG21 ' A' ' 5' ' ' VAL . 52.9 t-20 -83.01 111.58 18.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.775 -1.194 . . . . 73.2 107.775 -177.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.478 ' HG ' HD22 ' A' ' 14' ' ' LEU . 40.0 tp -118.01 132.93 56.33 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.482 0.658 . . . . 61.34 112.627 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.44 ' HD2' ' OE1' ' A' ' 23' ' ' GLU . 19.0 ttt85 -113.48 122.34 47.02 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 114.994 -1.003 . . . . 61.11 108.878 175.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.517 ' CB ' HG21 ' A' ' 39' ' ' VAL . 1.9 mm? -100.09 125.11 46.14 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 124.502 1.121 . . . . 73.1 108.609 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.637 HD12 HG22 ' A' ' 21' ' ' THR . 18.8 mm -99.28 123.71 52.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.629 -1.248 . . . . 73.33 107.629 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.23 156.87 24.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.399 -0.593 . . . . 74.53 109.399 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.435 ' CG1' ' HA ' ' A' ' 89' ' ' VAL . 35.3 m -66.21 -14.24 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.153 0.427 . . . . 53.11 112.153 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.2 t -76.27 -16.85 59.71 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.859 -0.61 . . . . 72.02 109.686 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.57 -6.19 57.33 Favored Glycine 0 N--CA 1.433 -1.559 0 C-N-CA 120.576 -0.821 . . . . 52.3 112.178 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -86.88 140.05 30.03 Favored 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 119.182 -1.007 . . . . 51.5 110.401 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.637 HG22 HD12 ' A' ' 15' ' ' ILE . 62.0 p -99.11 137.15 38.04 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 115.07 -0.968 . . . . 42.34 109.651 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -126.86 138.28 53.3 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.29 -1.744 . . . . 72.32 106.29 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 26.3 tt0 -137.71 131.15 30.94 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.09 -1.044 . . . . 64.24 110.818 -176.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.587 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 86.1 m-85 -145.03 159.79 42.39 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 123.382 0.673 . . . . 74.32 109.267 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.47 HD11 HG13 ' A' ' 5' ' ' VAL . 41.2 tp -84.67 125.15 32.25 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.386 -0.968 . . . . 63.23 108.386 176.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.587 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 96.3 m-85 -128.9 174.44 9.5 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.225 -0.657 . . . . 74.31 109.225 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.0 p -97.59 154.14 38.05 Favored Pre-proline 0 N--CA 1.431 -1.408 0 C-N-CA 119.193 -1.003 . . . . 64.55 108.818 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.589 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 45.0 Cg_endo -64.18 -12.9 34.84 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.576 2.184 . . . . 74.1 112.105 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -93.33 -7.33 45.13 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.161 -0.472 . . . . 65.53 111.642 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -79.2 153.28 30.12 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 120.485 -0.486 . . . . 72.41 111.186 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.489 ' O ' HG13 ' A' ' 35' ' ' ILE . 45.5 m -93.17 122.41 35.53 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.664 0.269 . . . . 73.4 110.775 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.717 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -49.34 -46.81 47.35 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.919 1.288 . . . . 42.32 113.409 -176.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 p -67.5 -33.71 75.65 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 113.05 0.759 . . . . 65.53 113.05 -177.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.54 -44.89 66.57 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.606 -1.257 . . . . 63.2 107.606 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 31' ' ' SER . 69.4 mt -55.29 -40.79 58.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 114.539 -1.209 . . . . 75.54 111.148 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.431 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.7 -37.65 42.55 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 123.549 0.74 . . . . 75.44 111.647 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.67 ' HB2' ' HG3' ' A' ' 44' ' ' PRO . 98.3 mttt -73.81 -34.58 64.66 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 120.755 0.312 . . . . 73.04 111.208 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.408 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 71.7 t60 -71.93 -44.25 63.94 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.405 -0.361 . . . . 70.44 111.829 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.517 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.4 m -65.24 -31.07 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 120.814 0.34 . . . . 72.34 110.886 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -70.76 -51.09 29.39 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.431 -0.804 . . . . 73.02 111.542 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -179.13 137.31 0.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 118.096 0.407 . . . . 73.13 111.996 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 38' ' ' HIS . 24.9 t-20 60.04 -172.7 0.12 Allowed 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 124.741 1.216 . . . . 74.44 108.289 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 67.3 p-90 -114.09 130.29 24.04 Favored Pre-proline 0 N--CA 1.43 -1.457 0 N-CA-C 107.312 -1.366 . . . . 61.23 107.312 171.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.67 ' HG3' ' HB2' ' A' ' 37' ' ' LYS . 44.3 Cg_endo -92.46 152.43 2.97 Favored 'Trans proline' 0 N--CA 1.423 -2.623 0 C-N-CA 120.906 1.07 . . . . 73.22 112.567 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 25.2 ttt -91.82 -36.97 13.22 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.501 -1.666 . . . . 71.22 106.501 169.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.8 t70 42.97 67.77 0.59 Allowed 'General case' 0 CA--C 1.503 -0.852 0 O-C-N 125.829 1.956 . . . . 63.1 111.258 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 29.2 t90 -101.6 -40.77 6.86 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 113.574 -1.648 . . . . 74.43 108.856 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -112.72 -177.49 3.16 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.911 -0.774 . . . . 62.24 108.911 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.634 ' HG2' ' H ' ' A' ' 50' ' ' GLU . 41.2 tt0 -141.14 -173.88 3.85 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.417 -1.327 . . . . 61.45 107.417 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.634 ' H ' ' HG2' ' A' ' 49' ' ' GLU . 18.9 mm-40 -50.49 163.64 0.16 Allowed 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.364 1.066 . . . . 50.41 113.002 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -45.05 -59.6 2.51 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.027 1.331 . . . . 62.25 114.561 -172.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.4 p -100.16 -2.36 9.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-O 121.983 0.897 . . . . 72.21 109.239 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.0 m 66.82 162.11 0.17 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.289 -1.323 . . . . 75.4 113.161 176.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.2 m -165.84 85.41 0.98 Allowed Pre-proline 0 C--N 1.31 -1.117 0 C-N-CA 125.158 1.383 . . . . 75.44 108.013 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -59.1 -16.64 34.22 Favored 'Trans proline' 0 N--CA 1.487 1.146 0 C-N-CA 123.023 2.482 . . . . 55.3 113.398 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -61.51 -19.4 62.04 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.541 0.736 . . . . 73.53 110.327 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.434 HG22 ' HB2' ' A' ' 91' ' ' ARG . 1.7 pp -80.14 -16.29 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 116.206 -0.452 . . . . 74.23 110.785 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.3 mt -109.43 92.26 3.98 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 116.183 -0.462 . . . . 75.33 110.02 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 27.9 ptt180 -147.1 143.79 28.57 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.981 0.419 . . . . 72.24 111.003 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.717 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.4 pp -113.89 144.02 43.73 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.739 -0.664 . . . . 64.3 111.478 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 90.9 mt -109.65 124.68 66.56 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 108.358 -0.979 . . . . 65.23 108.358 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.425 ' CD2' HD11 ' A' ' 67' ' ' LEU . 19.4 t80 -100.49 92.17 5.02 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 106.825 -1.546 . . . . 74.35 106.825 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 65.43 -67.09 0.14 Allowed 'General case' 0 N--CA 1.399 -2.981 0 C-N-CA 127.341 2.256 . . . . 50.1 112.173 -175.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.57 -44.93 0.87 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.633 -0.794 . . . . 23.25 114.135 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.15 159.04 23.23 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 115.435 1.643 . . . . 74.42 115.435 -174.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 63.9 m-85 -80.13 113.33 18.23 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.274 -0.875 . . . . 62.21 108.875 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.555 HD12 HD22 ' A' ' 76' ' ' LEU . 85.4 mt -81.33 -48.77 11.53 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.579 0.955 . . . . 71.33 113.579 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.715 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 14.7 t-80 -169.25 167.07 10.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.799 -1.556 . . . . 75.23 106.799 -173.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -85.25 -0.57 88.56 Favored Glycine 0 C--N 1.299 -1.489 0 N-CA-C 115.227 0.851 . . . . 55.21 115.227 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -168.04 28.69 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 118.187 0.993 . . . . 70.05 109.801 -169.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.483 HG12 HD21 ' A' ' 60' ' ' LEU . 10.9 p -85.12 138.02 19.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 C-N-CA 119.696 -0.801 . . . . 75.41 109.528 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.1 p -79.81 159.6 26.44 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.333 0.494 . . . . 75.42 112.333 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 3.3 mm? -59.42 -41.4 89.44 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 123.521 0.728 . . . . 72.33 111.844 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.99 -29.94 69.03 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.404 -0.427 . . . . 63.01 112.564 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.72 -15.17 59.32 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 122.923 0.489 . . . . 60.3 110.891 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.555 HD22 HD12 ' A' ' 67' ' ' LEU . 42.9 mt -83.46 5.4 23.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.387 -0.37 . . . . 70.03 110.404 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 8.8 mptt 62.67 76.92 0.35 Allowed 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.455 1.102 . . . . 61.11 109.434 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 73' ' ' LEU . 84.4 mt -131.26 120.81 18.25 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 116.224 -0.444 . . . . 70.35 111.371 -174.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.11 157.85 38.02 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 121.943 1.762 . . . . 75.03 109.669 170.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -78.71 150.62 32.47 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.767 -0.457 . . . . 71.31 109.767 -175.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.09 -11.45 72.09 Favored Glycine 0 C--N 1.308 -1.003 0 N-CA-C 114.756 0.662 . . . . 52.12 114.756 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.43 154.54 19.73 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.97 -1.092 . . . . 61.05 110.756 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.403 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 44.0 m -85.13 117.82 24.32 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.306 0.574 . . . . 72.12 111.017 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.7 m -105.41 125.52 51.08 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.386 -0.968 . . . . 53.55 108.386 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.3 p -108.74 122.3 63.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.643 0.735 . . . . 54.43 110.752 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.62 ' O ' HG12 ' A' ' 15' ' ' ILE . 87.0 mtp -122.97 150.63 42.73 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-N 116.192 -0.458 . . . . 71.44 109.899 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 39.9 m-70 -106.31 128.9 54.33 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.67 -1.233 . . . . 73.14 107.67 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.431 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.8 mm? -118.48 139.46 51.39 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 120.163 -0.615 . . . . 72.22 110.641 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.435 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 33.0 m -123.06 131.18 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.127 0 N-CA-C 108.582 -0.896 . . . . 70.42 108.582 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.01 143.59 42.82 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.174 -0.466 . . . . 51.14 110.359 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.434 ' HB2' HG22 ' A' ' 57' ' ' ILE . 98.9 mtt180 -133.39 148.72 51.83 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.303 -1.74 . . . . 75.31 106.303 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 56.2 29.3 14.54 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.491 0.662 . . . . 70.01 110.546 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.7 t -72.02 146.22 47.79 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.082 -0.963 . . . . 73.43 111.837 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 mp -97.14 125.44 45.84 Favored Pre-proline 0 C--N 1.291 -1.945 0 CA-C-N 114.887 -1.052 . . . . 73.44 108.298 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -89.07 8.65 3.81 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.65 2.233 . . . . 74.31 111.584 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 98' ' ' ASN . 9.6 pt-20 -165.55 137.96 3.39 Favored Pre-proline 0 N--CA 1.439 -1.0 0 CA-C-N 116.116 -0.493 . . . . 75.21 111.706 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -60.06 -50.41 7.55 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.86 2.373 . . . . 74.02 108.898 171.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 96' ' ' GLU . 9.5 t30 -151.97 174.04 14.12 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 100.468 -3.901 . . . . 73.33 100.468 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.3 m -74.21 71.6 1.7 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 120.779 1.627 . . . . 73.35 112.507 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -87.76 -43.06 12.16 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-N 115.894 -0.594 . . . . 74.33 109.612 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.7 12.1 63.79 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.162 -0.926 . . . . 65.11 113.189 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -80.88 109.06 15.09 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 118.37 -1.332 . . . . 73.31 110.637 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -116.51 1.0 12.87 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 108.267 -1.012 . . . . 65.1 108.267 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -58.92 140.46 55.42 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 113.174 -1.83 . . . . 75.53 110.203 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.446 ' HD2' ' OG ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -60.47 -35.32 75.6 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.507 1.123 . . . . 74.42 110.578 -177.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 107' ' ' LYS . 1.9 tm-20 65.59 178.88 0.2 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 124.696 1.198 . . . . 65.15 109.02 174.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.433 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 87.2 tttt 72.49 127.41 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.746 0.818 . . . . 71.31 111.962 -177.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.0 p -54.55 116.24 2.56 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.375 -0.83 . . . . 62.03 111.521 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 136.71 -35.15 2.14 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 120.75 -0.738 . . . . 74.22 111.583 -177.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 62.08 28.88 17.44 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.501 0.721 . . . . 75.13 110.511 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.446 ' OG ' ' HD2' ' A' ' 105' ' ' ARG . 67.7 m 75.03 124.6 0.04 OUTLIER 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.057 0.943 . . . . 75.42 110.904 -173.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -66.72 102.44 0.93 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.396 -0.82 . . . . 64.1 110.24 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.6 m -82.96 103.53 12.49 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.725 -0.843 . . . . 40.11 108.725 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 68.7 m -72.57 111.24 7.56 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 116.015 -0.539 . . . . 64.42 110.214 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.7 t -79.39 -36.02 17.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.509 -0.769 . . . . 61.44 109.001 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.464 HD13 ' H ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -136.8 176.1 8.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.3 -0.863 . . . . 54.4 108.924 179.082 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--N 1.303 -1.416 0 N-CA-C 106.991 -1.485 . . . . 74.13 106.991 178.547 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.4 p . . . . . 0 N--CA 1.428 -1.546 0 N-CA-C 109.759 -0.46 . . . . 73.24 109.759 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.8 t -132.4 91.21 2.9 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.581 -0.896 . . . . 74.42 108.581 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 67.38 -174.1 0.19 Allowed 'General case' 0 C--O 1.25 1.099 0 C-N-CA 123.928 0.891 . . . . 74.21 110.436 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.499 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 25.8 t -124.87 115.63 26.4 Favored Pre-proline 0 N--CA 1.431 -1.387 0 N-CA-C 107.863 -1.162 . . . . 74.13 107.863 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -68.92 145.65 62.77 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 122.249 1.966 . . . . 62.22 112.11 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.3 78.01 7.01 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 122.396 1.093 . . . . 75.33 109.82 176.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -160.4 -41.88 0.05 OUTLIER 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 113.034 -1.894 . . . . 62.0 106.958 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.501 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 8.5 ptm -124.44 159.98 29.25 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.287 -1.324 . . . . 64.21 111.047 -175.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.89 140.6 28.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.338 0.589 . . . . 74.53 112.582 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -87.59 107.85 18.79 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.393 -0.966 . . . . 53.25 108.393 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.545 ' HG ' HD22 ' A' ' 14' ' ' LEU . 43.2 tp -117.24 132.85 56.54 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.291 0.567 . . . . 73.25 112.411 -173.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 35.7 ttp-105 -107.44 120.9 43.46 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 108.733 -0.84 . . . . 72.53 108.733 173.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.604 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.5 mm? -97.34 121.96 39.82 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.219 -1.355 . . . . 74.54 109.337 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.411 HG12 HG22 ' A' ' 21' ' ' THR . 31.6 mt -99.77 119.36 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 N-CA-C 108.272 -1.01 . . . . 72.34 108.272 176.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.04 166.79 23.11 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.478 -0.783 . . . . 74.32 111.436 -175.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.42 HG11 ' H ' ' A' ' 90' ' ' ALA . 28.7 m -70.74 -14.35 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.504 0.669 . . . . 73.25 110.665 177.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 m -83.69 -6.24 59.39 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 114.923 -1.035 . . . . 40.41 110.11 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.81 -4.67 84.96 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.852 -0.69 . . . . 52.44 112.64 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -87.54 131.9 34.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.898 0.38 . . . . 62.1 110.252 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.411 HG22 HG12 ' A' ' 15' ' ' ILE . 80.8 p -98.94 129.94 45.28 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.998 -0.546 . . . . 75.14 110.068 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -131.44 139.11 49.32 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.043 -0.725 . . . . 72.32 109.043 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 29.4 tt0 -125.23 133.84 52.56 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.324 -0.55 . . . . 75.55 110.587 -174.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.661 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 95.3 m-85 -144.66 160.0 41.9 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.105 0.562 . . . . 61.22 109.489 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.7 tp -87.52 126.17 34.76 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.174 -1.047 . . . . 72.03 108.174 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.661 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 96.8 m-85 -132.77 173.94 10.84 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.749 -0.834 . . . . 74.44 108.749 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 99.7 p -97.09 151.34 37.65 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 108.515 -0.92 . . . . 71.05 108.515 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.551 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 37.3 Cg_endo -63.11 -11.87 27.13 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.594 2.196 . . . . 53.0 112.409 177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -86.2 -17.24 35.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.542 -0.754 . . . . 54.2 109.999 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -69.93 154.76 41.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.486 0.66 . . . . 73.41 112.429 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.533 ' O ' HG13 ' A' ' 35' ' ' ILE . 3.3 p -91.69 118.21 30.45 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 115.357 -0.838 . . . . 64.33 110.848 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.4 -51.29 59.86 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.83 1.252 . . . . 34.11 113.623 -174.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.1 m -72.11 -22.6 61.31 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 120.861 0.362 . . . . 72.11 111.6 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -70.66 -48.88 52.64 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.502 -0.925 . . . . 64.24 108.502 172.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 31' ' ' SER . 72.5 mt -54.81 -43.91 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 114.278 -1.328 . . . . 73.03 110.102 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.471 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.27 -34.37 23.09 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.165 0.986 . . . . 74.23 111.763 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.676 ' HB2' ' HG3' ' A' ' 44' ' ' PRO . 33.4 mmtp -74.03 -49.7 23.08 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 109.539 -0.541 . . . . 53.53 109.539 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -59.95 -40.76 90.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.41 -0.814 . . . . 63.13 111.568 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.604 HG21 ' CB ' ' A' ' 14' ' ' LEU . 36.0 m -73.95 -31.3 30.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.418 -0.355 . . . . 71.43 111.654 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -56.47 -49.71 73.83 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 123.446 0.466 . . . . 74.2 110.855 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.5 t70 171.86 -57.68 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 O-C-N 123.733 0.646 . . . . 72.43 110.773 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -81.81 166.04 20.35 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.468 -0.938 . . . . 64.12 108.468 -175.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -111.24 122.27 38.19 Favored Pre-proline 0 C--N 1.29 -2.011 0 CA-C-O 120.669 0.271 . . . . 61.41 110.392 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.676 ' HG3' ' HB2' ' A' ' 37' ' ' LYS . 75.4 Cg_exo -49.61 99.77 0.04 OUTLIER 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 123.375 2.716 . . . . 74.24 114.993 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 96.5 mmm -148.81 -43.83 0.15 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.741 0.816 . . . . 73.12 110.55 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 95' ' ' PRO . 9.9 m-20 -133.73 175.97 8.97 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.652 -0.869 . . . . 73.0 108.652 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.8 p90 -156.35 169.48 24.49 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.608 -0.437 . . . . 70.34 109.999 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -141.72 109.16 5.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 105.493 -2.04 . . . . 74.41 105.493 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.68 124.68 32.48 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.917 1.08 . . . . 71.03 113.917 -169.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.2 154.0 38.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.616 -0.72 . . . . 62.32 109.221 172.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 60.88 24.52 14.51 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.92 1.081 . . . . 63.34 113.92 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 52' ' ' VAL . 25.9 t 67.98 38.66 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 122.049 0.928 . . . . 74.5 109.207 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.452 ' HB3' HD21 ' A' ' 94' ' ' LEU . 70.1 m -60.76 104.8 0.38 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.398 1.094 . . . . 25.11 112.749 178.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 20.0 m -106.65 -176.35 0.41 Allowed Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 114.008 -1.451 . . . . 51.51 107.813 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 54' ' ' SER . 87.4 Cg_exo -52.06 -16.37 4.42 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 122.916 2.411 . . . . 61.43 112.596 176.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 103' ' ' ARG . 78.7 m-20 -56.07 -23.59 34.65 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.434 1.493 . . . . 72.44 111.586 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.556 HG22 ' HB3' ' A' ' 91' ' ' ARG . 2.3 pp -77.69 -11.16 13.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 112.442 0.534 . . . . 74.3 112.442 -178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.1 mt -91.77 116.55 28.99 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 120.915 0.388 . . . . 73.32 111.86 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 39.0 mmt180 -144.82 164.16 31.88 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 124.149 0.98 . . . . 70.51 108.41 175.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.673 HD21 ' H ' ' A' ' 71' ' ' VAL . 3.7 pp -147.17 148.4 31.49 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 109.444 -0.576 . . . . 75.11 109.444 172.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 90.3 mt -118.27 129.63 74.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 108.644 -0.873 . . . . 74.23 108.644 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -100.03 81.51 2.43 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 106.292 -1.744 . . . . 74.41 106.292 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.324 17.6 tm0? 59.34 -38.56 0.07 Allowed 'General case' 0 N--CA 1.414 -2.228 0 C-N-CA 129.042 2.937 . . . . 62.23 116.38 -176.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.35 -52.25 0.18 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.801 -0.714 . . . . 73.33 112.651 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.64 162.24 14.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.49 1.293 . . . . 74.1 114.49 -178.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 43.9 m-85 -88.28 113.54 23.99 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.866 -1.161 . . . . 74.22 107.866 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.21 -48.93 12.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 119.179 -1.008 . . . . 51.51 112.31 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.532 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 60.1 m80 -159.81 177.88 10.36 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.698 -0.853 . . . . 64.31 108.698 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.495 ' HA3' ' HB2' ' A' ' 103' ' ' ARG . . . -85.63 -4.17 85.62 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.978 -0.629 . . . . 71.22 112.584 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.523 HD22 ' HA ' ' A' ' 102' ' ' GLN . 56.4 t30 175.74 79.61 0.0 OUTLIER 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.527 1.131 . . . . 54.25 110.273 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.673 ' H ' HD21 ' A' ' 60' ' ' LEU . 9.2 p -104.33 146.15 12.09 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.765 0 N-CA-C 106.783 -1.562 . . . . 64.14 106.783 172.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.3 p -78.52 158.19 28.64 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.397 -0.521 . . . . 64.3 111.532 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 2.0 mm? -66.26 -34.71 78.62 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.148 0.499 . . . . 60.32 111.003 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.14 -31.38 79.08 Favored Glycine 0 CA--C 1.516 0.155 0 C-N-CA 120.6 -0.81 . . . . 72.33 111.234 176.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -72.4 -15.0 61.84 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 122.959 0.503 . . . . 64.34 110.872 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.553 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 64.5 mt -82.19 3.38 27.5 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.88 -0.415 . . . . 75.43 109.88 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.23 26.12 2.78 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.451 1.1 . . . . 72.34 111.135 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.553 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 65.1 mt -76.53 127.68 83.9 Favored Pre-proline 0 C--O 1.244 0.791 0 CA-C-N 116.555 -0.293 . . . . 75.54 111.138 -178.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.71 147.0 30.82 Favored 'Trans proline' 0 N--CA 1.435 -1.919 0 C-N-CA 121.439 1.426 . . . . 73.13 108.46 170.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.506 ' CE1' ' HG3' ' A' ' 28' ' ' PRO . 12.4 m-30 -69.51 145.67 52.48 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.191 -0.67 . . . . 73.42 109.191 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 89.41 1.77 77.73 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 120.165 -1.016 . . . . 64.31 113.55 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -101.49 145.22 29.28 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 117.041 0.42 . . . . 74.11 109.955 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.4 m -87.19 117.48 25.96 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.917 -0.772 . . . . 64.43 108.917 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.9 m -114.21 134.97 54.55 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.609 -0.723 . . . . 75.32 110.935 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.8 131.25 62.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 120.991 0.424 . . . . 55.15 110.349 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 89.7 mtp -135.51 153.2 51.8 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-O 120.81 0.338 . . . . 70.54 110.479 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.506 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 51.4 m80 -106.58 135.42 48.13 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.474 -1.306 . . . . 75.4 107.474 176.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.471 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.4 mm? -123.53 137.05 54.85 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 120.249 -0.58 . . . . 71.55 110.188 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.404 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 26.4 m -126.46 133.47 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-O 121.58 0.705 . . . . 74.33 111.199 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.42 ' H ' HG11 ' A' ' 17' ' ' VAL . . . -135.12 133.28 39.05 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.469 -0.937 . . . . 73.03 108.469 176.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.556 ' HB3' HG22 ' A' ' 57' ' ' ILE . 56.6 ttt180 -88.0 134.85 33.64 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.277 -1.379 . . . . 72.44 107.277 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 71.59 -43.09 0.55 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.957 1.303 . . . . 64.22 112.123 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 45.4 m 73.74 83.44 0.12 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 124.933 1.293 . . . . 74.15 112.604 177.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 53' ' ' SER . 2.1 mm? -82.45 143.34 47.73 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 114.28 -1.327 . . . . 72.24 107.796 176.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.506 ' HB2' ' O ' ' A' ' 46' ' ' ASP . 46.2 Cg_exo -56.35 -54.58 3.72 Favored 'Trans proline' 0 C--O 1.213 -0.763 0 C-N-CA 122.482 2.122 . . . . 74.54 111.273 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.89 148.51 75.74 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 107.869 -1.16 . . . . 71.35 107.869 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.586 ' CG ' ' HA2' ' A' ' 101' ' ' GLY . 14.1 Cg_endo -54.35 -67.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.746 2.297 . . . . 52.51 110.621 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 176.06 80.25 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 126.127 1.771 . . . . 74.31 106.353 173.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.1 m 65.11 -63.53 0.19 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.406 1.483 . . . . 72.42 114.86 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -89.94 -50.48 6.0 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.464 0.65 . . . . 74.22 109.708 -171.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.586 ' HA2' ' CG ' ' A' ' 97' ' ' PRO . . . 131.73 -33.33 2.76 Favored Glycine 0 CA--C 1.488 -1.641 0 N-CA-C 110.184 -1.166 . . . . 75.31 110.184 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.523 ' HA ' HD22 ' A' ' 70' ' ' ASN . 57.3 tt0 -90.0 148.4 23.1 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.817 -0.692 . . . . 74.12 109.775 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.495 ' HB2' ' HA3' ' A' ' 69' ' ' GLY . 14.6 tpt180 -48.77 -58.73 4.34 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.567 1.147 . . . . 64.55 109.426 173.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -177.09 158.89 1.58 Allowed 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.055 -1.832 . . . . 64.22 106.055 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.483 ' HD3' ' OE1' ' A' ' 102' ' ' GLN . 40.7 mmt180 -65.41 -31.5 72.64 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.103 -0.702 . . . . 75.45 109.103 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 76.71 151.57 0.12 Allowed 'General case' 0 C--N 1.353 0.737 0 C-N-CA 125.706 1.602 . . . . 62.43 110.251 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.54 -48.65 76.83 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.26 0.553 . . . . 62.42 109.808 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.5 p -90.83 89.55 7.53 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 107.26 -1.385 . . . . 74.24 107.26 170.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 154.59 -32.35 0.69 Allowed Glycine 0 N--CA 1.432 -1.576 0 C-N-CA 119.61 -1.281 . . . . 55.1 112.9 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.436 ' HA ' ' HB3' ' A' ' 105' ' ' ARG . 10.1 pt-20 -63.1 98.18 0.13 Allowed 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.209 0.528 . . . . 73.51 110.835 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.9 t 63.25 88.79 0.09 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 114.578 -1.192 . . . . 73.11 108.097 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -53.0 107.7 0.25 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 115.542 -0.754 . . . . 74.44 111.311 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 11.9 p -67.7 133.83 50.01 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.677 -1.147 . . . . 72.33 111.875 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 23.5 p -85.09 87.34 7.36 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-O 121.725 0.774 . . . . 73.13 109.31 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.48 127.97 73.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.161 -0.927 . . . . 65.22 110.518 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 13.5 tt -158.7 108.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-O 121.588 0.708 . . . . 71.5 110.962 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 tm? . . . . . 0 C--N 1.308 -1.197 0 N-CA-C 106.401 -1.703 . . . . 70.04 106.401 178.697 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.426 -1.658 0 N-CA-C 107.671 -1.233 . . . . 75.31 107.671 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.3 m -151.65 174.56 13.33 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 116.505 -0.316 . . . . 65.44 110.236 -176.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -78.88 156.2 28.74 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.984 -1.117 . . . . 74.33 107.984 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.458 HG13 HD22 ' A' ' 25' ' ' LEU . 24.9 t -80.76 121.79 81.45 Favored Pre-proline 0 C--N 1.308 -1.204 0 C-N-CA 120.325 -0.55 . . . . 74.43 109.652 -176.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.479 ' HA ' ' CD1' ' A' ' 117' ' ' LEU . 3.4 Cg_exo -64.3 142.45 79.54 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.426 2.084 . . . . 74.23 112.395 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.97 70.82 6.61 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 122.121 0.962 . . . . 73.13 109.884 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -168.0 -37.04 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 104.909 -2.256 . . . . 74.11 104.909 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 86.0 mmm -102.58 156.74 17.41 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.622 -1.627 . . . . 75.24 108.985 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.41 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.8 pp -117.92 140.22 42.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 107.509 -1.293 . . . . 74.35 107.509 172.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 67.1 t30 -91.81 125.24 36.45 Favored 'General case' 0 CA--C 1.485 -1.537 0 C-N-CA 118.765 -1.174 . . . . 64.43 107.876 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.575 ' HG ' HD22 ' A' ' 14' ' ' LEU . 44.7 tp -126.21 133.65 51.46 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-O 121.149 0.5 . . . . 70.31 112.112 -174.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 17.8 ttp180 -106.1 120.63 42.3 Favored 'General case' 0 N--CA 1.405 -2.71 0 N-CA-C 108.659 -0.867 . . . . 72.55 108.659 173.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.575 HD22 ' HG ' ' A' ' 12' ' ' LEU . 2.1 mm? -99.56 122.31 42.44 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 113.966 -1.47 . . . . 63.0 109.275 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.522 HG23 HG22 ' A' ' 21' ' ' THR . 15.0 mm -105.07 123.31 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.513 -1.291 . . . . 64.0 107.513 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 2.5 mm? -93.92 158.3 15.71 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.245 -0.582 . . . . 54.11 110.969 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.502 ' CG1' ' HA ' ' A' ' 89' ' ' VAL . 32.2 m -52.85 -30.29 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 115.009 1.485 . . . . 73.13 115.009 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.4 m -86.61 4.88 38.41 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.992 0.425 . . . . 63.01 111.351 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.47 24.92 49.17 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.208 -0.757 . . . . 61.24 111.208 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 73.4 mmtt -86.97 130.82 34.3 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 104.688 -2.338 . . . . 64.45 104.688 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.522 HG22 HG23 ' A' ' 15' ' ' ILE . 38.7 p -126.3 128.68 47.51 Favored 'General case' 0 C--N 1.278 -2.53 0 C-N-CA 119.644 -0.822 . . . . 72.24 111.648 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -142.39 147.21 35.84 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.32 -0.4 . . . . 75.53 111.025 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 21.0 tt0 -125.9 130.2 50.85 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 107.68 -1.23 . . . . 63.51 107.68 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.698 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 96.4 m-85 -145.11 158.97 43.67 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.703 0.287 . . . . 63.2 110.452 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.458 HD22 HG13 ' A' ' 5' ' ' VAL . 96.5 mt -79.76 125.66 29.96 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.99 -1.115 . . . . 71.3 107.99 175.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.698 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 90.1 m-85 -129.86 163.15 26.94 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.59 -0.522 . . . . 72.33 109.59 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.0 m -88.99 141.13 29.29 Favored Pre-proline 0 N--CA 1.395 -3.185 0 N-CA-C 107.613 -1.255 . . . . 60.33 107.613 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 34.7 Cg_endo -62.4 -11.98 25.4 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.203 1.935 . . . . 73.51 112.186 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -78.89 -20.27 49.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.433 1.093 . . . . 72.25 110.046 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.448 ' O ' HD22 ' A' ' 73' ' ' LEU . 63.5 m-20 -75.44 154.16 37.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.184 -0.462 . . . . 64.33 111.347 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.515 ' O ' HG13 ' A' ' 35' ' ' ILE . 13.4 p -101.1 132.07 46.73 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.276 0.473 . . . . 62.42 112.276 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.434 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -48.47 -59.34 3.56 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.662 1.727 . . . . 62.13 115.662 -174.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.7 m -72.78 -19.7 61.31 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.504 0.668 . . . . 55.55 111.258 -174.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.537 ' OD2' ' HG3' ' A' ' 97' ' ' PRO . 14.3 t70 -70.15 -47.93 59.55 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.493 -1.299 . . . . 62.31 107.493 172.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 31' ' ' SER . 73.3 mt -59.03 -35.28 56.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.671 -1.149 . . . . 73.14 110.84 176.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.418 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.41 -33.56 21.22 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.029 0.532 . . . . 72.55 110.665 175.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.481 ' HB2' ' HG3' ' A' ' 44' ' ' PRO . 5.5 mptp? -68.87 -51.72 37.31 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.71 0.291 . . . . 73.33 110.312 174.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.488 ' ND1' ' HE3' ' A' ' 43' ' ' TRP . 51.8 t60 -57.52 -43.0 83.94 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.992 -0.549 . . . . 71.01 111.889 -177.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 14' ' ' LEU . 35.8 m -76.9 -31.53 19.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 112.381 0.512 . . . . 63.42 112.381 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -68.38 -47.15 68.12 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.404 -0.519 . . . . 61.03 109.761 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.464 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . 6.5 m-20 -137.42 -89.95 0.25 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.55 0.944 . . . . 74.02 113.55 176.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 38' ' ' HIS . 40.3 t-20 -129.22 170.72 13.24 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.949 -1.5 . . . . 63.24 106.949 -176.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.493 ' HE1' ' HB2' ' A' ' 100' ' ' GLN . 58.5 t-105 -61.07 134.49 92.97 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.499 -0.556 . . . . 72.25 109.499 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.524 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 64.0 Cg_exo -42.41 101.54 0.04 OUTLIER 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 124.105 3.203 . . . . 73.14 113.024 176.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 43' ' ' TRP . 69.2 mtm -137.55 -60.64 0.65 Allowed 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 115.353 -0.84 . . . . 63.32 110.375 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -107.0 -73.77 0.68 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.233 -0.587 . . . . 74.32 110.184 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' A' ' 41' ' ' ASP . 89.3 m95 60.08 -179.77 0.09 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 115.408 1.632 . . . . 75.54 115.408 177.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -155.98 164.03 38.97 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.813 -0.63 . . . . 73.54 109.492 -172.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.493 ' HA ' HG23 ' A' ' 93' ' ' THR . 12.7 pt-20 -131.22 140.91 49.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.05 -1.092 . . . . 70.33 108.05 173.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.463 ' HB2' ' CD ' ' A' ' 92' ' ' GLU . 0.6 OUTLIER -60.52 -72.91 0.1 Allowed 'General case' 0 C--O 1.24 0.569 0 N-CA-C 111.775 0.287 . . . . 65.02 111.775 -179.303 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -113.13 -91.06 0.5 Allowed 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 119.915 -0.714 . . . . 74.02 109.1 174.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.0 m -151.66 125.48 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 123.974 0.91 . . . . 70.11 108.943 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.2 m -130.15 169.58 15.17 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 120.662 -0.415 . . . . 73.12 110.451 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.643 ' O ' HG13 ' A' ' 57' ' ' ILE . 45.7 p -91.48 123.31 64.21 Favored Pre-proline 0 N--CA 1.429 -1.496 0 N-CA-C 109.14 -0.689 . . . . 75.33 109.14 177.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.78 -17.02 9.42 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 123.117 2.545 . . . . 74.44 112.998 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -63.4 -13.28 38.08 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.774 0.83 . . . . 74.14 111.204 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.643 HG13 ' O ' ' A' ' 54' ' ' SER . 2.0 pp -78.18 -16.03 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 122.204 -0.31 . . . . 73.53 111.773 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.9 mt -78.84 96.1 5.56 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 107.27 -1.381 . . . . 62.14 107.27 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 10.3 ptt180 -146.46 162.72 37.67 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.442 -0.799 . . . . 64.32 111.567 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.631 HD21 HG12 ' A' ' 71' ' ' VAL . 4.5 pp -127.11 150.32 49.54 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 115.6 -0.727 . . . . 75.03 112.044 -171.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.428 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 97.4 mt -118.79 120.02 62.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.17 -0.923 . . . . 74.23 108.58 176.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.432 ' CD2' HD11 ' A' ' 67' ' ' LEU . 17.0 t80 -101.53 65.52 1.04 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.057 -1.09 . . . . 72.44 108.057 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 53.83 83.93 0.07 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.828 -1.533 . . . . 74.32 113.496 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.55 -58.51 0.5 Allowed Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.535 -0.841 . . . . 64.21 112.803 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -130.87 162.88 28.65 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 120.095 -0.642 . . . . 75.33 112.693 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 78.8 m-85 -83.73 122.27 28.42 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.073 -1.454 . . . . 73.25 107.073 175.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.462 HD12 ' CD2' ' A' ' 76' ' ' LEU . 54.6 mt -79.71 -46.37 17.22 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 118.804 -1.158 . . . . 72.22 111.289 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.486 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.0 t-160 -165.86 178.88 6.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.361 -2.089 . . . . 72.41 105.361 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -71.54 -42.23 55.89 Favored Glycine 0 C--O 1.208 -1.472 0 C-N-CA 120.346 -0.931 . . . . 74.55 112.675 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.503 ' OD1' ' HB2' ' A' ' 31' ' ' SER . 60.7 t30 -159.93 75.93 0.62 Allowed 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 108.613 -0.884 . . . . 63.03 108.613 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.631 HG12 HD21 ' A' ' 60' ' ' LEU . 11.2 p -102.06 152.08 5.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.228 -1.351 . . . . 70.4 109.066 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.1 p -77.61 160.68 28.38 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.488 0.551 . . . . 74.43 112.488 -173.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.538 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.3 mm? -68.98 -34.55 75.49 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 116.134 -0.484 . . . . 72.32 111.189 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.05 -29.67 75.09 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.496 -0.859 . . . . 41.32 111.193 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.469 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -73.79 -15.24 61.19 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 122.972 0.509 . . . . 74.33 111.199 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.465 HD11 ' SD ' ' A' ' 86' ' ' MET . 58.6 mt -83.83 2.39 38.48 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.867 0.467 . . . . 55.33 110.224 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER 65.22 78.06 0.29 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.984 0.914 . . . . 62.13 109.276 -176.544 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 85.0 mt -133.46 133.33 22.58 Favored Pre-proline 0 C--O 1.243 0.749 0 CA-C-N 116.093 -0.503 . . . . 74.11 111.239 -175.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 2.0 Cg_endo -81.33 155.97 19.23 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.293 1.996 . . . . 65.12 109.229 171.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -76.71 153.65 34.9 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.74 -0.837 . . . . 73.45 108.74 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 83.97 2.37 89.56 Favored Glycine 0 C--N 1.3 -1.467 0 C-N-CA 120.25 -0.976 . . . . 73.53 113.09 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.21 151.68 23.78 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 110.2 -0.296 . . . . 54.44 110.2 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.47 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 90.1 m -102.18 127.17 49.23 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.146 0.498 . . . . 64.44 110.158 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 84.8 m -128.72 141.98 51.15 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.938 -0.573 . . . . 60.24 110.604 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.9 137.5 41.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.779 0.323 . . . . 72.12 110.877 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.465 ' SD ' HD11 ' A' ' 76' ' ' LEU . 93.6 mtp -135.51 152.73 51.61 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 122.882 0.473 . . . . 71.44 110.176 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.428 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 29.1 m-70 -109.61 131.06 55.41 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.662 -0.866 . . . . 73.12 108.662 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.418 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.5 mm? -117.87 137.63 52.66 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 110.06 -0.348 . . . . 74.11 110.06 -175.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.502 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 32.6 m -121.71 133.87 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-O 121.142 0.496 . . . . 74.31 110.706 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.38 120.93 19.34 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.645 -0.707 . . . . 64.11 109.991 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.512 ' H ' HD13 ' A' ' 57' ' ' ILE . 2.5 tmt_? -88.17 112.67 23.0 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 108.076 -1.083 . . . . 72.01 108.076 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.514 ' O ' ' HB ' ' A' ' 93' ' ' THR . 31.2 tt0 64.95 -88.21 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 124.766 1.291 . . . . 75.32 107.939 -176.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 92' ' ' GLU . 12.7 t 154.91 143.71 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.911 1.284 . . . . 73.03 110.55 175.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.74 160.32 27.69 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 104.825 -2.287 . . . . 72.12 104.825 165.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.64 -84.55 0.01 OUTLIER 'Trans proline' 0 C--O 1.26 1.622 0 C-N-CA 121.745 1.63 . . . . 73.44 113.899 -176.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.582 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 1.3 pp20? -172.35 167.98 3.09 Favored Pre-proline 0 CA--C 1.56 1.356 0 CA-C-O 119.32 -0.371 . . . . 73.24 110.619 -176.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.582 ' HD2' ' HB2' ' A' ' 96' ' ' GLU . 7.3 Cg_endo -46.44 -66.32 0.15 Allowed 'Trans proline' 0 CA--C 1.555 1.528 0 C-N-CA 124.577 3.518 . . . . 65.53 117.595 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -165.38 18.76 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.364 0.602 . . . . 73.34 111.316 -167.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.9 t 62.13 75.0 0.42 Allowed 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 124.038 0.935 . . . . 72.42 108.978 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.493 ' HB2' ' HE1' ' A' ' 43' ' ' TRP . 50.3 mt-30 -68.89 -51.09 43.82 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 114.707 -1.133 . . . . 73.11 111.708 -175.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.87 11.13 60.1 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.845 -0.693 . . . . 64.03 112.597 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -78.29 111.69 14.52 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.421 0.629 . . . . 72.1 111.945 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -150.44 22.93 0.82 Allowed 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.394 -0.821 . . . . 71.42 110.287 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.509 ' HB3' ' HG3' ' A' ' 106' ' ' GLU . 37.6 t30 -110.43 175.07 5.57 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.885 -1.524 . . . . 54.11 106.885 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -67.4 -48.96 65.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 118.269 0.486 . . . . 65.55 109.775 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.509 ' HG3' ' HB3' ' A' ' 104' ' ' ASN . 45.9 mt-10 55.97 26.1 9.5 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.113 1.153 . . . . 71.02 114.113 169.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -136.49 155.75 49.55 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.502 -0.317 . . . . 73.2 110.5 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.6 p -66.79 133.27 49.79 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.76 -0.654 . . . . 72.31 112.384 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.758 ' HA3' ' SG ' ' A' ' 113' ' ' CYS . . . 91.13 -50.09 3.05 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.589 -0.605 . . . . 74.33 111.589 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 75.13 91.72 0.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.416 1.487 . . . . 63.13 113.845 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.4 m 69.97 -33.04 0.25 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 115.391 1.626 . . . . 44.14 115.391 172.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -82.53 -11.38 58.49 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.008 0.744 . . . . 75.03 113.008 -176.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.758 ' SG ' ' HA3' ' A' ' 109' ' ' GLY . 60.4 m -74.23 95.24 2.59 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.489 -0.56 . . . . 71.52 109.489 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 80.3 m -152.23 107.51 3.28 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.533 -0.303 . . . . 52.42 111.054 -177.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.2 m -82.74 130.58 35.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 109.363 -0.606 . . . . 74.11 109.363 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 60.8 mt 62.04 84.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.776 0.83 . . . . 53.23 111.01 -177.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.479 ' CD1' ' HA ' ' A' ' 6' ' ' PRO . 5.1 tt . . . . . 0 C--O 1.252 1.231 0 N-CA-C 106.877 -1.527 . . . . 75.11 106.877 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 p . . . . . 0 N--CA 1.427 -1.613 0 N-CA-C 110.169 -0.308 . . . . 52.42 110.169 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.7 m -151.3 136.62 17.65 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.456 -0.572 . . . . 71.51 109.456 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -76.02 138.7 41.06 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 108.637 -0.875 . . . . 65.43 108.637 176.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.481 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 39.0 t -100.41 116.61 64.19 Favored Pre-proline 0 N--CA 1.418 -2.066 0 N-CA-C 109.306 -0.627 . . . . 61.04 109.306 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.39 172.52 14.44 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.5 2.134 . . . . 64.13 111.972 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.42 30.22 0.29 Allowed 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.992 0.917 . . . . 71.4 110.639 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -133.42 -14.68 2.54 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.714 -0.676 . . . . 65.31 110.14 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.3 mmm -121.68 155.4 35.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.036 -0.529 . . . . 73.25 110.092 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 pp -120.28 140.27 44.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-O 120.883 0.373 . . . . 65.52 110.949 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -90.84 111.04 22.28 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 109.06 -0.719 . . . . 70.51 109.06 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.542 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.1 tp -119.54 133.11 55.82 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.758 -0.656 . . . . 73.14 112.31 -174.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -108.63 121.25 44.62 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 114.986 -1.007 . . . . 72.25 108.388 173.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.547 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.1 mm? -99.44 123.72 43.96 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.061 -0.972 . . . . 72.34 109.273 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.476 HG23 HG22 ' A' ' 21' ' ' THR . 29.6 mt -104.46 129.22 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 N-CA-C 108.736 -0.838 . . . . 74.42 108.736 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.68 166.17 17.29 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.789 -0.642 . . . . 74.51 110.169 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.13 -19.43 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-O 121.745 0.784 . . . . 74.43 109.983 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 p -76.06 -10.6 59.55 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.561 -0.745 . . . . 74.3 111.35 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.44 2.52 76.45 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 110.715 -0.954 . . . . 73.13 110.715 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.4 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 12.6 mptt -86.65 133.61 33.68 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.791 -0.448 . . . . 75.1 109.791 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.476 HG22 HG23 ' A' ' 15' ' ' ILE . 80.9 p -113.73 137.26 51.87 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 116.117 -0.492 . . . . 62.13 111.531 -173.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -134.88 147.5 49.87 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.064 -0.717 . . . . 71.3 109.064 174.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -135.46 131.58 36.34 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.397 -0.594 . . . . 75.44 109.397 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.717 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 94.4 m-85 -144.04 160.02 41.6 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.951 -0.759 . . . . 65.21 108.951 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.446 HD11 HG13 ' A' ' 5' ' ' VAL . 41.3 tp -82.28 125.04 30.5 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.292 -1.373 . . . . 74.24 107.292 175.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.717 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 83.8 m-85 -128.97 166.59 18.88 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.446 -0.575 . . . . 74.31 109.446 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.7 p -92.83 146.94 33.09 Favored Pre-proline 0 N--CA 1.417 -2.092 0 C-N-CA 119.308 -0.957 . . . . 75.42 108.62 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.512 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 35.3 Cg_endo -61.86 -11.4 20.93 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.72 2.28 . . . . 71.34 112.1 177.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -79.97 -23.06 41.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.216 -0.902 . . . . 71.13 110.973 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.423 ' O ' HD22 ' A' ' 73' ' ' LEU . 22.6 m-20 -67.44 154.78 40.59 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 112.88 0.696 . . . . 75.44 112.88 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.524 ' O ' HG13 ' A' ' 35' ' ' ILE . 43.7 m -97.08 124.6 41.14 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.65 -0.705 . . . . 44.22 109.829 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.84 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -50.5 -50.0 54.04 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.539 0.735 . . . . 61.43 112.937 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 p -65.65 -30.63 71.36 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 112.355 0.502 . . . . 73.5 112.355 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.66 -46.24 66.56 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.8 -0.815 . . . . 72.01 108.8 174.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 31' ' ' SER . 67.3 mt -60.22 -39.15 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 114.811 -1.086 . . . . 72.44 111.138 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.88 -38.61 36.37 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.418 0.687 . . . . 71.43 111.299 176.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -72.49 -40.92 66.52 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.242 -0.435 . . . . 64.15 111.079 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -65.89 -42.54 90.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.629 -0.714 . . . . 61.1 111.161 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.547 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.4 m -76.84 -30.72 18.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 112.157 0.428 . . . . 72.52 112.157 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -47.29 -48.85 24.73 Favored 'General case' 0 C--O 1.243 0.719 0 O-C-N 123.565 0.54 . . . . 75.55 111.795 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.3 t70 178.98 -60.47 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.561 -0.533 . . . . 72.21 109.561 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -98.03 -161.17 0.85 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.504 -0.771 . . . . 72.34 109.655 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.6 p-90 -111.69 137.73 21.32 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 109.492 -0.558 . . . . 74.41 109.492 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -55.49 111.24 0.7 Allowed 'Trans proline' 0 C--O 1.254 1.296 0 C-N-CA 122.576 2.184 . . . . 54.45 112.026 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.667 ' SD ' ' HA3' ' A' ' 109' ' ' GLY . 55.1 mtt -87.21 153.21 21.67 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.491 -0.777 . . . . 73.31 110.488 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -65.54 -42.03 92.38 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.652 -0.704 . . . . 44.45 112.047 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -93.89 -4.14 50.47 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.209 0.818 . . . . 74.43 113.209 -174.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 45' ' ' MET . 8.5 pt-20 -67.93 -43.06 80.03 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.783 -0.767 . . . . 73.1 111.933 -175.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.427 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 43.0 mt-10 64.15 -78.5 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.265 1.026 . . . . 74.03 112.025 -175.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 43.95 63.22 1.67 Allowed 'General case' 0 C--N 1.355 0.809 0 CA-C-O 122.554 1.169 . . . . 71.43 108.693 -173.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.481 ' OE1' ' HA ' ' A' ' 55' ' ' PRO . 10.0 tt0 -174.65 -46.64 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 104.929 -2.249 . . . . 71.25 104.929 -171.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.0 t 46.78 78.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 113.251 -1.795 . . . . 75.42 113.58 172.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.3 t 64.91 1.88 1.58 Allowed 'General case' 0 CA--C 1.559 1.325 0 CA-C-N 115.027 -0.988 . . . . 64.13 112.838 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.8 m -119.11 82.65 22.57 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 109.154 -0.684 . . . . 43.53 109.154 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.481 ' HA ' ' OE1' ' A' ' 51' ' ' GLN . 57.2 Cg_endo -71.54 -16.92 30.45 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.443 2.096 . . . . 72.21 113.908 -173.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -62.34 -16.0 51.69 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.276 0.631 . . . . 72.14 112.677 -176.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.406 ' HB ' ' HB3' ' A' ' 91' ' ' ARG . 2.1 pp -77.93 -21.73 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 120.809 0.338 . . . . 72.02 111.731 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.7 tp -90.78 99.52 12.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.494 -0.928 . . . . 65.33 108.494 -177.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -137.22 160.53 38.75 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.088 -0.505 . . . . 72.03 109.721 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.84 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.5 pp -127.62 140.76 51.89 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.581 -0.736 . . . . 73.14 109.495 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 92.5 mt -111.89 126.33 69.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.783 -0.821 . . . . 61.15 108.783 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -100.58 84.32 2.74 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.715 -1.217 . . . . 73.22 107.715 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 68.16 -50.24 0.54 Allowed 'General case' 0 N--CA 1.405 -2.676 0 C-N-CA 127.505 2.322 . . . . 53.53 112.69 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.9 -45.76 0.18 Allowed Glycine 0 N--CA 1.436 -1.338 0 C-N-CA 120.601 -0.809 . . . . 61.2 113.987 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -110.58 160.9 16.24 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.55 0.574 . . . . 64.41 112.55 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 68.4 m-85 -87.1 113.79 23.14 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.018 -1.104 . . . . 64.42 108.018 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.587 HD12 HD22 ' A' ' 76' ' ' LEU . 43.2 mt -80.63 -45.21 17.64 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 114.113 1.153 . . . . 64.45 114.113 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.664 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 8.1 t60 -167.48 169.93 11.73 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.735 -1.58 . . . . 75.01 106.735 -175.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.85 -1.31 88.98 Favored Glycine 0 C--N 1.309 -0.954 0 C-N-CA 120.73 -0.748 . . . . 72.13 113.148 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 178.49 64.9 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.826 -0.805 . . . . 62.44 108.826 -173.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.718 HG12 HD21 ' A' ' 60' ' ' LEU . 11.2 p -104.18 151.17 6.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.852 -1.166 . . . . 72.0 107.852 174.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.439 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 58.9 p -84.04 158.28 21.52 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 121.42 -0.112 . . . . 62.12 110.962 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.581 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.5 mm? -65.29 -32.75 74.57 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.977 0.418 . . . . 65.44 110.79 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.48 -32.31 83.77 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.098 -0.801 . . . . 61.31 111.098 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.479 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -79.19 -15.14 58.51 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 122.803 0.441 . . . . 70.22 111.088 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.587 HD22 HD12 ' A' ' 67' ' ' LEU . 66.8 mt -82.38 1.16 38.57 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.945 -0.761 . . . . 71.42 108.945 176.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.1 mptt 78.84 14.89 1.16 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.056 1.342 . . . . 63.44 113.18 178.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.6 mp -60.67 120.26 51.33 Favored Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 113.485 0.92 . . . . 74.42 113.485 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 16.2 Cg_exo -73.05 150.41 48.31 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.485 2.123 . . . . 74.33 108.565 170.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -78.06 142.24 38.3 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.454 -0.943 . . . . 75.24 108.454 -175.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.481 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 92.63 -3.25 74.57 Favored Glycine 0 C--N 1.298 -1.533 0 C-N-CA 119.955 -1.117 . . . . 60.33 114.151 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -104.42 153.89 20.54 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 117.367 0.583 . . . . 63.45 111.621 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.7 m -92.61 118.6 31.19 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.33 -0.619 . . . . 71.34 109.33 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 84.1 m -119.98 136.93 54.36 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 116.39 -0.368 . . . . 74.53 110.516 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.4 p -110.52 135.45 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-O 121.045 0.45 . . . . 72.22 110.964 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 87.6 mtp -134.48 153.72 51.78 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 120.896 0.379 . . . . 71.55 111.64 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.537 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 63.3 m-70 -107.73 135.13 49.67 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.682 -1.229 . . . . 72.04 107.682 176.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.432 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.4 mm? -121.73 133.76 54.94 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 120.161 -0.616 . . . . 73.31 110.156 -177.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.51 134.57 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 121.662 0.744 . . . . 60.11 111.827 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.03 145.85 49.82 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.407 -1.331 . . . . 55.55 107.407 175.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.406 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 14.5 ttm180 -109.98 153.15 24.96 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.017 -1.475 . . . . 74.25 107.017 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 102' ' ' GLN . 6.9 tp10 -36.38 -53.13 0.84 Allowed 'General case' 0 N--CA 1.48 1.06 0 O-C-N 124.972 1.42 . . . . 73.32 110.019 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 92' ' ' GLU . 1.8 p -169.93 -85.94 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 125.718 1.607 . . . . 65.42 109.833 172.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.421 HD12 ' HB ' ' A' ' 93' ' ' THR . 6.7 mp -91.72 160.7 35.75 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 109.395 -0.594 . . . . 74.03 109.395 178.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -62.31 90.59 0.12 Allowed 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.47 2.113 . . . . 73.33 111.772 175.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 49.4 85.84 0.17 Allowed Pre-proline 0 C--N 1.319 -0.745 0 C-N-CA 126.333 1.853 . . . . 75.44 114.611 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.88 -60.96 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.787 1.658 . . . . 71.33 109.52 175.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -175.45 17.16 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 106.757 -1.572 . . . . 71.52 106.757 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.4 m 50.38 69.29 0.64 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.801 -1.09 . . . . 50.32 111.374 -172.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -88.08 -23.13 23.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.897 -1.047 . . . . 71.13 110.631 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.62 21.82 20.51 Favored Glycine 0 C--N 1.303 -1.297 0 N-CA-C 108.363 -1.895 . . . . 61.11 108.363 -170.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.497 ' O ' ' HG3' ' A' ' 92' ' ' GLU . 25.0 tt0 -82.03 110.39 17.23 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.446 -0.877 . . . . 74.44 110.75 -178.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.431 ' HA ' HG23 ' A' ' 93' ' ' THR . 30.1 ptt180 -161.08 -164.43 1.17 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.962 -1.866 . . . . 71.34 105.962 175.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -69.93 157.11 38.05 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 119.247 0.931 . . . . 64.21 111.591 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -52.72 -24.68 9.16 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.811 1.644 . . . . 72.42 113.984 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.423 ' HG2' ' HD3' ' A' ' 107' ' ' LYS . 33.4 tt0 78.83 111.72 0.07 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.061 0.944 . . . . 72.42 111.192 174.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.423 ' HD3' ' HG2' ' A' ' 106' ' ' GLU . 0.7 OUTLIER 72.17 -60.93 0.51 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.052 1.341 . . . . 74.32 112.207 -177.688 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.2 p -88.54 107.12 18.73 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 107.664 -1.235 . . . . 72.24 107.664 175.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.667 ' HA3' ' SD ' ' A' ' 45' ' ' MET . . . -72.14 -28.03 69.08 Favored Glycine 0 C--N 1.306 -1.107 0 C-N-CA 120.374 -0.917 . . . . 55.02 112.526 -176.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.78 151.42 38.84 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 120.832 0.348 . . . . 73.42 111.068 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 49.1 m -104.38 -51.12 3.17 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.253 -1.388 . . . . 75.11 107.253 170.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 64.53 -80.9 0.03 OUTLIER 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.856 1.262 . . . . 74.44 111.841 175.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 84.0 m -162.49 -45.7 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.049 -1.834 . . . . 70.34 106.049 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 24.4 p -151.9 139.52 19.7 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.164 -1.38 . . . . 73.52 107.322 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.8 m -108.26 95.19 3.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.361 1.077 . . . . 74.24 111.03 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.3 tp -153.75 129.71 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 114.029 -1.441 . . . . 73.33 108.695 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.255 1.358 0 CA-C-O 118.149 -0.929 . . . . 73.43 112.915 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.1 m . . . . . 0 C--O 1.235 0.292 0 N-CA-C 115.051 1.501 . . . . 73.43 115.051 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.8 t -133.71 123.01 24.21 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 104.371 -2.455 . . . . 62.23 104.371 172.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 74.23 100.31 0.07 Allowed 'General case' 0 N--CA 1.476 0.873 0 O-C-N 124.249 0.968 . . . . 71.42 109.767 -169.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.477 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 47.5 t -90.26 129.1 46.8 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 109.019 -0.734 . . . . 65.22 109.019 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -70.87 149.68 60.23 Favored 'Trans proline' 0 C--O 1.25 1.097 0 C-N-CA 122.332 2.022 . . . . 72.42 112.089 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.42 75.33 7.26 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.905 0.86 . . . . 62.12 108.73 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -171.99 -25.55 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.642 -1.617 . . . . 71.04 107.646 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.6 mmm -114.42 144.84 42.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.947 -1.024 . . . . 72.13 109.626 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -105.76 135.66 43.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.014 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.406 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 2.3 t-20 -89.7 110.71 21.58 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.744 -0.836 . . . . 73.02 108.744 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.518 ' HG ' HD22 ' A' ' 14' ' ' LEU . 43.6 tp -119.51 132.85 55.85 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.629 -0.714 . . . . 64.44 111.769 -174.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.8 ttp-105 -109.26 120.76 43.49 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 108.651 -0.87 . . . . 62.12 108.651 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.518 HD22 ' HG ' ' A' ' 12' ' ' LEU . 2.1 mm? -96.44 120.91 37.61 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.787 -1.097 . . . . 64.42 109.966 -177.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.483 HG23 ' OG1' ' A' ' 21' ' ' THR . 19.0 mt -108.91 117.51 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 N-CA-C 107.045 -1.465 . . . . 75.42 107.045 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.58 156.96 20.51 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 116.073 -0.512 . . . . 62.24 111.576 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -58.04 -25.77 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 124.019 0.928 . . . . 64.43 111.91 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.2 m -76.81 -1.33 27.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.94 0.4 . . . . 73.52 111.017 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.03 15.85 71.35 Favored Glycine 0 CA--C 1.496 -1.123 0 N-CA-C 111.65 -0.58 . . . . 54.14 111.65 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -92.42 143.3 26.51 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.892 -1.522 . . . . 75.33 106.892 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.483 ' OG1' HG23 ' A' ' 15' ' ' ILE . 78.4 m -131.31 141.38 49.93 Favored 'General case' 0 C--N 1.277 -2.555 0 C-N-CA 120.136 -0.626 . . . . 71.32 109.758 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -150.63 139.82 21.2 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.608 -0.886 . . . . 72.41 108.608 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -123.69 133.09 53.95 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.787 -0.365 . . . . 74.41 110.533 -177.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.708 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 90.2 m-85 -145.17 161.21 40.06 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 123.4 0.68 . . . . 61.52 109.728 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.72 125.84 30.18 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.68 -1.23 . . . . 73.22 107.68 170.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.708 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 85.7 m-85 -125.16 167.35 14.95 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.886 -0.783 . . . . 71.14 108.886 177.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 99.0 p -94.65 147.54 33.36 Favored Pre-proline 0 N--CA 1.414 -2.249 0 C-N-CA 118.895 -1.122 . . . . 62.41 108.225 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.414 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 37.5 Cg_endo -61.82 -11.56 21.52 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.686 2.257 . . . . 64.34 112.312 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -84.44 -18.39 36.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.553 -0.748 . . . . 53.45 110.983 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' O ' HD22 ' A' ' 73' ' ' LEU . 35.1 m-20 -74.07 153.86 39.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.874 0.368 . . . . 74.25 110.374 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.414 ' O ' HG13 ' A' ' 35' ' ' ILE . 36.2 m -98.97 131.6 44.91 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.937 -0.764 . . . . 51.2 108.937 176.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.823 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -51.29 -36.57 43.0 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.396 0.887 . . . . 70.3 113.396 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.514 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 7.2 p -69.24 -36.66 77.41 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.851 0.685 . . . . 63.41 112.851 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.66 -43.29 89.82 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.145 -1.057 . . . . 75.34 108.145 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.527 HG23 ' CZ ' ' A' ' 26' ' ' PHE . 57.0 mt -59.5 -41.31 84.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 114.847 -1.07 . . . . 75.34 111.964 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.94 -42.38 48.37 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 123.043 0.537 . . . . 70.32 111.472 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.592 ' HB2' ' HG3' ' A' ' 44' ' ' PRO . 28.6 mmmt -73.52 -38.62 65.24 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 120.69 0.281 . . . . 65.13 111.323 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -59.77 -45.2 93.0 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.581 -0.736 . . . . 73.21 110.535 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.494 HG11 HD23 ' A' ' 14' ' ' LEU . 34.9 m -75.29 -31.83 24.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-O 121.047 0.451 . . . . 74.25 112.139 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -68.87 -22.37 64.21 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.783 -0.644 . . . . 73.31 110.76 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . 0.315 29.6 t70 91.62 84.56 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 125.806 1.642 . . . . 74.22 113.835 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 171.69 132.9 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 127.208 2.203 . . . . 63.43 105.652 175.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -85.65 120.49 72.97 Favored Pre-proline 0 C--N 1.284 -2.245 0 C-N-CA 119.938 -0.705 . . . . 74.21 109.649 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.592 ' HG3' ' HB2' ' A' ' 37' ' ' LYS . 53.8 Cg_exo -59.28 94.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.679 2.253 . . . . 73.31 112.264 172.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 50.3 ttm -155.11 117.54 4.24 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.75 -1.574 . . . . 73.31 106.75 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t70 78.2 134.59 0.06 Allowed 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.607 1.163 . . . . 71.11 110.131 -173.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.536 ' NE1' ' HA ' ' A' ' 98' ' ' ASN . 25.2 m-90 -55.85 -50.41 70.67 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 113.649 0.981 . . . . 70.15 113.649 -173.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.52 ' OE2' ' HG3' ' A' ' 95' ' ' PRO . 47.8 mt-10 67.24 -55.77 0.45 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.882 0.873 . . . . 73.44 110.468 -170.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 52' ' ' VAL . 45.7 mt-10 73.1 -19.12 0.33 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.987 1.715 . . . . 73.33 114.764 174.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 70.07 -55.96 0.59 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.902 0.881 . . . . 73.31 111.601 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -173.66 -37.72 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.276 0.63 . . . . 75.34 109.412 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.502 ' O ' ' HB3' ' A' ' 49' ' ' GLU . 29.4 m -91.86 172.26 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.82 -0.627 . . . . 64.25 110.19 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -138.83 94.36 2.82 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 109.322 -0.621 . . . . 70.23 109.322 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.3 m -160.8 117.67 1.43 Allowed Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 123.977 0.911 . . . . 62.02 108.838 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.53 -16.55 30.56 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.433 2.088 . . . . 70.51 111.271 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -74.39 0.27 15.04 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.685 -1.143 . . . . 62.41 112.724 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.548 ' HB ' ' HB3' ' A' ' 91' ' ' ARG . 2.5 pp -76.77 -21.28 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.086 0.47 . . . . 73.21 110.912 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 96.4 mt -89.3 125.35 35.07 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 107.251 -1.388 . . . . 72.44 107.251 176.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -137.93 142.55 40.58 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.594 -0.842 . . . . 64.0 109.249 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.823 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.6 pp -114.19 134.97 54.55 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.969 -0.56 . . . . 74.44 110.707 -178.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 72.3 mt -109.39 119.92 59.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 115.295 -0.866 . . . . 74.05 108.763 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -101.91 102.78 13.38 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 102.917 -2.994 . . . . 64.4 102.917 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -18.78 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 127.999 2.52 . . . . 71.04 113.881 -163.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.52 -67.81 0.4 Allowed Glycine 0 N--CA 1.42 -2.394 0 CA-C-N 113.165 -1.834 . . . . 61.2 110.27 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -130.61 173.65 10.68 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 120.788 0.327 . . . . 72.3 111.539 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -94.66 114.18 26.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.956 -1.868 . . . . 75.02 105.956 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.667 HD12 HD22 ' A' ' 76' ' ' LEU . 90.6 mt -79.19 -48.12 14.78 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 119.224 -0.99 . . . . 74.14 113.537 -175.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.666 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -167.69 174.52 7.62 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.043 -0.355 . . . . 64.44 110.043 179.682 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.47 -1.52 85.76 Favored Glycine 0 C--N 1.306 -1.131 0 N-CA-C 115.279 0.872 . . . . 55.34 115.279 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.444 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 2.7 t-20 -173.22 25.04 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.727 1.264 . . . . 73.24 110.529 -171.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.659 HG12 HD21 ' A' ' 60' ' ' LEU . 13.3 p -80.42 145.47 9.04 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 O-C-N 122.082 -0.386 . . . . 63.12 110.121 -176.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.535 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 64.0 p -79.02 157.52 28.06 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 122.992 0.517 . . . . 62.52 111.993 -175.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.594 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.7 mm? -65.38 -32.68 74.45 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 120.943 0.402 . . . . 73.1 110.526 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.76 -34.94 88.82 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.817 -0.706 . . . . 74.24 111.353 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.444 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -78.64 -15.58 58.35 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.898 0.479 . . . . 74.34 110.863 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.667 HD22 HD12 ' A' ' 67' ' ' LEU . 65.8 mt -86.33 -3.69 59.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 74.04 110.083 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.6 mptt 70.27 72.05 0.22 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.561 1.145 . . . . 72.54 111.421 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.467 HD22 ' HB3' ' A' ' 73' ' ' LEU . 10.4 mp -115.37 118.55 39.53 Favored Pre-proline 0 CA--C 1.491 -1.314 0 CA-C-N 116.0 -0.546 . . . . 75.3 110.822 175.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.425 ' HG2' ' HD2' ' A' ' 82' ' ' LYS . 16.8 Cg_exo -69.07 139.96 44.01 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.99 1.794 . . . . 73.13 109.085 172.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -69.7 140.82 53.59 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.0 -0.741 . . . . 74.45 109.0 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.477 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 92.05 -9.14 77.12 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.254 -0.974 . . . . 64.32 113.359 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' HD2' ' HG2' ' A' ' 79' ' ' PRO . 94.6 mttt -101.65 153.28 19.91 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.456 -0.498 . . . . 54.35 112.275 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.406 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 30.3 m -91.12 118.31 30.32 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.19 -0.914 . . . . 62.02 110.275 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.3 m -122.4 138.88 54.39 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.951 -0.568 . . . . 75.24 109.708 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.53 140.44 28.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 110.281 -0.266 . . . . 75.42 110.281 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 86.6 mtp -138.96 153.76 48.23 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 111.819 0.303 . . . . 73.52 111.819 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.555 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 83.5 m-70 -106.37 137.39 44.42 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.801 -0.814 . . . . 55.14 108.801 175.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.458 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.1 mm? -125.28 131.64 53.05 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 122.215 -0.303 . . . . 65.44 110.894 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.13 135.25 64.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.047 0.451 . . . . 74.23 110.03 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.29 127.65 32.21 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 122.279 -0.263 . . . . 52.31 111.238 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.548 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 58.3 ttt180 -84.42 117.07 23.4 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.605 -0.517 . . . . 64.45 109.605 175.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 70.94 -4.08 1.84 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.053 0.941 . . . . 75.34 112.902 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.2 m 55.42 79.64 0.15 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.496 1.518 . . . . 53.24 114.062 172.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.504 ' HB2' HD11 ' A' ' 57' ' ' ILE . 6.5 mp -94.17 142.0 24.34 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.739 -0.838 . . . . 71.44 108.739 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.565 ' HA ' ' HG3' ' A' ' 37' ' ' LYS . 36.7 Cg_endo -67.53 -65.15 0.04 OUTLIER 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 122.824 2.35 . . . . 70.45 114.277 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -111.41 122.32 37.87 Favored Pre-proline 0 N--CA 1.416 -2.156 0 CA-C-N 116.308 -0.405 . . . . 50.03 109.912 -174.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -59.15 -53.89 3.18 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.683 2.255 . . . . 64.14 112.851 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.536 ' HA ' ' NE1' ' A' ' 47' ' ' TRP . 9.8 t30 -169.8 24.35 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.192 0.52 . . . . 72.21 111.58 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.8 m 62.66 14.81 7.5 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.35 0.66 . . . . 61.23 111.544 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -87.41 -51.84 5.71 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 115.327 1.602 . . . . 72.22 115.327 -172.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.93 31.99 80.43 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.153 -1.179 . . . . 73.24 110.153 -173.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -125.96 164.47 20.72 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.114 -1.069 . . . . 74.14 108.114 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -84.06 92.34 7.85 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.72 -0.792 . . . . 73.41 111.384 -175.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 60.7 t30 69.58 -177.88 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.692 0.797 . . . . 65.14 111.555 174.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -52.68 -42.14 64.49 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.588 1.155 . . . . 65.23 110.464 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.25 148.09 34.43 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 105.08 -2.193 . . . . 71.44 105.08 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -60.92 -44.61 96.97 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 123.458 0.703 . . . . 75.44 112.799 -176.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.4 p -133.17 -30.29 1.35 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.585 0.587 . . . . 72.3 112.585 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.9 59.83 3.55 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 121.19 -0.529 . . . . 74.14 113.233 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.0 110.37 4.42 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.876 -0.787 . . . . 73.11 108.876 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.2 t -83.54 123.42 29.73 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.747 -1.115 . . . . 72.34 113.474 -168.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -105.81 93.94 4.92 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 105.165 -2.161 . . . . 41.23 105.165 167.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 25.9 p -86.07 170.09 12.55 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 112.81 0.671 . . . . 73.1 112.81 -171.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 41.3 t -74.02 104.46 4.87 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.183 -0.917 . . . . 75.44 108.945 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.79 107.58 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.893 0 CA-C-O 122.184 0.992 . . . . 72.42 110.585 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.9 tp -131.25 138.64 52.8 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 107.463 -1.31 . . . . 73.44 107.463 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.8 tt . . . . . 0 C--N 1.298 -1.635 0 N-CA-C 107.353 -1.351 . . . . 74.4 107.353 -179.173 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 p . . . . . 0 N--CA 1.431 -1.375 0 N-CA-C 111.721 0.267 . . . . 64.3 111.721 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.1 m -78.72 102.71 8.22 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.325 -1.361 . . . . 51.55 107.325 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 71.98 175.38 0.29 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 107.29 -1.374 . . . . 72.21 107.29 -171.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.565 HG22 HD21 ' A' ' 11' ' ' ASN . 16.7 t -100.52 131.81 23.27 Favored Pre-proline 0 C--N 1.284 -2.246 0 O-C-N 121.524 -0.735 . . . . 71.14 110.133 -174.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -68.87 147.42 68.52 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.09 1.86 . . . . 73.43 110.83 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.05 65.86 7.37 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.979 0.895 . . . . 64.33 112.055 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -163.26 -31.49 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.688 -1.597 . . . . 73.31 106.688 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.9 mmm -102.79 148.81 25.15 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.244 -1.343 . . . . 71.05 109.007 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.43 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.9 pp -107.69 132.1 56.18 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 108.816 -0.809 . . . . 74.15 108.816 173.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.565 HD21 HG22 ' A' ' 5' ' ' VAL . 45.8 t-20 -88.76 113.78 24.68 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.955 -1.498 . . . . 73.24 106.955 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.551 ' HG ' HD22 ' A' ' 14' ' ' LEU . 42.6 tp -118.96 133.11 56.04 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 121.164 0.506 . . . . 73.44 112.087 -173.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.484 ' HD2' ' OE1' ' A' ' 23' ' ' GLU . 20.6 ttt85 -107.02 121.32 44.22 Favored 'General case' 0 N--CA 1.407 -2.578 0 CA-C-N 115.365 -0.834 . . . . 65.11 108.815 174.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.639 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.0 mm? -101.3 120.72 40.68 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.568 -1.196 . . . . 54.23 108.893 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.541 HG23 HG22 ' A' ' 21' ' ' THR . 26.8 mt -104.69 124.71 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 N-CA-C 108.953 -0.758 . . . . 60.45 108.953 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.3 mt -79.46 168.81 18.95 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.918 -0.583 . . . . 52.32 110.91 -177.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.431 ' CG2' ' HA ' ' A' ' 89' ' ' VAL . 60.0 t -63.84 -31.16 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 122.676 0.39 . . . . 73.24 111.587 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.1 m -79.0 6.1 10.13 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 122.033 -0.417 . . . . 74.22 112.069 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.27 13.67 82.54 Favored Glycine 0 CA--C 1.507 -0.412 0 C-N-CA 120.474 -0.869 . . . . 60.11 111.681 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -88.03 137.48 32.29 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.845 -1.169 . . . . 74.01 107.845 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.541 HG22 HG23 ' A' ' 15' ' ' ILE . 73.2 p -117.97 138.02 52.46 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.731 -0.788 . . . . 65.24 112.841 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HD2' ' O ' ' A' ' 39' ' ' VAL . 58.7 mttp -133.26 147.35 51.93 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.511 -0.922 . . . . 74.53 108.511 169.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.484 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 29.5 tt0 -135.78 131.29 35.29 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.671 -0.863 . . . . 61.32 108.671 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.623 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.6 m-85 -144.75 160.15 41.71 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 122.664 0.386 . . . . 71.12 109.989 -177.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -82.46 125.73 31.42 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.325 -0.991 . . . . 70.04 108.325 173.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.623 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 89.8 m-85 -128.92 173.84 10.04 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.537 -0.912 . . . . 74.54 108.537 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.0 p -100.22 153.14 37.92 Favored Pre-proline 0 N--CA 1.408 -2.556 0 N-CA-C 107.494 -1.298 . . . . 75.43 107.494 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.547 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 40.0 Cg_endo -61.76 -11.45 20.81 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 122.801 2.334 . . . . 74.12 112.161 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -96.81 -4.24 40.77 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.636 -0.711 . . . . 74.41 112.243 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' HB2' HD11 ' A' ' 35' ' ' ILE . 27.4 m-20 -74.7 153.31 38.92 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 119.861 -0.735 . . . . 64.54 110.833 177.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.523 ' O ' HG13 ' A' ' 35' ' ' ILE . 53.7 m -92.54 119.89 32.46 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 120.567 0.222 . . . . 74.21 110.619 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.425 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -45.44 -41.7 9.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.337 1.455 . . . . 72.05 113.568 -178.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 24.2 p -69.53 -41.28 76.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.014 0.435 . . . . 75.42 111.658 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -63.55 -41.77 98.42 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.514 -1.291 . . . . 75.3 107.514 177.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.532 ' O ' HG22 ' A' ' 39' ' ' VAL . 60.7 mt -61.78 -49.21 85.18 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.565 0 CA-C-N 114.619 -1.173 . . . . 75.03 110.408 178.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.02 -44.93 51.58 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.905 0.882 . . . . 73.22 112.043 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.456 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 1.8 tmtp? -73.21 -41.21 64.03 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.515 -0.921 . . . . 73.22 108.515 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -56.54 -45.26 81.26 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.646 1.179 . . . . 75.42 110.671 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.639 HG21 ' CB ' ' A' ' 14' ' ' LEU . 33.8 m -77.62 -29.64 16.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.371 -0.831 . . . . 74.43 111.826 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -47.13 -48.26 23.26 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.356 -0.979 . . . . 74.34 108.356 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . 0.254 11.1 m-20 179.28 -52.35 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 125.865 1.666 . . . . 65.53 113.0 170.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -116.32 -177.86 3.27 Favored 'General case' 0 C--O 1.209 -1.043 0 N-CA-C 109.518 -0.549 . . . . 61.51 109.518 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -90.37 138.78 26.86 Favored Pre-proline 0 C--N 1.309 -1.181 0 O-C-N 121.901 -0.499 . . . . 74.25 110.994 -175.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -72.42 99.28 1.01 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.761 1.641 . . . . 65.42 110.275 172.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 51.1 ttm -149.94 89.26 1.59 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.928 -0.578 . . . . 74.4 110.287 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -159.37 152.89 22.64 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.007 -1.479 . . . . 73.35 107.007 177.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -63.85 -34.5 78.07 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 123.179 0.299 . . . . 64.1 111.733 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 11.2 pt-20 -132.29 -40.94 1.0 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.288 -0.565 . . . . 74.3 112.326 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 65.18 -71.59 0.08 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.267 1.427 . . . . 61.34 109.657 -173.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -129.23 109.98 11.59 Favored 'General case' 0 C--O 1.253 1.27 0 C-N-CA 122.998 0.519 . . . . 72.24 111.614 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.473 ' HG2' HG23 ' A' ' 52' ' ' VAL . 35.7 tt0 73.74 -68.23 0.23 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.323 1.449 . . . . 63.35 113.729 175.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.473 HG23 ' HG2' ' A' ' 51' ' ' GLN . 97.3 t -137.43 -53.69 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.653 -0.869 . . . . 62.31 108.653 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.3 m -171.66 -43.14 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 104.794 -2.299 . . . . 72.01 104.794 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.636 ' O ' HG12 ' A' ' 57' ' ' ILE . 18.1 m 55.1 71.21 1.34 Allowed Pre-proline 0 N--CA 1.441 -0.879 0 CA-C-N 113.157 -1.838 . . . . 75.03 112.46 174.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -62.76 -20.48 71.22 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.234 1.956 . . . . 60.33 112.887 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -61.81 -16.35 49.3 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.994 0.738 . . . . 44.44 112.994 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 54' ' ' SER . 27.5 pt -84.55 -29.15 6.89 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 C-N-CA 120.723 -0.391 . . . . 72.13 111.123 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.559 ' HG ' HG13 ' A' ' 57' ' ' ILE . 88.9 mt -107.15 107.51 18.51 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 116.24 -0.436 . . . . 71.34 109.964 -177.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -144.8 147.84 33.34 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.743 -0.662 . . . . 73.43 110.764 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 1.2 pt? -101.56 133.24 46.53 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 113.248 0.832 . . . . 64.22 113.248 -174.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 82.4 mt -102.49 119.03 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 107.302 -1.37 . . . . 62.13 107.302 175.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -101.64 73.6 1.45 Allowed 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.711 0.767 . . . . 71.11 109.16 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 70.53 -48.5 0.65 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 113.406 -1.725 . . . . 74.22 112.942 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.42 -65.42 0.74 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 121.03 -0.605 . . . . 54.1 113.198 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.554 ' NH1' ' HA ' ' A' ' 67' ' ' LEU . 3.1 ppt_? -131.06 176.64 8.08 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.702 0.63 . . . . 73.12 112.702 -174.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 71.8 m-85 -79.16 118.0 20.71 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.483 -0.932 . . . . 64.33 108.483 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.554 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 92.8 mt -79.26 -48.82 13.49 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.425 -0.91 . . . . 64.14 110.763 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -162.92 -171.77 2.81 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 124.293 1.037 . . . . 54.3 108.983 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.04 -43.22 7.22 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 110.99 -0.844 . . . . 62.1 110.99 175.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.483 ' HB3' ' OG ' ' A' ' 33' ' ' SER . 4.4 p-10 -148.71 77.86 1.39 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 122.447 1.118 . . . . 71.3 112.033 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.477 ' CG1' HD11 ' A' ' 60' ' ' LEU . 9.4 p -102.11 142.7 15.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 106.166 -1.791 . . . . 72.51 106.166 173.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.466 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 57.2 p -78.25 157.75 29.16 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.169 0.433 . . . . 65.32 112.169 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.568 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.9 mm? -64.82 -30.94 71.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.031 -0.531 . . . . 62.23 110.952 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.51 -36.62 92.75 Favored Glycine 0 C--N 1.33 0.207 0 N-CA-C 110.833 -0.907 . . . . 73.33 110.833 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.99 -15.35 62.57 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.262 0.625 . . . . 73.22 110.686 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 72' ' ' THR . 62.9 mt -84.11 13.73 4.86 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.056 -0.52 . . . . 73.42 111.116 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.471 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.5 mptt 67.37 24.68 8.87 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.663 0.785 . . . . 71.22 110.528 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.481 HD22 ' HE3' ' A' ' 82' ' ' LYS . 80.2 mt -93.97 122.33 62.19 Favored Pre-proline 0 C--N 1.311 -1.09 0 CA-C-N 115.798 -0.637 . . . . 53.51 111.04 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.93 171.45 16.47 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.242 1.961 . . . . 62.43 109.699 172.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.426 ' CE1' ' HG3' ' A' ' 28' ' ' PRO . 5.1 m-85 -84.97 170.74 12.73 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.829 -0.804 . . . . 73.33 108.829 -176.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.45 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 74.83 10.17 83.43 Favored Glycine 0 C--N 1.306 -1.101 0 N-CA-C 115.218 0.847 . . . . 71.23 115.218 173.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HE3' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -131.28 162.7 29.44 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 118.237 1.019 . . . . 65.31 111.914 178.24 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.555 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 33.3 m -96.81 126.71 42.16 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 116.145 -0.479 . . . . 74.1 110.804 -178.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.1 m -115.51 141.48 48.0 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.708 -0.678 . . . . 74.22 109.691 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.0 p -111.31 130.39 64.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 120.916 0.388 . . . . 45.41 110.016 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.461 ' HE1' HD12 ' A' ' 60' ' ' LEU . 90.9 mtp -138.38 153.11 48.93 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.051 0.453 . . . . 73.51 112.071 -178.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.515 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 60.5 m-70 -108.97 131.32 55.17 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.658 -0.868 . . . . 72.31 108.658 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.466 HD22 ' C ' ' A' ' 87' ' ' HIS . 3.2 mm? -121.95 144.65 48.75 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 120.784 0.326 . . . . 62.04 110.893 -177.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.431 ' HA ' ' CG2' ' A' ' 17' ' ' VAL . 27.8 m -119.78 136.69 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 CA-C-N 115.777 -0.647 . . . . 75.12 110.423 176.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.5 ' HB1' ' OG1' ' A' ' 93' ' ' THR . . . -133.1 145.07 50.39 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.293 -1.373 . . . . 72.23 107.293 174.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -139.62 128.27 23.15 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.128 -1.434 . . . . 63.1 107.128 -173.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 71.25 -10.09 0.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.74 0.816 . . . . 73.42 111.939 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.5 ' OG1' ' HB1' ' A' ' 90' ' ' ALA . 43.8 m -56.32 128.35 35.42 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.859 1.264 . . . . 45.1 111.727 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -86.72 150.33 50.44 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 115.499 -0.773 . . . . 70.15 109.13 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.51 -42.38 55.44 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.414 2.076 . . . . 75.24 111.345 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -130.33 139.64 36.23 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 107.8 -1.185 . . . . 71.55 107.8 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -39.81 -64.67 0.21 Allowed 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 124.777 3.652 . . . . 54.44 115.378 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -167.54 79.39 0.18 Allowed 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 121.122 -0.231 . . . . 72.32 111.331 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.5 m 46.29 33.8 1.97 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 113.293 0.849 . . . . 71.42 113.293 175.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.537 ' HB2' ' HG2' ' A' ' 102' ' ' GLN . 11.6 pt20 -68.85 -44.79 72.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.354 0.501 . . . . 74.23 112.354 -174.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.8 25.51 59.08 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.487 -0.387 . . . . 45.51 112.882 -176.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.537 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 12.3 mm-40 -85.08 119.63 25.69 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.695 -0.297 . . . . 74.0 111.394 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.486 ' O ' ' HD2' ' A' ' 103' ' ' ARG . 1.2 tmm_? 72.14 -35.81 0.34 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.847 1.659 . . . . 74.24 111.745 175.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 55.9 t30 76.47 -174.86 0.11 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.415 1.086 . . . . 74.1 109.858 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -58.36 -28.92 65.57 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 123.762 0.825 . . . . 73.22 110.74 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 108' ' ' THR . 12.0 tp10 -177.35 157.41 1.32 Allowed 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 104.702 -2.333 . . . . 61.45 104.702 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -74.0 -20.79 60.22 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.055 -0.658 . . . . 63.22 110.67 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.484 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 7.4 t -153.79 95.65 1.9 Allowed 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 115.036 -0.984 . . . . 72.14 108.396 170.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.47 33.7 0.02 OUTLIER Glycine 0 C--N 1.305 -1.173 0 CA-C-N 115.403 -0.817 . . . . 61.44 111.69 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.78 -167.8 1.46 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.445 -0.946 . . . . 65.33 108.445 176.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.1 m -71.45 82.8 0.8 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.588 0.709 . . . . 73.2 111.715 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.9 p30 179.87 -27.18 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 126.195 1.798 . . . . 44.33 108.387 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 83.6 m -88.56 87.88 7.42 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 108.907 -0.775 . . . . 64.4 108.907 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 18.2 p -107.06 116.16 31.45 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.125 -0.943 . . . . 64.14 110.006 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 p -92.63 89.62 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 CA-C-O 122.166 0.984 . . . . 74.24 109.766 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.2 tt -118.96 132.03 70.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.097 -0.956 . . . . 63.32 109.173 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.6 tp . . . . . 0 C--N 1.291 -1.952 0 CA-C-O 118.653 -0.689 . . . . 45.35 109.211 -177.939 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.425 -1.721 0 N-CA-C 107.445 -1.317 . . . . 53.12 107.445 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.0 t -149.41 -165.65 2.34 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.563 -1.273 . . . . 71.22 107.563 -176.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -71.56 117.22 12.84 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.705 -0.479 . . . . 74.43 109.705 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 11' ' ' ASN . 21.2 t -80.88 119.72 76.89 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 108.853 -0.795 . . . . 54.32 108.853 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -72.34 153.23 55.94 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.165 1.91 . . . . 54.43 111.664 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.86 71.3 5.31 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 122.379 1.085 . . . . 62.12 109.623 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -167.12 -27.81 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 112.883 -1.962 . . . . 51.21 106.954 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.1 mmm -112.8 153.08 28.38 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.861 -1.063 . . . . 63.23 108.778 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.408 HD11 ' HG ' ' A' ' 73' ' ' LEU . 2.8 pp -113.9 136.74 49.41 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 N-CA-C 109.757 -0.46 . . . . 63.14 109.757 172.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 50.0 t-20 -86.3 107.63 18.05 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.359 -1.349 . . . . 65.34 107.359 -176.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.498 ' HG ' HD22 ' A' ' 14' ' ' LEU . 40.7 tp -119.75 133.6 55.55 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 112.742 0.645 . . . . 74.13 112.742 -173.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.8 ttp-105 -108.58 121.21 44.53 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.492 -0.776 . . . . 73.02 109.027 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.606 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.0 mm? -99.3 121.13 40.65 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 114.701 -1.136 . . . . 73.33 108.365 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.436 HG12 HG22 ' A' ' 21' ' ' THR . 24.1 mt -101.37 123.93 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 C-N-CA 119.126 -1.03 . . . . 64.14 109.459 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.6 mt -81.79 165.07 21.23 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.896 -0.593 . . . . 71.01 110.383 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.9 m -69.27 -14.6 18.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.503 0.668 . . . . 62.12 110.81 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.3 m -78.83 1.51 23.13 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 124.43 1.092 . . . . 44.2 110.482 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.61 20.28 77.1 Favored Glycine 0 CA--C 1.499 -0.96 0 N-CA-C 110.705 -0.958 . . . . 33.52 110.705 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -108.47 134.67 50.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.076 -1.083 . . . . 75.32 108.076 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.436 HG22 HG12 ' A' ' 15' ' ' ILE . 75.9 p -108.33 137.71 45.83 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 120.247 -0.581 . . . . 62.43 111.07 -177.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -124.93 139.23 54.01 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.969 -1.123 . . . . 73.45 107.969 169.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -130.81 130.39 43.6 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.354 -0.98 . . . . 53.32 108.354 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.656 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.0 m-85 -145.18 159.87 42.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.373 -0.603 . . . . 74.35 109.373 -178.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.408 HD22 HG13 ' A' ' 5' ' ' VAL . 74.6 mt -80.42 125.72 30.28 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 107.637 -1.246 . . . . 71.24 107.637 173.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.656 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 84.4 m-85 -128.27 166.02 19.39 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.1 -1.074 . . . . 73.11 108.1 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.4 p -92.47 149.44 38.24 Favored Pre-proline 0 N--CA 1.414 -2.266 0 C-N-CA 118.903 -1.119 . . . . 74.25 108.218 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.501 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 40.2 Cg_endo -62.16 -11.2 20.94 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 122.773 2.316 . . . . 61.44 112.214 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -93.03 -10.05 37.55 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.727 -0.67 . . . . 75.24 111.579 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -73.94 153.65 39.69 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.824 0.345 . . . . 72.12 111.02 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 35' ' ' ILE . 20.4 m -87.24 118.45 26.67 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.348 -0.982 . . . . 74.52 108.348 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.636 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -54.33 -39.52 67.13 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.663 0.785 . . . . 71.43 112.689 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 p -73.4 -32.63 64.55 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.223 0.535 . . . . 63.23 111.526 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -66.9 -43.77 82.54 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.964 -1.125 . . . . 73.13 107.964 175.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.587 ' O ' HG22 ' A' ' 39' ' ' VAL . 69.4 mt -60.82 -41.59 89.19 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.946 0 CA-C-N 114.364 -1.289 . . . . 65.54 110.291 177.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 40' ' ' TYR . . . -50.13 -40.08 45.08 Favored 'General case' 0 C--O 1.212 -0.875 0 C-N-CA 122.855 0.462 . . . . 74.12 111.255 176.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.466 ' HB2' ' HG3' ' A' ' 44' ' ' PRO . 53.3 mtpt -73.29 -38.46 65.89 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.255 0.55 . . . . 61.04 110.403 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 6.0 t60 -59.08 -50.35 74.38 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.895 1.278 . . . . 73.55 110.292 177.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.606 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.2 m -76.09 -30.35 20.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 123.413 0.685 . . . . 53.03 112.223 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 47.6 t80 -47.39 -48.51 25.94 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.669 0.787 . . . . 73.41 110.78 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -151.83 -62.34 0.17 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.945 0.402 . . . . 71.4 110.222 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -150.59 167.26 27.8 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 106.544 -1.651 . . . . 75.33 106.544 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.5 t90 -59.61 125.16 79.02 Favored Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 122.61 0.364 . . . . 71.01 110.832 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.466 ' HG3' ' HB2' ' A' ' 37' ' ' LYS . 48.6 Cg_endo -68.54 99.03 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.228 1.952 . . . . 62.1 112.953 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 28.0 ttt -82.37 -42.34 18.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.748 -1.204 . . . . 72.22 107.748 176.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -100.28 150.23 22.78 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 105.031 -2.211 . . . . 75.52 105.031 172.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -86.37 -90.49 0.11 Allowed 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.986 -1.086 . . . . 73.23 112.952 -174.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.51 ' HB2' ' HA ' ' A' ' 53' ' ' SER . 5.5 mp0 -133.97 134.87 43.04 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.999 -1.482 . . . . 71.31 106.999 175.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.519 ' HB3' ' O ' ' A' ' 95' ' ' PRO . 30.8 tt0 -143.9 27.86 1.45 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.883 0.849 . . . . 73.05 108.754 177.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.93 -48.22 81.39 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 105.955 -1.869 . . . . 74.11 105.955 176.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -138.84 -59.66 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.258 -0.883 . . . . 71.01 109.673 173.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.9 t -147.43 139.36 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.257 -1.016 . . . . 51.04 108.257 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.51 ' HA ' ' HB2' ' A' ' 48' ' ' GLU . 36.9 m -57.06 121.38 9.87 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 109.744 -0.465 . . . . 75.3 109.744 176.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.451 ' O ' HG13 ' A' ' 57' ' ' ILE . 38.2 m -135.89 109.56 10.0 Favored Pre-proline 0 N--CA 1.432 -1.37 0 CA-C-N 116.035 -0.53 . . . . 62.11 110.687 -173.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.79 -15.32 46.92 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.537 2.158 . . . . 72.12 111.528 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -62.98 -13.96 41.65 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 124.26 1.024 . . . . 73.4 112.174 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 54' ' ' SER . 2.1 pp -84.45 -16.17 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-O 121.16 0.505 . . . . 64.43 110.383 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.609 ' O ' ' HD2' ' A' ' 59' ' ' ARG . 96.2 mt -83.52 93.58 7.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.489 -0.778 . . . . 70.13 110.435 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.609 ' HD2' ' O ' ' A' ' 58' ' ' LEU . 4.4 mpt_? -129.88 150.32 51.23 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 123.291 0.636 . . . . 71.44 110.118 176.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.636 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.0 pp -135.34 140.34 44.99 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.805 0.336 . . . . 54.24 111.123 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 95.6 mt -112.66 122.42 66.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 109.03 -0.73 . . . . 71.31 109.03 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -100.96 87.57 3.32 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 107.048 -1.464 . . . . 75.01 107.048 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 69.45 -61.5 0.44 Allowed 'General case' 0 N--CA 1.404 -2.74 0 C-N-CA 127.168 2.187 . . . . 71.23 112.885 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.27 -28.42 1.22 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.177 -1.011 . . . . 73.34 114.591 -177.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.19 161.31 31.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.483 1.142 . . . . 74.14 111.992 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.612 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 79.7 m-85 -81.53 117.11 21.66 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.408 -0.96 . . . . 74.23 108.408 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.623 HD12 HD22 ' A' ' 76' ' ' LEU . 47.6 mt -80.16 -47.68 14.34 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.836 1.05 . . . . 71.35 113.836 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.476 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 9.2 t60 178.53 134.16 0.08 Allowed 'General case' 0 C--O 1.21 -0.995 0 N-CA-C 107.534 -1.284 . . . . 63.13 107.534 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.19 1.41 0.09 OUTLIER Glycine 0 CA--C 1.547 2.044 0 N-CA-C 118.335 2.094 . . . . 73.11 118.335 -174.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -162.77 21.04 0.09 Allowed 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 119.115 1.457 . . . . 74.33 109.313 -172.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.483 HG12 HD21 ' A' ' 60' ' ' LEU . 11.0 p -81.38 144.89 9.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 119.939 -0.705 . . . . 64.34 110.161 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.433 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 40.5 p -82.71 162.44 21.79 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.903 -0.589 . . . . 63.5 111.545 -177.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.546 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.7 mm? -66.99 -35.82 80.8 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.187 -0.46 . . . . 74.25 111.693 -175.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.53 -33.33 86.16 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.374 -0.917 . . . . 73.45 111.164 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.438 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -74.89 -15.92 60.69 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 123.03 0.532 . . . . 72.44 111.485 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.623 HD22 HD12 ' A' ' 67' ' ' LEU . 42.5 mt -84.87 -3.48 58.7 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.904 -0.776 . . . . 74.31 108.904 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.31 77.77 0.12 Allowed 'General case' 0 C--O 1.244 0.8 0 C-N-CA 125.701 1.601 . . . . 73.22 111.278 -175.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.479 HD22 ' HB3' ' A' ' 73' ' ' LEU . 10.6 mp -126.31 111.05 23.63 Favored Pre-proline 0 CA--C 1.497 -1.093 0 CA-C-N 115.274 -0.876 . . . . 74.51 111.048 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.85 142.37 62.65 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 121.915 1.744 . . . . 70.31 108.631 172.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -65.51 146.46 54.82 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.872 0.368 . . . . 73.25 110.619 -174.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.48 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 82.57 4.22 90.2 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.866 -0.606 . . . . 73.43 113.778 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -106.28 154.32 20.92 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 117.51 0.655 . . . . 54.44 112.409 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.55 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 52.6 m -91.62 121.1 32.98 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 115.534 -0.757 . . . . 75.12 110.315 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.5 m -130.82 135.63 47.92 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.832 -0.622 . . . . 74.34 110.501 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.8 p -108.14 142.2 21.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.98 -0.555 . . . . 73.14 110.851 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 91.2 mtp -135.55 153.29 51.75 Favored 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 123.021 0.528 . . . . 73.25 109.948 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.516 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 64.4 m-70 -105.2 125.49 51.03 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.067 -1.457 . . . . 73.21 107.067 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.79 142.75 46.51 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 120.04 -0.664 . . . . 73.52 110.938 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.62 132.58 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 N-CA-C 108.013 -1.106 . . . . 74.1 108.013 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.39 140.26 46.18 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.563 -0.532 . . . . 75.12 109.563 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -138.08 149.2 45.77 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.875 -1.157 . . . . 74.32 107.875 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 51.27 31.49 7.03 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 123.875 0.734 . . . . 71.22 111.203 175.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.8 m -78.0 16.95 0.65 Allowed 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 124.339 1.055 . . . . 71.41 111.389 -173.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 6.2 mp -105.72 134.78 19.55 Favored Pre-proline 0 N--CA 1.42 -1.954 0 CA-C-N 115.937 -0.574 . . . . 54.21 110.254 -178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.519 ' O ' ' HB3' ' A' ' 49' ' ' GLU . 11.8 Cg_exo -73.27 3.35 4.73 Favored 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 123.425 2.75 . . . . 54.23 112.174 177.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.421 ' HG2' ' HD2' ' A' ' 97' ' ' PRO . 0.0 OUTLIER -159.33 137.4 7.47 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 104.982 -2.229 . . . . 64.42 104.982 176.924 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.421 ' HD2' ' HG2' ' A' ' 96' ' ' GLU . 14.2 Cg_exo -24.27 -56.72 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.906 1 C-N-CA 126.081 4.52 . . . . 73.52 116.041 -176.183 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -155.82 14.56 0.35 Allowed 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.22 -0.592 . . . . 71.23 109.567 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.4 m 65.98 35.68 6.29 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.707 -1.22 . . . . 72.15 107.707 -174.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.435 ' HG3' ' H ' ' A' ' 102' ' ' GLN . 11.9 pt20 -68.32 -29.79 68.62 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 113.836 -1.529 . . . . 73.5 111.202 -178.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.02 -29.73 9.42 Favored Glycine 0 N--CA 1.424 -2.163 0 N-CA-C 110.724 -0.951 . . . . 64.13 110.724 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.435 ' H ' ' HG3' ' A' ' 100' ' ' GLN . 18.3 mp0 -85.81 109.82 18.94 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.785 -0.766 . . . . 75.1 109.129 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -176.13 103.31 0.07 Allowed 'General case' 0 C--N 1.308 -1.218 0 O-C-N 124.102 0.876 . . . . 74.25 110.288 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -96.72 135.02 39.24 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.804 -1.184 . . . . 75.4 107.804 172.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -58.14 -49.97 75.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.484 -1.302 . . . . 73.33 107.484 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.558 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 45.0 mt-10 -156.85 167.33 30.78 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 105.451 -2.055 . . . . 73.12 105.451 173.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -68.07 100.3 0.98 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.316 0.579 . . . . 73.23 109.715 176.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.8 m 63.59 34.43 12.47 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 122.266 1.031 . . . . 73.11 108.22 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.558 ' HA3' ' HB2' ' A' ' 106' ' ' GLU . . . -124.03 22.71 6.7 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 119.071 -1.538 . . . . 73.1 115.779 -174.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.74 87.17 7.15 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 118.225 -1.39 . . . . 74.3 109.789 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 73.9 m 69.48 92.74 0.08 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 113.678 -1.601 . . . . 73.21 110.953 -172.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -78.65 -33.59 47.06 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.09 -0.959 . . . . 42.2 109.264 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.4 m 63.45 84.07 0.15 Allowed 'General case' 0 C--O 1.243 0.715 0 N-CA-C 107.799 -1.186 . . . . 74.41 107.799 -172.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 60.1 m -78.01 114.11 16.57 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 114.22 -1.354 . . . . 70.3 111.887 -172.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -90.81 83.73 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-O 122.458 1.123 . . . . 71.52 110.032 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.6 tp -101.53 109.97 27.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.569 -1.196 . . . . 73.14 109.246 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.2 tp . . . . . 0 C--N 1.298 -1.637 0 N-CA-C 109.004 -0.739 . . . . 63.03 109.004 -177.094 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.7 p . . . . . 0 N--CA 1.44 -0.937 0 N-CA-C 108.767 -0.827 . . . . 73.33 108.767 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.0 t -101.08 0.7 38.4 Favored 'General case' 0 N--CA 1.421 -1.883 0 C-N-CA 120.952 -0.299 . . . . 45.31 111.725 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -155.54 -70.06 0.12 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 119.877 -0.729 . . . . 71.13 112.204 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.4 t -97.06 115.39 65.72 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 107.759 -1.2 . . . . 61.23 107.759 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.18 19.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.534 3.489 . . . . 73.03 118.374 -170.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 63.41 -32.41 0.11 Allowed 'General case' 0 C--O 1.194 -1.855 0 C-N-CA 125.187 1.395 . . . . 73.34 114.607 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -86.89 -10.03 54.31 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.94 0.876 . . . . 72.45 110.089 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.1 mmm -124.52 153.47 42.02 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.382 -0.827 . . . . 73.44 109.22 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.511 HG22 ' HA ' ' A' ' 80' ' ' PHE . 2.8 pp -100.04 139.13 22.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 107.979 -1.119 . . . . 55.03 107.979 173.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -98.9 121.96 41.52 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.18 -1.044 . . . . 73.44 108.18 -175.636 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.56 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.1 tp -126.68 133.66 50.89 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 112.458 0.54 . . . . 62.34 112.458 -175.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -108.18 121.47 44.92 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.697 -0.683 . . . . 74.34 109.558 171.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.568 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.3 mm? -95.92 127.22 41.75 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 124.854 1.262 . . . . 64.23 108.685 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.601 HD12 HG22 ' A' ' 21' ' ' THR . 17.8 mm -99.72 120.25 48.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.568 -0.901 . . . . 72.45 108.568 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.2 mp -78.45 153.52 31.38 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.059 -0.719 . . . . 61.0 109.059 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.4 m -69.72 -13.64 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.579 0.704 . . . . 73.03 111.128 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.7 m -76.42 -9.78 58.9 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.392 -0.822 . . . . 75.42 109.792 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.56 7.19 61.94 Favored Glycine 0 CA--C 1.498 -0.997 0 CA-C-N 116.105 -0.498 . . . . 74.33 112.744 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -87.61 131.58 34.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.49 -0.929 . . . . 75.32 108.49 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.601 HG22 HD12 ' A' ' 15' ' ' ILE . 29.1 p -104.83 129.09 53.2 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.157 -1.423 . . . . 51.25 107.157 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -131.42 138.71 49.2 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.534 -0.913 . . . . 73.31 108.534 -175.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.463 ' CD ' HD21 ' A' ' 11' ' ' ASN . 1.0 OUTLIER -132.38 131.33 41.74 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.185 0.439 . . . . 72.25 112.185 -170.762 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.632 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 94.2 m-85 -144.61 160.24 41.48 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 115.276 -0.875 . . . . 74.11 110.513 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.7 mt -80.75 126.04 30.81 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.85 -1.167 . . . . 64.22 107.85 173.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.632 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 80.0 m-85 -128.35 165.09 21.25 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.876 -0.416 . . . . 63.42 109.876 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.5 m -92.51 142.92 26.45 Favored Pre-proline 0 N--CA 1.414 -2.259 0 N-CA-C 107.431 -1.322 . . . . 60.23 107.431 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.0 -11.34 21.11 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.751 2.301 . . . . 55.33 113.087 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -83.0 -17.49 43.2 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.055 0.942 . . . . 64.33 110.879 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.79 154.34 42.11 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.806 0.669 . . . . 55.45 112.806 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.522 ' O ' HG13 ' A' ' 35' ' ' ILE . 18.3 m -96.16 122.82 39.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.339 -0.846 . . . . 73.31 109.638 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.75 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -50.16 -51.8 40.62 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.834 1.049 . . . . 63.55 113.834 -176.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -69.58 -28.1 65.68 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.267 0.556 . . . . 60.04 110.831 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.44 -46.58 72.69 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.264 -1.013 . . . . 73.51 108.264 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 31' ' ' SER . 69.5 mt -59.89 -43.49 92.23 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.342 0 CA-C-N 114.543 -1.208 . . . . 71.45 110.29 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.41 -48.63 56.05 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.89 0.876 . . . . 74.23 111.799 178.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -72.41 -32.16 66.11 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.68 -0.859 . . . . 73.51 108.68 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -69.74 -51.23 35.98 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.625 0.77 . . . . 75.03 110.7 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.568 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.2 m -62.42 -32.07 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 123.103 0.561 . . . . 54.13 112.355 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -56.31 -49.91 72.94 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.662 0.601 . . . . 75.53 110.045 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.0 t70 169.44 -76.22 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.298 1.039 . . . . 71.22 110.803 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -79.89 114.61 18.94 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.684 -0.689 . . . . 75.41 110.268 -176.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -59.98 141.22 90.02 Favored Pre-proline 0 C--O 1.241 0.62 0 O-C-N 123.48 0.488 . . . . 74.41 111.808 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HA ' ' OE1' ' A' ' 49' ' ' GLU . 23.9 Cg_endo -65.2 137.62 52.67 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.707 2.272 . . . . 60.12 113.131 -177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 50.9 ttp 87.11 9.77 0.17 Allowed 'General case' 0 C--O 1.245 0.817 0 C-N-CA 126.431 1.893 . . . . 70.43 111.691 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 47' ' ' TRP . 25.8 t70 -73.46 -87.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.917 -0.771 . . . . 75.42 108.917 173.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.401 ' HB2' ' O ' ' A' ' 46' ' ' ASP . 11.5 t90 173.23 170.83 0.14 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 106.457 -1.683 . . . . 73.34 106.457 175.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 59.13 24.19 12.52 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.372 0.606 . . . . 72.24 111.419 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.566 ' OE1' ' HA ' ' A' ' 44' ' ' PRO . 40.2 mt-10 -73.22 -23.59 60.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.521 -0.918 . . . . 74.2 108.521 177.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . 0.305 0.0 OUTLIER -175.9 -55.97 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 129.097 2.959 . . . . 73.43 105.881 169.206 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.515 ' HB2' ' OG ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -149.99 -54.5 0.16 Allowed 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 102.868 -3.012 . . . . 72.1 102.868 167.119 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 58.2 t -119.61 -76.55 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 114.089 -1.414 . . . . 74.54 107.331 173.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.7 m 171.11 174.57 0.07 Allowed 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 127.598 2.359 . . . . 74.43 107.714 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.595 ' O ' HG13 ' A' ' 57' ' ' ILE . 17.2 m -121.9 136.31 26.08 Favored Pre-proline 0 C--N 1.294 -1.806 0 N-CA-C 107.656 -1.239 . . . . 60.1 107.656 176.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -75.72 -37.7 1.59 Allowed 'Trans proline' 0 CA--C 1.541 0.873 0 N-CA-C 115.524 1.317 . . . . 71.11 115.524 -177.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -79.44 -0.75 34.28 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.866 0.691 . . . . 72.32 112.866 -174.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 54' ' ' SER . 1.8 pp -93.69 -16.68 7.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-O 121.157 0.503 . . . . 63.31 110.114 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.3 tp -81.25 91.61 6.22 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.867 -0.79 . . . . 75.12 108.867 -176.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -141.57 163.3 33.31 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.142 0.496 . . . . 53.44 111.171 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.75 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.5 pp -141.08 150.69 43.23 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.554 -0.748 . . . . 61.22 110.265 -176.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.0 mt -122.82 126.78 74.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 108.891 -0.781 . . . . 51.15 108.891 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -100.16 72.22 1.64 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.483 -1.303 . . . . 75.42 107.483 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 65.06 -56.58 0.29 Allowed 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 128.109 2.564 . . . . 61.43 112.672 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.39 -62.17 1.35 Allowed Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 121.59 -0.338 . . . . 62.42 113.225 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.522 ' HD3' ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -131.03 175.96 8.64 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 117.369 0.585 . . . . 71.53 111.873 -175.643 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 56.0 m-85 -80.21 118.86 22.27 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.976 -1.12 . . . . 73.41 107.976 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.0 mt -79.72 -47.2 15.71 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.482 -0.887 . . . . 74.12 111.926 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.527 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 12.3 t60 -169.08 168.19 10.15 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 105.278 -2.119 . . . . 72.21 105.278 -174.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.88 -1.77 87.69 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 120.276 -0.964 . . . . 32.13 113.318 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' A' ' 31' ' ' SER . 48.8 t-20 -177.84 73.62 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.449 0.642 . . . . 74.32 109.775 -174.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.656 HG12 HD21 ' A' ' 60' ' ' LEU . 14.5 p -104.51 151.76 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 N-CA-C 108.726 -0.842 . . . . 64.43 108.726 175.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.46 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 64.2 p -87.18 162.6 17.4 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 118.124 0.42 . . . . 74.43 110.682 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.558 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.5 mm? -68.59 -34.8 76.41 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.783 0.325 . . . . 70.33 111.055 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.9 -34.22 89.26 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.717 -0.754 . . . . 65.3 111.26 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -72.8 -15.52 61.63 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.014 0.525 . . . . 60.51 111.571 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 72' ' ' THR . 70.9 mt -82.31 -1.66 50.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 75.42 109.93 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 77' ' ' LYS . 9.8 mptt 65.19 72.17 0.43 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 108.936 -0.764 . . . . 71.01 108.936 -175.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.427 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 94.5 mt -131.32 123.34 19.55 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-N 115.567 -0.742 . . . . 74.11 110.508 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 4.5 Cg_exo -80.07 143.65 16.22 Favored 'Trans proline' 0 N--CA 1.429 -2.269 0 C-N-CA 122.041 1.827 . . . . 72.23 110.326 173.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.511 ' HA ' HG22 ' A' ' 10' ' ' ILE . 1.6 p90 -75.36 148.38 39.29 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 115.033 -0.985 . . . . 74.41 110.227 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.59 2.73 67.24 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.174 -1.012 . . . . 62.33 110.912 -174.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -120.93 157.97 28.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 122.1 0.16 . . . . 61.24 110.645 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.519 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 26.2 m -105.69 127.32 53.0 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.147 0.498 . . . . 74.34 110.574 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.2 m -125.67 142.93 51.26 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.807 -0.633 . . . . 75.32 110.196 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.66 138.19 42.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 120.826 0.346 . . . . 65.32 110.203 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.568 ' O ' HG12 ' A' ' 15' ' ' ILE . 90.1 mtp -135.1 152.2 51.43 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.948 -0.39 . . . . 72.44 109.948 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.456 ' C ' HD22 ' A' ' 88' ' ' LEU . 50.4 m-70 -104.07 134.14 47.83 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 109.045 -0.724 . . . . 71.15 109.045 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.533 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.4 mm? -123.02 144.09 49.5 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 120.482 -0.487 . . . . 74.54 109.798 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.63 134.05 62.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 116.011 -0.54 . . . . 71.25 109.948 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.14 145.96 49.78 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.815 -0.63 . . . . 73.32 109.361 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.408 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 69.2 mtp180 -145.6 146.83 31.52 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 106.626 -1.62 . . . . 75.14 106.626 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 56.81 35.35 26.14 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 124.214 0.946 . . . . 60.25 109.383 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.2 t -95.41 2.36 54.52 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 114.85 -1.068 . . . . 64.12 111.059 -176.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.1 mp -102.22 144.04 27.8 Favored Pre-proline 0 CA--C 1.513 -0.452 0 CA-C-N 116.236 -0.438 . . . . 74.23 110.465 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.81 135.86 39.76 Favored 'Trans proline' 0 C--O 1.246 0.88 0 C-N-CA 122.81 2.34 . . . . 65.13 113.363 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -111.68 152.07 43.83 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.165 -1.05 . . . . 63.13 108.165 170.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -41.97 -60.24 0.73 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.768 2.979 . . . . 65.42 112.687 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -142.91 13.95 1.89 Allowed 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.512 -1.292 . . . . 63.32 107.512 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.515 ' OG ' ' HB2' ' A' ' 51' ' ' GLN . 69.6 m 63.11 80.64 0.23 Allowed 'General case' 0 C--O 1.247 0.948 0 CA-C-N 114.326 -1.306 . . . . 72.24 113.207 -174.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -85.91 -40.28 16.07 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.706 -1.134 . . . . 73.23 110.255 174.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.23 0.52 10.58 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.592 -0.276 . . . . 73.54 113.443 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -131.93 111.86 11.92 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.714 -0.847 . . . . 63.01 108.714 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -80.89 -39.11 26.88 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.481 -0.781 . . . . 71.22 111.367 -176.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -89.73 172.84 8.63 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.913 -0.585 . . . . 70.4 110.518 -174.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.586 ' HB3' ' OE2' ' A' ' 110' ' ' GLU . 60.5 ttt180 -54.68 -51.84 64.23 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 109.52 -0.548 . . . . 55.32 109.52 176.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -139.52 -79.49 0.31 Allowed 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.514 -0.766 . . . . 73.02 111.742 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -177.12 177.67 1.21 Allowed 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 106.779 -1.563 . . . . 72.43 106.779 -169.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.2 p -56.08 115.73 2.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.032 0.444 . . . . 65.14 111.614 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 129.71 -41.18 1.58 Allowed Glycine 0 C--N 1.302 -1.348 0 N-CA-C 108.703 -1.759 . . . . 74.14 108.703 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.586 ' OE2' ' HB3' ' A' ' 105' ' ' ARG . 3.4 tp10 57.38 93.29 0.03 OUTLIER 'General case' 0 C--O 1.242 0.685 0 C-N-CA 126.366 1.866 . . . . 62.22 112.325 176.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.7 m -163.47 -158.48 0.47 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.337 -0.986 . . . . 54.53 108.337 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -121.3 87.13 2.7 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.915 -1.143 . . . . 74.34 107.915 172.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 60.0 m -90.61 89.2 7.43 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 115.126 -0.943 . . . . 74.12 110.985 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 50.5 t -127.64 98.2 5.12 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.404 -1.702 . . . . 74.11 106.404 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 29.9 m -76.35 99.17 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.973 0.892 . . . . 75.1 113.18 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.6 tt -106.38 89.05 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.057 -0.974 . . . . 75.35 108.612 175.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--N 1.297 -1.709 0 CA-C-N 115.087 -0.961 . . . . 64.12 109.945 -175.573 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.2 t . . . . . 0 N--CA 1.432 -1.34 0 N-CA-C 108.63 -0.878 . . . . 73.24 108.63 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.9 p -98.44 -5.68 31.99 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.724 0.773 . . . . 74.24 111.1 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.462 HD22 ' HA ' ' A' ' 117' ' ' LEU . 48.1 t30 -131.35 153.96 49.09 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.839 -1.171 . . . . 55.45 107.839 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.476 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 38.3 t -80.87 123.19 82.44 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 109.051 -0.722 . . . . 63.5 109.051 -178.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.22 166.67 8.77 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.682 2.254 . . . . 75.12 112.52 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.61 7.78 39.86 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.697 -0.683 . . . . 75.32 110.358 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -123.09 -0.22 8.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.033 -0.53 . . . . 75.35 110.184 175.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.1 mmm -130.74 155.77 46.09 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.964 -0.754 . . . . 64.15 108.964 -178.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.43 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.9 pp -122.73 134.11 66.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.002 -0.74 . . . . 71.42 109.002 174.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -90.83 109.87 21.08 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.536 -0.913 . . . . 74.32 108.536 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.547 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.0 tp -113.4 135.56 53.73 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 112.563 0.579 . . . . 75.51 112.563 -172.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 33.5 ttp180 -106.22 120.26 41.37 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 108.684 -0.858 . . . . 60.04 108.684 172.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.547 HD22 ' HG ' ' A' ' 12' ' ' LEU . 2.7 mm? -93.19 127.36 38.73 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.123 -1.399 . . . . 63.45 109.392 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.587 HG12 HG22 ' A' ' 21' ' ' THR . 22.6 mt -101.33 119.95 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 C-N-CA 118.937 -1.105 . . . . 53.05 109.369 176.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.5 tp -78.38 159.63 28.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.499 -0.773 . . . . 75.31 110.689 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.7 m -61.83 -13.76 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.913 0.885 . . . . 73.24 113.156 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.3 t -82.28 -10.03 59.26 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.566 -0.531 . . . . 63.21 109.566 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.23 11.44 62.89 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.069 -0.813 . . . . 73.12 111.069 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.67 148.99 26.78 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.093 -0.706 . . . . 63.32 109.093 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.587 HG22 HG12 ' A' ' 15' ' ' ILE . 69.5 p -112.33 152.55 28.42 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.084 0.468 . . . . 71.22 112.244 -174.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.417 ' CG ' ' HD2' ' A' ' 103' ' ' ARG . 8.1 mmtp -146.22 139.7 26.02 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.445 -0.798 . . . . 72.04 110.575 169.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 27.4 tt0 -122.18 132.31 54.39 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.809 -0.632 . . . . 74.22 109.939 -173.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.718 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 89.7 m-85 -144.26 158.83 43.52 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.859 -0.793 . . . . 74.15 108.859 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 111' ' ' SER . 39.8 tp -85.62 125.39 33.1 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.043 -1.095 . . . . 74.31 108.043 176.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 89.9 m-85 -130.31 172.87 11.37 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.474 -0.565 . . . . 53.23 109.474 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.7 p -95.52 150.52 37.61 Favored Pre-proline 0 N--CA 1.409 -2.514 0 N-CA-C 107.099 -1.445 . . . . 53.5 107.099 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.678 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 57.9 Cg_endo -64.61 -11.51 29.17 Favored 'Trans proline' 0 C--N 1.321 -0.868 0 C-N-CA 122.297 1.998 . . . . 72.45 111.423 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -91.58 -6.0 53.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.387 -0.824 . . . . 64.05 111.83 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.428 ' HB2' HD11 ' A' ' 35' ' ' ILE . 26.9 m-20 -75.77 151.48 37.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 120.628 -0.429 . . . . 74.41 110.504 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.598 ' O ' HG13 ' A' ' 35' ' ' ILE . 54.0 m -87.07 119.98 27.87 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 110.001 -0.37 . . . . 62.23 110.001 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.484 ' CB ' HD13 ' A' ' 60' ' ' LEU . . . -45.01 -56.18 4.87 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.723 1.379 . . . . 33.02 114.723 -176.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.403 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . 28.2 m -75.65 -21.71 57.42 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.215 -0.594 . . . . 54.3 111.957 -176.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.09 -40.2 78.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.032 -1.47 . . . . 74.5 107.032 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.598 HG13 ' O ' ' A' ' 31' ' ' SER . 70.0 mt -63.74 -42.42 95.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 CA-C-N 114.401 -1.272 . . . . 75.1 109.986 176.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.61 -36.76 56.94 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.058 0.543 . . . . 73.42 111.771 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.573 ' HB2' ' HG3' ' A' ' 44' ' ' PRO . 73.3 mmtt -72.62 -37.06 68.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.065 0.46 . . . . 75.12 110.068 176.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.633 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 28.3 t60 -70.08 -48.26 58.45 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.619 -0.719 . . . . 74.24 111.802 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.456 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.6 m -63.26 -31.07 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.021 0.439 . . . . 73.52 111.431 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 70.2 t80 -61.34 -50.85 71.28 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.182 -0.917 . . . . 73.33 111.761 175.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 40' ' ' TYR . 12.8 t70 169.34 122.73 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.191 -0.67 . . . . 73.43 109.191 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.633 ' O ' ' HA ' ' A' ' 38' ' ' HIS . 53.7 t30 70.1 174.3 0.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 123.818 0.698 . . . . 74.45 110.085 177.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 32.4 p-90 -106.52 130.92 22.19 Favored Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 108.812 -0.81 . . . . 65.34 108.812 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HG3' ' HB2' ' A' ' 37' ' ' LYS . 55.6 Cg_endo -69.24 94.45 0.49 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 121.85 1.7 . . . . 73.42 113.059 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.4 ttt -81.98 -31.14 31.27 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.274 -1.38 . . . . 73.4 107.274 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -155.77 -65.67 0.12 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.708 -1.96 . . . . 50.31 105.708 175.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.6 t90 59.95 5.78 0.81 Allowed 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 126.685 1.994 . . . . 74.3 114.308 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 68.36 119.02 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 124.204 1.002 . . . . 73.11 109.718 177.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -91.19 75.13 6.2 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.751 -0.593 . . . . 62.43 112.44 -175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 93' ' ' THR 0.265 0.4 OUTLIER 41.59 69.18 0.37 Allowed 'General case' 0 C--O 1.255 1.367 0 N-CA-C 114.92 1.452 . . . . 75.15 114.92 179.3 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 61.19 20.8 11.31 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.408 1.483 . . . . 71.24 111.233 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.7 t 62.43 10.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.224 1.41 . . . . 73.43 110.123 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.0 t -98.96 -30.5 12.32 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 115.683 -0.69 . . . . 62.15 110.4 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.1 m -125.14 84.08 59.82 Favored Pre-proline 0 N--CA 1.439 -1.016 0 N-CA-C 112.705 0.632 . . . . 74.45 112.705 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -98.05 -18.69 0.18 Allowed 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 122.706 2.27 . . . . 65.33 112.521 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -83.44 -0.32 49.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.135 0.574 . . . . 62.43 111.259 -175.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.435 ' CG2' ' HB3' ' A' ' 91' ' ' ARG . 2.1 pp -77.46 -3.25 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 115.657 -0.702 . . . . 73.51 112.708 -176.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.436 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 97.0 mt -81.29 111.8 18.01 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.199 -1.037 . . . . 33.52 108.199 176.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 68' ' ' HIS . 18.2 tpt180 -146.85 141.62 26.8 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.096 -0.705 . . . . 73.43 109.096 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.484 HD13 ' CB ' ' A' ' 32' ' ' ALA . 1.2 pt? -112.81 140.93 47.18 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 121.064 -0.254 . . . . 71.21 111.201 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 61.9 mt -111.64 117.38 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.926 -0.768 . . . . 75.24 108.926 176.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.547 ' CB ' HD21 ' A' ' 67' ' ' LEU . 33.4 t80 -105.35 76.08 1.2 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.842 -0.743 . . . . 73.24 109.002 174.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 63' ' ' GLN 0.331 15.0 mm100 36.2 83.69 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 116.222 1.934 . . . . 62.31 116.222 178.515 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.89 -63.3 0.62 Allowed Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 114.879 -1.055 . . . . 70.42 110.908 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -130.81 156.4 45.06 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.047 -0.661 . . . . 75.11 112.077 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.426 ' HB3' ' HE ' ' A' ' 59' ' ' ARG . 1.6 m-85 -87.48 114.08 23.77 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 104.648 -2.353 . . . . 63.21 104.648 175.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.547 HD21 ' CB ' ' A' ' 62' ' ' TYR . 1.4 mm? -72.3 -50.31 27.96 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 119.603 -0.839 . . . . 72.53 112.198 -168.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.641 ' HB2' HG23 ' A' ' 71' ' ' VAL . 19.6 m80 179.73 -161.31 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 126.65 1.98 . . . . 74.21 106.262 -176.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.454 ' H ' ' HB3' ' A' ' 68' ' ' HIS . . . -84.51 -46.3 5.83 Favored Glycine 0 C--O 1.208 -1.476 0 N-CA-C 115.46 0.944 . . . . 73.1 115.46 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -134.64 34.58 3.19 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.392 1.096 . . . . 71.51 113.231 -172.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.641 HG23 ' HB2' ' A' ' 68' ' ' HIS . 74.0 t -62.03 137.65 23.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.533 -0.543 . . . . 75.55 109.533 176.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.598 ' HB ' ' O ' ' A' ' 28' ' ' PRO . 29.0 p -78.52 156.81 29.07 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.848 -0.615 . . . . 72.34 110.805 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.567 ' H ' HD22 ' A' ' 73' ' ' LEU . 2.2 mm? -64.86 -35.44 81.12 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.594 -0.73 . . . . 72.21 110.133 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.57 -36.54 93.36 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.907 -0.588 . . . . 65.3 111.864 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.41 -16.62 63.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.986 0.422 . . . . 61.44 110.939 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 73' ' ' LEU . 75.4 mt -83.79 12.43 6.02 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.765 0.826 . . . . 53.11 111.046 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.74 19.65 9.63 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.204 1.002 . . . . 73.12 110.491 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.514 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 94.0 mt -80.7 116.98 65.81 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.191 -0.459 . . . . 72.13 111.224 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.404 ' HD2' ' HE2' ' A' ' 82' ' ' LYS . 74.4 Cg_endo -77.58 161.27 31.21 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 C-N-CA 122.071 1.847 . . . . 61.44 110.829 175.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.678 ' CE2' ' HG3' ' A' ' 28' ' ' PRO . 71.7 m-85 -79.36 163.53 24.78 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.685 -0.857 . . . . 64.11 108.685 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 83.52 0.14 89.85 Favored Glycine 0 C--N 1.301 -1.371 0 C-N-CA 120.624 -0.798 . . . . 74.21 114.784 175.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.404 ' HE2' ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -124.95 157.68 35.47 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 118.971 -1.092 . . . . 74.25 112.688 -179.285 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.6 m -90.02 120.92 31.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.564 -0.744 . . . . 71.44 110.247 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.0 m -113.42 135.17 54.17 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.605 -0.271 . . . . 52.43 110.977 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.15 126.88 70.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 N-CA-C 109.676 -0.49 . . . . 74.21 109.676 175.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.419 ' O ' HG13 ' A' ' 15' ' ' ILE . 85.4 mtp -136.39 153.46 51.1 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-O 121.198 0.523 . . . . 75.44 112.098 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 59.5 m80 -102.24 137.15 40.87 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.458 -0.792 . . . . 74.23 109.936 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.416 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.6 mm? -120.53 141.42 50.27 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.958 -0.756 . . . . 63.55 108.958 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 59' ' ' ARG . 30.2 m -125.36 136.08 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-O 121.731 0.777 . . . . 72.34 111.05 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.93 146.97 51.0 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 106.343 -1.725 . . . . 75.23 106.343 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.435 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 79.2 ttt180 -134.59 132.65 39.31 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.183 -1.043 . . . . 73.24 108.183 -168.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 66.24 13.65 9.27 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.932 0.872 . . . . 71.11 109.904 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.453 ' HA ' ' CG ' ' A' ' 50' ' ' GLU . 4.9 t -88.24 177.94 6.74 Favored 'General case' 0 N--CA 1.401 -2.898 0 CA-C-N 115.023 -0.99 . . . . 64.24 108.822 -176.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mp -74.87 140.25 74.13 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 110.071 -0.344 . . . . 70.04 110.071 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -79.06 -178.93 5.01 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.172 1.914 . . . . 54.13 109.509 175.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.509 ' OE2' ' HA ' ' A' ' 99' ' ' SER . 0.3 OUTLIER -69.61 122.67 86.51 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 107.636 -1.246 . . . . 72.4 107.636 179.075 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -9.79 -67.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.379 2.154 1 C-N-CA 127.408 5.405 . . . . 73.44 117.075 -167.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -156.98 26.39 0.31 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.225 -1.768 . . . . 73.34 106.225 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.509 ' HA ' ' OE2' ' A' ' 96' ' ' GLU . 71.3 m 63.58 51.06 2.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.402 -1.272 . . . . 63.22 108.324 -170.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -87.79 -23.13 24.16 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 113.053 -1.885 . . . . 32.04 109.039 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.08 -24.16 5.55 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.351 -0.841 . . . . 73.42 112.228 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -81.44 111.92 18.23 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-O 121.088 0.47 . . . . 64.55 110.77 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.417 ' HD2' ' CG ' ' A' ' 22' ' ' LYS . 4.1 ptp180 -120.82 114.77 22.09 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 106.19 -1.781 . . . . 75.31 106.19 175.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . 0.296 53.2 m-80 -75.21 116.12 15.59 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 117.68 2.474 . . . . 73.43 117.68 -167.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.543 ' HE ' ' HB2' ' A' ' 110' ' ' GLU . 29.7 ttt180 -66.59 -30.48 70.77 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 112.653 -2.067 . . . . 72.02 109.783 171.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 70.14 104.44 0.06 Allowed 'General case' 0 C--O 1.212 -0.915 0 O-C-N 124.656 1.222 . . . . 74.13 110.431 -177.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.83 -18.04 64.1 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.562 -0.745 . . . . 62.2 112.805 -175.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.3 p -93.58 1.35 56.72 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.006 -0.678 . . . . 50.51 111.645 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.06 43.7 0.56 Allowed Glycine 0 C--O 1.24 0.517 0 N-CA-C 110.15 -1.18 . . . . 72.42 110.15 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.543 ' HB2' ' HE ' ' A' ' 105' ' ' ARG . 9.7 pt-20 -87.35 171.44 10.59 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.825 1.046 . . . . 63.21 113.825 -174.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 45.4 m -106.0 111.48 24.13 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.564 -1.198 . . . . 64.03 108.175 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.407 ' HB2' ' NH2' ' A' ' 105' ' ' ARG . 47.4 t30 -172.86 176.83 2.99 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.801 -0.814 . . . . 74.01 108.801 -174.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.0 m 66.91 -156.14 0.23 Allowed 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.658 0.783 . . . . 64.32 109.775 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 85.8 m 66.66 41.49 2.99 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.986 -0.746 . . . . 51.34 108.986 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.6 t -69.75 96.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.06 -0.973 . . . . 63.24 112.06 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.4 tp -144.64 103.45 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.225 -1.028 . . . . 65.13 108.225 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.609 ' H ' HD23 ' A' ' 117' ' ' LEU . 1.2 pt? . . . . . 0 N--CA 1.422 -1.835 0 CA-C-N 115.196 -0.911 . . . . 42.04 111.491 -174.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.443 -0.784 0 N-CA-C 109.839 -0.43 . . . . 74.44 109.839 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.9 t -125.17 5.71 7.84 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.654 -0.869 . . . . 75.33 108.654 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -151.39 155.05 37.84 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.213 -1.403 . . . . 72.41 107.213 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.537 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 17.0 t -99.95 115.26 65.7 Favored Pre-proline 0 C--N 1.313 -0.996 0 N-CA-C 109.713 -0.477 . . . . 74.53 109.713 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.65 170.92 16.4 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.387 2.058 . . . . 62.03 111.616 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HA ' ' HB2' ' A' ' 80' ' ' PHE . . . -79.14 14.56 1.41 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.341 0.591 . . . . 53.45 111.484 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -108.32 -11.37 15.22 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.486 -0.561 . . . . 73.15 109.486 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.4 mmm -130.9 158.03 41.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.024 -0.535 . . . . 74.42 110.328 -174.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.448 ' CD1' ' HG ' ' A' ' 73' ' ' LEU . 2.8 pp -119.01 140.88 41.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.586 -0.524 . . . . 74.24 109.586 174.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.436 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 13.1 t-20 -94.83 115.73 27.85 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.424 -0.954 . . . . 73.51 108.424 -176.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.537 ' HG ' HD22 ' A' ' 14' ' ' LEU . 42.3 tp -117.77 133.88 55.49 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.646 0.736 . . . . 54.23 112.57 -173.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.509 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . 21.8 ttt85 -106.61 120.52 42.18 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 108.14 -1.059 . . . . 63.21 108.14 176.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.537 HD22 ' HG ' ' A' ' 12' ' ' LEU . 2.0 mm? -100.67 127.48 47.06 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.875 -1.057 . . . . 64.24 109.635 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.491 HD12 HG22 ' A' ' 21' ' ' THR . 21.3 mm -99.28 116.53 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 106.917 -1.512 . . . . 62.2 106.917 175.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.77 158.38 33.6 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.348 -0.387 . . . . 71.54 110.619 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.494 HG21 ' H ' ' A' ' 90' ' ' ALA . 90.2 t -66.01 -23.32 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 121.602 0.715 . . . . 75.21 110.2 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.2 m -75.56 -3.87 36.71 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.12 -0.945 . . . . 61.14 110.127 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.15 8.8 84.97 Favored Glycine 0 CA--C 1.495 -1.189 0 N-CA-C 111.579 -0.609 . . . . 53.21 111.579 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -87.19 131.44 34.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.558 -1.275 . . . . 74.41 107.558 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.491 HG22 HD12 ' A' ' 15' ' ' ILE . 64.5 p -107.76 129.28 55.06 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 109.905 -0.406 . . . . 55.53 109.905 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -148.47 149.92 32.53 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.183 -0.607 . . . . 72.2 110.344 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.476 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 29.7 tt0 -130.45 132.74 45.85 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.893 -0.14 . . . . 74.53 110.97 -170.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.525 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 35.0 m-85 -143.23 160.57 40.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.624 0.726 . . . . 73.21 112.107 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.478 HD11 HG13 ' A' ' 5' ' ' VAL . 37.3 tp -85.66 126.07 33.65 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.15 -0.932 . . . . 63.01 109.325 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.525 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 97.5 m-85 -133.42 171.12 14.5 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.672 -0.492 . . . . 73.41 109.672 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.3 p -94.99 150.65 38.05 Favored Pre-proline 0 N--CA 1.419 -2.001 0 C-N-CA 119.054 -1.058 . . . . 63.24 108.206 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 42.2 Cg_endo -62.85 -11.39 24.03 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.43 2.087 . . . . 74.22 111.784 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -79.68 -21.35 44.81 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.199 1.0 . . . . 73.3 109.777 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -75.77 152.27 37.4 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 116.321 -0.4 . . . . 70.23 110.429 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.522 ' O ' HG13 ' A' ' 35' ' ' ILE . 77.1 p -106.16 138.29 42.6 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 109.972 -0.381 . . . . 62.54 109.972 178.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.723 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -50.95 -49.62 59.53 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.864 1.061 . . . . 61.12 113.864 -175.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.0 m -64.52 -31.63 72.93 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 120.949 0.404 . . . . 52.22 110.891 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.553 ' O ' ' HG3' ' A' ' 44' ' ' PRO . 20.6 t70 -70.12 -45.47 66.82 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.869 -0.789 . . . . 72.31 108.869 175.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 31' ' ' SER . 60.9 mt -60.78 -33.64 56.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.155 -0.93 . . . . 72.31 112.281 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.71 -40.43 40.49 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 110.491 -0.188 . . . . 72.42 110.491 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -64.11 -44.68 91.52 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.343 0.592 . . . . 72.05 109.838 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -62.57 -43.42 98.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.053 -1.43 . . . . 61.14 110.118 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.502 HG11 HD23 ' A' ' 14' ' ' LEU . 36.0 m -74.9 -32.17 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 113.76 1.022 . . . . 64.13 113.76 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.426 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 39.0 m-85 -54.67 -49.61 70.22 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.266 0.839 . . . . 75.15 113.266 176.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 40' ' ' TYR . 5.4 p-10 165.59 -30.36 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.417 0.627 . . . . 54.53 109.332 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -91.36 169.79 10.51 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.736 -0.665 . . . . 75.21 110.91 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.439 ' C ' ' H ' ' A' ' 45' ' ' MET . 5.5 m-90 -111.17 122.8 36.81 Favored Pre-proline 0 N--CA 1.423 -1.785 0 N-CA-C 109.312 -0.625 . . . . 74.33 109.312 174.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HG3' ' O ' ' A' ' 34' ' ' ASP . 19.7 Cg_endo -66.96 33.83 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 124.012 3.141 . . . . 75.43 113.841 177.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.439 ' H ' ' C ' ' A' ' 43' ' ' TRP . 54.7 ttm -127.5 75.34 1.59 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.998 -1.853 . . . . 65.1 105.998 173.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -147.41 -155.0 0.59 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 105.078 -2.193 . . . . 75.01 105.078 -173.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -101.03 -29.21 12.29 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 108.607 -0.886 . . . . 74.32 108.607 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.419 ' HG2' HD21 ' A' ' 94' ' ' LEU . 40.1 mt-10 54.76 82.63 0.09 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.036 0.934 . . . . 74.44 110.03 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 95' ' ' PRO . 40.6 tt0 -93.68 85.51 4.88 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 119.592 -0.843 . . . . 65.55 112.066 -174.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.526 ' HB2' ' HD3' ' A' ' 95' ' ' PRO . 8.6 tp10 -139.76 135.15 32.78 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.922 -1.036 . . . . 72.11 108.358 176.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -83.22 95.87 8.27 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.876 -1.157 . . . . 73.54 107.876 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.94 104.68 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.933 0 CA-C-O 122.249 1.023 . . . . 54.35 112.038 -174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.485 ' C ' ' HD3' ' A' ' 55' ' ' PRO . 33.7 t -97.43 3.42 50.9 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.01 -1.107 . . . . 72.44 108.01 177.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.553 ' O ' HG13 ' A' ' 57' ' ' ILE . 11.5 p -123.24 47.7 1.76 Allowed Pre-proline 0 CA--C 1.571 1.755 0 CA-C-N 114.193 -1.367 . . . . 72.15 111.579 -178.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.485 ' HD3' ' C ' ' A' ' 53' ' ' SER . 38.9 Cg_exo -60.18 -16.36 39.78 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 122.703 2.269 . . . . 70.23 113.487 -172.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -75.8 -1.07 23.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.953 -0.567 . . . . 71.11 111.842 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 54' ' ' SER . 2.2 pp -77.08 -18.82 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 120.9 0.381 . . . . 74.1 111.066 177.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 57' ' ' ILE . 96.9 mt -79.03 90.85 4.82 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 107.639 -1.245 . . . . 75.52 107.639 175.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.473 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 17.3 ptt180 -147.2 159.93 43.05 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.226 0.536 . . . . 72.13 112.262 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.723 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.4 pp -127.83 144.62 51.09 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.407 -0.815 . . . . 63.33 111.445 -172.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 85.6 mt -112.87 118.79 58.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.82 -0.807 . . . . 72.21 108.82 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -105.1 74.75 1.13 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.558 -0.534 . . . . 63.21 109.558 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 43.26 80.03 0.04 OUTLIER 'General case' 0 C--O 1.244 0.786 0 O-C-N 124.725 1.266 . . . . 63.51 113.367 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.74 -72.05 0.48 Allowed Glycine 0 N--CA 1.419 -2.439 0 CA-C-N 114.879 -1.055 . . . . 41.24 111.624 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -130.83 174.41 10.0 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.23 0.538 . . . . 70.22 112.375 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 71.0 m-85 -87.78 117.34 26.55 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 105.905 -1.887 . . . . 71.43 105.905 172.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.424 ' CD1' HD22 ' A' ' 76' ' ' LEU . 81.1 mt -79.81 -47.96 14.33 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.728 -0.789 . . . . 63.12 112.258 -176.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.514 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 10.4 t60 -172.67 158.04 3.97 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.736 -1.579 . . . . 72.43 106.736 -177.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -69.45 -0.65 24.63 Favored Glycine 0 CA--C 1.542 1.736 0 N-CA-C 117.091 1.596 . . . . 51.32 117.091 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -175.71 31.65 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.239 1.52 . . . . 62.34 109.362 -171.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.577 HG12 HD21 ' A' ' 60' ' ' LEU . 10.6 p -78.85 138.77 19.5 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 119.527 -0.869 . . . . 75.54 109.171 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.413 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 47.3 p -79.56 157.48 27.36 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.015 0.436 . . . . 62.3 112.032 -175.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.448 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 3.1 mm? -61.36 -34.22 74.93 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.612 -0.722 . . . . 72.13 111.487 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.32 -30.03 76.7 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.0 -0.619 . . . . 63.32 111.907 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.68 -15.74 58.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.397 0.617 . . . . 61.1 110.276 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.511 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 53.3 mt -83.19 12.89 4.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.825 -0.625 . . . . 74.14 111.158 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.0 mptt 69.46 12.56 8.27 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.209 1.004 . . . . 73.42 111.106 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.511 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 89.7 mt -76.03 121.81 85.72 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 112.374 0.509 . . . . 74.12 112.374 -175.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.443 ' HG2' ' HG3' ' A' ' 82' ' ' LYS . 45.8 Cg_endo -75.57 159.04 39.67 Favored 'Trans proline' 0 N--CA 1.442 -1.515 0 C-N-CA 122.091 1.861 . . . . 51.43 109.754 174.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.477 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 12.0 m-85 -80.67 151.51 28.92 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.059 -0.719 . . . . 63.54 109.059 -174.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.537 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 84.95 4.01 87.4 Favored Glycine 0 C--N 1.306 -1.112 0 C-N-CA 120.493 -0.861 . . . . 64.32 113.53 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.443 ' HG3' ' HG2' ' A' ' 79' ' ' PRO . 75.2 mmtt -110.35 149.27 30.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 117.013 0.406 . . . . 72.11 111.085 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.436 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 94.6 m -91.2 123.49 34.68 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.596 -0.729 . . . . 73.43 110.38 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.3 m -118.56 131.38 56.21 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.264 -0.88 . . . . 73.01 110.316 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.509 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 7.5 p -103.25 124.46 57.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.989 0.423 . . . . 75.34 110.281 177.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.484 ' O ' HG12 ' A' ' 15' ' ' ILE . 91.0 mtp -129.37 152.21 49.17 Favored 'General case' 0 CA--C 1.486 -1.5 0 CA-C-O 121.368 0.604 . . . . 75.32 110.603 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.489 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 38.5 m-70 -106.32 126.17 51.91 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.433 -0.803 . . . . 71.32 108.913 -178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.484 HD11 ' HB1' ' A' ' 32' ' ' ALA . 4.1 mm? -115.05 144.03 44.27 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-O 121.071 0.462 . . . . 62.43 111.992 -176.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.96 132.17 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 115.462 -0.79 . . . . 65.21 108.987 176.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.494 ' H ' HG21 ' A' ' 17' ' ' VAL . . . -136.83 145.47 44.48 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.59 -0.732 . . . . 65.42 109.686 177.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.528 ' H ' HD13 ' A' ' 57' ' ' ILE . 36.0 ttt-85 -135.0 151.68 51.05 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 105.544 -2.021 . . . . 61.22 105.544 178.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 70.26 -73.82 0.09 Allowed 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.516 0.51 . . . . 72.14 110.712 -175.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.573 HG22 ' H ' ' A' ' 94' ' ' LEU . 20.9 m 63.33 179.06 0.15 Allowed 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 124.687 1.195 . . . . 72.33 109.816 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.573 ' H ' HG22 ' A' ' 93' ' ' THR . 5.3 mp -68.33 127.02 93.3 Favored Pre-proline 0 C--N 1.293 -1.849 0 O-C-N 122.028 -0.42 . . . . 74.11 111.381 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 50' ' ' GLU . 33.1 Cg_exo -62.35 129.9 28.41 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 N-CA-C 106.348 -2.212 . . . . 61.04 106.348 168.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.413 ' HA ' ' HD2' ' A' ' 97' ' ' PRO . 35.2 mt-10 -73.37 131.23 83.11 Favored Pre-proline 0 C--N 1.292 -1.897 0 C-N-CA 120.382 -0.527 . . . . 73.23 111.35 -171.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 96' ' ' GLU . 6.3 Cg_exo -43.99 -48.31 9.42 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 124.227 3.285 . . . . 72.22 109.35 176.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -161.28 143.45 12.07 Favored 'General case' 0 N--CA 1.387 -3.608 1 N-CA-C 99.496 -4.261 . . . . 72.52 99.496 175.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.9 m -69.45 80.26 0.39 Allowed 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 119.176 0.898 . . . . 64.04 110.76 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -57.57 -50.08 74.28 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 115.629 -0.714 . . . . 72.33 110.865 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.32 -36.53 1.77 Allowed Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 121.235 -0.507 . . . . 71.51 112.706 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -110.17 111.45 22.79 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 122.182 0.991 . . . . 74.2 112.498 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 178.64 36.41 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 101.153 -3.647 . . . . 72.02 101.153 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -94.36 -33.07 13.32 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.438 -1.71 . . . . 64.21 111.366 -169.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.426 ' HA ' ' HB3' ' A' ' 111' ' ' SER . 0.0 OUTLIER -60.84 -51.81 67.71 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.198 0.814 . . . . 70.15 113.198 -178.623 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.264 12.4 tt0 60.3 -47.91 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.399 1.629 . . . . 74.41 115.399 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.63 157.04 17.19 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.89 -0.782 . . . . 51.24 108.89 177.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.1 t -82.97 147.4 28.23 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.151 -0.685 . . . . 62.12 109.151 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.65 30.18 22.0 Favored Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 111.223 -0.751 . . . . 45.15 111.223 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 68.43 159.56 0.17 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.218 1.007 . . . . 73.1 111.856 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.426 ' HB3' ' HA ' ' A' ' 105' ' ' ARG . 11.4 p -89.32 88.38 7.48 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-O 121.596 0.712 . . . . 74.24 110.246 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -135.64 106.54 6.63 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.08 -0.964 . . . . 73.4 109.143 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 65.5 m -115.47 169.21 9.33 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.198 -0.668 . . . . 45.12 109.198 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 46.1 t -135.74 145.17 46.35 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 110.12 -0.326 . . . . 74.24 110.12 -176.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.4 m -69.81 117.02 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-O 121.498 0.666 . . . . 70.13 111.284 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.9 tp -103.81 4.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 122.541 1.162 . . . . 72.24 108.486 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 N--CA 1.432 -1.355 0 CA-C-N 114.833 -1.076 . . . . 70.55 108.78 179.511 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.435 -1.22 0 CA-C-O 121.299 0.571 . . . . 74.41 111.573 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.4 m -147.37 112.61 5.53 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.643 -0.502 . . . . 74.43 109.643 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.1 t30 71.84 113.23 0.06 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.245 1.418 . . . . 71.24 111.554 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.437 HG13 ' CD1' ' A' ' 25' ' ' LEU . 11.7 t -103.78 115.41 63.5 Favored Pre-proline 0 N--CA 1.431 -1.376 0 N-CA-C 109.445 -0.576 . . . . 71.04 109.445 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -71.9 149.01 52.75 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 122.11 1.873 . . . . 72.13 109.876 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.35 73.32 5.98 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.059 0.933 . . . . 52.12 110.137 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -169.51 -37.91 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.458 -1.682 . . . . 61.53 106.458 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.0 mmm -96.99 143.64 27.65 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.523 -1.671 . . . . 75.3 108.675 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -98.66 140.81 17.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-O 121.033 0.444 . . . . 53.42 111.273 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.57 ' OD1' HG23 ' A' ' 83' ' ' THR . 18.7 t-20 -87.64 125.85 34.61 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.282 -0.636 . . . . 51.02 109.282 177.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.573 ' HG ' HD22 ' A' ' 14' ' ' LEU . 30.6 tp -131.8 132.21 43.56 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-O 121.326 0.584 . . . . 75.2 111.468 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.534 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . 23.1 ttt85 -106.93 120.99 43.53 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-N 114.917 -1.038 . . . . 75.23 109.115 175.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.573 HD22 ' HG ' ' A' ' 12' ' ' LEU . 1.8 mm? -103.74 126.49 50.91 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.04 -0.982 . . . . 74.44 108.823 -178.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.2 mt -99.47 119.36 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 107.944 -1.132 . . . . 73.0 107.944 175.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.9 mt -72.15 154.12 41.25 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.485 -0.779 . . . . 72.11 110.245 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.5 t -63.71 -15.99 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 122.086 0.946 . . . . 71.42 109.577 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.3 t -80.2 -10.19 59.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.187 -0.915 . . . . 50.14 110.447 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.51 70.4 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.574 -0.822 . . . . 63.4 112.392 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -87.32 135.53 33.29 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.666 -0.414 . . . . 63.03 110.901 176.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.6 p -100.95 129.88 46.86 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.721 -0.672 . . . . 64.22 110.316 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -140.6 138.68 34.61 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.2 -0.6 . . . . 72.04 111.183 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 28.7 tt0 -121.93 140.8 52.0 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 115.502 -0.772 . . . . 71.01 109.133 -173.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.707 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 72.1 m-85 -143.72 160.32 40.92 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 123.523 0.729 . . . . 75.21 109.985 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.437 ' CD1' HG13 ' A' ' 5' ' ' VAL . 32.9 tp -82.25 125.75 31.31 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 107.338 -1.356 . . . . 55.03 107.338 175.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.707 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 86.3 m-85 -132.07 172.77 11.96 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.862 -0.421 . . . . 61.41 109.862 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.1 p -100.02 148.93 35.51 Favored Pre-proline 0 C--N 1.286 -2.188 0 N-CA-C 107.589 -1.264 . . . . 60.34 107.589 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.69 -11.94 22.82 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 121.73 1.62 . . . . 72.13 112.079 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -80.05 -23.29 41.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.331 0.652 . . . . 63.12 111.156 177.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.403 ' O ' HD22 ' A' ' 73' ' ' LEU . 36.2 m-20 -66.89 154.38 41.12 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 120.769 0.319 . . . . 63.1 111.655 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.567 ' O ' HG13 ' A' ' 35' ' ' ILE . 44.2 m -98.52 124.03 43.02 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 122.295 -0.253 . . . . 62.23 110.579 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.651 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -46.63 -59.4 3.04 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 114.503 1.297 . . . . 61.15 114.503 -176.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 m -67.06 -27.83 67.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.223 0.535 . . . . 75.13 111.455 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.588 ' O ' ' HG3' ' A' ' 44' ' ' PRO . 23.8 t70 -68.49 -47.26 67.5 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.733 -1.21 . . . . 70.14 107.733 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 31' ' ' SER . 77.1 mt -56.16 -36.34 45.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.132 -0.94 . . . . 73.23 111.621 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.75 -36.85 38.74 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.098 0.559 . . . . 72.32 112.357 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.526 ' HB3' ' HB3' ' A' ' 44' ' ' PRO . 0.6 OUTLIER -72.6 -42.96 63.95 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 107.096 -1.446 . . . . 63.11 107.096 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 43.2 t-80 -55.87 -54.05 49.37 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.016 -1.447 . . . . 72.41 111.124 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.562 HG21 ' CB ' ' A' ' 14' ' ' LEU . 28.9 m -70.68 -31.64 46.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.035 -0.984 . . . . 64.21 112.362 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -71.35 -48.58 49.35 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 112.447 0.536 . . . . 74.41 112.447 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -147.36 -56.08 0.24 Allowed 'General case' 0 C--O 1.241 0.653 0 N-CA-C 114.838 1.422 . . . . 64.41 114.838 -173.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.557 ' O ' ' HA ' ' A' ' 38' ' ' HIS . 66.6 t30 -151.5 -179.87 7.76 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.953 -1.128 . . . . 73.34 107.953 -171.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -71.29 130.12 88.2 Favored Pre-proline 0 C--N 1.309 -1.186 0 CA-C-N 118.294 0.497 . . . . 72.24 111.57 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.588 ' HG3' ' O ' ' A' ' 34' ' ' ASP . 35.2 Cg_endo -69.38 154.69 68.88 Favored 'Trans proline' 0 CA--C 1.506 -0.915 0 C-N-CA 123.136 2.558 . . . . 75.0 113.001 175.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 89.0 mmm -117.84 164.71 14.62 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.1 -1.444 . . . . 74.4 107.1 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -77.65 127.62 32.75 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.511 -0.922 . . . . 64.45 108.511 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 66.71 79.18 0.24 Allowed 'General case' 0 C--O 1.241 0.617 0 O-C-N 124.238 0.961 . . . . 73.04 109.449 -168.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.418 ' OE1' ' HG3' ' A' ' 37' ' ' LYS . 8.1 tp10 -75.23 -34.83 61.48 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.579 -1.191 . . . . 53.22 108.322 -176.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 69.31 122.4 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 116.106 1.891 . . . . 64.54 116.106 174.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.36 -58.79 2.26 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 105.411 -2.07 . . . . 61.14 105.411 173.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -167.55 105.78 0.54 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.559 -0.746 . . . . 73.44 110.566 175.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.5 t 53.4 87.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.713 1.205 . . . . 71.14 112.672 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.8 m 63.48 91.38 0.07 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.476 1.111 . . . . 74.41 111.042 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.1 m -127.27 80.19 72.04 Favored Pre-proline 0 C--N 1.297 -1.683 0 C-N-CA 120.16 -0.616 . . . . 25.11 111.398 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -94.5 -21.31 0.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.729 1.619 . . . . 73.41 112.132 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -83.67 -2.45 56.2 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.63 -0.714 . . . . 63.0 111.102 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.3 pp -83.7 -15.18 11.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.825 -0.625 . . . . 75.23 111.231 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.9 mt -86.26 112.84 21.76 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.076 -1.083 . . . . 70.21 108.076 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.451 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 97.4 mtt180 -143.53 142.82 31.28 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.366 -0.605 . . . . 75.43 109.366 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.6 pp -130.31 132.72 46.0 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 120.99 0.424 . . . . 64.0 110.758 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 86.8 mt -108.32 120.6 59.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 121.47 0.652 . . . . 63.14 109.545 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -101.83 85.39 2.7 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 108.683 -0.858 . . . . 64.15 108.683 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 59.86 18.42 7.4 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.141 -1.391 . . . . 73.44 114.19 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.58 -52.85 0.37 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.367 -0.92 . . . . 73.44 112.985 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.467 ' HD3' ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -113.4 156.32 23.67 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.065 -0.654 . . . . 63.31 111.361 -177.298 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 85.8 m-85 -78.6 122.53 26.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.617 -1.253 . . . . 73.24 107.617 176.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.573 HD12 HD22 ' A' ' 76' ' ' LEU . 45.9 mt -79.71 -46.54 16.91 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 118.978 -1.089 . . . . 61.14 112.711 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.525 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.3 t-80 -165.48 172.6 11.93 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.005 -1.85 . . . . 73.32 106.005 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.56 -25.58 75.47 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.289 -0.958 . . . . 74.53 114.064 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -175.25 72.21 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.998 0.904 . . . . 74.23 109.054 -175.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.575 HG12 HD21 ' A' ' 60' ' ' LEU . 7.2 p -102.88 151.25 6.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 114.194 -1.366 . . . . 70.31 108.821 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.534 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 40.4 p -78.46 157.35 28.97 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 120.718 0.294 . . . . 54.11 111.212 -175.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.596 ' HA ' HD12 ' A' ' 76' ' ' LEU . 1.2 mm? -63.85 -27.5 69.21 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.765 0.426 . . . . 74.31 111.478 -177.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.66 -37.69 93.79 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.513 -1.035 . . . . 63.04 110.513 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -79.56 -16.87 55.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.341 0.591 . . . . 54.41 109.91 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' ' 73' ' ' LEU . 92.7 mt -86.51 2.96 46.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.693 -0.685 . . . . 64.5 110.716 176.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 11.1 mptt 69.56 21.2 6.81 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.9 0.88 . . . . 71.03 112.911 178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.428 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.4 mp -67.54 126.26 92.33 Favored Pre-proline 0 CA--C 1.511 -0.543 0 C-N-CA 119.726 -0.789 . . . . 65.21 111.426 176.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -86.6 137.22 4.8 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 122.427 2.085 . . . . 71.11 112.029 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -73.92 128.15 34.74 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.643 -0.708 . . . . 74.12 111.12 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.82 -6.01 76.67 Favored Glycine 0 C--N 1.3 -1.435 0 CA-C-N 115.096 -0.957 . . . . 51.11 111.925 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 11' ' ' ASN . 92.6 mttt -116.67 149.29 40.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 117.389 0.594 . . . . 74.32 111.655 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.57 HG23 ' OD1' ' A' ' 11' ' ' ASN . 30.7 m -84.81 136.35 33.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.12 -0.491 . . . . 74.3 110.86 -177.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.9 m -139.55 132.11 28.76 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.886 -0.412 . . . . 71.13 109.886 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.534 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 10.8 p -99.79 138.87 22.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.21 0.528 . . . . 65.31 111.441 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.469 ' SD ' HD13 ' A' ' 76' ' ' LEU . 81.4 mtp -137.97 152.38 48.86 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 116.074 -0.512 . . . . 73.53 110.315 177.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.527 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 25.2 m-70 -111.14 128.25 55.83 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.844 -1.539 . . . . 73.42 106.844 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.36 140.15 49.38 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.178 -0.609 . . . . 70.13 110.383 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 59' ' ' ARG . 6.1 m -129.99 142.12 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 109.291 -0.633 . . . . 73.31 109.291 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.595 ' HB1' ' HB ' ' A' ' 93' ' ' THR . . . -129.31 146.01 51.27 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 105.854 -1.906 . . . . 40.42 105.854 176.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.27 108.58 20.05 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 106.879 -1.526 . . . . 72.54 106.879 -171.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 52.08 23.27 2.18 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.131 0.972 . . . . 63.44 111.188 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.595 ' HB ' ' HB1' ' A' ' 90' ' ' ALA . 21.2 m -92.59 115.4 28.07 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 115.911 -0.586 . . . . 73.24 111.467 -172.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mp -84.51 152.38 60.45 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.627 -1.249 . . . . 70.44 107.627 174.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.402 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 37.0 Cg_endo -67.9 83.97 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.188 1.925 . . . . 52.33 109.413 174.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 95' ' ' PRO . 8.7 pt-20 66.75 144.17 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 128.418 2.687 . . . . 74.14 109.785 -169.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -69.63 -4.29 13.64 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.026 1.817 . . . . 71.03 111.108 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 76.04 4.16 3.76 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 125.802 1.641 . . . . 74.43 110.96 -176.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.3 m -87.48 -9.31 54.91 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 114.944 -1.026 . . . . 65.22 109.539 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.461 ' HB3' ' HG3' ' A' ' 102' ' ' GLN . 50.9 mt-30 -87.75 -52.37 5.35 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 108.685 -0.857 . . . . 74.32 108.685 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.22 21.32 66.05 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.869 -1.059 . . . . 52.42 110.803 -178.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.461 ' HG3' ' HB3' ' A' ' 100' ' ' GLN . 78.1 mt-30 -78.25 110.67 13.46 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 122.058 0.932 . . . . 54.4 111.565 -175.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -108.82 4.68 23.84 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.035 -1.438 . . . . 65.24 108.93 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -91.97 129.77 37.86 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.168 -1.378 . . . . 51.31 107.855 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.426 ' C ' ' H ' ' A' ' 107' ' ' LYS . 18.3 mmt180 -62.72 -32.5 73.62 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.369 0.418 . . . . 61.11 110.977 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 72.54 -39.7 0.45 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.801 1.241 . . . . 72.44 110.638 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.443 ' HE2' ' O ' ' A' ' 109' ' ' GLY . 86.8 tttt -66.47 125.9 27.15 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 125.124 1.37 . . . . 74.11 107.302 173.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.9 t -71.83 -29.24 64.21 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.194 0.521 . . . . 65.33 110.632 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.443 ' O ' ' HE2' ' A' ' 107' ' ' LYS . . . -89.53 74.03 1.98 Allowed Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 109.665 -1.374 . . . . 45.12 109.665 176.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -55.1 128.74 35.16 Favored 'General case' 0 C--O 1.248 0.991 0 C-N-CA 123.066 0.546 . . . . 64.22 111.193 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.7 m -80.96 71.72 7.94 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.757 0.789 . . . . 60.12 112.313 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -164.98 19.11 0.05 OUTLIER 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.726 -1.124 . . . . 52.2 108.328 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 23.6 p -147.37 96.45 2.7 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.313 -0.858 . . . . 63.35 109.993 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 66.8 m -77.34 119.31 20.79 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.787 -0.82 . . . . 64.22 108.787 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.73 102.2 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 122.134 0.968 . . . . 74.01 111.668 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.5 tp -139.74 128.06 26.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 114.595 -1.184 . . . . 73.24 108.358 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 tm? . . . . . 0 C--N 1.293 -1.877 0 N-CA-C 106.788 -1.56 . . . . 71.23 106.788 -178.5 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.2 p . . . . . 0 N--CA 1.427 -1.612 0 CA-C-O 121.174 0.512 . . . . 74.53 110.42 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.6 p -151.59 179.57 8.26 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 116.005 -0.543 . . . . 71.22 110.486 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -90.06 -179.63 5.73 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.941 -1.503 . . . . 54.33 106.941 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.46 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 3.6 t -83.48 118.27 71.03 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 118.609 0.64 . . . . 73.5 110.036 -174.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.44 ' C ' ' H ' ' A' ' 8' ' ' ASP . 88.2 Cg_endo -84.95 166.99 11.22 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.957 1.771 . . . . 60.03 111.077 177.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.39 30.63 0.41 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.828 0.823 . . . . 62.02 109.837 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 6' ' ' PRO . 19.6 t70 -120.43 -28.75 4.93 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.842 -1.072 . . . . 72.15 109.369 175.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.8 mtp -121.83 155.51 35.2 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 115.955 -0.566 . . . . 62.11 110.44 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.24 137.5 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 CA-C-N 115.591 -0.731 . . . . 71.12 109.507 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.449 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 2.4 t-20 -91.05 107.59 19.3 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 108.134 -1.062 . . . . 62.23 108.134 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.529 ' HG ' HD22 ' A' ' 14' ' ' LEU . 39.8 tp -112.56 132.97 54.85 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 115.283 -0.871 . . . . 71.04 111.545 -174.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 74.6 ttt180 -107.6 120.87 43.4 Favored 'General case' 0 N--CA 1.402 -2.863 0 N-CA-C 108.069 -1.085 . . . . 71.54 108.069 173.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.546 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.0 mm? -98.32 120.3 38.5 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.757 -1.11 . . . . 72.45 109.075 -178.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.523 HG12 HG22 ' A' ' 21' ' ' THR . 30.7 mt -103.64 118.4 50.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.565 -0.902 . . . . 71.52 108.565 177.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.87 163.51 26.68 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 123.691 0.619 . . . . 60.11 110.835 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.6 m -57.7 -27.11 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.09 0.774 . . . . 73.45 113.09 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.5 t -77.39 -16.08 59.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.653 0.263 . . . . 75.43 111.165 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.428 ' C ' ' HE3' ' A' ' 20' ' ' LYS . . . 100.81 5.68 53.33 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.994 -1.098 . . . . 62.22 111.843 -176.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.611 ' HE3' ' N ' ' A' ' 20' ' ' LYS . 0.5 OUTLIER -86.5 131.44 34.18 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.126 -1.065 . . . . 72.42 108.126 177.344 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.523 HG22 HG12 ' A' ' 15' ' ' ILE . 72.5 p -107.2 133.05 52.36 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 120.457 -0.497 . . . . 71.32 111.6 -175.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -122.37 139.57 53.68 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.591 -0.892 . . . . 62.35 108.591 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 26.0 tt0 -131.42 129.55 41.4 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.649 -0.82 . . . . 71.21 109.087 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.638 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.0 m-85 -146.54 160.7 41.8 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.035 0.534 . . . . 65.41 110.581 -178.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.444 ' CD2' HG13 ' A' ' 5' ' ' VAL . 75.4 mt -79.64 126.54 31.05 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.441 -0.578 . . . . 60.43 109.441 172.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.638 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 94.5 m-85 -131.58 167.75 18.87 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.213 -1.032 . . . . 62.32 108.213 175.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.3 p -94.35 151.7 39.61 Favored Pre-proline 0 N--CA 1.411 -2.387 0 C-N-CA 119.129 -1.028 . . . . 53.13 108.246 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.505 ' O ' ' HB ' ' A' ' 72' ' ' THR . 31.3 Cg_endo -60.17 -11.73 16.96 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.628 2.219 . . . . 63.33 112.418 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -96.17 -4.86 41.84 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.055 0.391 . . . . 72.12 112.055 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -76.02 154.06 36.0 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 120.474 -0.49 . . . . 63.42 110.363 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.594 ' O ' HG13 ' A' ' 35' ' ' ILE . 47.9 t -89.93 118.96 29.89 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.167 -0.679 . . . . 74.11 109.167 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.739 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -50.94 -41.9 59.36 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.173 0.989 . . . . 75.01 113.157 -176.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.2 t -77.34 -32.34 55.11 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.221 0.534 . . . . 55.02 110.24 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.0 -37.53 84.35 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.825 -1.176 . . . . 75.32 107.825 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.594 HG13 ' O ' ' A' ' 31' ' ' SER . 71.7 mt -64.45 -39.77 86.74 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 CA-C-N 114.587 -1.188 . . . . 64.31 110.611 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.88 -38.9 62.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.982 0.42 . . . . 54.24 111.463 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.412 ' HD2' ' HB3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -72.46 -40.81 66.7 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 107.262 -1.384 . . . . 73.33 107.262 178.612 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.424 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 49.6 t-80 -57.96 -54.09 50.87 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.16 0.984 . . . . 71.54 110.916 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.546 HG21 ' CB ' ' A' ' 14' ' ' LEU . 29.6 m -66.38 -30.92 51.37 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 N-CA-C 113.255 0.835 . . . . 75.21 113.255 -178.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -49.55 -44.06 46.36 Favored 'General case' 0 C--O 1.243 0.745 0 O-C-N 123.609 0.568 . . . . 63.14 110.708 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.0 t70 177.65 -78.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.703 0.801 . . . . 63.55 110.647 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -101.52 143.64 31.27 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.269 -0.641 . . . . 63.51 109.269 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 35.4 p90 -77.63 142.29 66.0 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.121 -0.49 . . . . 75.43 112.022 -174.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.11 -48.56 6.18 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.879 3.053 . . . . 71.52 115.507 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 94.1 mmm 69.26 -71.42 0.12 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.857 0.863 . . . . 72.33 111.872 -173.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -157.38 -164.11 1.51 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 105.579 -2.008 . . . . 70.33 105.579 -175.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 28.6 p-90 -82.14 83.16 7.43 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 119.971 1.26 . . . . 73.22 110.313 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.02 -54.59 0.16 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.334 -1.303 . . . . 54.42 108.75 -175.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.06 -72.58 0.27 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 108.876 -0.787 . . . . 63.54 108.876 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HB3' ' HD2' ' A' ' 37' ' ' LYS . 10.6 tp10 -140.65 89.75 2.29 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.965 -0.383 . . . . 55.33 109.965 179.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 165.85 142.06 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 126.203 1.801 . . . . 74.43 107.266 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 95' ' ' PRO . 5.7 p -148.35 -59.1 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 111.696 0.258 . . . . 73.12 111.696 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.2 t -154.87 78.28 1.05 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 119.828 -0.749 . . . . 74.32 111.95 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.492 ' HB2' ' HB3' ' A' ' 94' ' ' LEU . 34.2 t -178.53 104.31 0.2 Allowed Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 115.855 -0.612 . . . . 62.31 110.532 174.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -81.62 -15.97 9.43 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.024 1.816 . . . . 75.32 110.803 175.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -65.49 -17.31 64.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.287 -0.87 . . . . 70.4 111.703 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.2 pp -80.46 -13.31 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 116.379 -0.373 . . . . 71.04 111.972 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.6 mp -87.44 100.65 12.91 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 110.015 -0.365 . . . . 64.54 110.015 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 39.2 mmt180 -137.14 148.43 46.63 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.641 -0.503 . . . . 73.15 109.641 177.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.739 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.4 pp -130.92 139.71 50.11 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 110.115 -0.328 . . . . 74.05 110.115 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 87' ' ' HIS . 79.0 mt -112.75 119.65 60.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.288 0.566 . . . . 54.51 109.535 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -102.0 73.88 1.42 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.662 -1.236 . . . . 61.05 107.662 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 58.61 86.05 0.09 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 113.344 -1.753 . . . . 75.13 112.085 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.11 -56.59 0.6 Allowed Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.677 -0.692 . . . . 23.11 114.02 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -117.52 153.98 32.25 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.667 0.988 . . . . 75.23 113.667 -172.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 93.3 m-85 -82.91 117.15 22.55 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 108.443 -0.947 . . . . 74.41 108.443 176.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.663 HD12 HD22 ' A' ' 76' ' ' LEU . 81.8 mt -80.73 -47.98 13.2 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.288 -0.965 . . . . 71.11 112.749 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.73 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.5 t-80 -170.01 167.33 9.0 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 105.909 -1.885 . . . . 65.03 105.909 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.52 -1.28 87.83 Favored Glycine 0 C--N 1.3 -1.425 0 N-CA-C 115.785 1.074 . . . . 74.33 115.785 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -164.9 22.75 0.06 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.255 1.026 . . . . 72.24 110.442 -170.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.561 HG13 HD21 ' A' ' 76' ' ' LEU . 9.0 p -79.53 136.88 22.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 119.419 -0.912 . . . . 74.43 109.031 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.63 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 42.7 p -78.7 158.49 28.31 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.424 -0.353 . . . . 41.44 111.658 -173.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.616 HD13 HD12 ' A' ' 76' ' ' LEU . 1.9 mm? -64.07 -27.08 68.86 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.106 -0.497 . . . . 64.4 110.897 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.26 -38.43 95.1 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.352 -1.099 . . . . 71.33 110.352 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.29 -16.81 57.39 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.194 0.521 . . . . 53.03 110.096 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.663 HD22 HD12 ' A' ' 67' ' ' LEU . 86.9 mt -86.24 4.41 38.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.918 -0.583 . . . . 72.41 111.33 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER 68.88 25.3 6.17 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.947 0.899 . . . . 75.32 113.254 177.641 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.446 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.2 mp -72.76 123.53 89.66 Favored Pre-proline 0 C--O 1.236 0.384 0 C-N-CA 120.083 -0.647 . . . . 64.04 111.322 175.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 1.3 Cg_endo -80.2 146.96 18.15 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.444 2.096 . . . . 65.33 111.088 176.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -73.73 141.94 46.34 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.191 -1.04 . . . . 70.25 108.191 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.46 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 82.01 -3.92 78.07 Favored Glycine 0 C--N 1.3 -1.435 0 C-N-CA 120.735 -0.745 . . . . 53.12 113.521 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -116.13 145.64 42.9 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 117.163 0.481 . . . . 73.15 111.463 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.449 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 23.5 m -85.19 125.1 32.57 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.967 -0.56 . . . . 73.42 110.99 -177.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.1 m -125.09 135.9 53.13 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.977 -0.556 . . . . 73.42 109.508 176.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.43 137.8 31.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.352 -0.385 . . . . 73.13 110.889 -178.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 82.8 mtp -138.69 153.45 48.54 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 120.902 0.382 . . . . 52.23 111.325 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.441 ' C ' HD22 ' A' ' 88' ' ' LEU . 25.6 m-70 -103.93 129.27 51.46 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 107.229 -1.397 . . . . 71.32 107.229 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.441 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.8 mm? -123.9 140.19 53.23 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 119.66 -0.816 . . . . 75.14 110.681 -176.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.43 ' CG2' ' HB2' ' A' ' 59' ' ' ARG . 25.2 m -118.7 133.68 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.829 0 CA-C-O 121.711 0.767 . . . . 74.44 109.445 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.5 135.2 44.31 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 105.108 -2.182 . . . . 65.44 105.108 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.474 ' C ' ' H ' ' A' ' 93' ' ' THR . 82.0 mtt180 -106.22 151.67 24.49 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 106.635 -1.617 . . . . 64.44 106.635 -176.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.412 ' H ' ' HG2' ' A' ' 92' ' ' GLU . 8.0 pt-20 -63.26 17.37 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 115.032 1.493 . . . . 55.24 115.032 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.474 ' H ' ' C ' ' A' ' 91' ' ' ARG . 27.1 m 69.44 153.37 0.11 Allowed 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.181 1.792 . . . . 53.02 112.612 175.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 25.4 tp -108.04 132.66 20.9 Favored Pre-proline 0 N--CA 1.424 -1.752 0 N-CA-C 105.137 -2.172 . . . . 62.14 105.137 174.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.461 ' HA ' ' CG1' ' A' ' 52' ' ' VAL . 51.6 Cg_endo -74.4 -15.28 22.42 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.279 1.986 . . . . 70.34 114.145 -174.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -163.41 152.8 12.56 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 108.649 -0.871 . . . . 73.13 108.649 -175.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.07 -59.09 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.082 1.855 . . . . 72.21 110.781 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.4 t30 179.48 76.04 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.066 0.546 . . . . 75.31 110.825 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.9 m 42.9 35.92 0.8 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.139 1.376 . . . . 50.22 114.034 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -85.1 -16.78 39.42 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.561 0.696 . . . . 72.1 109.205 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.44 12.04 76.54 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 109.905 -1.278 . . . . 74.45 109.905 -177.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -114.57 144.25 43.69 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.013 -0.594 . . . . 70.21 109.737 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.561 ' HG3' ' O ' ' A' ' 104' ' ' ASN . 15.3 ptt-85 -147.17 -172.25 3.96 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.984 -1.487 . . . . 75.54 106.984 -177.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.561 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 79.5 m-20 -66.03 136.52 56.14 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.077 -1.453 . . . . 74.41 107.077 172.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.459 ' HD2' ' HB2' ' A' ' 110' ' ' GLU . 25.0 mmt180 -59.98 -36.15 76.53 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 122.017 0.913 . . . . 71.55 109.022 -176.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 173.89 -57.92 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 102.514 -3.143 . . . . 73.41 102.514 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -156.62 -46.47 0.07 Allowed 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 102.996 -2.964 . . . . 73.54 102.996 170.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.6 p -143.03 -168.43 2.79 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 112.949 -1.932 . . . . 72.32 106.613 172.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 131.99 -76.39 0.41 Allowed Glycine 0 CA--C 1.494 -1.281 0 C-N-CA 120.024 -1.084 . . . . 75.24 111.698 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.459 ' HB2' ' HD2' ' A' ' 105' ' ' ARG . 1.8 mp0 -84.47 -18.01 37.26 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 121.739 0.78 . . . . 74.32 109.521 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.4 t -161.51 155.26 21.84 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 106.496 -1.668 . . . . 71.03 106.496 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -143.17 125.0 15.07 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.725 -1.213 . . . . 71.23 107.725 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 t -82.14 101.85 10.69 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.517 0.675 . . . . 72.42 111.914 -175.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 12.5 p -72.89 124.57 25.68 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 108.106 -1.072 . . . . 64.51 108.106 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.6 m -64.9 121.79 14.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.269 0.556 . . . . 63.43 111.736 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 30.8 pt -80.82 156.02 4.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.714 -0.676 . . . . 71.24 110.727 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.9 tp . . . . . 0 C--N 1.292 -1.915 0 N-CA-C 108.546 -0.909 . . . . 64.5 108.546 -179.324 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.2 p . . . . . 0 C--O 1.251 1.14 0 N-CA-C 110.355 -0.239 . . . . 63.3 110.355 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.5 m 65.69 16.87 10.69 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.361 0.874 . . . . 54.31 113.361 173.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -147.09 107.65 4.11 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.151 -0.685 . . . . 74.23 109.151 176.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.489 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 17.7 t -107.74 123.03 39.11 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 110.087 -0.338 . . . . 72.41 110.087 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.07 162.69 36.54 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.204 1.936 . . . . 74.23 111.05 175.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.88 36.85 0.63 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.864 0.84 . . . . 53.22 109.597 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.72 -19.13 2.1 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.632 -1.167 . . . . 70.22 109.446 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.2 mmm -124.29 150.68 45.12 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.641 -0.708 . . . . 71.41 110.07 -174.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -101.61 139.09 23.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.998 -0.742 . . . . 52.4 108.998 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.432 HD22 HG23 ' A' ' 83' ' ' THR . 6.0 t30 -96.69 114.39 26.03 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.234 -1.024 . . . . 74.54 108.234 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.546 ' HG ' HD22 ' A' ' 14' ' ' LEU . 44.4 tp -120.16 133.46 55.49 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 112.586 0.587 . . . . 74.35 112.586 -172.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 49.1 ttt180 -108.47 120.71 43.21 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 108.443 -0.947 . . . . 75.31 108.443 174.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.573 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.3 mm? -98.53 122.29 41.54 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-N 114.531 -1.213 . . . . 55.32 109.605 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.642 HG23 HG22 ' A' ' 21' ' ' THR . 22.1 mt -112.22 125.46 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.635 -0.876 . . . . 74.31 108.635 177.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -94.47 161.57 14.17 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 116.323 -0.399 . . . . 64.35 110.884 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.417 ' CG1' HG12 ' A' ' 89' ' ' VAL . 28.6 m -60.5 -14.67 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.4 0.68 . . . . 60.55 112.757 179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.1 m -79.79 -7.16 58.5 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 116.199 -0.455 . . . . 54.24 110.351 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.55 0.54 81.92 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 116.265 -0.425 . . . . 60.3 112.598 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -87.67 133.93 33.74 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.237 -0.653 . . . . 75.44 109.237 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.642 HG22 HG23 ' A' ' 15' ' ' ILE . 40.2 p -116.73 131.87 56.84 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 109.585 -0.524 . . . . 75.44 109.585 -177.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HD2' ' O ' ' A' ' 39' ' ' VAL . 63.8 mttp -129.32 139.97 51.56 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 110.022 -0.362 . . . . 64.41 110.022 174.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 27.2 tt0 -125.09 130.0 51.37 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.257 -0.646 . . . . 72.41 109.257 -177.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.608 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 95.8 m-85 -146.14 160.52 41.82 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 122.946 0.498 . . . . 74.42 111.081 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.2 mt -82.57 126.28 32.11 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.503 -0.555 . . . . 71.13 109.503 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.608 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 95.5 m-85 -132.58 166.1 22.89 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.115 -1.068 . . . . 62.23 108.115 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.4 p -89.71 150.46 44.11 Favored Pre-proline 0 N--CA 1.418 -2.054 0 N-CA-C 108.194 -1.039 . . . . 65.13 108.194 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.451 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 34.2 Cg_endo -60.32 -11.68 17.26 Favored 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 122.59 2.194 . . . . 63.21 112.287 177.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -91.72 -9.81 42.41 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.582 0.753 . . . . 72.32 111.221 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -71.15 154.09 41.99 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.147 0.499 . . . . 72.24 111.409 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.519 ' O ' HG13 ' A' ' 35' ' ' ILE . 49.9 m -95.11 121.23 36.53 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.76 -0.655 . . . . 72.15 110.425 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.426 ' HB3' ' HG ' ' A' ' 60' ' ' LEU . . . -49.22 -42.66 41.15 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.207 1.003 . . . . 50.5 113.088 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 5.8 p -73.06 -34.13 66.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.895 0.379 . . . . 63.13 112.008 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.4 -47.12 80.41 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.03 -1.1 . . . . 75.31 108.03 175.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.54 ' O ' HG22 ' A' ' 39' ' ' VAL . 68.6 mt -59.67 -46.24 93.52 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.379 0 CA-C-N 114.342 -1.299 . . . . 72.32 110.683 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.402 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.45 -46.6 56.72 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.438 0.695 . . . . 72.14 111.742 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.541 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 7.6 tmtt? -73.28 -33.63 65.32 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.736 -0.839 . . . . 54.44 108.736 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -66.2 -51.97 52.56 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.196 0.998 . . . . 51.12 110.734 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.573 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.7 m -65.29 -30.22 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.744 0.817 . . . . 74.14 111.509 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.541 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 64.9 t80 -47.61 -48.18 28.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.303 -0.862 . . . . 65.23 111.861 175.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.442 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 18.5 t70 -173.36 -49.16 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.71 0.767 . . . . 74.13 111.013 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -142.84 152.68 42.42 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.884 -1.053 . . . . 75.14 109.918 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -65.52 136.9 96.31 Favored Pre-proline 0 C--N 1.317 -0.835 0 O-C-N 123.42 0.45 . . . . 60.32 110.596 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.47 ' HA ' ' OD1' ' A' ' 46' ' ' ASP . 9.4 Cg_endo -56.08 101.87 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.646 2.231 . . . . 64.34 113.529 178.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 23.4 ptp -112.67 7.04 18.55 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 105.823 -1.918 . . . . 74.45 105.823 176.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.47 ' OD1' ' HA ' ' A' ' 44' ' ' PRO . 3.1 m-20 -74.87 168.76 19.27 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 112.159 -2.291 . . . . 61.21 110.567 -174.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -99.18 4.76 46.87 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.837 -0.62 . . . . 74.42 111.016 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 62.88 20.9 12.51 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 123.046 1.403 . . . . 74.31 108.751 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -124.45 126.35 45.78 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.064 -1.426 . . . . 75.53 109.776 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.404 ' HG2' ' HB3' ' A' ' 92' ' ' GLU . 10.8 tp10 -144.88 112.76 6.34 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 105.865 -1.902 . . . . 73.13 105.865 174.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 76.25 -50.98 0.6 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.159 1.383 . . . . 73.42 108.754 -172.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.9 p -155.11 158.91 3.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 106.936 -1.505 . . . . 74.35 106.936 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.2 m -54.93 106.96 0.25 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.971 0.508 . . . . 73.54 109.897 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 m -136.6 98.08 11.16 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-O 120.871 0.367 . . . . 61.44 110.739 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.33 -16.46 10.81 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 C-N-CA 122.334 2.023 . . . . 74.21 112.739 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -70.45 -5.69 30.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.576 0.584 . . . . 41.34 112.576 -175.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.554 HD12 ' HG ' ' A' ' 58' ' ' LEU . 2.4 pp -80.72 -14.14 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-O 120.681 0.277 . . . . 75.52 110.965 177.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.554 ' HG ' HD12 ' A' ' 57' ' ' ILE . 83.2 mt -111.2 103.08 11.47 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.693 -0.484 . . . . 74.34 109.693 176.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -137.28 144.67 42.81 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.024 -1.102 . . . . 71.35 108.024 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -109.38 147.0 33.5 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 113.959 1.096 . . . . 72.41 113.959 178.314 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -117.53 119.51 61.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.214 -1.032 . . . . 63.31 108.214 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.576 ' HB3' HD11 ' A' ' 67' ' ' LEU . 11.8 t80 -100.33 90.95 4.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.74 -1.207 . . . . 72.51 107.74 176.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 71.96 -70.3 0.16 Allowed 'General case' 0 N--CA 1.401 -2.913 0 C-N-CA 127.05 2.14 . . . . 73.02 112.392 -176.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.9 -47.75 1.07 Allowed Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 119.877 -1.154 . . . . 62.25 115.196 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -124.19 170.34 10.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 118.049 0.924 . . . . 72.41 112.991 -172.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.548 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 73.7 m-85 -83.7 118.33 23.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.742 -0.836 . . . . 73.21 108.742 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 62' ' ' TYR . 7.0 mp -80.77 -45.96 16.17 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 113.553 0.945 . . . . 64.41 113.553 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -168.84 172.27 7.89 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 106.774 -1.565 . . . . 51.42 106.774 -173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.44 -1.51 87.85 Favored Glycine 0 C--N 1.306 -1.126 0 N-CA-C 111.783 -0.527 . . . . 75.33 111.783 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -175.92 80.93 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.497 -1.297 . . . . 75.42 107.497 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 p -104.93 151.7 7.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.546 -1.279 . . . . 72.04 107.546 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.2 p -91.17 158.11 16.81 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 118.232 0.469 . . . . 73.04 110.203 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.528 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.9 mm? -69.32 -30.63 68.73 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.04 0.447 . . . . 44.23 110.642 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.1 -35.02 91.51 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.187 -0.765 . . . . 72.41 111.187 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.03 -15.7 63.05 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.2 0.6 . . . . 34.21 111.282 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.426 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 65.2 mt -85.11 -1.6 57.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 73.42 110.158 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 8.8 mptt 63.41 72.34 0.48 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.359 1.064 . . . . 55.15 109.375 -177.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 73' ' ' LEU . 87.7 mt -125.17 117.74 25.43 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 115.479 -0.782 . . . . 71.33 111.423 -175.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.67 152.12 64.36 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.403 2.068 . . . . 74.23 110.147 172.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -75.92 148.39 38.26 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.734 -0.839 . . . . 64.34 108.734 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.489 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 91.99 -10.79 73.71 Favored Glycine 0 C--N 1.296 -1.671 0 C-N-CA 119.744 -1.217 . . . . 63.24 113.043 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -101.23 138.98 37.53 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.148 0.499 . . . . 62.33 111.884 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.432 HG23 HD22 ' A' ' 11' ' ' ASN . 35.1 m -79.88 118.46 21.66 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.201 -0.909 . . . . 73.24 109.94 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.7 m -116.78 129.42 56.09 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.921 -0.581 . . . . 64.02 109.55 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -104.89 140.36 23.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.905 -0.405 . . . . 70.3 109.905 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 92.4 mtp -138.23 153.58 49.11 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 120.869 0.366 . . . . 75.32 111.042 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -106.59 129.6 54.49 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.077 -1.083 . . . . 75.12 108.077 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.0 mm? -122.6 139.34 54.04 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 122.126 -0.359 . . . . 55.11 110.447 -175.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.417 HG12 ' CG1' ' A' ' 17' ' ' VAL . 29.1 m -116.87 132.48 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 C-N-CA 119.892 -0.723 . . . . 64.53 109.721 176.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 57' ' ' ILE . . . -134.58 142.52 46.97 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.789 -1.189 . . . . 70.11 107.789 176.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.3 mtm105 -136.56 151.35 49.29 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.969 -0.382 . . . . 64.41 109.969 -174.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 50' ' ' GLU . 0.5 OUTLIER 46.43 62.09 2.46 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 125.076 1.485 . . . . 64.24 110.835 177.787 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.8 m -73.8 136.16 43.54 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-N 113.807 -1.542 . . . . 52.44 110.204 -175.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.57 154.47 93.15 Favored Pre-proline 0 C--N 1.308 -1.22 0 CA-C-N 115.849 -0.614 . . . . 70.52 110.585 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -51.6 135.02 47.99 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 123.206 2.604 . . . . 74.13 112.548 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.39 156.35 68.71 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 114.866 -1.061 . . . . 73.25 109.268 -175.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.75 -56.27 1.83 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.273 1.982 . . . . 72.24 110.997 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -163.75 14.94 0.06 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.555 -1.276 . . . . 71.44 107.555 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 26.3 t 54.32 79.64 0.13 Allowed 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.202 -1.363 . . . . 64.2 110.709 -172.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -87.39 -48.08 8.26 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.652 -0.703 . . . . 63.43 110.273 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 41' ' ' ASP . . . 64.97 15.06 59.81 Favored Glycine 0 N--CA 1.465 0.623 0 CA-C-N 116.049 -0.523 . . . . 73.11 112.999 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -137.43 149.19 46.71 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.676 -1.231 . . . . 74.53 107.676 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -101.71 134.7 44.46 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.702 -1.592 . . . . 72.32 106.702 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -132.71 143.04 49.35 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.795 -0.762 . . . . 75.51 109.178 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -61.43 -50.98 70.62 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.166 -0.925 . . . . 75.45 110.075 -176.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 176.08 140.9 0.06 Allowed 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.435 0.694 . . . . 74.04 109.361 -174.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 60.3 pttt 54.31 8.41 0.19 Allowed 'General case' 0 N--CA 1.507 2.409 0 C-N-CA 126.979 2.112 . . . . 64.45 114.905 174.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.6 m 65.43 26.36 11.91 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-O 122.977 1.37 . . . . 62.33 109.519 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.14 69.98 0.33 Allowed Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 108.324 -1.91 . . . . 71.32 108.324 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.69 -177.19 0.73 Allowed 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 115.461 1.652 . . . . 65.43 115.461 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.3 m -67.02 99.45 0.65 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.679 -1.146 . . . . 65.21 110.866 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.96 135.62 0.37 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.384 1.074 . . . . 65.14 108.656 177.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 53.7 t -139.92 -60.36 0.54 Allowed 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.626 -0.509 . . . . 50.14 109.626 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 52.6 t -153.1 120.83 6.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.756 -0.831 . . . . 74.15 108.756 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.8 p -70.99 96.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 122.013 0.911 . . . . 75.05 110.75 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.5 tt -103.95 112.31 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-N 115.409 -0.814 . . . . 54.24 109.769 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.279 0.9 OUTLIER . . . . . 0 C--N 1.3 -1.563 0 CA-C-O 118.075 -0.964 . . . . 65.42 113.287 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.4 t . . . . . 0 N--CA 1.428 -1.559 0 N-CA-C 108.319 -0.993 . . . . 65.14 108.319 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -72.52 156.13 54.34 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.077 1.851 . . . . 71.54 111.012 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.57 7.2 1.14 Allowed 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.671 0.989 . . . . 44.13 113.671 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -109.24 -6.06 15.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.644 -0.502 . . . . 74.21 109.644 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.4 mmm -130.19 154.51 47.47 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.237 0.541 . . . . 71.24 110.543 -172.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.48 HG22 ' HA ' ' A' ' 80' ' ' PHE . 2.7 pp -115.92 131.12 69.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.946 -0.57 . . . . 62.51 110.072 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.554 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -84.57 114.5 22.02 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.039 -1.467 . . . . 71.24 107.039 -177.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.495 ' HG ' HD22 ' A' ' 14' ' ' LEU . 41.7 tp -121.32 133.17 55.11 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.946 0.721 . . . . 62.44 112.946 -172.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.447 ' HE ' ' HB ' ' A' ' 21' ' ' THR . 75.5 ttt180 -108.57 121.39 44.9 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 115.14 -0.937 . . . . 64.41 108.737 174.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.529 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.2 mm? -99.37 120.27 39.31 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.885 -1.052 . . . . 62.42 108.612 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.476 HG23 HG22 ' A' ' 21' ' ' THR . 32.1 mt -107.33 122.88 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 108.451 -0.944 . . . . 75.11 108.451 177.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.59 160.48 18.17 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 116.384 -0.371 . . . . 63.41 110.346 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.7 t -58.66 -26.15 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.643 0.777 . . . . 74.43 111.569 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -76.43 -6.09 50.2 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.768 -0.651 . . . . 64.33 111.214 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.08 6.74 66.51 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.502 -0.856 . . . . 65.34 112.032 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -87.61 131.41 34.43 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.045 -0.724 . . . . 75.44 109.045 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.476 HG22 HG23 ' A' ' 15' ' ' ILE . 68.5 p -111.44 129.77 55.92 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 120.364 -0.534 . . . . 71.03 110.276 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.64 139.77 53.57 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.482 -1.303 . . . . 72.45 107.482 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -133.58 130.61 38.64 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.927 -1.109 . . . . 71.21 109.285 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.673 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.6 m-85 -145.17 160.35 41.58 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 123.526 0.73 . . . . 63.54 109.299 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.1 tp -84.09 125.7 32.37 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.689 -1.226 . . . . 64.12 107.689 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.673 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 82.4 m-85 -127.81 168.47 15.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.05 0.453 . . . . 55.43 111.022 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.461 ' HB2' ' OD2' ' A' ' 30' ' ' ASP . 20.4 m -92.87 140.53 23.59 Favored Pre-proline 0 N--CA 1.424 -1.774 0 N-CA-C 108.366 -0.976 . . . . 70.51 108.366 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.464 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 27.3 Cg_endo -60.01 -18.79 52.42 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.632 2.221 . . . . 61.34 113.267 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -81.35 -11.76 59.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.208 -0.451 . . . . 60.22 111.197 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' A' ' 27' ' ' SER . 22.0 m-20 -78.99 153.76 30.06 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.836 -0.54 . . . . 74.23 111.751 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.471 ' O ' HG13 ' A' ' 35' ' ' ILE . 25.8 p -95.35 131.31 41.6 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.111 0.481 . . . . 74.22 111.521 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.713 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -51.93 -41.83 62.33 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 124.262 1.025 . . . . 62.2 113.706 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.7 p -74.86 -30.95 61.49 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.471 0.545 . . . . 72.13 112.471 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -69.08 -42.48 76.13 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 107.402 -1.333 . . . . 74.32 107.402 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.511 HG23 ' CZ ' ' A' ' 26' ' ' PHE . 67.0 mt -60.97 -43.61 96.36 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.216 0 CA-C-N 114.175 -1.375 . . . . 53.41 110.745 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.72 -42.6 57.36 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.086 0.555 . . . . 74.44 111.874 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.596 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -72.14 -39.77 68.55 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.078 -1.452 . . . . 71.02 107.078 -178.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -61.87 -45.74 92.46 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.612 -0.722 . . . . 74.12 110.97 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 14' ' ' LEU . 26.8 m -71.61 -31.99 44.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 112.693 0.627 . . . . 73.15 112.693 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 . . . . . 0 N--CA 1.482 1.132 0 O-C-N 123.127 0.267 . . . . 71.14 111.471 173.13 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 CA--C 1.502 -0.902 0 N-CA-C 108.715 -0.846 . . . . 72.0 108.715 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.5 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 83.0 mtp180 -138.26 162.3 34.67 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.174 0.511 . . . . 74.21 109.892 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.713 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.5 pp -123.12 135.54 54.41 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 115.603 -0.726 . . . . 71.1 110.727 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 85.7 mt -110.45 123.32 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 N-CA-C 108.48 -0.933 . . . . 70.51 108.48 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -100.91 50.27 0.87 Allowed 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 106.649 -1.612 . . . . 74.34 106.649 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 60.69 93.5 0.04 OUTLIER 'General case' 0 N--CA 1.394 -3.243 0 C-N-CA 127.6 2.36 . . . . 72.21 112.168 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.99 -29.42 10.01 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.236 -0.893 . . . . 72.23 112.848 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -130.51 137.76 49.9 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.972 0.731 . . . . 72.4 112.972 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -88.6 113.67 24.42 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 106.293 -1.743 . . . . 74.23 106.293 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.559 HD12 ' CD2' ' A' ' 76' ' ' LEU 0.258 29.1 mt -79.16 -43.54 23.74 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 117.936 -1.506 . . . . 73.12 112.471 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.669 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.6 t-80 -173.82 -175.62 1.1 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.552 -1.277 . . . . 71.33 107.552 176.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -85.03 -14.16 70.07 Favored Glycine 0 C--N 1.302 -1.347 0 N-CA-C 115.743 1.057 . . . . 43.02 115.743 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -167.64 28.08 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 118.192 0.996 . . . . 64.5 109.846 -172.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.561 HG12 HD21 ' A' ' 60' ' ' LEU . 11.9 p -74.67 147.63 8.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.265 -0.643 . . . . 73.55 109.265 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.573 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 45.7 p -78.77 158.4 28.25 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 112.419 0.526 . . . . 72.24 112.419 -173.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.52 HD13 HD12 ' A' ' 76' ' ' LEU . 3.6 mm? -60.02 -41.38 92.04 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.413 0.685 . . . . 73.14 111.862 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.57 -37.99 94.24 Favored Glycine 0 C--N 1.317 -0.521 0 N-CA-C 111.36 -0.696 . . . . 54.13 111.36 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.439 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -74.88 -16.04 60.69 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 122.798 0.439 . . . . 53.32 111.547 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 72' ' ' THR . 62.7 mt -83.77 -4.7 58.85 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.252 -0.647 . . . . 63.01 109.252 177.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.6 mptt 71.28 79.55 0.16 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.69 1.196 . . . . 74.3 111.297 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 73' ' ' LEU . 10.8 mp -123.47 117.11 27.94 Favored Pre-proline 0 CA--C 1.494 -1.192 0 CA-C-N 115.526 -0.761 . . . . 75.1 111.474 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.513 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 11.0 Cg_exo -64.11 122.85 10.98 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 121.728 1.618 . . . . 75.33 109.197 171.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.48 ' HA ' HG22 ' A' ' 10' ' ' ILE . 1.1 p90 -69.77 144.44 52.69 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.338 0.589 . . . . 74.14 112.171 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.38 9.05 60.71 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.087 -0.96 . . . . 65.42 113.157 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -132.01 163.87 27.45 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 117.863 0.831 . . . . 75.34 110.622 176.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.554 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 25.7 m -91.66 129.37 37.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.407 0.622 . . . . 53.13 111.361 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.6 m -122.23 133.37 54.71 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.834 -0.621 . . . . 74.41 110.292 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.2 p -104.57 139.34 25.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 109.887 -0.412 . . . . 71.33 109.887 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 85.7 mtp -138.25 153.49 49.08 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-O 121.009 0.433 . . . . 54.33 111.079 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.484 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 59.1 m-70 -111.26 126.84 55.31 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.609 -1.256 . . . . 53.15 107.609 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.4 mm? -113.47 142.2 46.2 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 122.156 -0.34 . . . . 44.43 110.201 -176.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.84 134.01 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 121.223 0.535 . . . . 74.05 111.009 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 107.983 -1.118 . . . . 73.31 107.983 176.515 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.4 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 29.3 t . . . . . 0 N--CA 1.43 -1.438 0 N-CA-C 108.631 -0.877 . . . . 53.13 108.631 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -63.52 166.42 15.44 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.22 1.947 . . . . 71.41 112.197 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.46 11.74 20.74 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.607 -0.724 . . . . 64.32 109.491 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -121.72 -3.67 9.24 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.174 -0.921 . . . . 73.53 108.582 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.7 mmm -126.93 152.32 47.29 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.925 -0.768 . . . . 74.44 108.925 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -111.88 139.37 36.65 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 N-CA-C 109.275 -0.639 . . . . 71.35 109.275 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.596 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -88.17 116.28 26.26 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.923 -1.14 . . . . 55.15 107.923 -176.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.502 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.7 tp -127.36 132.99 50.1 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 121.156 0.503 . . . . 74.05 112.185 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.409 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 35.2 ttp180 -109.6 120.65 43.14 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 108.561 -0.903 . . . . 70.53 108.561 174.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.547 ' CB ' HG21 ' A' ' 39' ' ' VAL . 1.8 mm? -100.23 120.71 40.32 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 114.591 -1.186 . . . . 75.41 108.677 -178.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.463 HG23 HG22 ' A' ' 21' ' ' THR . 23.2 mt -104.36 123.01 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 108.811 -0.811 . . . . 73.5 108.811 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.39 165.0 20.66 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.632 -0.713 . . . . 74.33 110.745 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.6 t -65.18 -21.07 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-O 121.887 0.851 . . . . 43.42 109.399 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.6 m -76.03 -4.45 41.35 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.45 1.1 . . . . 53.11 111.418 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.26 6.93 88.97 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.805 -0.918 . . . . 51.23 110.805 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -87.89 131.14 34.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.283 -1.006 . . . . 64.24 108.283 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.463 HG22 HG23 ' A' ' 15' ' ' ILE . 80.5 p -111.31 129.32 56.03 Favored 'General case' 0 N--CA 1.417 -2.096 0 C-N-CA 120.269 -0.572 . . . . 72.4 109.562 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 39' ' ' VAL . 95.8 mttt -131.66 139.31 49.05 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.282 -1.007 . . . . 73.11 108.282 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.409 ' HG3' ' HB2' ' A' ' 13' ' ' ARG . 30.1 tt0 -130.43 131.1 45.06 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.774 -0.77 . . . . 62.1 109.617 -175.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.676 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.2 m-85 -144.9 159.7 42.48 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 122.795 0.438 . . . . 62.34 109.83 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.45 126.47 32.26 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.624 -1.25 . . . . 63.23 107.624 174.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.676 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 90.1 m-85 -127.36 163.47 23.92 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.572 -0.529 . . . . 74.24 109.572 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.7 p -85.33 147.35 46.96 Favored Pre-proline 0 N--CA 1.41 -2.439 0 N-CA-C 107.741 -1.207 . . . . 73.11 107.741 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.494 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 55.6 Cg_endo -62.31 -11.36 22.16 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.803 2.335 . . . . 72.51 111.712 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -86.6 -15.87 38.48 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.29 -0.868 . . . . 71.22 111.242 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -71.76 153.74 41.78 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.15 0.5 . . . . 61.43 111.245 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.438 ' O ' HG13 ' A' ' 35' ' ' ILE . 19.4 m -96.52 129.46 43.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.006 -1.109 . . . . 71.3 108.006 177.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.805 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -51.03 -38.27 50.37 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.637 0.977 . . . . 74.02 113.637 -176.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 p -77.62 -29.05 51.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.132 0.492 . . . . 53.22 111.93 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.99 -41.58 82.08 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.907 -1.516 . . . . 63.32 106.907 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.48 HG23 ' CZ ' ' A' ' 26' ' ' PHE . 70.5 mt -64.13 -42.63 96.17 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.472 0 CA-C-N 113.715 -1.584 . . . . 74.53 110.43 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.406 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.01 -40.15 43.71 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 123.173 0.589 . . . . 74.41 111.842 175.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.83 -31.17 64.6 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.441 0.638 . . . . 74.55 110.323 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -74.13 -47.9 32.98 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.207 -0.906 . . . . 65.55 110.009 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.547 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.4 m -71.37 -32.1 45.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.923 -0.485 . . . . 72.24 111.9 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 63.7 t80 . . . . . 0 C--O 1.246 0.888 0 N-CA-C 108.508 -0.923 . . . . 73.22 108.508 177.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 N--CA 1.445 -0.722 0 N-CA-C 109.506 -0.553 . . . . 63.42 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.413 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 98.7 mtt180 -140.29 142.73 35.67 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.828 -0.804 . . . . 72.24 108.828 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.805 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.5 pp -126.05 138.9 53.75 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.052 0.453 . . . . 72.42 111.451 -176.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.467 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 90.1 mt -108.96 119.91 59.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 108.456 -0.942 . . . . 55.32 108.456 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -101.3 75.59 1.64 Allowed 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.353 -1.351 . . . . 75.22 107.353 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 36.78 85.68 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.77 0 C-N-CA 127.587 2.355 . . . . 53.04 113.23 -176.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.87 -57.29 0.62 Allowed Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 115.447 -0.797 . . . . 75.11 113.156 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -130.07 159.66 36.09 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 112.627 0.603 . . . . 71.13 112.627 -176.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 33.1 m-85 -89.35 112.82 24.01 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.926 -1.138 . . . . 74.42 107.926 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.507 HD12 HD22 ' A' ' 76' ' ' LEU . 83.5 mt -80.2 -47.19 15.06 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 113.547 0.943 . . . . 65.14 113.547 -175.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.642 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.4 t-80 -165.33 174.74 9.8 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 106.614 -1.624 . . . . 74.33 106.614 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.11 -1.88 88.37 Favored Glycine 0 C--N 1.307 -1.067 0 C-N-CA 120.261 -0.971 . . . . 31.22 114.396 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -175.72 28.16 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 117.822 0.811 . . . . 73.35 112.221 -173.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.583 HG12 HD21 ' A' ' 60' ' ' LEU . 13.0 p -70.24 142.68 15.51 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 C-N-CA 120.46 -0.496 . . . . 73.24 109.808 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.457 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 31.8 p -78.54 157.67 28.75 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.852 -0.613 . . . . 44.03 111.836 -175.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.575 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.8 mm? -66.25 -32.87 74.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.406 -0.361 . . . . 61.42 110.784 -177.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.04 -36.38 92.82 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 111.178 -0.769 . . . . 75.22 111.178 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.406 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -73.97 -15.27 61.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.12 0.568 . . . . 73.54 110.893 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.507 HD22 HD12 ' A' ' 67' ' ' LEU . 73.4 mt -82.79 14.87 2.94 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.675 0.39 . . . . 72.14 111.226 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.6 24.1 10.21 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.759 0.824 . . . . 64.04 110.619 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.476 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 96.2 mt -91.8 125.14 58.32 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 112.511 0.56 . . . . 73.0 112.511 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 3.5 Cg_endo -86.35 170.3 8.08 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.846 2.364 . . . . 73.11 110.484 172.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.494 ' CE2' ' HG3' ' A' ' 28' ' ' PRO . 75.2 m-85 -78.7 151.35 32.21 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.781 -0.451 . . . . 75.41 109.781 -178.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.4 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 82.93 0.96 90.59 Favored Glycine 0 C--N 1.308 -1.022 0 C-N-CA 120.668 -0.777 . . . . 73.23 114.232 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -102.37 136.45 42.18 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 117.509 0.655 . . . . 65.31 110.021 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.596 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 54.6 m -87.19 116.78 25.49 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.006 -0.739 . . . . 71.35 109.006 176.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.3 m -115.81 142.43 46.77 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.55 -0.75 . . . . 53.41 110.471 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -111.45 135.59 50.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 120.793 0.33 . . . . 73.32 110.354 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 87.0 mtp -138.35 153.24 48.97 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 120.862 0.363 . . . . 63.41 110.276 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.467 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 21.5 m-70 -111.59 132.7 54.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.989 -1.115 . . . . 74.3 107.989 178.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.465 HD21 HD12 ' A' ' 14' ' ' LEU . 2.5 mm? -119.47 144.53 46.93 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 120.614 -0.434 . . . . 65.35 111.113 -176.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 59' ' ' ARG . 26.7 m -120.52 134.94 62.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.8 -0.636 . . . . 74.04 109.43 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.496 0 CA-C-N 115.878 -0.601 . . . . 73.14 109.788 -176.967 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.409 HG13 HD22 ' A' ' 25' ' ' LEU . 16.8 t . . . . . 0 N--CA 1.432 -1.341 0 N-CA-C 108.676 -0.861 . . . . 72.23 108.676 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -72.01 143.24 40.14 Favored 'Trans proline' 0 C--O 1.251 1.159 0 C-N-CA 121.889 1.726 . . . . 73.01 110.421 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.81 72.14 4.33 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 121.996 0.903 . . . . 70.21 109.821 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.422 ' H ' ' H ' ' A' ' 9' ' ' MET . 27.8 t70 -169.11 -28.18 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 113.612 -1.631 . . . . 75.31 107.727 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.422 ' H ' ' H ' ' A' ' 8' ' ' ASP . 92.9 mmm -117.52 145.73 44.03 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.819 -1.082 . . . . 71.22 109.128 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.471 HG22 ' HA ' ' A' ' 80' ' ' PHE . 2.8 pp -99.31 136.06 32.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 109.208 -0.664 . . . . 73.44 109.208 175.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.49 HD22 HG23 ' A' ' 83' ' ' THR . 5.4 t30 -91.93 107.69 19.39 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.7 -1.222 . . . . 63.31 107.7 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.504 ' HG ' HD22 ' A' ' 14' ' ' LEU . 43.5 tp -112.77 132.77 55.09 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 116.055 -0.52 . . . . 61.43 111.723 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -106.82 121.51 44.55 Favored 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 108.291 -1.003 . . . . 73.44 108.291 173.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.551 ' CB ' HG21 ' A' ' 39' ' ' VAL . 1.7 mm? -98.74 128.61 45.04 Favored 'General case' 0 C--N 1.268 -2.947 0 CA-C-N 114.258 -1.337 . . . . 62.31 109.353 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.487 HD12 HG22 ' A' ' 21' ' ' THR . 14.8 mm -107.47 119.33 56.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 107.744 -1.206 . . . . 73.25 107.744 175.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.7 tp -84.09 153.05 23.99 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 110.058 -0.349 . . . . 72.5 110.058 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.49 ' CG1' ' HA ' ' A' ' 89' ' ' VAL . 30.7 m -60.0 -13.36 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.829 0.851 . . . . 63.11 113.059 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.413 ' HB3' ' HD3' ' A' ' 20' ' ' LYS . 16.3 t -89.53 -2.78 58.46 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.275 -0.639 . . . . 64.32 109.275 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.21 7.93 79.19 Favored Glycine 0 C--N 1.337 0.583 0 CA-C-N 115.922 -0.581 . . . . 33.24 112.597 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HD3' ' HB3' ' A' ' 18' ' ' SER . 12.3 mptt -87.78 131.05 34.65 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.345 -0.983 . . . . 73.24 108.345 176.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.487 HG22 HD12 ' A' ' 15' ' ' ILE . 63.1 p -107.46 143.65 35.52 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.538 -0.912 . . . . 72.12 108.538 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 48.5 tptt -145.08 147.23 32.33 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.595 -0.842 . . . . 75.54 109.155 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -137.06 131.09 32.27 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 119.713 -0.795 . . . . 65.53 110.201 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.737 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 84.6 m-85 -145.14 160.97 40.6 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 123.888 0.875 . . . . 63.31 110.387 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.409 HD22 HG13 ' A' ' 5' ' ' VAL . 97.3 mt -79.7 126.02 30.4 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.634 -1.247 . . . . 53.33 107.634 171.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.737 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 83.6 m-85 -130.68 164.45 25.0 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.37 -0.974 . . . . 74.32 108.37 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.5 p -90.1 150.3 43.13 Favored Pre-proline 0 N--CA 1.42 -1.947 0 N-CA-C 107.747 -1.205 . . . . 61.44 107.747 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.428 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 28.7 Cg_endo -60.11 -14.75 30.19 Favored 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 122.044 1.829 . . . . 71.53 112.077 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -87.15 -9.68 54.64 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.892 -0.595 . . . . 62.22 110.545 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -76.02 154.01 36.06 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.81 -0.556 . . . . 71.53 111.193 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.532 ' O ' HG13 ' A' ' 35' ' ' ILE . 41.0 m -96.52 121.59 38.5 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 109.649 -0.5 . . . . 55.14 109.649 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.503 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -49.2 -52.5 26.38 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.115 1.524 . . . . 71.24 115.115 -173.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 14.4 m -79.46 -20.01 48.43 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 121.823 -0.548 . . . . 70.43 111.465 -175.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.87 -41.46 78.34 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.14 -1.8 . . . . 75.22 106.14 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 31' ' ' SER . 73.3 mt -62.79 -34.68 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 114.034 -1.439 . . . . 75.23 110.749 175.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 40' ' ' TYR . . . -52.94 -32.9 48.26 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 122.442 0.297 . . . . 55.51 111.577 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.551 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -72.91 -38.13 66.99 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 107.154 -1.425 . . . . 73.43 107.154 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 43.0 t-80 -62.95 -54.02 44.99 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.897 0.879 . . . . 72.31 110.747 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.551 HG21 ' CB ' ' A' ' 14' ' ' LEU . 26.8 m -68.22 -29.98 46.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.023 -0.989 . . . . 75.24 112.411 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 64.3 t80 . . . . . 0 N--CA 1.469 0.481 0 C-N-CA 124.278 1.031 . . . . 74.11 111.09 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.547 ' O ' HD12 ' A' ' 58' ' ' LEU 0.257 3.5 pp . . . . . 0 N--CA 1.429 -1.504 0 CA-C-O 121.973 0.892 . . . . 71.33 111.995 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.425 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 97.4 mtt180 -142.61 163.15 33.61 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.53 -1.213 . . . . 65.45 109.899 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 4.1 pp -129.16 142.39 50.89 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.178 0.807 . . . . 73.35 113.178 -173.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.7 mt -117.56 124.41 73.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 114.907 -1.042 . . . . 51.02 108.359 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.465 ' CD2' HD11 ' A' ' 67' ' ' LEU . 1.8 t80 -101.32 60.87 0.92 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 122.038 0.923 . . . . 74.32 109.629 -176.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 63.91 17.39 10.52 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 113.902 -1.499 . . . . 73.22 112.488 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.39 -65.96 0.01 OUTLIER Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 120.734 -0.746 . . . . 72.14 112.031 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -130.49 176.03 8.49 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.822 0.344 . . . . 72.2 110.583 -177.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 85.8 m-85 -86.84 120.96 28.68 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.465 -1.309 . . . . 74.21 107.465 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.575 ' CD1' HD22 ' A' ' 76' ' ' LEU . 76.5 mt -80.1 -47.07 15.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.747 0.784 . . . . 71.4 109.915 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -163.11 -173.46 3.43 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 125.602 1.561 . . . . 74.43 107.771 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -84.34 -37.3 11.11 Favored Glycine 0 N--CA 1.416 -2.688 0 C-N-CA 120.499 -0.858 . . . . 53.32 113.72 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.406 ' OD1' ' HB3' ' A' ' 31' ' ' SER . 64.3 t30 -160.22 39.12 0.18 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.312 1.053 . . . . 72.21 108.961 -172.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.586 HG12 HD21 ' A' ' 60' ' ' LEU . 7.6 p -66.2 147.42 12.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-N 114.593 -1.185 . . . . 74.14 110.023 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.557 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 42.4 p -78.55 156.91 28.96 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 116.21 -0.45 . . . . 70.43 111.408 -175.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.461 ' H ' HD22 ' A' ' 73' ' ' LEU . 2.5 mm? -66.34 -30.76 71.23 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.517 0.562 . . . . 63.01 112.517 -176.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.48 -30.37 76.41 Favored Glycine 0 C--O 1.229 -0.167 0 N-CA-C 111.192 -0.763 . . . . 63.3 111.192 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.31 -15.51 60.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.371 0.605 . . . . 73.12 109.961 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.575 HD22 ' CD1' ' A' ' 67' ' ' LEU . 61.2 mt -92.84 11.95 25.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.425 -0.807 . . . . 72.52 111.834 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.532 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.6 mptt 67.74 19.27 9.7 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.539 0.736 . . . . 61.55 110.975 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.433 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 79.4 mt -83.66 122.14 76.51 Favored Pre-proline 0 N--CA 1.441 -0.918 0 CA-C-N 116.03 -0.532 . . . . 63.35 110.895 -177.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.455 ' HG2' ' HG3' ' A' ' 82' ' ' LYS . 6.6 Cg_endo -83.71 140.21 9.15 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 122.227 1.951 . . . . 74.2 111.708 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.471 ' HA ' HG22 ' A' ' 10' ' ' ILE . 4.8 p90 -70.44 141.97 52.04 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 112.596 0.591 . . . . 75.4 112.596 177.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.85 -1.17 70.73 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.759 -1.109 . . . . 74.33 111.599 -174.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.455 ' HG3' ' HG2' ' A' ' 79' ' ' PRO . 31.7 mmmt -108.36 158.04 17.85 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.82 0.343 . . . . 73.0 110.41 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.49 HG23 HD22 ' A' ' 11' ' ' ASN . 86.5 m -103.69 125.22 50.03 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.666 -0.697 . . . . 73.22 110.077 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.0 m -133.64 142.76 48.22 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.127 -0.488 . . . . 74.32 110.402 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.4 132.62 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 121.066 0.46 . . . . 54.13 110.688 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 90.4 mtp -136.17 153.43 51.26 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.153 0.502 . . . . 74.31 111.395 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -103.05 132.88 48.99 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.648 -0.705 . . . . 75.3 109.413 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.407 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.4 mm? -120.04 142.38 48.89 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.125 -0.694 . . . . 74.44 109.125 -176.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.49 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 35.2 m -116.78 133.76 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 C-N-CA 119.932 -0.707 . . . . 73.43 110.994 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.547 0 N-CA-C 105.909 -1.885 . . . . 53.05 105.909 175.524 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.569 HG21 ' HB2' ' A' ' 11' ' ' ASN . 10.8 t . . . . . 0 N--CA 1.426 -1.664 0 N-CA-C 109.077 -0.712 . . . . 41.31 109.077 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -69.81 152.02 68.95 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.025 1.817 . . . . 75.52 110.646 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.47 72.23 4.98 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-O 122.462 1.125 . . . . 74.34 109.162 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -170.65 -28.41 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 112.784 -2.007 . . . . 71.34 107.566 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.6 mmm -113.87 160.67 18.5 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.05 -0.977 . . . . 55.3 108.734 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -121.79 139.58 48.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.189 -0.671 . . . . 62.44 109.189 173.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.569 ' HB2' HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -94.02 110.78 22.45 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.785 -1.191 . . . . 64.42 107.785 -177.166 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.478 ' HG ' HD22 ' A' ' 14' ' ' LEU . 46.2 tp -115.9 132.91 56.51 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.826 -0.625 . . . . 75.25 112.069 -174.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -111.36 121.27 44.79 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 114.994 -1.003 . . . . 54.44 109.018 173.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.592 ' CB ' HG21 ' A' ' 39' ' ' VAL . 1.9 mm? -98.6 121.4 40.5 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.825 -1.08 . . . . 75.0 108.316 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.1 mt -102.95 127.15 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 C-N-CA 119.586 -0.846 . . . . 74.1 109.642 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -83.8 155.51 22.97 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.44 -0.8 . . . . 72.35 110.24 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.3 m -64.12 -19.11 24.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 122.893 0.477 . . . . 70.42 111.898 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.437 ' HB2' ' HG2' ' A' ' 20' ' ' LYS . 20.2 m -80.95 1.93 28.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.21 0.529 . . . . 74.35 110.424 177.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.08 12.75 82.11 Favored Glycine 0 CA--C 1.501 -0.803 0 N-CA-C 111.804 -0.518 . . . . 73.42 111.804 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.437 ' HG2' ' HB2' ' A' ' 18' ' ' SER . 74.1 mmtt -88.63 135.77 33.33 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.035 -1.469 . . . . 74.3 107.035 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.6 p -112.67 129.28 56.45 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 119.801 -0.76 . . . . 73.52 109.88 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -122.93 137.53 54.92 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.939 -1.134 . . . . 74.43 107.939 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -138.13 131.65 30.79 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.755 -0.778 . . . . 70.12 110.08 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.653 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 89.3 m-85 -145.5 160.14 42.05 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 123.933 0.893 . . . . 73.22 109.011 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.1 mt -79.57 125.5 29.68 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 107.065 -1.457 . . . . 65.41 107.065 170.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.653 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 87.8 m-85 -123.8 163.16 21.76 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.927 -1.138 . . . . 63.31 107.927 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 84.7 p -87.62 148.47 44.07 Favored Pre-proline 0 C--N 1.288 -2.095 0 N-CA-C 108.226 -1.027 . . . . 73.21 108.226 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.98 -14.87 35.42 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.252 1.968 . . . . 44.3 111.355 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -82.9 -17.8 42.46 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.066 -0.97 . . . . 73.14 110.281 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.431 ' O ' HD22 ' A' ' 73' ' ' LEU . 18.1 m-20 -67.95 154.61 41.23 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.009 0.433 . . . . 63.11 110.666 176.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.552 ' O ' HG13 ' A' ' 35' ' ' ILE . 51.1 m -105.13 129.53 53.51 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 116.039 -0.528 . . . . 74.21 110.536 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.807 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -49.86 -50.22 46.4 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.007 1.484 . . . . 54.31 115.007 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m -76.14 -27.15 56.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.284 0.493 . . . . 73.13 110.676 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.89 -45.55 91.98 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.239 -1.393 . . . . 60.41 107.239 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 31' ' ' SER . 66.1 mt -65.18 -42.49 94.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 114.348 -1.296 . . . . 74.22 110.657 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.419 ' O ' ' HD1' ' A' ' 40' ' ' TYR . . . -50.07 -50.08 49.24 Favored 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 122.856 0.462 . . . . 75.35 111.154 175.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -64.4 -38.44 91.03 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 108.142 -1.058 . . . . 73.04 108.142 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.496 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 35.3 t-80 -61.21 -54.26 46.45 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 114.844 -1.071 . . . . 72.34 110.706 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.592 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.1 m -69.97 -32.17 50.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 115.756 -0.656 . . . . 72.52 112.264 -178.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.419 ' HD1' ' O ' ' A' ' 36' ' ' ALA . 11.7 m-85 . . . . . 0 C--O 1.235 0.33 0 N-CA-C 112.764 0.653 . . . . 74.15 112.764 174.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 CA--C 1.5 -0.962 0 N-CA-C 109.195 -0.668 . . . . 32.5 109.195 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.42 ' HD3' ' HA2' ' A' ' 69' ' ' GLY . 18.4 mmt180 -140.77 155.06 46.5 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.081 -0.711 . . . . 75.34 109.081 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.807 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.3 pp -135.39 144.47 46.59 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.395 -0.821 . . . . 75.44 110.189 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.459 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 98.7 mt -117.34 122.45 69.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 108.708 -0.849 . . . . 63.44 108.708 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -100.97 87.94 3.41 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.906 -1.516 . . . . 74.43 106.906 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 69.55 -64.94 0.32 Allowed 'General case' 0 N--CA 1.408 -2.527 0 C-N-CA 127.409 2.283 . . . . 63.04 112.401 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.47 -43.88 0.62 Allowed Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.205 -0.997 . . . . 74.4 113.712 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.85 162.26 18.4 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 115.049 1.5 . . . . 65.03 115.049 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.625 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 38.4 m-85 -84.19 117.5 23.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.018 -0.992 . . . . 72.31 108.335 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.504 HD12 ' CD2' ' A' ' 76' ' ' LEU . 66.4 mt -80.18 -47.2 15.07 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 114.6 1.333 . . . . 71.34 114.6 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.404 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 9.7 t60 -165.83 167.31 16.99 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.138 -1.43 . . . . 71.0 107.138 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.42 ' HA2' ' HD3' ' A' ' 59' ' ' ARG . . . -63.99 -19.08 63.11 Favored Glycine 0 C--O 1.209 -1.435 0 N-CA-C 114.187 0.435 . . . . 74.42 114.187 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.424 ' OD1' ' HB3' ' A' ' 31' ' ' SER . 65.3 t30 177.88 80.36 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 108.864 -0.791 . . . . 72.22 108.864 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.715 HG12 HD21 ' A' ' 60' ' ' LEU . 9.1 p -102.55 151.34 6.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.028 -0.73 . . . . 70.34 109.028 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.492 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 55.1 p -78.51 157.64 28.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.598 0.237 . . . . 74.0 111.172 -178.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.518 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.9 mm? -67.74 -32.43 73.03 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 120.715 0.293 . . . . 72.4 110.766 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.62 -41.22 99.84 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.672 -0.971 . . . . 44.34 110.672 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -68.99 -15.84 63.58 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.099 0.56 . . . . 43.22 111.269 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.624 ' HB2' HD13 ' A' ' 78' ' ' LEU . 87.1 mt -82.52 -1.6 50.98 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.852 0.461 . . . . 74.23 110.105 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.5 mptt 69.77 57.56 0.31 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.331 1.052 . . . . 64.25 110.551 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.624 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.3 mp -109.52 124.2 34.47 Favored Pre-proline 0 C--N 1.304 -1.382 0 CA-C-N 115.382 -0.826 . . . . 75.44 110.41 175.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 4.6 Cg_exo -76.17 154.48 37.13 Favored 'Trans proline' 0 N--CA 1.432 -2.09 0 C-N-CA 121.608 1.539 . . . . 54.22 108.883 173.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -72.74 154.41 40.69 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.048 -0.723 . . . . 73.43 109.048 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 75.91 10.65 85.04 Favored Glycine 0 C--N 1.304 -1.228 0 C-N-CA 120.802 -0.713 . . . . 62.2 113.04 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -110.62 153.57 25.0 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.638 -0.504 . . . . 62.24 109.638 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.558 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 56.9 m -104.98 129.74 53.34 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.347 -0.612 . . . . 62.41 109.347 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.8 m -138.72 142.26 38.9 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.119 0.485 . . . . 64.32 110.928 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.9 p -109.56 142.39 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 115.672 -0.695 . . . . 51.23 110.374 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 91.1 mtp -135.78 153.88 51.4 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 120.987 0.422 . . . . 62.35 110.403 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.469 ' C ' HD22 ' A' ' 88' ' ' LEU . 82.4 m-70 -106.02 131.25 53.54 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.925 -1.139 . . . . 74.22 107.925 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.469 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.5 mm? -122.85 143.91 49.55 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.578 -0.449 . . . . 73.12 110.781 -176.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.74 137.0 52.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 121.051 0.453 . . . . 73.22 110.682 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.41 0 CA-C-N 115.6 -0.727 . . . . 55.33 109.046 178.877 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.5 HG21 ' HB2' ' A' ' 11' ' ' ASN . 3.7 t . . . . . 0 N--CA 1.436 -1.147 0 N-CA-C 110.664 -0.124 . . . . 32.01 110.664 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -74.9 165.28 31.72 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.674 2.249 . . . . 72.14 110.585 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.83 68.57 10.52 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 122.013 0.911 . . . . 75.15 110.179 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.41 ' H ' ' H ' ' A' ' 9' ' ' MET . 27.9 t70 -167.44 -30.03 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 113.66 -1.609 . . . . 75.24 107.929 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.41 ' H ' ' H ' ' A' ' 8' ' ' ASP . 90.5 mmm -105.41 158.57 16.56 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.472 -1.24 . . . . 72.15 109.312 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -119.32 140.12 44.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 109.313 -0.625 . . . . 74.53 109.313 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -90.93 112.7 24.68 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.897 -1.149 . . . . 73.24 107.897 -176.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.484 ' HG ' HD22 ' A' ' 14' ' ' LEU . 35.4 tp -117.29 132.96 56.5 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.44 0.638 . . . . 75.42 112.578 -174.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.414 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . 26.5 ttt85 -106.95 121.44 44.44 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 115.12 -0.945 . . . . 63.14 108.853 174.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.546 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.2 mm? -99.48 120.87 40.33 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.209 -0.905 . . . . 72.33 108.884 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.57 HD12 HG22 ' A' ' 21' ' ' THR . 23.4 mm -99.49 116.71 43.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 107.118 -1.438 . . . . 74.42 107.118 177.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.46 167.45 21.82 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 123.292 0.37 . . . . 73.33 111.693 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -67.61 -28.64 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.746 0.784 . . . . 63.41 110.242 -176.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -76.79 4.43 9.7 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.144 -0.935 . . . . 45.53 111.454 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.65 10.32 86.29 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 111.672 -0.571 . . . . 72.4 111.672 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -91.53 131.8 36.71 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.717 -0.846 . . . . 72.41 108.717 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.57 HG22 HD12 ' A' ' 15' ' ' ILE . 59.8 p -104.91 135.03 47.02 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 116.572 -0.285 . . . . 74.53 110.286 -175.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -142.46 139.61 31.63 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.266 -1.013 . . . . 74.15 108.266 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -134.44 132.57 39.49 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.016 -0.674 . . . . 63.21 111.55 -171.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.611 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 90.7 m-85 -144.99 160.81 40.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.161 0.584 . . . . 73.42 110.881 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.4 mt -79.36 126.6 31.02 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.306 -0.998 . . . . 45.33 108.306 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.611 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 78.4 m-85 -127.35 161.57 28.34 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.104 0.478 . . . . 73.21 110.411 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.502 ' HB2' ' OD2' ' A' ' 30' ' ' ASP . 31.4 m -84.71 137.05 38.62 Favored Pre-proline 0 N--CA 1.411 -2.386 0 N-CA-C 107.951 -1.129 . . . . 73.32 107.951 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.438 ' O ' ' HB ' ' A' ' 72' ' ' THR . 30.4 Cg_endo -60.18 -14.55 29.53 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.083 2.522 . . . . 70.43 113.878 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -85.89 -8.17 58.22 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.017 0.377 . . . . 74.13 112.017 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.502 ' OD2' ' HB2' ' A' ' 27' ' ' SER . 11.8 m-20 -79.28 153.71 29.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.736 0.303 . . . . 65.43 111.078 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.445 ' O ' HG13 ' A' ' 35' ' ' ILE . 67.2 m -95.03 124.35 39.02 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.509 -0.314 . . . . 55.31 110.492 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.718 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -49.32 -41.34 38.24 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.563 1.145 . . . . 74.12 113.782 -177.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 p -71.48 -32.78 68.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.023 0.439 . . . . 75.03 111.872 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.68 -42.25 82.42 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.098 -1.075 . . . . 75.03 108.098 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.46 ' O ' HG22 ' A' ' 39' ' ' VAL . 68.7 mt -60.9 -43.18 95.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.011 -1.449 . . . . 71.3 110.906 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.456 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -51.0 -41.89 60.05 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.504 0.721 . . . . 60.54 112.106 176.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.504 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -72.59 -33.78 66.96 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 107.153 -1.425 . . . . 71.44 107.153 -177.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -70.09 -50.97 35.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.362 1.065 . . . . 74.53 111.789 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.546 HG21 ' CB ' ' A' ' 14' ' ' LEU . 30.6 m -68.05 -31.47 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 113.35 0.87 . . . . 44.13 113.35 -177.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.6 t80 . . . . . 0 N--CA 1.468 0.47 0 O-C-N 124.061 0.85 . . . . 63.54 112.288 -177.73 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.413 ' C ' ' HD3' ' A' ' 59' ' ' ARG . 96.9 mt . . . . . 0 N--CA 1.44 -0.927 0 N-CA-C 110.359 -0.237 . . . . 23.31 110.359 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.461 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -137.97 148.84 45.6 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 109.75 -0.463 . . . . 62.25 109.75 172.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.718 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.5 pp -120.45 131.6 54.84 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 115.462 -0.79 . . . . 54.32 110.341 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 88.0 mt -103.14 124.3 57.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.507 0 N-CA-C 107.522 -1.288 . . . . 63.12 107.522 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -99.65 84.79 3.0 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 106.252 -1.759 . . . . 75.53 106.252 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 66.58 -65.64 0.2 Allowed 'General case' 0 N--CA 1.405 -2.7 0 C-N-CA 127.58 2.352 . . . . 75.12 111.724 -175.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.25 -14.48 2.97 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 120.859 -0.686 . . . . 60.31 114.747 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.492 ' H ' ' HD2' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -122.92 148.0 45.96 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 118.612 1.206 . . . . 73.41 110.826 -178.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -84.36 111.59 19.57 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.559 -1.274 . . . . 73.52 107.559 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.629 HD12 HD22 ' A' ' 76' ' ' LEU . 59.5 mt -81.18 -46.99 14.03 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 114.404 1.261 . . . . 70.05 114.404 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.694 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.0 t-80 -171.65 176.17 3.79 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.925 -1.509 . . . . 61.0 106.925 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -85.71 -1.07 87.56 Favored Glycine 0 C--N 1.3 -1.44 0 N-CA-C 115.867 1.107 . . . . 74.22 115.867 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -169.39 19.32 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 118.429 1.115 . . . . 71.32 111.935 -170.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.574 HG12 HD21 ' A' ' 60' ' ' LEU . 11.3 p -74.92 146.74 9.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 120.653 -0.419 . . . . 55.32 110.223 -175.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.482 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 38.6 p -78.88 157.85 28.22 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.743 -0.662 . . . . 75.22 111.292 -175.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.576 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.2 mm? -66.4 -34.97 79.16 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.473 -0.33 . . . . 62.31 110.752 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.33 -35.06 90.38 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.556 -0.83 . . . . 70.31 111.281 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -75.42 -16.45 60.35 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 122.796 0.438 . . . . 72.11 111.404 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.629 HD22 HD12 ' A' ' 67' ' ' LEU . 45.4 mt -82.87 1.93 36.87 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.129 -0.693 . . . . 70.11 109.129 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.94 74.32 0.14 Allowed 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.08 1.352 . . . . 54.35 111.356 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.468 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.5 mp -127.33 112.13 21.31 Favored Pre-proline 0 CA--C 1.497 -1.067 0 CA-C-N 115.302 -0.863 . . . . 71.24 111.49 176.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.28 154.46 72.1 Favored 'Trans proline' 0 N--CA 1.445 -1.337 0 C-N-CA 122.08 1.853 . . . . 52.34 108.011 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -69.48 144.25 53.28 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.181 -0.674 . . . . 72.34 109.181 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.42 9.98 68.72 Favored Glycine 0 C--N 1.305 -1.155 0 C-N-CA 119.892 -1.147 . . . . 35.05 113.347 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -101.55 138.2 38.86 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 117.374 0.587 . . . . 74.13 110.342 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.641 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 58.8 m -92.13 117.51 29.92 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.872 -1.159 . . . . 75.13 107.872 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.0 m -130.68 135.91 48.29 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.083 -0.508 . . . . 64.15 111.229 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.414 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 7.7 p -102.14 138.46 26.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 116.065 -0.516 . . . . 74.45 111.453 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.537 ' O ' HG12 ' A' ' 15' ' ' ILE . 86.1 mtp -134.46 152.07 51.56 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.96 -0.385 . . . . 71.24 109.96 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 23.1 m-70 -108.13 132.02 54.04 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.098 -1.075 . . . . 53.33 108.098 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.5 mm? -116.9 141.88 47.65 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 120.366 -0.534 . . . . 64.14 111.016 -176.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.62 132.65 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 CA-C-N 115.863 -0.608 . . . . 62.22 109.773 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.267 0 CA-C-N 115.824 -0.625 . . . . 51.4 109.513 179.648 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.428 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 15.1 t . . . . . 0 N--CA 1.423 -1.798 0 N-CA-C 107.91 -1.144 . . . . 65.35 107.91 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -69.71 151.22 69.3 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 122.298 1.999 . . . . 64.23 111.888 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.65 69.9 6.04 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 122.061 0.934 . . . . 43.23 109.949 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.409 ' H ' ' H ' ' A' ' 9' ' ' MET . 31.0 t70 -173.47 -21.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.386 -1.733 . . . . 60.32 107.672 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.409 ' H ' ' H ' ' A' ' 8' ' ' ASP . 94.2 mmm -118.26 160.11 22.18 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.892 -1.049 . . . . 73.11 108.968 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -125.11 137.91 56.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.843 -0.799 . . . . 73.54 108.843 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.582 HD22 HG23 ' A' ' 83' ' ' THR . 4.9 t30 -92.06 107.73 19.42 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.713 -1.217 . . . . 72.3 107.713 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.55 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.5 tp -111.11 133.1 53.74 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.656 -0.702 . . . . 71.01 112.559 -171.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.422 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 35.9 ttp180 -109.5 121.03 44.29 Favored 'General case' 0 N--CA 1.414 -2.244 0 CA-C-N 115.195 -0.911 . . . . 75.11 109.008 174.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.581 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.0 mm? -101.45 126.71 48.27 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-N 114.462 -1.245 . . . . 63.34 108.504 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 21' ' ' THR . 26.0 mt -104.32 127.31 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 C-N-CA 119.379 -0.928 . . . . 73.21 109.477 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.14 156.87 20.85 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.365 -0.606 . . . . 74.52 109.365 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.52 -13.01 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.474 0.546 . . . . 75.11 112.474 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.8 t -76.1 -12.15 60.06 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.717 0.77 . . . . 74.42 109.06 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.13 -3.28 64.24 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.677 -0.569 . . . . 65.23 111.677 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.1 134.74 33.69 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.731 0.3 . . . . 74.05 110.332 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 15' ' ' ILE . 67.5 p -98.61 150.11 22.08 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 121.193 0.521 . . . . 64.13 110.753 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.447 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -132.4 138.44 47.69 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.027 -1.471 . . . . 71.23 107.027 174.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HG3' ' HB2' ' A' ' 13' ' ' ARG . 27.0 tt0 -137.68 129.65 28.83 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.072 -1.084 . . . . 70.54 108.072 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.694 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 97.3 m-85 -145.91 159.41 43.27 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.905 -0.776 . . . . 73.31 108.905 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.0 tp -83.19 124.92 31.0 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 106.862 -1.533 . . . . 70.45 106.862 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.694 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 94.2 m-85 -129.52 163.6 25.59 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.76 -0.83 . . . . 71.2 108.76 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.8 p -87.79 145.1 36.1 Favored Pre-proline 0 N--CA 1.41 -2.443 0 N-CA-C 107.339 -1.356 . . . . 74.41 107.339 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.553 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 26.6 Cg_endo -61.62 -11.63 21.17 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 122.329 2.02 . . . . 62.31 112.37 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.88 -7.27 49.77 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 109.364 -0.606 . . . . 65.14 109.364 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -71.9 154.09 41.45 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 122.087 -0.383 . . . . 75.1 110.09 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.532 ' O ' HG13 ' A' ' 35' ' ' ILE . 8.3 p -94.77 121.4 36.32 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-O 121.04 0.448 . . . . 54.31 111.445 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.417 ' CB ' HD22 ' A' ' 60' ' ' LEU . . . -46.0 -51.68 13.11 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.178 1.548 . . . . 72.21 115.178 -174.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.532 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 18.7 m -78.16 -20.69 51.48 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.633 -0.827 . . . . 71.13 112.502 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -69.25 -42.44 75.61 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 106.45 -1.685 . . . . 61.31 106.45 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.534 ' O ' HG22 ' A' ' 39' ' ' VAL . 61.3 mt -62.29 -40.21 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.473 -1.239 . . . . 72.43 110.055 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.402 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.31 -43.96 53.9 Favored 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 123.051 0.54 . . . . 73.41 111.332 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.515 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 1.7 tmtp? -72.83 -37.91 67.29 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.898 -0.778 . . . . 74.24 108.898 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -56.87 -50.75 71.53 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.419 -0.81 . . . . 73.33 109.971 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.581 HG21 ' CB ' ' A' ' 14' ' ' LEU . 29.5 m -73.29 -32.38 37.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.629 -0.714 . . . . 64.4 111.129 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.0 t80 . . . . . 0 CA--C 1.519 -0.224 0 C-N-CA 123.555 0.742 . . . . 75.31 110.755 176.263 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 2.1 pt? . . . . . 0 CA--C 1.488 -1.431 0 N-CA-C 107.109 -1.441 . . . . 64.11 107.109 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 38.5 ptt180 -131.45 159.78 37.07 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-O 121.847 0.832 . . . . 65.3 112.828 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.647 HD21 HG12 ' A' ' 71' ' ' VAL . 4.4 pp -115.4 146.72 41.33 Favored 'General case' 0 N--CA 1.407 -2.585 0 CA-C-N 114.657 -1.156 . . . . 62.24 112.349 -171.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 94.9 mt -116.67 122.79 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.637 0 CA-C-N 114.351 -1.295 . . . . 72.54 107.773 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -100.16 89.42 4.01 Favored 'General case' 0 C--N 1.263 -3.18 0 N-CA-C 105.667 -1.975 . . . . 62.42 105.667 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 69.94 -70.05 0.16 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.325 -1.761 . . . . 73.25 112.717 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.47 2.44 3.46 Favored Glycine 0 C--N 1.313 -0.73 0 C-N-CA 119.94 -1.124 . . . . 74.44 113.043 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -130.72 140.94 50.37 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.121 0.415 . . . . 65.2 112.121 -176.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -83.59 113.82 21.09 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.464 -1.309 . . . . 75.3 107.464 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.611 HD12 HD22 ' A' ' 76' ' ' LEU . 60.8 mt -79.79 -46.21 17.38 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 119.48 -0.888 . . . . 65.03 112.733 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.552 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.6 t60 -169.9 169.71 8.1 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 104.091 -2.559 . . . . 60.01 104.091 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -63.67 -47.13 89.56 Favored Glycine 0 C--O 1.201 -1.966 0 C-N-CA 120.185 -1.007 . . . . 64.24 113.589 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.453 ' OD1' ' HB2' ' A' ' 31' ' ' SER . 10.2 t30 -152.58 72.0 0.96 Allowed 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 122.348 1.07 . . . . 61.05 109.517 -172.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.647 HG12 HD21 ' A' ' 60' ' ' LEU . 7.2 p -101.62 151.29 5.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 113.617 -1.629 . . . . 73.34 108.079 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.458 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 42.0 p -78.12 158.73 29.0 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.677 0.275 . . . . 71.44 111.406 -175.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.59 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.2 mm? -68.27 -32.72 73.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.365 -0.38 . . . . 72.53 111.146 -176.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.19 -36.95 93.88 Favored Glycine 0 C--O 1.24 0.507 0 N-CA-C 110.743 -0.943 . . . . 72.43 110.743 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.464 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -71.48 -15.43 62.32 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.011 0.524 . . . . 74.21 110.835 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.611 HD22 HD12 ' A' ' 67' ' ' LEU . 86.5 mt -82.58 6.31 18.05 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.402 0.681 . . . . 71.35 110.237 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 77.03 10.94 2.47 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.824 1.249 . . . . 52.45 111.828 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.606 HD13 ' HB2' ' A' ' 76' ' ' LEU . 9.6 mp -72.37 119.26 73.89 Favored Pre-proline 0 C--O 1.24 0.565 0 N-CA-C 112.95 0.722 . . . . 74.43 112.95 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 4.3 Cg_exo -76.85 159.41 34.63 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.022 2.481 . . . . 65.43 109.75 173.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.41 ' CE1' ' HG3' ' A' ' 28' ' ' PRO . 7.6 m-85 -77.25 156.73 31.24 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.388 -0.597 . . . . 73.43 109.388 -176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.428 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 79.55 10.19 86.11 Favored Glycine 0 C--N 1.308 -0.973 0 C-N-CA 120.896 -0.669 . . . . 74.51 113.546 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -115.62 155.81 26.98 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 120.798 0.332 . . . . 44.51 111.414 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.582 HG23 HD22 ' A' ' 11' ' ' ASN . 84.1 m -105.2 125.89 51.48 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.761 -0.654 . . . . 74.21 109.266 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.3 m -136.34 142.2 43.82 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.905 0.383 . . . . 75.33 111.85 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.47 142.2 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.031 -0.531 . . . . 51.41 110.744 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 93.0 mtp -137.0 153.26 50.71 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.276 0.56 . . . . 74.13 110.949 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.481 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 35.0 m-70 -111.56 130.8 55.62 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.773 -1.566 . . . . 61.52 106.773 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.2 mm? -119.12 143.49 47.15 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.635 -0.426 . . . . 70.41 111.249 -174.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.88 134.24 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.503 -0.554 . . . . 54.41 109.503 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.635 0 N-CA-C 109.717 -0.475 . . . . 54.2 109.717 177.409 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 11' ' ' ASN . 2.0 t . . . . . 0 N--CA 1.407 -2.602 0 N-CA-C 110.605 -0.146 . . . . 75.43 110.605 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.07 144.07 51.24 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.918 1.745 . . . . 72.04 109.109 172.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.35 71.3 3.83 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.772 0.796 . . . . 74.13 111.23 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -175.48 -27.43 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.95 -1.477 . . . . 64.42 108.14 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.9 mmm -110.45 157.46 19.55 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.605 -1.18 . . . . 74.13 108.866 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.458 HG22 ' HA ' ' A' ' 80' ' ' PHE . 2.7 pp -111.13 134.79 52.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 110.079 -0.341 . . . . 73.01 110.079 174.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.47 HD22 HG23 ' A' ' 83' ' ' THR . 3.6 t30 -92.75 107.55 19.31 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 107.964 -1.124 . . . . 64.21 107.964 -176.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.575 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.1 tp -111.84 132.57 54.61 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.676 0.75 . . . . 74.32 112.389 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -107.19 119.98 40.86 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 108.333 -0.988 . . . . 72.53 108.333 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.575 HD22 ' HG ' ' A' ' 12' ' ' LEU . 2.5 mm? -99.09 125.73 44.68 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 124.704 1.201 . . . . 74.01 110.023 -177.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.439 HG23 HG22 ' A' ' 21' ' ' THR . 29.0 mt -100.2 117.61 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 108.441 -0.948 . . . . 75.52 108.441 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.497 HD21 HG23 ' A' ' 39' ' ' VAL . 68.8 mt -75.1 162.21 28.73 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.108 -0.496 . . . . 64.43 111.733 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.32 -15.8 20.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.484 -0.78 . . . . 71.35 110.219 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.0 m -76.81 -14.71 59.88 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.438 -0.801 . . . . 61.3 109.295 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.7 1.83 67.82 Favored Glycine 0 CA--C 1.501 -0.837 0 CA-C-N 115.882 -0.599 . . . . 53.04 112.076 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -89.12 133.06 34.53 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.103 -1.073 . . . . 75.11 108.103 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.439 HG22 HG23 ' A' ' 15' ' ' ILE . 76.9 p -98.78 129.8 45.21 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.877 -0.786 . . . . 63.15 108.877 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.454 ' HD2' HD11 ' A' ' 16' ' ' LEU . 26.6 mtpp -127.93 149.38 50.35 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.702 -0.851 . . . . 71.44 108.702 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -136.34 131.25 34.05 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.447 -0.901 . . . . 51.22 109.791 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.602 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.5 m-85 -144.73 159.21 43.22 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 123.735 0.814 . . . . 74.42 108.85 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.5 tp -89.36 128.5 35.91 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.626 -0.879 . . . . 54.25 108.626 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.602 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 97.0 m-85 -132.2 173.95 10.72 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.977 -0.379 . . . . 71.3 109.977 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.2 p -98.76 150.46 36.72 Favored Pre-proline 0 N--CA 1.421 -1.896 0 N-CA-C 108.331 -0.988 . . . . 73.14 108.331 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.431 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 36.2 Cg_endo -62.33 -11.38 22.29 Favored 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 122.257 1.971 . . . . 75.02 111.989 177.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -79.82 -22.15 43.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.301 1.041 . . . . 73.05 111.258 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -67.55 153.46 43.65 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.319 0.489 . . . . 72.44 112.319 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.476 ' O ' HG13 ' A' ' 35' ' ' ILE . 51.7 p -100.38 118.91 37.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.54 -0.541 . . . . 74.11 109.54 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.693 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -46.09 -51.19 14.29 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 115.205 1.557 . . . . 70.13 115.205 -173.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.7 m -71.85 -26.15 62.25 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 122.011 -0.43 . . . . 70.34 111.649 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.37 -41.19 76.84 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 107.75 -1.204 . . . . 73.4 107.75 173.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.554 ' O ' HG22 ' A' ' 39' ' ' VAL . 66.2 mt -60.66 -40.11 83.68 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 CA-C-N 114.031 -1.44 . . . . 72.42 110.186 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.489 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.12 -40.64 46.67 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 123.4 0.68 . . . . 71.43 111.026 176.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -73.22 -43.64 60.91 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.793 -0.639 . . . . 73.43 109.746 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -61.45 -39.91 92.55 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.728 0.811 . . . . 72.12 111.636 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 35' ' ' ILE . 29.4 m -77.08 -31.86 18.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.192 -0.458 . . . . 72.52 111.69 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 50.9 t80 . . . . . 0 CA--C 1.535 0.396 0 O-C-N 124.102 0.876 . . . . 74.01 110.273 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.599 ' O ' ' HD2' ' A' ' 59' ' ' ARG . 2.9 mm? . . . . . 0 CA--C 1.504 -0.814 0 CA-C-O 120.759 0.314 . . . . 71.43 110.922 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.599 ' HD2' ' O ' ' A' ' 58' ' ' LEU . 3.3 mpt_? -130.07 162.85 27.84 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 123.78 0.832 . . . . 72.21 109.138 174.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.693 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.2 pp -148.19 144.49 27.77 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.671 -0.492 . . . . 72.42 109.671 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.552 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 88.5 mt -117.67 119.17 60.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.774 -0.825 . . . . 75.14 108.774 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -101.97 86.01 2.8 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.351 -0.611 . . . . 74.5 109.351 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 44.98 70.55 0.33 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.707 -1.588 . . . . 74.25 112.228 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.06 -72.5 0.45 Allowed Glycine 0 N--CA 1.431 -1.666 0 C-N-CA 119.907 -1.139 . . . . 75.11 113.261 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -117.13 164.77 14.26 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 117.518 0.659 . . . . 72.45 112.772 -173.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 67.9 m-85 -86.11 113.85 22.49 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.46 -1.311 . . . . 72.31 107.46 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.575 HD12 HD22 ' A' ' 76' ' ' LEU . 70.0 mt -80.13 -47.32 14.94 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.398 1.259 . . . . 71.11 114.398 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.523 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 8.4 t60 -174.64 151.82 1.54 Allowed 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 107.218 -1.401 . . . . 63.31 107.218 -174.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.83 1.3 39.63 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.073 1.189 . . . . 65.03 116.073 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -168.7 27.55 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.144 0.972 . . . . 72.5 110.053 -169.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.548 HG12 HD21 ' A' ' 60' ' ' LEU . 12.6 p -84.17 142.92 12.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 119.592 -0.843 . . . . 65.21 110.219 -177.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 49.2 p -81.44 160.22 24.06 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.94 -0.573 . . . . 63.33 111.304 -177.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.564 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.9 mm? -65.42 -33.09 75.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.208 -0.451 . . . . 72.25 111.811 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.64 -30.87 75.14 Favored Glycine 0 C--O 1.238 0.352 0 C-N-CA 120.099 -1.048 . . . . 74.13 111.085 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -74.5 -15.35 60.88 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.456 0.702 . . . . 52.41 110.646 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.575 HD22 HD12 ' A' ' 67' ' ' LEU . 74.3 mt -81.95 11.49 5.01 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.413 -0.588 . . . . 72.13 109.413 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.405 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER 67.99 17.79 9.54 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.771 1.228 . . . . 73.03 110.856 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.526 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 91.5 mt -82.86 120.08 75.59 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 115.775 -0.648 . . . . 60.13 110.753 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -82.21 138.83 10.23 Favored 'Trans proline' 0 N--CA 1.435 -1.964 0 C-N-CA 122.145 1.896 . . . . 55.45 110.531 175.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.458 ' HA ' HG22 ' A' ' 10' ' ' ILE . 5.6 p90 -67.41 149.91 49.64 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.358 0.599 . . . . 71.31 112.504 178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.69 5.79 64.44 Favored Glycine 0 N--CA 1.432 -1.573 0 CA-C-N 115.203 -0.908 . . . . 72.01 111.763 -174.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -124.0 164.89 18.42 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 109.843 -0.429 . . . . 63.22 109.843 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.47 HG23 HD22 ' A' ' 11' ' ' ASN . 64.2 m -106.69 134.65 49.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.7 0.286 . . . . 72.23 110.283 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.5 m -141.02 142.36 34.24 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 122.212 -0.305 . . . . 74.32 111.706 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.7 p -108.92 142.76 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 122.774 0.43 . . . . 74.02 110.118 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 92.8 mtp -136.22 152.94 51.29 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 120.994 0.426 . . . . 71.24 110.515 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.552 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 30.6 m-70 -104.46 130.16 52.39 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.269 -1.382 . . . . 72.01 107.269 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.489 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.5 mm? -117.79 144.4 45.38 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.524 -0.471 . . . . 64.52 110.762 -176.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.1 m -133.28 134.65 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 109.344 -0.613 . . . . 72.14 109.344 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.27 0 CA-C-O 121.066 0.46 . . . . 73.15 110.759 177.746 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.47 HG13 HD11 ' A' ' 25' ' ' LEU . 26.0 t . . . . . 0 N--CA 1.432 -1.339 0 N-CA-C 109.201 -0.666 . . . . 53.21 109.201 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.89 161.26 33.34 Favored 'Trans proline' 0 C--O 1.247 0.955 0 C-N-CA 122.574 2.183 . . . . 71.42 111.207 177.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.94 74.13 6.69 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 121.869 0.843 . . . . 72.12 109.101 175.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -171.2 -28.64 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.524 -1.671 . . . . 74.54 108.594 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 89.1 mmm -111.97 151.86 28.76 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.776 -1.102 . . . . 74.03 108.867 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.461 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.7 pp -111.34 136.32 47.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-O 120.817 0.341 . . . . 65.22 110.687 176.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.409 ' HB2' HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -83.01 111.58 18.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.775 -1.194 . . . . 73.2 107.775 -177.026 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.478 ' HG ' HD22 ' A' ' 14' ' ' LEU . 40.0 tp -118.01 132.93 56.33 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.482 0.658 . . . . 61.34 112.627 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.44 ' HD2' ' OE1' ' A' ' 23' ' ' GLU . 19.0 ttt85 -113.48 122.34 47.02 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 114.994 -1.003 . . . . 61.11 108.878 175.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.517 ' CB ' HG21 ' A' ' 39' ' ' VAL . 1.9 mm? -100.09 125.11 46.14 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 124.502 1.121 . . . . 73.1 108.609 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.637 HD12 HG22 ' A' ' 21' ' ' THR . 18.8 mm -99.28 123.71 52.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.629 -1.248 . . . . 73.33 107.629 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.23 156.87 24.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.399 -0.593 . . . . 74.53 109.399 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.435 ' CG1' ' HA ' ' A' ' 89' ' ' VAL . 35.3 m -66.21 -14.24 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.153 0.427 . . . . 53.11 112.153 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.2 t -76.27 -16.85 59.71 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.859 -0.61 . . . . 72.02 109.686 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.57 -6.19 57.33 Favored Glycine 0 N--CA 1.433 -1.559 0 C-N-CA 120.576 -0.821 . . . . 52.3 112.178 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -86.88 140.05 30.03 Favored 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 119.182 -1.007 . . . . 51.5 110.401 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.637 HG22 HD12 ' A' ' 15' ' ' ILE . 62.0 p -99.11 137.15 38.04 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 115.07 -0.968 . . . . 42.34 109.651 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -126.86 138.28 53.3 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.29 -1.744 . . . . 72.32 106.29 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 26.3 tt0 -137.71 131.15 30.94 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.09 -1.044 . . . . 64.24 110.818 -176.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.587 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 86.1 m-85 -145.03 159.79 42.39 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 123.382 0.673 . . . . 74.32 109.267 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.47 HD11 HG13 ' A' ' 5' ' ' VAL . 41.2 tp -84.67 125.15 32.25 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.386 -0.968 . . . . 63.23 108.386 176.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.587 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 96.3 m-85 -128.9 174.44 9.5 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.225 -0.657 . . . . 74.31 109.225 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.0 p -97.59 154.14 38.05 Favored Pre-proline 0 N--CA 1.431 -1.408 0 C-N-CA 119.193 -1.003 . . . . 64.55 108.818 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.589 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 45.0 Cg_endo -64.18 -12.9 34.84 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.576 2.184 . . . . 74.1 112.105 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -93.33 -7.33 45.13 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.161 -0.472 . . . . 65.53 111.642 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -79.2 153.28 30.12 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 120.485 -0.486 . . . . 72.41 111.186 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.489 ' O ' HG13 ' A' ' 35' ' ' ILE . 45.5 m -93.17 122.41 35.53 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.664 0.269 . . . . 73.4 110.775 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.717 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -49.34 -46.81 47.35 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.919 1.288 . . . . 42.32 113.409 -176.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 p -67.5 -33.71 75.65 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 113.05 0.759 . . . . 65.53 113.05 -177.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.54 -44.89 66.57 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.606 -1.257 . . . . 63.2 107.606 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 31' ' ' SER . 69.4 mt -55.29 -40.79 58.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 114.539 -1.209 . . . . 75.54 111.148 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.431 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.7 -37.65 42.55 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 123.549 0.74 . . . . 75.44 111.647 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -73.81 -34.58 64.66 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 120.755 0.312 . . . . 73.04 111.208 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -71.93 -44.25 63.94 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.405 -0.361 . . . . 70.44 111.829 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.517 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.4 m -65.24 -31.07 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 120.814 0.34 . . . . 72.34 110.886 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.7 t80 . . . . . 0 C--O 1.242 0.701 0 CA-C-N 115.431 -0.804 . . . . 73.02 111.542 175.807 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 CA--C 1.502 -0.87 0 CA-C-O 120.875 0.369 . . . . 75.33 110.02 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 27.9 ptt180 -147.1 143.79 28.57 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.981 0.419 . . . . 72.24 111.003 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.717 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.4 pp -113.89 144.02 43.73 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.739 -0.664 . . . . 64.3 111.478 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 90.9 mt -109.65 124.68 66.56 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 108.358 -0.979 . . . . 65.23 108.358 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.425 ' CD2' HD11 ' A' ' 67' ' ' LEU . 19.4 t80 -100.49 92.17 5.02 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 106.825 -1.546 . . . . 74.35 106.825 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 65.43 -67.09 0.14 Allowed 'General case' 0 N--CA 1.399 -2.981 0 C-N-CA 127.341 2.256 . . . . 50.1 112.173 -175.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.57 -44.93 0.87 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.633 -0.794 . . . . 23.25 114.135 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.15 159.04 23.23 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 115.435 1.643 . . . . 74.42 115.435 -174.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 63.9 m-85 -80.13 113.33 18.23 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.274 -0.875 . . . . 62.21 108.875 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.555 HD12 HD22 ' A' ' 76' ' ' LEU . 85.4 mt -81.33 -48.77 11.53 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.579 0.955 . . . . 71.33 113.579 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.715 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 14.7 t-80 -169.25 167.07 10.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.799 -1.556 . . . . 75.23 106.799 -173.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -85.25 -0.57 88.56 Favored Glycine 0 C--N 1.299 -1.489 0 N-CA-C 115.227 0.851 . . . . 55.21 115.227 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -168.04 28.69 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 118.187 0.993 . . . . 70.05 109.801 -169.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.483 HG12 HD21 ' A' ' 60' ' ' LEU . 10.9 p -85.12 138.02 19.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 C-N-CA 119.696 -0.801 . . . . 75.41 109.528 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.1 p -79.81 159.6 26.44 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.333 0.494 . . . . 75.42 112.333 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 3.3 mm? -59.42 -41.4 89.44 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 123.521 0.728 . . . . 72.33 111.844 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.99 -29.94 69.03 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.404 -0.427 . . . . 63.01 112.564 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.72 -15.17 59.32 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 122.923 0.489 . . . . 60.3 110.891 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.555 HD22 HD12 ' A' ' 67' ' ' LEU . 42.9 mt -83.46 5.4 23.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.387 -0.37 . . . . 70.03 110.404 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 8.8 mptt 62.67 76.92 0.35 Allowed 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.455 1.102 . . . . 61.11 109.434 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 73' ' ' LEU . 84.4 mt -131.26 120.81 18.25 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 116.224 -0.444 . . . . 70.35 111.371 -174.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.11 157.85 38.02 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 121.943 1.762 . . . . 75.03 109.669 170.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -78.71 150.62 32.47 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.767 -0.457 . . . . 71.31 109.767 -175.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.09 -11.45 72.09 Favored Glycine 0 C--N 1.308 -1.003 0 N-CA-C 114.756 0.662 . . . . 52.12 114.756 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.43 154.54 19.73 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.97 -1.092 . . . . 61.05 110.756 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.403 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 44.0 m -85.13 117.82 24.32 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.306 0.574 . . . . 72.12 111.017 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.7 m -105.41 125.52 51.08 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.386 -0.968 . . . . 53.55 108.386 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.3 p -108.74 122.3 63.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.643 0.735 . . . . 54.43 110.752 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.62 ' O ' HG12 ' A' ' 15' ' ' ILE . 87.0 mtp -122.97 150.63 42.73 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-N 116.192 -0.458 . . . . 71.44 109.899 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 39.9 m-70 -106.31 128.9 54.33 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.67 -1.233 . . . . 73.14 107.67 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.431 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.8 mm? -118.48 139.46 51.39 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 120.163 -0.615 . . . . 72.22 110.641 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.435 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 33.0 m -123.06 131.18 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.127 0 N-CA-C 108.582 -0.896 . . . . 70.42 108.582 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.553 0 CA-C-N 116.174 -0.466 . . . . 51.14 110.359 176.253 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.499 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 25.8 t . . . . . 0 N--CA 1.431 -1.387 0 N-CA-C 107.863 -1.162 . . . . 74.13 107.863 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -68.92 145.65 62.77 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 122.249 1.966 . . . . 62.22 112.11 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.3 78.01 7.01 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 122.396 1.093 . . . . 75.33 109.82 176.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -160.4 -41.88 0.05 OUTLIER 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 113.034 -1.894 . . . . 62.0 106.958 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.501 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 8.5 ptm -124.44 159.98 29.25 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.287 -1.324 . . . . 64.21 111.047 -175.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.89 140.6 28.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.338 0.589 . . . . 74.53 112.582 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -87.59 107.85 18.79 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.393 -0.966 . . . . 53.25 108.393 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.545 ' HG ' HD22 ' A' ' 14' ' ' LEU . 43.2 tp -117.24 132.85 56.54 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.291 0.567 . . . . 73.25 112.411 -173.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 35.7 ttp-105 -107.44 120.9 43.46 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 108.733 -0.84 . . . . 72.53 108.733 173.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.604 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.5 mm? -97.34 121.96 39.82 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.219 -1.355 . . . . 74.54 109.337 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.411 HG12 HG22 ' A' ' 21' ' ' THR . 31.6 mt -99.77 119.36 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 N-CA-C 108.272 -1.01 . . . . 72.34 108.272 176.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.04 166.79 23.11 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.478 -0.783 . . . . 74.32 111.436 -175.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.42 HG11 ' H ' ' A' ' 90' ' ' ALA . 28.7 m -70.74 -14.35 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.504 0.669 . . . . 73.25 110.665 177.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 m -83.69 -6.24 59.39 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 114.923 -1.035 . . . . 40.41 110.11 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.81 -4.67 84.96 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.852 -0.69 . . . . 52.44 112.64 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -87.54 131.9 34.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.898 0.38 . . . . 62.1 110.252 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.411 HG22 HG12 ' A' ' 15' ' ' ILE . 80.8 p -98.94 129.94 45.28 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.998 -0.546 . . . . 75.14 110.068 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -131.44 139.11 49.32 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.043 -0.725 . . . . 72.32 109.043 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 29.4 tt0 -125.23 133.84 52.56 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.324 -0.55 . . . . 75.55 110.587 -174.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.661 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 95.3 m-85 -144.66 160.0 41.9 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.105 0.562 . . . . 61.22 109.489 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.7 tp -87.52 126.17 34.76 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.174 -1.047 . . . . 72.03 108.174 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.661 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 96.8 m-85 -132.77 173.94 10.84 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.749 -0.834 . . . . 74.44 108.749 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 99.7 p -97.09 151.34 37.65 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 108.515 -0.92 . . . . 71.05 108.515 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.551 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 37.3 Cg_endo -63.11 -11.87 27.13 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.594 2.196 . . . . 53.0 112.409 177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -86.2 -17.24 35.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.542 -0.754 . . . . 54.2 109.999 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -69.93 154.76 41.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.486 0.66 . . . . 73.41 112.429 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.533 ' O ' HG13 ' A' ' 35' ' ' ILE . 3.3 p -91.69 118.21 30.45 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 115.357 -0.838 . . . . 64.33 110.848 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.4 -51.29 59.86 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.83 1.252 . . . . 34.11 113.623 -174.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.1 m -72.11 -22.6 61.31 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 120.861 0.362 . . . . 72.11 111.6 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -70.66 -48.88 52.64 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.502 -0.925 . . . . 64.24 108.502 172.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 31' ' ' SER . 72.5 mt -54.81 -43.91 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 114.278 -1.328 . . . . 73.03 110.102 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.471 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.27 -34.37 23.09 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.165 0.986 . . . . 74.23 111.763 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -74.03 -49.7 23.08 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 109.539 -0.541 . . . . 53.53 109.539 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -59.95 -40.76 90.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.41 -0.814 . . . . 63.13 111.568 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.604 HG21 ' CB ' ' A' ' 14' ' ' LEU . 36.0 m -73.95 -31.3 30.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.418 -0.355 . . . . 71.43 111.654 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.4 t80 . . . . . 0 C--O 1.232 0.157 0 O-C-N 123.446 0.466 . . . . 74.2 110.855 179.386 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 C--O 1.241 0.636 0 CA-C-O 120.915 0.388 . . . . 73.32 111.86 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 39.0 mmt180 -144.82 164.16 31.88 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 124.149 0.98 . . . . 70.51 108.41 175.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.673 HD21 ' H ' ' A' ' 71' ' ' VAL . 3.7 pp -147.17 148.4 31.49 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 109.444 -0.576 . . . . 75.11 109.444 172.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 90.3 mt -118.27 129.63 74.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 108.644 -0.873 . . . . 74.23 108.644 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -100.03 81.51 2.43 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 106.292 -1.744 . . . . 74.41 106.292 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.324 17.6 tm0? 59.34 -38.56 0.07 Allowed 'General case' 0 N--CA 1.414 -2.228 0 C-N-CA 129.042 2.937 . . . . 62.23 116.38 -176.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.35 -52.25 0.18 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.801 -0.714 . . . . 73.33 112.651 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.64 162.24 14.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.49 1.293 . . . . 74.1 114.49 -178.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 43.9 m-85 -88.28 113.54 23.99 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.866 -1.161 . . . . 74.22 107.866 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.21 -48.93 12.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 119.179 -1.008 . . . . 51.51 112.31 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.532 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 60.1 m80 -159.81 177.88 10.36 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.698 -0.853 . . . . 64.31 108.698 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -85.63 -4.17 85.62 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.978 -0.629 . . . . 71.22 112.584 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.4 t30 175.74 79.61 0.0 OUTLIER 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.527 1.131 . . . . 54.25 110.273 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.673 ' H ' HD21 ' A' ' 60' ' ' LEU . 9.2 p -104.33 146.15 12.09 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.765 0 N-CA-C 106.783 -1.562 . . . . 64.14 106.783 172.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.3 p -78.52 158.19 28.64 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.397 -0.521 . . . . 64.3 111.532 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 2.0 mm? -66.26 -34.71 78.62 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.148 0.499 . . . . 60.32 111.003 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.14 -31.38 79.08 Favored Glycine 0 CA--C 1.516 0.155 0 C-N-CA 120.6 -0.81 . . . . 72.33 111.234 176.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -72.4 -15.0 61.84 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 122.959 0.503 . . . . 64.34 110.872 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.553 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 64.5 mt -82.19 3.38 27.5 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.88 -0.415 . . . . 75.43 109.88 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.23 26.12 2.78 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.451 1.1 . . . . 72.34 111.135 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.553 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 65.1 mt -76.53 127.68 83.9 Favored Pre-proline 0 C--O 1.244 0.791 0 CA-C-N 116.555 -0.293 . . . . 75.54 111.138 -178.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.71 147.0 30.82 Favored 'Trans proline' 0 N--CA 1.435 -1.919 0 C-N-CA 121.439 1.426 . . . . 73.13 108.46 170.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.506 ' CE1' ' HG3' ' A' ' 28' ' ' PRO . 12.4 m-30 -69.51 145.67 52.48 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.191 -0.67 . . . . 73.42 109.191 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 89.41 1.77 77.73 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 120.165 -1.016 . . . . 64.31 113.55 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -101.49 145.22 29.28 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 117.041 0.42 . . . . 74.11 109.955 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.4 m -87.19 117.48 25.96 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.917 -0.772 . . . . 64.43 108.917 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.9 m -114.21 134.97 54.55 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.609 -0.723 . . . . 75.32 110.935 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.8 131.25 62.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 120.991 0.424 . . . . 55.15 110.349 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 89.7 mtp -135.51 153.2 51.8 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-O 120.81 0.338 . . . . 70.54 110.479 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.506 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 27.8 m-70 -106.58 135.42 48.13 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.474 -1.306 . . . . 75.4 107.474 176.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.471 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.4 mm? -123.53 137.05 54.85 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 120.249 -0.58 . . . . 71.55 110.188 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.404 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 26.4 m -126.46 133.47 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-O 121.58 0.705 . . . . 74.33 111.199 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.42 ' H ' HG11 ' A' ' 17' ' ' VAL . . . . . . . . 0 C--N 1.295 -1.772 0 N-CA-C 108.469 -0.937 . . . . 73.03 108.469 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.458 HG13 HD22 ' A' ' 25' ' ' LEU . 24.9 t . . . . . 0 N--CA 1.442 -0.859 0 N-CA-C 109.652 -0.499 . . . . 74.43 109.652 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.3 142.45 79.54 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.426 2.084 . . . . 74.23 112.395 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.97 70.82 6.61 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 122.121 0.962 . . . . 73.13 109.884 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -168.0 -37.04 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 104.909 -2.256 . . . . 74.11 104.909 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 86.0 mmm -102.58 156.74 17.41 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.622 -1.627 . . . . 75.24 108.985 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.41 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.8 pp -117.92 140.22 42.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 107.509 -1.293 . . . . 74.35 107.509 172.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 67.1 t30 -91.81 125.24 36.45 Favored 'General case' 0 CA--C 1.485 -1.537 0 C-N-CA 118.765 -1.174 . . . . 64.43 107.876 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.575 ' HG ' HD22 ' A' ' 14' ' ' LEU . 44.7 tp -126.21 133.65 51.46 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-O 121.149 0.5 . . . . 70.31 112.112 -174.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 17.8 ttp180 -106.1 120.63 42.3 Favored 'General case' 0 N--CA 1.405 -2.71 0 N-CA-C 108.659 -0.867 . . . . 72.55 108.659 173.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.575 HD22 ' HG ' ' A' ' 12' ' ' LEU . 2.1 mm? -99.56 122.31 42.44 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 113.966 -1.47 . . . . 63.0 109.275 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.522 HG23 HG22 ' A' ' 21' ' ' THR . 15.0 mm -105.07 123.31 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.513 -1.291 . . . . 64.0 107.513 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 2.5 mm? -93.92 158.3 15.71 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.245 -0.582 . . . . 54.11 110.969 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.502 ' CG1' ' HA ' ' A' ' 89' ' ' VAL . 32.2 m -52.85 -30.29 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 115.009 1.485 . . . . 73.13 115.009 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.4 m -86.61 4.88 38.41 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.992 0.425 . . . . 63.01 111.351 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.47 24.92 49.17 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.208 -0.757 . . . . 61.24 111.208 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 73.4 mmtt -86.97 130.82 34.3 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 104.688 -2.338 . . . . 64.45 104.688 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.522 HG22 HG23 ' A' ' 15' ' ' ILE . 38.7 p -126.3 128.68 47.51 Favored 'General case' 0 C--N 1.278 -2.53 0 C-N-CA 119.644 -0.822 . . . . 72.24 111.648 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -142.39 147.21 35.84 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.32 -0.4 . . . . 75.53 111.025 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 21.0 tt0 -125.9 130.2 50.85 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 107.68 -1.23 . . . . 63.51 107.68 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.698 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 96.4 m-85 -145.11 158.97 43.67 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.703 0.287 . . . . 63.2 110.452 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.458 HD22 HG13 ' A' ' 5' ' ' VAL . 96.5 mt -79.76 125.66 29.96 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.99 -1.115 . . . . 71.3 107.99 175.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.698 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 90.1 m-85 -129.86 163.15 26.94 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.59 -0.522 . . . . 72.33 109.59 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.0 m -88.99 141.13 29.29 Favored Pre-proline 0 N--CA 1.395 -3.185 0 N-CA-C 107.613 -1.255 . . . . 60.33 107.613 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 34.7 Cg_endo -62.4 -11.98 25.4 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.203 1.935 . . . . 73.51 112.186 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -78.89 -20.27 49.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.433 1.093 . . . . 72.25 110.046 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.448 ' O ' HD22 ' A' ' 73' ' ' LEU . 63.5 m-20 -75.44 154.16 37.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.184 -0.462 . . . . 64.33 111.347 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.515 ' O ' HG13 ' A' ' 35' ' ' ILE . 13.4 p -101.1 132.07 46.73 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.276 0.473 . . . . 62.42 112.276 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.434 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -48.47 -59.34 3.56 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.662 1.727 . . . . 62.13 115.662 -174.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.7 m -72.78 -19.7 61.31 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.504 0.668 . . . . 55.55 111.258 -174.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 31' ' ' SER . 14.3 t70 -70.15 -47.93 59.55 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.493 -1.299 . . . . 62.31 107.493 172.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 31' ' ' SER . 73.3 mt -59.03 -35.28 56.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.671 -1.149 . . . . 73.14 110.84 176.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.418 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.41 -33.56 21.22 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.029 0.532 . . . . 72.55 110.665 175.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 5.5 mptp? -68.87 -51.72 37.31 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.71 0.291 . . . . 73.33 110.312 174.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -57.52 -43.0 83.94 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.992 -0.549 . . . . 71.01 111.889 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 14' ' ' LEU . 35.8 m -76.9 -31.53 19.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 112.381 0.512 . . . . 63.42 112.381 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 65.1 t80 . . . . . 0 C--N 1.323 -0.559 0 C-N-CA 120.404 -0.519 . . . . 61.03 109.761 176.647 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.9 mt . . . . . 0 CA--C 1.483 -1.605 0 N-CA-C 107.27 -1.381 . . . . 62.14 107.27 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 10.3 ptt180 -146.46 162.72 37.67 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.442 -0.799 . . . . 64.32 111.567 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.631 HD21 HG12 ' A' ' 71' ' ' VAL . 4.5 pp -127.11 150.32 49.54 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 115.6 -0.727 . . . . 75.03 112.044 -171.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.428 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 97.4 mt -118.79 120.02 62.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.17 -0.923 . . . . 74.23 108.58 176.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.432 ' CD2' HD11 ' A' ' 67' ' ' LEU . 17.0 t80 -101.53 65.52 1.04 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.057 -1.09 . . . . 72.44 108.057 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 53.83 83.93 0.07 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.828 -1.533 . . . . 74.32 113.496 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.55 -58.51 0.5 Allowed Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.535 -0.841 . . . . 64.21 112.803 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -130.87 162.88 28.65 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 120.095 -0.642 . . . . 75.33 112.693 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 78.8 m-85 -83.73 122.27 28.42 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.073 -1.454 . . . . 73.25 107.073 175.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.462 HD12 ' CD2' ' A' ' 76' ' ' LEU . 54.6 mt -79.71 -46.37 17.22 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 118.804 -1.158 . . . . 72.22 111.289 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.486 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.0 t-160 -165.86 178.88 6.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.361 -2.089 . . . . 72.41 105.361 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -71.54 -42.23 55.89 Favored Glycine 0 C--O 1.208 -1.472 0 C-N-CA 120.346 -0.931 . . . . 74.55 112.675 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.503 ' OD1' ' HB2' ' A' ' 31' ' ' SER . 60.7 t30 -159.93 75.93 0.62 Allowed 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 108.613 -0.884 . . . . 63.03 108.613 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.631 HG12 HD21 ' A' ' 60' ' ' LEU . 11.2 p -102.06 152.08 5.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.228 -1.351 . . . . 70.4 109.066 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.1 p -77.61 160.68 28.38 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.488 0.551 . . . . 74.43 112.488 -173.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.538 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.3 mm? -68.98 -34.55 75.49 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 116.134 -0.484 . . . . 72.32 111.189 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.05 -29.67 75.09 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.496 -0.859 . . . . 41.32 111.193 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.469 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -73.79 -15.24 61.19 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 122.972 0.509 . . . . 74.33 111.199 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.465 HD11 ' SD ' ' A' ' 86' ' ' MET . 58.6 mt -83.83 2.39 38.48 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.867 0.467 . . . . 55.33 110.224 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER 65.22 78.06 0.29 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.984 0.914 . . . . 62.13 109.276 -176.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 85.0 mt -133.46 133.33 22.58 Favored Pre-proline 0 C--O 1.243 0.749 0 CA-C-N 116.093 -0.503 . . . . 74.11 111.239 -175.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 2.0 Cg_endo -81.33 155.97 19.23 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.293 1.996 . . . . 65.12 109.229 171.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -76.71 153.65 34.9 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.74 -0.837 . . . . 73.45 108.74 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 83.97 2.37 89.56 Favored Glycine 0 C--N 1.3 -1.467 0 C-N-CA 120.25 -0.976 . . . . 73.53 113.09 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.21 151.68 23.78 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 110.2 -0.296 . . . . 54.44 110.2 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.47 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 90.1 m -102.18 127.17 49.23 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.146 0.498 . . . . 64.44 110.158 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 84.8 m -128.72 141.98 51.15 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.938 -0.573 . . . . 60.24 110.604 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.9 137.5 41.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.779 0.323 . . . . 72.12 110.877 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.465 ' SD ' HD11 ' A' ' 76' ' ' LEU . 93.6 mtp -135.51 152.73 51.61 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 122.882 0.473 . . . . 71.44 110.176 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.428 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 29.1 m-70 -109.61 131.06 55.41 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.662 -0.866 . . . . 73.12 108.662 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.418 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.5 mm? -117.87 137.63 52.66 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 110.06 -0.348 . . . . 74.11 110.06 -175.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.502 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 32.6 m -121.71 133.87 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-O 121.142 0.496 . . . . 74.31 110.706 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.035 0 CA-C-N 115.645 -0.707 . . . . 64.11 109.991 176.963 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.481 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 39.0 t . . . . . 0 N--CA 1.418 -2.066 0 N-CA-C 109.306 -0.627 . . . . 61.04 109.306 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.39 172.52 14.44 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.5 2.134 . . . . 64.13 111.972 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.42 30.22 0.29 Allowed 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.992 0.917 . . . . 71.4 110.639 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -133.42 -14.68 2.54 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.714 -0.676 . . . . 65.31 110.14 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.3 mmm -121.68 155.4 35.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.036 -0.529 . . . . 73.25 110.092 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 pp -120.28 140.27 44.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-O 120.883 0.373 . . . . 65.52 110.949 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -90.84 111.04 22.28 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 109.06 -0.719 . . . . 70.51 109.06 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.542 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.1 tp -119.54 133.11 55.82 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.758 -0.656 . . . . 73.14 112.31 -174.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -108.63 121.25 44.62 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 114.986 -1.007 . . . . 72.25 108.388 173.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.547 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.1 mm? -99.44 123.72 43.96 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.061 -0.972 . . . . 72.34 109.273 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.476 HG23 HG22 ' A' ' 21' ' ' THR . 29.6 mt -104.46 129.22 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 N-CA-C 108.736 -0.838 . . . . 74.42 108.736 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.68 166.17 17.29 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.789 -0.642 . . . . 74.51 110.169 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.13 -19.43 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-O 121.745 0.784 . . . . 74.43 109.983 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 p -76.06 -10.6 59.55 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.561 -0.745 . . . . 74.3 111.35 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.44 2.52 76.45 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 110.715 -0.954 . . . . 73.13 110.715 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.4 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 12.6 mptt -86.65 133.61 33.68 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.791 -0.448 . . . . 75.1 109.791 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.476 HG22 HG23 ' A' ' 15' ' ' ILE . 80.9 p -113.73 137.26 51.87 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 116.117 -0.492 . . . . 62.13 111.531 -173.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -134.88 147.5 49.87 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.064 -0.717 . . . . 71.3 109.064 174.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -135.46 131.58 36.34 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.397 -0.594 . . . . 75.44 109.397 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.717 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 94.4 m-85 -144.04 160.02 41.6 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.951 -0.759 . . . . 65.21 108.951 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.446 HD11 HG13 ' A' ' 5' ' ' VAL . 41.3 tp -82.28 125.04 30.5 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.292 -1.373 . . . . 74.24 107.292 175.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.717 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 83.8 m-85 -128.97 166.59 18.88 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.446 -0.575 . . . . 74.31 109.446 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.7 p -92.83 146.94 33.09 Favored Pre-proline 0 N--CA 1.417 -2.092 0 C-N-CA 119.308 -0.957 . . . . 75.42 108.62 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.512 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 35.3 Cg_endo -61.86 -11.4 20.93 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.72 2.28 . . . . 71.34 112.1 177.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -79.97 -23.06 41.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.216 -0.902 . . . . 71.13 110.973 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.423 ' O ' HD22 ' A' ' 73' ' ' LEU . 22.6 m-20 -67.44 154.78 40.59 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 112.88 0.696 . . . . 75.44 112.88 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.524 ' O ' HG13 ' A' ' 35' ' ' ILE . 43.7 m -97.08 124.6 41.14 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.65 -0.705 . . . . 44.22 109.829 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.84 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -50.5 -50.0 54.04 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.539 0.735 . . . . 61.43 112.937 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 p -65.65 -30.63 71.36 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 112.355 0.502 . . . . 73.5 112.355 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.66 -46.24 66.56 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.8 -0.815 . . . . 72.01 108.8 174.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 31' ' ' SER . 67.3 mt -60.22 -39.15 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 114.811 -1.086 . . . . 72.44 111.138 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.88 -38.61 36.37 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.418 0.687 . . . . 71.43 111.299 176.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -72.49 -40.92 66.52 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.242 -0.435 . . . . 64.15 111.079 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -65.89 -42.54 90.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.629 -0.714 . . . . 61.1 111.161 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.547 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.4 m -76.84 -30.72 18.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 112.157 0.428 . . . . 72.52 112.157 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.2 t80 . . . . . 0 C--O 1.243 0.719 0 O-C-N 123.565 0.54 . . . . 75.55 111.795 -179.452 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.7 tp . . . . . 0 N--CA 1.447 -0.605 0 N-CA-C 108.494 -0.928 . . . . 65.33 108.494 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -137.22 160.53 38.75 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.088 -0.505 . . . . 72.03 109.721 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.84 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.5 pp -127.62 140.76 51.89 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.581 -0.736 . . . . 73.14 109.495 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 92.5 mt -111.89 126.33 69.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.783 -0.821 . . . . 61.15 108.783 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -100.58 84.32 2.74 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.715 -1.217 . . . . 73.22 107.715 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 68.16 -50.24 0.54 Allowed 'General case' 0 N--CA 1.405 -2.676 0 C-N-CA 127.505 2.322 . . . . 53.53 112.69 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.9 -45.76 0.18 Allowed Glycine 0 N--CA 1.436 -1.338 0 C-N-CA 120.601 -0.809 . . . . 61.2 113.987 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -110.58 160.9 16.24 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.55 0.574 . . . . 64.41 112.55 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 68.4 m-85 -87.1 113.79 23.14 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.018 -1.104 . . . . 64.42 108.018 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.587 HD12 HD22 ' A' ' 76' ' ' LEU . 43.2 mt -80.63 -45.21 17.64 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 114.113 1.153 . . . . 64.45 114.113 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.664 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 8.1 t60 -167.48 169.93 11.73 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.735 -1.58 . . . . 75.01 106.735 -175.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.85 -1.31 88.98 Favored Glycine 0 C--N 1.309 -0.954 0 C-N-CA 120.73 -0.748 . . . . 72.13 113.148 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 178.49 64.9 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.826 -0.805 . . . . 62.44 108.826 -173.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.718 HG12 HD21 ' A' ' 60' ' ' LEU . 11.2 p -104.18 151.17 6.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.852 -1.166 . . . . 72.0 107.852 174.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.439 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 58.9 p -84.04 158.28 21.52 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 121.42 -0.112 . . . . 62.12 110.962 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.581 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.5 mm? -65.29 -32.75 74.57 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.977 0.418 . . . . 65.44 110.79 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.48 -32.31 83.77 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.098 -0.801 . . . . 61.31 111.098 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.479 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -79.19 -15.14 58.51 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 122.803 0.441 . . . . 70.22 111.088 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.587 HD22 HD12 ' A' ' 67' ' ' LEU . 66.8 mt -82.38 1.16 38.57 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.945 -0.761 . . . . 71.42 108.945 176.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.1 mptt 78.84 14.89 1.16 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.056 1.342 . . . . 63.44 113.18 178.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.6 mp -60.67 120.26 51.33 Favored Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 113.485 0.92 . . . . 74.42 113.485 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 16.2 Cg_exo -73.05 150.41 48.31 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.485 2.123 . . . . 74.33 108.565 170.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -78.06 142.24 38.3 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.454 -0.943 . . . . 75.24 108.454 -175.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.481 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 92.63 -3.25 74.57 Favored Glycine 0 C--N 1.298 -1.533 0 C-N-CA 119.955 -1.117 . . . . 60.33 114.151 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -104.42 153.89 20.54 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 117.367 0.583 . . . . 63.45 111.621 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.7 m -92.61 118.6 31.19 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.33 -0.619 . . . . 71.34 109.33 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 84.1 m -119.98 136.93 54.36 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 116.39 -0.368 . . . . 74.53 110.516 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.4 p -110.52 135.45 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-O 121.045 0.45 . . . . 72.22 110.964 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 87.6 mtp -134.48 153.72 51.78 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 120.896 0.379 . . . . 71.55 111.64 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.537 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 63.3 m-70 -107.73 135.13 49.67 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.682 -1.229 . . . . 72.04 107.682 176.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.432 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.4 mm? -121.73 133.76 54.94 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 120.161 -0.616 . . . . 73.31 110.156 -177.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.51 134.57 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 121.662 0.744 . . . . 60.11 111.827 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.826 0 N-CA-C 107.407 -1.331 . . . . 55.55 107.407 175.321 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.477 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 47.5 t . . . . . 0 N--CA 1.435 -1.207 0 N-CA-C 109.019 -0.734 . . . . 65.22 109.019 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -70.87 149.68 60.23 Favored 'Trans proline' 0 C--O 1.25 1.097 0 C-N-CA 122.332 2.022 . . . . 72.42 112.089 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.42 75.33 7.26 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.905 0.86 . . . . 62.12 108.73 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -171.99 -25.55 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.642 -1.617 . . . . 71.04 107.646 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.6 mmm -114.42 144.84 42.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.947 -1.024 . . . . 72.13 109.626 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -105.76 135.66 43.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.014 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.406 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 2.3 t-20 -89.7 110.71 21.58 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.744 -0.836 . . . . 73.02 108.744 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.518 ' HG ' HD22 ' A' ' 14' ' ' LEU . 43.6 tp -119.51 132.85 55.85 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.629 -0.714 . . . . 64.44 111.769 -174.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.8 ttp-105 -109.26 120.76 43.49 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 108.651 -0.87 . . . . 62.12 108.651 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.518 HD22 ' HG ' ' A' ' 12' ' ' LEU . 2.1 mm? -96.44 120.91 37.61 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.787 -1.097 . . . . 64.42 109.966 -177.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.483 HG23 ' OG1' ' A' ' 21' ' ' THR . 19.0 mt -108.91 117.51 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 N-CA-C 107.045 -1.465 . . . . 75.42 107.045 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.58 156.96 20.51 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 116.073 -0.512 . . . . 62.24 111.576 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -58.04 -25.77 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 124.019 0.928 . . . . 64.43 111.91 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.2 m -76.81 -1.33 27.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.94 0.4 . . . . 73.52 111.017 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.03 15.85 71.35 Favored Glycine 0 CA--C 1.496 -1.123 0 N-CA-C 111.65 -0.58 . . . . 54.14 111.65 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -92.42 143.3 26.51 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.892 -1.522 . . . . 75.33 106.892 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.483 ' OG1' HG23 ' A' ' 15' ' ' ILE . 78.4 m -131.31 141.38 49.93 Favored 'General case' 0 C--N 1.277 -2.555 0 C-N-CA 120.136 -0.626 . . . . 71.32 109.758 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -150.63 139.82 21.2 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.608 -0.886 . . . . 72.41 108.608 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -123.69 133.09 53.95 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.787 -0.365 . . . . 74.41 110.533 -177.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.708 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 90.2 m-85 -145.17 161.21 40.06 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 123.4 0.68 . . . . 61.52 109.728 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.72 125.84 30.18 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.68 -1.23 . . . . 73.22 107.68 170.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.708 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 85.7 m-85 -125.16 167.35 14.95 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.886 -0.783 . . . . 71.14 108.886 177.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 99.0 p -94.65 147.54 33.36 Favored Pre-proline 0 N--CA 1.414 -2.249 0 C-N-CA 118.895 -1.122 . . . . 62.41 108.225 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.414 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 37.5 Cg_endo -61.82 -11.56 21.52 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.686 2.257 . . . . 64.34 112.312 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -84.44 -18.39 36.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.553 -0.748 . . . . 53.45 110.983 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' O ' HD22 ' A' ' 73' ' ' LEU . 35.1 m-20 -74.07 153.86 39.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.874 0.368 . . . . 74.25 110.374 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.414 ' O ' HG13 ' A' ' 35' ' ' ILE . 36.2 m -98.97 131.6 44.91 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.937 -0.764 . . . . 51.2 108.937 176.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.823 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -51.29 -36.57 43.0 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.396 0.887 . . . . 70.3 113.396 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.514 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 7.2 p -69.24 -36.66 77.41 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.851 0.685 . . . . 63.41 112.851 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.66 -43.29 89.82 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.145 -1.057 . . . . 75.34 108.145 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.527 HG23 ' CZ ' ' A' ' 26' ' ' PHE . 57.0 mt -59.5 -41.31 84.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 114.847 -1.07 . . . . 75.34 111.964 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.94 -42.38 48.37 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 123.043 0.537 . . . . 70.32 111.472 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -73.52 -38.62 65.24 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 120.69 0.281 . . . . 65.13 111.323 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -59.77 -45.2 93.0 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.581 -0.736 . . . . 73.21 110.535 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.494 HG11 HD23 ' A' ' 14' ' ' LEU . 34.9 m -75.29 -31.83 24.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-O 121.047 0.451 . . . . 74.25 112.139 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.8 t80 . . . . . 0 N--CA 1.48 1.055 0 CA-C-N 115.783 -0.644 . . . . 73.31 110.76 176.614 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 96.4 mt . . . . . 0 N--CA 1.44 -0.974 0 N-CA-C 107.251 -1.388 . . . . 72.44 107.251 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -137.93 142.55 40.58 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.594 -0.842 . . . . 64.0 109.249 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.823 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.6 pp -114.19 134.97 54.55 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.969 -0.56 . . . . 74.44 110.707 -178.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 72.3 mt -109.39 119.92 59.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 115.295 -0.866 . . . . 74.05 108.763 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -101.91 102.78 13.38 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 102.917 -2.994 . . . . 64.4 102.917 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -18.78 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 127.999 2.52 . . . . 71.04 113.881 -163.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.52 -67.81 0.4 Allowed Glycine 0 N--CA 1.42 -2.394 0 CA-C-N 113.165 -1.834 . . . . 61.2 110.27 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -130.61 173.65 10.68 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 120.788 0.327 . . . . 72.3 111.539 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -94.66 114.18 26.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.956 -1.868 . . . . 75.02 105.956 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.667 HD12 HD22 ' A' ' 76' ' ' LEU . 90.6 mt -79.19 -48.12 14.78 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 119.224 -0.99 . . . . 74.14 113.537 -175.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.666 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -167.69 174.52 7.62 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.043 -0.355 . . . . 64.44 110.043 179.682 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.47 -1.52 85.76 Favored Glycine 0 C--N 1.306 -1.131 0 N-CA-C 115.279 0.872 . . . . 55.34 115.279 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.444 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 2.7 t-20 -173.22 25.04 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.727 1.264 . . . . 73.24 110.529 -171.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.659 HG12 HD21 ' A' ' 60' ' ' LEU . 13.3 p -80.42 145.47 9.04 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 O-C-N 122.082 -0.386 . . . . 63.12 110.121 -176.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.535 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 64.0 p -79.02 157.52 28.06 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 122.992 0.517 . . . . 62.52 111.993 -175.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.594 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.7 mm? -65.38 -32.68 74.45 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 120.943 0.402 . . . . 73.1 110.526 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.76 -34.94 88.82 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.817 -0.706 . . . . 74.24 111.353 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.444 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -78.64 -15.58 58.35 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.898 0.479 . . . . 74.34 110.863 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.667 HD22 HD12 ' A' ' 67' ' ' LEU . 65.8 mt -86.33 -3.69 59.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 74.04 110.083 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.6 mptt 70.27 72.05 0.22 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.561 1.145 . . . . 72.54 111.421 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.467 HD22 ' HB3' ' A' ' 73' ' ' LEU . 10.4 mp -115.37 118.55 39.53 Favored Pre-proline 0 CA--C 1.491 -1.314 0 CA-C-N 116.0 -0.546 . . . . 75.3 110.822 175.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.425 ' HG2' ' HD2' ' A' ' 82' ' ' LYS . 16.8 Cg_exo -69.07 139.96 44.01 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.99 1.794 . . . . 73.13 109.085 172.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -69.7 140.82 53.59 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.0 -0.741 . . . . 74.45 109.0 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.477 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 92.05 -9.14 77.12 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.254 -0.974 . . . . 64.32 113.359 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.425 ' HD2' ' HG2' ' A' ' 79' ' ' PRO . 94.6 mttt -101.65 153.28 19.91 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.456 -0.498 . . . . 54.35 112.275 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.406 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 30.3 m -91.12 118.31 30.32 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.19 -0.914 . . . . 62.02 110.275 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.3 m -122.4 138.88 54.39 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.951 -0.568 . . . . 75.24 109.708 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.53 140.44 28.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 110.281 -0.266 . . . . 75.42 110.281 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 86.6 mtp -138.96 153.76 48.23 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 111.819 0.303 . . . . 73.52 111.819 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.555 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 83.5 m-70 -106.37 137.39 44.42 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.801 -0.814 . . . . 55.14 108.801 175.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.458 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.1 mm? -125.28 131.64 53.05 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 122.215 -0.303 . . . . 65.44 110.894 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.13 135.25 64.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.047 0.451 . . . . 74.23 110.03 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.259 0 O-C-N 122.279 -0.263 . . . . 52.31 111.238 -177.857 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.45 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 16.7 t . . . . . 0 N--CA 1.437 -1.08 0 N-CA-C 110.133 -0.321 . . . . 71.14 110.133 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -68.87 147.42 68.52 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.09 1.86 . . . . 73.43 110.83 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.05 65.86 7.37 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.979 0.895 . . . . 64.33 112.055 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -163.26 -31.49 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.688 -1.597 . . . . 73.31 106.688 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.9 mmm -102.79 148.81 25.15 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.244 -1.343 . . . . 71.05 109.007 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.43 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.9 pp -107.69 132.1 56.18 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 108.816 -0.809 . . . . 74.15 108.816 173.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -88.76 113.78 24.68 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.955 -1.498 . . . . 73.24 106.955 -177.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.551 ' HG ' HD22 ' A' ' 14' ' ' LEU . 42.6 tp -118.96 133.11 56.04 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 121.164 0.506 . . . . 73.44 112.087 -173.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.484 ' HD2' ' OE1' ' A' ' 23' ' ' GLU . 20.6 ttt85 -107.02 121.32 44.22 Favored 'General case' 0 N--CA 1.407 -2.578 0 CA-C-N 115.365 -0.834 . . . . 65.11 108.815 174.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.639 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.0 mm? -101.3 120.72 40.68 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.568 -1.196 . . . . 54.23 108.893 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.541 HG23 HG22 ' A' ' 21' ' ' THR . 26.8 mt -104.69 124.71 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 N-CA-C 108.953 -0.758 . . . . 60.45 108.953 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.3 mt -79.46 168.81 18.95 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.918 -0.583 . . . . 52.32 110.91 -177.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.431 ' CG2' ' HA ' ' A' ' 89' ' ' VAL . 60.0 t -63.84 -31.16 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 122.676 0.39 . . . . 73.24 111.587 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.1 m -79.0 6.1 10.13 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 122.033 -0.417 . . . . 74.22 112.069 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.27 13.67 82.54 Favored Glycine 0 CA--C 1.507 -0.412 0 C-N-CA 120.474 -0.869 . . . . 60.11 111.681 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -88.03 137.48 32.29 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.845 -1.169 . . . . 74.01 107.845 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.541 HG22 HG23 ' A' ' 15' ' ' ILE . 73.2 p -117.97 138.02 52.46 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.731 -0.788 . . . . 65.24 112.841 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HD2' ' O ' ' A' ' 39' ' ' VAL . 58.7 mttp -133.26 147.35 51.93 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.511 -0.922 . . . . 74.53 108.511 169.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.484 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 29.5 tt0 -135.78 131.29 35.29 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.671 -0.863 . . . . 61.32 108.671 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.623 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.6 m-85 -144.75 160.15 41.71 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 122.664 0.386 . . . . 71.12 109.989 -177.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -82.46 125.73 31.42 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.325 -0.991 . . . . 70.04 108.325 173.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.623 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 89.8 m-85 -128.92 173.84 10.04 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.537 -0.912 . . . . 74.54 108.537 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.0 p -100.22 153.14 37.92 Favored Pre-proline 0 N--CA 1.408 -2.556 0 N-CA-C 107.494 -1.298 . . . . 75.43 107.494 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.547 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 40.0 Cg_endo -61.76 -11.45 20.81 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 122.801 2.334 . . . . 74.12 112.161 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -96.81 -4.24 40.77 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.636 -0.711 . . . . 74.41 112.243 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' HB2' HD11 ' A' ' 35' ' ' ILE . 27.4 m-20 -74.7 153.31 38.92 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 119.861 -0.735 . . . . 64.54 110.833 177.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.523 ' O ' HG13 ' A' ' 35' ' ' ILE . 53.7 m -92.54 119.89 32.46 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 120.567 0.222 . . . . 74.21 110.619 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.425 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -45.44 -41.7 9.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.337 1.455 . . . . 72.05 113.568 -178.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 24.2 p -69.53 -41.28 76.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.014 0.435 . . . . 75.42 111.658 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -63.55 -41.77 98.42 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.514 -1.291 . . . . 75.3 107.514 177.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.532 ' O ' HG22 ' A' ' 39' ' ' VAL . 60.7 mt -61.78 -49.21 85.18 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.565 0 CA-C-N 114.619 -1.173 . . . . 75.03 110.408 178.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.419 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.02 -44.93 51.58 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.905 0.882 . . . . 73.22 112.043 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.456 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 1.8 tmtp? -73.21 -41.21 64.03 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.515 -0.921 . . . . 73.22 108.515 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -56.54 -45.26 81.26 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.646 1.179 . . . . 75.42 110.671 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.639 HG21 ' CB ' ' A' ' 14' ' ' LEU . 33.8 m -77.62 -29.64 16.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.371 -0.831 . . . . 74.43 111.826 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.4 t80 . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.356 -0.979 . . . . 74.34 108.356 176.86 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 88.9 mt . . . . . 0 CA--C 1.493 -1.219 0 N-CA-C 109.964 -0.384 . . . . 71.34 109.964 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -144.8 147.84 33.34 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.743 -0.662 . . . . 73.43 110.764 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 1.2 pt? -101.56 133.24 46.53 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 113.248 0.832 . . . . 64.22 113.248 -174.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 82.4 mt -102.49 119.03 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 107.302 -1.37 . . . . 62.13 107.302 175.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -101.64 73.6 1.45 Allowed 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.711 0.767 . . . . 71.11 109.16 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 70.53 -48.5 0.65 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 113.406 -1.725 . . . . 74.22 112.942 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.42 -65.42 0.74 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 121.03 -0.605 . . . . 54.1 113.198 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.554 ' NH1' ' HA ' ' A' ' 67' ' ' LEU . 3.1 ppt_? -131.06 176.64 8.08 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.702 0.63 . . . . 73.12 112.702 -174.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 71.8 m-85 -79.16 118.0 20.71 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.483 -0.932 . . . . 64.33 108.483 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.554 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 92.8 mt -79.26 -48.82 13.49 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.425 -0.91 . . . . 64.14 110.763 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -162.92 -171.77 2.81 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 124.293 1.037 . . . . 54.3 108.983 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.04 -43.22 7.22 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 110.99 -0.844 . . . . 62.1 110.99 175.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.483 ' HB3' ' OG ' ' A' ' 33' ' ' SER . 4.4 p-10 -148.71 77.86 1.39 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 122.447 1.118 . . . . 71.3 112.033 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.477 ' CG1' HD11 ' A' ' 60' ' ' LEU . 9.4 p -102.11 142.7 15.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 106.166 -1.791 . . . . 72.51 106.166 173.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.466 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 57.2 p -78.25 157.75 29.16 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.169 0.433 . . . . 65.32 112.169 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.568 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.9 mm? -64.82 -30.94 71.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.031 -0.531 . . . . 62.23 110.952 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.51 -36.62 92.75 Favored Glycine 0 C--N 1.33 0.207 0 N-CA-C 110.833 -0.907 . . . . 73.33 110.833 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.99 -15.35 62.57 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.262 0.625 . . . . 73.22 110.686 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 72' ' ' THR . 62.9 mt -84.11 13.73 4.86 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.056 -0.52 . . . . 73.42 111.116 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.471 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.5 mptt 67.37 24.68 8.87 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.663 0.785 . . . . 71.22 110.528 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.481 HD22 ' HE3' ' A' ' 82' ' ' LYS . 80.2 mt -93.97 122.33 62.19 Favored Pre-proline 0 C--N 1.311 -1.09 0 CA-C-N 115.798 -0.637 . . . . 53.51 111.04 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.93 171.45 16.47 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.242 1.961 . . . . 62.43 109.699 172.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.426 ' CE1' ' HG3' ' A' ' 28' ' ' PRO . 5.1 m-85 -84.97 170.74 12.73 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.829 -0.804 . . . . 73.33 108.829 -176.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.45 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 74.83 10.17 83.43 Favored Glycine 0 C--N 1.306 -1.101 0 N-CA-C 115.218 0.847 . . . . 71.23 115.218 173.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HE3' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -131.28 162.7 29.44 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 118.237 1.019 . . . . 65.31 111.914 178.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.555 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 33.3 m -96.81 126.71 42.16 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 116.145 -0.479 . . . . 74.1 110.804 -178.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.1 m -115.51 141.48 48.0 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.708 -0.678 . . . . 74.22 109.691 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.0 p -111.31 130.39 64.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 120.916 0.388 . . . . 45.41 110.016 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.461 ' HE1' HD12 ' A' ' 60' ' ' LEU . 90.9 mtp -138.38 153.11 48.93 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.051 0.453 . . . . 73.51 112.071 -178.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.515 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 60.5 m-70 -108.97 131.32 55.17 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.658 -0.868 . . . . 72.31 108.658 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.466 HD22 ' C ' ' A' ' 87' ' ' HIS . 3.2 mm? -121.95 144.65 48.75 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 120.784 0.326 . . . . 62.04 110.893 -177.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.431 ' HA ' ' CG2' ' A' ' 17' ' ' VAL . 27.8 m -119.78 136.69 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 CA-C-N 115.777 -0.647 . . . . 75.12 110.423 176.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.659 0 N-CA-C 107.293 -1.373 . . . . 72.23 107.293 174.142 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 11' ' ' ASN . 21.2 t . . . . . 0 N--CA 1.438 -1.059 0 N-CA-C 108.853 -0.795 . . . . 54.32 108.853 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -72.34 153.23 55.94 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.165 1.91 . . . . 54.43 111.664 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.86 71.3 5.31 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 122.379 1.085 . . . . 62.12 109.623 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -167.12 -27.81 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 112.883 -1.962 . . . . 51.21 106.954 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.1 mmm -112.8 153.08 28.38 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.861 -1.063 . . . . 63.23 108.778 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.408 HD11 ' HG ' ' A' ' 73' ' ' LEU . 2.8 pp -113.9 136.74 49.41 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 N-CA-C 109.757 -0.46 . . . . 63.14 109.757 172.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -86.3 107.63 18.05 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.359 -1.349 . . . . 65.34 107.359 -176.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.498 ' HG ' HD22 ' A' ' 14' ' ' LEU . 40.7 tp -119.75 133.6 55.55 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 112.742 0.645 . . . . 74.13 112.742 -173.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.8 ttp-105 -108.58 121.21 44.53 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.492 -0.776 . . . . 73.02 109.027 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.606 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.0 mm? -99.3 121.13 40.65 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 114.701 -1.136 . . . . 73.33 108.365 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.436 HG12 HG22 ' A' ' 21' ' ' THR . 24.1 mt -101.37 123.93 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 C-N-CA 119.126 -1.03 . . . . 64.14 109.459 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.6 mt -81.79 165.07 21.23 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.896 -0.593 . . . . 71.01 110.383 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.9 m -69.27 -14.6 18.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.503 0.668 . . . . 62.12 110.81 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.3 m -78.83 1.51 23.13 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 124.43 1.092 . . . . 44.2 110.482 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.61 20.28 77.1 Favored Glycine 0 CA--C 1.499 -0.96 0 N-CA-C 110.705 -0.958 . . . . 33.52 110.705 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -108.47 134.67 50.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.076 -1.083 . . . . 75.32 108.076 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.436 HG22 HG12 ' A' ' 15' ' ' ILE . 75.9 p -108.33 137.71 45.83 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 120.247 -0.581 . . . . 62.43 111.07 -177.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -124.93 139.23 54.01 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.969 -1.123 . . . . 73.45 107.969 169.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -130.81 130.39 43.6 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.354 -0.98 . . . . 53.32 108.354 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.656 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.0 m-85 -145.18 159.87 42.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.373 -0.603 . . . . 74.35 109.373 -178.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.408 HD22 HG13 ' A' ' 5' ' ' VAL . 74.6 mt -80.42 125.72 30.28 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 107.637 -1.246 . . . . 71.24 107.637 173.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.656 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 84.4 m-85 -128.27 166.02 19.39 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.1 -1.074 . . . . 73.11 108.1 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.4 p -92.47 149.44 38.24 Favored Pre-proline 0 N--CA 1.414 -2.266 0 C-N-CA 118.903 -1.119 . . . . 74.25 108.218 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.501 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 40.2 Cg_endo -62.16 -11.2 20.94 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 122.773 2.316 . . . . 61.44 112.214 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -93.03 -10.05 37.55 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.727 -0.67 . . . . 75.24 111.579 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -73.94 153.65 39.69 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.824 0.345 . . . . 72.12 111.02 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 35' ' ' ILE . 20.4 m -87.24 118.45 26.67 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.348 -0.982 . . . . 74.52 108.348 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.636 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -54.33 -39.52 67.13 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.663 0.785 . . . . 71.43 112.689 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 p -73.4 -32.63 64.55 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.223 0.535 . . . . 63.23 111.526 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -66.9 -43.77 82.54 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.964 -1.125 . . . . 73.13 107.964 175.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.587 ' O ' HG22 ' A' ' 39' ' ' VAL . 69.4 mt -60.82 -41.59 89.19 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.946 0 CA-C-N 114.364 -1.289 . . . . 65.54 110.291 177.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 40' ' ' TYR . . . -50.13 -40.08 45.08 Favored 'General case' 0 C--O 1.212 -0.875 0 C-N-CA 122.855 0.462 . . . . 74.12 111.255 176.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -73.29 -38.46 65.89 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.255 0.55 . . . . 61.04 110.403 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 6.0 t60 -59.08 -50.35 74.38 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.895 1.278 . . . . 73.55 110.292 177.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.606 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.2 m -76.09 -30.35 20.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 123.413 0.685 . . . . 53.03 112.223 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 47.6 t80 . . . . . 0 N--CA 1.487 1.413 0 C-N-CA 123.669 0.787 . . . . 73.41 110.78 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.609 ' O ' ' HD2' ' A' ' 59' ' ' ARG . 96.2 mt . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 110.435 -0.209 . . . . 70.13 110.435 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.609 ' HD2' ' O ' ' A' ' 58' ' ' LEU . 4.4 mpt_? -129.88 150.32 51.23 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 123.291 0.636 . . . . 71.44 110.118 176.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.636 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.0 pp -135.34 140.34 44.99 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.805 0.336 . . . . 54.24 111.123 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 95.6 mt -112.66 122.42 66.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 109.03 -0.73 . . . . 71.31 109.03 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -100.96 87.57 3.32 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 107.048 -1.464 . . . . 75.01 107.048 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 69.45 -61.5 0.44 Allowed 'General case' 0 N--CA 1.404 -2.74 0 C-N-CA 127.168 2.187 . . . . 71.23 112.885 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.27 -28.42 1.22 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.177 -1.011 . . . . 73.34 114.591 -177.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.19 161.31 31.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.483 1.142 . . . . 74.14 111.992 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.612 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 79.7 m-85 -81.53 117.11 21.66 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.408 -0.96 . . . . 74.23 108.408 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.623 HD12 HD22 ' A' ' 76' ' ' LEU . 47.6 mt -80.16 -47.68 14.34 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.836 1.05 . . . . 71.35 113.836 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.476 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 9.2 t60 178.53 134.16 0.08 Allowed 'General case' 0 C--O 1.21 -0.995 0 N-CA-C 107.534 -1.284 . . . . 63.13 107.534 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.19 1.41 0.09 OUTLIER Glycine 0 CA--C 1.547 2.044 0 N-CA-C 118.335 2.094 . . . . 73.11 118.335 -174.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -162.77 21.04 0.09 Allowed 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 119.115 1.457 . . . . 74.33 109.313 -172.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.483 HG12 HD21 ' A' ' 60' ' ' LEU . 11.0 p -81.38 144.89 9.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 119.939 -0.705 . . . . 64.34 110.161 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.433 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 40.5 p -82.71 162.44 21.79 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.903 -0.589 . . . . 63.5 111.545 -177.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.546 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.7 mm? -66.99 -35.82 80.8 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.187 -0.46 . . . . 74.25 111.693 -175.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.53 -33.33 86.16 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.374 -0.917 . . . . 73.45 111.164 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.438 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -74.89 -15.92 60.69 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 123.03 0.532 . . . . 72.44 111.485 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.623 HD22 HD12 ' A' ' 67' ' ' LEU . 42.5 mt -84.87 -3.48 58.7 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.904 -0.776 . . . . 74.31 108.904 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.31 77.77 0.12 Allowed 'General case' 0 C--O 1.244 0.8 0 C-N-CA 125.701 1.601 . . . . 73.22 111.278 -175.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.479 HD22 ' HB3' ' A' ' 73' ' ' LEU . 10.6 mp -126.31 111.05 23.63 Favored Pre-proline 0 CA--C 1.497 -1.093 0 CA-C-N 115.274 -0.876 . . . . 74.51 111.048 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.85 142.37 62.65 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 121.915 1.744 . . . . 70.31 108.631 172.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -65.51 146.46 54.82 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.872 0.368 . . . . 73.25 110.619 -174.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.48 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 82.57 4.22 90.2 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.866 -0.606 . . . . 73.43 113.778 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -106.28 154.32 20.92 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 117.51 0.655 . . . . 54.44 112.409 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.55 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 52.6 m -91.62 121.1 32.98 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 115.534 -0.757 . . . . 75.12 110.315 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.5 m -130.82 135.63 47.92 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.832 -0.622 . . . . 74.34 110.501 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.8 p -108.14 142.2 21.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.98 -0.555 . . . . 73.14 110.851 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 91.2 mtp -135.55 153.29 51.75 Favored 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 123.021 0.528 . . . . 73.25 109.948 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.516 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 64.4 m-70 -105.2 125.49 51.03 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.067 -1.457 . . . . 73.21 107.067 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.79 142.75 46.51 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 120.04 -0.664 . . . . 73.52 110.938 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.62 132.58 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 N-CA-C 108.013 -1.106 . . . . 74.1 108.013 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.559 0 N-CA-C 109.563 -0.532 . . . . 75.12 109.563 179.685 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.4 t . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 107.759 -1.2 . . . . 61.23 107.759 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.18 19.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.534 3.489 . . . . 73.03 118.374 -170.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 63.41 -32.41 0.11 Allowed 'General case' 0 C--O 1.194 -1.855 0 C-N-CA 125.187 1.395 . . . . 73.34 114.607 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -86.89 -10.03 54.31 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.94 0.876 . . . . 72.45 110.089 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.1 mmm -124.52 153.47 42.02 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.382 -0.827 . . . . 73.44 109.22 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.511 HG22 ' HA ' ' A' ' 80' ' ' PHE . 2.8 pp -100.04 139.13 22.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 107.979 -1.119 . . . . 55.03 107.979 173.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -98.9 121.96 41.52 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.18 -1.044 . . . . 73.44 108.18 -175.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.56 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.1 tp -126.68 133.66 50.89 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 112.458 0.54 . . . . 62.34 112.458 -175.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -108.18 121.47 44.92 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.697 -0.683 . . . . 74.34 109.558 171.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.568 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.3 mm? -95.92 127.22 41.75 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 124.854 1.262 . . . . 64.23 108.685 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.601 HD12 HG22 ' A' ' 21' ' ' THR . 17.8 mm -99.72 120.25 48.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.568 -0.901 . . . . 72.45 108.568 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.2 mp -78.45 153.52 31.38 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.059 -0.719 . . . . 61.0 109.059 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.4 m -69.72 -13.64 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.579 0.704 . . . . 73.03 111.128 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.7 m -76.42 -9.78 58.9 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.392 -0.822 . . . . 75.42 109.792 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.56 7.19 61.94 Favored Glycine 0 CA--C 1.498 -0.997 0 CA-C-N 116.105 -0.498 . . . . 74.33 112.744 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -87.61 131.58 34.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.49 -0.929 . . . . 75.32 108.49 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.601 HG22 HD12 ' A' ' 15' ' ' ILE . 29.1 p -104.83 129.09 53.2 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.157 -1.423 . . . . 51.25 107.157 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -131.42 138.71 49.2 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.534 -0.913 . . . . 73.31 108.534 -175.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.463 ' CD ' HD21 ' A' ' 11' ' ' ASN . 1.0 OUTLIER -132.38 131.33 41.74 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.185 0.439 . . . . 72.25 112.185 -170.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.632 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 94.2 m-85 -144.61 160.24 41.48 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 115.276 -0.875 . . . . 74.11 110.513 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.7 mt -80.75 126.04 30.81 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.85 -1.167 . . . . 64.22 107.85 173.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.632 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 80.0 m-85 -128.35 165.09 21.25 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.876 -0.416 . . . . 63.42 109.876 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.5 m -92.51 142.92 26.45 Favored Pre-proline 0 N--CA 1.414 -2.259 0 N-CA-C 107.431 -1.322 . . . . 60.23 107.431 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.0 -11.34 21.11 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.751 2.301 . . . . 55.33 113.087 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -83.0 -17.49 43.2 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.055 0.942 . . . . 64.33 110.879 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.79 154.34 42.11 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.806 0.669 . . . . 55.45 112.806 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.522 ' O ' HG13 ' A' ' 35' ' ' ILE . 18.3 m -96.16 122.82 39.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.339 -0.846 . . . . 73.31 109.638 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.75 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -50.16 -51.8 40.62 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.834 1.049 . . . . 63.55 113.834 -176.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -69.58 -28.1 65.68 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.267 0.556 . . . . 60.04 110.831 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.44 -46.58 72.69 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.264 -1.013 . . . . 73.51 108.264 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 31' ' ' SER . 69.5 mt -59.89 -43.49 92.23 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.342 0 CA-C-N 114.543 -1.208 . . . . 71.45 110.29 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.41 -48.63 56.05 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.89 0.876 . . . . 74.23 111.799 178.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -72.41 -32.16 66.11 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.68 -0.859 . . . . 73.51 108.68 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -69.74 -51.23 35.98 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.625 0.77 . . . . 75.03 110.7 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.568 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.2 m -62.42 -32.07 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 123.103 0.561 . . . . 54.13 112.355 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.5 t80 . . . . . 0 C--O 1.239 0.518 0 O-C-N 123.662 0.601 . . . . 75.53 110.045 178.506 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.3 tp . . . . . 0 N--CA 1.445 -0.71 0 N-CA-C 108.867 -0.79 . . . . 75.12 108.867 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -141.57 163.3 33.31 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.142 0.496 . . . . 53.44 111.171 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.75 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.5 pp -141.08 150.69 43.23 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.554 -0.748 . . . . 61.22 110.265 -176.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.0 mt -122.82 126.78 74.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 108.891 -0.781 . . . . 51.15 108.891 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -100.16 72.22 1.64 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.483 -1.303 . . . . 75.42 107.483 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 65.06 -56.58 0.29 Allowed 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 128.109 2.564 . . . . 61.43 112.672 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.39 -62.17 1.35 Allowed Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 121.59 -0.338 . . . . 62.42 113.225 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.522 ' HD3' ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -131.03 175.96 8.64 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 117.369 0.585 . . . . 71.53 111.873 -175.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 56.0 m-85 -80.21 118.86 22.27 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.976 -1.12 . . . . 73.41 107.976 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.0 mt -79.72 -47.2 15.71 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.482 -0.887 . . . . 74.12 111.926 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.527 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 12.3 t60 -169.08 168.19 10.15 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 105.278 -2.119 . . . . 72.21 105.278 -174.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.88 -1.77 87.69 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 120.276 -0.964 . . . . 32.13 113.318 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' A' ' 31' ' ' SER . 48.8 t-20 -177.84 73.62 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.449 0.642 . . . . 74.32 109.775 -174.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.656 HG12 HD21 ' A' ' 60' ' ' LEU . 14.5 p -104.51 151.76 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 N-CA-C 108.726 -0.842 . . . . 64.43 108.726 175.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.46 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 64.2 p -87.18 162.6 17.4 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 118.124 0.42 . . . . 74.43 110.682 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.558 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.5 mm? -68.59 -34.8 76.41 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.783 0.325 . . . . 70.33 111.055 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.9 -34.22 89.26 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.717 -0.754 . . . . 65.3 111.26 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -72.8 -15.52 61.63 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.014 0.525 . . . . 60.51 111.571 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 72' ' ' THR . 70.9 mt -82.31 -1.66 50.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 75.42 109.93 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 77' ' ' LYS . 9.8 mptt 65.19 72.17 0.43 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 108.936 -0.764 . . . . 71.01 108.936 -175.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.427 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 94.5 mt -131.32 123.34 19.55 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-N 115.567 -0.742 . . . . 74.11 110.508 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 4.5 Cg_exo -80.07 143.65 16.22 Favored 'Trans proline' 0 N--CA 1.429 -2.269 0 C-N-CA 122.041 1.827 . . . . 72.23 110.326 173.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.511 ' HA ' HG22 ' A' ' 10' ' ' ILE . 1.6 p90 -75.36 148.38 39.29 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 115.033 -0.985 . . . . 74.41 110.227 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.59 2.73 67.24 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.174 -1.012 . . . . 62.33 110.912 -174.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -120.93 157.97 28.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 122.1 0.16 . . . . 61.24 110.645 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.519 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 26.2 m -105.69 127.32 53.0 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.147 0.498 . . . . 74.34 110.574 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.2 m -125.67 142.93 51.26 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.807 -0.633 . . . . 75.32 110.196 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.66 138.19 42.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 120.826 0.346 . . . . 65.32 110.203 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.568 ' O ' HG12 ' A' ' 15' ' ' ILE . 90.1 mtp -135.1 152.2 51.43 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.948 -0.39 . . . . 72.44 109.948 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.456 ' C ' HD22 ' A' ' 88' ' ' LEU . 50.4 m-70 -104.07 134.14 47.83 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 109.045 -0.724 . . . . 71.15 109.045 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.533 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.4 mm? -123.02 144.09 49.5 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 120.482 -0.487 . . . . 74.54 109.798 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.63 134.05 62.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 116.011 -0.54 . . . . 71.25 109.948 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.568 0 CA-C-N 115.815 -0.63 . . . . 73.32 109.361 179.314 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.476 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 38.3 t . . . . . 0 N--CA 1.431 -1.388 0 N-CA-C 109.051 -0.722 . . . . 63.5 109.051 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.22 166.67 8.77 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.682 2.254 . . . . 75.12 112.52 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.61 7.78 39.86 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.697 -0.683 . . . . 75.32 110.358 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -123.09 -0.22 8.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.033 -0.53 . . . . 75.35 110.184 175.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.1 mmm -130.74 155.77 46.09 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.964 -0.754 . . . . 64.15 108.964 -178.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.43 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.9 pp -122.73 134.11 66.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.002 -0.74 . . . . 71.42 109.002 174.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.539 HD22 HG23 ' A' ' 83' ' ' THR . 6.4 t30 -90.83 109.87 21.08 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.536 -0.913 . . . . 74.32 108.536 -175.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.547 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.0 tp -113.4 135.56 53.73 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 112.563 0.579 . . . . 75.51 112.563 -172.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 33.5 ttp180 -106.22 120.26 41.37 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 108.684 -0.858 . . . . 60.04 108.684 172.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.547 HD22 ' HG ' ' A' ' 12' ' ' LEU . 2.7 mm? -93.19 127.36 38.73 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.123 -1.399 . . . . 63.45 109.392 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.587 HG12 HG22 ' A' ' 21' ' ' THR . 22.6 mt -101.33 119.95 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 C-N-CA 118.937 -1.105 . . . . 53.05 109.369 176.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.5 tp -78.38 159.63 28.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.499 -0.773 . . . . 75.31 110.689 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.7 m -61.83 -13.76 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.913 0.885 . . . . 73.24 113.156 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.3 t -82.28 -10.03 59.26 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.566 -0.531 . . . . 63.21 109.566 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.23 11.44 62.89 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.069 -0.813 . . . . 73.12 111.069 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.67 148.99 26.78 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.093 -0.706 . . . . 63.32 109.093 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.587 HG22 HG12 ' A' ' 15' ' ' ILE . 69.5 p -112.33 152.55 28.42 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.084 0.468 . . . . 71.22 112.244 -174.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -146.22 139.7 26.02 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.445 -0.798 . . . . 72.04 110.575 169.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 27.4 tt0 -122.18 132.31 54.39 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.809 -0.632 . . . . 74.22 109.939 -173.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.718 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 89.7 m-85 -144.26 158.83 43.52 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.859 -0.793 . . . . 74.15 108.859 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.8 tp -85.62 125.39 33.1 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.043 -1.095 . . . . 74.31 108.043 176.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 89.9 m-85 -130.31 172.87 11.37 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.474 -0.565 . . . . 53.23 109.474 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.7 p -95.52 150.52 37.61 Favored Pre-proline 0 N--CA 1.409 -2.514 0 N-CA-C 107.099 -1.445 . . . . 53.5 107.099 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.678 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 57.9 Cg_endo -64.61 -11.51 29.17 Favored 'Trans proline' 0 C--N 1.321 -0.868 0 C-N-CA 122.297 1.998 . . . . 72.45 111.423 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -91.58 -6.0 53.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.387 -0.824 . . . . 64.05 111.83 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.428 ' HB2' HD11 ' A' ' 35' ' ' ILE . 26.9 m-20 -75.77 151.48 37.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 120.628 -0.429 . . . . 74.41 110.504 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.598 ' O ' HG13 ' A' ' 35' ' ' ILE . 54.0 m -87.07 119.98 27.87 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 110.001 -0.37 . . . . 62.23 110.001 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.484 ' CB ' HD13 ' A' ' 60' ' ' LEU . . . -45.01 -56.18 4.87 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.723 1.379 . . . . 33.02 114.723 -176.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.403 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . 28.2 m -75.65 -21.71 57.42 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.215 -0.594 . . . . 54.3 111.957 -176.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.09 -40.2 78.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.032 -1.47 . . . . 74.5 107.032 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.598 HG13 ' O ' ' A' ' 31' ' ' SER . 70.0 mt -63.74 -42.42 95.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 CA-C-N 114.401 -1.272 . . . . 75.1 109.986 176.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.61 -36.76 56.94 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.058 0.543 . . . . 73.42 111.771 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -72.62 -37.06 68.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.065 0.46 . . . . 75.12 110.068 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -70.08 -48.26 58.45 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.619 -0.719 . . . . 74.24 111.802 -178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.456 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.6 m -63.26 -31.07 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.021 0.439 . . . . 73.52 111.431 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.2 t80 . . . . . 0 CA--C 1.543 0.71 0 CA-C-N 115.182 -0.917 . . . . 73.33 111.761 175.864 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.436 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 97.0 mt . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 108.199 -1.037 . . . . 33.52 108.199 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 68' ' ' HIS . 18.2 tpt180 -146.85 141.62 26.8 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.096 -0.705 . . . . 73.43 109.096 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.484 HD13 ' CB ' ' A' ' 32' ' ' ALA . 1.2 pt? -112.81 140.93 47.18 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 121.064 -0.254 . . . . 71.21 111.201 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 61.9 mt -111.64 117.38 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.926 -0.768 . . . . 75.24 108.926 176.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.547 ' CB ' HD21 ' A' ' 67' ' ' LEU . 33.4 t80 -105.35 76.08 1.2 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.842 -0.743 . . . . 73.24 109.002 174.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 63' ' ' GLN 0.331 15.0 mm100 36.2 83.69 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 116.222 1.934 . . . . 62.31 116.222 178.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.89 -63.3 0.62 Allowed Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 114.879 -1.055 . . . . 70.42 110.908 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -130.81 156.4 45.06 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.047 -0.661 . . . . 75.11 112.077 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.426 ' HB3' ' HE ' ' A' ' 59' ' ' ARG . 1.6 m-85 -87.48 114.08 23.77 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 104.648 -2.353 . . . . 63.21 104.648 175.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.547 HD21 ' CB ' ' A' ' 62' ' ' TYR . 1.4 mm? -72.3 -50.31 27.96 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 119.603 -0.839 . . . . 72.53 112.198 -168.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.641 ' HB2' HG23 ' A' ' 71' ' ' VAL . 19.6 m80 179.73 -161.31 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 126.65 1.98 . . . . 74.21 106.262 -176.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.454 ' H ' ' HB3' ' A' ' 68' ' ' HIS . . . -84.51 -46.3 5.83 Favored Glycine 0 C--O 1.208 -1.476 0 N-CA-C 115.46 0.944 . . . . 73.1 115.46 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -134.64 34.58 3.19 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.392 1.096 . . . . 71.51 113.231 -172.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.641 HG23 ' HB2' ' A' ' 68' ' ' HIS . 74.0 t -62.03 137.65 23.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.533 -0.543 . . . . 75.55 109.533 176.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.598 ' HB ' ' O ' ' A' ' 28' ' ' PRO . 29.0 p -78.52 156.81 29.07 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.848 -0.615 . . . . 72.34 110.805 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.567 ' H ' HD22 ' A' ' 73' ' ' LEU . 2.2 mm? -64.86 -35.44 81.12 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.594 -0.73 . . . . 72.21 110.133 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.57 -36.54 93.36 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.907 -0.588 . . . . 65.3 111.864 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.41 -16.62 63.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.986 0.422 . . . . 61.44 110.939 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 73' ' ' LEU . 75.4 mt -83.79 12.43 6.02 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.765 0.826 . . . . 53.11 111.046 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.74 19.65 9.63 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.204 1.002 . . . . 73.12 110.491 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.514 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 94.0 mt -80.7 116.98 65.81 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.191 -0.459 . . . . 72.13 111.224 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.404 ' HD2' ' HE2' ' A' ' 82' ' ' LYS . 74.4 Cg_endo -77.58 161.27 31.21 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 C-N-CA 122.071 1.847 . . . . 61.44 110.829 175.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.678 ' CE2' ' HG3' ' A' ' 28' ' ' PRO . 71.7 m-85 -79.36 163.53 24.78 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.685 -0.857 . . . . 64.11 108.685 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 83.52 0.14 89.85 Favored Glycine 0 C--N 1.301 -1.371 0 C-N-CA 120.624 -0.798 . . . . 74.21 114.784 175.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.404 ' HE2' ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -124.95 157.68 35.47 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 118.971 -1.092 . . . . 74.25 112.688 -179.285 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.539 HG23 HD22 ' A' ' 11' ' ' ASN . 24.6 m -90.02 120.92 31.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.564 -0.744 . . . . 71.44 110.247 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.0 m -113.42 135.17 54.17 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.605 -0.271 . . . . 52.43 110.977 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.15 126.88 70.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 N-CA-C 109.676 -0.49 . . . . 74.21 109.676 175.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.419 ' O ' HG13 ' A' ' 15' ' ' ILE . 85.4 mtp -136.39 153.46 51.1 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-O 121.198 0.523 . . . . 75.44 112.098 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 40.9 m-70 -102.24 137.15 40.87 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.458 -0.792 . . . . 74.23 109.936 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.416 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.6 mm? -120.53 141.42 50.27 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.958 -0.756 . . . . 63.55 108.958 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 59' ' ' ARG . 30.2 m -125.36 136.08 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-O 121.731 0.777 . . . . 72.34 111.05 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.413 0 N-CA-C 106.343 -1.725 . . . . 75.23 106.343 177.235 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.537 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 17.0 t . . . . . 0 N--CA 1.443 -0.808 0 N-CA-C 109.713 -0.477 . . . . 74.53 109.713 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.65 170.92 16.4 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.387 2.058 . . . . 62.03 111.616 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HA ' ' HB2' ' A' ' 80' ' ' PHE . . . -79.14 14.56 1.41 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.341 0.591 . . . . 53.45 111.484 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -108.32 -11.37 15.22 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.486 -0.561 . . . . 73.15 109.486 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.4 mmm -130.9 158.03 41.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.024 -0.535 . . . . 74.42 110.328 -174.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.448 ' CD1' ' HG ' ' A' ' 73' ' ' LEU . 2.8 pp -119.01 140.88 41.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.586 -0.524 . . . . 74.24 109.586 174.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.528 HD22 HG23 ' A' ' 83' ' ' THR . 7.3 t30 -94.83 115.73 27.85 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.424 -0.954 . . . . 73.51 108.424 -176.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.537 ' HG ' HD22 ' A' ' 14' ' ' LEU . 42.3 tp -117.77 133.88 55.49 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.646 0.736 . . . . 54.23 112.57 -173.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.509 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . 21.8 ttt85 -106.61 120.52 42.18 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 108.14 -1.059 . . . . 63.21 108.14 176.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.537 HD22 ' HG ' ' A' ' 12' ' ' LEU . 2.0 mm? -100.67 127.48 47.06 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.875 -1.057 . . . . 64.24 109.635 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.491 HD12 HG22 ' A' ' 21' ' ' THR . 21.3 mm -99.28 116.53 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 106.917 -1.512 . . . . 62.2 106.917 175.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.77 158.38 33.6 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.348 -0.387 . . . . 71.54 110.619 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.494 HG21 ' H ' ' A' ' 90' ' ' ALA . 90.2 t -66.01 -23.32 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 121.602 0.715 . . . . 75.21 110.2 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.2 m -75.56 -3.87 36.71 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.12 -0.945 . . . . 61.14 110.127 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.15 8.8 84.97 Favored Glycine 0 CA--C 1.495 -1.189 0 N-CA-C 111.579 -0.609 . . . . 53.21 111.579 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -87.19 131.44 34.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.558 -1.275 . . . . 74.41 107.558 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.491 HG22 HD12 ' A' ' 15' ' ' ILE . 64.5 p -107.76 129.28 55.06 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 109.905 -0.406 . . . . 55.53 109.905 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -148.47 149.92 32.53 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.183 -0.607 . . . . 72.2 110.344 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.476 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 29.7 tt0 -130.45 132.74 45.85 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.893 -0.14 . . . . 74.53 110.97 -170.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.525 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 35.0 m-85 -143.23 160.57 40.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.624 0.726 . . . . 73.21 112.107 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.478 HD11 HG13 ' A' ' 5' ' ' VAL . 37.3 tp -85.66 126.07 33.65 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.15 -0.932 . . . . 63.01 109.325 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.525 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 97.5 m-85 -133.42 171.12 14.5 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.672 -0.492 . . . . 73.41 109.672 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.3 p -94.99 150.65 38.05 Favored Pre-proline 0 N--CA 1.419 -2.001 0 C-N-CA 119.054 -1.058 . . . . 63.24 108.206 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 42.2 Cg_endo -62.85 -11.39 24.03 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.43 2.087 . . . . 74.22 111.784 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -79.68 -21.35 44.81 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.199 1.0 . . . . 73.3 109.777 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -75.77 152.27 37.4 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 116.321 -0.4 . . . . 70.23 110.429 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.522 ' O ' HG13 ' A' ' 35' ' ' ILE . 77.1 p -106.16 138.29 42.6 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 109.972 -0.381 . . . . 62.54 109.972 178.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.723 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -50.95 -49.62 59.53 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.864 1.061 . . . . 61.12 113.864 -175.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.0 m -64.52 -31.63 72.93 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 120.949 0.404 . . . . 52.22 110.891 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -70.12 -45.47 66.82 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.869 -0.789 . . . . 72.31 108.869 175.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 31' ' ' SER . 60.9 mt -60.78 -33.64 56.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.155 -0.93 . . . . 72.31 112.281 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.71 -40.43 40.49 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 110.491 -0.188 . . . . 72.42 110.491 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -64.11 -44.68 91.52 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.343 0.592 . . . . 72.05 109.838 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -62.57 -43.42 98.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.053 -1.43 . . . . 61.14 110.118 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.502 HG11 HD23 ' A' ' 14' ' ' LEU . 36.0 m -74.9 -32.17 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 113.76 1.022 . . . . 64.13 113.76 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 113.266 0.839 . . . . 75.15 113.266 176.326 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 CA--C 1.488 -1.407 0 N-CA-C 107.639 -1.245 . . . . 75.52 107.639 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.473 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 17.3 ptt180 -147.2 159.93 43.05 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.226 0.536 . . . . 72.13 112.262 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.723 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.4 pp -127.83 144.62 51.09 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.407 -0.815 . . . . 63.33 111.445 -172.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 85.6 mt -112.87 118.79 58.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.82 -0.807 . . . . 72.21 108.82 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -105.1 74.75 1.13 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.558 -0.534 . . . . 63.21 109.558 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 43.26 80.03 0.04 OUTLIER 'General case' 0 C--O 1.244 0.786 0 O-C-N 124.725 1.266 . . . . 63.51 113.367 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.74 -72.05 0.48 Allowed Glycine 0 N--CA 1.419 -2.439 0 CA-C-N 114.879 -1.055 . . . . 41.24 111.624 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -130.83 174.41 10.0 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.23 0.538 . . . . 70.22 112.375 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 71.0 m-85 -87.78 117.34 26.55 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 105.905 -1.887 . . . . 71.43 105.905 172.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.424 ' CD1' HD22 ' A' ' 76' ' ' LEU . 81.1 mt -79.81 -47.96 14.33 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.728 -0.789 . . . . 63.12 112.258 -176.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.514 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 10.4 t60 -172.67 158.04 3.97 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.736 -1.579 . . . . 72.43 106.736 -177.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -69.45 -0.65 24.63 Favored Glycine 0 CA--C 1.542 1.736 0 N-CA-C 117.091 1.596 . . . . 51.32 117.091 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -175.71 31.65 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.239 1.52 . . . . 62.34 109.362 -171.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.577 HG12 HD21 ' A' ' 60' ' ' LEU . 10.6 p -78.85 138.77 19.5 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 119.527 -0.869 . . . . 75.54 109.171 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.413 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 47.3 p -79.56 157.48 27.36 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.015 0.436 . . . . 62.3 112.032 -175.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.448 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 3.1 mm? -61.36 -34.22 74.93 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.612 -0.722 . . . . 72.13 111.487 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.32 -30.03 76.7 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.0 -0.619 . . . . 63.32 111.907 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.68 -15.74 58.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.397 0.617 . . . . 61.1 110.276 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.511 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 53.3 mt -83.19 12.89 4.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.825 -0.625 . . . . 74.14 111.158 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.0 mptt 69.46 12.56 8.27 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.209 1.004 . . . . 73.42 111.106 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.511 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 89.7 mt -76.03 121.81 85.72 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 112.374 0.509 . . . . 74.12 112.374 -175.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.443 ' HG2' ' HG3' ' A' ' 82' ' ' LYS . 45.8 Cg_endo -75.57 159.04 39.67 Favored 'Trans proline' 0 N--CA 1.442 -1.515 0 C-N-CA 122.091 1.861 . . . . 51.43 109.754 174.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.477 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 12.0 m-85 -80.67 151.51 28.92 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.059 -0.719 . . . . 63.54 109.059 -174.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.537 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 84.95 4.01 87.4 Favored Glycine 0 C--N 1.306 -1.112 0 C-N-CA 120.493 -0.861 . . . . 64.32 113.53 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.443 ' HG3' ' HG2' ' A' ' 79' ' ' PRO . 75.2 mmtt -110.35 149.27 30.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 117.013 0.406 . . . . 72.11 111.085 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.528 HG23 HD22 ' A' ' 11' ' ' ASN . 94.6 m -91.2 123.49 34.68 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.596 -0.729 . . . . 73.43 110.38 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.3 m -118.56 131.38 56.21 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.264 -0.88 . . . . 73.01 110.316 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.509 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 7.5 p -103.25 124.46 57.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.989 0.423 . . . . 75.34 110.281 177.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.484 ' O ' HG12 ' A' ' 15' ' ' ILE . 91.0 mtp -129.37 152.21 49.17 Favored 'General case' 0 CA--C 1.486 -1.5 0 CA-C-O 121.368 0.604 . . . . 75.32 110.603 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.489 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 38.5 m-70 -106.32 126.17 51.91 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.433 -0.803 . . . . 71.32 108.913 -178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.484 HD11 ' HB1' ' A' ' 32' ' ' ALA . 4.1 mm? -115.05 144.03 44.27 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-O 121.071 0.462 . . . . 62.43 111.992 -176.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.96 132.17 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 115.462 -0.79 . . . . 65.21 108.987 176.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.494 ' H ' HG21 ' A' ' 17' ' ' VAL . . . . . . . . 0 C--N 1.301 -1.505 0 CA-C-N 115.59 -0.732 . . . . 65.42 109.686 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.437 HG13 ' CD1' ' A' ' 25' ' ' LEU . 11.7 t . . . . . 0 N--CA 1.431 -1.376 0 N-CA-C 109.445 -0.576 . . . . 71.04 109.445 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -71.9 149.01 52.75 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 122.11 1.873 . . . . 72.13 109.876 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.35 73.32 5.98 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.059 0.933 . . . . 52.12 110.137 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -169.51 -37.91 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.458 -1.682 . . . . 61.53 106.458 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.0 mmm -96.99 143.64 27.65 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.523 -1.671 . . . . 75.3 108.675 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -98.66 140.81 17.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-O 121.033 0.444 . . . . 53.42 111.273 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.57 ' OD1' HG23 ' A' ' 83' ' ' THR . 18.7 t-20 -87.64 125.85 34.61 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.282 -0.636 . . . . 51.02 109.282 177.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.573 ' HG ' HD22 ' A' ' 14' ' ' LEU . 30.6 tp -131.8 132.21 43.56 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-O 121.326 0.584 . . . . 75.2 111.468 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.534 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . 23.1 ttt85 -106.93 120.99 43.53 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-N 114.917 -1.038 . . . . 75.23 109.115 175.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.573 HD22 ' HG ' ' A' ' 12' ' ' LEU . 1.8 mm? -103.74 126.49 50.91 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.04 -0.982 . . . . 74.44 108.823 -178.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.2 mt -99.47 119.36 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 107.944 -1.132 . . . . 73.0 107.944 175.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.9 mt -72.15 154.12 41.25 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.485 -0.779 . . . . 72.11 110.245 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.5 t -63.71 -15.99 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 122.086 0.946 . . . . 71.42 109.577 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.3 t -80.2 -10.19 59.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.187 -0.915 . . . . 50.14 110.447 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.51 70.4 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.574 -0.822 . . . . 63.4 112.392 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -87.32 135.53 33.29 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.666 -0.414 . . . . 63.03 110.901 176.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.6 p -100.95 129.88 46.86 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.721 -0.672 . . . . 64.22 110.316 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -140.6 138.68 34.61 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.2 -0.6 . . . . 72.04 111.183 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 28.7 tt0 -121.93 140.8 52.0 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 115.502 -0.772 . . . . 71.01 109.133 -173.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.707 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 72.1 m-85 -143.72 160.32 40.92 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 123.523 0.729 . . . . 75.21 109.985 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.437 ' CD1' HG13 ' A' ' 5' ' ' VAL . 32.9 tp -82.25 125.75 31.31 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 107.338 -1.356 . . . . 55.03 107.338 175.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.707 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 86.3 m-85 -132.07 172.77 11.96 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.862 -0.421 . . . . 61.41 109.862 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.1 p -100.02 148.93 35.51 Favored Pre-proline 0 C--N 1.286 -2.188 0 N-CA-C 107.589 -1.264 . . . . 60.34 107.589 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.69 -11.94 22.82 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 121.73 1.62 . . . . 72.13 112.079 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -80.05 -23.29 41.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.331 0.652 . . . . 63.12 111.156 177.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.403 ' O ' HD22 ' A' ' 73' ' ' LEU . 36.2 m-20 -66.89 154.38 41.12 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 120.769 0.319 . . . . 63.1 111.655 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.567 ' O ' HG13 ' A' ' 35' ' ' ILE . 44.2 m -98.52 124.03 43.02 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 122.295 -0.253 . . . . 62.23 110.579 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.651 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -46.63 -59.4 3.04 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 114.503 1.297 . . . . 61.15 114.503 -176.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 m -67.06 -27.83 67.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.223 0.535 . . . . 75.13 111.455 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.49 -47.26 67.5 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.733 -1.21 . . . . 70.14 107.733 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 31' ' ' SER . 77.1 mt -56.16 -36.34 45.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.132 -0.94 . . . . 73.23 111.621 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.75 -36.85 38.74 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.098 0.559 . . . . 72.32 112.357 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.6 -42.96 63.95 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 107.096 -1.446 . . . . 63.11 107.096 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.493 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 43.2 t-80 -55.87 -54.05 49.37 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.016 -1.447 . . . . 72.41 111.124 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.562 HG21 ' CB ' ' A' ' 14' ' ' LEU . 28.9 m -70.68 -31.64 46.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.035 -0.984 . . . . 64.21 112.362 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 86.6 t80 . . . . . 0 C--O 1.244 0.782 0 N-CA-C 112.447 0.536 . . . . 74.41 112.447 -179.162 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 CA--C 1.503 -0.858 0 N-CA-C 108.076 -1.083 . . . . 70.21 108.076 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.451 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 97.4 mtt180 -143.53 142.82 31.28 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.366 -0.605 . . . . 75.43 109.366 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.6 pp -130.31 132.72 46.0 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 120.99 0.424 . . . . 64.0 110.758 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 86.8 mt -108.32 120.6 59.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 121.47 0.652 . . . . 63.14 109.545 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -101.83 85.39 2.7 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 108.683 -0.858 . . . . 64.15 108.683 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 59.86 18.42 7.4 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.141 -1.391 . . . . 73.44 114.19 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.58 -52.85 0.37 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.367 -0.92 . . . . 73.44 112.985 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.467 ' HD3' ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -113.4 156.32 23.67 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.065 -0.654 . . . . 63.31 111.361 -177.298 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 85.8 m-85 -78.6 122.53 26.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.617 -1.253 . . . . 73.24 107.617 176.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.573 HD12 HD22 ' A' ' 76' ' ' LEU . 45.9 mt -79.71 -46.54 16.91 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 118.978 -1.089 . . . . 61.14 112.711 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.525 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.3 t-80 -165.48 172.6 11.93 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.005 -1.85 . . . . 73.32 106.005 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.56 -25.58 75.47 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.289 -0.958 . . . . 74.53 114.064 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -175.25 72.21 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.998 0.904 . . . . 74.23 109.054 -175.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.575 HG12 HD21 ' A' ' 60' ' ' LEU . 7.2 p -102.88 151.25 6.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 114.194 -1.366 . . . . 70.31 108.821 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.534 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 40.4 p -78.46 157.35 28.97 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 120.718 0.294 . . . . 54.11 111.212 -175.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.596 ' HA ' HD12 ' A' ' 76' ' ' LEU . 1.2 mm? -63.85 -27.5 69.21 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.765 0.426 . . . . 74.31 111.478 -177.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.66 -37.69 93.79 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.513 -1.035 . . . . 63.04 110.513 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -79.56 -16.87 55.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.341 0.591 . . . . 54.41 109.91 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' ' 73' ' ' LEU . 92.7 mt -86.51 2.96 46.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.693 -0.685 . . . . 64.5 110.716 176.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 11.1 mptt 69.56 21.2 6.81 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.9 0.88 . . . . 71.03 112.911 178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.428 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.4 mp -67.54 126.26 92.33 Favored Pre-proline 0 CA--C 1.511 -0.543 0 C-N-CA 119.726 -0.789 . . . . 65.21 111.426 176.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -86.6 137.22 4.8 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 122.427 2.085 . . . . 71.11 112.029 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -73.92 128.15 34.74 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.643 -0.708 . . . . 74.12 111.12 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.82 -6.01 76.67 Favored Glycine 0 C--N 1.3 -1.435 0 CA-C-N 115.096 -0.957 . . . . 51.11 111.925 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 11' ' ' ASN . 92.6 mttt -116.67 149.29 40.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 117.389 0.594 . . . . 74.32 111.655 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.57 HG23 ' OD1' ' A' ' 11' ' ' ASN . 30.7 m -84.81 136.35 33.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.12 -0.491 . . . . 74.3 110.86 -177.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.9 m -139.55 132.11 28.76 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.886 -0.412 . . . . 71.13 109.886 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.534 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 10.8 p -99.79 138.87 22.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.21 0.528 . . . . 65.31 111.441 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.469 ' SD ' HD13 ' A' ' 76' ' ' LEU . 81.4 mtp -137.97 152.38 48.86 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 116.074 -0.512 . . . . 73.53 110.315 177.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.527 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 25.2 m-70 -111.14 128.25 55.83 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.844 -1.539 . . . . 73.42 106.844 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.36 140.15 49.38 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.178 -0.609 . . . . 70.13 110.383 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 59' ' ' ARG . 6.1 m -129.99 142.12 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 109.291 -0.633 . . . . 73.31 109.291 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.278 -2.507 0 N-CA-C 105.854 -1.906 . . . . 40.42 105.854 176.002 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.46 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 3.6 t . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 110.036 -0.357 . . . . 73.5 110.036 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.44 ' C ' ' H ' ' A' ' 8' ' ' ASP . 88.2 Cg_endo -84.95 166.99 11.22 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.957 1.771 . . . . 60.03 111.077 177.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.39 30.63 0.41 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.828 0.823 . . . . 62.02 109.837 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 6' ' ' PRO . 19.6 t70 -120.43 -28.75 4.93 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.842 -1.072 . . . . 72.15 109.369 175.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.8 mtp -121.83 155.51 35.2 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 115.955 -0.566 . . . . 62.11 110.44 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.24 137.5 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 CA-C-N 115.591 -0.731 . . . . 71.12 109.507 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.449 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 2.4 t-20 -91.05 107.59 19.3 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 108.134 -1.062 . . . . 62.23 108.134 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.529 ' HG ' HD22 ' A' ' 14' ' ' LEU . 39.8 tp -112.56 132.97 54.85 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 115.283 -0.871 . . . . 71.04 111.545 -174.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 74.6 ttt180 -107.6 120.87 43.4 Favored 'General case' 0 N--CA 1.402 -2.863 0 N-CA-C 108.069 -1.085 . . . . 71.54 108.069 173.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.546 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.0 mm? -98.32 120.3 38.5 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.757 -1.11 . . . . 72.45 109.075 -178.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.523 HG12 HG22 ' A' ' 21' ' ' THR . 30.7 mt -103.64 118.4 50.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.565 -0.902 . . . . 71.52 108.565 177.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.87 163.51 26.68 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 123.691 0.619 . . . . 60.11 110.835 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.6 m -57.7 -27.11 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.09 0.774 . . . . 73.45 113.09 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.5 t -77.39 -16.08 59.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.653 0.263 . . . . 75.43 111.165 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.428 ' C ' ' HE3' ' A' ' 20' ' ' LYS . . . 100.81 5.68 53.33 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.994 -1.098 . . . . 62.22 111.843 -176.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.611 ' HE3' ' N ' ' A' ' 20' ' ' LYS . 0.5 OUTLIER -86.5 131.44 34.18 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.126 -1.065 . . . . 72.42 108.126 177.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.523 HG22 HG12 ' A' ' 15' ' ' ILE . 72.5 p -107.2 133.05 52.36 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 120.457 -0.497 . . . . 71.32 111.6 -175.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -122.37 139.57 53.68 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.591 -0.892 . . . . 62.35 108.591 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 26.0 tt0 -131.42 129.55 41.4 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.649 -0.82 . . . . 71.21 109.087 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.638 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.0 m-85 -146.54 160.7 41.8 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.035 0.534 . . . . 65.41 110.581 -178.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.444 ' CD2' HG13 ' A' ' 5' ' ' VAL . 75.4 mt -79.64 126.54 31.05 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.441 -0.578 . . . . 60.43 109.441 172.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.638 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 94.5 m-85 -131.58 167.75 18.87 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.213 -1.032 . . . . 62.32 108.213 175.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.3 p -94.35 151.7 39.61 Favored Pre-proline 0 N--CA 1.411 -2.387 0 C-N-CA 119.129 -1.028 . . . . 53.13 108.246 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.505 ' O ' ' HB ' ' A' ' 72' ' ' THR . 31.3 Cg_endo -60.17 -11.73 16.96 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.628 2.219 . . . . 63.33 112.418 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -96.17 -4.86 41.84 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.055 0.391 . . . . 72.12 112.055 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -76.02 154.06 36.0 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 120.474 -0.49 . . . . 63.42 110.363 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.594 ' O ' HG13 ' A' ' 35' ' ' ILE . 47.9 t -89.93 118.96 29.89 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.167 -0.679 . . . . 74.11 109.167 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.739 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -50.94 -41.9 59.36 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.173 0.989 . . . . 75.01 113.157 -176.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.2 t -77.34 -32.34 55.11 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.221 0.534 . . . . 55.02 110.24 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.0 -37.53 84.35 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.825 -1.176 . . . . 75.32 107.825 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.594 HG13 ' O ' ' A' ' 31' ' ' SER . 71.7 mt -64.45 -39.77 86.74 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 CA-C-N 114.587 -1.188 . . . . 64.31 110.611 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.88 -38.9 62.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.982 0.42 . . . . 54.24 111.463 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 -40.81 66.7 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 107.262 -1.384 . . . . 73.33 107.262 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.424 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 49.6 t-80 -57.96 -54.09 50.87 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.16 0.984 . . . . 71.54 110.916 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.546 HG21 ' CB ' ' A' ' 14' ' ' LEU . 29.6 m -66.38 -30.92 51.37 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 N-CA-C 113.255 0.835 . . . . 75.21 113.255 -178.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 76.4 t80 . . . . . 0 C--O 1.243 0.745 0 O-C-N 123.609 0.568 . . . . 63.14 110.708 177.14 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 CA--C 1.512 -0.507 0 N-CA-C 110.015 -0.365 . . . . 64.54 110.015 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 39.2 mmt180 -137.14 148.43 46.63 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.641 -0.503 . . . . 73.15 109.641 177.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.739 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.4 pp -130.92 139.71 50.11 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 110.115 -0.328 . . . . 74.05 110.115 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 87' ' ' HIS . 79.0 mt -112.75 119.65 60.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.288 0.566 . . . . 54.51 109.535 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -102.0 73.88 1.42 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.662 -1.236 . . . . 61.05 107.662 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 58.61 86.05 0.09 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 113.344 -1.753 . . . . 75.13 112.085 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.11 -56.59 0.6 Allowed Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.677 -0.692 . . . . 23.11 114.02 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -117.52 153.98 32.25 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.667 0.988 . . . . 75.23 113.667 -172.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 93.3 m-85 -82.91 117.15 22.55 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 108.443 -0.947 . . . . 74.41 108.443 176.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.663 HD12 HD22 ' A' ' 76' ' ' LEU . 81.8 mt -80.73 -47.98 13.2 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.288 -0.965 . . . . 71.11 112.749 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.73 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.5 t-80 -170.01 167.33 9.0 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 105.909 -1.885 . . . . 65.03 105.909 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.52 -1.28 87.83 Favored Glycine 0 C--N 1.3 -1.425 0 N-CA-C 115.785 1.074 . . . . 74.33 115.785 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -164.9 22.75 0.06 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.255 1.026 . . . . 72.24 110.442 -170.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.561 HG13 HD21 ' A' ' 76' ' ' LEU . 9.0 p -79.53 136.88 22.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 119.419 -0.912 . . . . 74.43 109.031 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.63 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 42.7 p -78.7 158.49 28.31 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.424 -0.353 . . . . 41.44 111.658 -173.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.616 HD13 HD12 ' A' ' 76' ' ' LEU . 1.9 mm? -64.07 -27.08 68.86 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.106 -0.497 . . . . 64.4 110.897 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.26 -38.43 95.1 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.352 -1.099 . . . . 71.33 110.352 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.29 -16.81 57.39 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.194 0.521 . . . . 53.03 110.096 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.663 HD22 HD12 ' A' ' 67' ' ' LEU . 86.9 mt -86.24 4.41 38.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.918 -0.583 . . . . 72.41 111.33 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER 68.88 25.3 6.17 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.947 0.899 . . . . 75.32 113.254 177.641 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.446 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.2 mp -72.76 123.53 89.66 Favored Pre-proline 0 C--O 1.236 0.384 0 C-N-CA 120.083 -0.647 . . . . 64.04 111.322 175.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 1.3 Cg_endo -80.2 146.96 18.15 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.444 2.096 . . . . 65.33 111.088 176.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -73.73 141.94 46.34 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.191 -1.04 . . . . 70.25 108.191 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.46 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 82.01 -3.92 78.07 Favored Glycine 0 C--N 1.3 -1.435 0 C-N-CA 120.735 -0.745 . . . . 53.12 113.521 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -116.13 145.64 42.9 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 117.163 0.481 . . . . 73.15 111.463 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.449 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 23.5 m -85.19 125.1 32.57 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.967 -0.56 . . . . 73.42 110.99 -177.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.1 m -125.09 135.9 53.13 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.977 -0.556 . . . . 73.42 109.508 176.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.43 137.8 31.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.352 -0.385 . . . . 73.13 110.889 -178.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 82.8 mtp -138.69 153.45 48.54 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 120.902 0.382 . . . . 52.23 111.325 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.441 ' C ' HD22 ' A' ' 88' ' ' LEU . 25.6 m-70 -103.93 129.27 51.46 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 107.229 -1.397 . . . . 71.32 107.229 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.441 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.8 mm? -123.9 140.19 53.23 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 119.66 -0.816 . . . . 75.14 110.681 -176.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.43 ' CG2' ' HB2' ' A' ' 59' ' ' ARG . 25.2 m -118.7 133.68 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.829 0 CA-C-O 121.711 0.767 . . . . 74.44 109.445 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.268 -2.942 0 N-CA-C 105.108 -2.182 . . . . 65.44 105.108 174.647 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.489 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 17.7 t . . . . . 0 N--CA 1.431 -1.387 0 N-CA-C 110.087 -0.338 . . . . 72.41 110.087 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.07 162.69 36.54 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.204 1.936 . . . . 74.23 111.05 175.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.88 36.85 0.63 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.864 0.84 . . . . 53.22 109.597 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.72 -19.13 2.1 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.632 -1.167 . . . . 70.22 109.446 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.2 mmm -124.29 150.68 45.12 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.641 -0.708 . . . . 71.41 110.07 -174.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -101.61 139.09 23.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.998 -0.742 . . . . 52.4 108.998 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.432 HD22 HG23 ' A' ' 83' ' ' THR . 6.0 t30 -96.69 114.39 26.03 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.234 -1.024 . . . . 74.54 108.234 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.546 ' HG ' HD22 ' A' ' 14' ' ' LEU . 44.4 tp -120.16 133.46 55.49 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 112.586 0.587 . . . . 74.35 112.586 -172.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 49.1 ttt180 -108.47 120.71 43.21 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 108.443 -0.947 . . . . 75.31 108.443 174.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.573 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.3 mm? -98.53 122.29 41.54 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-N 114.531 -1.213 . . . . 55.32 109.605 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.642 HG23 HG22 ' A' ' 21' ' ' THR . 22.1 mt -112.22 125.46 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.635 -0.876 . . . . 74.31 108.635 177.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -94.47 161.57 14.17 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 116.323 -0.399 . . . . 64.35 110.884 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.417 ' CG1' HG12 ' A' ' 89' ' ' VAL . 28.6 m -60.5 -14.67 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.4 0.68 . . . . 60.55 112.757 179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.1 m -79.79 -7.16 58.5 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 116.199 -0.455 . . . . 54.24 110.351 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.55 0.54 81.92 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 116.265 -0.425 . . . . 60.3 112.598 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -87.67 133.93 33.74 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.237 -0.653 . . . . 75.44 109.237 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.642 HG22 HG23 ' A' ' 15' ' ' ILE . 40.2 p -116.73 131.87 56.84 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 109.585 -0.524 . . . . 75.44 109.585 -177.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HD2' ' O ' ' A' ' 39' ' ' VAL . 63.8 mttp -129.32 139.97 51.56 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 110.022 -0.362 . . . . 64.41 110.022 174.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 27.2 tt0 -125.09 130.0 51.37 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.257 -0.646 . . . . 72.41 109.257 -177.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.608 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 95.8 m-85 -146.14 160.52 41.82 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 122.946 0.498 . . . . 74.42 111.081 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.2 mt -82.57 126.28 32.11 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.503 -0.555 . . . . 71.13 109.503 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.608 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 95.5 m-85 -132.58 166.1 22.89 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.115 -1.068 . . . . 62.23 108.115 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.4 p -89.71 150.46 44.11 Favored Pre-proline 0 N--CA 1.418 -2.054 0 N-CA-C 108.194 -1.039 . . . . 65.13 108.194 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.451 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 34.2 Cg_endo -60.32 -11.68 17.26 Favored 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 122.59 2.194 . . . . 63.21 112.287 177.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -91.72 -9.81 42.41 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.582 0.753 . . . . 72.32 111.221 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -71.15 154.09 41.99 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.147 0.499 . . . . 72.24 111.409 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.519 ' O ' HG13 ' A' ' 35' ' ' ILE . 49.9 m -95.11 121.23 36.53 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.76 -0.655 . . . . 72.15 110.425 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.426 ' HB3' ' HG ' ' A' ' 60' ' ' LEU . . . -49.22 -42.66 41.15 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.207 1.003 . . . . 50.5 113.088 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 5.8 p -73.06 -34.13 66.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.895 0.379 . . . . 63.13 112.008 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.4 -47.12 80.41 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.03 -1.1 . . . . 75.31 108.03 175.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.54 ' O ' HG22 ' A' ' 39' ' ' VAL . 68.6 mt -59.67 -46.24 93.52 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.379 0 CA-C-N 114.342 -1.299 . . . . 72.32 110.683 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.402 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.45 -46.6 56.72 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.438 0.695 . . . . 72.14 111.742 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.541 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 7.6 tmtt? -73.28 -33.63 65.32 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.736 -0.839 . . . . 54.44 108.736 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -66.2 -51.97 52.56 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.196 0.998 . . . . 51.12 110.734 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.573 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.7 m -65.29 -30.22 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.744 0.817 . . . . 74.14 111.509 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.541 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 64.9 t80 . . . . . 0 C--O 1.234 0.257 0 CA-C-N 115.303 -0.862 . . . . 65.23 111.861 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 83.2 mt . . . . . 0 CA--C 1.509 -0.621 0 N-CA-C 109.693 -0.484 . . . . 74.34 109.693 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -137.28 144.67 42.81 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.024 -1.102 . . . . 71.35 108.024 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -109.38 147.0 33.5 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 113.959 1.096 . . . . 72.41 113.959 178.314 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -117.53 119.51 61.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.214 -1.032 . . . . 63.31 108.214 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.576 ' HB3' HD11 ' A' ' 67' ' ' LEU . 11.8 t80 -100.33 90.95 4.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.74 -1.207 . . . . 72.51 107.74 176.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 71.96 -70.3 0.16 Allowed 'General case' 0 N--CA 1.401 -2.913 0 C-N-CA 127.05 2.14 . . . . 73.02 112.392 -176.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.9 -47.75 1.07 Allowed Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 119.877 -1.154 . . . . 62.25 115.196 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -124.19 170.34 10.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 118.049 0.924 . . . . 72.41 112.991 -172.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.548 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 73.7 m-85 -83.7 118.33 23.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.742 -0.836 . . . . 73.21 108.742 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 62' ' ' TYR . 7.0 mp -80.77 -45.96 16.17 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 113.553 0.945 . . . . 64.41 113.553 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -168.84 172.27 7.89 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 106.774 -1.565 . . . . 51.42 106.774 -173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.44 -1.51 87.85 Favored Glycine 0 C--N 1.306 -1.126 0 N-CA-C 111.783 -0.527 . . . . 75.33 111.783 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -175.92 80.93 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.497 -1.297 . . . . 75.42 107.497 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 p -104.93 151.7 7.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.546 -1.279 . . . . 72.04 107.546 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.2 p -91.17 158.11 16.81 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 118.232 0.469 . . . . 73.04 110.203 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.528 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.9 mm? -69.32 -30.63 68.73 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.04 0.447 . . . . 44.23 110.642 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.1 -35.02 91.51 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.187 -0.765 . . . . 72.41 111.187 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.03 -15.7 63.05 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.2 0.6 . . . . 34.21 111.282 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.426 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 65.2 mt -85.11 -1.6 57.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 73.42 110.158 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 8.8 mptt 63.41 72.34 0.48 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.359 1.064 . . . . 55.15 109.375 -177.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 73' ' ' LEU . 87.7 mt -125.17 117.74 25.43 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 115.479 -0.782 . . . . 71.33 111.423 -175.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.67 152.12 64.36 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.403 2.068 . . . . 74.23 110.147 172.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -75.92 148.39 38.26 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.734 -0.839 . . . . 64.34 108.734 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.489 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 91.99 -10.79 73.71 Favored Glycine 0 C--N 1.296 -1.671 0 C-N-CA 119.744 -1.217 . . . . 63.24 113.043 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -101.23 138.98 37.53 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.148 0.499 . . . . 62.33 111.884 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.432 HG23 HD22 ' A' ' 11' ' ' ASN . 35.1 m -79.88 118.46 21.66 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.201 -0.909 . . . . 73.24 109.94 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.7 m -116.78 129.42 56.09 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.921 -0.581 . . . . 64.02 109.55 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -104.89 140.36 23.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.905 -0.405 . . . . 70.3 109.905 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 92.4 mtp -138.23 153.58 49.11 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 120.869 0.366 . . . . 75.32 111.042 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -106.59 129.6 54.49 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.077 -1.083 . . . . 75.12 108.077 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.0 mm? -122.6 139.34 54.04 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 122.126 -0.359 . . . . 55.11 110.447 -175.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.417 HG12 ' CG1' ' A' ' 17' ' ' VAL . 29.1 m -116.87 132.48 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 C-N-CA 119.892 -0.723 . . . . 64.53 109.721 176.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.711 0 N-CA-C 107.789 -1.189 . . . . 70.11 107.789 176.03 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.429 -1.51 0 N-CA-C 107.788 -1.19 . . . . 75.34 107.788 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.7 t -127.86 125.44 39.71 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.331 -0.989 . . . . 61.52 108.331 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 68.27 108.83 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.346 1.029 . . . . 72.13 110.428 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.4 t -92.03 115.34 64.46 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 108.319 -0.993 . . . . 65.14 108.319 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -72.52 156.13 54.34 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.077 1.851 . . . . 71.54 111.012 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.57 7.2 1.14 Allowed 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.671 0.989 . . . . 44.13 113.671 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -109.24 -6.06 15.68 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.644 -0.502 . . . . 74.21 109.644 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.4 mmm -130.19 154.51 47.47 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.237 0.541 . . . . 71.24 110.543 -172.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.48 HG22 ' HA ' ' A' ' 80' ' ' PHE . 2.7 pp -115.92 131.12 69.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.946 -0.57 . . . . 62.51 110.072 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.554 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -84.57 114.5 22.02 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.039 -1.467 . . . . 71.24 107.039 -177.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.495 ' HG ' HD22 ' A' ' 14' ' ' LEU . 41.7 tp -121.32 133.17 55.11 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.946 0.721 . . . . 62.44 112.946 -172.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.447 ' HE ' ' HB ' ' A' ' 21' ' ' THR . 75.5 ttt180 -108.57 121.39 44.9 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 115.14 -0.937 . . . . 64.41 108.737 174.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.529 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.2 mm? -99.37 120.27 39.31 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.885 -1.052 . . . . 62.42 108.612 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.476 HG23 HG22 ' A' ' 21' ' ' THR . 32.1 mt -107.33 122.88 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 108.451 -0.944 . . . . 75.11 108.451 177.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.59 160.48 18.17 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 116.384 -0.371 . . . . 63.41 110.346 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.7 t -58.66 -26.15 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.643 0.777 . . . . 74.43 111.569 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -76.43 -6.09 50.2 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.768 -0.651 . . . . 64.33 111.214 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.08 6.74 66.51 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.502 -0.856 . . . . 65.34 112.032 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -87.61 131.41 34.43 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.045 -0.724 . . . . 75.44 109.045 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.476 HG22 HG23 ' A' ' 15' ' ' ILE . 68.5 p -111.44 129.77 55.92 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 120.364 -0.534 . . . . 71.03 110.276 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.64 139.77 53.57 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.482 -1.303 . . . . 72.45 107.482 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -133.58 130.61 38.64 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.927 -1.109 . . . . 71.21 109.285 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.673 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.6 m-85 -145.17 160.35 41.58 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 123.526 0.73 . . . . 63.54 109.299 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.1 tp -84.09 125.7 32.37 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.689 -1.226 . . . . 64.12 107.689 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.673 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 82.4 m-85 -127.81 168.47 15.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.05 0.453 . . . . 55.43 111.022 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.461 ' HB2' ' OD2' ' A' ' 30' ' ' ASP . 20.4 m -92.87 140.53 23.59 Favored Pre-proline 0 N--CA 1.424 -1.774 0 N-CA-C 108.366 -0.976 . . . . 70.51 108.366 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.464 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 27.3 Cg_endo -60.01 -18.79 52.42 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.632 2.221 . . . . 61.34 113.267 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -81.35 -11.76 59.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.208 -0.451 . . . . 60.22 111.197 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' A' ' 27' ' ' SER . 22.0 m-20 -78.99 153.76 30.06 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.836 -0.54 . . . . 74.23 111.751 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.471 ' O ' HG13 ' A' ' 35' ' ' ILE . 25.8 p -95.35 131.31 41.6 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.111 0.481 . . . . 74.22 111.521 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.713 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -51.93 -41.83 62.33 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 124.262 1.025 . . . . 62.2 113.706 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.7 p -74.86 -30.95 61.49 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.471 0.545 . . . . 72.13 112.471 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -69.08 -42.48 76.13 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 107.402 -1.333 . . . . 74.32 107.402 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.511 HG23 ' CZ ' ' A' ' 26' ' ' PHE . 67.0 mt -60.97 -43.61 96.36 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.216 0 CA-C-N 114.175 -1.375 . . . . 53.41 110.745 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.72 -42.6 57.36 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.086 0.555 . . . . 74.44 111.874 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.596 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -72.14 -39.77 68.55 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.078 -1.452 . . . . 71.02 107.078 -178.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -61.87 -45.74 92.46 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.612 -0.722 . . . . 74.12 110.97 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 14' ' ' LEU . 26.8 m -71.61 -31.99 44.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 112.693 0.627 . . . . 73.15 112.693 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -51.38 -48.87 62.41 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 123.127 0.267 . . . . 71.14 111.471 173.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -167.26 -86.88 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.598 0.962 . . . . 72.05 113.598 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -109.19 164.74 12.18 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 110.041 -0.355 . . . . 71.42 110.041 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 55.6 p-90 -64.98 134.58 96.11 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 113.153 0.797 . . . . 71.24 113.153 -174.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.02 137.57 76.64 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 123.481 2.787 . . . . 75.25 111.978 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 64.6 mtt -95.45 -60.07 1.74 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.402 -0.363 . . . . 74.0 111.383 -176.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -154.44 75.59 1.0 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.877 0.846 . . . . 55.21 112.751 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.439 ' CD1' ' HB3' ' A' ' 49' ' ' GLU . 70.4 t-105 57.39 86.94 0.07 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.083 -1.417 . . . . 74.31 112.152 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.508 ' HG3' ' HD3' ' A' ' 97' ' ' PRO . 13.7 mp0 -73.82 87.53 1.75 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.915 -1.039 . . . . 73.21 110.352 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.499 ' HA ' HD11 ' A' ' 57' ' ' ILE . 16.8 pt-20 -106.61 -171.55 1.91 Allowed 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.87 -1.059 . . . . 70.3 110.252 -177.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 3.1 tm-20 -78.09 141.68 38.63 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 106.215 -1.772 . . . . 73.1 106.215 173.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -53.75 -44.88 70.34 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.352 1.612 . . . . 63.31 115.352 -169.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.7 m -85.93 14.91 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.879 0 CA-C-O 121.789 0.804 . . . . 45.41 111.06 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 t 81.07 114.23 0.06 Allowed 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 127.163 2.185 . . . . 43.52 114.07 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 46.5 m -151.92 99.46 2.92 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 114.064 -1.425 . . . . 42.54 107.609 175.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.26 -27.59 9.47 Favored 'Trans proline' 0 C--N 1.329 -0.497 0 C-N-CA 122.056 1.837 . . . . 74.42 112.787 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -73.66 -4.7 35.9 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.136 0.493 . . . . 71.42 112.321 -174.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.499 HD11 ' HA ' ' A' ' 49' ' ' GLU . 2.3 pp -77.89 -15.54 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 O-C-N 121.964 -0.46 . . . . 73.04 111.987 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.481 ' HG ' HD12 ' A' ' 57' ' ' ILE . 84.9 mt -104.61 105.06 15.01 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.715 -0.846 . . . . 72.0 108.715 175.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.5 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 83.0 mtp180 -138.26 162.3 34.67 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.174 0.511 . . . . 74.21 109.892 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.713 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.5 pp -123.12 135.54 54.41 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 115.603 -0.726 . . . . 71.1 110.727 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 85.7 mt -110.45 123.32 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 N-CA-C 108.48 -0.933 . . . . 70.51 108.48 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -100.91 50.27 0.87 Allowed 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 106.649 -1.612 . . . . 74.34 106.649 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 60.69 93.5 0.04 OUTLIER 'General case' 0 N--CA 1.394 -3.243 0 C-N-CA 127.6 2.36 . . . . 72.21 112.168 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.99 -29.42 10.01 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.236 -0.893 . . . . 72.23 112.848 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -130.51 137.76 49.9 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.972 0.731 . . . . 72.4 112.972 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -88.6 113.67 24.42 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 106.293 -1.743 . . . . 74.23 106.293 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.559 HD12 ' CD2' ' A' ' 76' ' ' LEU 0.258 29.1 mt -79.16 -43.54 23.74 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 117.936 -1.506 . . . . 73.12 112.471 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.669 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.6 t-80 -173.82 -175.62 1.1 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.552 -1.277 . . . . 71.33 107.552 176.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -85.03 -14.16 70.07 Favored Glycine 0 C--N 1.302 -1.347 0 N-CA-C 115.743 1.057 . . . . 43.02 115.743 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -167.64 28.08 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 118.192 0.996 . . . . 64.5 109.846 -172.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.561 HG12 HD21 ' A' ' 60' ' ' LEU . 11.9 p -74.67 147.63 8.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.265 -0.643 . . . . 73.55 109.265 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.573 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 45.7 p -78.77 158.4 28.25 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 112.419 0.526 . . . . 72.24 112.419 -173.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.52 HD13 HD12 ' A' ' 76' ' ' LEU . 3.6 mm? -60.02 -41.38 92.04 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.413 0.685 . . . . 73.14 111.862 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.57 -37.99 94.24 Favored Glycine 0 C--N 1.317 -0.521 0 N-CA-C 111.36 -0.696 . . . . 54.13 111.36 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.439 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -74.88 -16.04 60.69 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 122.798 0.439 . . . . 53.32 111.547 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 72' ' ' THR . 62.7 mt -83.77 -4.7 58.85 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.252 -0.647 . . . . 63.01 109.252 177.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.6 mptt 71.28 79.55 0.16 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.69 1.196 . . . . 74.3 111.297 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 73' ' ' LEU . 10.8 mp -123.47 117.11 27.94 Favored Pre-proline 0 CA--C 1.494 -1.192 0 CA-C-N 115.526 -0.761 . . . . 75.1 111.474 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.513 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 11.0 Cg_exo -64.11 122.85 10.98 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 121.728 1.618 . . . . 75.33 109.197 171.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.48 ' HA ' HG22 ' A' ' 10' ' ' ILE . 1.1 p90 -69.77 144.44 52.69 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.338 0.589 . . . . 74.14 112.171 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.38 9.05 60.71 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.087 -0.96 . . . . 65.42 113.157 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -132.01 163.87 27.45 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 117.863 0.831 . . . . 75.34 110.622 176.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.554 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 25.7 m -91.66 129.37 37.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.407 0.622 . . . . 53.13 111.361 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.6 m -122.23 133.37 54.71 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.834 -0.621 . . . . 74.41 110.292 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.2 p -104.57 139.34 25.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 109.887 -0.412 . . . . 71.33 109.887 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 85.7 mtp -138.25 153.49 49.08 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-O 121.009 0.433 . . . . 54.33 111.079 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.484 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 59.1 m-70 -111.26 126.84 55.31 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.609 -1.256 . . . . 53.15 107.609 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.4 mm? -113.47 142.2 46.2 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 122.156 -0.34 . . . . 44.43 110.201 -176.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.84 134.01 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 121.223 0.535 . . . . 74.05 111.009 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 57' ' ' ILE . . . -134.42 136.42 43.27 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 107.983 -1.118 . . . . 73.31 107.983 176.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.409 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 99.3 mtt180 -133.48 126.92 32.17 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 110.074 -0.343 . . . . 53.3 110.074 -174.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 58.23 23.1 9.94 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.398 0.679 . . . . 74.2 111.159 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 t -79.95 137.4 36.85 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.455 -0.793 . . . . 75.23 110.04 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.2 mp -98.08 135.91 21.22 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 109.03 -0.73 . . . . 72.21 109.03 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -66.98 106.53 1.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.584 1.522 . . . . 73.12 108.85 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 66.74 109.43 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.192 0.997 . . . . 73.34 110.166 -174.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.508 ' HD3' ' HG3' ' A' ' 48' ' ' GLU . 4.1 Cg_endo -49.45 -66.22 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.36 2.707 . . . . 71.44 113.777 -174.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.526 ' HB3' HE22 ' A' ' 100' ' ' GLN . 7.9 t30 -147.08 15.71 1.18 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.181 0.991 . . . . 74.21 108.631 174.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.6 t 71.93 17.72 5.18 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.456 -1.247 . . . . 60.32 113.377 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.526 HE22 ' HB3' ' A' ' 98' ' ' ASN . 1.8 mp0 -63.1 -50.94 68.53 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 119.62 -0.832 . . . . 60.03 111.388 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.24 34.64 57.75 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 107.939 -2.064 . . . . 63.53 107.939 -172.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -71.11 115.99 10.89 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.406 -0.897 . . . . 63.11 110.437 -176.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -138.98 176.77 8.4 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.648 -1.16 . . . . 65.11 108.967 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -99.96 169.96 8.84 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 105.792 -1.929 . . . . 62.03 105.792 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.506 ' NE ' ' HA ' ' A' ' 105' ' ' ARG . 3.8 mmp_? -61.79 -50.46 72.26 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 118.11 0.413 . . . . 75.12 111.355 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 54.3 29.98 11.73 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.225 1.01 . . . . 63.11 110.81 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -148.62 122.82 9.55 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 115.477 -0.783 . . . . 72.3 110.355 -174.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.0 p -67.84 130.4 42.87 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 116.09 -0.505 . . . . 73.45 109.91 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.86 -27.14 6.92 Favored Glycine 0 C--N 1.308 -1.0 0 N-CA-C 108.317 -1.913 . . . . 44.02 108.317 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -93.96 -175.17 3.63 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 114.06 -1.07 . . . . 70.04 108.466 176.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.6 m 67.0 100.1 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.043 0.937 . . . . 51.41 111.962 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -96.88 102.72 14.56 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.194 0.521 . . . . 74.31 110.066 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 65.4 m -92.68 159.96 15.21 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.071 -0.714 . . . . 70.34 109.071 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 67.9 m -73.33 138.56 45.47 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.071 0.462 . . . . 63.24 110.194 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.1 m -119.27 153.61 21.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 116.093 -0.503 . . . . 75.5 109.784 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.1 tp -165.73 80.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.829 0.823 . . . . 71.41 110.328 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 C--N 1.316 -0.861 0 N-CA-C 105.764 -1.939 . . . . 74.34 105.764 179.856 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.5 p . . . . . 0 N--CA 1.428 -1.546 0 CA-C-O 122.229 1.014 . . . . 75.04 111.378 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.0 m -149.18 16.05 0.93 Allowed 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.145 -1.428 . . . . 54.23 107.145 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -150.32 -174.08 4.64 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 104.383 -2.451 . . . . 73.11 104.383 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.4 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 29.3 t -92.26 115.64 65.08 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 108.631 -0.877 . . . . 53.13 108.631 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -63.52 166.42 15.44 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.22 1.947 . . . . 71.41 112.197 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.46 11.74 20.74 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.607 -0.724 . . . . 64.32 109.491 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -121.72 -3.67 9.24 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.174 -0.921 . . . . 73.53 108.582 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.7 mmm -126.93 152.32 47.29 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.925 -0.768 . . . . 74.44 108.925 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -111.88 139.37 36.65 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 N-CA-C 109.275 -0.639 . . . . 71.35 109.275 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.596 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -88.17 116.28 26.26 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.923 -1.14 . . . . 55.15 107.923 -176.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.502 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.7 tp -127.36 132.99 50.1 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 121.156 0.503 . . . . 74.05 112.185 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.409 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 35.2 ttp180 -109.6 120.65 43.14 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 108.561 -0.903 . . . . 70.53 108.561 174.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.547 ' CB ' HG21 ' A' ' 39' ' ' VAL . 1.8 mm? -100.23 120.71 40.32 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 114.591 -1.186 . . . . 75.41 108.677 -178.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.463 HG23 HG22 ' A' ' 21' ' ' THR . 23.2 mt -104.36 123.01 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 108.811 -0.811 . . . . 73.5 108.811 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.39 165.0 20.66 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.632 -0.713 . . . . 74.33 110.745 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.6 t -65.18 -21.07 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-O 121.887 0.851 . . . . 43.42 109.399 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.6 m -76.03 -4.45 41.35 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.45 1.1 . . . . 53.11 111.418 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.26 6.93 88.97 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.805 -0.918 . . . . 51.23 110.805 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -87.89 131.14 34.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.283 -1.006 . . . . 64.24 108.283 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.463 HG22 HG23 ' A' ' 15' ' ' ILE . 80.5 p -111.31 129.32 56.03 Favored 'General case' 0 N--CA 1.417 -2.096 0 C-N-CA 120.269 -0.572 . . . . 72.4 109.562 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 39' ' ' VAL . 95.8 mttt -131.66 139.31 49.05 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.282 -1.007 . . . . 73.11 108.282 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.409 ' HG3' ' HB2' ' A' ' 13' ' ' ARG . 30.1 tt0 -130.43 131.1 45.06 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.774 -0.77 . . . . 62.1 109.617 -175.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.676 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.2 m-85 -144.9 159.7 42.48 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 122.795 0.438 . . . . 62.34 109.83 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.45 126.47 32.26 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.624 -1.25 . . . . 63.23 107.624 174.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.676 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 90.1 m-85 -127.36 163.47 23.92 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.572 -0.529 . . . . 74.24 109.572 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.7 p -85.33 147.35 46.96 Favored Pre-proline 0 N--CA 1.41 -2.439 0 N-CA-C 107.741 -1.207 . . . . 73.11 107.741 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.494 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 55.6 Cg_endo -62.31 -11.36 22.16 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.803 2.335 . . . . 72.51 111.712 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -86.6 -15.87 38.48 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.29 -0.868 . . . . 71.22 111.242 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -71.76 153.74 41.78 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.15 0.5 . . . . 61.43 111.245 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.438 ' O ' HG13 ' A' ' 35' ' ' ILE . 19.4 m -96.52 129.46 43.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.006 -1.109 . . . . 71.3 108.006 177.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.805 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -51.03 -38.27 50.37 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.637 0.977 . . . . 74.02 113.637 -176.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 p -77.62 -29.05 51.61 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.132 0.492 . . . . 53.22 111.93 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.99 -41.58 82.08 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.907 -1.516 . . . . 63.32 106.907 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.48 HG23 ' CZ ' ' A' ' 26' ' ' PHE . 70.5 mt -64.13 -42.63 96.17 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.472 0 CA-C-N 113.715 -1.584 . . . . 74.53 110.43 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.406 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.01 -40.15 43.71 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 123.173 0.589 . . . . 74.41 111.842 175.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.83 -31.17 64.6 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.441 0.638 . . . . 74.55 110.323 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -74.13 -47.9 32.98 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.207 -0.906 . . . . 65.55 110.009 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.547 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.4 m -71.37 -32.1 45.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.923 -0.485 . . . . 72.24 111.9 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -49.67 -49.78 46.1 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 108.508 -0.923 . . . . 73.22 108.508 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -177.41 106.18 0.06 Allowed 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 124.166 0.916 . . . . 72.24 110.378 172.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.251 43.0 m-80 65.09 -116.22 0.36 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.229 1.566 . . . . 63.54 115.229 177.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -115.52 145.4 34.38 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 108.591 -0.892 . . . . 73.2 108.591 175.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -44.98 110.98 0.26 Allowed 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 121.944 1.763 . . . . 74.02 109.827 168.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 27.9 ttt -51.53 140.01 19.04 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 112.926 0.713 . . . . 72.23 112.926 -173.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -54.39 -56.91 13.83 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.749 -1.114 . . . . 74.43 111.194 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 10.4 m0 -79.98 99.34 7.58 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.444 -0.947 . . . . 71.23 108.444 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -120.09 104.37 10.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.267 -0.424 . . . . 73.25 110.555 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -161.19 103.24 1.26 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.926 -1.138 . . . . 74.22 107.926 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.531 ' OE1' ' HG3' ' A' ' 51' ' ' GLN . 0.2 OUTLIER -135.55 104.0 5.66 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 104.487 -2.412 . . . . 74.12 104.487 176.17 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.531 ' HG3' ' OE1' ' A' ' 50' ' ' GLU . 49.0 mt-30 59.67 38.83 21.75 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.714 0.634 . . . . 64.32 109.858 -174.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.6 t 78.11 -39.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.82 1.248 . . . . 72.42 111.261 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.6 m 66.16 97.86 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.2 1.0 . . . . 62.11 111.723 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.1 p -79.83 158.19 73.21 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 122.054 -0.404 . . . . 44.32 110.351 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -71.83 -15.72 29.73 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 121.993 1.795 . . . . 64.34 109.615 173.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -68.22 -13.34 62.17 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.98 -1.464 . . . . 52.03 111.411 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.0 pp -77.92 -19.82 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 120.791 0.329 . . . . 74.24 110.42 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.4 mp -78.63 106.59 10.71 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.506 -0.553 . . . . 63.42 109.506 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.413 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 98.7 mtt180 -140.29 142.73 35.67 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.828 -0.804 . . . . 72.24 108.828 177.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.805 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.5 pp -126.05 138.9 53.75 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.052 0.453 . . . . 72.42 111.451 -176.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.467 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 90.1 mt -108.96 119.91 59.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 108.456 -0.942 . . . . 55.32 108.456 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -101.3 75.59 1.64 Allowed 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.353 -1.351 . . . . 75.22 107.353 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 36.78 85.68 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.77 0 C-N-CA 127.587 2.355 . . . . 53.04 113.23 -176.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.87 -57.29 0.62 Allowed Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 115.447 -0.797 . . . . 75.11 113.156 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -130.07 159.66 36.09 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 112.627 0.603 . . . . 71.13 112.627 -176.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 33.1 m-85 -89.35 112.82 24.01 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.926 -1.138 . . . . 74.42 107.926 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.507 HD12 HD22 ' A' ' 76' ' ' LEU . 83.5 mt -80.2 -47.19 15.06 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 113.547 0.943 . . . . 65.14 113.547 -175.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.642 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.4 t-80 -165.33 174.74 9.8 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 106.614 -1.624 . . . . 74.33 106.614 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.11 -1.88 88.37 Favored Glycine 0 C--N 1.307 -1.067 0 C-N-CA 120.261 -0.971 . . . . 31.22 114.396 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -175.72 28.16 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 117.822 0.811 . . . . 73.35 112.221 -173.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.583 HG12 HD21 ' A' ' 60' ' ' LEU . 13.0 p -70.24 142.68 15.51 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 C-N-CA 120.46 -0.496 . . . . 73.24 109.808 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.457 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 31.8 p -78.54 157.67 28.75 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.852 -0.613 . . . . 44.03 111.836 -175.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.575 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.8 mm? -66.25 -32.87 74.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.406 -0.361 . . . . 61.42 110.784 -177.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.04 -36.38 92.82 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 111.178 -0.769 . . . . 75.22 111.178 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.406 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -73.97 -15.27 61.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.12 0.568 . . . . 73.54 110.893 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.507 HD22 HD12 ' A' ' 67' ' ' LEU . 73.4 mt -82.79 14.87 2.94 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.675 0.39 . . . . 72.14 111.226 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.6 24.1 10.21 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.759 0.824 . . . . 64.04 110.619 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.476 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 96.2 mt -91.8 125.14 58.32 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 112.511 0.56 . . . . 73.0 112.511 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 3.5 Cg_endo -86.35 170.3 8.08 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.846 2.364 . . . . 73.11 110.484 172.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.494 ' CE2' ' HG3' ' A' ' 28' ' ' PRO . 75.2 m-85 -78.7 151.35 32.21 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.781 -0.451 . . . . 75.41 109.781 -178.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.4 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 82.93 0.96 90.59 Favored Glycine 0 C--N 1.308 -1.022 0 C-N-CA 120.668 -0.777 . . . . 73.23 114.232 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -102.37 136.45 42.18 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 117.509 0.655 . . . . 65.31 110.021 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.596 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 54.6 m -87.19 116.78 25.49 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.006 -0.739 . . . . 71.35 109.006 176.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.3 m -115.81 142.43 46.77 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.55 -0.75 . . . . 53.41 110.471 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -111.45 135.59 50.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 120.793 0.33 . . . . 73.32 110.354 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 87.0 mtp -138.35 153.24 48.97 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 120.862 0.363 . . . . 63.41 110.276 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.467 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 21.5 m-70 -111.59 132.7 54.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.989 -1.115 . . . . 74.3 107.989 178.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.465 HD21 HD12 ' A' ' 14' ' ' LEU . 2.5 mm? -119.47 144.53 46.93 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 120.614 -0.434 . . . . 65.35 111.113 -176.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 59' ' ' ARG . 26.7 m -120.52 134.94 62.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.8 -0.636 . . . . 74.04 109.43 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.454 ' HB1' ' OG1' ' A' ' 93' ' ' THR . . . -133.01 144.9 50.4 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.878 -0.601 . . . . 73.14 109.788 -176.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -140.78 147.94 39.88 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 108.024 -1.102 . . . . 61.15 108.024 -177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 53.7 28.53 8.2 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 122.18 0.99 . . . . 62.15 110.391 -177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.454 ' OG1' ' HB1' ' A' ' 90' ' ' ALA . 44.1 m -89.77 139.8 30.22 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 114.578 -1.192 . . . . 73.54 109.615 -176.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.3 mp -68.55 131.11 91.64 Favored Pre-proline 0 C--N 1.304 -1.375 0 CA-C-N 115.512 -0.767 . . . . 63.32 110.517 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.24 -38.1 95.6 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.181 2.588 . . . . 75.02 113.683 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -159.35 142.32 10.4 Favored Pre-proline 0 C--N 1.322 -0.602 0 C-N-CA 120.994 -0.283 . . . . 73.14 111.107 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.2 -63.62 0.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.003 1.802 . . . . 74.3 109.982 170.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -168.05 76.9 0.14 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 112.763 0.653 . . . . 73.24 112.763 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.7 m 45.87 28.04 0.55 Allowed 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 116.644 2.09 . . . . 71.33 116.644 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -81.06 -51.14 8.81 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.598 -0.841 . . . . 61.24 110.603 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.36 -18.96 6.11 Favored Glycine 0 C--N 1.32 -0.36 0 CA-C-N 115.665 -0.698 . . . . 74.44 112.666 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -136.14 156.81 48.15 Favored 'General case' 0 CA--C 1.485 -1.548 0 O-C-N 122.526 -0.396 . . . . 64.13 111.178 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -109.05 -40.79 4.89 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 124.134 0.896 . . . . 73.01 108.79 175.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -163.43 146.66 10.3 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.993 -1.114 . . . . 71.24 107.993 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.402 HH22 ' HB2' ' A' ' 112' ' ' ASN . 74.9 ttt180 -71.91 -50.8 26.02 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.151 0.5 . . . . 74.42 110.26 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -167.27 156.19 10.06 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 104.348 -2.464 . . . . 74.21 104.348 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.609 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 1.2 tpmt? -53.71 -43.62 69.17 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 123.512 0.725 . . . . 73.23 110.892 -178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.8 t -158.61 -23.53 0.08 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.644 -0.422 . . . . 64.13 111.826 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -83.39 75.48 2.37 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 121.001 -0.619 . . . . 63.43 112.843 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.442 ' HB2' ' HB2' ' A' ' 113' ' ' CYS . 19.4 mm-40 -54.18 133.0 44.33 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 122.741 0.416 . . . . 75.23 110.307 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.2 t -61.73 -43.43 98.86 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.329 0.585 . . . . 72.51 109.938 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.402 ' HB2' HH22 ' A' ' 105' ' ' ARG . 16.9 m120 -111.63 113.29 25.58 Favored 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 106.676 -1.601 . . . . 74.2 106.676 176.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 110' ' ' GLU . 45.1 t -149.64 154.18 38.21 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.537 -0.912 . . . . 61.14 108.537 -175.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 63.9 m -77.07 95.77 4.29 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.654 -0.869 . . . . 60.13 108.654 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.4 m -115.95 160.43 15.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.81 -0.632 . . . . 71.3 110.704 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.412 HD12 ' N ' ' A' ' 116' ' ' ILE . 2.1 mp -86.52 95.9 5.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 121.862 0.839 . . . . 71.32 108.835 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.6 tp . . . . . 0 C--N 1.291 -1.935 0 N-CA-C 107.312 -1.366 . . . . 75.54 107.312 -177.399 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 112.81 0.67 . . . . 65.35 112.81 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.6 t -98.42 136.58 38.36 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 106.625 -1.62 . . . . 73.0 106.625 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.5 m120 69.43 115.53 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.844 0.83 . . . . 72.21 111.729 -173.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.409 HG13 HD22 ' A' ' 25' ' ' LEU . 16.8 t -87.93 131.75 42.17 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 108.676 -0.861 . . . . 72.23 108.676 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -72.01 143.24 40.14 Favored 'Trans proline' 0 C--O 1.251 1.159 0 C-N-CA 121.889 1.726 . . . . 73.01 110.421 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.81 72.14 4.33 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 121.996 0.903 . . . . 70.21 109.821 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.422 ' H ' ' H ' ' A' ' 9' ' ' MET . 27.8 t70 -169.11 -28.18 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 113.612 -1.631 . . . . 75.31 107.727 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.422 ' H ' ' H ' ' A' ' 8' ' ' ASP . 92.9 mmm -117.52 145.73 44.03 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.819 -1.082 . . . . 71.22 109.128 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.471 HG22 ' HA ' ' A' ' 80' ' ' PHE . 2.8 pp -99.31 136.06 32.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 109.208 -0.664 . . . . 73.44 109.208 175.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.49 HD22 HG23 ' A' ' 83' ' ' THR . 5.4 t30 -91.93 107.69 19.39 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.7 -1.222 . . . . 63.31 107.7 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.504 ' HG ' HD22 ' A' ' 14' ' ' LEU . 43.5 tp -112.77 132.77 55.09 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 116.055 -0.52 . . . . 61.43 111.723 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -106.82 121.51 44.55 Favored 'General case' 0 N--CA 1.407 -2.59 0 N-CA-C 108.291 -1.003 . . . . 73.44 108.291 173.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.551 ' CB ' HG21 ' A' ' 39' ' ' VAL . 1.7 mm? -98.74 128.61 45.04 Favored 'General case' 0 C--N 1.268 -2.947 0 CA-C-N 114.258 -1.337 . . . . 62.31 109.353 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.487 HD12 HG22 ' A' ' 21' ' ' THR . 14.8 mm -107.47 119.33 56.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 107.744 -1.206 . . . . 73.25 107.744 175.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.7 tp -84.09 153.05 23.99 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 110.058 -0.349 . . . . 72.5 110.058 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.49 ' CG1' ' HA ' ' A' ' 89' ' ' VAL . 30.7 m -60.0 -13.36 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.829 0.851 . . . . 63.11 113.059 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.413 ' HB3' ' HD3' ' A' ' 20' ' ' LYS . 16.3 t -89.53 -2.78 58.46 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.275 -0.639 . . . . 64.32 109.275 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.21 7.93 79.19 Favored Glycine 0 C--N 1.337 0.583 0 CA-C-N 115.922 -0.581 . . . . 33.24 112.597 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HD3' ' HB3' ' A' ' 18' ' ' SER . 12.3 mptt -87.78 131.05 34.65 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.345 -0.983 . . . . 73.24 108.345 176.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.487 HG22 HD12 ' A' ' 15' ' ' ILE . 63.1 p -107.46 143.65 35.52 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.538 -0.912 . . . . 72.12 108.538 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 48.5 tptt -145.08 147.23 32.33 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.595 -0.842 . . . . 75.54 109.155 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -137.06 131.09 32.27 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 119.713 -0.795 . . . . 65.53 110.201 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.737 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 84.6 m-85 -145.14 160.97 40.6 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 123.888 0.875 . . . . 63.31 110.387 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.409 HD22 HG13 ' A' ' 5' ' ' VAL . 97.3 mt -79.7 126.02 30.4 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.634 -1.247 . . . . 53.33 107.634 171.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.737 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 83.6 m-85 -130.68 164.45 25.0 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.37 -0.974 . . . . 74.32 108.37 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.5 p -90.1 150.3 43.13 Favored Pre-proline 0 N--CA 1.42 -1.947 0 N-CA-C 107.747 -1.205 . . . . 61.44 107.747 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.428 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 28.7 Cg_endo -60.11 -14.75 30.19 Favored 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 122.044 1.829 . . . . 71.53 112.077 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -87.15 -9.68 54.64 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.892 -0.595 . . . . 62.22 110.545 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -76.02 154.01 36.06 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.81 -0.556 . . . . 71.53 111.193 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.532 ' O ' HG13 ' A' ' 35' ' ' ILE . 41.0 m -96.52 121.59 38.5 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 109.649 -0.5 . . . . 55.14 109.649 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.503 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -49.2 -52.5 26.38 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.115 1.524 . . . . 71.24 115.115 -173.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 14.4 m -79.46 -20.01 48.43 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 121.823 -0.548 . . . . 70.43 111.465 -175.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.87 -41.46 78.34 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.14 -1.8 . . . . 75.22 106.14 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 31' ' ' SER . 73.3 mt -62.79 -34.68 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 114.034 -1.439 . . . . 75.23 110.749 175.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 40' ' ' TYR . . . -52.94 -32.9 48.26 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 122.442 0.297 . . . . 55.51 111.577 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.551 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -72.91 -38.13 66.99 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 107.154 -1.425 . . . . 73.43 107.154 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 43' ' ' TRP . 43.0 t-80 -62.95 -54.02 44.99 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.897 0.879 . . . . 72.31 110.747 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.551 HG21 ' CB ' ' A' ' 14' ' ' LEU . 26.8 m -68.22 -29.98 46.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.023 -0.989 . . . . 75.24 112.411 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 64.3 t80 -46.63 -48.86 19.8 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.278 1.031 . . . . 74.11 111.09 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -177.15 -74.59 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.299 0.374 . . . . 71.02 110.305 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -103.16 150.16 23.93 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.215 -1.402 . . . . 64.13 107.215 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.614 ' HA ' ' HA ' ' A' ' 38' ' ' HIS . 30.2 p-90 -79.44 147.21 67.67 Favored Pre-proline 0 C--N 1.301 -1.533 0 C-N-CA 120.362 -0.535 . . . . 52.41 110.511 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.56 96.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.899 2.399 . . . . 64.14 113.851 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.492 ' HA ' ' CE ' ' A' ' 45' ' ' MET . 0.3 OUTLIER -138.51 74.81 1.49 Allowed 'General case' 0 N--CA 1.428 -1.565 0 CA-C-O 122.023 0.916 . . . . 74.34 109.17 177.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -169.66 -165.5 0.51 Allowed 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 104.14 -2.541 . . . . 64.55 104.14 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.3 t90 -108.99 -84.98 0.54 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 119.678 1.126 . . . . 72.21 110.94 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.417 ' HB3' HG12 ' A' ' 52' ' ' VAL . 21.8 mm-40 -155.21 134.67 12.54 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.424 -1.324 . . . . 72.42 107.424 -177.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -154.09 -60.07 0.13 Allowed 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.485 -0.561 . . . . 35.31 109.485 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.429 ' HG2' ' HB2' ' A' ' 94' ' ' LEU . 8.1 tp10 -96.01 115.25 27.14 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 106.93 -1.507 . . . . 70.32 106.93 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 86.0 mm-40 66.87 94.14 0.07 Allowed 'General case' 0 C--O 1.24 0.563 0 O-C-N 124.355 1.034 . . . . 74.43 109.703 -174.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.417 HG12 ' HB3' ' A' ' 48' ' ' GLU . 28.6 m -108.25 135.55 46.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 115.092 -0.958 . . . . 73.33 112.129 -172.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.0 m 58.57 27.62 15.95 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.921 0.888 . . . . 70.44 112.454 174.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.6 t -126.83 104.78 23.23 Favored Pre-proline 0 N--CA 1.425 -1.675 0 C-N-CA 120.639 -0.424 . . . . 70.55 110.878 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.28 -15.74 22.51 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.274 1.983 . . . . 74.34 110.671 176.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -61.01 -20.23 62.25 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 123.879 0.871 . . . . 62.31 112.129 -177.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 90' ' ' ALA . 33.8 pt -77.28 -28.14 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 120.522 -0.471 . . . . 62.11 111.133 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.547 ' O ' HD12 ' A' ' 58' ' ' LEU 0.257 3.5 pp -106.29 109.03 20.84 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.973 0.892 . . . . 71.33 111.995 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.425 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 97.4 mtt180 -142.61 163.15 33.61 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.53 -1.213 . . . . 65.45 109.899 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 4.1 pp -129.16 142.39 50.89 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.178 0.807 . . . . 73.35 113.178 -173.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.7 mt -117.56 124.41 73.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 114.907 -1.042 . . . . 51.02 108.359 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.465 ' CD2' HD11 ' A' ' 67' ' ' LEU . 1.8 t80 -101.32 60.87 0.92 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 122.038 0.923 . . . . 74.32 109.629 -176.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 63.91 17.39 10.52 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 113.902 -1.499 . . . . 73.22 112.488 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.39 -65.96 0.01 OUTLIER Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 120.734 -0.746 . . . . 72.14 112.031 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -130.49 176.03 8.49 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.822 0.344 . . . . 72.2 110.583 -177.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 85.8 m-85 -86.84 120.96 28.68 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.465 -1.309 . . . . 74.21 107.465 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.575 ' CD1' HD22 ' A' ' 76' ' ' LEU . 76.5 mt -80.1 -47.07 15.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.747 0.784 . . . . 71.4 109.915 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -163.11 -173.46 3.43 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 125.602 1.561 . . . . 74.43 107.771 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -84.34 -37.3 11.11 Favored Glycine 0 N--CA 1.416 -2.688 0 C-N-CA 120.499 -0.858 . . . . 53.32 113.72 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.406 ' OD1' ' HB3' ' A' ' 31' ' ' SER . 64.3 t30 -160.22 39.12 0.18 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.312 1.053 . . . . 72.21 108.961 -172.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.586 HG12 HD21 ' A' ' 60' ' ' LEU . 7.6 p -66.2 147.42 12.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-N 114.593 -1.185 . . . . 74.14 110.023 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.557 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 42.4 p -78.55 156.91 28.96 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 116.21 -0.45 . . . . 70.43 111.408 -175.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.461 ' H ' HD22 ' A' ' 73' ' ' LEU . 2.5 mm? -66.34 -30.76 71.23 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.517 0.562 . . . . 63.01 112.517 -176.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.48 -30.37 76.41 Favored Glycine 0 C--O 1.229 -0.167 0 N-CA-C 111.192 -0.763 . . . . 63.3 111.192 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.31 -15.51 60.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.371 0.605 . . . . 73.12 109.961 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.575 HD22 ' CD1' ' A' ' 67' ' ' LEU . 61.2 mt -92.84 11.95 25.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.425 -0.807 . . . . 72.52 111.834 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.532 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.6 mptt 67.74 19.27 9.7 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.539 0.736 . . . . 61.55 110.975 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.433 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 79.4 mt -83.66 122.14 76.51 Favored Pre-proline 0 N--CA 1.441 -0.918 0 CA-C-N 116.03 -0.532 . . . . 63.35 110.895 -177.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.455 ' HG2' ' HG3' ' A' ' 82' ' ' LYS . 6.6 Cg_endo -83.71 140.21 9.15 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 122.227 1.951 . . . . 74.2 111.708 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.471 ' HA ' HG22 ' A' ' 10' ' ' ILE . 4.8 p90 -70.44 141.97 52.04 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 112.596 0.591 . . . . 75.4 112.596 177.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.85 -1.17 70.73 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.759 -1.109 . . . . 74.33 111.599 -174.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.455 ' HG3' ' HG2' ' A' ' 79' ' ' PRO . 31.7 mmmt -108.36 158.04 17.85 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.82 0.343 . . . . 73.0 110.41 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.49 HG23 HD22 ' A' ' 11' ' ' ASN . 86.5 m -103.69 125.22 50.03 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.666 -0.697 . . . . 73.22 110.077 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.0 m -133.64 142.76 48.22 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.127 -0.488 . . . . 74.32 110.402 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.4 132.62 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 121.066 0.46 . . . . 54.13 110.688 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 90.4 mtp -136.17 153.43 51.26 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 121.153 0.502 . . . . 74.31 111.395 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -103.05 132.88 48.99 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.648 -0.705 . . . . 75.3 109.413 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.407 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.4 mm? -120.04 142.38 48.89 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.125 -0.694 . . . . 74.44 109.125 -176.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.49 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 35.2 m -116.78 133.76 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 C-N-CA 119.932 -0.707 . . . . 73.43 110.994 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 57' ' ' ILE . . . -133.77 146.5 50.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 105.909 -1.885 . . . . 53.05 105.909 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 51' ' ' GLN . 40.3 ttm180 -124.77 112.21 16.43 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 120.037 -0.665 . . . . 71.1 110.641 -172.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 39.2 mt-10 55.69 37.62 29.09 Favored 'General case' 0 C--O 1.203 -1.384 0 O-C-N 124.412 1.07 . . . . 74.51 110.97 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 36.9 m -88.65 113.22 23.99 Favored 'General case' 0 N--CA 1.409 -2.523 0 CA-C-N 114.567 -1.197 . . . . 34.22 108.751 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.429 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 10.9 mp -106.08 161.83 21.6 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 123.32 0.648 . . . . 60.42 112.344 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.04 155.36 19.01 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.79 2.327 . . . . 73.32 111.206 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -64.79 145.32 98.88 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 115.826 -0.624 . . . . 73.32 111.631 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -75.06 -30.34 7.17 Favored 'Trans proline' 0 N--CA 1.431 -2.188 0 C-N-CA 121.531 1.488 . . . . 73.54 109.16 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 70.84 17.11 6.48 Favored 'General case' 0 C--N 1.378 1.846 0 C-N-CA 124.686 1.194 . . . . 72.25 108.215 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.3 p -88.66 -5.67 57.98 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.191 -1.368 . . . . 65.41 111.212 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -83.56 -30.34 27.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 119.318 -0.953 . . . . 74.33 109.827 176.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.67 24.35 75.39 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.519 -0.764 . . . . 61.52 111.569 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -89.7 111.75 22.82 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 120.465 -0.494 . . . . 64.04 109.934 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -125.37 106.98 10.23 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.378 -0.971 . . . . 74.11 108.378 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -82.34 121.32 26.54 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.038 -0.528 . . . . 64.04 110.7 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.433 ' HD2' ' OG ' ' A' ' 111' ' ' SER . 41.6 mmt180 -71.5 -24.65 62.02 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.322 -0.854 . . . . 75.35 112.129 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 70.53 101.18 0.06 Allowed 'General case' 0 C--O 1.25 1.082 0 C-N-CA 123.812 0.845 . . . . 73.23 113.258 175.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? 72.22 -59.11 0.57 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.404 1.482 . . . . 73.41 109.787 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.1 p -70.95 136.6 48.58 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.655 -1.239 . . . . 71.23 107.655 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -69.84 -32.16 70.19 Favored Glycine 0 CA--C 1.5 -0.855 0 C-N-CA 120.323 -0.942 . . . . 65.12 111.201 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -144.73 146.9 32.41 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 108.671 -0.863 . . . . 63.11 108.671 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.433 ' OG ' ' HD2' ' A' ' 105' ' ' ARG . 50.2 m -86.77 74.79 9.74 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.276 -1.009 . . . . 71.21 108.276 176.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -157.66 116.69 3.24 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.145 -1.389 . . . . 64.15 108.336 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.6 t -76.78 121.8 23.85 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.481 -0.563 . . . . 62.15 109.481 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 20.7 p -69.34 122.27 18.57 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 108.9 -0.778 . . . . 73.13 108.9 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.7 m -95.47 127.61 47.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.65 0.738 . . . . 74.42 112.515 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.69 108.57 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 108.295 -1.002 . . . . 74.31 108.295 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 tm? . . . . . 0 C--N 1.287 -2.132 0 N-CA-C 105.702 -1.962 . . . . 55.14 105.702 -179.943 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.42 -1.94 0 N-CA-C 107.465 -1.309 . . . . 73.11 107.465 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.0 t -136.12 119.02 16.26 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.167 -0.613 . . . . 64.42 110.683 -174.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -77.47 128.22 33.84 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 107.648 -1.241 . . . . 63.12 107.648 174.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.569 HG21 ' HB2' ' A' ' 11' ' ' ASN . 10.8 t -80.76 119.73 77.0 Favored Pre-proline 0 C--N 1.283 -2.287 0 N-CA-C 109.077 -0.712 . . . . 41.31 109.077 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -69.81 152.02 68.95 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.025 1.817 . . . . 75.52 110.646 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.47 72.23 4.98 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-O 122.462 1.125 . . . . 74.34 109.162 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -170.65 -28.41 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 112.784 -2.007 . . . . 71.34 107.566 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.6 mmm -113.87 160.67 18.5 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.05 -0.977 . . . . 55.3 108.734 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -121.79 139.58 48.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.189 -0.671 . . . . 62.44 109.189 173.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.569 ' HB2' HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -94.02 110.78 22.45 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.785 -1.191 . . . . 64.42 107.785 -177.166 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.478 ' HG ' HD22 ' A' ' 14' ' ' LEU . 46.2 tp -115.9 132.91 56.51 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.826 -0.625 . . . . 75.25 112.069 -174.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -111.36 121.27 44.79 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 114.994 -1.003 . . . . 54.44 109.018 173.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.592 ' CB ' HG21 ' A' ' 39' ' ' VAL . 1.9 mm? -98.6 121.4 40.5 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.825 -1.08 . . . . 75.0 108.316 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.1 mt -102.95 127.15 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 C-N-CA 119.586 -0.846 . . . . 74.1 109.642 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -83.8 155.51 22.97 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.44 -0.8 . . . . 72.35 110.24 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.3 m -64.12 -19.11 24.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 122.893 0.477 . . . . 70.42 111.898 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.437 ' HB2' ' HG2' ' A' ' 20' ' ' LYS . 20.2 m -80.95 1.93 28.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.21 0.529 . . . . 74.35 110.424 177.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.08 12.75 82.11 Favored Glycine 0 CA--C 1.501 -0.803 0 N-CA-C 111.804 -0.518 . . . . 73.42 111.804 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.437 ' HG2' ' HB2' ' A' ' 18' ' ' SER . 74.1 mmtt -88.63 135.77 33.33 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.035 -1.469 . . . . 74.3 107.035 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.6 p -112.67 129.28 56.45 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 119.801 -0.76 . . . . 73.52 109.88 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -122.93 137.53 54.92 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.939 -1.134 . . . . 74.43 107.939 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -138.13 131.65 30.79 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.755 -0.778 . . . . 70.12 110.08 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.653 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 89.3 m-85 -145.5 160.14 42.05 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 123.933 0.893 . . . . 73.22 109.011 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.1 mt -79.57 125.5 29.68 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 107.065 -1.457 . . . . 65.41 107.065 170.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.653 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 87.8 m-85 -123.8 163.16 21.76 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.927 -1.138 . . . . 63.31 107.927 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 84.7 p -87.62 148.47 44.07 Favored Pre-proline 0 C--N 1.288 -2.095 0 N-CA-C 108.226 -1.027 . . . . 73.21 108.226 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.98 -14.87 35.42 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.252 1.968 . . . . 44.3 111.355 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -82.9 -17.8 42.46 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.066 -0.97 . . . . 73.14 110.281 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.431 ' O ' HD22 ' A' ' 73' ' ' LEU . 18.1 m-20 -67.95 154.61 41.23 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.009 0.433 . . . . 63.11 110.666 176.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.552 ' O ' HG13 ' A' ' 35' ' ' ILE . 51.1 m -105.13 129.53 53.51 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 116.039 -0.528 . . . . 74.21 110.536 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.807 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -49.86 -50.22 46.4 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.007 1.484 . . . . 54.31 115.007 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m -76.14 -27.15 56.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.284 0.493 . . . . 73.13 110.676 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.89 -45.55 91.98 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.239 -1.393 . . . . 60.41 107.239 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 31' ' ' SER . 66.1 mt -65.18 -42.49 94.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 114.348 -1.296 . . . . 74.22 110.657 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' O ' ' HD1' ' A' ' 40' ' ' TYR . . . -50.07 -50.08 49.24 Favored 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 122.856 0.462 . . . . 75.35 111.154 175.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -64.4 -38.44 91.03 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 108.142 -1.058 . . . . 73.04 108.142 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.496 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 35.3 t-80 -61.21 -54.26 46.45 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 114.844 -1.071 . . . . 72.34 110.706 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.592 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.1 m -69.97 -32.17 50.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 115.756 -0.656 . . . . 72.52 112.264 -178.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.423 ' HB3' HD11 ' A' ' 94' ' ' LEU . 11.7 m-85 -64.44 -49.26 72.17 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.764 0.653 . . . . 74.15 112.764 174.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -135.25 -74.06 0.46 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.784 -0.767 . . . . 64.43 113.065 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -149.62 172.71 14.6 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 105.59 -2.004 . . . . 73.34 105.59 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 21.5 p-90 -67.67 128.83 93.55 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 118.972 0.805 . . . . 70.35 111.855 -175.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.23 137.13 39.45 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.961 2.441 . . . . 53.23 112.133 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 62.5 mtm -126.41 -75.25 0.58 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.922 -1.14 . . . . 74.33 107.922 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t70 177.13 89.09 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.184 -1.784 . . . . 73.03 106.184 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 20.6 t90 -128.03 -172.77 2.77 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.49 -0.93 . . . . 75.45 108.49 -174.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -86.2 -16.83 36.51 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 112.174 0.435 . . . . 70.24 112.174 -177.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 56.65 -91.5 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.422 0.689 . . . . 65.34 111.458 -173.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 10.4 tp10 -86.64 -54.55 4.33 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.555 -0.906 . . . . 73.24 108.555 175.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -169.5 -52.93 0.02 OUTLIER 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 115.837 -0.619 . . . . 72.23 112.488 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.02 13.18 5.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 113.177 0.806 . . . . 62.52 113.177 -175.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.459 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 42.6 m 65.9 110.71 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.671 0.788 . . . . 64.14 110.435 -176.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.2 m -108.97 99.57 35.84 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 116.434 -0.348 . . . . 72.21 111.428 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 53' ' ' SER . 9.3 Cg_endo -90.9 -20.24 0.86 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.946 1.764 . . . . 74.11 112.656 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -68.48 -22.81 64.54 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.494 0.664 . . . . 73.11 110.775 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.458 ' CG2' ' HB2' ' A' ' 91' ' ' ARG . 2.1 pp -78.24 -17.13 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-N 115.229 -0.896 . . . . 74.22 113.184 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 55' ' ' PRO . 7.1 mp -68.79 101.33 1.31 Allowed 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.195 -0.668 . . . . 32.5 109.195 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.42 ' HD3' ' HA2' ' A' ' 69' ' ' GLY . 18.4 mmt180 -140.77 155.06 46.5 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.081 -0.711 . . . . 75.34 109.081 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.807 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.3 pp -135.39 144.47 46.59 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.395 -0.821 . . . . 75.44 110.189 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.459 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 98.7 mt -117.34 122.45 69.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 108.708 -0.849 . . . . 63.44 108.708 177.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -100.97 87.94 3.41 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.906 -1.516 . . . . 74.43 106.906 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 69.55 -64.94 0.32 Allowed 'General case' 0 N--CA 1.408 -2.527 0 C-N-CA 127.409 2.283 . . . . 63.04 112.401 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.47 -43.88 0.62 Allowed Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.205 -0.997 . . . . 74.4 113.712 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.85 162.26 18.4 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 115.049 1.5 . . . . 65.03 115.049 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.625 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 38.4 m-85 -84.19 117.5 23.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.018 -0.992 . . . . 72.31 108.335 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.504 HD12 ' CD2' ' A' ' 76' ' ' LEU . 66.4 mt -80.18 -47.2 15.07 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 114.6 1.333 . . . . 71.34 114.6 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.404 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 9.7 t60 -165.83 167.31 16.99 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.138 -1.43 . . . . 71.0 107.138 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.42 ' HA2' ' HD3' ' A' ' 59' ' ' ARG . . . -63.99 -19.08 63.11 Favored Glycine 0 C--O 1.209 -1.435 0 N-CA-C 114.187 0.435 . . . . 74.42 114.187 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.424 ' OD1' ' HB3' ' A' ' 31' ' ' SER . 65.3 t30 177.88 80.36 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 108.864 -0.791 . . . . 72.22 108.864 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.715 HG12 HD21 ' A' ' 60' ' ' LEU . 9.1 p -102.55 151.34 6.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.028 -0.73 . . . . 70.34 109.028 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.492 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 55.1 p -78.51 157.64 28.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.598 0.237 . . . . 74.0 111.172 -178.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.518 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.9 mm? -67.74 -32.43 73.03 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 120.715 0.293 . . . . 72.4 110.766 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.62 -41.22 99.84 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.672 -0.971 . . . . 44.34 110.672 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -68.99 -15.84 63.58 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.099 0.56 . . . . 43.22 111.269 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.624 ' HB2' HD13 ' A' ' 78' ' ' LEU . 87.1 mt -82.52 -1.6 50.98 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.852 0.461 . . . . 74.23 110.105 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.5 mptt 69.77 57.56 0.31 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.331 1.052 . . . . 64.25 110.551 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.624 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.3 mp -109.52 124.2 34.47 Favored Pre-proline 0 C--N 1.304 -1.382 0 CA-C-N 115.382 -0.826 . . . . 75.44 110.41 175.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 4.6 Cg_exo -76.17 154.48 37.13 Favored 'Trans proline' 0 N--CA 1.432 -2.09 0 C-N-CA 121.608 1.539 . . . . 54.22 108.883 173.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -72.74 154.41 40.69 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.048 -0.723 . . . . 73.43 109.048 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 75.91 10.65 85.04 Favored Glycine 0 C--N 1.304 -1.228 0 C-N-CA 120.802 -0.713 . . . . 62.2 113.04 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -110.62 153.57 25.0 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.638 -0.504 . . . . 62.24 109.638 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.558 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 56.9 m -104.98 129.74 53.34 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.347 -0.612 . . . . 62.41 109.347 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.8 m -138.72 142.26 38.9 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.119 0.485 . . . . 64.32 110.928 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.9 p -109.56 142.39 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-N 115.672 -0.695 . . . . 51.23 110.374 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 91.1 mtp -135.78 153.88 51.4 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 120.987 0.422 . . . . 62.35 110.403 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.469 ' C ' HD22 ' A' ' 88' ' ' LEU . 82.4 m-70 -106.02 131.25 53.54 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.925 -1.139 . . . . 74.22 107.925 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.469 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.5 mm? -122.85 143.91 49.55 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.578 -0.449 . . . . 73.12 110.781 -176.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.74 137.0 52.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 121.051 0.453 . . . . 73.22 110.682 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.45 137.52 45.76 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.6 -0.727 . . . . 55.33 109.046 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.458 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 99.6 mtt180 -134.72 112.83 11.08 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.084 -0.507 . . . . 72.32 109.713 -177.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 42.3 mt-10 59.37 28.48 17.84 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.362 1.077 . . . . 75.22 109.696 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.9 m -80.39 -33.48 37.1 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.207 -1.361 . . . . 71.53 109.246 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.423 HD11 ' HB3' ' A' ' 40' ' ' TYR . 4.9 mp -109.16 141.24 23.03 Favored Pre-proline 0 N--CA 1.426 -1.628 0 N-CA-C 107.534 -1.284 . . . . 75.11 107.534 175.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.02 16.1 1.82 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.379 2.053 . . . . 73.32 110.625 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -143.01 161.99 45.72 Favored Pre-proline 0 N--CA 1.437 -1.114 0 C-N-CA 125.371 1.469 . . . . 71.2 107.171 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -61.25 -63.71 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.925 1.75 . . . . 61.31 110.134 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 178.54 79.97 0.01 OUTLIER 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.735 0.814 . . . . 73.5 110.211 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.9 m 64.21 -36.06 0.17 Allowed 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 117.063 2.245 . . . . 74.22 117.063 173.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -79.05 -51.04 10.11 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 121.707 -0.621 . . . . 71.52 111.929 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.55 7.04 85.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.914 -0.66 . . . . 73.43 112.863 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -137.16 135.74 37.62 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 122.491 -0.417 . . . . 75.43 110.361 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -107.32 83.88 1.88 Allowed 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.427 -1.323 . . . . 72.31 107.427 175.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -145.66 -178.72 6.24 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.157 0.504 . . . . 75.44 112.105 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.491 ' HG3' ' HB2' ' A' ' 110' ' ' GLU . 4.8 mpt_? -72.09 -44.96 62.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.082 -0.963 . . . . 53.33 112.242 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 71.9 -62.82 0.45 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.74 0.816 . . . . 73.53 109.045 -171.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 21.8 ptmt -132.63 -179.88 5.73 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.808 -1.553 . . . . 72.35 106.808 174.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.7 p -71.54 111.88 7.2 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.494 0.664 . . . . 61.42 110.877 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.91 -56.17 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 110.591 -1.004 . . . . 65.32 110.591 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 105' ' ' ARG . 58.4 mm-40 -63.25 -56.95 12.27 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.064 -0.254 . . . . 72.55 111.054 176.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.7 p -179.99 178.11 0.62 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.069 -1.086 . . . . 74.33 108.069 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -166.91 134.66 2.57 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 122.567 0.347 . . . . 75.11 110.556 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 20.4 p -149.72 177.94 9.33 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.572 -1.27 . . . . 64.23 107.572 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 24.8 p -67.28 106.73 2.14 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.215 0.531 . . . . 73.52 110.11 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.8 m -113.57 147.35 17.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 121.11 0.481 . . . . 75.43 111.485 -176.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.34 101.24 12.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.44 -0.948 . . . . 74.34 108.44 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 tm? . . . . . 0 C--N 1.295 -1.79 0 N-CA-C 107.041 -1.466 . . . . 64.5 107.041 -177.783 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.4 m . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 109.195 -0.668 . . . . 42.11 109.195 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.0 m -90.75 97.22 11.05 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.736 -0.666 . . . . 71.1 110.335 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -73.19 119.42 17.4 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 109.063 -0.717 . . . . 72.43 109.063 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.5 HG21 ' HB2' ' A' ' 11' ' ' ASN . 3.7 t -95.88 119.69 64.38 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 115.509 -0.769 . . . . 32.01 110.664 -173.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -74.9 165.28 31.72 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.674 2.249 . . . . 72.14 110.585 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.83 68.57 10.52 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 122.013 0.911 . . . . 75.15 110.179 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.41 ' H ' ' H ' ' A' ' 9' ' ' MET . 27.9 t70 -167.44 -30.03 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 113.66 -1.609 . . . . 75.24 107.929 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.41 ' H ' ' H ' ' A' ' 8' ' ' ASP . 90.5 mmm -105.41 158.57 16.56 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.472 -1.24 . . . . 72.15 109.312 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -119.32 140.12 44.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 109.313 -0.625 . . . . 74.53 109.313 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -90.93 112.7 24.68 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.897 -1.149 . . . . 73.24 107.897 -176.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.484 ' HG ' HD22 ' A' ' 14' ' ' LEU . 35.4 tp -117.29 132.96 56.5 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.44 0.638 . . . . 75.42 112.578 -174.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.414 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . 26.5 ttt85 -106.95 121.44 44.44 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 115.12 -0.945 . . . . 63.14 108.853 174.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.546 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.2 mm? -99.48 120.87 40.33 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.209 -0.905 . . . . 72.33 108.884 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.57 HD12 HG22 ' A' ' 21' ' ' THR . 23.4 mm -99.49 116.71 43.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 107.118 -1.438 . . . . 74.42 107.118 177.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -76.46 167.45 21.82 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 123.292 0.37 . . . . 73.33 111.693 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -67.61 -28.64 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.746 0.784 . . . . 63.41 110.242 -176.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -76.79 4.43 9.7 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.144 -0.935 . . . . 45.53 111.454 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.65 10.32 86.29 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 111.672 -0.571 . . . . 72.4 111.672 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -91.53 131.8 36.71 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.717 -0.846 . . . . 72.41 108.717 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.57 HG22 HD12 ' A' ' 15' ' ' ILE . 59.8 p -104.91 135.03 47.02 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 116.572 -0.285 . . . . 74.53 110.286 -175.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -142.46 139.61 31.63 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.266 -1.013 . . . . 74.15 108.266 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -134.44 132.57 39.49 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.016 -0.674 . . . . 63.21 111.55 -171.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.611 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 90.7 m-85 -144.99 160.81 40.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.161 0.584 . . . . 73.42 110.881 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.4 mt -79.36 126.6 31.02 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.306 -0.998 . . . . 45.33 108.306 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.611 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 78.4 m-85 -127.35 161.57 28.34 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.104 0.478 . . . . 73.21 110.411 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.502 ' HB2' ' OD2' ' A' ' 30' ' ' ASP . 31.4 m -84.71 137.05 38.62 Favored Pre-proline 0 N--CA 1.411 -2.386 0 N-CA-C 107.951 -1.129 . . . . 73.32 107.951 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.438 ' O ' ' HB ' ' A' ' 72' ' ' THR . 30.4 Cg_endo -60.18 -14.55 29.53 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.083 2.522 . . . . 70.43 113.878 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -85.89 -8.17 58.22 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.017 0.377 . . . . 74.13 112.017 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.502 ' OD2' ' HB2' ' A' ' 27' ' ' SER . 11.8 m-20 -79.28 153.71 29.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.736 0.303 . . . . 65.43 111.078 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.445 ' O ' HG13 ' A' ' 35' ' ' ILE . 67.2 m -95.03 124.35 39.02 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.509 -0.314 . . . . 55.31 110.492 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.718 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -49.32 -41.34 38.24 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.563 1.145 . . . . 74.12 113.782 -177.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 p -71.48 -32.78 68.65 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.023 0.439 . . . . 75.03 111.872 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.68 -42.25 82.42 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.098 -1.075 . . . . 75.03 108.098 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.46 ' O ' HG22 ' A' ' 39' ' ' VAL . 68.7 mt -60.9 -43.18 95.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.011 -1.449 . . . . 71.3 110.906 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.456 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -51.0 -41.89 60.05 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.504 0.721 . . . . 60.54 112.106 176.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.504 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -72.59 -33.78 66.96 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 107.153 -1.425 . . . . 71.44 107.153 -177.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -70.09 -50.97 35.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.362 1.065 . . . . 74.53 111.789 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.546 HG21 ' CB ' ' A' ' 14' ' ' LEU . 30.6 m -68.05 -31.47 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 113.35 0.87 . . . . 44.13 113.35 -177.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -46.79 -49.28 20.12 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 124.061 0.85 . . . . 63.54 112.288 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.8 t70 170.72 -69.82 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.622 -0.881 . . . . 70.22 108.622 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -89.01 127.24 35.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.895 -1.502 . . . . 71.31 107.918 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -81.01 147.01 60.36 Favored Pre-proline 0 C--N 1.3 -1.548 0 C-N-CA 120.798 -0.361 . . . . 75.12 111.643 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.47 0.51 0.25 Allowed 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 124.228 3.285 . . . . 71.34 116.465 -173.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 52.8 ttm -76.49 -23.73 53.76 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 122.015 -0.428 . . . . 75.2 110.381 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.02 -27.64 64.83 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.869 0.692 . . . . 61.21 112.869 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.464 ' CZ3' ' HB3' ' A' ' 96' ' ' GLU . 8.5 t-105 72.16 106.59 0.07 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.978 0.911 . . . . 75.44 111.879 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.31 115.74 28.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.12 0.486 . . . . 65.41 111.936 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -88.22 98.37 11.53 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 108.853 -0.795 . . . . 73.21 108.853 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -96.35 153.14 17.99 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.059 -0.719 . . . . 73.55 109.059 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -63.06 -57.03 12.02 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.281 -0.637 . . . . 71.51 109.281 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.0 p -104.24 93.46 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 122.037 0.922 . . . . 51.42 109.657 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.2 m -88.81 148.47 23.89 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.609 -0.723 . . . . 64.44 109.21 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 57' ' ' ILE . 46.4 m -147.94 130.36 7.73 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 109.711 -0.477 . . . . 52.34 109.711 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 54' ' ' SER . 5.5 Cg_exo -82.75 -28.88 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 121.79 1.66 . . . . 72.2 111.98 176.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -76.75 -0.21 22.89 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.624 0.972 . . . . 74.5 113.624 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.549 ' HA ' ' NH1' ' A' ' 59' ' ' ARG . 2.5 pp -77.56 -9.32 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 112.381 0.511 . . . . 64.22 112.381 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.413 ' C ' ' HD3' ' A' ' 59' ' ' ARG . 96.9 mt -81.96 108.21 15.28 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.02 -0.537 . . . . 23.31 110.359 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.549 ' NH1' ' HA ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -137.97 148.84 45.6 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 109.75 -0.463 . . . . 62.25 109.75 172.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.718 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.5 pp -120.45 131.6 54.84 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 115.462 -0.79 . . . . 54.32 110.341 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 88.0 mt -103.14 124.3 57.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.507 0 N-CA-C 107.522 -1.288 . . . . 63.12 107.522 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -99.65 84.79 3.0 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 106.252 -1.759 . . . . 75.53 106.252 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 66.58 -65.64 0.2 Allowed 'General case' 0 N--CA 1.405 -2.7 0 C-N-CA 127.58 2.352 . . . . 75.12 111.724 -175.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.25 -14.48 2.97 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 120.859 -0.686 . . . . 60.31 114.747 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.492 ' H ' ' HD2' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -122.92 148.0 45.96 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 118.612 1.206 . . . . 73.41 110.826 -178.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -84.36 111.59 19.57 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.559 -1.274 . . . . 73.52 107.559 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.629 HD12 HD22 ' A' ' 76' ' ' LEU . 59.5 mt -81.18 -46.99 14.03 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 114.404 1.261 . . . . 70.05 114.404 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.694 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.0 t-80 -171.65 176.17 3.79 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.925 -1.509 . . . . 61.0 106.925 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -85.71 -1.07 87.56 Favored Glycine 0 C--N 1.3 -1.44 0 N-CA-C 115.867 1.107 . . . . 74.22 115.867 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -169.39 19.32 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 118.429 1.115 . . . . 71.32 111.935 -170.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.574 HG12 HD21 ' A' ' 60' ' ' LEU . 11.3 p -74.92 146.74 9.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 120.653 -0.419 . . . . 55.32 110.223 -175.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.482 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 38.6 p -78.88 157.85 28.22 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.743 -0.662 . . . . 75.22 111.292 -175.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.576 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.2 mm? -66.4 -34.97 79.16 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.473 -0.33 . . . . 62.31 110.752 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.33 -35.06 90.38 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.556 -0.83 . . . . 70.31 111.281 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -75.42 -16.45 60.35 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 122.796 0.438 . . . . 72.11 111.404 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.629 HD22 HD12 ' A' ' 67' ' ' LEU . 45.4 mt -82.87 1.93 36.87 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.129 -0.693 . . . . 70.11 109.129 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.94 74.32 0.14 Allowed 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.08 1.352 . . . . 54.35 111.356 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.468 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.5 mp -127.33 112.13 21.31 Favored Pre-proline 0 CA--C 1.497 -1.067 0 CA-C-N 115.302 -0.863 . . . . 71.24 111.49 176.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.28 154.46 72.1 Favored 'Trans proline' 0 N--CA 1.445 -1.337 0 C-N-CA 122.08 1.853 . . . . 52.34 108.011 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -69.48 144.25 53.28 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.181 -0.674 . . . . 72.34 109.181 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.42 9.98 68.72 Favored Glycine 0 C--N 1.305 -1.155 0 C-N-CA 119.892 -1.147 . . . . 35.05 113.347 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -101.55 138.2 38.86 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 117.374 0.587 . . . . 74.13 110.342 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.641 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 58.8 m -92.13 117.51 29.92 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.872 -1.159 . . . . 75.13 107.872 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.0 m -130.68 135.91 48.29 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.083 -0.508 . . . . 64.15 111.229 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.414 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 7.7 p -102.14 138.46 26.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 116.065 -0.516 . . . . 74.45 111.453 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.537 ' O ' HG12 ' A' ' 15' ' ' ILE . 86.1 mtp -134.46 152.07 51.56 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 109.96 -0.385 . . . . 71.24 109.96 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 23.1 m-70 -108.13 132.02 54.04 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.098 -1.075 . . . . 53.33 108.098 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.5 mm? -116.9 141.88 47.65 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 120.366 -0.534 . . . . 64.14 111.016 -176.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.62 132.65 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 CA-C-N 115.863 -0.608 . . . . 62.22 109.773 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.3 130.34 34.92 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.824 -0.625 . . . . 51.4 109.513 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.473 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 99.8 mtt180 -123.7 130.75 53.12 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.959 -0.756 . . . . 75.14 108.959 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 70.41 -19.15 0.22 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 113.394 0.887 . . . . 60.4 113.394 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.402 ' H ' ' C ' ' A' ' 91' ' ' ARG . 77.7 m 78.77 141.7 0.07 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.563 1.145 . . . . 72.13 110.995 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 24.0 tp -81.49 126.98 74.86 Favored Pre-proline 0 N--CA 1.435 -1.207 0 CA-C-N 116.069 -0.514 . . . . 75.45 109.772 -177.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 94' ' ' LEU . 7.8 Cg_exo -68.07 -58.44 0.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.801 2.334 . . . . 72.13 111.416 176.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.464 ' HB3' ' CZ3' ' A' ' 47' ' ' TRP . 0.1 OUTLIER -117.02 129.98 24.94 Favored Pre-proline 0 N--CA 1.434 -1.25 0 CA-C-N 115.869 -0.605 . . . . 75.23 111.628 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -48.27 -47.71 18.98 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 123.854 3.036 . . . . 64.34 113.762 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -166.13 -66.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.025 0.38 . . . . 71.44 112.025 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 63.6 p -173.05 24.17 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.851 0.358 . . . . 54.21 110.752 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -60.25 -52.41 65.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.339 -0.392 . . . . 74.32 111.753 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 56.18 27.47 52.31 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.328 -0.463 . . . . 52.23 112.291 -176.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -132.07 143.41 50.02 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 122.95 0.5 . . . . 72.43 110.331 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -115.85 -172.23 2.12 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.238 -1.764 . . . . 74.4 106.238 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -68.79 105.34 2.29 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.125 -0.63 . . . . 73.31 109.482 174.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.665 ' NH1' ' HA ' ' A' ' 110' ' ' GLU . 3.2 tmm_? -69.31 -39.84 78.0 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.139 -0.937 . . . . 52.05 108.831 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 66.28 -78.18 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.816 1.246 . . . . 71.32 112.617 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -140.94 -44.99 0.39 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.297 -0.41 . . . . 61.12 110.195 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.3 p -53.0 128.34 26.97 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.732 0.813 . . . . 72.3 112.767 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.28 -47.14 3.28 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.986 -0.446 . . . . 73.51 111.986 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.665 ' HA ' ' NH1' ' A' ' 105' ' ' ARG . 15.3 tp10 61.27 86.45 0.1 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.262 1.025 . . . . 72.0 112.383 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.2 m -109.43 92.69 4.15 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 115.072 -0.967 . . . . 75.22 109.73 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -178.04 -58.37 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 105.499 -2.037 . . . . 74.04 105.499 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 51.6 t -163.35 100.4 0.94 Allowed 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 114.384 -1.28 . . . . 53.11 107.691 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 63.6 m -51.76 -60.98 2.55 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.303 0.641 . . . . 74.45 110.66 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.81 160.96 30.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 106.526 -1.657 . . . . 70.52 106.526 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.8 pt -75.61 88.45 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 122.359 1.076 . . . . 71.43 111.759 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.6 tm? . . . . . 0 N--CA 1.424 -1.761 0 N-CA-C 106.139 -1.8 . . . . 74.12 106.139 179.793 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.245 0.865 0 N-CA-C 107.296 -1.372 . . . . 65.21 107.296 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.4 p -80.63 108.63 14.43 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.365 -0.606 . . . . 73.42 109.365 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 65.16 -162.11 0.27 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.271 -1.381 . . . . 72.0 107.271 -177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.428 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 15.1 t -107.05 114.67 61.17 Favored Pre-proline 0 N--CA 1.423 -1.798 0 N-CA-C 107.91 -1.144 . . . . 65.35 107.91 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -69.71 151.22 69.3 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 122.298 1.999 . . . . 64.23 111.888 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.65 69.9 6.04 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 122.061 0.934 . . . . 43.23 109.949 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.409 ' H ' ' H ' ' A' ' 9' ' ' MET . 31.0 t70 -173.47 -21.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.386 -1.733 . . . . 60.32 107.672 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.409 ' H ' ' H ' ' A' ' 8' ' ' ASP . 94.2 mmm -118.26 160.11 22.18 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.892 -1.049 . . . . 73.11 108.968 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -125.11 137.91 56.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.843 -0.799 . . . . 73.54 108.843 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.582 HD22 HG23 ' A' ' 83' ' ' THR . 4.9 t30 -92.06 107.73 19.42 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.713 -1.217 . . . . 72.3 107.713 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.55 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.5 tp -111.11 133.1 53.74 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.656 -0.702 . . . . 71.01 112.559 -171.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.422 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 35.9 ttp180 -109.5 121.03 44.29 Favored 'General case' 0 N--CA 1.414 -2.244 0 CA-C-N 115.195 -0.911 . . . . 75.11 109.008 174.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.581 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.0 mm? -101.45 126.71 48.27 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-N 114.462 -1.245 . . . . 63.34 108.504 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 21' ' ' THR . 26.0 mt -104.32 127.31 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 C-N-CA 119.379 -0.928 . . . . 73.21 109.477 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.14 156.87 20.85 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.365 -0.606 . . . . 74.52 109.365 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.52 -13.01 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.474 0.546 . . . . 75.11 112.474 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.8 t -76.1 -12.15 60.06 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.717 0.77 . . . . 74.42 109.06 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.13 -3.28 64.24 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.677 -0.569 . . . . 65.23 111.677 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.1 134.74 33.69 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.731 0.3 . . . . 74.05 110.332 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 15' ' ' ILE . 67.5 p -98.61 150.11 22.08 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 121.193 0.521 . . . . 64.13 110.753 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.447 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -132.4 138.44 47.69 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.027 -1.471 . . . . 71.23 107.027 174.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HG3' ' HB2' ' A' ' 13' ' ' ARG . 27.0 tt0 -137.68 129.65 28.83 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.072 -1.084 . . . . 70.54 108.072 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.694 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 97.3 m-85 -145.91 159.41 43.27 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.905 -0.776 . . . . 73.31 108.905 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.0 tp -83.19 124.92 31.0 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 106.862 -1.533 . . . . 70.45 106.862 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.694 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 94.2 m-85 -129.52 163.6 25.59 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.76 -0.83 . . . . 71.2 108.76 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.8 p -87.79 145.1 36.1 Favored Pre-proline 0 N--CA 1.41 -2.443 0 N-CA-C 107.339 -1.356 . . . . 74.41 107.339 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.553 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 26.6 Cg_endo -61.62 -11.63 21.17 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 122.329 2.02 . . . . 62.31 112.37 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.88 -7.27 49.77 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 109.364 -0.606 . . . . 65.14 109.364 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -71.9 154.09 41.45 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 122.087 -0.383 . . . . 75.1 110.09 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.532 ' O ' HG13 ' A' ' 35' ' ' ILE . 8.3 p -94.77 121.4 36.32 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-O 121.04 0.448 . . . . 54.31 111.445 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.417 ' CB ' HD22 ' A' ' 60' ' ' LEU . . . -46.0 -51.68 13.11 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.178 1.548 . . . . 72.21 115.178 -174.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.532 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 18.7 m -78.16 -20.69 51.48 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.633 -0.827 . . . . 71.13 112.502 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -69.25 -42.44 75.61 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 106.45 -1.685 . . . . 61.31 106.45 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.534 ' O ' HG22 ' A' ' 39' ' ' VAL . 61.3 mt -62.29 -40.21 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.473 -1.239 . . . . 72.43 110.055 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.402 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.31 -43.96 53.9 Favored 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 123.051 0.54 . . . . 73.41 111.332 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.515 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 1.7 tmtp? -72.83 -37.91 67.29 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.898 -0.778 . . . . 74.24 108.898 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 32.8 t-80 -56.87 -50.75 71.53 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.419 -0.81 . . . . 73.33 109.971 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.581 HG21 ' CB ' ' A' ' 14' ' ' LEU . 29.5 m -73.29 -32.38 37.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.629 -0.714 . . . . 64.4 111.129 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -56.16 -48.18 76.8 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.555 0.742 . . . . 75.31 110.755 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -141.99 -65.53 0.41 Allowed 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.046 -0.662 . . . . 73.43 110.482 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 38' ' ' HIS . 56.7 t30 -161.26 174.13 14.03 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.697 -1.594 . . . . 73.21 106.697 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.3 p-90 -59.26 127.42 84.16 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 118.249 0.477 . . . . 73.34 111.268 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -65.97 127.43 17.69 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.92 1.747 . . . . 65.11 109.736 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 51.1 ttm -79.52 -17.2 54.58 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.916 -0.584 . . . . 73.25 110.778 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -147.04 -168.27 3.0 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.152 -1.795 . . . . 74.41 106.152 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -87.23 135.15 33.41 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 118.81 0.732 . . . . 75.14 111.197 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.509 ' O ' HD11 ' A' ' 57' ' ' ILE . 24.3 mm-40 -83.26 107.99 16.18 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.55 -0.75 . . . . 44.13 110.359 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.24 170.42 16.29 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 123.752 0.657 . . . . 52.15 110.672 176.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -103.62 41.78 1.24 Allowed 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.1 -0.704 . . . . 73.51 109.1 -172.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 59.91 44.01 14.16 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.487 1.137 . . . . 71.54 109.652 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.08 -21.88 4.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 113.941 -1.481 . . . . 61.41 110.56 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.6 m 67.79 -12.88 0.27 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.885 1.274 . . . . 75.53 112.876 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.7 m -80.24 114.36 46.42 Favored Pre-proline 0 N--CA 1.436 -1.175 0 C-N-CA 123.186 0.595 . . . . 73.44 110.528 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.447 ' O ' HD23 ' A' ' 58' ' ' LEU . 40.2 Cg_endo -65.99 -14.96 46.88 Favored 'Trans proline' 0 C--O 1.209 -0.964 0 C-N-CA 123.428 2.752 . . . . 42.44 114.68 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.02 -5.83 1.15 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 115.147 1.536 . . . . 73.13 115.147 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.509 HD11 ' O ' ' A' ' 48' ' ' GLU . 2.5 pp -82.94 -29.38 8.23 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.123 0 C-N-CA 120.195 -0.602 . . . . 64.51 110.152 174.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 2.1 pt? -111.33 95.34 5.46 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 107.109 -1.441 . . . . 64.11 107.109 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 38.5 ptt180 -131.45 159.78 37.07 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-O 121.847 0.832 . . . . 65.3 112.828 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.647 HD21 HG12 ' A' ' 71' ' ' VAL . 4.4 pp -115.4 146.72 41.33 Favored 'General case' 0 N--CA 1.407 -2.585 0 CA-C-N 114.657 -1.156 . . . . 62.24 112.349 -171.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 94.9 mt -116.67 122.79 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.637 0 CA-C-N 114.351 -1.295 . . . . 72.54 107.773 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -100.16 89.42 4.01 Favored 'General case' 0 C--N 1.263 -3.18 0 N-CA-C 105.667 -1.975 . . . . 62.42 105.667 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 69.94 -70.05 0.16 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.325 -1.761 . . . . 73.25 112.717 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.47 2.44 3.46 Favored Glycine 0 C--N 1.313 -0.73 0 C-N-CA 119.94 -1.124 . . . . 74.44 113.043 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -130.72 140.94 50.37 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.121 0.415 . . . . 65.2 112.121 -176.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -83.59 113.82 21.09 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.464 -1.309 . . . . 75.3 107.464 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.611 HD12 HD22 ' A' ' 76' ' ' LEU . 60.8 mt -79.79 -46.21 17.38 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 119.48 -0.888 . . . . 65.03 112.733 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.552 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.6 t60 -169.9 169.71 8.1 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 104.091 -2.559 . . . . 60.01 104.091 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -63.67 -47.13 89.56 Favored Glycine 0 C--O 1.201 -1.966 0 C-N-CA 120.185 -1.007 . . . . 64.24 113.589 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.453 ' OD1' ' HB2' ' A' ' 31' ' ' SER . 10.2 t30 -152.58 72.0 0.96 Allowed 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 122.348 1.07 . . . . 61.05 109.517 -172.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.647 HG12 HD21 ' A' ' 60' ' ' LEU . 7.2 p -101.62 151.29 5.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 113.617 -1.629 . . . . 73.34 108.079 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.458 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 42.0 p -78.12 158.73 29.0 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 120.677 0.275 . . . . 71.44 111.406 -175.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.59 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.2 mm? -68.27 -32.72 73.09 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.365 -0.38 . . . . 72.53 111.146 -176.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.19 -36.95 93.88 Favored Glycine 0 C--O 1.24 0.507 0 N-CA-C 110.743 -0.943 . . . . 72.43 110.743 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.464 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -71.48 -15.43 62.32 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.011 0.524 . . . . 74.21 110.835 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.611 HD22 HD12 ' A' ' 67' ' ' LEU . 86.5 mt -82.58 6.31 18.05 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.402 0.681 . . . . 71.35 110.237 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 77.03 10.94 2.47 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.824 1.249 . . . . 52.45 111.828 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.606 HD13 ' HB2' ' A' ' 76' ' ' LEU . 9.6 mp -72.37 119.26 73.89 Favored Pre-proline 0 C--O 1.24 0.565 0 N-CA-C 112.95 0.722 . . . . 74.43 112.95 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 4.3 Cg_exo -76.85 159.41 34.63 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.022 2.481 . . . . 65.43 109.75 173.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.41 ' CE1' ' HG3' ' A' ' 28' ' ' PRO . 7.6 m-85 -77.25 156.73 31.24 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.388 -0.597 . . . . 73.43 109.388 -176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.428 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 79.55 10.19 86.11 Favored Glycine 0 C--N 1.308 -0.973 0 C-N-CA 120.896 -0.669 . . . . 74.51 113.546 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -115.62 155.81 26.98 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 120.798 0.332 . . . . 44.51 111.414 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.582 HG23 HD22 ' A' ' 11' ' ' ASN . 84.1 m -105.2 125.89 51.48 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.761 -0.654 . . . . 74.21 109.266 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.3 m -136.34 142.2 43.82 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.905 0.383 . . . . 75.33 111.85 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.47 142.2 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.031 -0.531 . . . . 51.41 110.744 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 93.0 mtp -137.0 153.26 50.71 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.276 0.56 . . . . 74.13 110.949 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.481 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 35.0 m-70 -111.56 130.8 55.62 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.773 -1.566 . . . . 61.52 106.773 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.2 mm? -119.12 143.49 47.15 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.635 -0.426 . . . . 70.41 111.249 -174.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.88 134.24 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.503 -0.554 . . . . 54.41 109.503 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 57' ' ' ILE . . . -134.01 138.03 45.12 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.717 -0.475 . . . . 54.2 109.717 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.402 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 72.1 mtp180 -119.48 134.98 54.96 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 107.289 -1.374 . . . . 74.33 107.289 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 62.56 28.66 16.79 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 123.938 0.774 . . . . 73.53 109.025 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.405 ' HB ' ' HB1' ' A' ' 90' ' ' ALA . 12.8 t -71.12 153.05 42.84 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 109.438 -0.578 . . . . 62.13 109.438 -176.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 mp -98.82 141.37 22.78 Favored Pre-proline 0 C--N 1.282 -2.341 0 CA-C-O 120.918 0.389 . . . . 75.21 111.15 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.83 -152.11 0.04 OUTLIER 'Trans proline' 0 C--O 1.258 1.498 0 C-N-CA 122.563 2.175 . . . . 71.33 109.255 173.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.14 135.97 76.26 Favored Pre-proline 0 C--N 1.314 -0.975 0 C-N-CA 119.422 -0.911 . . . . 70.31 110.587 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.22 -1.69 11.83 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.146 1.897 . . . . 65.53 111.216 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 71.51 -7.03 1.27 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.563 1.145 . . . . 70.22 112.216 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.3 m -85.03 -0.49 54.62 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 122.852 0.461 . . . . 71.42 110.844 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -84.36 -51.26 7.1 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.909 0.707 . . . . 72.43 112.909 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 57.43 20.19 36.51 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 121.152 -0.547 . . . . 75.23 112.307 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.566 ' NE2' ' HB2' ' A' ' 106' ' ' GLU . 37.9 tt0 -111.69 127.17 55.69 Favored 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 123.054 0.542 . . . . 75.31 111.582 -177.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -75.47 -57.06 4.12 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.089 -1.448 . . . . 72.23 107.089 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -177.38 -49.02 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.443 -1.253 . . . . 54.41 110.589 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 105' ' ' ARG . 49.4 mtt180 -59.63 -50.28 74.48 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.392 0.516 . . . . 73.13 112.392 -176.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.566 ' HB2' ' NE2' ' A' ' 102' ' ' GLN . 0.3 OUTLIER 66.65 -74.74 0.06 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.715 1.206 . . . . 65.31 111.671 176.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -146.68 135.66 22.45 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.957 -0.757 . . . . 65.24 108.957 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.9 m 74.16 -12.79 0.84 Allowed 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 123.932 0.893 . . . . 64.3 112.0 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.54 -12.92 71.48 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 111.045 -0.822 . . . . 75.23 111.045 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -56.01 132.91 51.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.581 0.752 . . . . 74.01 111.394 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.1 m -117.4 109.0 16.24 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.763 -0.653 . . . . 71.43 109.844 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -76.92 108.24 9.82 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.433 -1.321 . . . . 65.21 107.433 177.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.18 -21.55 66.78 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.782 -0.644 . . . . 74.41 112.05 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 68.0 m 62.77 92.56 0.06 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.744 0.817 . . . . 65.03 110.323 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.3 m -71.61 82.38 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 114.275 1.213 . . . . 73.2 114.275 -175.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.5 pt -120.49 107.86 21.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 114.738 -1.119 . . . . 62.54 108.403 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 C--N 1.294 -1.815 0 CA-C-O 118.411 -0.804 . . . . 71.12 109.861 -177.109 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.435 -1.187 0 N-CA-C 110.16 -0.311 . . . . 74.31 110.16 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.45 ' N ' HG11 ' A' ' 115' ' ' VAL . 33.7 m -96.32 94.99 7.77 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.215 0.531 . . . . 63.14 111.033 177.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.407 ' HB3' ' CB ' ' A' ' 111' ' ' SER . 47.7 t30 -127.86 130.1 48.03 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 105.282 -2.118 . . . . 73.53 105.282 172.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 11' ' ' ASN . 2.0 t -121.68 124.44 27.13 Favored Pre-proline 0 N--CA 1.407 -2.602 0 C-N-CA 119.047 -1.061 . . . . 75.43 110.605 -171.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.07 144.07 51.24 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.918 1.745 . . . . 72.04 109.109 172.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.35 71.3 3.83 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.772 0.796 . . . . 74.13 111.23 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -175.48 -27.43 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.95 -1.477 . . . . 64.42 108.14 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.9 mmm -110.45 157.46 19.55 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.605 -1.18 . . . . 74.13 108.866 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.458 HG22 ' HA ' ' A' ' 80' ' ' PHE . 2.7 pp -111.13 134.79 52.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 110.079 -0.341 . . . . 73.01 110.079 174.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.47 HD22 HG23 ' A' ' 83' ' ' THR . 3.6 t30 -92.75 107.55 19.31 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 107.964 -1.124 . . . . 64.21 107.964 -176.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.575 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.1 tp -111.84 132.57 54.61 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.676 0.75 . . . . 74.32 112.389 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -107.19 119.98 40.86 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 108.333 -0.988 . . . . 72.53 108.333 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.575 HD22 ' HG ' ' A' ' 12' ' ' LEU . 2.5 mm? -99.09 125.73 44.68 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 124.704 1.201 . . . . 74.01 110.023 -177.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.439 HG23 HG22 ' A' ' 21' ' ' THR . 29.0 mt -100.2 117.61 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 108.441 -0.948 . . . . 75.52 108.441 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.497 HD21 HG23 ' A' ' 39' ' ' VAL . 68.8 mt -75.1 162.21 28.73 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.108 -0.496 . . . . 64.43 111.733 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.32 -15.8 20.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.484 -0.78 . . . . 71.35 110.219 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.0 m -76.81 -14.71 59.88 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.438 -0.801 . . . . 61.3 109.295 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.7 1.83 67.82 Favored Glycine 0 CA--C 1.501 -0.837 0 CA-C-N 115.882 -0.599 . . . . 53.04 112.076 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -89.12 133.06 34.53 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.103 -1.073 . . . . 75.11 108.103 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.439 HG22 HG23 ' A' ' 15' ' ' ILE . 76.9 p -98.78 129.8 45.21 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.877 -0.786 . . . . 63.15 108.877 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.454 ' HD2' HD11 ' A' ' 16' ' ' LEU . 26.6 mtpp -127.93 149.38 50.35 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.702 -0.851 . . . . 71.44 108.702 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -136.34 131.25 34.05 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.447 -0.901 . . . . 51.22 109.791 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.602 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.5 m-85 -144.73 159.21 43.22 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 123.735 0.814 . . . . 74.42 108.85 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.5 tp -89.36 128.5 35.91 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.626 -0.879 . . . . 54.25 108.626 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.602 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 97.0 m-85 -132.2 173.95 10.72 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.977 -0.379 . . . . 71.3 109.977 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.2 p -98.76 150.46 36.72 Favored Pre-proline 0 N--CA 1.421 -1.896 0 N-CA-C 108.331 -0.988 . . . . 73.14 108.331 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.431 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 36.2 Cg_endo -62.33 -11.38 22.29 Favored 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 122.257 1.971 . . . . 75.02 111.989 177.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -79.82 -22.15 43.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.301 1.041 . . . . 73.05 111.258 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -67.55 153.46 43.65 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.319 0.489 . . . . 72.44 112.319 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.476 ' O ' HG13 ' A' ' 35' ' ' ILE . 51.7 p -100.38 118.91 37.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.54 -0.541 . . . . 74.11 109.54 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.693 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -46.09 -51.19 14.29 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 115.205 1.557 . . . . 70.13 115.205 -173.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.7 m -71.85 -26.15 62.25 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 122.011 -0.43 . . . . 70.34 111.649 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.37 -41.19 76.84 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 107.75 -1.204 . . . . 73.4 107.75 173.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.554 ' O ' HG22 ' A' ' 39' ' ' VAL . 66.2 mt -60.66 -40.11 83.68 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 CA-C-N 114.031 -1.44 . . . . 72.42 110.186 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.489 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.12 -40.64 46.67 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 123.4 0.68 . . . . 71.43 111.026 176.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.557 ' HB2' ' HG3' ' A' ' 44' ' ' PRO . 35.0 mmtp -73.22 -43.64 60.91 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.793 -0.639 . . . . 73.43 109.746 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.513 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 13.2 t60 -61.45 -39.91 92.55 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.728 0.811 . . . . 72.12 111.636 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 35' ' ' ILE . 29.4 m -77.08 -31.86 18.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.192 -0.458 . . . . 72.52 111.69 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 50.9 t80 -59.67 -49.58 77.17 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 124.102 0.876 . . . . 74.01 110.273 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -179.65 90.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.615 0.572 . . . . 71.41 111.576 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 38' ' ' HIS . 23.1 t-20 72.24 170.49 0.32 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.388 1.075 . . . . 74.03 111.119 176.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -73.87 123.9 89.71 Favored Pre-proline 0 C--N 1.312 -1.043 0 O-C-N 122.023 -0.423 . . . . 75.13 111.278 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HG3' ' HB2' ' A' ' 37' ' ' LYS . 34.3 Cg_endo -62.0 -50.01 5.7 Favored 'Trans proline' 0 C--O 1.248 0.999 0 C-N-CA 122.804 2.336 . . . . 50.2 112.536 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.459 ' HA ' ' CE ' ' A' ' 45' ' ' MET . 2.4 mmt 69.92 -64.82 0.34 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.266 1.027 . . . . 74.31 112.848 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -172.19 -37.78 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.262 0.553 . . . . 71.42 110.367 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 25.6 m-90 -82.98 91.09 7.09 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.348 0.594 . . . . 74.5 111.152 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -119.27 -171.33 2.09 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.114 -1.069 . . . . 72.35 108.114 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -73.95 135.46 43.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.983 -1.118 . . . . 72.44 107.983 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 71.26 5.8 5.57 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 124.292 0.995 . . . . 74.35 110.042 -172.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 62.95 -85.61 0.02 OUTLIER 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.146 1.378 . . . . 62.34 110.884 -176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.5 m -128.2 86.11 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.784 0.802 . . . . 74.55 110.397 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.3 m -61.2 -58.15 9.5 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.019 -0.991 . . . . 71.11 110.332 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.502 ' O ' HG12 ' A' ' 57' ' ' ILE . 77.2 p 178.96 158.24 0.66 Allowed Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 107.144 -1.428 . . . . 65.54 107.144 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.31 -16.53 24.78 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 121.809 1.673 . . . . 73.4 110.725 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -75.02 -3.04 30.09 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.591 -0.731 . . . . 64.11 111.822 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 91' ' ' ARG . 34.3 pt -81.76 -11.56 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 120.141 -0.624 . . . . 71.03 109.769 176.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.599 ' O ' ' HD2' ' A' ' 59' ' ' ARG . 2.9 mm? -95.11 108.88 21.0 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 115.852 -0.613 . . . . 71.43 110.922 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.599 ' HD2' ' O ' ' A' ' 58' ' ' LEU . 3.3 mpt_? -130.07 162.85 27.84 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 123.78 0.832 . . . . 72.21 109.138 174.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.693 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.2 pp -148.19 144.49 27.77 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.671 -0.492 . . . . 72.42 109.671 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.552 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 88.5 mt -117.67 119.17 60.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.774 -0.825 . . . . 75.14 108.774 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -101.97 86.01 2.8 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.351 -0.611 . . . . 74.5 109.351 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 44.98 70.55 0.33 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 113.707 -1.588 . . . . 74.25 112.228 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.06 -72.5 0.45 Allowed Glycine 0 N--CA 1.431 -1.666 0 C-N-CA 119.907 -1.139 . . . . 75.11 113.261 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -117.13 164.77 14.26 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 117.518 0.659 . . . . 72.45 112.772 -173.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 67.9 m-85 -86.11 113.85 22.49 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.46 -1.311 . . . . 72.31 107.46 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.575 HD12 HD22 ' A' ' 76' ' ' LEU . 70.0 mt -80.13 -47.32 14.94 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.398 1.259 . . . . 71.11 114.398 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.523 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 8.4 t60 -174.64 151.82 1.54 Allowed 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 107.218 -1.401 . . . . 63.31 107.218 -174.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.83 1.3 39.63 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.073 1.189 . . . . 65.03 116.073 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -168.7 27.55 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.144 0.972 . . . . 72.5 110.053 -169.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.548 HG12 HD21 ' A' ' 60' ' ' LEU . 12.6 p -84.17 142.92 12.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 119.592 -0.843 . . . . 65.21 110.219 -177.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 49.2 p -81.44 160.22 24.06 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.94 -0.573 . . . . 63.33 111.304 -177.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.564 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.9 mm? -65.42 -33.09 75.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.208 -0.451 . . . . 72.25 111.811 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.64 -30.87 75.14 Favored Glycine 0 C--O 1.238 0.352 0 C-N-CA 120.099 -1.048 . . . . 74.13 111.085 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -74.5 -15.35 60.88 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.456 0.702 . . . . 52.41 110.646 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.575 HD22 HD12 ' A' ' 67' ' ' LEU . 74.3 mt -81.95 11.49 5.01 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.413 -0.588 . . . . 72.13 109.413 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.405 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER 67.99 17.79 9.54 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.771 1.228 . . . . 73.03 110.856 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.526 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 91.5 mt -82.86 120.08 75.59 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 115.775 -0.648 . . . . 60.13 110.753 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -82.21 138.83 10.23 Favored 'Trans proline' 0 N--CA 1.435 -1.964 0 C-N-CA 122.145 1.896 . . . . 55.45 110.531 175.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.458 ' HA ' HG22 ' A' ' 10' ' ' ILE . 5.6 p90 -67.41 149.91 49.64 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.358 0.599 . . . . 71.31 112.504 178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.69 5.79 64.44 Favored Glycine 0 N--CA 1.432 -1.573 0 CA-C-N 115.203 -0.908 . . . . 72.01 111.763 -174.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -124.0 164.89 18.42 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 109.843 -0.429 . . . . 63.22 109.843 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.47 HG23 HD22 ' A' ' 11' ' ' ASN . 64.2 m -106.69 134.65 49.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.7 0.286 . . . . 72.23 110.283 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.5 m -141.02 142.36 34.24 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 122.212 -0.305 . . . . 74.32 111.706 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.7 p -108.92 142.76 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 122.774 0.43 . . . . 74.02 110.118 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 92.8 mtp -136.22 152.94 51.29 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-O 120.994 0.426 . . . . 71.24 110.515 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.552 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 30.6 m-70 -104.46 130.16 52.39 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.269 -1.382 . . . . 72.01 107.269 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.489 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.5 mm? -117.79 144.4 45.38 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.524 -0.471 . . . . 64.52 110.762 -176.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.1 m -133.28 134.65 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 109.344 -0.613 . . . . 72.14 109.344 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.33 139.4 45.63 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.066 0.46 . . . . 73.15 110.759 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.518 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -101.63 141.84 33.88 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 103.122 -2.918 . . . . 72.24 103.122 175.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 57.25 48.65 14.7 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.966 -1.124 . . . . 72.34 107.966 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 t -56.5 164.84 1.27 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.235 1.017 . . . . 73.52 113.143 -175.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 37' ' ' LYS . 32.1 tp -65.28 148.88 97.67 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-N 113.975 -1.466 . . . . 60.43 109.239 -178.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.461 ' HD2' HD12 ' A' ' 94' ' ' LEU . 71.4 Cg_exo -54.94 156.7 14.83 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.313 2.008 . . . . 64.24 110.952 172.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -135.32 152.42 76.67 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 116.465 -0.334 . . . . 65.52 110.562 -174.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.28 -64.84 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.009 1.806 . . . . 72.52 109.409 172.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -174.86 91.7 0.06 Allowed 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 115.166 -0.925 . . . . 64.23 110.107 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.7 p 58.45 -37.13 0.05 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 117.464 2.394 . . . . 70.23 117.464 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -79.87 -51.65 8.86 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.756 0.65 . . . . 74.23 112.756 -173.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.98 45.52 95.97 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 107.847 -2.101 . . . . 75.02 107.847 -171.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -70.78 122.31 19.63 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 114.704 1.372 . . . . 75.13 114.704 -171.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -163.37 148.6 11.28 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 127.602 2.361 . . . . 70.52 105.327 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.608 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 13.9 m120 -120.8 -168.91 1.73 Allowed 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 104.966 -2.235 . . . . 74.13 104.966 174.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -71.82 -36.12 70.14 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 117.548 -1.661 . . . . 72.32 107.326 171.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.62 ' O ' ' HB3' ' A' ' 110' ' ' GLU . 46.5 mt-10 57.98 -167.21 0.14 Allowed 'General case' 0 C--N 1.354 0.803 0 CA-C-N 114.322 -1.308 . . . . 65.05 111.754 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.624 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 7.0 tmtm? -86.35 -8.51 57.63 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.17 -1.048 . . . . 62.23 108.17 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.8 m -91.61 94.66 9.52 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 115.736 -0.665 . . . . 74.21 110.182 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.95 40.12 5.62 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.881 -0.888 . . . . 55.04 110.881 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.62 ' HB3' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -99.67 -176.36 3.25 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.188 0.994 . . . . 72.42 113.62 -177.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.407 ' CB ' ' HB3' ' A' ' 4' ' ' ASN . 40.1 m -148.17 97.21 2.74 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.032 -1.84 . . . . 65.41 106.032 174.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -75.07 89.5 2.46 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.465 0.65 . . . . 74.3 110.702 -174.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 70.0 m -148.99 160.43 43.31 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.494 -0.775 . . . . 74.3 109.64 -177.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 60.2 m -87.06 110.41 20.07 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.346 -1.353 . . . . 51.43 107.346 176.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.45 HG11 ' N ' ' A' ' 3' ' ' SER . 23.2 m -85.24 154.07 3.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.046 0.45 . . . . 74.3 111.981 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.4 tp -120.83 123.65 70.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.955 -0.566 . . . . 72.41 109.507 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.5 tm? . . . . . 0 C--N 1.306 -1.294 0 N-CA-C 107.516 -1.29 . . . . 75.14 107.516 -179.298 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.1 m . . . . . 0 N--CA 1.427 -1.583 0 N-CA-C 108.642 -0.873 . . . . 72.35 108.642 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.6 m 70.56 -165.46 0.16 Allowed 'General case' 0 C--O 1.248 0.984 0 C-N-CA 123.661 0.784 . . . . 74.41 110.303 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -57.1 152.1 14.03 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.287 0.565 . . . . 73.01 111.269 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.47 HG13 HD11 ' A' ' 25' ' ' LEU . 26.0 t -92.22 114.46 62.3 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 109.201 -0.666 . . . . 53.21 109.201 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.89 161.26 33.34 Favored 'Trans proline' 0 C--O 1.247 0.955 0 C-N-CA 122.574 2.183 . . . . 71.42 111.207 177.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.94 74.13 6.69 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 121.869 0.843 . . . . 72.12 109.101 175.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -171.2 -28.64 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.524 -1.671 . . . . 74.54 108.594 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 89.1 mmm -111.97 151.86 28.76 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.776 -1.102 . . . . 74.03 108.867 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.461 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.7 pp -111.34 136.32 47.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-O 120.817 0.341 . . . . 65.22 110.687 176.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.409 ' HB2' HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -83.01 111.58 18.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.775 -1.194 . . . . 73.2 107.775 -177.026 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.478 ' HG ' HD22 ' A' ' 14' ' ' LEU . 40.0 tp -118.01 132.93 56.33 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.482 0.658 . . . . 61.34 112.627 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.44 ' HD2' ' OE1' ' A' ' 23' ' ' GLU . 19.0 ttt85 -113.48 122.34 47.02 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 114.994 -1.003 . . . . 61.11 108.878 175.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.517 ' CB ' HG21 ' A' ' 39' ' ' VAL . 1.9 mm? -100.09 125.11 46.14 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 124.502 1.121 . . . . 73.1 108.609 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.637 HD12 HG22 ' A' ' 21' ' ' THR . 18.8 mm -99.28 123.71 52.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.629 -1.248 . . . . 73.33 107.629 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.23 156.87 24.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.399 -0.593 . . . . 74.53 109.399 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.435 ' CG1' ' HA ' ' A' ' 89' ' ' VAL . 35.3 m -66.21 -14.24 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.153 0.427 . . . . 53.11 112.153 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.2 t -76.27 -16.85 59.71 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.859 -0.61 . . . . 72.02 109.686 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.57 -6.19 57.33 Favored Glycine 0 N--CA 1.433 -1.559 0 C-N-CA 120.576 -0.821 . . . . 52.3 112.178 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -86.88 140.05 30.03 Favored 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 119.182 -1.007 . . . . 51.5 110.401 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.637 HG22 HD12 ' A' ' 15' ' ' ILE . 62.0 p -99.11 137.15 38.04 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 115.07 -0.968 . . . . 42.34 109.651 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -126.86 138.28 53.3 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.29 -1.744 . . . . 72.32 106.29 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 26.3 tt0 -137.71 131.15 30.94 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.09 -1.044 . . . . 64.24 110.818 -176.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.587 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 86.1 m-85 -145.03 159.79 42.39 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 123.382 0.673 . . . . 74.32 109.267 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.47 HD11 HG13 ' A' ' 5' ' ' VAL . 41.2 tp -84.67 125.15 32.25 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.386 -0.968 . . . . 63.23 108.386 176.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.587 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 96.3 m-85 -128.9 174.44 9.5 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.225 -0.657 . . . . 74.31 109.225 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.0 p -97.59 154.14 38.05 Favored Pre-proline 0 N--CA 1.431 -1.408 0 C-N-CA 119.193 -1.003 . . . . 64.55 108.818 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.589 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 45.0 Cg_endo -64.18 -12.9 34.84 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.576 2.184 . . . . 74.1 112.105 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -93.33 -7.33 45.13 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.161 -0.472 . . . . 65.53 111.642 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -79.2 153.28 30.12 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 120.485 -0.486 . . . . 72.41 111.186 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.489 ' O ' HG13 ' A' ' 35' ' ' ILE . 45.5 m -93.17 122.41 35.53 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.664 0.269 . . . . 73.4 110.775 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.717 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -49.34 -46.81 47.35 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.919 1.288 . . . . 42.32 113.409 -176.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 p -67.5 -33.71 75.65 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 113.05 0.759 . . . . 65.53 113.05 -177.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.54 -44.89 66.57 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.606 -1.257 . . . . 63.2 107.606 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 31' ' ' SER . 69.4 mt -55.29 -40.79 58.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 114.539 -1.209 . . . . 75.54 111.148 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.431 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.7 -37.65 42.55 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 123.549 0.74 . . . . 75.44 111.647 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.67 ' HB2' ' HG3' ' A' ' 44' ' ' PRO . 98.3 mttt -73.81 -34.58 64.66 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 120.755 0.312 . . . . 73.04 111.208 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.408 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 71.7 t60 -71.93 -44.25 63.94 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.405 -0.361 . . . . 70.44 111.829 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.517 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.4 m -65.24 -31.07 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 120.814 0.34 . . . . 72.34 110.886 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -70.76 -51.09 29.39 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.431 -0.804 . . . . 73.02 111.542 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -179.13 137.31 0.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 118.096 0.407 . . . . 73.13 111.996 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.741 HD22 ' H ' ' A' ' 43' ' ' TRP . 0.3 OUTLIER 60.04 -172.7 0.12 Allowed 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 124.741 1.216 . . . . 74.44 108.289 -179.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.741 ' H ' HD22 ' A' ' 42' ' ' ASN . 67.3 p-90 -114.09 130.29 24.04 Favored Pre-proline 0 N--CA 1.43 -1.457 0 N-CA-C 107.312 -1.366 . . . . 61.23 107.312 171.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.67 ' HG3' ' HB2' ' A' ' 37' ' ' LYS . 44.3 Cg_endo -92.46 152.43 2.97 Favored 'Trans proline' 0 N--CA 1.423 -2.623 0 C-N-CA 120.906 1.07 . . . . 73.22 112.567 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 25.2 ttt -91.82 -36.97 13.22 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 106.501 -1.666 . . . . 71.22 106.501 169.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.8 t70 42.97 67.77 0.59 Allowed 'General case' 0 CA--C 1.503 -0.852 0 O-C-N 125.829 1.956 . . . . 63.1 111.258 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 29.2 t90 -101.6 -40.77 6.86 Favored 'General case' 0 N--CA 1.418 -2.029 0 CA-C-N 113.574 -1.648 . . . . 74.43 108.856 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -112.72 -177.49 3.16 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.911 -0.774 . . . . 62.24 108.911 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.634 ' HG2' ' H ' ' A' ' 50' ' ' GLU . 41.2 tt0 -141.14 -173.88 3.85 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.417 -1.327 . . . . 61.45 107.417 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.634 ' H ' ' HG2' ' A' ' 49' ' ' GLU . 18.9 mm-40 -50.49 163.64 0.16 Allowed 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.364 1.066 . . . . 50.41 113.002 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -45.05 -59.6 2.51 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.027 1.331 . . . . 62.25 114.561 -172.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.4 p -100.16 -2.36 9.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-O 121.983 0.897 . . . . 72.21 109.239 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.0 m 66.82 162.11 0.17 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.289 -1.323 . . . . 75.4 113.161 176.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.2 m -165.84 85.41 0.98 Allowed Pre-proline 0 C--N 1.31 -1.117 0 C-N-CA 125.158 1.383 . . . . 75.44 108.013 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -59.1 -16.64 34.22 Favored 'Trans proline' 0 N--CA 1.487 1.146 0 C-N-CA 123.023 2.482 . . . . 55.3 113.398 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -61.51 -19.4 62.04 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.541 0.736 . . . . 73.53 110.327 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.434 HG22 ' HB2' ' A' ' 91' ' ' ARG . 1.7 pp -80.14 -16.29 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 116.206 -0.452 . . . . 74.23 110.785 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.3 mt -109.43 92.26 3.98 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 116.183 -0.462 . . . . 75.33 110.02 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 27.9 ptt180 -147.1 143.79 28.57 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.981 0.419 . . . . 72.24 111.003 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.717 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.4 pp -113.89 144.02 43.73 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.739 -0.664 . . . . 64.3 111.478 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 90.9 mt -109.65 124.68 66.56 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 108.358 -0.979 . . . . 65.23 108.358 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.425 ' CD2' HD11 ' A' ' 67' ' ' LEU . 19.4 t80 -100.49 92.17 5.02 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 106.825 -1.546 . . . . 74.35 106.825 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 65.43 -67.09 0.14 Allowed 'General case' 0 N--CA 1.399 -2.981 0 C-N-CA 127.341 2.256 . . . . 50.1 112.173 -175.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.57 -44.93 0.87 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.633 -0.794 . . . . 23.25 114.135 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.15 159.04 23.23 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 115.435 1.643 . . . . 74.42 115.435 -174.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 63.9 m-85 -80.13 113.33 18.23 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.274 -0.875 . . . . 62.21 108.875 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.555 HD12 HD22 ' A' ' 76' ' ' LEU . 85.4 mt -81.33 -48.77 11.53 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.579 0.955 . . . . 71.33 113.579 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.715 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 14.7 t-80 -169.25 167.07 10.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.799 -1.556 . . . . 75.23 106.799 -173.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -85.25 -0.57 88.56 Favored Glycine 0 C--N 1.299 -1.489 0 N-CA-C 115.227 0.851 . . . . 55.21 115.227 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -168.04 28.69 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 118.187 0.993 . . . . 70.05 109.801 -169.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.483 HG12 HD21 ' A' ' 60' ' ' LEU . 10.9 p -85.12 138.02 19.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 C-N-CA 119.696 -0.801 . . . . 75.41 109.528 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.1 p -79.81 159.6 26.44 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.333 0.494 . . . . 75.42 112.333 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 3.3 mm? -59.42 -41.4 89.44 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 123.521 0.728 . . . . 72.33 111.844 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.99 -29.94 69.03 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.404 -0.427 . . . . 63.01 112.564 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.72 -15.17 59.32 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 122.923 0.489 . . . . 60.3 110.891 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.555 HD22 HD12 ' A' ' 67' ' ' LEU . 42.9 mt -83.46 5.4 23.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.387 -0.37 . . . . 70.03 110.404 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 8.8 mptt 62.67 76.92 0.35 Allowed 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.455 1.102 . . . . 61.11 109.434 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 73' ' ' LEU . 84.4 mt -131.26 120.81 18.25 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 116.224 -0.444 . . . . 70.35 111.371 -174.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.11 157.85 38.02 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 121.943 1.762 . . . . 75.03 109.669 170.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -78.71 150.62 32.47 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.767 -0.457 . . . . 71.31 109.767 -175.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.09 -11.45 72.09 Favored Glycine 0 C--N 1.308 -1.003 0 N-CA-C 114.756 0.662 . . . . 52.12 114.756 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.43 154.54 19.73 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.97 -1.092 . . . . 61.05 110.756 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.403 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 44.0 m -85.13 117.82 24.32 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.306 0.574 . . . . 72.12 111.017 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.7 m -105.41 125.52 51.08 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.386 -0.968 . . . . 53.55 108.386 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.3 p -108.74 122.3 63.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.643 0.735 . . . . 54.43 110.752 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.62 ' O ' HG12 ' A' ' 15' ' ' ILE . 87.0 mtp -122.97 150.63 42.73 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-N 116.192 -0.458 . . . . 71.44 109.899 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 39.9 m-70 -106.31 128.9 54.33 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.67 -1.233 . . . . 73.14 107.67 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.431 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.8 mm? -118.48 139.46 51.39 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 120.163 -0.615 . . . . 72.22 110.641 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.435 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 33.0 m -123.06 131.18 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.127 0 N-CA-C 108.582 -0.896 . . . . 70.42 108.582 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.01 143.59 42.82 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.174 -0.466 . . . . 51.14 110.359 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.434 ' HB2' HG22 ' A' ' 57' ' ' ILE . 98.9 mtt180 -133.39 148.72 51.83 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.303 -1.74 . . . . 75.31 106.303 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 56.2 29.3 14.54 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.491 0.662 . . . . 70.01 110.546 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.7 t -72.02 146.22 47.79 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.082 -0.963 . . . . 73.43 111.837 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 mp -97.14 125.44 45.84 Favored Pre-proline 0 C--N 1.291 -1.945 0 CA-C-N 114.887 -1.052 . . . . 73.44 108.298 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -89.07 8.65 3.81 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.65 2.233 . . . . 74.31 111.584 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 98' ' ' ASN . 9.6 pt-20 -165.55 137.96 3.39 Favored Pre-proline 0 N--CA 1.439 -1.0 0 CA-C-N 116.116 -0.493 . . . . 75.21 111.706 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -60.06 -50.41 7.55 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.86 2.373 . . . . 74.02 108.898 171.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 96' ' ' GLU . 9.5 t30 -151.97 174.04 14.12 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 100.468 -3.901 . . . . 73.33 100.468 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.3 m -74.21 71.6 1.7 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 120.779 1.627 . . . . 73.35 112.507 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -87.76 -43.06 12.16 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-N 115.894 -0.594 . . . . 74.33 109.612 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.7 12.1 63.79 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.162 -0.926 . . . . 65.11 113.189 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -80.88 109.06 15.09 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 118.37 -1.332 . . . . 73.31 110.637 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -116.51 1.0 12.87 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 108.267 -1.012 . . . . 65.1 108.267 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -58.92 140.46 55.42 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 113.174 -1.83 . . . . 75.53 110.203 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.446 ' HD2' ' OG ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -60.47 -35.32 75.6 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.507 1.123 . . . . 74.42 110.578 -177.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 107' ' ' LYS . 1.9 tm-20 65.59 178.88 0.2 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 124.696 1.198 . . . . 65.15 109.02 174.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.433 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 87.2 tttt 72.49 127.41 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.746 0.818 . . . . 71.31 111.962 -177.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.0 p -54.55 116.24 2.56 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.375 -0.83 . . . . 62.03 111.521 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 136.71 -35.15 2.14 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 120.75 -0.738 . . . . 74.22 111.583 -177.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 62.08 28.88 17.44 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.501 0.721 . . . . 75.13 110.511 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.446 ' OG ' ' HD2' ' A' ' 105' ' ' ARG . 67.7 m 75.03 124.6 0.04 OUTLIER 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.057 0.943 . . . . 75.42 110.904 -173.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -66.72 102.44 0.93 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.396 -0.82 . . . . 64.1 110.24 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 61.6 m -82.96 103.53 12.49 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.725 -0.843 . . . . 40.11 108.725 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 68.7 m -72.57 111.24 7.56 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 116.015 -0.539 . . . . 64.42 110.214 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.7 t -79.39 -36.02 17.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.509 -0.769 . . . . 61.44 109.001 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.464 HD13 ' H ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -136.8 176.1 8.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.3 -0.863 . . . . 54.4 108.924 179.082 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--N 1.303 -1.416 0 N-CA-C 106.991 -1.485 . . . . 74.13 106.991 178.547 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.4 p . . . . . 0 N--CA 1.428 -1.546 0 N-CA-C 109.759 -0.46 . . . . 73.24 109.759 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.8 t -132.4 91.21 2.9 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.581 -0.896 . . . . 74.42 108.581 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.461 HD22 ' N ' ' A' ' 4' ' ' ASN . 0.7 OUTLIER 67.38 -174.1 0.19 Allowed 'General case' 0 C--O 1.25 1.099 0 C-N-CA 123.928 0.891 . . . . 74.21 110.436 -177.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.499 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 25.8 t -124.87 115.63 26.4 Favored Pre-proline 0 N--CA 1.431 -1.387 0 N-CA-C 107.863 -1.162 . . . . 74.13 107.863 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -68.92 145.65 62.77 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 122.249 1.966 . . . . 62.22 112.11 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.3 78.01 7.01 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-O 122.396 1.093 . . . . 75.33 109.82 176.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -160.4 -41.88 0.05 OUTLIER 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 113.034 -1.894 . . . . 62.0 106.958 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.501 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 8.5 ptm -124.44 159.98 29.25 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.287 -1.324 . . . . 64.21 111.047 -175.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.89 140.6 28.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.338 0.589 . . . . 74.53 112.582 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -87.59 107.85 18.79 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.393 -0.966 . . . . 53.25 108.393 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.545 ' HG ' HD22 ' A' ' 14' ' ' LEU . 43.2 tp -117.24 132.85 56.54 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.291 0.567 . . . . 73.25 112.411 -173.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 35.7 ttp-105 -107.44 120.9 43.46 Favored 'General case' 0 N--CA 1.408 -2.573 0 N-CA-C 108.733 -0.84 . . . . 72.53 108.733 173.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.604 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.5 mm? -97.34 121.96 39.82 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.219 -1.355 . . . . 74.54 109.337 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.411 HG12 HG22 ' A' ' 21' ' ' THR . 31.6 mt -99.77 119.36 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 N-CA-C 108.272 -1.01 . . . . 72.34 108.272 176.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.04 166.79 23.11 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.478 -0.783 . . . . 74.32 111.436 -175.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.42 HG11 ' H ' ' A' ' 90' ' ' ALA . 28.7 m -70.74 -14.35 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.504 0.669 . . . . 73.25 110.665 177.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 m -83.69 -6.24 59.39 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 114.923 -1.035 . . . . 40.41 110.11 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.81 -4.67 84.96 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.852 -0.69 . . . . 52.44 112.64 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -87.54 131.9 34.22 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.898 0.38 . . . . 62.1 110.252 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.411 HG22 HG12 ' A' ' 15' ' ' ILE . 80.8 p -98.94 129.94 45.28 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.998 -0.546 . . . . 75.14 110.068 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -131.44 139.11 49.32 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.043 -0.725 . . . . 72.32 109.043 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 29.4 tt0 -125.23 133.84 52.56 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.324 -0.55 . . . . 75.55 110.587 -174.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.661 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 95.3 m-85 -144.66 160.0 41.9 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.105 0.562 . . . . 61.22 109.489 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.7 tp -87.52 126.17 34.76 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.174 -1.047 . . . . 72.03 108.174 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.661 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 96.8 m-85 -132.77 173.94 10.84 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.749 -0.834 . . . . 74.44 108.749 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 99.7 p -97.09 151.34 37.65 Favored Pre-proline 0 C--N 1.294 -1.807 0 N-CA-C 108.515 -0.92 . . . . 71.05 108.515 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.551 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 37.3 Cg_endo -63.11 -11.87 27.13 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.594 2.196 . . . . 53.0 112.409 177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -86.2 -17.24 35.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.542 -0.754 . . . . 54.2 109.999 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -69.93 154.76 41.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.486 0.66 . . . . 73.41 112.429 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.533 ' O ' HG13 ' A' ' 35' ' ' ILE . 3.3 p -91.69 118.21 30.45 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 115.357 -0.838 . . . . 64.33 110.848 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.4 -51.29 59.86 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.83 1.252 . . . . 34.11 113.623 -174.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.1 m -72.11 -22.6 61.31 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 120.861 0.362 . . . . 72.11 111.6 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -70.66 -48.88 52.64 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.502 -0.925 . . . . 64.24 108.502 172.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 31' ' ' SER . 72.5 mt -54.81 -43.91 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 114.278 -1.328 . . . . 73.03 110.102 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.471 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.27 -34.37 23.09 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.165 0.986 . . . . 74.23 111.763 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.676 ' HB2' ' HG3' ' A' ' 44' ' ' PRO . 33.4 mmtp -74.03 -49.7 23.08 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 109.539 -0.541 . . . . 53.53 109.539 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -59.95 -40.76 90.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.41 -0.814 . . . . 63.13 111.568 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.604 HG21 ' CB ' ' A' ' 14' ' ' LEU . 36.0 m -73.95 -31.3 30.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.418 -0.355 . . . . 71.43 111.654 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -56.47 -49.71 73.83 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 123.446 0.466 . . . . 74.2 110.855 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.5 t70 171.86 -57.68 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 O-C-N 123.733 0.646 . . . . 72.43 110.773 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -81.81 166.04 20.35 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.468 -0.938 . . . . 64.12 108.468 -175.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -111.24 122.27 38.19 Favored Pre-proline 0 C--N 1.29 -2.011 0 CA-C-O 120.669 0.271 . . . . 61.41 110.392 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.676 ' HG3' ' HB2' ' A' ' 37' ' ' LYS . 75.4 Cg_exo -49.61 99.77 0.04 OUTLIER 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 123.375 2.716 . . . . 74.24 114.993 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 96.5 mmm -148.81 -43.83 0.15 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.741 0.816 . . . . 73.12 110.55 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 95' ' ' PRO . 9.9 m-20 -133.73 175.97 8.97 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.652 -0.869 . . . . 73.0 108.652 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.8 p90 -156.35 169.48 24.49 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.608 -0.437 . . . . 70.34 109.999 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -141.72 109.16 5.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 105.493 -2.04 . . . . 74.41 105.493 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.68 124.68 32.48 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.917 1.08 . . . . 71.03 113.917 -169.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.2 154.0 38.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.616 -0.72 . . . . 62.32 109.221 172.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 60.88 24.52 14.51 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.92 1.081 . . . . 63.34 113.92 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 52' ' ' VAL . 25.9 t 67.98 38.66 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 122.049 0.928 . . . . 74.5 109.207 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.452 ' HB3' HD21 ' A' ' 94' ' ' LEU . 70.1 m -60.76 104.8 0.38 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.398 1.094 . . . . 25.11 112.749 178.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 20.0 m -106.65 -176.35 0.41 Allowed Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 114.008 -1.451 . . . . 51.51 107.813 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 54' ' ' SER . 87.4 Cg_exo -52.06 -16.37 4.42 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 122.916 2.411 . . . . 61.43 112.596 176.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 103' ' ' ARG . 78.7 m-20 -56.07 -23.59 34.65 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.434 1.493 . . . . 72.44 111.586 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.556 HG22 ' HB3' ' A' ' 91' ' ' ARG . 2.3 pp -77.69 -11.16 13.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 112.442 0.534 . . . . 74.3 112.442 -178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.1 mt -91.77 116.55 28.99 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 120.915 0.388 . . . . 73.32 111.86 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 39.0 mmt180 -144.82 164.16 31.88 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 124.149 0.98 . . . . 70.51 108.41 175.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.673 HD21 ' H ' ' A' ' 71' ' ' VAL . 3.7 pp -147.17 148.4 31.49 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 109.444 -0.576 . . . . 75.11 109.444 172.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 90.3 mt -118.27 129.63 74.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 108.644 -0.873 . . . . 74.23 108.644 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -100.03 81.51 2.43 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 106.292 -1.744 . . . . 74.41 106.292 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.324 17.6 tm0? 59.34 -38.56 0.07 Allowed 'General case' 0 N--CA 1.414 -2.228 0 C-N-CA 129.042 2.937 . . . . 62.23 116.38 -176.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.35 -52.25 0.18 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.801 -0.714 . . . . 73.33 112.651 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.64 162.24 14.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.49 1.293 . . . . 74.1 114.49 -178.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 43.9 m-85 -88.28 113.54 23.99 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.866 -1.161 . . . . 74.22 107.866 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.21 -48.93 12.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 119.179 -1.008 . . . . 51.51 112.31 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.532 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 60.1 m80 -159.81 177.88 10.36 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.698 -0.853 . . . . 64.31 108.698 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.495 ' HA3' ' HB2' ' A' ' 103' ' ' ARG . . . -85.63 -4.17 85.62 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.978 -0.629 . . . . 71.22 112.584 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.523 HD22 ' HA ' ' A' ' 102' ' ' GLN . 56.4 t30 175.74 79.61 0.0 OUTLIER 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.527 1.131 . . . . 54.25 110.273 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.673 ' H ' HD21 ' A' ' 60' ' ' LEU . 9.2 p -104.33 146.15 12.09 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.765 0 N-CA-C 106.783 -1.562 . . . . 64.14 106.783 172.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.3 p -78.52 158.19 28.64 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.397 -0.521 . . . . 64.3 111.532 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 2.0 mm? -66.26 -34.71 78.62 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.148 0.499 . . . . 60.32 111.003 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.14 -31.38 79.08 Favored Glycine 0 CA--C 1.516 0.155 0 C-N-CA 120.6 -0.81 . . . . 72.33 111.234 176.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -72.4 -15.0 61.84 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 122.959 0.503 . . . . 64.34 110.872 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.553 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 64.5 mt -82.19 3.38 27.5 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.88 -0.415 . . . . 75.43 109.88 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.23 26.12 2.78 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.451 1.1 . . . . 72.34 111.135 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.553 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 65.1 mt -76.53 127.68 83.9 Favored Pre-proline 0 C--O 1.244 0.791 0 CA-C-N 116.555 -0.293 . . . . 75.54 111.138 -178.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.71 147.0 30.82 Favored 'Trans proline' 0 N--CA 1.435 -1.919 0 C-N-CA 121.439 1.426 . . . . 73.13 108.46 170.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.506 ' CE1' ' HG3' ' A' ' 28' ' ' PRO . 12.4 m-30 -69.51 145.67 52.48 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.191 -0.67 . . . . 73.42 109.191 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 89.41 1.77 77.73 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 120.165 -1.016 . . . . 64.31 113.55 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -101.49 145.22 29.28 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 117.041 0.42 . . . . 74.11 109.955 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.4 m -87.19 117.48 25.96 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 108.917 -0.772 . . . . 64.43 108.917 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.9 m -114.21 134.97 54.55 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.609 -0.723 . . . . 75.32 110.935 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.8 131.25 62.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 120.991 0.424 . . . . 55.15 110.349 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 89.7 mtp -135.51 153.2 51.8 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-O 120.81 0.338 . . . . 70.54 110.479 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.506 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 27.8 m-70 -106.58 135.42 48.13 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.474 -1.306 . . . . 75.4 107.474 176.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.471 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.4 mm? -123.53 137.05 54.85 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 120.249 -0.58 . . . . 71.55 110.188 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.404 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 26.4 m -126.46 133.47 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-O 121.58 0.705 . . . . 74.33 111.199 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.42 ' H ' HG11 ' A' ' 17' ' ' VAL . . . -135.12 133.28 39.05 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.469 -0.937 . . . . 73.03 108.469 176.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.556 ' HB3' HG22 ' A' ' 57' ' ' ILE . 56.6 ttt180 -88.0 134.85 33.64 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.277 -1.379 . . . . 72.44 107.277 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 71.59 -43.09 0.55 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.957 1.303 . . . . 64.22 112.123 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 45.4 m 73.74 83.44 0.12 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 124.933 1.293 . . . . 74.15 112.604 177.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 53' ' ' SER . 2.1 mm? -82.45 143.34 47.73 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 114.28 -1.327 . . . . 72.24 107.796 176.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.506 ' HB2' ' O ' ' A' ' 46' ' ' ASP . 46.2 Cg_exo -56.35 -54.58 3.72 Favored 'Trans proline' 0 C--O 1.213 -0.763 0 C-N-CA 122.482 2.122 . . . . 74.54 111.273 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.89 148.51 75.74 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 107.869 -1.16 . . . . 71.35 107.869 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.586 ' CG ' ' HA2' ' A' ' 101' ' ' GLY . 14.1 Cg_endo -54.35 -67.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.746 2.297 . . . . 52.51 110.621 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.7 t30 176.06 80.25 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 126.127 1.771 . . . . 74.31 106.353 173.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.1 m 65.11 -63.53 0.19 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.406 1.483 . . . . 72.42 114.86 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -89.94 -50.48 6.0 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.464 0.65 . . . . 74.22 109.708 -171.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.586 ' HA2' ' CG ' ' A' ' 97' ' ' PRO . . . 131.73 -33.33 2.76 Favored Glycine 0 CA--C 1.488 -1.641 0 N-CA-C 110.184 -1.166 . . . . 75.31 110.184 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.523 ' HA ' HD22 ' A' ' 70' ' ' ASN . 57.3 tt0 -90.0 148.4 23.1 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.817 -0.692 . . . . 74.12 109.775 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.495 ' HB2' ' HA3' ' A' ' 69' ' ' GLY . 14.6 tpt180 -48.77 -58.73 4.34 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.567 1.147 . . . . 64.55 109.426 173.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -177.09 158.89 1.58 Allowed 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.055 -1.832 . . . . 64.22 106.055 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.483 ' HD3' ' OE1' ' A' ' 102' ' ' GLN . 40.7 mmt180 -65.41 -31.5 72.64 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.103 -0.702 . . . . 75.45 109.103 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 76.71 151.57 0.12 Allowed 'General case' 0 C--N 1.353 0.737 0 C-N-CA 125.706 1.602 . . . . 62.43 110.251 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.54 -48.65 76.83 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.26 0.553 . . . . 62.42 109.808 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.5 p -90.83 89.55 7.53 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 107.26 -1.385 . . . . 74.24 107.26 170.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 154.59 -32.35 0.69 Allowed Glycine 0 N--CA 1.432 -1.576 0 C-N-CA 119.61 -1.281 . . . . 55.1 112.9 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.436 ' HA ' ' HB3' ' A' ' 105' ' ' ARG . 10.1 pt-20 -63.1 98.18 0.13 Allowed 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.209 0.528 . . . . 73.51 110.835 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.9 t 63.25 88.79 0.09 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 114.578 -1.192 . . . . 73.11 108.097 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -53.0 107.7 0.25 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 115.542 -0.754 . . . . 74.44 111.311 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 11.9 p -67.7 133.83 50.01 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.677 -1.147 . . . . 72.33 111.875 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 23.5 p -85.09 87.34 7.36 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-O 121.725 0.774 . . . . 73.13 109.31 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.48 127.97 73.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.161 -0.927 . . . . 65.22 110.518 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 13.5 tt -158.7 108.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-O 121.588 0.708 . . . . 71.5 110.962 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 tm? . . . . . 0 C--N 1.308 -1.197 0 N-CA-C 106.401 -1.703 . . . . 70.04 106.401 178.697 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.426 -1.658 0 N-CA-C 107.671 -1.233 . . . . 75.31 107.671 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.3 m -151.65 174.56 13.33 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 116.505 -0.316 . . . . 65.44 110.236 -176.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -78.88 156.2 28.74 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.984 -1.117 . . . . 74.33 107.984 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.458 HG13 HD22 ' A' ' 25' ' ' LEU . 24.9 t -80.76 121.79 81.45 Favored Pre-proline 0 C--N 1.308 -1.204 0 C-N-CA 120.325 -0.55 . . . . 74.43 109.652 -176.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.479 ' HA ' ' CD1' ' A' ' 117' ' ' LEU . 3.4 Cg_exo -64.3 142.45 79.54 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.426 2.084 . . . . 74.23 112.395 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.97 70.82 6.61 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 122.121 0.962 . . . . 73.13 109.884 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -168.0 -37.04 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 104.909 -2.256 . . . . 74.11 104.909 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 86.0 mmm -102.58 156.74 17.41 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 113.622 -1.627 . . . . 75.24 108.985 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.41 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.8 pp -117.92 140.22 42.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 107.509 -1.293 . . . . 74.35 107.509 172.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 67.1 t30 -91.81 125.24 36.45 Favored 'General case' 0 CA--C 1.485 -1.537 0 C-N-CA 118.765 -1.174 . . . . 64.43 107.876 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.575 ' HG ' HD22 ' A' ' 14' ' ' LEU . 44.7 tp -126.21 133.65 51.46 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-O 121.149 0.5 . . . . 70.31 112.112 -174.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 17.8 ttp180 -106.1 120.63 42.3 Favored 'General case' 0 N--CA 1.405 -2.71 0 N-CA-C 108.659 -0.867 . . . . 72.55 108.659 173.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.575 HD22 ' HG ' ' A' ' 12' ' ' LEU . 2.1 mm? -99.56 122.31 42.44 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 113.966 -1.47 . . . . 63.0 109.275 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.522 HG23 HG22 ' A' ' 21' ' ' THR . 15.0 mm -105.07 123.31 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.513 -1.291 . . . . 64.0 107.513 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 2.5 mm? -93.92 158.3 15.71 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.245 -0.582 . . . . 54.11 110.969 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.502 ' CG1' ' HA ' ' A' ' 89' ' ' VAL . 32.2 m -52.85 -30.29 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 115.009 1.485 . . . . 73.13 115.009 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.4 m -86.61 4.88 38.41 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.992 0.425 . . . . 63.01 111.351 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.47 24.92 49.17 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.208 -0.757 . . . . 61.24 111.208 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 73.4 mmtt -86.97 130.82 34.3 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 104.688 -2.338 . . . . 64.45 104.688 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.522 HG22 HG23 ' A' ' 15' ' ' ILE . 38.7 p -126.3 128.68 47.51 Favored 'General case' 0 C--N 1.278 -2.53 0 C-N-CA 119.644 -0.822 . . . . 72.24 111.648 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -142.39 147.21 35.84 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.32 -0.4 . . . . 75.53 111.025 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 21.0 tt0 -125.9 130.2 50.85 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 107.68 -1.23 . . . . 63.51 107.68 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.698 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 96.4 m-85 -145.11 158.97 43.67 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.703 0.287 . . . . 63.2 110.452 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.458 HD22 HG13 ' A' ' 5' ' ' VAL . 96.5 mt -79.76 125.66 29.96 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.99 -1.115 . . . . 71.3 107.99 175.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.698 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 90.1 m-85 -129.86 163.15 26.94 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.59 -0.522 . . . . 72.33 109.59 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.0 m -88.99 141.13 29.29 Favored Pre-proline 0 N--CA 1.395 -3.185 0 N-CA-C 107.613 -1.255 . . . . 60.33 107.613 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 34.7 Cg_endo -62.4 -11.98 25.4 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.203 1.935 . . . . 73.51 112.186 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -78.89 -20.27 49.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.433 1.093 . . . . 72.25 110.046 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.448 ' O ' HD22 ' A' ' 73' ' ' LEU . 63.5 m-20 -75.44 154.16 37.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.184 -0.462 . . . . 64.33 111.347 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.515 ' O ' HG13 ' A' ' 35' ' ' ILE . 13.4 p -101.1 132.07 46.73 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.276 0.473 . . . . 62.42 112.276 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.434 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -48.47 -59.34 3.56 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.662 1.727 . . . . 62.13 115.662 -174.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.7 m -72.78 -19.7 61.31 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.504 0.668 . . . . 55.55 111.258 -174.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.537 ' OD2' ' HG3' ' A' ' 97' ' ' PRO . 14.3 t70 -70.15 -47.93 59.55 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.493 -1.299 . . . . 62.31 107.493 172.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 31' ' ' SER . 73.3 mt -59.03 -35.28 56.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.671 -1.149 . . . . 73.14 110.84 176.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.418 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.41 -33.56 21.22 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.029 0.532 . . . . 72.55 110.665 175.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.481 ' HB2' ' HG3' ' A' ' 44' ' ' PRO . 5.5 mptp? -68.87 -51.72 37.31 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.71 0.291 . . . . 73.33 110.312 174.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.488 ' ND1' ' HE3' ' A' ' 43' ' ' TRP . 51.8 t60 -57.52 -43.0 83.94 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.992 -0.549 . . . . 71.01 111.889 -177.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 14' ' ' LEU . 35.8 m -76.9 -31.53 19.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 112.381 0.512 . . . . 63.42 112.381 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -68.38 -47.15 68.12 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.404 -0.519 . . . . 61.03 109.761 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.464 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . 6.5 m-20 -137.42 -89.95 0.25 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.55 0.944 . . . . 74.02 113.55 176.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 38' ' ' HIS . 40.3 t-20 -129.22 170.72 13.24 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.949 -1.5 . . . . 63.24 106.949 -176.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.493 ' HE1' ' HB2' ' A' ' 100' ' ' GLN . 58.5 t-105 -61.07 134.49 92.97 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.499 -0.556 . . . . 72.25 109.499 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.524 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 64.0 Cg_exo -42.41 101.54 0.04 OUTLIER 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 124.105 3.203 . . . . 73.14 113.024 176.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 43' ' ' TRP . 69.2 mtm -137.55 -60.64 0.65 Allowed 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 115.353 -0.84 . . . . 63.32 110.375 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -107.0 -73.77 0.68 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.233 -0.587 . . . . 74.32 110.184 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' A' ' 41' ' ' ASP . 89.3 m95 60.08 -179.77 0.09 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 115.408 1.632 . . . . 75.54 115.408 177.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -155.98 164.03 38.97 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.813 -0.63 . . . . 73.54 109.492 -172.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.493 ' HA ' HG23 ' A' ' 93' ' ' THR . 12.7 pt-20 -131.22 140.91 49.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.05 -1.092 . . . . 70.33 108.05 173.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.463 ' HB2' ' CD ' ' A' ' 92' ' ' GLU . 0.6 OUTLIER -60.52 -72.91 0.1 Allowed 'General case' 0 C--O 1.24 0.569 0 N-CA-C 111.775 0.287 . . . . 65.02 111.775 -179.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.13 -91.06 0.5 Allowed 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 119.915 -0.714 . . . . 74.02 109.1 174.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.0 m -151.66 125.48 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 123.974 0.91 . . . . 70.11 108.943 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.2 m -130.15 169.58 15.17 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 120.662 -0.415 . . . . 73.12 110.451 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.643 ' O ' HG13 ' A' ' 57' ' ' ILE . 45.7 p -91.48 123.31 64.21 Favored Pre-proline 0 N--CA 1.429 -1.496 0 N-CA-C 109.14 -0.689 . . . . 75.33 109.14 177.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.78 -17.02 9.42 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 123.117 2.545 . . . . 74.44 112.998 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -63.4 -13.28 38.08 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.774 0.83 . . . . 74.14 111.204 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.643 HG13 ' O ' ' A' ' 54' ' ' SER . 2.0 pp -78.18 -16.03 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 122.204 -0.31 . . . . 73.53 111.773 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.9 mt -78.84 96.1 5.56 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 107.27 -1.381 . . . . 62.14 107.27 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 10.3 ptt180 -146.46 162.72 37.67 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.442 -0.799 . . . . 64.32 111.567 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.631 HD21 HG12 ' A' ' 71' ' ' VAL . 4.5 pp -127.11 150.32 49.54 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 115.6 -0.727 . . . . 75.03 112.044 -171.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.428 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 97.4 mt -118.79 120.02 62.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 115.17 -0.923 . . . . 74.23 108.58 176.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.432 ' CD2' HD11 ' A' ' 67' ' ' LEU . 17.0 t80 -101.53 65.52 1.04 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.057 -1.09 . . . . 72.44 108.057 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 53.83 83.93 0.07 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.828 -1.533 . . . . 74.32 113.496 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.55 -58.51 0.5 Allowed Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.535 -0.841 . . . . 64.21 112.803 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -130.87 162.88 28.65 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 120.095 -0.642 . . . . 75.33 112.693 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 78.8 m-85 -83.73 122.27 28.42 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.073 -1.454 . . . . 73.25 107.073 175.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.462 HD12 ' CD2' ' A' ' 76' ' ' LEU . 54.6 mt -79.71 -46.37 17.22 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 118.804 -1.158 . . . . 72.22 111.289 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.486 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.0 t-160 -165.86 178.88 6.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.361 -2.089 . . . . 72.41 105.361 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -71.54 -42.23 55.89 Favored Glycine 0 C--O 1.208 -1.472 0 C-N-CA 120.346 -0.931 . . . . 74.55 112.675 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.503 ' OD1' ' HB2' ' A' ' 31' ' ' SER . 60.7 t30 -159.93 75.93 0.62 Allowed 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 108.613 -0.884 . . . . 63.03 108.613 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.631 HG12 HD21 ' A' ' 60' ' ' LEU . 11.2 p -102.06 152.08 5.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.228 -1.351 . . . . 70.4 109.066 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.1 p -77.61 160.68 28.38 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.488 0.551 . . . . 74.43 112.488 -173.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.538 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.3 mm? -68.98 -34.55 75.49 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 116.134 -0.484 . . . . 72.32 111.189 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.05 -29.67 75.09 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.496 -0.859 . . . . 41.32 111.193 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.469 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -73.79 -15.24 61.19 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 122.972 0.509 . . . . 74.33 111.199 178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.465 HD11 ' SD ' ' A' ' 86' ' ' MET . 58.6 mt -83.83 2.39 38.48 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.867 0.467 . . . . 55.33 110.224 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER 65.22 78.06 0.29 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.984 0.914 . . . . 62.13 109.276 -176.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 85.0 mt -133.46 133.33 22.58 Favored Pre-proline 0 C--O 1.243 0.749 0 CA-C-N 116.093 -0.503 . . . . 74.11 111.239 -175.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 2.0 Cg_endo -81.33 155.97 19.23 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.293 1.996 . . . . 65.12 109.229 171.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -76.71 153.65 34.9 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.74 -0.837 . . . . 73.45 108.74 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 83.97 2.37 89.56 Favored Glycine 0 C--N 1.3 -1.467 0 C-N-CA 120.25 -0.976 . . . . 73.53 113.09 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.21 151.68 23.78 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 110.2 -0.296 . . . . 54.44 110.2 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.47 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 90.1 m -102.18 127.17 49.23 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.146 0.498 . . . . 64.44 110.158 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 84.8 m -128.72 141.98 51.15 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.938 -0.573 . . . . 60.24 110.604 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.9 137.5 41.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.779 0.323 . . . . 72.12 110.877 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.465 ' SD ' HD11 ' A' ' 76' ' ' LEU . 93.6 mtp -135.51 152.73 51.61 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 122.882 0.473 . . . . 71.44 110.176 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.428 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 29.1 m-70 -109.61 131.06 55.41 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.662 -0.866 . . . . 73.12 108.662 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.418 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.5 mm? -117.87 137.63 52.66 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 110.06 -0.348 . . . . 74.11 110.06 -175.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.502 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 32.6 m -121.71 133.87 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-O 121.142 0.496 . . . . 74.31 110.706 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.38 120.93 19.34 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.645 -0.707 . . . . 64.11 109.991 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.512 ' H ' HD13 ' A' ' 57' ' ' ILE . 2.5 tmt_? -88.17 112.67 23.0 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 108.076 -1.083 . . . . 72.01 108.076 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.514 ' O ' ' HB ' ' A' ' 93' ' ' THR . 31.2 tt0 64.95 -88.21 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 124.766 1.291 . . . . 75.32 107.939 -176.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 92' ' ' GLU . 12.7 t 154.91 143.71 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.911 1.284 . . . . 73.03 110.55 175.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.74 160.32 27.69 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 104.825 -2.287 . . . . 72.12 104.825 165.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.64 -84.55 0.01 OUTLIER 'Trans proline' 0 C--O 1.26 1.622 0 C-N-CA 121.745 1.63 . . . . 73.44 113.899 -176.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.582 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 1.3 pp20? -172.35 167.98 3.09 Favored Pre-proline 0 CA--C 1.56 1.356 0 CA-C-O 119.32 -0.371 . . . . 73.24 110.619 -176.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.582 ' HD2' ' HB2' ' A' ' 96' ' ' GLU . 7.3 Cg_endo -46.44 -66.32 0.15 Allowed 'Trans proline' 0 CA--C 1.555 1.528 0 C-N-CA 124.577 3.518 . . . . 65.53 117.595 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -165.38 18.76 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.364 0.602 . . . . 73.34 111.316 -167.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.9 t 62.13 75.0 0.42 Allowed 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 124.038 0.935 . . . . 72.42 108.978 -174.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.493 ' HB2' ' HE1' ' A' ' 43' ' ' TRP . 45.7 mt-30 -68.89 -51.09 43.82 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 114.707 -1.133 . . . . 73.11 111.708 -175.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.87 11.13 60.1 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.845 -0.693 . . . . 64.03 112.597 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -78.29 111.69 14.52 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.421 0.629 . . . . 72.1 111.945 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -150.44 22.93 0.82 Allowed 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.394 -0.821 . . . . 71.42 110.287 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.509 ' HB3' ' HG3' ' A' ' 106' ' ' GLU . 37.6 t30 -110.43 175.07 5.57 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.885 -1.524 . . . . 54.11 106.885 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -67.4 -48.96 65.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 118.269 0.486 . . . . 65.55 109.775 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.509 ' HG3' ' HB3' ' A' ' 104' ' ' ASN . 45.9 mt-10 55.97 26.1 9.5 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.113 1.153 . . . . 71.02 114.113 169.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -136.49 155.75 49.55 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.502 -0.317 . . . . 73.2 110.5 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.6 p -66.79 133.27 49.79 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.76 -0.654 . . . . 72.31 112.384 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.758 ' HA3' ' SG ' ' A' ' 113' ' ' CYS . . . 91.13 -50.09 3.05 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.589 -0.605 . . . . 74.33 111.589 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 75.13 91.72 0.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.416 1.487 . . . . 63.13 113.845 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.4 m 69.97 -33.04 0.25 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 115.391 1.626 . . . . 44.14 115.391 172.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -82.53 -11.38 58.49 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.008 0.744 . . . . 75.03 113.008 -176.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.758 ' SG ' ' HA3' ' A' ' 109' ' ' GLY . 60.4 m -74.23 95.24 2.59 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.489 -0.56 . . . . 71.52 109.489 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 80.3 m -152.23 107.51 3.28 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.533 -0.303 . . . . 52.42 111.054 -177.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.2 m -82.74 130.58 35.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 109.363 -0.606 . . . . 74.11 109.363 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 60.8 mt 62.04 84.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.776 0.83 . . . . 53.23 111.01 -177.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.479 ' CD1' ' HA ' ' A' ' 6' ' ' PRO . 5.1 tt . . . . . 0 C--O 1.252 1.231 0 N-CA-C 106.877 -1.527 . . . . 75.11 106.877 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 p . . . . . 0 N--CA 1.427 -1.613 0 N-CA-C 110.169 -0.308 . . . . 52.42 110.169 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.7 m -151.3 136.62 17.65 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.456 -0.572 . . . . 71.51 109.456 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -76.02 138.7 41.06 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 108.637 -0.875 . . . . 65.43 108.637 176.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.481 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 39.0 t -100.41 116.61 64.19 Favored Pre-proline 0 N--CA 1.418 -2.066 0 N-CA-C 109.306 -0.627 . . . . 61.04 109.306 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.39 172.52 14.44 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.5 2.134 . . . . 64.13 111.972 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.42 30.22 0.29 Allowed 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.992 0.917 . . . . 71.4 110.639 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -133.42 -14.68 2.54 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.714 -0.676 . . . . 65.31 110.14 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.3 mmm -121.68 155.4 35.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.036 -0.529 . . . . 73.25 110.092 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 pp -120.28 140.27 44.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-O 120.883 0.373 . . . . 65.52 110.949 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -90.84 111.04 22.28 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 109.06 -0.719 . . . . 70.51 109.06 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.542 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.1 tp -119.54 133.11 55.82 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.758 -0.656 . . . . 73.14 112.31 -174.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -108.63 121.25 44.62 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 114.986 -1.007 . . . . 72.25 108.388 173.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.547 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.1 mm? -99.44 123.72 43.96 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.061 -0.972 . . . . 72.34 109.273 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.476 HG23 HG22 ' A' ' 21' ' ' THR . 29.6 mt -104.46 129.22 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 N-CA-C 108.736 -0.838 . . . . 74.42 108.736 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.4 mt -84.68 166.17 17.29 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.789 -0.642 . . . . 74.51 110.169 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.13 -19.43 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-O 121.745 0.784 . . . . 74.43 109.983 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 p -76.06 -10.6 59.55 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.561 -0.745 . . . . 74.3 111.35 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.44 2.52 76.45 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 110.715 -0.954 . . . . 73.13 110.715 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.4 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 12.6 mptt -86.65 133.61 33.68 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 109.791 -0.448 . . . . 75.1 109.791 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.476 HG22 HG23 ' A' ' 15' ' ' ILE . 80.9 p -113.73 137.26 51.87 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 116.117 -0.492 . . . . 62.13 111.531 -173.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -134.88 147.5 49.87 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.064 -0.717 . . . . 71.3 109.064 174.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -135.46 131.58 36.34 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.397 -0.594 . . . . 75.44 109.397 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.717 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 94.4 m-85 -144.04 160.02 41.6 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.951 -0.759 . . . . 65.21 108.951 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.446 HD11 HG13 ' A' ' 5' ' ' VAL . 41.3 tp -82.28 125.04 30.5 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.292 -1.373 . . . . 74.24 107.292 175.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.717 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 83.8 m-85 -128.97 166.59 18.88 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.446 -0.575 . . . . 74.31 109.446 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.7 p -92.83 146.94 33.09 Favored Pre-proline 0 N--CA 1.417 -2.092 0 C-N-CA 119.308 -0.957 . . . . 75.42 108.62 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.512 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 35.3 Cg_endo -61.86 -11.4 20.93 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.72 2.28 . . . . 71.34 112.1 177.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -79.97 -23.06 41.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.216 -0.902 . . . . 71.13 110.973 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.423 ' O ' HD22 ' A' ' 73' ' ' LEU . 22.6 m-20 -67.44 154.78 40.59 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 112.88 0.696 . . . . 75.44 112.88 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.524 ' O ' HG13 ' A' ' 35' ' ' ILE . 43.7 m -97.08 124.6 41.14 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.65 -0.705 . . . . 44.22 109.829 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.84 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -50.5 -50.0 54.04 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.539 0.735 . . . . 61.43 112.937 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 p -65.65 -30.63 71.36 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 112.355 0.502 . . . . 73.5 112.355 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -69.66 -46.24 66.56 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.8 -0.815 . . . . 72.01 108.8 174.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 31' ' ' SER . 67.3 mt -60.22 -39.15 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 114.811 -1.086 . . . . 72.44 111.138 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.88 -38.61 36.37 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.418 0.687 . . . . 71.43 111.299 176.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -72.49 -40.92 66.52 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.242 -0.435 . . . . 64.15 111.079 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -65.89 -42.54 90.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.629 -0.714 . . . . 61.1 111.161 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.547 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.4 m -76.84 -30.72 18.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 112.157 0.428 . . . . 72.52 112.157 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -47.29 -48.85 24.73 Favored 'General case' 0 C--O 1.243 0.719 0 O-C-N 123.565 0.54 . . . . 75.55 111.795 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.3 t70 178.98 -60.47 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.561 -0.533 . . . . 72.21 109.561 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -98.03 -161.17 0.85 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.504 -0.771 . . . . 72.34 109.655 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.6 p-90 -111.69 137.73 21.32 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 109.492 -0.558 . . . . 74.41 109.492 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -55.49 111.24 0.7 Allowed 'Trans proline' 0 C--O 1.254 1.296 0 C-N-CA 122.576 2.184 . . . . 54.45 112.026 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.667 ' SD ' ' HA3' ' A' ' 109' ' ' GLY . 55.1 mtt -87.21 153.21 21.67 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.491 -0.777 . . . . 73.31 110.488 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -65.54 -42.03 92.38 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.652 -0.704 . . . . 44.45 112.047 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -93.89 -4.14 50.47 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.209 0.818 . . . . 74.43 113.209 -174.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 45' ' ' MET . 8.5 pt-20 -67.93 -43.06 80.03 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.783 -0.767 . . . . 73.1 111.933 -175.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.427 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 43.0 mt-10 64.15 -78.5 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.265 1.026 . . . . 74.03 112.025 -175.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 43.95 63.22 1.67 Allowed 'General case' 0 C--N 1.355 0.809 0 CA-C-O 122.554 1.169 . . . . 71.43 108.693 -173.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.634 ' NE2' ' HA ' ' A' ' 55' ' ' PRO . 63.2 tt0 -174.65 -46.64 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 104.929 -2.249 . . . . 71.25 104.929 -171.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.0 t 46.78 78.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 113.251 -1.795 . . . . 75.42 113.58 172.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.3 t 64.91 1.88 1.58 Allowed 'General case' 0 CA--C 1.559 1.325 0 CA-C-N 115.027 -0.988 . . . . 64.13 112.838 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.8 m -119.11 82.65 22.57 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 109.154 -0.684 . . . . 43.53 109.154 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.634 ' HA ' ' NE2' ' A' ' 51' ' ' GLN . 57.2 Cg_endo -71.54 -16.92 30.45 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.443 2.096 . . . . 72.21 113.908 -173.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -62.34 -16.0 51.69 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.276 0.631 . . . . 72.14 112.677 -176.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.406 ' HB ' ' HB3' ' A' ' 91' ' ' ARG . 2.1 pp -77.93 -21.73 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 120.809 0.338 . . . . 72.02 111.731 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.7 tp -90.78 99.52 12.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.494 -0.928 . . . . 65.33 108.494 -177.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -137.22 160.53 38.75 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.088 -0.505 . . . . 72.03 109.721 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.84 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.5 pp -127.62 140.76 51.89 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.581 -0.736 . . . . 73.14 109.495 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 92.5 mt -111.89 126.33 69.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.783 -0.821 . . . . 61.15 108.783 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -100.58 84.32 2.74 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.715 -1.217 . . . . 73.22 107.715 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 68.16 -50.24 0.54 Allowed 'General case' 0 N--CA 1.405 -2.676 0 C-N-CA 127.505 2.322 . . . . 53.53 112.69 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.9 -45.76 0.18 Allowed Glycine 0 N--CA 1.436 -1.338 0 C-N-CA 120.601 -0.809 . . . . 61.2 113.987 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -110.58 160.9 16.24 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.55 0.574 . . . . 64.41 112.55 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 68.4 m-85 -87.1 113.79 23.14 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.018 -1.104 . . . . 64.42 108.018 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.587 HD12 HD22 ' A' ' 76' ' ' LEU . 43.2 mt -80.63 -45.21 17.64 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 114.113 1.153 . . . . 64.45 114.113 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.664 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 8.1 t60 -167.48 169.93 11.73 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.735 -1.58 . . . . 75.01 106.735 -175.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.85 -1.31 88.98 Favored Glycine 0 C--N 1.309 -0.954 0 C-N-CA 120.73 -0.748 . . . . 72.13 113.148 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 178.49 64.9 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.826 -0.805 . . . . 62.44 108.826 -173.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.718 HG12 HD21 ' A' ' 60' ' ' LEU . 11.2 p -104.18 151.17 6.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.852 -1.166 . . . . 72.0 107.852 174.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.439 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 58.9 p -84.04 158.28 21.52 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 121.42 -0.112 . . . . 62.12 110.962 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.581 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.5 mm? -65.29 -32.75 74.57 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.977 0.418 . . . . 65.44 110.79 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.48 -32.31 83.77 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.098 -0.801 . . . . 61.31 111.098 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.479 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -79.19 -15.14 58.51 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 122.803 0.441 . . . . 70.22 111.088 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.587 HD22 HD12 ' A' ' 67' ' ' LEU . 66.8 mt -82.38 1.16 38.57 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.945 -0.761 . . . . 71.42 108.945 176.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.1 mptt 78.84 14.89 1.16 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.056 1.342 . . . . 63.44 113.18 178.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.6 mp -60.67 120.26 51.33 Favored Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 113.485 0.92 . . . . 74.42 113.485 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 16.2 Cg_exo -73.05 150.41 48.31 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.485 2.123 . . . . 74.33 108.565 170.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -78.06 142.24 38.3 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.454 -0.943 . . . . 75.24 108.454 -175.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.481 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 92.63 -3.25 74.57 Favored Glycine 0 C--N 1.298 -1.533 0 C-N-CA 119.955 -1.117 . . . . 60.33 114.151 178.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -104.42 153.89 20.54 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 117.367 0.583 . . . . 63.45 111.621 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.7 m -92.61 118.6 31.19 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.33 -0.619 . . . . 71.34 109.33 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 84.1 m -119.98 136.93 54.36 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 116.39 -0.368 . . . . 74.53 110.516 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.4 p -110.52 135.45 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-O 121.045 0.45 . . . . 72.22 110.964 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 87.6 mtp -134.48 153.72 51.78 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 120.896 0.379 . . . . 71.55 111.64 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.537 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 63.3 m-70 -107.73 135.13 49.67 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.682 -1.229 . . . . 72.04 107.682 176.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.432 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.4 mm? -121.73 133.76 54.94 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 120.161 -0.616 . . . . 73.31 110.156 -177.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.51 134.57 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 121.662 0.744 . . . . 60.11 111.827 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.03 145.85 49.82 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.407 -1.331 . . . . 55.55 107.407 175.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.406 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 14.5 ttm180 -109.98 153.15 24.96 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.017 -1.475 . . . . 74.25 107.017 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 102' ' ' GLN . 6.9 tp10 -36.38 -53.13 0.84 Allowed 'General case' 0 N--CA 1.48 1.06 0 O-C-N 124.972 1.42 . . . . 73.32 110.019 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 92' ' ' GLU . 1.8 p -169.93 -85.94 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 125.718 1.607 . . . . 65.42 109.833 172.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.421 HD12 ' HB ' ' A' ' 93' ' ' THR . 6.7 mp -91.72 160.7 35.75 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 109.395 -0.594 . . . . 74.03 109.395 178.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -62.31 90.59 0.12 Allowed 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.47 2.113 . . . . 73.33 111.772 175.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 49.4 85.84 0.17 Allowed Pre-proline 0 C--N 1.319 -0.745 0 C-N-CA 126.333 1.853 . . . . 75.44 114.611 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.88 -60.96 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.787 1.658 . . . . 71.33 109.52 175.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -175.45 17.16 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 106.757 -1.572 . . . . 71.52 106.757 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.4 m 50.38 69.29 0.64 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.801 -1.09 . . . . 50.32 111.374 -172.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -88.08 -23.13 23.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.897 -1.047 . . . . 71.13 110.631 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.62 21.82 20.51 Favored Glycine 0 C--N 1.303 -1.297 0 N-CA-C 108.363 -1.895 . . . . 61.11 108.363 -170.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.497 ' O ' ' HG3' ' A' ' 92' ' ' GLU . 25.0 tt0 -82.03 110.39 17.23 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.446 -0.877 . . . . 74.44 110.75 -178.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.431 ' HA ' HG23 ' A' ' 93' ' ' THR . 30.1 ptt180 -161.08 -164.43 1.17 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 105.962 -1.866 . . . . 71.34 105.962 175.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -69.93 157.11 38.05 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 119.247 0.931 . . . . 64.21 111.591 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -52.72 -24.68 9.16 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.811 1.644 . . . . 72.42 113.984 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.423 ' HG2' ' HD3' ' A' ' 107' ' ' LYS . 33.4 tt0 78.83 111.72 0.07 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.061 0.944 . . . . 72.42 111.192 174.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.423 ' HD3' ' HG2' ' A' ' 106' ' ' GLU . 0.7 OUTLIER 72.17 -60.93 0.51 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.052 1.341 . . . . 74.32 112.207 -177.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.2 p -88.54 107.12 18.73 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 107.664 -1.235 . . . . 72.24 107.664 175.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.667 ' HA3' ' SD ' ' A' ' 45' ' ' MET . . . -72.14 -28.03 69.08 Favored Glycine 0 C--N 1.306 -1.107 0 C-N-CA 120.374 -0.917 . . . . 55.02 112.526 -176.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.78 151.42 38.84 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 120.832 0.348 . . . . 73.42 111.068 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 49.1 m -104.38 -51.12 3.17 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.253 -1.388 . . . . 75.11 107.253 170.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 64.53 -80.9 0.03 OUTLIER 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.856 1.262 . . . . 74.44 111.841 175.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 84.0 m -162.49 -45.7 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.049 -1.834 . . . . 70.34 106.049 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 24.4 p -151.9 139.52 19.7 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.164 -1.38 . . . . 73.52 107.322 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.8 m -108.26 95.19 3.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.361 1.077 . . . . 74.24 111.03 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.3 tp -153.75 129.71 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 114.029 -1.441 . . . . 73.33 108.695 -178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.255 1.358 0 CA-C-O 118.149 -0.929 . . . . 73.43 112.915 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.1 m . . . . . 0 C--O 1.235 0.292 0 N-CA-C 115.051 1.501 . . . . 73.43 115.051 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.8 t -133.71 123.01 24.21 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 104.371 -2.455 . . . . 62.23 104.371 172.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 74.23 100.31 0.07 Allowed 'General case' 0 N--CA 1.476 0.873 0 O-C-N 124.249 0.968 . . . . 71.42 109.767 -169.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.477 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 47.5 t -90.26 129.1 46.8 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 109.019 -0.734 . . . . 65.22 109.019 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -70.87 149.68 60.23 Favored 'Trans proline' 0 C--O 1.25 1.097 0 C-N-CA 122.332 2.022 . . . . 72.42 112.089 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.42 75.33 7.26 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.905 0.86 . . . . 62.12 108.73 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -171.99 -25.55 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.642 -1.617 . . . . 71.04 107.646 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.6 mmm -114.42 144.84 42.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.947 -1.024 . . . . 72.13 109.626 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -105.76 135.66 43.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.014 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.406 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 2.3 t-20 -89.7 110.71 21.58 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.744 -0.836 . . . . 73.02 108.744 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.518 ' HG ' HD22 ' A' ' 14' ' ' LEU . 43.6 tp -119.51 132.85 55.85 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 115.629 -0.714 . . . . 64.44 111.769 -174.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.8 ttp-105 -109.26 120.76 43.49 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 108.651 -0.87 . . . . 62.12 108.651 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.518 HD22 ' HG ' ' A' ' 12' ' ' LEU . 2.1 mm? -96.44 120.91 37.61 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.787 -1.097 . . . . 64.42 109.966 -177.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.483 HG23 ' OG1' ' A' ' 21' ' ' THR . 19.0 mt -108.91 117.51 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 N-CA-C 107.045 -1.465 . . . . 75.42 107.045 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.58 156.96 20.51 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 116.073 -0.512 . . . . 62.24 111.576 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.2 p -58.04 -25.77 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 124.019 0.928 . . . . 64.43 111.91 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.2 m -76.81 -1.33 27.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.94 0.4 . . . . 73.52 111.017 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.03 15.85 71.35 Favored Glycine 0 CA--C 1.496 -1.123 0 N-CA-C 111.65 -0.58 . . . . 54.14 111.65 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -92.42 143.3 26.51 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.892 -1.522 . . . . 75.33 106.892 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.483 ' OG1' HG23 ' A' ' 15' ' ' ILE . 78.4 m -131.31 141.38 49.93 Favored 'General case' 0 C--N 1.277 -2.555 0 C-N-CA 120.136 -0.626 . . . . 71.32 109.758 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -150.63 139.82 21.2 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.608 -0.886 . . . . 72.41 108.608 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -123.69 133.09 53.95 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.787 -0.365 . . . . 74.41 110.533 -177.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.708 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 90.2 m-85 -145.17 161.21 40.06 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 123.4 0.68 . . . . 61.52 109.728 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.1 mt -79.72 125.84 30.18 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.68 -1.23 . . . . 73.22 107.68 170.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.708 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 85.7 m-85 -125.16 167.35 14.95 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.886 -0.783 . . . . 71.14 108.886 177.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 99.0 p -94.65 147.54 33.36 Favored Pre-proline 0 N--CA 1.414 -2.249 0 C-N-CA 118.895 -1.122 . . . . 62.41 108.225 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.414 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 37.5 Cg_endo -61.82 -11.56 21.52 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.686 2.257 . . . . 64.34 112.312 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -84.44 -18.39 36.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.553 -0.748 . . . . 53.45 110.983 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' O ' HD22 ' A' ' 73' ' ' LEU . 35.1 m-20 -74.07 153.86 39.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.874 0.368 . . . . 74.25 110.374 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.414 ' O ' HG13 ' A' ' 35' ' ' ILE . 36.2 m -98.97 131.6 44.91 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.937 -0.764 . . . . 51.2 108.937 176.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.823 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -51.29 -36.57 43.0 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.396 0.887 . . . . 70.3 113.396 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.514 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 7.2 p -69.24 -36.66 77.41 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.851 0.685 . . . . 63.41 112.851 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.66 -43.29 89.82 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.145 -1.057 . . . . 75.34 108.145 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.527 HG23 ' CZ ' ' A' ' 26' ' ' PHE . 57.0 mt -59.5 -41.31 84.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 114.847 -1.07 . . . . 75.34 111.964 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.94 -42.38 48.37 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 123.043 0.537 . . . . 70.32 111.472 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.592 ' HB2' ' HG3' ' A' ' 44' ' ' PRO . 28.6 mmmt -73.52 -38.62 65.24 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 120.69 0.281 . . . . 65.13 111.323 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -59.77 -45.2 93.0 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.581 -0.736 . . . . 73.21 110.535 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.494 HG11 HD23 ' A' ' 14' ' ' LEU . 34.9 m -75.29 -31.83 24.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-O 121.047 0.451 . . . . 74.25 112.139 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -68.87 -22.37 64.21 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.783 -0.644 . . . . 73.31 110.76 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . 0.315 29.6 t70 91.62 84.56 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 125.806 1.642 . . . . 74.22 113.835 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.1 t30 171.69 132.9 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 127.208 2.203 . . . . 63.43 105.652 175.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -85.65 120.49 72.97 Favored Pre-proline 0 C--N 1.284 -2.245 0 C-N-CA 119.938 -0.705 . . . . 74.21 109.649 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.592 ' HG3' ' HB2' ' A' ' 37' ' ' LYS . 53.8 Cg_exo -59.28 94.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.679 2.253 . . . . 73.31 112.264 172.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 50.3 ttm -155.11 117.54 4.24 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.75 -1.574 . . . . 73.31 106.75 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t70 78.2 134.59 0.06 Allowed 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.607 1.163 . . . . 71.11 110.131 -173.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.536 ' NE1' ' HA ' ' A' ' 98' ' ' ASN . 25.2 m-90 -55.85 -50.41 70.67 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 113.649 0.981 . . . . 70.15 113.649 -173.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.52 ' OE2' ' HG3' ' A' ' 95' ' ' PRO . 47.8 mt-10 67.24 -55.77 0.45 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.882 0.873 . . . . 73.44 110.468 -170.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 52' ' ' VAL . 45.7 mt-10 73.1 -19.12 0.33 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.987 1.715 . . . . 73.33 114.764 174.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 70.07 -55.96 0.59 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.902 0.881 . . . . 73.31 111.601 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -173.66 -37.72 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 123.276 0.63 . . . . 75.34 109.412 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.502 ' O ' ' HB3' ' A' ' 49' ' ' GLU . 29.4 m -91.86 172.26 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.82 -0.627 . . . . 64.25 110.19 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -138.83 94.36 2.82 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 109.322 -0.621 . . . . 70.23 109.322 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.3 m -160.8 117.67 1.43 Allowed Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 123.977 0.911 . . . . 62.02 108.838 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.53 -16.55 30.56 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.433 2.088 . . . . 70.51 111.271 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -74.39 0.27 15.04 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.685 -1.143 . . . . 62.41 112.724 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.548 ' HB ' ' HB3' ' A' ' 91' ' ' ARG . 2.5 pp -76.77 -21.28 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-O 121.086 0.47 . . . . 73.21 110.912 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 96.4 mt -89.3 125.35 35.07 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 107.251 -1.388 . . . . 72.44 107.251 176.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -137.93 142.55 40.58 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.594 -0.842 . . . . 64.0 109.249 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.823 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.6 pp -114.19 134.97 54.55 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.969 -0.56 . . . . 74.44 110.707 -178.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 72.3 mt -109.39 119.92 59.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 115.295 -0.866 . . . . 74.05 108.763 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -101.91 102.78 13.38 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 102.917 -2.994 . . . . 64.4 102.917 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -18.78 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 127.999 2.52 . . . . 71.04 113.881 -163.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.52 -67.81 0.4 Allowed Glycine 0 N--CA 1.42 -2.394 0 CA-C-N 113.165 -1.834 . . . . 61.2 110.27 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -130.61 173.65 10.68 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 120.788 0.327 . . . . 72.3 111.539 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -94.66 114.18 26.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.956 -1.868 . . . . 75.02 105.956 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.667 HD12 HD22 ' A' ' 76' ' ' LEU . 90.6 mt -79.19 -48.12 14.78 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 119.224 -0.99 . . . . 74.14 113.537 -175.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.666 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -167.69 174.52 7.62 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.043 -0.355 . . . . 64.44 110.043 179.682 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.47 -1.52 85.76 Favored Glycine 0 C--N 1.306 -1.131 0 N-CA-C 115.279 0.872 . . . . 55.34 115.279 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.444 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 2.7 t-20 -173.22 25.04 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.727 1.264 . . . . 73.24 110.529 -171.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.659 HG12 HD21 ' A' ' 60' ' ' LEU . 13.3 p -80.42 145.47 9.04 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 O-C-N 122.082 -0.386 . . . . 63.12 110.121 -176.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.535 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 64.0 p -79.02 157.52 28.06 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 122.992 0.517 . . . . 62.52 111.993 -175.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.594 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.7 mm? -65.38 -32.68 74.45 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 120.943 0.402 . . . . 73.1 110.526 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.76 -34.94 88.82 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.817 -0.706 . . . . 74.24 111.353 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.444 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -78.64 -15.58 58.35 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.898 0.479 . . . . 74.34 110.863 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.667 HD22 HD12 ' A' ' 67' ' ' LEU . 65.8 mt -86.33 -3.69 59.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 74.04 110.083 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 9.6 mptt 70.27 72.05 0.22 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.561 1.145 . . . . 72.54 111.421 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.467 HD22 ' HB3' ' A' ' 73' ' ' LEU . 10.4 mp -115.37 118.55 39.53 Favored Pre-proline 0 CA--C 1.491 -1.314 0 CA-C-N 116.0 -0.546 . . . . 75.3 110.822 175.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.425 ' HG2' ' HD2' ' A' ' 82' ' ' LYS . 16.8 Cg_exo -69.07 139.96 44.01 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.99 1.794 . . . . 73.13 109.085 172.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -69.7 140.82 53.59 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.0 -0.741 . . . . 74.45 109.0 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.477 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 92.05 -9.14 77.12 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.254 -0.974 . . . . 64.32 113.359 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' HD2' ' HG2' ' A' ' 79' ' ' PRO . 94.6 mttt -101.65 153.28 19.91 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.456 -0.498 . . . . 54.35 112.275 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.406 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 30.3 m -91.12 118.31 30.32 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.19 -0.914 . . . . 62.02 110.275 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.3 m -122.4 138.88 54.39 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.951 -0.568 . . . . 75.24 109.708 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.53 140.44 28.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 110.281 -0.266 . . . . 75.42 110.281 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 86.6 mtp -138.96 153.76 48.23 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 111.819 0.303 . . . . 73.52 111.819 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.555 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 83.5 m-70 -106.37 137.39 44.42 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.801 -0.814 . . . . 55.14 108.801 175.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.458 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.1 mm? -125.28 131.64 53.05 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 122.215 -0.303 . . . . 65.44 110.894 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.13 135.25 64.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.047 0.451 . . . . 74.23 110.03 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.29 127.65 32.21 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 122.279 -0.263 . . . . 52.31 111.238 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.548 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 58.3 ttt180 -84.42 117.07 23.4 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.605 -0.517 . . . . 64.45 109.605 175.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 70.94 -4.08 1.84 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.053 0.941 . . . . 75.34 112.902 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.2 m 55.42 79.64 0.15 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.496 1.518 . . . . 53.24 114.062 172.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.504 ' HB2' HD11 ' A' ' 57' ' ' ILE . 6.5 mp -94.17 142.0 24.34 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.739 -0.838 . . . . 71.44 108.739 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.565 ' HA ' ' HG3' ' A' ' 37' ' ' LYS . 36.7 Cg_endo -67.53 -65.15 0.04 OUTLIER 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 122.824 2.35 . . . . 70.45 114.277 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -111.41 122.32 37.87 Favored Pre-proline 0 N--CA 1.416 -2.156 0 CA-C-N 116.308 -0.405 . . . . 50.03 109.912 -174.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -59.15 -53.89 3.18 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.683 2.255 . . . . 64.14 112.851 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.536 ' HA ' ' NE1' ' A' ' 47' ' ' TRP . 9.8 t30 -169.8 24.35 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.192 0.52 . . . . 72.21 111.58 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.8 m 62.66 14.81 7.5 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.35 0.66 . . . . 61.23 111.544 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -87.41 -51.84 5.71 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 115.327 1.602 . . . . 72.22 115.327 -172.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.93 31.99 80.43 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.153 -1.179 . . . . 73.24 110.153 -173.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -125.96 164.47 20.72 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.114 -1.069 . . . . 74.14 108.114 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -84.06 92.34 7.85 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.72 -0.792 . . . . 73.41 111.384 -175.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 60.7 t30 69.58 -177.88 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.692 0.797 . . . . 65.14 111.555 174.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -52.68 -42.14 64.49 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.588 1.155 . . . . 65.23 110.464 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.25 148.09 34.43 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 105.08 -2.193 . . . . 71.44 105.08 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -60.92 -44.61 96.97 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 123.458 0.703 . . . . 75.44 112.799 -176.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.4 p -133.17 -30.29 1.35 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.585 0.587 . . . . 72.3 112.585 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.9 59.83 3.55 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 121.19 -0.529 . . . . 74.14 113.233 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.0 110.37 4.42 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.876 -0.787 . . . . 73.11 108.876 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.2 t -83.54 123.42 29.73 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.747 -1.115 . . . . 72.34 113.474 -168.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -105.81 93.94 4.92 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 105.165 -2.161 . . . . 41.23 105.165 167.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 25.9 p -86.07 170.09 12.55 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 112.81 0.671 . . . . 73.1 112.81 -171.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 41.3 t -74.02 104.46 4.87 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.183 -0.917 . . . . 75.44 108.945 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.79 107.58 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.893 0 CA-C-O 122.184 0.992 . . . . 72.42 110.585 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.9 tp -131.25 138.64 52.8 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 107.463 -1.31 . . . . 73.44 107.463 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.8 tt . . . . . 0 C--N 1.298 -1.635 0 N-CA-C 107.353 -1.351 . . . . 74.4 107.353 -179.173 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 p . . . . . 0 N--CA 1.431 -1.375 0 N-CA-C 111.721 0.267 . . . . 64.3 111.721 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.1 m -78.72 102.71 8.22 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.325 -1.361 . . . . 51.55 107.325 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 71.98 175.38 0.29 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 107.29 -1.374 . . . . 72.21 107.29 -171.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.45 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 16.7 t -100.52 131.81 23.27 Favored Pre-proline 0 C--N 1.284 -2.246 0 O-C-N 121.524 -0.735 . . . . 71.14 110.133 -174.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -68.87 147.42 68.52 Favored 'Trans proline' 0 C--O 1.244 0.818 0 C-N-CA 122.09 1.86 . . . . 73.43 110.83 176.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.05 65.86 7.37 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.979 0.895 . . . . 64.33 112.055 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -163.26 -31.49 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.688 -1.597 . . . . 73.31 106.688 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.9 mmm -102.79 148.81 25.15 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.244 -1.343 . . . . 71.05 109.007 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.43 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.9 pp -107.69 132.1 56.18 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 108.816 -0.809 . . . . 74.15 108.816 173.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -88.76 113.78 24.68 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.955 -1.498 . . . . 73.24 106.955 -177.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.551 ' HG ' HD22 ' A' ' 14' ' ' LEU . 42.6 tp -118.96 133.11 56.04 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 121.164 0.506 . . . . 73.44 112.087 -173.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.484 ' HD2' ' OE1' ' A' ' 23' ' ' GLU . 20.6 ttt85 -107.02 121.32 44.22 Favored 'General case' 0 N--CA 1.407 -2.578 0 CA-C-N 115.365 -0.834 . . . . 65.11 108.815 174.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.639 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.0 mm? -101.3 120.72 40.68 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.568 -1.196 . . . . 54.23 108.893 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.541 HG23 HG22 ' A' ' 21' ' ' THR . 26.8 mt -104.69 124.71 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 N-CA-C 108.953 -0.758 . . . . 60.45 108.953 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.3 mt -79.46 168.81 18.95 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.918 -0.583 . . . . 52.32 110.91 -177.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.431 ' CG2' ' HA ' ' A' ' 89' ' ' VAL . 60.0 t -63.84 -31.16 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 122.676 0.39 . . . . 73.24 111.587 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.1 m -79.0 6.1 10.13 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 122.033 -0.417 . . . . 74.22 112.069 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.27 13.67 82.54 Favored Glycine 0 CA--C 1.507 -0.412 0 C-N-CA 120.474 -0.869 . . . . 60.11 111.681 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -88.03 137.48 32.29 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.845 -1.169 . . . . 74.01 107.845 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.541 HG22 HG23 ' A' ' 15' ' ' ILE . 73.2 p -117.97 138.02 52.46 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.731 -0.788 . . . . 65.24 112.841 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HD2' ' O ' ' A' ' 39' ' ' VAL . 58.7 mttp -133.26 147.35 51.93 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.511 -0.922 . . . . 74.53 108.511 169.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.484 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 29.5 tt0 -135.78 131.29 35.29 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.671 -0.863 . . . . 61.32 108.671 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.623 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.6 m-85 -144.75 160.15 41.71 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 122.664 0.386 . . . . 71.12 109.989 -177.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -82.46 125.73 31.42 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.325 -0.991 . . . . 70.04 108.325 173.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.623 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 89.8 m-85 -128.92 173.84 10.04 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.537 -0.912 . . . . 74.54 108.537 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.0 p -100.22 153.14 37.92 Favored Pre-proline 0 N--CA 1.408 -2.556 0 N-CA-C 107.494 -1.298 . . . . 75.43 107.494 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.547 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 40.0 Cg_endo -61.76 -11.45 20.81 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 122.801 2.334 . . . . 74.12 112.161 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -96.81 -4.24 40.77 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.636 -0.711 . . . . 74.41 112.243 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' HB2' HD11 ' A' ' 35' ' ' ILE . 27.4 m-20 -74.7 153.31 38.92 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 119.861 -0.735 . . . . 64.54 110.833 177.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.523 ' O ' HG13 ' A' ' 35' ' ' ILE . 53.7 m -92.54 119.89 32.46 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 120.567 0.222 . . . . 74.21 110.619 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.425 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -45.44 -41.7 9.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.337 1.455 . . . . 72.05 113.568 -178.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 24.2 p -69.53 -41.28 76.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.014 0.435 . . . . 75.42 111.658 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -63.55 -41.77 98.42 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.514 -1.291 . . . . 75.3 107.514 177.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.532 ' O ' HG22 ' A' ' 39' ' ' VAL . 60.7 mt -61.78 -49.21 85.18 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.565 0 CA-C-N 114.619 -1.173 . . . . 75.03 110.408 178.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.02 -44.93 51.58 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.905 0.882 . . . . 73.22 112.043 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.456 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 1.8 tmtp? -73.21 -41.21 64.03 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.515 -0.921 . . . . 73.22 108.515 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -56.54 -45.26 81.26 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.646 1.179 . . . . 75.42 110.671 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.639 HG21 ' CB ' ' A' ' 14' ' ' LEU . 33.8 m -77.62 -29.64 16.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.371 -0.831 . . . . 74.43 111.826 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -47.13 -48.26 23.26 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.356 -0.979 . . . . 74.34 108.356 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . 0.254 11.1 m-20 179.28 -52.35 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 125.865 1.666 . . . . 65.53 113.0 170.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -116.32 -177.86 3.27 Favored 'General case' 0 C--O 1.209 -1.043 0 N-CA-C 109.518 -0.549 . . . . 61.51 109.518 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -90.37 138.78 26.86 Favored Pre-proline 0 C--N 1.309 -1.181 0 O-C-N 121.901 -0.499 . . . . 74.25 110.994 -175.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -72.42 99.28 1.01 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.761 1.641 . . . . 65.42 110.275 172.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 51.1 ttm -149.94 89.26 1.59 Allowed 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.928 -0.578 . . . . 74.4 110.287 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -159.37 152.89 22.64 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.007 -1.479 . . . . 73.35 107.007 177.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -63.85 -34.5 78.07 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 123.179 0.299 . . . . 64.1 111.733 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 11.2 pt-20 -132.29 -40.94 1.0 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.288 -0.565 . . . . 74.3 112.326 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 65.18 -71.59 0.08 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.267 1.427 . . . . 61.34 109.657 -173.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -129.23 109.98 11.59 Favored 'General case' 0 C--O 1.253 1.27 0 C-N-CA 122.998 0.519 . . . . 72.24 111.614 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.473 ' HG2' HG23 ' A' ' 52' ' ' VAL . 35.7 tt0 73.74 -68.23 0.23 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.323 1.449 . . . . 63.35 113.729 175.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.473 HG23 ' HG2' ' A' ' 51' ' ' GLN . 97.3 t -137.43 -53.69 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.653 -0.869 . . . . 62.31 108.653 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.3 m -171.66 -43.14 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 104.794 -2.299 . . . . 72.01 104.794 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.636 ' O ' HG12 ' A' ' 57' ' ' ILE . 18.1 m 55.1 71.21 1.34 Allowed Pre-proline 0 N--CA 1.441 -0.879 0 CA-C-N 113.157 -1.838 . . . . 75.03 112.46 174.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -62.76 -20.48 71.22 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.234 1.956 . . . . 60.33 112.887 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -16.35 49.3 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.994 0.738 . . . . 44.44 112.994 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 54' ' ' SER . 27.5 pt -84.55 -29.15 6.89 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 C-N-CA 120.723 -0.391 . . . . 72.13 111.123 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.559 ' HG ' HG13 ' A' ' 57' ' ' ILE . 88.9 mt -107.15 107.51 18.51 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 116.24 -0.436 . . . . 71.34 109.964 -177.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -144.8 147.84 33.34 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.743 -0.662 . . . . 73.43 110.764 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 1.2 pt? -101.56 133.24 46.53 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 113.248 0.832 . . . . 64.22 113.248 -174.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 82.4 mt -102.49 119.03 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 107.302 -1.37 . . . . 62.13 107.302 175.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -101.64 73.6 1.45 Allowed 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.711 0.767 . . . . 71.11 109.16 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 70.53 -48.5 0.65 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 113.406 -1.725 . . . . 74.22 112.942 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.42 -65.42 0.74 Allowed Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 121.03 -0.605 . . . . 54.1 113.198 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.554 ' NH1' ' HA ' ' A' ' 67' ' ' LEU . 3.1 ppt_? -131.06 176.64 8.08 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.702 0.63 . . . . 73.12 112.702 -174.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 71.8 m-85 -79.16 118.0 20.71 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.483 -0.932 . . . . 64.33 108.483 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.554 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 92.8 mt -79.26 -48.82 13.49 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.425 -0.91 . . . . 64.14 110.763 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -162.92 -171.77 2.81 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 124.293 1.037 . . . . 54.3 108.983 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.04 -43.22 7.22 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 110.99 -0.844 . . . . 62.1 110.99 175.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.483 ' HB3' ' OG ' ' A' ' 33' ' ' SER . 4.4 p-10 -148.71 77.86 1.39 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 122.447 1.118 . . . . 71.3 112.033 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.477 ' CG1' HD11 ' A' ' 60' ' ' LEU . 9.4 p -102.11 142.7 15.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 106.166 -1.791 . . . . 72.51 106.166 173.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.466 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 57.2 p -78.25 157.75 29.16 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.169 0.433 . . . . 65.32 112.169 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.568 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.9 mm? -64.82 -30.94 71.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.031 -0.531 . . . . 62.23 110.952 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.51 -36.62 92.75 Favored Glycine 0 C--N 1.33 0.207 0 N-CA-C 110.833 -0.907 . . . . 73.33 110.833 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.99 -15.35 62.57 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.262 0.625 . . . . 73.22 110.686 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 72' ' ' THR . 62.9 mt -84.11 13.73 4.86 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.056 -0.52 . . . . 73.42 111.116 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.471 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.5 mptt 67.37 24.68 8.87 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.663 0.785 . . . . 71.22 110.528 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.481 HD22 ' HE3' ' A' ' 82' ' ' LYS . 80.2 mt -93.97 122.33 62.19 Favored Pre-proline 0 C--N 1.311 -1.09 0 CA-C-N 115.798 -0.637 . . . . 53.51 111.04 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.93 171.45 16.47 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.242 1.961 . . . . 62.43 109.699 172.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.426 ' CE1' ' HG3' ' A' ' 28' ' ' PRO . 5.1 m-85 -84.97 170.74 12.73 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.829 -0.804 . . . . 73.33 108.829 -176.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.45 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 74.83 10.17 83.43 Favored Glycine 0 C--N 1.306 -1.101 0 N-CA-C 115.218 0.847 . . . . 71.23 115.218 173.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HE3' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -131.28 162.7 29.44 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 118.237 1.019 . . . . 65.31 111.914 178.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.555 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 33.3 m -96.81 126.71 42.16 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 116.145 -0.479 . . . . 74.1 110.804 -178.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.1 m -115.51 141.48 48.0 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.708 -0.678 . . . . 74.22 109.691 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.0 p -111.31 130.39 64.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 120.916 0.388 . . . . 45.41 110.016 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.461 ' HE1' HD12 ' A' ' 60' ' ' LEU . 90.9 mtp -138.38 153.11 48.93 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.051 0.453 . . . . 73.51 112.071 -178.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.515 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 60.5 m-70 -108.97 131.32 55.17 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.658 -0.868 . . . . 72.31 108.658 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.466 HD22 ' C ' ' A' ' 87' ' ' HIS . 3.2 mm? -121.95 144.65 48.75 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 120.784 0.326 . . . . 62.04 110.893 -177.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.431 ' HA ' ' CG2' ' A' ' 17' ' ' VAL . 27.8 m -119.78 136.69 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 CA-C-N 115.777 -0.647 . . . . 75.12 110.423 176.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.5 ' HB1' ' OG1' ' A' ' 93' ' ' THR . . . -133.1 145.07 50.39 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.293 -1.373 . . . . 72.23 107.293 174.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -139.62 128.27 23.15 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.128 -1.434 . . . . 63.1 107.128 -173.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 71.25 -10.09 0.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.74 0.816 . . . . 73.42 111.939 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.5 ' OG1' ' HB1' ' A' ' 90' ' ' ALA . 43.8 m -56.32 128.35 35.42 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.859 1.264 . . . . 45.1 111.727 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -86.72 150.33 50.44 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 115.499 -0.773 . . . . 70.15 109.13 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.51 -42.38 55.44 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.414 2.076 . . . . 75.24 111.345 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -130.33 139.64 36.23 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 107.8 -1.185 . . . . 71.55 107.8 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -39.81 -64.67 0.21 Allowed 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 124.777 3.652 . . . . 54.44 115.378 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -167.54 79.39 0.18 Allowed 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 121.122 -0.231 . . . . 72.32 111.331 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.5 m 46.29 33.8 1.97 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 113.293 0.849 . . . . 71.42 113.293 175.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.537 ' HB2' ' HG2' ' A' ' 102' ' ' GLN . 11.6 pt20 -68.85 -44.79 72.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.354 0.501 . . . . 74.23 112.354 -174.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.8 25.51 59.08 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.487 -0.387 . . . . 45.51 112.882 -176.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.537 ' HG2' ' HB2' ' A' ' 100' ' ' GLN . 12.3 mm-40 -85.08 119.63 25.69 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.695 -0.297 . . . . 74.0 111.394 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.486 ' O ' ' HD2' ' A' ' 103' ' ' ARG . 1.2 tmm_? 72.14 -35.81 0.34 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.847 1.659 . . . . 74.24 111.745 175.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 55.9 t30 76.47 -174.86 0.11 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.415 1.086 . . . . 74.1 109.858 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -58.36 -28.92 65.57 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 123.762 0.825 . . . . 73.22 110.74 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 108' ' ' THR . 12.0 tp10 -177.35 157.41 1.32 Allowed 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 104.702 -2.333 . . . . 61.45 104.702 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -74.0 -20.79 60.22 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.055 -0.658 . . . . 63.22 110.67 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.484 ' H ' ' HG3' ' A' ' 106' ' ' GLU . 7.4 t -153.79 95.65 1.9 Allowed 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 115.036 -0.984 . . . . 72.14 108.396 170.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.47 33.7 0.02 OUTLIER Glycine 0 C--N 1.305 -1.173 0 CA-C-N 115.403 -0.817 . . . . 61.44 111.69 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.78 -167.8 1.46 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.445 -0.946 . . . . 65.33 108.445 176.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.1 m -71.45 82.8 0.8 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.588 0.709 . . . . 73.2 111.715 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.9 p30 179.87 -27.18 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 126.195 1.798 . . . . 44.33 108.387 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 83.6 m -88.56 87.88 7.42 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 108.907 -0.775 . . . . 64.4 108.907 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 18.2 p -107.06 116.16 31.45 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.125 -0.943 . . . . 64.14 110.006 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 p -92.63 89.62 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 CA-C-O 122.166 0.984 . . . . 74.24 109.766 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.2 tt -118.96 132.03 70.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.097 -0.956 . . . . 63.32 109.173 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.6 tp . . . . . 0 C--N 1.291 -1.952 0 CA-C-O 118.653 -0.689 . . . . 45.35 109.211 -177.939 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.425 -1.721 0 N-CA-C 107.445 -1.317 . . . . 53.12 107.445 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.0 t -149.41 -165.65 2.34 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.563 -1.273 . . . . 71.22 107.563 -176.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -71.56 117.22 12.84 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.705 -0.479 . . . . 74.43 109.705 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 11' ' ' ASN . 21.2 t -80.88 119.72 76.89 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 108.853 -0.795 . . . . 54.32 108.853 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -72.34 153.23 55.94 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.165 1.91 . . . . 54.43 111.664 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.86 71.3 5.31 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 122.379 1.085 . . . . 62.12 109.623 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -167.12 -27.81 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 112.883 -1.962 . . . . 51.21 106.954 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.1 mmm -112.8 153.08 28.38 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.861 -1.063 . . . . 63.23 108.778 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.408 HD11 ' HG ' ' A' ' 73' ' ' LEU . 2.8 pp -113.9 136.74 49.41 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 N-CA-C 109.757 -0.46 . . . . 63.14 109.757 172.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -86.3 107.63 18.05 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.359 -1.349 . . . . 65.34 107.359 -176.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.498 ' HG ' HD22 ' A' ' 14' ' ' LEU . 40.7 tp -119.75 133.6 55.55 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 112.742 0.645 . . . . 74.13 112.742 -173.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.8 ttp-105 -108.58 121.21 44.53 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.492 -0.776 . . . . 73.02 109.027 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.606 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.0 mm? -99.3 121.13 40.65 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 114.701 -1.136 . . . . 73.33 108.365 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.436 HG12 HG22 ' A' ' 21' ' ' THR . 24.1 mt -101.37 123.93 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 C-N-CA 119.126 -1.03 . . . . 64.14 109.459 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.6 mt -81.79 165.07 21.23 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.896 -0.593 . . . . 71.01 110.383 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.9 m -69.27 -14.6 18.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.503 0.668 . . . . 62.12 110.81 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.3 m -78.83 1.51 23.13 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 124.43 1.092 . . . . 44.2 110.482 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.61 20.28 77.1 Favored Glycine 0 CA--C 1.499 -0.96 0 N-CA-C 110.705 -0.958 . . . . 33.52 110.705 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -108.47 134.67 50.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.076 -1.083 . . . . 75.32 108.076 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.436 HG22 HG12 ' A' ' 15' ' ' ILE . 75.9 p -108.33 137.71 45.83 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 120.247 -0.581 . . . . 62.43 111.07 -177.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -124.93 139.23 54.01 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.969 -1.123 . . . . 73.45 107.969 169.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -130.81 130.39 43.6 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.354 -0.98 . . . . 53.32 108.354 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.656 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.0 m-85 -145.18 159.87 42.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.373 -0.603 . . . . 74.35 109.373 -178.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.408 HD22 HG13 ' A' ' 5' ' ' VAL . 74.6 mt -80.42 125.72 30.28 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 107.637 -1.246 . . . . 71.24 107.637 173.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.656 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 84.4 m-85 -128.27 166.02 19.39 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.1 -1.074 . . . . 73.11 108.1 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.4 p -92.47 149.44 38.24 Favored Pre-proline 0 N--CA 1.414 -2.266 0 C-N-CA 118.903 -1.119 . . . . 74.25 108.218 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.501 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 40.2 Cg_endo -62.16 -11.2 20.94 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 122.773 2.316 . . . . 61.44 112.214 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -93.03 -10.05 37.55 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.727 -0.67 . . . . 75.24 111.579 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -73.94 153.65 39.69 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.824 0.345 . . . . 72.12 111.02 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 35' ' ' ILE . 20.4 m -87.24 118.45 26.67 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.348 -0.982 . . . . 74.52 108.348 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.636 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -54.33 -39.52 67.13 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.663 0.785 . . . . 71.43 112.689 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.1 p -73.4 -32.63 64.55 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.223 0.535 . . . . 63.23 111.526 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -66.9 -43.77 82.54 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.964 -1.125 . . . . 73.13 107.964 175.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.587 ' O ' HG22 ' A' ' 39' ' ' VAL . 69.4 mt -60.82 -41.59 89.19 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.946 0 CA-C-N 114.364 -1.289 . . . . 65.54 110.291 177.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 40' ' ' TYR . . . -50.13 -40.08 45.08 Favored 'General case' 0 C--O 1.212 -0.875 0 C-N-CA 122.855 0.462 . . . . 74.12 111.255 176.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.466 ' HB2' ' HG3' ' A' ' 44' ' ' PRO . 53.3 mtpt -73.29 -38.46 65.89 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.255 0.55 . . . . 61.04 110.403 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 6.0 t60 -59.08 -50.35 74.38 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.895 1.278 . . . . 73.55 110.292 177.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.606 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.2 m -76.09 -30.35 20.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 123.413 0.685 . . . . 53.03 112.223 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 47.6 t80 -47.39 -48.51 25.94 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.669 0.787 . . . . 73.41 110.78 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -151.83 -62.34 0.17 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.945 0.402 . . . . 71.4 110.222 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -150.59 167.26 27.8 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 106.544 -1.651 . . . . 75.33 106.544 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.5 t90 -59.61 125.16 79.02 Favored Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 122.61 0.364 . . . . 71.01 110.832 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.466 ' HG3' ' HB2' ' A' ' 37' ' ' LYS . 48.6 Cg_endo -68.54 99.03 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.228 1.952 . . . . 62.1 112.953 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 28.0 ttt -82.37 -42.34 18.8 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.748 -1.204 . . . . 72.22 107.748 176.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -100.28 150.23 22.78 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 105.031 -2.211 . . . . 75.52 105.031 172.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -86.37 -90.49 0.11 Allowed 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.986 -1.086 . . . . 73.23 112.952 -174.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.51 ' HB2' ' HA ' ' A' ' 53' ' ' SER . 5.5 mp0 -133.97 134.87 43.04 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 106.999 -1.482 . . . . 71.31 106.999 175.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.519 ' HB3' ' O ' ' A' ' 95' ' ' PRO . 30.8 tt0 -143.9 27.86 1.45 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.883 0.849 . . . . 73.05 108.754 177.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.93 -48.22 81.39 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 105.955 -1.869 . . . . 74.11 105.955 176.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -138.84 -59.66 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.258 -0.883 . . . . 71.01 109.673 173.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.9 t -147.43 139.36 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.257 -1.016 . . . . 51.04 108.257 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.51 ' HA ' ' HB2' ' A' ' 48' ' ' GLU . 36.9 m -57.06 121.38 9.87 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 109.744 -0.465 . . . . 75.3 109.744 176.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.451 ' O ' HG13 ' A' ' 57' ' ' ILE . 38.2 m -135.89 109.56 10.0 Favored Pre-proline 0 N--CA 1.432 -1.37 0 CA-C-N 116.035 -0.53 . . . . 62.11 110.687 -173.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.79 -15.32 46.92 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.537 2.158 . . . . 72.12 111.528 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -62.98 -13.96 41.65 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 124.26 1.024 . . . . 73.4 112.174 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 54' ' ' SER . 2.1 pp -84.45 -16.17 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-O 121.16 0.505 . . . . 64.43 110.383 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.609 ' O ' ' HD2' ' A' ' 59' ' ' ARG . 96.2 mt -83.52 93.58 7.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.489 -0.778 . . . . 70.13 110.435 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.609 ' HD2' ' O ' ' A' ' 58' ' ' LEU . 4.4 mpt_? -129.88 150.32 51.23 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 123.291 0.636 . . . . 71.44 110.118 176.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.636 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.0 pp -135.34 140.34 44.99 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.805 0.336 . . . . 54.24 111.123 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 95.6 mt -112.66 122.42 66.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 109.03 -0.73 . . . . 71.31 109.03 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -100.96 87.57 3.32 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 107.048 -1.464 . . . . 75.01 107.048 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 69.45 -61.5 0.44 Allowed 'General case' 0 N--CA 1.404 -2.74 0 C-N-CA 127.168 2.187 . . . . 71.23 112.885 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.27 -28.42 1.22 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.177 -1.011 . . . . 73.34 114.591 -177.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.19 161.31 31.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 118.483 1.142 . . . . 74.14 111.992 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.612 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 79.7 m-85 -81.53 117.11 21.66 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.408 -0.96 . . . . 74.23 108.408 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.623 HD12 HD22 ' A' ' 76' ' ' LEU . 47.6 mt -80.16 -47.68 14.34 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.836 1.05 . . . . 71.35 113.836 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.476 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 9.2 t60 178.53 134.16 0.08 Allowed 'General case' 0 C--O 1.21 -0.995 0 N-CA-C 107.534 -1.284 . . . . 63.13 107.534 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.19 1.41 0.09 OUTLIER Glycine 0 CA--C 1.547 2.044 0 N-CA-C 118.335 2.094 . . . . 73.11 118.335 -174.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -162.77 21.04 0.09 Allowed 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 119.115 1.457 . . . . 74.33 109.313 -172.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.483 HG12 HD21 ' A' ' 60' ' ' LEU . 11.0 p -81.38 144.89 9.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 119.939 -0.705 . . . . 64.34 110.161 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.433 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 40.5 p -82.71 162.44 21.79 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 115.903 -0.589 . . . . 63.5 111.545 -177.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.546 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.7 mm? -66.99 -35.82 80.8 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.187 -0.46 . . . . 74.25 111.693 -175.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.53 -33.33 86.16 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.374 -0.917 . . . . 73.45 111.164 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.438 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -74.89 -15.92 60.69 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 123.03 0.532 . . . . 72.44 111.485 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.623 HD22 HD12 ' A' ' 67' ' ' LEU . 42.5 mt -84.87 -3.48 58.7 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.904 -0.776 . . . . 74.31 108.904 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.31 77.77 0.12 Allowed 'General case' 0 C--O 1.244 0.8 0 C-N-CA 125.701 1.601 . . . . 73.22 111.278 -175.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.479 HD22 ' HB3' ' A' ' 73' ' ' LEU . 10.6 mp -126.31 111.05 23.63 Favored Pre-proline 0 CA--C 1.497 -1.093 0 CA-C-N 115.274 -0.876 . . . . 74.51 111.048 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.85 142.37 62.65 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 121.915 1.744 . . . . 70.31 108.631 172.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -65.51 146.46 54.82 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.872 0.368 . . . . 73.25 110.619 -174.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.48 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 82.57 4.22 90.2 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.866 -0.606 . . . . 73.43 113.778 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -106.28 154.32 20.92 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 117.51 0.655 . . . . 54.44 112.409 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.55 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 52.6 m -91.62 121.1 32.98 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 115.534 -0.757 . . . . 75.12 110.315 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.5 m -130.82 135.63 47.92 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.832 -0.622 . . . . 74.34 110.501 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.8 p -108.14 142.2 21.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.98 -0.555 . . . . 73.14 110.851 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 91.2 mtp -135.55 153.29 51.75 Favored 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 123.021 0.528 . . . . 73.25 109.948 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.516 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 64.4 m-70 -105.2 125.49 51.03 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.067 -1.457 . . . . 73.21 107.067 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.79 142.75 46.51 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 120.04 -0.664 . . . . 73.52 110.938 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.62 132.58 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 N-CA-C 108.013 -1.106 . . . . 74.1 108.013 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.39 140.26 46.18 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.563 -0.532 . . . . 75.12 109.563 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -138.08 149.2 45.77 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.875 -1.157 . . . . 74.32 107.875 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 51.27 31.49 7.03 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 123.875 0.734 . . . . 71.22 111.203 175.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.8 m -78.0 16.95 0.65 Allowed 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 124.339 1.055 . . . . 71.41 111.389 -173.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 95' ' ' PRO . 6.2 mp -105.72 134.78 19.55 Favored Pre-proline 0 N--CA 1.42 -1.954 0 CA-C-N 115.937 -0.574 . . . . 54.21 110.254 -178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.519 ' O ' ' HB3' ' A' ' 49' ' ' GLU . 11.8 Cg_exo -73.27 3.35 4.73 Favored 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 123.425 2.75 . . . . 54.23 112.174 177.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.421 ' HG2' ' HD2' ' A' ' 97' ' ' PRO . 0.0 OUTLIER -159.33 137.4 7.47 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 104.982 -2.229 . . . . 64.42 104.982 176.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.421 ' HD2' ' HG2' ' A' ' 96' ' ' GLU . 14.2 Cg_exo -24.27 -56.72 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.906 1 C-N-CA 126.081 4.52 . . . . 73.52 116.041 -176.183 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -155.82 14.56 0.35 Allowed 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.22 -0.592 . . . . 71.23 109.567 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.4 m 65.98 35.68 6.29 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.707 -1.22 . . . . 72.15 107.707 -174.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.435 ' HG3' ' H ' ' A' ' 102' ' ' GLN . 11.9 pt20 -68.32 -29.79 68.62 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 113.836 -1.529 . . . . 73.5 111.202 -178.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.02 -29.73 9.42 Favored Glycine 0 N--CA 1.424 -2.163 0 N-CA-C 110.724 -0.951 . . . . 64.13 110.724 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.435 ' H ' ' HG3' ' A' ' 100' ' ' GLN . 18.3 mp0 -85.81 109.82 18.94 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.785 -0.766 . . . . 75.1 109.129 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -176.13 103.31 0.07 Allowed 'General case' 0 C--N 1.308 -1.218 0 O-C-N 124.102 0.876 . . . . 74.25 110.288 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -96.72 135.02 39.24 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.804 -1.184 . . . . 75.4 107.804 172.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -58.14 -49.97 75.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.484 -1.302 . . . . 73.33 107.484 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.558 ' HB2' ' HA3' ' A' ' 109' ' ' GLY . 45.0 mt-10 -156.85 167.33 30.78 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 105.451 -2.055 . . . . 73.12 105.451 173.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -68.07 100.3 0.98 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.316 0.579 . . . . 73.23 109.715 176.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.8 m 63.59 34.43 12.47 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 122.266 1.031 . . . . 73.11 108.22 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.558 ' HA3' ' HB2' ' A' ' 106' ' ' GLU . . . -124.03 22.71 6.7 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 119.071 -1.538 . . . . 73.1 115.779 -174.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.74 87.17 7.15 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 118.225 -1.39 . . . . 74.3 109.789 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 73.9 m 69.48 92.74 0.08 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 113.678 -1.601 . . . . 73.21 110.953 -172.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -78.65 -33.59 47.06 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.09 -0.959 . . . . 42.2 109.264 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.4 m 63.45 84.07 0.15 Allowed 'General case' 0 C--O 1.243 0.715 0 N-CA-C 107.799 -1.186 . . . . 74.41 107.799 -172.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 60.1 m -78.01 114.11 16.57 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 114.22 -1.354 . . . . 70.3 111.887 -172.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -90.81 83.73 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-O 122.458 1.123 . . . . 71.52 110.032 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.6 tp -101.53 109.97 27.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.569 -1.196 . . . . 73.14 109.246 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.2 tp . . . . . 0 C--N 1.298 -1.637 0 N-CA-C 109.004 -0.739 . . . . 63.03 109.004 -177.094 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.7 p . . . . . 0 N--CA 1.44 -0.937 0 N-CA-C 108.767 -0.827 . . . . 73.33 108.767 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.0 t -101.08 0.7 38.4 Favored 'General case' 0 N--CA 1.421 -1.883 0 C-N-CA 120.952 -0.299 . . . . 45.31 111.725 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.473 HD22 HG23 ' A' ' 5' ' ' VAL . 7.7 t30 -155.54 -70.06 0.12 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 119.877 -0.729 . . . . 71.13 112.204 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.473 HG23 HD22 ' A' ' 4' ' ' ASN . 17.4 t -97.06 115.39 65.72 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 107.759 -1.2 . . . . 61.23 107.759 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.18 19.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.534 3.489 . . . . 73.03 118.374 -170.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 63.41 -32.41 0.11 Allowed 'General case' 0 C--O 1.194 -1.855 0 C-N-CA 125.187 1.395 . . . . 73.34 114.607 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -86.89 -10.03 54.31 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.94 0.876 . . . . 72.45 110.089 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.1 mmm -124.52 153.47 42.02 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.382 -0.827 . . . . 73.44 109.22 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.511 HG22 ' HA ' ' A' ' 80' ' ' PHE . 2.8 pp -100.04 139.13 22.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 107.979 -1.119 . . . . 55.03 107.979 173.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -98.9 121.96 41.52 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.18 -1.044 . . . . 73.44 108.18 -175.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.56 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.1 tp -126.68 133.66 50.89 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 112.458 0.54 . . . . 62.34 112.458 -175.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -108.18 121.47 44.92 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.697 -0.683 . . . . 74.34 109.558 171.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.568 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.3 mm? -95.92 127.22 41.75 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 124.854 1.262 . . . . 64.23 108.685 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.601 HD12 HG22 ' A' ' 21' ' ' THR . 17.8 mm -99.72 120.25 48.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.568 -0.901 . . . . 72.45 108.568 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.2 mp -78.45 153.52 31.38 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.059 -0.719 . . . . 61.0 109.059 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.4 m -69.72 -13.64 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.579 0.704 . . . . 73.03 111.128 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.7 m -76.42 -9.78 58.9 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.392 -0.822 . . . . 75.42 109.792 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.56 7.19 61.94 Favored Glycine 0 CA--C 1.498 -0.997 0 CA-C-N 116.105 -0.498 . . . . 74.33 112.744 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -87.61 131.58 34.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.49 -0.929 . . . . 75.32 108.49 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.601 HG22 HD12 ' A' ' 15' ' ' ILE . 29.1 p -104.83 129.09 53.2 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.157 -1.423 . . . . 51.25 107.157 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -131.42 138.71 49.2 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.534 -0.913 . . . . 73.31 108.534 -175.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.463 ' CD ' HD21 ' A' ' 11' ' ' ASN . 1.0 OUTLIER -132.38 131.33 41.74 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.185 0.439 . . . . 72.25 112.185 -170.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.632 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 94.2 m-85 -144.61 160.24 41.48 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 115.276 -0.875 . . . . 74.11 110.513 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.7 mt -80.75 126.04 30.81 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.85 -1.167 . . . . 64.22 107.85 173.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.632 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 80.0 m-85 -128.35 165.09 21.25 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.876 -0.416 . . . . 63.42 109.876 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.5 m -92.51 142.92 26.45 Favored Pre-proline 0 N--CA 1.414 -2.259 0 N-CA-C 107.431 -1.322 . . . . 60.23 107.431 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.0 -11.34 21.11 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.751 2.301 . . . . 55.33 113.087 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -83.0 -17.49 43.2 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.055 0.942 . . . . 64.33 110.879 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.79 154.34 42.11 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.806 0.669 . . . . 55.45 112.806 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.522 ' O ' HG13 ' A' ' 35' ' ' ILE . 18.3 m -96.16 122.82 39.42 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.339 -0.846 . . . . 73.31 109.638 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.75 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -50.16 -51.8 40.62 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.834 1.049 . . . . 63.55 113.834 -176.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -69.58 -28.1 65.68 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.267 0.556 . . . . 60.04 110.831 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.44 -46.58 72.69 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.264 -1.013 . . . . 73.51 108.264 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 31' ' ' SER . 69.5 mt -59.89 -43.49 92.23 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.342 0 CA-C-N 114.543 -1.208 . . . . 71.45 110.29 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.41 -48.63 56.05 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.89 0.876 . . . . 74.23 111.799 178.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -72.41 -32.16 66.11 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.68 -0.859 . . . . 73.51 108.68 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -69.74 -51.23 35.98 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.625 0.77 . . . . 75.03 110.7 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.568 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.2 m -62.42 -32.07 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 C-N-CA 123.103 0.561 . . . . 54.13 112.355 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -56.31 -49.91 72.94 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.662 0.601 . . . . 75.53 110.045 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.0 t70 169.44 -76.22 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.298 1.039 . . . . 71.22 110.803 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -79.89 114.61 18.94 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.684 -0.689 . . . . 75.41 110.268 -176.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -59.98 141.22 90.02 Favored Pre-proline 0 C--O 1.241 0.62 0 O-C-N 123.48 0.488 . . . . 74.41 111.808 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HA ' ' OE1' ' A' ' 49' ' ' GLU . 23.9 Cg_endo -65.2 137.62 52.67 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.707 2.272 . . . . 60.12 113.131 -177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 50.9 ttp 87.11 9.77 0.17 Allowed 'General case' 0 C--O 1.245 0.817 0 C-N-CA 126.431 1.893 . . . . 70.43 111.691 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 47' ' ' TRP . 25.8 t70 -73.46 -87.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.917 -0.771 . . . . 75.42 108.917 173.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.401 ' HB2' ' O ' ' A' ' 46' ' ' ASP . 11.5 t90 173.23 170.83 0.14 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 106.457 -1.683 . . . . 73.34 106.457 175.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 59.13 24.19 12.52 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.372 0.606 . . . . 72.24 111.419 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.566 ' OE1' ' HA ' ' A' ' 44' ' ' PRO . 40.2 mt-10 -73.22 -23.59 60.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.521 -0.918 . . . . 74.2 108.521 177.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . 0.305 0.0 OUTLIER -175.9 -55.97 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 129.097 2.959 . . . . 73.43 105.881 169.206 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.515 ' HB2' ' OG ' ' A' ' 99' ' ' SER . 0.4 OUTLIER -149.99 -54.5 0.16 Allowed 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 102.868 -3.012 . . . . 72.1 102.868 167.119 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 58.2 t -119.61 -76.55 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 114.089 -1.414 . . . . 74.54 107.331 173.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.7 m 171.11 174.57 0.07 Allowed 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 127.598 2.359 . . . . 74.43 107.714 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.595 ' O ' HG13 ' A' ' 57' ' ' ILE . 17.2 m -121.9 136.31 26.08 Favored Pre-proline 0 C--N 1.294 -1.806 0 N-CA-C 107.656 -1.239 . . . . 60.1 107.656 176.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -75.72 -37.7 1.59 Allowed 'Trans proline' 0 CA--C 1.541 0.873 0 N-CA-C 115.524 1.317 . . . . 71.11 115.524 -177.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -79.44 -0.75 34.28 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.866 0.691 . . . . 72.32 112.866 -174.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 54' ' ' SER . 1.8 pp -93.69 -16.68 7.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-O 121.157 0.503 . . . . 63.31 110.114 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.3 tp -81.25 91.61 6.22 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.867 -0.79 . . . . 75.12 108.867 -176.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -141.57 163.3 33.31 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.142 0.496 . . . . 53.44 111.171 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.75 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.5 pp -141.08 150.69 43.23 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.554 -0.748 . . . . 61.22 110.265 -176.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.0 mt -122.82 126.78 74.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 108.891 -0.781 . . . . 51.15 108.891 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -100.16 72.22 1.64 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.483 -1.303 . . . . 75.42 107.483 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 65.06 -56.58 0.29 Allowed 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 128.109 2.564 . . . . 61.43 112.672 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.39 -62.17 1.35 Allowed Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 121.59 -0.338 . . . . 62.42 113.225 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.522 ' HD3' ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -131.03 175.96 8.64 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 117.369 0.585 . . . . 71.53 111.873 -175.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 56.0 m-85 -80.21 118.86 22.27 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.976 -1.12 . . . . 73.41 107.976 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.0 mt -79.72 -47.2 15.71 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.482 -0.887 . . . . 74.12 111.926 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.527 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 12.3 t60 -169.08 168.19 10.15 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 105.278 -2.119 . . . . 72.21 105.278 -174.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.88 -1.77 87.69 Favored Glycine 0 C--N 1.298 -1.547 0 C-N-CA 120.276 -0.964 . . . . 32.13 113.318 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' A' ' 31' ' ' SER . 48.8 t-20 -177.84 73.62 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.449 0.642 . . . . 74.32 109.775 -174.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.656 HG12 HD21 ' A' ' 60' ' ' LEU . 14.5 p -104.51 151.76 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 N-CA-C 108.726 -0.842 . . . . 64.43 108.726 175.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.46 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 64.2 p -87.18 162.6 17.4 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 118.124 0.42 . . . . 74.43 110.682 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.558 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.5 mm? -68.59 -34.8 76.41 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.783 0.325 . . . . 70.33 111.055 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.9 -34.22 89.26 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.717 -0.754 . . . . 65.3 111.26 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -72.8 -15.52 61.63 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.014 0.525 . . . . 60.51 111.571 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 72' ' ' THR . 70.9 mt -82.31 -1.66 50.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 75.42 109.93 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 77' ' ' LYS . 9.8 mptt 65.19 72.17 0.43 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 108.936 -0.764 . . . . 71.01 108.936 -175.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.427 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 94.5 mt -131.32 123.34 19.55 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-N 115.567 -0.742 . . . . 74.11 110.508 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 4.5 Cg_exo -80.07 143.65 16.22 Favored 'Trans proline' 0 N--CA 1.429 -2.269 0 C-N-CA 122.041 1.827 . . . . 72.23 110.326 173.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.511 ' HA ' HG22 ' A' ' 10' ' ' ILE . 1.6 p90 -75.36 148.38 39.29 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 115.033 -0.985 . . . . 74.41 110.227 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.59 2.73 67.24 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.174 -1.012 . . . . 62.33 110.912 -174.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -120.93 157.97 28.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 122.1 0.16 . . . . 61.24 110.645 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.519 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 26.2 m -105.69 127.32 53.0 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.147 0.498 . . . . 74.34 110.574 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.2 m -125.67 142.93 51.26 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.807 -0.633 . . . . 75.32 110.196 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.66 138.19 42.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 120.826 0.346 . . . . 65.32 110.203 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.568 ' O ' HG12 ' A' ' 15' ' ' ILE . 90.1 mtp -135.1 152.2 51.43 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.948 -0.39 . . . . 72.44 109.948 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.456 ' C ' HD22 ' A' ' 88' ' ' LEU . 50.4 m-70 -104.07 134.14 47.83 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 109.045 -0.724 . . . . 71.15 109.045 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.533 ' HG ' ' HB2' ' A' ' 36' ' ' ALA . 2.4 mm? -123.02 144.09 49.5 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 120.482 -0.487 . . . . 74.54 109.798 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.63 134.05 62.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 116.011 -0.54 . . . . 71.25 109.948 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.14 145.96 49.78 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.815 -0.63 . . . . 73.32 109.361 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.408 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 69.2 mtp180 -145.6 146.83 31.52 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 106.626 -1.62 . . . . 75.14 106.626 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 56.81 35.35 26.14 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 124.214 0.946 . . . . 60.25 109.383 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.2 t -95.41 2.36 54.52 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 114.85 -1.068 . . . . 64.12 111.059 -176.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.1 mp -102.22 144.04 27.8 Favored Pre-proline 0 CA--C 1.513 -0.452 0 CA-C-N 116.236 -0.438 . . . . 74.23 110.465 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.81 135.86 39.76 Favored 'Trans proline' 0 C--O 1.246 0.88 0 C-N-CA 122.81 2.34 . . . . 65.13 113.363 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -111.68 152.07 43.83 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.165 -1.05 . . . . 63.13 108.165 170.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -41.97 -60.24 0.73 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.768 2.979 . . . . 65.42 112.687 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -142.91 13.95 1.89 Allowed 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.512 -1.292 . . . . 63.32 107.512 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.515 ' OG ' ' HB2' ' A' ' 51' ' ' GLN . 69.6 m 63.11 80.64 0.23 Allowed 'General case' 0 C--O 1.247 0.948 0 CA-C-N 114.326 -1.306 . . . . 72.24 113.207 -174.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -85.91 -40.28 16.07 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.706 -1.134 . . . . 73.23 110.255 174.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.23 0.52 10.58 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.592 -0.276 . . . . 73.54 113.443 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -131.93 111.86 11.92 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.714 -0.847 . . . . 63.01 108.714 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -80.89 -39.11 26.88 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.481 -0.781 . . . . 71.22 111.367 -176.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -89.73 172.84 8.63 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.913 -0.585 . . . . 70.4 110.518 -174.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.586 ' HB3' ' OE2' ' A' ' 110' ' ' GLU . 60.5 ttt180 -54.68 -51.84 64.23 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 109.52 -0.548 . . . . 55.32 109.52 176.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -139.52 -79.49 0.31 Allowed 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.514 -0.766 . . . . 73.02 111.742 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -177.12 177.67 1.21 Allowed 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 106.779 -1.563 . . . . 72.43 106.779 -169.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.2 p -56.08 115.73 2.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.032 0.444 . . . . 65.14 111.614 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 129.71 -41.18 1.58 Allowed Glycine 0 C--N 1.302 -1.348 0 N-CA-C 108.703 -1.759 . . . . 74.14 108.703 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.586 ' OE2' ' HB3' ' A' ' 105' ' ' ARG . 3.4 tp10 57.38 93.29 0.03 OUTLIER 'General case' 0 C--O 1.242 0.685 0 C-N-CA 126.366 1.866 . . . . 62.22 112.325 176.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.7 m -163.47 -158.48 0.47 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.337 -0.986 . . . . 54.53 108.337 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -121.3 87.13 2.7 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.915 -1.143 . . . . 74.34 107.915 172.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 60.0 m -90.61 89.2 7.43 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 115.126 -0.943 . . . . 74.12 110.985 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 50.5 t -127.64 98.2 5.12 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.404 -1.702 . . . . 74.11 106.404 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 29.9 m -76.35 99.17 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.973 0.892 . . . . 75.1 113.18 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.6 tt -106.38 89.05 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.057 -0.974 . . . . 75.35 108.612 175.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--N 1.297 -1.709 0 CA-C-N 115.087 -0.961 . . . . 64.12 109.945 -175.573 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.2 t . . . . . 0 N--CA 1.432 -1.34 0 N-CA-C 108.63 -0.878 . . . . 73.24 108.63 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.9 p -98.44 -5.68 31.99 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.724 0.773 . . . . 74.24 111.1 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.462 HD22 ' HA ' ' A' ' 117' ' ' LEU . 48.1 t30 -131.35 153.96 49.09 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.839 -1.171 . . . . 55.45 107.839 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.476 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 38.3 t -80.87 123.19 82.44 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 109.051 -0.722 . . . . 63.5 109.051 -178.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.22 166.67 8.77 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.682 2.254 . . . . 75.12 112.52 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.61 7.78 39.86 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.697 -0.683 . . . . 75.32 110.358 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -123.09 -0.22 8.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.033 -0.53 . . . . 75.35 110.184 175.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.1 mmm -130.74 155.77 46.09 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.964 -0.754 . . . . 64.15 108.964 -178.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.43 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.9 pp -122.73 134.11 66.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.002 -0.74 . . . . 71.42 109.002 174.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.539 HD22 HG23 ' A' ' 83' ' ' THR . 6.4 t30 -90.83 109.87 21.08 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.536 -0.913 . . . . 74.32 108.536 -175.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.547 ' HG ' HD22 ' A' ' 14' ' ' LEU . 45.0 tp -113.4 135.56 53.73 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 112.563 0.579 . . . . 75.51 112.563 -172.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 33.5 ttp180 -106.22 120.26 41.37 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 108.684 -0.858 . . . . 60.04 108.684 172.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.547 HD22 ' HG ' ' A' ' 12' ' ' LEU . 2.7 mm? -93.19 127.36 38.73 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.123 -1.399 . . . . 63.45 109.392 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.587 HG12 HG22 ' A' ' 21' ' ' THR . 22.6 mt -101.33 119.95 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 C-N-CA 118.937 -1.105 . . . . 53.05 109.369 176.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.5 tp -78.38 159.63 28.24 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.499 -0.773 . . . . 75.31 110.689 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.7 m -61.83 -13.76 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.913 0.885 . . . . 73.24 113.156 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.3 t -82.28 -10.03 59.26 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.566 -0.531 . . . . 63.21 109.566 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.23 11.44 62.89 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.069 -0.813 . . . . 73.12 111.069 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.67 148.99 26.78 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.093 -0.706 . . . . 63.32 109.093 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.587 HG22 HG12 ' A' ' 15' ' ' ILE . 69.5 p -112.33 152.55 28.42 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.084 0.468 . . . . 71.22 112.244 -174.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.417 ' CG ' ' HD2' ' A' ' 103' ' ' ARG . 8.1 mmtp -146.22 139.7 26.02 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.445 -0.798 . . . . 72.04 110.575 169.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 27.4 tt0 -122.18 132.31 54.39 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.809 -0.632 . . . . 74.22 109.939 -173.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.718 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 89.7 m-85 -144.26 158.83 43.52 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.859 -0.793 . . . . 74.15 108.859 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 111' ' ' SER . 39.8 tp -85.62 125.39 33.1 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.043 -1.095 . . . . 74.31 108.043 176.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 89.9 m-85 -130.31 172.87 11.37 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.474 -0.565 . . . . 53.23 109.474 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.7 p -95.52 150.52 37.61 Favored Pre-proline 0 N--CA 1.409 -2.514 0 N-CA-C 107.099 -1.445 . . . . 53.5 107.099 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.678 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 57.9 Cg_endo -64.61 -11.51 29.17 Favored 'Trans proline' 0 C--N 1.321 -0.868 0 C-N-CA 122.297 1.998 . . . . 72.45 111.423 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -91.58 -6.0 53.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.387 -0.824 . . . . 64.05 111.83 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.428 ' HB2' HD11 ' A' ' 35' ' ' ILE . 26.9 m-20 -75.77 151.48 37.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 120.628 -0.429 . . . . 74.41 110.504 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.598 ' O ' HG13 ' A' ' 35' ' ' ILE . 54.0 m -87.07 119.98 27.87 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 110.001 -0.37 . . . . 62.23 110.001 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.484 ' CB ' HD13 ' A' ' 60' ' ' LEU . . . -45.01 -56.18 4.87 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.723 1.379 . . . . 33.02 114.723 -176.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.403 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . 28.2 m -75.65 -21.71 57.42 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.215 -0.594 . . . . 54.3 111.957 -176.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.09 -40.2 78.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.032 -1.47 . . . . 74.5 107.032 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.598 HG13 ' O ' ' A' ' 31' ' ' SER . 70.0 mt -63.74 -42.42 95.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 CA-C-N 114.401 -1.272 . . . . 75.1 109.986 176.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.61 -36.76 56.94 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.058 0.543 . . . . 73.42 111.771 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.573 ' HB2' ' HG3' ' A' ' 44' ' ' PRO . 73.3 mmtt -72.62 -37.06 68.17 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.065 0.46 . . . . 75.12 110.068 176.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.633 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 28.3 t60 -70.08 -48.26 58.45 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.619 -0.719 . . . . 74.24 111.802 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.456 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.6 m -63.26 -31.07 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.021 0.439 . . . . 73.52 111.431 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 70.2 t80 -61.34 -50.85 71.28 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.182 -0.917 . . . . 73.33 111.761 175.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 40' ' ' TYR . 12.8 t70 169.34 122.73 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.191 -0.67 . . . . 73.43 109.191 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.633 ' O ' ' HA ' ' A' ' 38' ' ' HIS . 53.7 t30 70.1 174.3 0.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 123.818 0.698 . . . . 74.45 110.085 177.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 32.4 p-90 -106.52 130.92 22.19 Favored Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 108.812 -0.81 . . . . 65.34 108.812 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HG3' ' HB2' ' A' ' 37' ' ' LYS . 55.6 Cg_endo -69.24 94.45 0.49 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 121.85 1.7 . . . . 73.42 113.059 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.4 ttt -81.98 -31.14 31.27 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.274 -1.38 . . . . 73.4 107.274 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -155.77 -65.67 0.12 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.708 -1.96 . . . . 50.31 105.708 175.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.6 t90 59.95 5.78 0.81 Allowed 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 126.685 1.994 . . . . 74.3 114.308 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 68.36 119.02 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 124.204 1.002 . . . . 73.11 109.718 177.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -91.19 75.13 6.2 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.751 -0.593 . . . . 62.43 112.44 -175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 93' ' ' THR 0.265 0.4 OUTLIER 41.59 69.18 0.37 Allowed 'General case' 0 C--O 1.255 1.367 0 N-CA-C 114.92 1.452 . . . . 75.15 114.92 179.3 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 61.19 20.8 11.31 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.408 1.483 . . . . 71.24 111.233 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.7 t 62.43 10.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.224 1.41 . . . . 73.43 110.123 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.0 t -98.96 -30.5 12.32 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 115.683 -0.69 . . . . 62.15 110.4 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.1 m -125.14 84.08 59.82 Favored Pre-proline 0 N--CA 1.439 -1.016 0 N-CA-C 112.705 0.632 . . . . 74.45 112.705 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -98.05 -18.69 0.18 Allowed 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 122.706 2.27 . . . . 65.33 112.521 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -83.44 -0.32 49.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.135 0.574 . . . . 62.43 111.259 -175.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.435 ' CG2' ' HB3' ' A' ' 91' ' ' ARG . 2.1 pp -77.46 -3.25 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-N 115.657 -0.702 . . . . 73.51 112.708 -176.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.436 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 97.0 mt -81.29 111.8 18.01 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.199 -1.037 . . . . 33.52 108.199 176.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 68' ' ' HIS . 18.2 tpt180 -146.85 141.62 26.8 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.096 -0.705 . . . . 73.43 109.096 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.484 HD13 ' CB ' ' A' ' 32' ' ' ALA . 1.2 pt? -112.81 140.93 47.18 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 121.064 -0.254 . . . . 71.21 111.201 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 61.9 mt -111.64 117.38 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.926 -0.768 . . . . 75.24 108.926 176.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.547 ' CB ' HD21 ' A' ' 67' ' ' LEU . 33.4 t80 -105.35 76.08 1.2 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.842 -0.743 . . . . 73.24 109.002 174.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 63' ' ' GLN 0.331 15.0 mm100 36.2 83.69 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 116.222 1.934 . . . . 62.31 116.222 178.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.89 -63.3 0.62 Allowed Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 114.879 -1.055 . . . . 70.42 110.908 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -130.81 156.4 45.06 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.047 -0.661 . . . . 75.11 112.077 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.426 ' HB3' ' HE ' ' A' ' 59' ' ' ARG . 1.6 m-85 -87.48 114.08 23.77 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 104.648 -2.353 . . . . 63.21 104.648 175.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.547 HD21 ' CB ' ' A' ' 62' ' ' TYR . 1.4 mm? -72.3 -50.31 27.96 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 119.603 -0.839 . . . . 72.53 112.198 -168.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.641 ' HB2' HG23 ' A' ' 71' ' ' VAL . 19.6 m80 179.73 -161.31 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 126.65 1.98 . . . . 74.21 106.262 -176.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.454 ' H ' ' HB3' ' A' ' 68' ' ' HIS . . . -84.51 -46.3 5.83 Favored Glycine 0 C--O 1.208 -1.476 0 N-CA-C 115.46 0.944 . . . . 73.1 115.46 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -134.64 34.58 3.19 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.392 1.096 . . . . 71.51 113.231 -172.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.641 HG23 ' HB2' ' A' ' 68' ' ' HIS . 74.0 t -62.03 137.65 23.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 109.533 -0.543 . . . . 75.55 109.533 176.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.598 ' HB ' ' O ' ' A' ' 28' ' ' PRO . 29.0 p -78.52 156.81 29.07 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.848 -0.615 . . . . 72.34 110.805 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.567 ' H ' HD22 ' A' ' 73' ' ' LEU . 2.2 mm? -64.86 -35.44 81.12 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.594 -0.73 . . . . 72.21 110.133 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.57 -36.54 93.36 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.907 -0.588 . . . . 65.3 111.864 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.41 -16.62 63.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.986 0.422 . . . . 61.44 110.939 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 73' ' ' LEU . 75.4 mt -83.79 12.43 6.02 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.765 0.826 . . . . 53.11 111.046 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.74 19.65 9.63 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.204 1.002 . . . . 73.12 110.491 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.514 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 94.0 mt -80.7 116.98 65.81 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.191 -0.459 . . . . 72.13 111.224 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.404 ' HD2' ' HE2' ' A' ' 82' ' ' LYS . 74.4 Cg_endo -77.58 161.27 31.21 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 C-N-CA 122.071 1.847 . . . . 61.44 110.829 175.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.678 ' CE2' ' HG3' ' A' ' 28' ' ' PRO . 71.7 m-85 -79.36 163.53 24.78 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.685 -0.857 . . . . 64.11 108.685 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 83.52 0.14 89.85 Favored Glycine 0 C--N 1.301 -1.371 0 C-N-CA 120.624 -0.798 . . . . 74.21 114.784 175.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.404 ' HE2' ' HD2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -124.95 157.68 35.47 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 118.971 -1.092 . . . . 74.25 112.688 -179.285 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.539 HG23 HD22 ' A' ' 11' ' ' ASN . 24.6 m -90.02 120.92 31.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.564 -0.744 . . . . 71.44 110.247 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.0 m -113.42 135.17 54.17 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.605 -0.271 . . . . 52.43 110.977 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.15 126.88 70.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 N-CA-C 109.676 -0.49 . . . . 74.21 109.676 175.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.419 ' O ' HG13 ' A' ' 15' ' ' ILE . 85.4 mtp -136.39 153.46 51.1 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-O 121.198 0.523 . . . . 75.44 112.098 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 40.9 m-70 -102.24 137.15 40.87 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.458 -0.792 . . . . 74.23 109.936 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.416 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.6 mm? -120.53 141.42 50.27 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.958 -0.756 . . . . 63.55 108.958 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 59' ' ' ARG . 30.2 m -125.36 136.08 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-O 121.731 0.777 . . . . 72.34 111.05 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.93 146.97 51.0 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 106.343 -1.725 . . . . 75.23 106.343 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.435 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 79.2 ttt180 -134.59 132.65 39.31 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.183 -1.043 . . . . 73.24 108.183 -168.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 66.24 13.65 9.27 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.932 0.872 . . . . 71.11 109.904 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.453 ' HA ' ' CG ' ' A' ' 50' ' ' GLU . 4.9 t -88.24 177.94 6.74 Favored 'General case' 0 N--CA 1.401 -2.898 0 CA-C-N 115.023 -0.99 . . . . 64.24 108.822 -176.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mp -74.87 140.25 74.13 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 110.071 -0.344 . . . . 70.04 110.071 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -79.06 -178.93 5.01 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.172 1.914 . . . . 54.13 109.509 175.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.509 ' OE2' ' HA ' ' A' ' 99' ' ' SER . 0.3 OUTLIER -69.61 122.67 86.51 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 107.636 -1.246 . . . . 72.4 107.636 179.075 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -9.79 -67.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.379 2.154 1 C-N-CA 127.408 5.405 . . . . 73.44 117.075 -167.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -156.98 26.39 0.31 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.225 -1.768 . . . . 73.34 106.225 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.509 ' HA ' ' OE2' ' A' ' 96' ' ' GLU . 71.3 m 63.58 51.06 2.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.402 -1.272 . . . . 63.22 108.324 -170.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.413 HE21 ' HB3' ' A' ' 102' ' ' GLN . 29.7 tt0 -87.79 -23.13 24.16 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 113.053 -1.885 . . . . 32.04 109.039 -176.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.08 -24.16 5.55 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.351 -0.841 . . . . 73.42 112.228 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.413 ' HB3' HE21 ' A' ' 100' ' ' GLN . 62.6 tt0 -81.44 111.92 18.23 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-O 121.088 0.47 . . . . 64.55 110.77 -177.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.417 ' HD2' ' CG ' ' A' ' 22' ' ' LYS . 4.1 ptp180 -120.82 114.77 22.09 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 106.19 -1.781 . . . . 75.31 106.19 175.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . 0.296 53.2 m-80 -75.21 116.12 15.59 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 117.68 2.474 . . . . 73.43 117.68 -167.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.543 ' HE ' ' HB2' ' A' ' 110' ' ' GLU . 29.7 ttt180 -66.59 -30.48 70.77 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 112.653 -2.067 . . . . 72.02 109.783 171.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 70.14 104.44 0.06 Allowed 'General case' 0 C--O 1.212 -0.915 0 O-C-N 124.656 1.222 . . . . 74.13 110.431 -177.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.83 -18.04 64.1 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.562 -0.745 . . . . 62.2 112.805 -175.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.3 p -93.58 1.35 56.72 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.006 -0.678 . . . . 50.51 111.645 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -155.06 43.7 0.56 Allowed Glycine 0 C--O 1.24 0.517 0 N-CA-C 110.15 -1.18 . . . . 72.42 110.15 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.543 ' HB2' ' HE ' ' A' ' 105' ' ' ARG . 9.7 pt-20 -87.35 171.44 10.59 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.825 1.046 . . . . 63.21 113.825 -174.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 25' ' ' LEU . 45.4 m -106.0 111.48 24.13 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.564 -1.198 . . . . 64.03 108.175 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.407 ' HB2' ' NH2' ' A' ' 105' ' ' ARG . 47.4 t30 -172.86 176.83 2.99 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.801 -0.814 . . . . 74.01 108.801 -174.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.0 m 66.91 -156.14 0.23 Allowed 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.658 0.783 . . . . 64.32 109.775 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 85.8 m 66.66 41.49 2.99 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.986 -0.746 . . . . 51.34 108.986 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.6 t -69.75 96.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.06 -0.973 . . . . 63.24 112.06 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.4 tp -144.64 103.45 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.225 -1.028 . . . . 65.13 108.225 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.609 ' H ' HD23 ' A' ' 117' ' ' LEU . 1.2 pt? . . . . . 0 N--CA 1.422 -1.835 0 CA-C-N 115.196 -0.911 . . . . 42.04 111.491 -174.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.443 -0.784 0 N-CA-C 109.839 -0.43 . . . . 74.44 109.839 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.9 t -125.17 5.71 7.84 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.654 -0.869 . . . . 75.33 108.654 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -151.39 155.05 37.84 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.213 -1.403 . . . . 72.41 107.213 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.537 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 17.0 t -99.95 115.26 65.7 Favored Pre-proline 0 C--N 1.313 -0.996 0 N-CA-C 109.713 -0.477 . . . . 74.53 109.713 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.65 170.92 16.4 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.387 2.058 . . . . 62.03 111.616 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HA ' ' HB2' ' A' ' 80' ' ' PHE . . . -79.14 14.56 1.41 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.341 0.591 . . . . 53.45 111.484 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -108.32 -11.37 15.22 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.486 -0.561 . . . . 73.15 109.486 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.4 mmm -130.9 158.03 41.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.024 -0.535 . . . . 74.42 110.328 -174.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.448 ' CD1' ' HG ' ' A' ' 73' ' ' LEU . 2.8 pp -119.01 140.88 41.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.586 -0.524 . . . . 74.24 109.586 174.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.528 HD22 HG23 ' A' ' 83' ' ' THR . 7.3 t30 -94.83 115.73 27.85 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.424 -0.954 . . . . 73.51 108.424 -176.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.537 ' HG ' HD22 ' A' ' 14' ' ' LEU . 42.3 tp -117.77 133.88 55.49 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.646 0.736 . . . . 54.23 112.57 -173.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.509 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . 21.8 ttt85 -106.61 120.52 42.18 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 108.14 -1.059 . . . . 63.21 108.14 176.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.537 HD22 ' HG ' ' A' ' 12' ' ' LEU . 2.0 mm? -100.67 127.48 47.06 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.875 -1.057 . . . . 64.24 109.635 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.491 HD12 HG22 ' A' ' 21' ' ' THR . 21.3 mm -99.28 116.53 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 106.917 -1.512 . . . . 62.2 106.917 175.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.8 mp -74.77 158.38 33.6 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.348 -0.387 . . . . 71.54 110.619 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.494 HG21 ' H ' ' A' ' 90' ' ' ALA . 90.2 t -66.01 -23.32 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 121.602 0.715 . . . . 75.21 110.2 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.2 m -75.56 -3.87 36.71 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.12 -0.945 . . . . 61.14 110.127 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.15 8.8 84.97 Favored Glycine 0 CA--C 1.495 -1.189 0 N-CA-C 111.579 -0.609 . . . . 53.21 111.579 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -87.19 131.44 34.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.558 -1.275 . . . . 74.41 107.558 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.491 HG22 HD12 ' A' ' 15' ' ' ILE . 64.5 p -107.76 129.28 55.06 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 109.905 -0.406 . . . . 55.53 109.905 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -148.47 149.92 32.53 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.183 -0.607 . . . . 72.2 110.344 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.476 ' OE1' ' HD2' ' A' ' 13' ' ' ARG . 29.7 tt0 -130.45 132.74 45.85 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.893 -0.14 . . . . 74.53 110.97 -170.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.525 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 35.0 m-85 -143.23 160.57 40.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.624 0.726 . . . . 73.21 112.107 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.478 HD11 HG13 ' A' ' 5' ' ' VAL . 37.3 tp -85.66 126.07 33.65 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.15 -0.932 . . . . 63.01 109.325 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.525 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 97.5 m-85 -133.42 171.12 14.5 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.672 -0.492 . . . . 73.41 109.672 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.3 p -94.99 150.65 38.05 Favored Pre-proline 0 N--CA 1.419 -2.001 0 C-N-CA 119.054 -1.058 . . . . 63.24 108.206 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 42.2 Cg_endo -62.85 -11.39 24.03 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.43 2.087 . . . . 74.22 111.784 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -79.68 -21.35 44.81 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.199 1.0 . . . . 73.3 109.777 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -75.77 152.27 37.4 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 116.321 -0.4 . . . . 70.23 110.429 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.522 ' O ' HG13 ' A' ' 35' ' ' ILE . 77.1 p -106.16 138.29 42.6 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 109.972 -0.381 . . . . 62.54 109.972 178.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.723 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -50.95 -49.62 59.53 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.864 1.061 . . . . 61.12 113.864 -175.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.0 m -64.52 -31.63 72.93 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 120.949 0.404 . . . . 52.22 110.891 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.553 ' O ' ' HG3' ' A' ' 44' ' ' PRO . 20.6 t70 -70.12 -45.47 66.82 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.869 -0.789 . . . . 72.31 108.869 175.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 31' ' ' SER . 60.9 mt -60.78 -33.64 56.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.155 -0.93 . . . . 72.31 112.281 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.71 -40.43 40.49 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 110.491 -0.188 . . . . 72.42 110.491 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -64.11 -44.68 91.52 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.343 0.592 . . . . 72.05 109.838 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -62.57 -43.42 98.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.053 -1.43 . . . . 61.14 110.118 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.502 HG11 HD23 ' A' ' 14' ' ' LEU . 36.0 m -74.9 -32.17 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 113.76 1.022 . . . . 64.13 113.76 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.426 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 39.0 m-85 -54.67 -49.61 70.22 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.266 0.839 . . . . 75.15 113.266 176.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 40' ' ' TYR . 5.4 p-10 165.59 -30.36 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.417 0.627 . . . . 54.53 109.332 177.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -91.36 169.79 10.51 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.736 -0.665 . . . . 75.21 110.91 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.439 ' C ' ' H ' ' A' ' 45' ' ' MET . 5.5 m-90 -111.17 122.8 36.81 Favored Pre-proline 0 N--CA 1.423 -1.785 0 N-CA-C 109.312 -0.625 . . . . 74.33 109.312 174.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HG3' ' O ' ' A' ' 34' ' ' ASP . 19.7 Cg_endo -66.96 33.83 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 124.012 3.141 . . . . 75.43 113.841 177.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.439 ' H ' ' C ' ' A' ' 43' ' ' TRP . 54.7 ttm -127.5 75.34 1.59 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.998 -1.853 . . . . 65.1 105.998 173.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -147.41 -155.0 0.59 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 105.078 -2.193 . . . . 75.01 105.078 -173.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -101.03 -29.21 12.29 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 108.607 -0.886 . . . . 74.32 108.607 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.419 ' HG2' HD21 ' A' ' 94' ' ' LEU . 40.1 mt-10 54.76 82.63 0.09 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.036 0.934 . . . . 74.44 110.03 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 95' ' ' PRO . 40.6 tt0 -93.68 85.51 4.88 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 119.592 -0.843 . . . . 65.55 112.066 -174.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.526 ' HB2' ' HD3' ' A' ' 95' ' ' PRO . 8.6 tp10 -139.76 135.15 32.78 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.922 -1.036 . . . . 72.11 108.358 176.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -83.22 95.87 8.27 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.876 -1.157 . . . . 73.54 107.876 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.94 104.68 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.933 0 CA-C-O 122.249 1.023 . . . . 54.35 112.038 -174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.485 ' C ' ' HD3' ' A' ' 55' ' ' PRO . 33.7 t -97.43 3.42 50.9 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.01 -1.107 . . . . 72.44 108.01 177.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.553 ' O ' HG13 ' A' ' 57' ' ' ILE . 11.5 p -123.24 47.7 1.76 Allowed Pre-proline 0 CA--C 1.571 1.755 0 CA-C-N 114.193 -1.367 . . . . 72.15 111.579 -178.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.485 ' HD3' ' C ' ' A' ' 53' ' ' SER . 38.9 Cg_exo -60.18 -16.36 39.78 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 122.703 2.269 . . . . 70.23 113.487 -172.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -75.8 -1.07 23.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.953 -0.567 . . . . 71.11 111.842 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 54' ' ' SER . 2.2 pp -77.08 -18.82 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 120.9 0.381 . . . . 74.1 111.066 177.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 57' ' ' ILE . 96.9 mt -79.03 90.85 4.82 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 107.639 -1.245 . . . . 75.52 107.639 175.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.473 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 17.3 ptt180 -147.2 159.93 43.05 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.226 0.536 . . . . 72.13 112.262 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.723 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.4 pp -127.83 144.62 51.09 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.407 -0.815 . . . . 63.33 111.445 -172.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 85.6 mt -112.87 118.79 58.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.82 -0.807 . . . . 72.21 108.82 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -105.1 74.75 1.13 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.558 -0.534 . . . . 63.21 109.558 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 43.26 80.03 0.04 OUTLIER 'General case' 0 C--O 1.244 0.786 0 O-C-N 124.725 1.266 . . . . 63.51 113.367 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.74 -72.05 0.48 Allowed Glycine 0 N--CA 1.419 -2.439 0 CA-C-N 114.879 -1.055 . . . . 41.24 111.624 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -130.83 174.41 10.0 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.23 0.538 . . . . 70.22 112.375 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 71.0 m-85 -87.78 117.34 26.55 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 105.905 -1.887 . . . . 71.43 105.905 172.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.424 ' CD1' HD22 ' A' ' 76' ' ' LEU . 81.1 mt -79.81 -47.96 14.33 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.728 -0.789 . . . . 63.12 112.258 -176.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.514 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 10.4 t60 -172.67 158.04 3.97 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.736 -1.579 . . . . 72.43 106.736 -177.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 59' ' ' ARG . . . -69.45 -0.65 24.63 Favored Glycine 0 CA--C 1.542 1.736 0 N-CA-C 117.091 1.596 . . . . 51.32 117.091 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -175.71 31.65 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.239 1.52 . . . . 62.34 109.362 -171.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.577 HG12 HD21 ' A' ' 60' ' ' LEU . 10.6 p -78.85 138.77 19.5 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 119.527 -0.869 . . . . 75.54 109.171 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.413 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 47.3 p -79.56 157.48 27.36 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.015 0.436 . . . . 62.3 112.032 -175.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.448 ' HG ' ' CD1' ' A' ' 10' ' ' ILE . 3.1 mm? -61.36 -34.22 74.93 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.612 -0.722 . . . . 72.13 111.487 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.32 -30.03 76.7 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.0 -0.619 . . . . 63.32 111.907 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.68 -15.74 58.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.397 0.617 . . . . 61.1 110.276 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.511 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 53.3 mt -83.19 12.89 4.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.825 -0.625 . . . . 74.14 111.158 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 10.0 mptt 69.46 12.56 8.27 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.209 1.004 . . . . 73.42 111.106 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.511 ' HG ' ' HB2' ' A' ' 76' ' ' LEU . 89.7 mt -76.03 121.81 85.72 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 112.374 0.509 . . . . 74.12 112.374 -175.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.443 ' HG2' ' HG3' ' A' ' 82' ' ' LYS . 45.8 Cg_endo -75.57 159.04 39.67 Favored 'Trans proline' 0 N--CA 1.442 -1.515 0 C-N-CA 122.091 1.861 . . . . 51.43 109.754 174.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.477 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 12.0 m-85 -80.67 151.51 28.92 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.059 -0.719 . . . . 63.54 109.059 -174.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.537 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 84.95 4.01 87.4 Favored Glycine 0 C--N 1.306 -1.112 0 C-N-CA 120.493 -0.861 . . . . 64.32 113.53 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.443 ' HG3' ' HG2' ' A' ' 79' ' ' PRO . 75.2 mmtt -110.35 149.27 30.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 117.013 0.406 . . . . 72.11 111.085 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.528 HG23 HD22 ' A' ' 11' ' ' ASN . 94.6 m -91.2 123.49 34.68 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.596 -0.729 . . . . 73.43 110.38 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.3 m -118.56 131.38 56.21 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.264 -0.88 . . . . 73.01 110.316 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.509 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 7.5 p -103.25 124.46 57.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.989 0.423 . . . . 75.34 110.281 177.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.484 ' O ' HG12 ' A' ' 15' ' ' ILE . 91.0 mtp -129.37 152.21 49.17 Favored 'General case' 0 CA--C 1.486 -1.5 0 CA-C-O 121.368 0.604 . . . . 75.32 110.603 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.489 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 38.5 m-70 -106.32 126.17 51.91 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.433 -0.803 . . . . 71.32 108.913 -178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.484 HD11 ' HB1' ' A' ' 32' ' ' ALA . 4.1 mm? -115.05 144.03 44.27 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-O 121.071 0.462 . . . . 62.43 111.992 -176.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.96 132.17 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 115.462 -0.79 . . . . 65.21 108.987 176.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.494 ' H ' HG21 ' A' ' 17' ' ' VAL . . . -136.83 145.47 44.48 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.59 -0.732 . . . . 65.42 109.686 177.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.528 ' H ' HD13 ' A' ' 57' ' ' ILE . 36.0 ttt-85 -135.0 151.68 51.05 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 105.544 -2.021 . . . . 61.22 105.544 178.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 70.26 -73.82 0.09 Allowed 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.516 0.51 . . . . 72.14 110.712 -175.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.573 HG22 ' H ' ' A' ' 94' ' ' LEU . 20.9 m 63.33 179.06 0.15 Allowed 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 124.687 1.195 . . . . 72.33 109.816 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.573 ' H ' HG22 ' A' ' 93' ' ' THR . 5.3 mp -68.33 127.02 93.3 Favored Pre-proline 0 C--N 1.293 -1.849 0 O-C-N 122.028 -0.42 . . . . 74.11 111.381 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 50' ' ' GLU . 33.1 Cg_exo -62.35 129.9 28.41 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 N-CA-C 106.348 -2.212 . . . . 61.04 106.348 168.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.413 ' HA ' ' HD2' ' A' ' 97' ' ' PRO . 35.2 mt-10 -73.37 131.23 83.11 Favored Pre-proline 0 C--N 1.292 -1.897 0 C-N-CA 120.382 -0.527 . . . . 73.23 111.35 -171.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 96' ' ' GLU . 6.3 Cg_exo -43.99 -48.31 9.42 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 124.227 3.285 . . . . 72.22 109.35 176.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -161.28 143.45 12.07 Favored 'General case' 0 N--CA 1.387 -3.608 1 N-CA-C 99.496 -4.261 . . . . 72.52 99.496 175.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.9 m -69.45 80.26 0.39 Allowed 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 119.176 0.898 . . . . 64.04 110.76 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -57.57 -50.08 74.28 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 115.629 -0.714 . . . . 72.33 110.865 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.32 -36.53 1.77 Allowed Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 121.235 -0.507 . . . . 71.51 112.706 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -110.17 111.45 22.79 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 122.182 0.991 . . . . 74.2 112.498 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 178.64 36.41 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 101.153 -3.647 . . . . 72.02 101.153 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -94.36 -33.07 13.32 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.438 -1.71 . . . . 64.21 111.366 -169.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.426 ' HA ' ' HB3' ' A' ' 111' ' ' SER . 0.0 OUTLIER -60.84 -51.81 67.71 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.198 0.814 . . . . 70.15 113.198 -178.623 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.264 12.4 tt0 60.3 -47.91 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.399 1.629 . . . . 74.41 115.399 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.63 157.04 17.19 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.89 -0.782 . . . . 51.24 108.89 177.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.1 t -82.97 147.4 28.23 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.151 -0.685 . . . . 62.12 109.151 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.65 30.18 22.0 Favored Glycine 0 N--CA 1.435 -1.376 0 N-CA-C 111.223 -0.751 . . . . 45.15 111.223 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 68.43 159.56 0.17 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.218 1.007 . . . . 73.1 111.856 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.426 ' HB3' ' HA ' ' A' ' 105' ' ' ARG . 11.4 p -89.32 88.38 7.48 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-O 121.596 0.712 . . . . 74.24 110.246 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -135.64 106.54 6.63 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.08 -0.964 . . . . 73.4 109.143 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 65.5 m -115.47 169.21 9.33 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.198 -0.668 . . . . 45.12 109.198 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 46.1 t -135.74 145.17 46.35 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 110.12 -0.326 . . . . 74.24 110.12 -176.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.4 m -69.81 117.02 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-O 121.498 0.666 . . . . 70.13 111.284 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.9 tp -103.81 4.83 10.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 122.541 1.162 . . . . 72.24 108.486 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 N--CA 1.432 -1.355 0 CA-C-N 114.833 -1.076 . . . . 70.55 108.78 179.511 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.435 -1.22 0 CA-C-O 121.299 0.571 . . . . 74.41 111.573 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.4 m -147.37 112.61 5.53 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.643 -0.502 . . . . 74.43 109.643 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.1 t30 71.84 113.23 0.06 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.245 1.418 . . . . 71.24 111.554 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.437 HG13 ' CD1' ' A' ' 25' ' ' LEU . 11.7 t -103.78 115.41 63.5 Favored Pre-proline 0 N--CA 1.431 -1.376 0 N-CA-C 109.445 -0.576 . . . . 71.04 109.445 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -71.9 149.01 52.75 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 122.11 1.873 . . . . 72.13 109.876 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.35 73.32 5.98 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.059 0.933 . . . . 52.12 110.137 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -169.51 -37.91 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 106.458 -1.682 . . . . 61.53 106.458 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.0 mmm -96.99 143.64 27.65 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.523 -1.671 . . . . 75.3 108.675 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -98.66 140.81 17.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-O 121.033 0.444 . . . . 53.42 111.273 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.57 ' OD1' HG23 ' A' ' 83' ' ' THR . 18.7 t-20 -87.64 125.85 34.61 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.282 -0.636 . . . . 51.02 109.282 177.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.573 ' HG ' HD22 ' A' ' 14' ' ' LEU . 30.6 tp -131.8 132.21 43.56 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-O 121.326 0.584 . . . . 75.2 111.468 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.534 ' HB3' ' HA ' ' A' ' 85' ' ' VAL . 23.1 ttt85 -106.93 120.99 43.53 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-N 114.917 -1.038 . . . . 75.23 109.115 175.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.573 HD22 ' HG ' ' A' ' 12' ' ' LEU . 1.8 mm? -103.74 126.49 50.91 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.04 -0.982 . . . . 74.44 108.823 -178.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.2 mt -99.47 119.36 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 107.944 -1.132 . . . . 73.0 107.944 175.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.9 mt -72.15 154.12 41.25 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.485 -0.779 . . . . 72.11 110.245 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.5 t -63.71 -15.99 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 122.086 0.946 . . . . 71.42 109.577 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.3 t -80.2 -10.19 59.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.187 -0.915 . . . . 50.14 110.447 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.51 70.4 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.574 -0.822 . . . . 63.4 112.392 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -87.32 135.53 33.29 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.666 -0.414 . . . . 63.03 110.901 176.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.6 p -100.95 129.88 46.86 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.721 -0.672 . . . . 64.22 110.316 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -140.6 138.68 34.61 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.2 -0.6 . . . . 72.04 111.183 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 28.7 tt0 -121.93 140.8 52.0 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 115.502 -0.772 . . . . 71.01 109.133 -173.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.707 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 72.1 m-85 -143.72 160.32 40.92 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 123.523 0.729 . . . . 75.21 109.985 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.437 ' CD1' HG13 ' A' ' 5' ' ' VAL . 32.9 tp -82.25 125.75 31.31 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 107.338 -1.356 . . . . 55.03 107.338 175.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.707 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 86.3 m-85 -132.07 172.77 11.96 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.862 -0.421 . . . . 61.41 109.862 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.1 p -100.02 148.93 35.51 Favored Pre-proline 0 C--N 1.286 -2.188 0 N-CA-C 107.589 -1.264 . . . . 60.34 107.589 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.69 -11.94 22.82 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 121.73 1.62 . . . . 72.13 112.079 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -80.05 -23.29 41.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.331 0.652 . . . . 63.12 111.156 177.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.403 ' O ' HD22 ' A' ' 73' ' ' LEU . 36.2 m-20 -66.89 154.38 41.12 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 120.769 0.319 . . . . 63.1 111.655 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.567 ' O ' HG13 ' A' ' 35' ' ' ILE . 44.2 m -98.52 124.03 43.02 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 122.295 -0.253 . . . . 62.23 110.579 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.651 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -46.63 -59.4 3.04 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 114.503 1.297 . . . . 61.15 114.503 -176.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 m -67.06 -27.83 67.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.223 0.535 . . . . 75.13 111.455 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.588 ' O ' ' HG3' ' A' ' 44' ' ' PRO . 23.8 t70 -68.49 -47.26 67.5 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.733 -1.21 . . . . 70.14 107.733 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 31' ' ' SER . 77.1 mt -56.16 -36.34 45.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.132 -0.94 . . . . 73.23 111.621 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.75 -36.85 38.74 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.098 0.559 . . . . 72.32 112.357 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.526 ' HB3' ' HB3' ' A' ' 44' ' ' PRO . 0.6 OUTLIER -72.6 -42.96 63.95 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 107.096 -1.446 . . . . 63.11 107.096 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 42' ' ' ASN . 43.2 t-80 -55.87 -54.05 49.37 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.016 -1.447 . . . . 72.41 111.124 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.562 HG21 ' CB ' ' A' ' 14' ' ' LEU . 28.9 m -70.68 -31.64 46.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.035 -0.984 . . . . 64.21 112.362 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -71.35 -48.58 49.35 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 112.447 0.536 . . . . 74.41 112.447 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -147.36 -56.08 0.24 Allowed 'General case' 0 C--O 1.241 0.653 0 N-CA-C 114.838 1.422 . . . . 64.41 114.838 -173.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.557 ' O ' ' HA ' ' A' ' 38' ' ' HIS . 66.6 t30 -151.5 -179.87 7.76 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.953 -1.128 . . . . 73.34 107.953 -171.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -71.29 130.12 88.2 Favored Pre-proline 0 C--N 1.309 -1.186 0 CA-C-N 118.294 0.497 . . . . 72.24 111.57 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.588 ' HG3' ' O ' ' A' ' 34' ' ' ASP . 35.2 Cg_endo -69.38 154.69 68.88 Favored 'Trans proline' 0 CA--C 1.506 -0.915 0 C-N-CA 123.136 2.558 . . . . 75.0 113.001 175.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 89.0 mmm -117.84 164.71 14.62 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.1 -1.444 . . . . 74.4 107.1 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -77.65 127.62 32.75 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.511 -0.922 . . . . 64.45 108.511 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 66.71 79.18 0.24 Allowed 'General case' 0 C--O 1.241 0.617 0 O-C-N 124.238 0.961 . . . . 73.04 109.449 -168.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.418 ' OE1' ' HG3' ' A' ' 37' ' ' LYS . 8.1 tp10 -75.23 -34.83 61.48 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.579 -1.191 . . . . 53.22 108.322 -176.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 69.31 122.4 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 116.106 1.891 . . . . 64.54 116.106 174.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.36 -58.79 2.26 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 105.411 -2.07 . . . . 61.14 105.411 173.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -167.55 105.78 0.54 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.559 -0.746 . . . . 73.44 110.566 175.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.5 t 53.4 87.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.713 1.205 . . . . 71.14 112.672 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.8 m 63.48 91.38 0.07 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.476 1.111 . . . . 74.41 111.042 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.1 m -127.27 80.19 72.04 Favored Pre-proline 0 C--N 1.297 -1.683 0 C-N-CA 120.16 -0.616 . . . . 25.11 111.398 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -94.5 -21.31 0.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.729 1.619 . . . . 73.41 112.132 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -83.67 -2.45 56.2 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.63 -0.714 . . . . 63.0 111.102 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.3 pp -83.7 -15.18 11.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.825 -0.625 . . . . 75.23 111.231 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.9 mt -86.26 112.84 21.76 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.076 -1.083 . . . . 70.21 108.076 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.451 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 97.4 mtt180 -143.53 142.82 31.28 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.366 -0.605 . . . . 75.43 109.366 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.6 pp -130.31 132.72 46.0 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 120.99 0.424 . . . . 64.0 110.758 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' A' ' 87' ' ' HIS . 86.8 mt -108.32 120.6 59.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 121.47 0.652 . . . . 63.14 109.545 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -101.83 85.39 2.7 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 108.683 -0.858 . . . . 64.15 108.683 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 59.86 18.42 7.4 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.141 -1.391 . . . . 73.44 114.19 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.58 -52.85 0.37 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.367 -0.92 . . . . 73.44 112.985 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.467 ' HD3' ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -113.4 156.32 23.67 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.065 -0.654 . . . . 63.31 111.361 -177.298 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 85.8 m-85 -78.6 122.53 26.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.617 -1.253 . . . . 73.24 107.617 176.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.573 HD12 HD22 ' A' ' 76' ' ' LEU . 45.9 mt -79.71 -46.54 16.91 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 118.978 -1.089 . . . . 61.14 112.711 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.525 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.3 t-80 -165.48 172.6 11.93 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.005 -1.85 . . . . 73.32 106.005 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.56 -25.58 75.47 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.289 -0.958 . . . . 74.53 114.064 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -175.25 72.21 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.998 0.904 . . . . 74.23 109.054 -175.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.575 HG12 HD21 ' A' ' 60' ' ' LEU . 7.2 p -102.88 151.25 6.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 114.194 -1.366 . . . . 70.31 108.821 178.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.534 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 40.4 p -78.46 157.35 28.97 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 120.718 0.294 . . . . 54.11 111.212 -175.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.596 ' HA ' HD12 ' A' ' 76' ' ' LEU . 1.2 mm? -63.85 -27.5 69.21 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.765 0.426 . . . . 74.31 111.478 -177.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.66 -37.69 93.79 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.513 -1.035 . . . . 63.04 110.513 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB3' HG22 ' A' ' 71' ' ' VAL . . . -79.56 -16.87 55.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.341 0.591 . . . . 54.41 109.91 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' ' 73' ' ' LEU . 92.7 mt -86.51 2.96 46.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.693 -0.685 . . . . 64.5 110.716 176.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 11.1 mptt 69.56 21.2 6.81 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.9 0.88 . . . . 71.03 112.911 178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.428 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.4 mp -67.54 126.26 92.33 Favored Pre-proline 0 CA--C 1.511 -0.543 0 C-N-CA 119.726 -0.789 . . . . 65.21 111.426 176.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -86.6 137.22 4.8 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 122.427 2.085 . . . . 71.11 112.029 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -73.92 128.15 34.74 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.643 -0.708 . . . . 74.12 111.12 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.82 -6.01 76.67 Favored Glycine 0 C--N 1.3 -1.435 0 CA-C-N 115.096 -0.957 . . . . 51.11 111.925 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 11' ' ' ASN . 92.6 mttt -116.67 149.29 40.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 117.389 0.594 . . . . 74.32 111.655 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.57 HG23 ' OD1' ' A' ' 11' ' ' ASN . 30.7 m -84.81 136.35 33.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.12 -0.491 . . . . 74.3 110.86 -177.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.9 m -139.55 132.11 28.76 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.886 -0.412 . . . . 71.13 109.886 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.534 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 10.8 p -99.79 138.87 22.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.21 0.528 . . . . 65.31 111.441 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.469 ' SD ' HD13 ' A' ' 76' ' ' LEU . 81.4 mtp -137.97 152.38 48.86 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 116.074 -0.512 . . . . 73.53 110.315 177.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.527 ' HB2' ' HB ' ' A' ' 61' ' ' ILE . 25.2 m-70 -111.14 128.25 55.83 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.844 -1.539 . . . . 73.42 106.844 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.36 140.15 49.38 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.178 -0.609 . . . . 70.13 110.383 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 59' ' ' ARG . 6.1 m -129.99 142.12 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 109.291 -0.633 . . . . 73.31 109.291 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.595 ' HB1' ' HB ' ' A' ' 93' ' ' THR . . . -129.31 146.01 51.27 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 105.854 -1.906 . . . . 40.42 105.854 176.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.27 108.58 20.05 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 106.879 -1.526 . . . . 72.54 106.879 -171.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 52.08 23.27 2.18 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.131 0.972 . . . . 63.44 111.188 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.595 ' HB ' ' HB1' ' A' ' 90' ' ' ALA . 21.2 m -92.59 115.4 28.07 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 115.911 -0.586 . . . . 73.24 111.467 -172.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mp -84.51 152.38 60.45 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.627 -1.249 . . . . 70.44 107.627 174.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.402 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 37.0 Cg_endo -67.9 83.97 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.188 1.925 . . . . 52.33 109.413 174.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.418 ' HB2' HE21 ' A' ' 100' ' ' GLN . 8.7 pt-20 66.75 144.17 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 128.418 2.687 . . . . 74.14 109.785 -169.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -69.63 -4.29 13.64 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.026 1.817 . . . . 71.03 111.108 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 76.04 4.16 3.76 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 125.802 1.641 . . . . 74.43 110.96 -176.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.3 m -87.48 -9.31 54.91 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 114.944 -1.026 . . . . 65.22 109.539 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.461 ' HB3' ' HG3' ' A' ' 102' ' ' GLN . 46.0 mt-30 -87.75 -52.37 5.35 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 108.685 -0.857 . . . . 74.32 108.685 176.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.22 21.32 66.05 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.869 -1.059 . . . . 52.42 110.803 -178.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.461 ' HG3' ' HB3' ' A' ' 100' ' ' GLN . 78.1 mt-30 -78.25 110.67 13.46 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 122.058 0.932 . . . . 54.4 111.565 -175.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -108.82 4.68 23.84 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.035 -1.438 . . . . 65.24 108.93 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -91.97 129.77 37.86 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.168 -1.378 . . . . 51.31 107.855 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.426 ' C ' ' H ' ' A' ' 107' ' ' LYS . 18.3 mmt180 -62.72 -32.5 73.62 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.369 0.418 . . . . 61.11 110.977 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 72.54 -39.7 0.45 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.801 1.241 . . . . 72.44 110.638 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.443 ' HE2' ' O ' ' A' ' 109' ' ' GLY . 86.8 tttt -66.47 125.9 27.15 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 125.124 1.37 . . . . 74.11 107.302 173.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.9 t -71.83 -29.24 64.21 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.194 0.521 . . . . 65.33 110.632 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.443 ' O ' ' HE2' ' A' ' 107' ' ' LYS . . . -89.53 74.03 1.98 Allowed Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 109.665 -1.374 . . . . 45.12 109.665 176.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -55.1 128.74 35.16 Favored 'General case' 0 C--O 1.248 0.991 0 C-N-CA 123.066 0.546 . . . . 64.22 111.193 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.7 m -80.96 71.72 7.94 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.757 0.789 . . . . 60.12 112.313 -176.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -164.98 19.11 0.05 OUTLIER 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.726 -1.124 . . . . 52.2 108.328 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 23.6 p -147.37 96.45 2.7 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.313 -0.858 . . . . 63.35 109.993 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 66.8 m -77.34 119.31 20.79 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.787 -0.82 . . . . 64.22 108.787 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.73 102.2 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 122.134 0.968 . . . . 74.01 111.668 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.5 tp -139.74 128.06 26.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 114.595 -1.184 . . . . 73.24 108.358 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 tm? . . . . . 0 C--N 1.293 -1.877 0 N-CA-C 106.788 -1.56 . . . . 71.23 106.788 -178.5 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.2 p . . . . . 0 N--CA 1.427 -1.612 0 CA-C-O 121.174 0.512 . . . . 74.53 110.42 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.6 p -151.59 179.57 8.26 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 116.005 -0.543 . . . . 71.22 110.486 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -90.06 -179.63 5.73 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.941 -1.503 . . . . 54.33 106.941 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.46 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 3.6 t -83.48 118.27 71.03 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 118.609 0.64 . . . . 73.5 110.036 -174.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.44 ' C ' ' H ' ' A' ' 8' ' ' ASP . 88.2 Cg_endo -84.95 166.99 11.22 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.957 1.771 . . . . 60.03 111.077 177.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.39 30.63 0.41 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.828 0.823 . . . . 62.02 109.837 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 6' ' ' PRO . 19.6 t70 -120.43 -28.75 4.93 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.842 -1.072 . . . . 72.15 109.369 175.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.8 mtp -121.83 155.51 35.2 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 115.955 -0.566 . . . . 62.11 110.44 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.24 137.5 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 CA-C-N 115.591 -0.731 . . . . 71.12 109.507 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.449 ' HB3' ' HA ' ' A' ' 83' ' ' THR . 2.4 t-20 -91.05 107.59 19.3 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 108.134 -1.062 . . . . 62.23 108.134 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.529 ' HG ' HD22 ' A' ' 14' ' ' LEU . 39.8 tp -112.56 132.97 54.85 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 115.283 -0.871 . . . . 71.04 111.545 -174.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 74.6 ttt180 -107.6 120.87 43.4 Favored 'General case' 0 N--CA 1.402 -2.863 0 N-CA-C 108.069 -1.085 . . . . 71.54 108.069 173.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.546 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.0 mm? -98.32 120.3 38.5 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.757 -1.11 . . . . 72.45 109.075 -178.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.523 HG12 HG22 ' A' ' 21' ' ' THR . 30.7 mt -103.64 118.4 50.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.565 -0.902 . . . . 71.52 108.565 177.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.87 163.51 26.68 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 123.691 0.619 . . . . 60.11 110.835 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.6 m -57.7 -27.11 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.09 0.774 . . . . 73.45 113.09 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.5 t -77.39 -16.08 59.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.653 0.263 . . . . 75.43 111.165 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.428 ' C ' ' HE3' ' A' ' 20' ' ' LYS . . . 100.81 5.68 53.33 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.994 -1.098 . . . . 62.22 111.843 -176.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.611 ' HE3' ' N ' ' A' ' 20' ' ' LYS . 0.5 OUTLIER -86.5 131.44 34.18 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.126 -1.065 . . . . 72.42 108.126 177.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.523 HG22 HG12 ' A' ' 15' ' ' ILE . 72.5 p -107.2 133.05 52.36 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 120.457 -0.497 . . . . 71.32 111.6 -175.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -122.37 139.57 53.68 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.591 -0.892 . . . . 62.35 108.591 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 26.0 tt0 -131.42 129.55 41.4 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.649 -0.82 . . . . 71.21 109.087 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.638 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 98.0 m-85 -146.54 160.7 41.8 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.035 0.534 . . . . 65.41 110.581 -178.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.444 ' CD2' HG13 ' A' ' 5' ' ' VAL . 75.4 mt -79.64 126.54 31.05 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.441 -0.578 . . . . 60.43 109.441 172.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.638 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 94.5 m-85 -131.58 167.75 18.87 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.213 -1.032 . . . . 62.32 108.213 175.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.3 p -94.35 151.7 39.61 Favored Pre-proline 0 N--CA 1.411 -2.387 0 C-N-CA 119.129 -1.028 . . . . 53.13 108.246 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.505 ' O ' ' HB ' ' A' ' 72' ' ' THR . 31.3 Cg_endo -60.17 -11.73 16.96 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.628 2.219 . . . . 63.33 112.418 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -96.17 -4.86 41.84 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.055 0.391 . . . . 72.12 112.055 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -76.02 154.06 36.0 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 120.474 -0.49 . . . . 63.42 110.363 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.594 ' O ' HG13 ' A' ' 35' ' ' ILE . 47.9 t -89.93 118.96 29.89 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.167 -0.679 . . . . 74.11 109.167 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.739 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -50.94 -41.9 59.36 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.173 0.989 . . . . 75.01 113.157 -176.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.2 t -77.34 -32.34 55.11 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.221 0.534 . . . . 55.02 110.24 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.0 -37.53 84.35 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.825 -1.176 . . . . 75.32 107.825 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.594 HG13 ' O ' ' A' ' 31' ' ' SER . 71.7 mt -64.45 -39.77 86.74 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 CA-C-N 114.587 -1.188 . . . . 64.31 110.611 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.88 -38.9 62.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.982 0.42 . . . . 54.24 111.463 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.412 ' HD2' ' HB3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -72.46 -40.81 66.7 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 107.262 -1.384 . . . . 73.33 107.262 178.612 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.424 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 49.6 t-80 -57.96 -54.09 50.87 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.16 0.984 . . . . 71.54 110.916 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.546 HG21 ' CB ' ' A' ' 14' ' ' LEU . 29.6 m -66.38 -30.92 51.37 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 N-CA-C 113.255 0.835 . . . . 75.21 113.255 -178.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -49.55 -44.06 46.36 Favored 'General case' 0 C--O 1.243 0.745 0 O-C-N 123.609 0.568 . . . . 63.14 110.708 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.0 t70 177.65 -78.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.703 0.801 . . . . 63.55 110.647 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -101.52 143.64 31.27 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.269 -0.641 . . . . 63.51 109.269 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 35.4 p90 -77.63 142.29 66.0 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.121 -0.49 . . . . 75.43 112.022 -174.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.11 -48.56 6.18 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.879 3.053 . . . . 71.52 115.507 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 94.1 mmm 69.26 -71.42 0.12 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.857 0.863 . . . . 72.33 111.872 -173.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -157.38 -164.11 1.51 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 105.579 -2.008 . . . . 70.33 105.579 -175.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 28.6 p-90 -82.14 83.16 7.43 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 119.971 1.26 . . . . 73.22 110.313 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.02 -54.59 0.16 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.334 -1.303 . . . . 54.42 108.75 -175.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.06 -72.58 0.27 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 108.876 -0.787 . . . . 63.54 108.876 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HB3' ' HD2' ' A' ' 37' ' ' LYS . 10.6 tp10 -140.65 89.75 2.29 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.965 -0.383 . . . . 55.33 109.965 179.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 165.85 142.06 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 126.203 1.801 . . . . 74.43 107.266 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 95' ' ' PRO . 5.7 p -148.35 -59.1 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 111.696 0.258 . . . . 73.12 111.696 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.2 t -154.87 78.28 1.05 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 119.828 -0.749 . . . . 74.32 111.95 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.492 ' HB2' ' HB3' ' A' ' 94' ' ' LEU . 34.2 t -178.53 104.31 0.2 Allowed Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 115.855 -0.612 . . . . 62.31 110.532 174.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -81.62 -15.97 9.43 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.024 1.816 . . . . 75.32 110.803 175.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -65.49 -17.31 64.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.287 -0.87 . . . . 70.4 111.703 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.2 pp -80.46 -13.31 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 116.379 -0.373 . . . . 71.04 111.972 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.6 mp -87.44 100.65 12.91 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 110.015 -0.365 . . . . 64.54 110.015 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 39.2 mmt180 -137.14 148.43 46.63 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.641 -0.503 . . . . 73.15 109.641 177.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.739 HD22 ' HB3' ' A' ' 32' ' ' ALA . 4.4 pp -130.92 139.71 50.11 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 110.115 -0.328 . . . . 74.05 110.115 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 87' ' ' HIS . 79.0 mt -112.75 119.65 60.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.288 0.566 . . . . 54.51 109.535 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -102.0 73.88 1.42 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.662 -1.236 . . . . 61.05 107.662 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 58.61 86.05 0.09 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 113.344 -1.753 . . . . 75.13 112.085 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.11 -56.59 0.6 Allowed Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.677 -0.692 . . . . 23.11 114.02 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -117.52 153.98 32.25 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.667 0.988 . . . . 75.23 113.667 -172.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 93.3 m-85 -82.91 117.15 22.55 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 108.443 -0.947 . . . . 74.41 108.443 176.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.663 HD12 HD22 ' A' ' 76' ' ' LEU . 81.8 mt -80.73 -47.98 13.2 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.288 -0.965 . . . . 71.11 112.749 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.73 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.5 t-80 -170.01 167.33 9.0 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 105.909 -1.885 . . . . 65.03 105.909 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.52 -1.28 87.83 Favored Glycine 0 C--N 1.3 -1.425 0 N-CA-C 115.785 1.074 . . . . 74.33 115.785 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -164.9 22.75 0.06 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.255 1.026 . . . . 72.24 110.442 -170.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.561 HG13 HD21 ' A' ' 76' ' ' LEU . 9.0 p -79.53 136.88 22.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 119.419 -0.912 . . . . 74.43 109.031 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.63 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 42.7 p -78.7 158.49 28.31 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.424 -0.353 . . . . 41.44 111.658 -173.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.616 HD13 HD12 ' A' ' 76' ' ' LEU . 1.9 mm? -64.07 -27.08 68.86 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.106 -0.497 . . . . 64.4 110.897 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.26 -38.43 95.1 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.352 -1.099 . . . . 71.33 110.352 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.29 -16.81 57.39 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.194 0.521 . . . . 53.03 110.096 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.663 HD22 HD12 ' A' ' 67' ' ' LEU . 86.9 mt -86.24 4.41 38.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.918 -0.583 . . . . 72.41 111.33 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER 68.88 25.3 6.17 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.947 0.899 . . . . 75.32 113.254 177.641 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.446 HD13 ' HB2' ' A' ' 76' ' ' LEU . 10.2 mp -72.76 123.53 89.66 Favored Pre-proline 0 C--O 1.236 0.384 0 C-N-CA 120.083 -0.647 . . . . 64.04 111.322 175.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 78' ' ' LEU . 1.3 Cg_endo -80.2 146.96 18.15 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.444 2.096 . . . . 65.33 111.088 176.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -73.73 141.94 46.34 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.191 -1.04 . . . . 70.25 108.191 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.46 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 82.01 -3.92 78.07 Favored Glycine 0 C--N 1.3 -1.435 0 C-N-CA 120.735 -0.745 . . . . 53.12 113.521 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -116.13 145.64 42.9 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 117.163 0.481 . . . . 73.15 111.463 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.449 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 23.5 m -85.19 125.1 32.57 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.967 -0.56 . . . . 73.42 110.99 -177.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.1 m -125.09 135.9 53.13 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.977 -0.556 . . . . 73.42 109.508 176.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.43 137.8 31.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.352 -0.385 . . . . 73.13 110.889 -178.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 82.8 mtp -138.69 153.45 48.54 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 120.902 0.382 . . . . 52.23 111.325 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.441 ' C ' HD22 ' A' ' 88' ' ' LEU . 25.6 m-70 -103.93 129.27 51.46 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 107.229 -1.397 . . . . 71.32 107.229 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.441 HD22 ' C ' ' A' ' 87' ' ' HIS . 2.8 mm? -123.9 140.19 53.23 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 119.66 -0.816 . . . . 75.14 110.681 -176.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.43 ' CG2' ' HB2' ' A' ' 59' ' ' ARG . 25.2 m -118.7 133.68 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.829 0 CA-C-O 121.711 0.767 . . . . 74.44 109.445 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.5 135.2 44.31 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 105.108 -2.182 . . . . 65.44 105.108 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.474 ' C ' ' H ' ' A' ' 93' ' ' THR . 82.0 mtt180 -106.22 151.67 24.49 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 106.635 -1.617 . . . . 64.44 106.635 -176.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.412 ' H ' ' HG2' ' A' ' 92' ' ' GLU . 8.0 pt-20 -63.26 17.37 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 115.032 1.493 . . . . 55.24 115.032 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.474 ' H ' ' C ' ' A' ' 91' ' ' ARG . 27.1 m 69.44 153.37 0.11 Allowed 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.181 1.792 . . . . 53.02 112.612 175.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 54' ' ' SER . 25.4 tp -108.04 132.66 20.9 Favored Pre-proline 0 N--CA 1.424 -1.752 0 N-CA-C 105.137 -2.172 . . . . 62.14 105.137 174.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.461 ' HA ' ' CG1' ' A' ' 52' ' ' VAL . 51.6 Cg_endo -74.4 -15.28 22.42 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.279 1.986 . . . . 70.34 114.145 -174.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -163.41 152.8 12.56 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 108.649 -0.871 . . . . 73.13 108.649 -175.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.07 -59.09 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.082 1.855 . . . . 72.21 110.781 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.4 t30 179.48 76.04 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.066 0.546 . . . . 75.31 110.825 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.9 m 42.9 35.92 0.8 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.139 1.376 . . . . 50.22 114.034 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -85.1 -16.78 39.42 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.561 0.696 . . . . 72.1 109.205 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.44 12.04 76.54 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 109.905 -1.278 . . . . 74.45 109.905 -177.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -114.57 144.25 43.69 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.013 -0.594 . . . . 70.21 109.737 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.561 ' HG3' ' O ' ' A' ' 104' ' ' ASN . 15.3 ptt-85 -147.17 -172.25 3.96 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.984 -1.487 . . . . 75.54 106.984 -177.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.561 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 79.5 m-20 -66.03 136.52 56.14 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.077 -1.453 . . . . 74.41 107.077 172.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.459 ' HD2' ' HB2' ' A' ' 110' ' ' GLU . 25.0 mmt180 -59.98 -36.15 76.53 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 122.017 0.913 . . . . 71.55 109.022 -176.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 173.89 -57.92 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 102.514 -3.143 . . . . 73.41 102.514 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -156.62 -46.47 0.07 Allowed 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 102.996 -2.964 . . . . 73.54 102.996 170.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.6 p -143.03 -168.43 2.79 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 112.949 -1.932 . . . . 72.32 106.613 172.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 131.99 -76.39 0.41 Allowed Glycine 0 CA--C 1.494 -1.281 0 C-N-CA 120.024 -1.084 . . . . 75.24 111.698 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.459 ' HB2' ' HD2' ' A' ' 105' ' ' ARG . 1.8 mp0 -84.47 -18.01 37.26 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 121.739 0.78 . . . . 74.32 109.521 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.4 t -161.51 155.26 21.84 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 106.496 -1.668 . . . . 71.03 106.496 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -143.17 125.0 15.07 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.725 -1.213 . . . . 71.23 107.725 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 t -82.14 101.85 10.69 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.517 0.675 . . . . 72.42 111.914 -175.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 12.5 p -72.89 124.57 25.68 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 108.106 -1.072 . . . . 64.51 108.106 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.6 m -64.9 121.79 14.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.269 0.556 . . . . 63.43 111.736 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 30.8 pt -80.82 156.02 4.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.714 -0.676 . . . . 71.24 110.727 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.9 tp . . . . . 0 C--N 1.292 -1.915 0 N-CA-C 108.546 -0.909 . . . . 64.5 108.546 -179.324 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.2 p . . . . . 0 C--O 1.251 1.14 0 N-CA-C 110.355 -0.239 . . . . 63.3 110.355 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.5 m 65.69 16.87 10.69 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.361 0.874 . . . . 54.31 113.361 173.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -147.09 107.65 4.11 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.151 -0.685 . . . . 74.23 109.151 176.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.489 ' CG1' ' HA2' ' A' ' 81' ' ' GLY . 17.7 t -107.74 123.03 39.11 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 110.087 -0.338 . . . . 72.41 110.087 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.07 162.69 36.54 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.204 1.936 . . . . 74.23 111.05 175.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.88 36.85 0.63 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.864 0.84 . . . . 53.22 109.597 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.72 -19.13 2.1 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.632 -1.167 . . . . 70.22 109.446 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.2 mmm -124.29 150.68 45.12 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.641 -0.708 . . . . 71.41 110.07 -174.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 pp -101.61 139.09 23.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.998 -0.742 . . . . 52.4 108.998 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.432 HD22 HG23 ' A' ' 83' ' ' THR . 6.0 t30 -96.69 114.39 26.03 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.234 -1.024 . . . . 74.54 108.234 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.546 ' HG ' HD22 ' A' ' 14' ' ' LEU . 44.4 tp -120.16 133.46 55.49 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 112.586 0.587 . . . . 74.35 112.586 -172.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 49.1 ttt180 -108.47 120.71 43.21 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 108.443 -0.947 . . . . 75.31 108.443 174.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.573 ' CB ' HG21 ' A' ' 39' ' ' VAL . 2.3 mm? -98.53 122.29 41.54 Favored 'General case' 0 C--N 1.272 -2.763 0 CA-C-N 114.531 -1.213 . . . . 55.32 109.605 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.642 HG23 HG22 ' A' ' 21' ' ' THR . 22.1 mt -112.22 125.46 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.635 -0.876 . . . . 74.31 108.635 177.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -94.47 161.57 14.17 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 116.323 -0.399 . . . . 64.35 110.884 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.417 ' CG1' HG12 ' A' ' 89' ' ' VAL . 28.6 m -60.5 -14.67 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.4 0.68 . . . . 60.55 112.757 179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.1 m -79.79 -7.16 58.5 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 116.199 -0.455 . . . . 54.24 110.351 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.55 0.54 81.92 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 116.265 -0.425 . . . . 60.3 112.598 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -87.67 133.93 33.74 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.237 -0.653 . . . . 75.44 109.237 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.642 HG22 HG23 ' A' ' 15' ' ' ILE . 40.2 p -116.73 131.87 56.84 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 109.585 -0.524 . . . . 75.44 109.585 -177.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HD2' ' O ' ' A' ' 39' ' ' VAL . 63.8 mttp -129.32 139.97 51.56 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 110.022 -0.362 . . . . 64.41 110.022 174.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 27.2 tt0 -125.09 130.0 51.37 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.257 -0.646 . . . . 72.41 109.257 -177.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.608 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . 95.8 m-85 -146.14 160.52 41.82 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 122.946 0.498 . . . . 74.42 111.081 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.2 mt -82.57 126.28 32.11 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.503 -0.555 . . . . 71.13 109.503 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.608 ' CE2' ' HB2' ' A' ' 24' ' ' PHE . 95.5 m-85 -132.58 166.1 22.89 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.115 -1.068 . . . . 62.23 108.115 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.4 p -89.71 150.46 44.11 Favored Pre-proline 0 N--CA 1.418 -2.054 0 N-CA-C 108.194 -1.039 . . . . 65.13 108.194 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.451 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 34.2 Cg_endo -60.32 -11.68 17.26 Favored 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 122.59 2.194 . . . . 63.21 112.287 177.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -91.72 -9.81 42.41 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.582 0.753 . . . . 72.32 111.221 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -71.15 154.09 41.99 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.147 0.499 . . . . 72.24 111.409 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.519 ' O ' HG13 ' A' ' 35' ' ' ILE . 49.9 m -95.11 121.23 36.53 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.76 -0.655 . . . . 72.15 110.425 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.426 ' HB3' ' HG ' ' A' ' 60' ' ' LEU . . . -49.22 -42.66 41.15 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.207 1.003 . . . . 50.5 113.088 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 58' ' ' LEU . 5.8 p -73.06 -34.13 66.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.895 0.379 . . . . 63.13 112.008 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.4 -47.12 80.41 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.03 -1.1 . . . . 75.31 108.03 175.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.54 ' O ' HG22 ' A' ' 39' ' ' VAL . 68.6 mt -59.67 -46.24 93.52 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.379 0 CA-C-N 114.342 -1.299 . . . . 72.32 110.683 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.402 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -50.45 -46.6 56.72 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.438 0.695 . . . . 72.14 111.742 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.541 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 7.6 tmtt? -73.28 -33.63 65.32 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.736 -0.839 . . . . 54.44 108.736 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -66.2 -51.97 52.56 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.196 0.998 . . . . 51.12 110.734 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.573 HG21 ' CB ' ' A' ' 14' ' ' LEU . 27.7 m -65.29 -30.22 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.744 0.817 . . . . 74.14 111.509 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.541 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 64.9 t80 -47.61 -48.18 28.48 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.303 -0.862 . . . . 65.23 111.861 175.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.442 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 18.5 t70 -173.36 -49.16 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.71 0.767 . . . . 74.13 111.013 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -142.84 152.68 42.42 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.884 -1.053 . . . . 75.14 109.918 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -65.52 136.9 96.31 Favored Pre-proline 0 C--N 1.317 -0.835 0 O-C-N 123.42 0.45 . . . . 60.32 110.596 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.47 ' HA ' ' OD1' ' A' ' 46' ' ' ASP . 9.4 Cg_endo -56.08 101.87 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.646 2.231 . . . . 64.34 113.529 178.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 23.4 ptp -112.67 7.04 18.55 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 105.823 -1.918 . . . . 74.45 105.823 176.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.47 ' OD1' ' HA ' ' A' ' 44' ' ' PRO . 3.1 m-20 -74.87 168.76 19.27 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 112.159 -2.291 . . . . 61.21 110.567 -174.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -99.18 4.76 46.87 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.837 -0.62 . . . . 74.42 111.016 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 62.88 20.9 12.51 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 123.046 1.403 . . . . 74.31 108.751 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -124.45 126.35 45.78 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.064 -1.426 . . . . 75.53 109.776 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.404 ' HG2' ' HB3' ' A' ' 92' ' ' GLU . 10.8 tp10 -144.88 112.76 6.34 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 105.865 -1.902 . . . . 73.13 105.865 174.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 76.25 -50.98 0.6 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.159 1.383 . . . . 73.42 108.754 -172.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.9 p -155.11 158.91 3.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 106.936 -1.505 . . . . 74.35 106.936 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.2 m -54.93 106.96 0.25 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.971 0.508 . . . . 73.54 109.897 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 m -136.6 98.08 11.16 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-O 120.871 0.367 . . . . 61.44 110.739 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.33 -16.46 10.81 Favored 'Trans proline' 0 C--N 1.331 -0.38 0 C-N-CA 122.334 2.023 . . . . 74.21 112.739 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -70.45 -5.69 30.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.576 0.584 . . . . 41.34 112.576 -175.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.554 HD12 ' HG ' ' A' ' 58' ' ' LEU . 2.4 pp -80.72 -14.14 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-O 120.681 0.277 . . . . 75.52 110.965 177.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.554 ' HG ' HD12 ' A' ' 57' ' ' ILE . 83.2 mt -111.2 103.08 11.47 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.693 -0.484 . . . . 74.34 109.693 176.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -137.28 144.67 42.81 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.024 -1.102 . . . . 71.35 108.024 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -109.38 147.0 33.5 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 113.959 1.096 . . . . 72.41 113.959 178.314 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -117.53 119.51 61.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.214 -1.032 . . . . 63.31 108.214 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.576 ' HB3' HD11 ' A' ' 67' ' ' LEU . 11.8 t80 -100.33 90.95 4.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.74 -1.207 . . . . 72.51 107.74 176.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 71.96 -70.3 0.16 Allowed 'General case' 0 N--CA 1.401 -2.913 0 C-N-CA 127.05 2.14 . . . . 73.02 112.392 -176.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.9 -47.75 1.07 Allowed Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 119.877 -1.154 . . . . 62.25 115.196 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -124.19 170.34 10.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 118.049 0.924 . . . . 72.41 112.991 -172.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.548 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 73.7 m-85 -83.7 118.33 23.81 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.742 -0.836 . . . . 73.21 108.742 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 62' ' ' TYR . 7.0 mp -80.77 -45.96 16.17 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 113.553 0.945 . . . . 64.41 113.553 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -168.84 172.27 7.89 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 106.774 -1.565 . . . . 51.42 106.774 -173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.44 -1.51 87.85 Favored Glycine 0 C--N 1.306 -1.126 0 N-CA-C 111.783 -0.527 . . . . 75.33 111.783 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -175.92 80.93 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.497 -1.297 . . . . 75.42 107.497 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 p -104.93 151.7 7.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.546 -1.279 . . . . 72.04 107.546 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.2 p -91.17 158.11 16.81 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 118.232 0.469 . . . . 73.04 110.203 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.528 ' H ' HD22 ' A' ' 73' ' ' LEU . 1.9 mm? -69.32 -30.63 68.73 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.04 0.447 . . . . 44.23 110.642 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.1 -35.02 91.51 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.187 -0.765 . . . . 72.41 111.187 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.03 -15.7 63.05 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.2 0.6 . . . . 34.21 111.282 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.426 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 65.2 mt -85.11 -1.6 57.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 73.42 110.158 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 8.8 mptt 63.41 72.34 0.48 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.359 1.064 . . . . 55.15 109.375 -177.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 73' ' ' LEU . 87.7 mt -125.17 117.74 25.43 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 115.479 -0.782 . . . . 71.33 111.423 -175.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.67 152.12 64.36 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.403 2.068 . . . . 74.23 110.147 172.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -75.92 148.39 38.26 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.734 -0.839 . . . . 64.34 108.734 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.489 ' HA2' ' CG1' ' A' ' 5' ' ' VAL . . . 91.99 -10.79 73.71 Favored Glycine 0 C--N 1.296 -1.671 0 C-N-CA 119.744 -1.217 . . . . 63.24 113.043 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -101.23 138.98 37.53 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.148 0.499 . . . . 62.33 111.884 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.432 HG23 HD22 ' A' ' 11' ' ' ASN . 35.1 m -79.88 118.46 21.66 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.201 -0.909 . . . . 73.24 109.94 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.7 m -116.78 129.42 56.09 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.921 -0.581 . . . . 64.02 109.55 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -104.89 140.36 23.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 109.905 -0.405 . . . . 70.3 109.905 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 92.4 mtp -138.23 153.58 49.11 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 120.869 0.366 . . . . 75.32 111.042 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -106.59 129.6 54.49 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.077 -1.083 . . . . 75.12 108.077 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.0 mm? -122.6 139.34 54.04 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 122.126 -0.359 . . . . 55.11 110.447 -175.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.417 HG12 ' CG1' ' A' ' 17' ' ' VAL . 29.1 m -116.87 132.48 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 C-N-CA 119.892 -0.723 . . . . 64.53 109.721 176.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 57' ' ' ILE . . . -134.58 142.52 46.97 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.789 -1.189 . . . . 70.11 107.789 176.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 49.3 mtm105 -136.56 151.35 49.29 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.969 -0.382 . . . . 64.41 109.969 -174.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 50' ' ' GLU . 0.5 OUTLIER 46.43 62.09 2.46 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 125.076 1.485 . . . . 64.24 110.835 177.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.8 m -73.8 136.16 43.54 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-N 113.807 -1.542 . . . . 52.44 110.204 -175.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.57 154.47 93.15 Favored Pre-proline 0 C--N 1.308 -1.22 0 CA-C-N 115.849 -0.614 . . . . 70.52 110.585 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -51.6 135.02 47.99 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 123.206 2.604 . . . . 74.13 112.548 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.39 156.35 68.71 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 114.866 -1.061 . . . . 73.25 109.268 -175.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.75 -56.27 1.83 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.273 1.982 . . . . 72.24 110.997 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -163.75 14.94 0.06 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.555 -1.276 . . . . 71.44 107.555 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 26.3 t 54.32 79.64 0.13 Allowed 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.202 -1.363 . . . . 64.2 110.709 -172.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -87.39 -48.08 8.26 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.652 -0.703 . . . . 63.43 110.273 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 41' ' ' ASP . . . 64.97 15.06 59.81 Favored Glycine 0 N--CA 1.465 0.623 0 CA-C-N 116.049 -0.523 . . . . 73.11 112.999 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -137.43 149.19 46.71 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.676 -1.231 . . . . 74.53 107.676 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -101.71 134.7 44.46 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.702 -1.592 . . . . 72.32 106.702 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -132.71 143.04 49.35 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.795 -0.762 . . . . 75.51 109.178 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -61.43 -50.98 70.62 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.166 -0.925 . . . . 75.45 110.075 -176.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 176.08 140.9 0.06 Allowed 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.435 0.694 . . . . 74.04 109.361 -174.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 60.3 pttt 54.31 8.41 0.19 Allowed 'General case' 0 N--CA 1.507 2.409 0 C-N-CA 126.979 2.112 . . . . 64.45 114.905 174.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.6 m 65.43 26.36 11.91 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-O 122.977 1.37 . . . . 62.33 109.519 -176.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.14 69.98 0.33 Allowed Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 108.324 -1.91 . . . . 71.32 108.324 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.69 -177.19 0.73 Allowed 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 115.461 1.652 . . . . 65.43 115.461 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.3 m -67.02 99.45 0.65 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.679 -1.146 . . . . 65.21 110.866 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.96 135.62 0.37 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.384 1.074 . . . . 65.14 108.656 177.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 53.7 t -139.92 -60.36 0.54 Allowed 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.626 -0.509 . . . . 50.14 109.626 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 52.6 t -153.1 120.83 6.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.756 -0.831 . . . . 74.15 108.756 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.8 p -70.99 96.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 122.013 0.911 . . . . 75.05 110.75 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.5 tt -103.95 112.31 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-N 115.409 -0.814 . . . . 54.24 109.769 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.279 0.9 OUTLIER . . . . . 0 C--N 1.3 -1.563 0 CA-C-O 118.075 -0.964 . . . . 65.42 113.287 -177.744 . . . . . . . . 2 2 . 1 stop_ save_